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ABSTRACTS
Abstracts of Papers to be Presented at the 33rd Annual
Scientific Session of the American College of Cardiology
Dallas, Texas, March 25·29, 1984
This year, 2,490 abstracts (original contributions) were
submitted for evaluation. Each was graded by seven
recognized authorities in a special area of interest. Ac-
ceptance for presentation was based on the relative grade
ranking in each of 25 categories.
Meeting space limited the total number of original
contributions that could be presented to approximately
25% of the number submitted, or 618 abstracts. This
represents one of the largest number of abstracts ac-
cepted for presentation at any Annual Scientific Session
of the American College of Cardiology. Many excellent
contributions were received for this year's competition,
and we appreciate your support and interest.
Melvin D. Cheitlin, MD, FACC
Julien I.E. Hoffman, MD, FACC
Co-Chairmen, /984 Scientific Session
Program Committee
* Not mutually exclusive categories
MULTIPLE LESION CORONARY ANGIOPLASTY IN "HIGH RISK"
PATIENT SUB-GROUPS.
Geoffrey O. Hartzler, M.D .• FACC; Barry D. Rutherford, M.D.
FACC; David R, McConahay, M.D., FACC. Mid-America Heart
Institute, St. Luke's Hospital, Kansas City, Missouri.
Of 1400 consecutive PTCAs, 507 procedures were multiple
vessel/lesion dilatation attempts (MV-PTCA). One-hundred
fifty-five/507 MV-PTCA pts (31%) were considered to be
at increased risk of complication because of associated
clinical circumstances. These included advanded age~ 70
yrs (68 pts), ejection fraction ~ 45% (71 pts), acute
myocardial infarction (18 pts) and prior CABG (70 pts).
In all sub-groups,~ 89% of all coronary lesions attemp-
ted were successfully dilated. Seventy-five % of elderly
pts, 83% of poor LV pts, 94% of acute MI pts and 83% of
prior CABG pts had successful MV-PTCA procedures.
Complications included:
Monday, March 26, 1984
10:30AM-12:00PM Grand Hall Meeting Room #2
Percutaneous Transluminal Coronary Angioplasty-
Patient Selection and Results
BALLOON ANGIOPLASTY IN MULTIVESSEL CORONARY DISEASE:
IMPORTANCE OF ANATOMIC SUBTYPING
Ronald E. Vlietstra, MB,ChB, FACC; David R. Holmes, Jr.,
MD, FACC; Guy S. Reeder, MD, FACC; Michael B. Mock, MD,
FACC; Alfred A. Bove, MD, FACC, Mayo Clinic, Rochester,
MN.
We tested the hypothesis that specific angiographic pat-
terns correlate with immediate outcome after percutaneous
trans luminal coronary angioplasty (PTCA) in patients with
multivessel disease (MVD). Four anatomic subtypes were
defined: >70% subtotal stenosis in 2 or all 3 major
coronary v;ssels (type A); >70% subtotal stenosis in 1
major vessel and 50-69% ste;osis in others (type B); com-
bination of total and subtotal occlusions with PTCA of
the totally occluded (type C) or of subtotally occluded
vessels (type D). Through July 1983, PTCA was performed
on 144 patients with MVD and was successful (>40% reduc-
tion in stenosis) in 109 (76%). Results by s;;btype were:
Anatomic subtype
ABC D
SUBGROUP* DEATH MI
Elderly 4 (5.8%) 2 (2.9%)
Poor LVF 1 (1.4%) 0
Acute Ml 0 0
Prior CABG 1 2 (2.9%)
URGENT CABG
(5.5%)
(4.2%)
Total cases, n 56 46 17 25
Successful, n-(%) 45(80) 35(76) 13(76) 16(64)
Occlusion/dissection, n (%) 3 (5) 5(11) 2(12) 3(12)
Transmural infarction,-n (%) 0 (0) 0 (0) 0 (0) 3(12)
Hospital death, n (%) - 0 (0) a (0) 0 (0) 1 (4)
Complete revascularization (no residual stenosis >70%)
was achieved in 60% of successf~l type A-C cases but was
not possible in type D. Thus, anatomic pattern
considerably influenced outcome: MVD patients with type
A-C anatomy had a higher rate of success, better
revascularization, and less morbidity than those with
type D. The increased morbidity specific to type D seems
to result from PTCA-related coronary occlusion impairing
blood supply to nearby and, by compromising collaterals.
to remote regions of myocardium.
Of 155 "high risk" pts, there were only 4 total deaths
(2.6%), 4 MIs (2.6%) and 2 urgent CABGs (1.3%).
In conclusion, multiple vessel/lesion PTCA can be per-
formed safely and effectively in common, "high risk" sub-
groups of pts with coronary artery disease. However, MV-
PTCA in the elderly may be performed with increased risk.
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Stenosis (%)
eXT time (min)
RNA Rest EF (%)
RNA Exer EF (%)
RNA Rest-Ex EF(%)
*p(0.05 (va.PRE);
CAN PATIENT SELECTION AND OPTIMIZATION OF TECHNIQUE RE-
DUCE THE RATE OF RESTENOSIS AFTER PERCUTANEOUS TRANSLU-
MINAL CORONARY ANGIOPLASTY?
Paul Robert Davidi lID. FACC; Jean Renkin, lID; AlainMoise, MD; fincen bansoine, lID; Pen Guiteras Val,
lID; Martial G. Bourassa, lID, FACC, Montreal Heart
Institute, Montreal, Canada
This Itudy was undertaken to investisate if restenos i s(RES) can be predicted before percutaneous transluminal
coronary ansioplasty (PTCA) and if frocedural factors
influence the rate of RES after PTC . Of 298 coronary
sepents (SEG) attempted in 265 consec utive pts, PTCA
was successful in 191 (69"). RES was observed in 53(29") of 180 SEG studied at repeat ansiosraphy 6 months
later. pts with RES and pts with continuous success
were compared in a univariate analysis of 65 clinical,
ansiosraphic and procedure-related variab18l. The only
baseline variables predictive of RES were the severity
of stenosis and the pr8lence of a calcified stenotic
artery. Amons the procedure-related factors, the desree
of residual stenosis, " change in diameter of the ste-
nosis, ratio of inflated balloon to coronary artery di-
ameter, mazimum inflation pressure and learning ezperi-
ence were predictive of RES. A stepwise loghtic re-
srenion including both borderline and s-ignifieant
variables in the univariate analysis selected variant
angina (present vs absent, p<.05), severity of stenosil
(?~ VI 7~, p<.OOl), length of stenosis (diffuse VI
dlBcrete, p<.Ol), and geometrJ of ltenosis (eccentric
VI concentric, pc .05) as the baseline characteristics
most predictive of RES. The only 2 procedure-related
factors selected were the degree of residual stenosis
(5~ vs 30", p<.OOOl) and absence of parietal dinec-
tion on the post-PTCA angiosram (absence vs fresence.
p<.OS). Thus pts with variant angina and pts w th a se-
vere diffuse and concentric coronary stenosis tend to
have a higher rate of RES after PTCA. A parietal dis-
section at the dilatation site without complication is
a good sign of continuous success . However, the degree
of relidual stenosis after PTCA appears to be the most
important predictor of RES. A high rate of continuous
sueCen requires a <5~ residual Itenosis after PTCA
and we believe that this can be achieved in ~st pts by
optimal selection of the balloon catheter and optimal
mazimum pressure application.
LONG-TEml FOLLOW-UP OF PATIENTS UNDER 40 YEARS AFTER
MYOCARDIAL INFARCTION WITH AND WITHOUT CORONARY ARTERY
DISEASE
George K. David, MD; Cees A, Visser, lID; K,I. Lie, MD;
Dirk Durrer, MD, FACC. Dept. of Cardiology & Clinical
Physiology, University of Amsterdam, The Netherlands
Myocardial infarction (tlI) in young adults can occur
with and without proven coronary artery disease (CAD).
In order to assess the incidence of CAD and the long-term
prognosis, 110 patients (pts) under 40 years, all survi-
vors of a first MI, were studied during a follow-up period
of 5.6±2.9 years (mean±SD), range 1-10 years. All pts
were catheterized within 6 weeks after MI: 22 pts (20%)
had normal coronary arteries (Group A), 88 pts (80%) had
CAD (Group B). LV ejection fraction (LVEF) in Group A was
normal (~5570) in 14 pts (64%), abnormal (>35-<55%) in 6
pts (27%) and severely impaired «35%) in 2 pts (9%). In
Group B LVEF was normal in 14 pts (16%), abnormal in 62
pts (70%) and severely impaired in 12 pts (14%).
During the follow-up period there was in Group A neither
cardiac mortality nor any new cardiac event. In Group B
10 pts (11%) died. Mortality was independant of the
number of coronary arteries involved, whereas a severely
impaired LVEF was of prognostic significance (p<0.005).
In 78 survivors of Group B re-infarction occurred in II
(14%), and 28 pts (36%) had CABG-operation. At the end
of the study period the large majority of pts in both
Group A and B (100% and 96% respectively) were in
functional class I or II.
It is concluded that in pts with MI at a young age a
rather large group (20%) has normal coronary arteries
and an excellent long-term prognosis, whereas in the
group of pts with CAD prognosis is less favourable and
mainly determined by LVEF and not by the extent of CAD.
THREE-YEAR ANATOMIC AND FUNCTIONAL FOLLOW-UP AFTER SUC-
CESSFUL PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY
Douglas R.Rosing, MO, FACC, Kenneth M.Kent, MD, FACC,
Robert O.Bonow, MD, FACC, Carolyn Ewels, BS, Rita Mince-
moyer, RN, Richard O.Cannon, III, MD, Rita M.Wstson, tID,
Martin B.Leon, MD, Stephen E.Epstein, MD, FACC, NHLBI,
Bethesda, Maryland
Although pts report continued marked symptomatic benefit
2-3 yrs after PTCA, few data are available documenting an-
atomic and functional results during long-term follow-up.
Thus 14 sequentially treated patients underwent repeat
catheterization, treadmill ECG (GXT), and bicycle radio-
nuclide (RNA) testing 37~4 mo after successful single le-
sion PTCA. Twelve pts had single vessel disease and 2 had
multiple vessel disease. Test results in these pts were:
Pre Immed 6 mo 3 year
PTCA Post PTCA Post PTCA Post PTCA
76+12 30+13* 32+11* 25+13**
6.S+7.l 17.9+7.4* 20.5+5.6* 17.6+8.2*
57+9 55+6 57+9 54+9
54+12 62+12* 60+12 59+9*
-3+9 7+8* 3+7* 5+5*
**p(O.Ol (vs~6 mo).
Before PTCA 1 pt was FC II, 12-FC III and l-FC IV. Three
yrs post PTCA 11 pts were asyptomatic, l-FCII and 2 still
FCIII. No pt with a succesaful result st 6 mo had a >10%
increase in stenosis at the dilated site at 3 yr but 7
pts had a ~10% decrease in stenosis over this time period.
Two pts developed new significant stenoses at nondilated
sitea during follow-up. These were the 2 pts with
multiple vessel disease and are the 2 FCIII pts 3 yrs post
PTCA. These results indicate that the short-term anatomic
and functional success of PTCA is maintained for at least
3 yrs.
CORONARY ANGIOPLASTY FOR UNSTABLE ANGINA: A COMPARISON
WITH CORONARY ARTERY BYPASS SURGERY
Ben D. McCallister, MD, FACC; Geoffrey O. Hartzler, MD,
FACC; Ililliam A. Reed, ~1D. FACC; Thomas ~!. Johnson, MD,
Mid America Heart Institute, St. Luke's Hospital, Kansas
City, Missouri.
Immediate and late follow-up results were analyzed in 374
patients with unstable angina: 123 patients had PTCA
(1980-83) (success rate = 75%); 251 patients had CA8P
(1971-76). Comparative data in PTCA and CABP patients:
average ag&--60 vs 54 years; all Functaional Class IV;
average hospital stay--3.1 vs 12.9 days; number of vessels
diseased--l vessel: 52 vs 18%; 2 vessels: 33 vs 22%; 3
vessels: 15 vs 60%; number of lesions dilated or bypassed
--1 vessel: 86 vs 36%; 2 vessels: 11 vs 41%; 3 vessels:
3 vs 21%; 4 vessels: 0 vs 2%; immediate complications--
total: 8.9 vs 12.4% (p(O.l); mortality: 0.8 vs 0.4%
(p~a.l); myocardial infarction: 4.1 vs 7.6% (p<o.l); CVA:
a vs 2%, respectively. In PTCA patients: 5.7% of patients
had acute occlusion; 2 patients (1.6%) had acute dissec-
tion. 24.4% of PTCA patients required CA8P; 5.7% as an
emergency; 9.8% for unsuccessful PTCA, 9% for restenosis.
24% of patients had restenosis (average = 4.4 months post
PTCA); 86% had repeat PTCA. Late results for PTCA and
CABP were: average follow-up--12.7 vs 91.6 months;
Functional Class I or II at late follow-up--82 vs 80%;
angina free--69 vs 73%; late deaths and myocardial infarc-
tions following CABP were 1.7%/year and a.8%/year, respec-
tively; thus far 4 late deaths and 2 late myocardial
infarctions have occurred in the PTCA group. In conclu-
sion, although further long-term studies will be necessary
to evaluate late results in patients after PTCA, this
study indicates that early mortality and complications
are similar in unstable angina patients treated with
either PTCA or CABP.
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Drug Therapy for Congestive Heart Failure
CAPTOPRIL IN HEART FAILURE: A DOUBLE BLIND STUDY OF
EXERCISE TOLERANCE, RgAL HEMODYllAMICS AND SODIUM AND
POTASSIUM BALANCE
John G.F. Clelandi MRCP, Henry J. Dar~ie, FRCP, GerardGillen, BSc, Ianobertson, BSc, Brian W. East, PhD,
Stephen G. Ball, MRCP, J. Ian S. Robertson, FRCP,
Department of Cardiology, Western Infirmary, Glasgow
en 6NT, U.K.
Captopril's effects in heart failure could include loss
of the direct renal actions of angiotensin II and a fall
of plasma aldosterone, thus promoting natriuresis. In
14 patients with heart failure (NYBA Grade 3-4) we
inYestigated the effects of captopril or placebo, for 6
week periods in a double blind crossoyer study, on ~lo­
merular filtration rate (GFR) and effectiYe renal plasma
now (ERPF) by radio-isotopic clearance, total body
sodium by in YiYO actiyation analysis and potassium by
whole body counting of endogenous 4OK. Values (llIeall+SEM)
refer to change from placebo. Exercise time increased
from 7.6~1.2 to 9.1~1.4 min (p .0.005); mean arterial
pressure rell from 9~ to 79+4 IIIIIl Kg (p .0.001), ERPF
rose from 24l~21 to 298~28 m17min (p .0.05) and reno-
Yascular resistance fell from 21.6+2.1 to 14.9+1.7 dyne/
sec/em (p .0.05); pla8llla aldosterone and angiotensin II
fell from 18.2+6.0 to 11.~.9 ng/dl and from 79.5+26.4
to 20.9~3.5 pmo1/l (p .0.05) reapecthely; total body
and plasma potassium rose from 2543+135 and 3.4+0.1 to
2667+111 mol (p.0.05) and 3.9+0.1-.-01/1 (p.0.005);
neither total body nor plasma sOd! \Ill changed (3223+108
and 140, and 3209+129 _01 and 140 mmol/l). Thus-
captopril caused renal ..aodilatation and a fall in
pla.a angiotensin II and aldosterone, but sodium
balance did not change duriDg Cll'tDpril thmspy. The poten-
tial natriuretic effects of c-,topril could be offset
by the fall in blood preaaure.
MINOXIDIL IN CHRONIC LEFT HEART FAILURE; PARADOXICAL
HEMODYNAMIC AND CLINICAL EFFECTS IN A CONTROLLED TRIAL
Randy A. Jordan, MD; Cheryl L. Leddy, ~ID; Mary Wilen;
Joseph A. Franciosa, MD, FACC, Veterans Administration
Medical Center and University of Arkansas for Medical
Sciences, Little Rock, Arkansas
We have previously reported sustained improvements in CI
and LV ejection fraction (LVEF) during minoxidil (M) ad-
ministration in chronic LV failure (LVF). We now report
clinical responses to long-term M treatment in patients
(pt) with LVF due to ischemic or primary cardiomyopathy.
In random double-blind fashion 9 pt received M, 20 mg BID,
and 8 other pt received placebo (PL) , in addition to
digoxin and diuretics for 3 mos. During M, CI rose from
2.7±0.6 (SO) to 3.8±1.7 L/min/m2, LVEF rose from 30±18 to
43±22%, and systemic vascular resistance fell from 17±3
to 12±6 units (all p<.05). These same variables were sim-
ilar at baseline and remained unchanged in PL treated pt.
Maximal exercise 02 uptake of 16±7 ml/min/kg changed to
17±4 ml/min/kg during Ii (ns) and remained unchanged at
15±7 ml/min/kg during PL. The following clinical events
were all more frequent during M than PL: increased diure-
tic need, 9 vs 4; angina, 2 vs 1; ventricular arrythmia,
2 vs 0; worse LVF symptoms, 6 vs 2; death, 2 vs O. Total
clinical events were 21 during Mvs 7 during PL (p<.Ol).
Thus, despite improving hemodynamics and LV function,
long-term Madministration was associated with a worse
clinical course and no effects on functional capacity in
pt with chronic LVF. Like other predominant arterial
dilators, M does not appear to be useful for long-term
vasodilator treatment of LVF. Furthermore, these results
suggest that demonstration of improved LV function alone
can not reliably be interpreted as proof of clinical
efficacy of therapeutic interventions in pt with LVF.
10 pts developed complications while on A: cardiac decom-
pensation (5), thrombocytopenia (3) and liver damage (4).
Two of these had positive biopsies for drug induced hep-
atitis. All complications reverted with no sequelae after
A withdrawal. Thus, A failed to improve the clinical
condition of pts with DC and was associated with signif-
icant adverse effects.
EFFECT AND COMPLICATIONS OF CHRONIC AMRINONE THERAPY IN
PATIENTS WITH DILATED CARDIOMYOPATHY
Ramon Corbalan MD, Pablo Casanegra MD FACC, Diego Mezzano
MD, Ivan Marinovic MD, Gaston Charnorro MD, Jose Rodriguez
MD and Paz Valenzuela RN
Catholic University Hospital, Santiago, Chile
The longterrn effects of Arnrinone(A) , a non glycosidic ino
tropic agent, were studied in 14 patients (pts)with dilat;d
cardiomyopathy (DC) , functional class II-III. The etiology
was idiopathic in 12 and ischemic in 2; 6 were males, B
females, the age ranged from 41-70 years. All pts were in
sinus rythm, 11 had left and 1 a right bundle branch block
P~i.or to entry they were treated only with diuretics and
K • Baseline cardiac evaluation included echocardiographic
fraction~l shortening (FS), radionuclide ejection fraction
(FE) and duration (D) of exercise testing(modified Naughton
protocol). Laboratory tests included SMA12, platelet counts
and bone marrow studies. Oral A was given in doses of 300-
600 mg daily for 4 weeks (phase I). Then pts were random-
ized and crossed-over in a double blind manner to A and
placebo for 12 weeks (phases II-III). 9 pts were able to
complete phase I, with the following results:
ENALAPRIL IN CHRONIC HEART FAILURE : A DOUBLE-BLIND
PLACEBO CONTROLLED TRIAL. Norman Sharpe MD FACC,
Judy Murphy RN, Rene Coxon RN, Department of Medicine,
University of Auckland School of Medicine, New Zealand.
To assess the efficacy of the oral angiotensin convert-
ing enzyme inhibitor enalapril in chronic heart failure,
36 patients (pts) with Functional Class (FC) II-III heart
failure despite digoxin and diuretics were randomised in
a double-blind trial to enalapril 5mg bid (Group I, n=18)
or ~acebo (Group 2, n=18). Symptoms, treadmill exercise
duration (Ex) and haemodynamic measurements were assessed
before and after 3 months treatment.
In Group I, mean FC improved from 2.8 to 1.7 (p<O.Ol)
and Ex from 9.1 to 17.0 min (p<O.Ol). Diuretics were
reduced in 6 pts and increased in one pt, one pt died and
another was withdrawn from the study. In Group 2 mean
FC and Ex did not change significantly, diuretics were
increased in 9 pts and 4 pts died.
Haemodynamic results (Mean, *p<0.05, tp<O.Ol vs base-
line) LVFP = LV filling pressure (mm Hg), CI = cardiac
index (L/min/m2), SVI = stroke volume index (ml/beat/m2),
MAP = mean arterial pressure (mm Hg), HR = heart rate
(beats/min), SVR = systemic vascular resistance (dsc-5):
Group 1 LVFP CI SVI MAP HR SVR
Baseline 23 2.02 25 95 83 1998
3 months 14t 2.55* 33t 86 77 1532*
Group 2
Baseline 20 2.32 28 100 89 1675
3 months 23 2.47 27 99 93 1425
In conclusion, enalapril produces significant haemo-
dynamic and symptomatic benefit in pts with heart failure.
The predominant haemodynamic effect appears to be on LV
preload and diuretic requirements are often reduced.
FC (%)
EF (%)
D (min)
BASELINE
16.5 + 7.2
26.7 +7.6
13.4 + 3.6
AMRINONE
17.5 + 5.5
2B.4 + 7.6
14.9 + 3.1
(NS)
(NS)
(NS)
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Baseline mean P (mmllg)
Baseline ESo (g/ cm2)
ESP-D slope (mmllg/cm)
%lID at ESo=40g/cm2
Vcf at ESo=40g/cm2
MILRINONE (WIN 47203): DIFFERENTIATION OF ITS INOTROPIC
AND VASODILATOR EFFECTS IN HilliANS.
Kenneth II. Borow, lID; Patricia Come, MD; Alexander Neumannj
Donald S. Baim, lIDj Eugene Braunwald, lID; ~1il1ial'l Grossman,
MD; Brigham & Women's Hosp., Beth Israel Hosp. , Boston, MA.
Milrinone(ll) increases LV shortening while decreasing af-
terload. It is controversial whether it also has positive
inotropic properties or whether the improved hemodynamics
can be explained by vasodilation alone. Recently an in-
crease in the slope of the end-systolic(ES) pressure(P)-
dimension(D) relation and an increase in LV shortening(%lID)
and velocity of shortening(Vcf) at a given level of ES
stress(o) have been shown to be load independent, highly
sensitive indices of inotropic state. These indices were
used to assess LV contractility under control(C) and II con-
ditions over a wide range of afterload generated by meth-
oxamine. 16 studies were performed using m-mode echo in
10 normal subjects. M loading doses of 30, 45 or 60ug/kg
were given over 10 minutes followed by maintenance infu-
sion and determination of plasma levels(PL). ESP was es-
timated from calibrated carotid pulse tracings. ESD and ES
wall thicknesses were I'leasured and ESo, %lID and Vcf cal-
culated. If induced the following dose related changes:
Low PL (126±3l) High PL (205±Z7)
n=8 studies n=8 studies
C M C M
88±9 82±10 9l±7 7&t9
45±8 36±12 49±9 28±8
l14±3l l26±35 l12±24 l52±25
30.4±2.9 32.2±4.l 32.4±2.6 36.3±3.5
1.12±.10 1.18±.13 1.20±.09 1.36±.06
p<:ti5 u vs C p<-:tiOl ~f vs C
Conclusions: (1) ~I has a dose related positive inotropic
effect which can be separated quantitatively from its vaso-
dilator effect. (2) Unlike the traditional indices of LV
performance, the end-systolic indices have utility for as-
sessing contractility independent of loading conditions.
LONG TERM IMPROVEMENT OF LEFT VENTRICULAR INOTROPIC STATE
WITH THE ~ 1 PARTIAL AGONIST CORWIN.
Michel F. Rousseau, MDj Paul Cheron, HO; Jean Etienne;
Hubert Pouleur t MO, University of Louvain, Brussels,
Belgium.
Corwin (ICI 118,587) is a positive inotrope with 43 % of
~l agonist activity,Le. approximately twice the inotropic
activity of digoxin.To determine if its positive inotropic
effects were maintained during chronic therapy, Corwin was
given orally to 10 patients (pts) with left ventricular
(LV) failure caused by previous myocardial infarct. LV
catheterization (Millar) was performed before and after 3
months of Corwin (400 mg/day; plasma levels 106+ZZ ng/ml).
Results were compared to those of 7 pts with similar LV
dysfunction but with indication for surgery and who under-
went successful bypass surgery. After Corwin, heart rate
and mean aortic pressure (P,97+6 to 107+4 mmHgjNS) were
unchanged but the LV filling P-decreased from 24+2 to
17+2 mmHg*. LV end-diastolic and end-systolic volumes also
de~lined respectively from 149 to 133* and from 68 to 59*
ml/m2 and the indexes of inotropic state were enhanced in
all pts : Emax, the maximal LVP/Volume ratio rose by 307~
and the slope of the end-systolic stress/end-systolic
volume relation increased by 257~. The slope of the stress
/velocity relation also increased by 707~. All changes in
LV volumes and in indexes of inotropic state were signifi-
cantly greater than after bypass surgery. Corwln also
improved by 30 Watt* the maximal exercise capacity while
decreasing heart rate at peak exercise by lZ7~. No side
effects were seen. In conclusion, LV inotropic state and
pump function are improved after prolonged therapy with
Corwin and tachyphylaxis does not appear to be a problem.
* P < 0.025
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Anti-Tachycardia Pacing
DUAL VENTRICULAR STIMULATION FOR PREVENTION OF REENTRANT
VENTRICULAR ARRHYTHMIAS. &ahul Mehra, Ph.D; William B
Gough, Ph.D; Robert Zeiler, Ph.Dj Nabil El-Sherif, MD,
FACC, SUNY Downstate & VA Medical Centers, Bklyn, N.Y.
Although electrical stimulation has been used in the
past for termination of ventricular arrhythmias, stimula-
tion techniques that prevent their occurrence may be cli-
nically more desirable. We investigated the efficacy of
dual ventricular stimulation for prevention of reentrant
ventricular arrhythmias (RVAS) in 8 dogs, 3-5 days fol-
lowing left anterior descending coronary occlusion. RVAs
were induced by premature electrical stimulation (PES)
£rom the base of the right ventricle (~V). Computerized
mapping of the epicardium with 62 bipolar electrodes
showed that RVAs developed when the circulating wavefron~
around an arc of functional conduction block (AFCB) joined
into a common wavefront in the ischemic zone (IZ) and the
conduction delay within the IZ was sufficient to reexcite
the normal myocardium. To prevent RVAs, simultaneous dual
ventricular pacing (Sl-Sl) was performed from the RV base
&a site within the IZ. In 7 of 8 dogs, a specific site
could be determined in the IZ such that when PES were de-
livered from the RV base, no RVAs were initiated. The
circulating wavefronts caused by premature stimulation
still travelled around an AFCB but the conduction time to
sites within the IZ was reduced and the common wavefront
blocked within the IZ. This relatively fast conduction of
the premature beat could be explained by the shift to the
left of the refractoriness of Sl within the IZ. However,
the faster wavefront encountered refractory tissue in the
IZ &was blocked. It is concluded that with proper elec-
trode placement, dual ventricular pacing (Sl-Sl) can be
used to prevent RVAs induced by premature beats.
SUBTHRESHOLD BURST PACING, A NEW METHOD FOR
TERMINATION OF VENTRICULAR AND SUPRAVENTRICULAR
TACHYCARDIA.
Enz-R.von Leitner,MD; Thomas Linderer,MD.
Kl inikum Shgl i t z , Freie Universi tat Berl in,
Germany
The use of anti tachycardia pacing has been 1 imi-
ted because of the potential risk of pacing in-
duced degeneration of tachyca~dias into more ra-
pid forms or into ventricular fibrillation. The
aim of this study was to develop a safer method.
METHODS: In 8 patients with recurrent sustained
ventricular tachycardia and in one patient with
WPW synd~ome and recurrent paroxysmal circus
movement tachycardia subthreshold burst pacing
was used to interrupt spontaneously occurring
episodes of tachyca~dias (~ates 120 to 240/min).
Transvenous bipolar leads were positioned in the
right ventricle (apex or outflow tract), and in
the coronary sinus ~espectively. Stimulation was
pe~formed with ~apid bursts of 10 to 30 impulses
at a rate of eOO/min.(impulse width 2,0 msec,
0,8-1,3 rnA). Cur~ent strength was adjusted at
10-20% below the patients individual stimulation
th~eshold.
RESULTS: In 6/8 patients with vent~icular tachy-
cardia and in the patient with WPW syndrome sub-
t hr-e shc l d bu~st pac i ng was successful in repro-
ducibly terminating the tachycardias.
Degene~ation into mo~e rapid tachyca~dias o~
ventricular fibrillation was not observed.
CONCLUSION: Subthreshold bu~st pacing is a pro-
mising new technique for the t~eatment of
patients with ~ecu~rent vent~icular or supraven-
tricular tachycardia.
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ANTI-TACHYCARDIA PROPHYLAXIS: PERMANENT PACED
PRE-EXCITATION
Paul V.L. Curry, MD; D. Wyn Davies, MB; Clifford A.
Bucknall, MB. Guy's Hospital, London, England.
Advances in dual chamber pacing have enabled us to use a
principle first described by Coumel, namely permanent
ventricular pre-excitation, to prevent rather than
interrupt re-entry supraventricurar-Iachycardias in 4
patients with frequent attacks (range 3 per day to 3 per
week, mean 10 per week) resistant to anti-arrhythmic
drugs.Initial electrophysiological studies showed ortho-
dromic tachycardias in all patients (2 WPW, 2 intranodal)
with wide initiation zones for atrial extrasystoles
(range 40-16Qmsecs, mean range BQmsecs). Only 1 patient
had tachycardia initiated by single ventricular extra-
systoles. All patients received a Siemens Elema 674 DOD
pacemaker programmed to a low standby rate (SObpm),
highest synchronous rate (160bpm), shortest atrial
refractory period (2SQmsecs) and shortest AV delay (7-10
msecs). Repeat electrophysiological studies performed 4
weeks after implantation showed a reduction in the
tachycardia initiation zone to a mean of 2Qmsecs, range
0-6Qmsecs. All patients described a reduction in the
incidence of attacks to a mean of 2 per month, range none
to 3 per month. Two patients noticed breakthrough
attacks during exertion due to a loss of paced pre-
excitation when the highest synchronous rate was
exceeded. These attacks were successfully treated with
the addition of beta blockade which should not be
necessary when higher synchronous rates become available.
We conclude that programMable dual chamber pacemakers can
provide anti-tachycardia prophylaxis in patients with
orthodromic re-entry supraventricular tachycardia.
DlFFERENfIATION OF SINUS TAOiYCARDIA FlOI PAROXYSMAL
TAOiYCARDIAS USING SINGLE LATE DIASTOLIC ATRIAL EXTRA-
STIMULI.
Frances C. MJnkenbeck, M.D.; Thomas E. BlIIIP, M.D.: Robert
C. Arzbaecher , PhD; University of Chicago, Chicago, IL.
Automatic antitachycardia devices should discriminate be-
tween sinus tachycardia (ST) and paroxysmal tachycardia
(Pl') • Characteristics of tachycardia such as rate and
abruptness of onset do not perfectly discriminate between
ST and PT with 1:1 atrioventricular (A-V) relationship
(1:1 PT). In the present study we tested the hypothesis
that the nature of the ventricular response to atrial
extrastimulation (AES) might distinguish between ST and
1:1 PT. We scanned atrial diastole with single AES de-
livered to the high right atr.itm during tachycardia in 4
patients (pts) with ST and 7 pts with 9 different 1:1 PI's
(4 A-V reentrant tachycardias using left-sided bypass
tracts, 3 A-V nodal reentrant tachycardias, and 2 atrial
tachycardias). 3 pts had in turn ST and 1:1 Pl', Pro-
gressively more premature AES made the next ventricular
beat progressively earlier in 4/4 STs and in 0/9 1:1 PTs.
For example, when the AES was 80 ms premature, the next
ventricular beat was made at least 30 ms early in 4/4
STs and less than 10 ms premature in 9/9 1:1 PTs. Single
AES during tachycardia did not provoke faster tachycardia
in any of our patients. Single AES tenninated 1/9 1:1
PTs.
We conclude that the nature of the ventricular response
to single late diastolic AES during tachycardia accu-
rately discriminates between ST and some forms of 1:1 PI'.
Further evaluation of this technique is warranted in
order to assess its applicability to other patients and
to other forms of 1:1 PT.
PROGRAMMABLE EXTRASTIMULUS PACING FOR LONG
TERM MANAGEMENT OF SUPRAVENTRICULAR AND VEN-
TRICULAR TACHYCARDIAS. EXPERIENCE OF 15 CASES.
Michel Bertholet. MD, Jean-Claude Demoulin, MD, Andr~
Waleffe, MD, FACC and Henri E. Kulbertus, MD, FACC,
Untverstty of Ltega, Belgtum.
15 pts with supraventricular (SVT : 12 cases) or ventricular
(VT : 3 cases) tachycardia refractory to drug therapy were
treated with an implantable unit. 7 SVT pts received the PASAR
4151 fully automatic system. The others received the Medtro-
ntc interactive tachy-system (MITS) which is composed of an
implanted unit (SF 500), an external activator (SPO 501) and an
external programmer (SF 503). This system offers a larger
range of pacing possibilities, contains a bradycardia support
and allows easy non invasive reinltlation of tachycardia and
control of efficacy. It must however be activated by the patient.
The follow-up (FU) of the 7 SVT pts treated wltb PASAR is of
73.5 month x patient. 6 pts had numerous short-lived tachycar-
die episodes which all stopped within seconds. 1 pt continued
to present episodes of very fast SVT and flutter. Reprogramma-
tion was needed In 3 cases. The FU of the 5 SVT pts treated
with MITS Is of 87 month x pts. The activator was used more
than 500 times: only 3 episodes of sustained SVT were noted
requiring reprogrammation (l), addltlon of propranolol (l) or
further explanation to the pt. The FU of 3 VT pts treated with
MITS is of 21, 18 and 11 months, respectively. Out of 253
activator uses, the electrical treatment was successful In all
but 1 episode (during general anesthesia). These devices cons-
titute an alternative treatment for most SVT and may be used
safely in selected cases of refractory recurrent VT.
LONG-TERM MANAGEMENT OF PAROXYSMAL TACHYCARDIA BY BURST
OVERDRIVE PACING
Robert W. Peters, ~1D; ~1elvin ~1. Scheinman, ~1[), FJI,CC; Fred
Morady, MD, FACC; Lester Jacobson, ~1D, F,6.CC, Veterans
Administration Medical Center and University of Maryland,
Baltimore, MD.
Patient-activated radiofrequency pacemakers (RFP) were
used to control drug-resistant paroxysmal suoraventri-
cular tachycardia (PSVT) in 10 oatients (nts) and ven-
tricular tachycardia (VT) in 6. The tachycardia ~'as re-
peatedly induced and terminated by overdrive pacin9. In
2 pts with PSVT followed for 2 and 2~ years respectively,
the arrhythmia was controlled ~y RFP alone. The remain-
in~ 8 pts (mean follow-up 8t4 years) required antiarrhy-
t~ic dru~s for PSVT control. RFP failure despite in-
tact pacemaker function eventually occurred in S of the
8. Failure was due to induction of atrial fibrillation
(RFP induced in 3, spontaneous in 1) or inability to ter-
minate the tachycardia (1). Accessory oathway and/or
His bundle ablation was required in 3 pts and 2 required
amiodarone therapy. In 6 pts with VT, RFP was effective
(6 months follow-up) in only 1. In 5 (mean follow-up
2±1 year) RFP proved ineffective in 3 and overdrive ac-
celeration occurred in 2, 1 of whom developed fatal ven-
tricular fibrillation. All survivin~ pts with VT re-
quired chronic arniodarone therapy. Long-term follow-uD
of PSVT pts treated with RFP show that conCOMitant dru~
or aggressive medical or surgical therapy is frequently
required for arrhythmia control. Overdrive pacin~
should be used with great caution if at all in those
with VT.
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New Antiarrhythmic Drugs I
AMBULATORY ELECTROCARDIOGRAPHIC EVALUATION OF THE
EFFICACY OF ETHMOZINE IN PATIENTS WITH VENTRICULAR
TACHYCARDIA.
A. Allen Seals, MD; LaDean English. RN; Ann M. Wierman,
PAC; David E. Mann. MD; Jerry C. Luck. MD. FACC;
Christopher R. Wyndham., MD. FACC; Robert Roberts, MD,
FACC; Craig M. Pratt, MD. FACC; Baylor College of
Medicine, Houston. TX.
Ethmozine (E) has been demonstrated to suppress ventricu-
lar premature beats in previous studies, but efficacy in
treatment of ventricular tachycardia (VT) has not been
proven. We used ambulatory electrocardiographic monitor-
ing (AECG) to document the efficacy of oral E (mean ±SD
daily dose 10.5±.5mg/kg) in 19 patients (pts) (mean age
54 years) with VT in a single-blind placebo controlled
study with follow-up of 93±106 days (d). Significantly,
the group was characterized by a mean LV ejection frac-
tion of 34±15% and a mean VT frequency of 2033±5316 VT
runs/d during baseline AECG P5.2±18.4 hrs). All 19 pts
had nonsustained (nonsus) VT and 6 also had sustained
(sus) VT. Complete AECG data (18 pts) within one week of
E (62.1±10.8 hrs) demonstrated >80% reduction of VT in 13
pts (72%) (3 sus; 10 nonsus) from 2726±6177 to 3.9±12 VT
runs/d (p<.002). Nine pts (50%) (3 sus, 6 nonsus ) had
100% VT suppression. Five pts (3 sus. 2 nonsus) showed no
response «80% VT suppress ion) to E. Follow-up mean VT
suppression at one month was 96% (n=11 pts). at 3 months
was 99.9% (n=7 pts) and at six months was 100% (n=5 pts).
No pt had E discontinued due to side effects. Death
occurred in 3 pts (l sudden. 1 myocardial infarction, 1
non-cardiac), and E was discontinued in one pt due to
non-compliance. In conclusion. ethmozine is highly
successful in producing total or near total suppression
of nonsus VT wi th no recurrence of VT after one week of
therapy.
HEMODYNAMIC EFFECTS OF ETHMOZINE IN PATIENTS WITH VENTRI-
CULAR TACHYCARDIA AND LEFT VENTRICULAR DYSFUNCTION.
Vinod B. Jivrajka, M.D., C.P. Reddy, M.D.,F.A.C.C.,
P.W. Frazier, R.N., A.N. DeMaria, M.D.,F.A.C.C., V.A. and
University of Kentucky Medical Centers, Lexington, KY
Ethmozine, a phenothiazine derivative, is a new anti-
arrhythmic agent for the treatment of ventricular arrhyth-
mias. However, no data exist regarding the hemodynamic
effects of ethmozine. Therefore, we evaluated the effects
of ethmozine on cardiac function in 8 patients (pts) with
depressed left ventricular(LV) function and ventricular
tachycardia. The mean LV ejection fraction (EF) was 38.5
+ 8.2%. Right heart catheterization and triplicate cardiac
output measurement using thermodilution technique were
performed before and after ethmozine (15 mg/kg/day given
orally in 3 divided doses for 5 days). Mean plasma ethmo-
zine concentration was 0.4 + 0.2 mg/ml.
RESULTS -CONTROL ETHMOZINE P VALUE
~ate(beats/min) 70+11 78+9.6 ~
Mean Blood Pressure(mm Hg) 89~9+11 87~5+8 > 0.2
PCWP(mm Hg) -5 10.8~3.4 11~2~2 > 0.2
SVR(dynt;s-sec-cm ) 1594~75 1444~238 < 0.05
SI(ml/W') 31.5+6.8 31.5+8.1 > 0.2
SWI(g-m/MZ) 33.5~8.6 32.8~9.3 > 0.2
SVR:systemic vascular resistance~SWI:stroke work index,
SI:stroke index;PCWP:pulmonary capillary wedge pressure.
One pt with baseline EF of 16%, developed severe conges-
tive heart failure during ethmozine administration neces-
sitating the discontinuation of drug.
CONCLUSIONS:I)Ethmozine caused a mild fall in SVR accom-
panied by reflex tachycardia;2)no significant alteration
of PCWP, SI or SWI was observed;3)although ethmozine was
well tolerated by most pts with depressed LV function, the
appearance of cardiac decompensation in one pt during ad-
ministration of ethmozine suggests that the agent should
be given with caution in pts with severe LV dysfunction.
PROPAFENONE HYDROCHLORIDE: ELECTROPHYSIOLOGIC PROPERTIES
AND EFFICACY IN PATIENTS WITH SUSTAINED VENTRICULAR
TACHYCARDIA
John U. Doherty. MD; Harvey L. Waxman. MD, FACC; Belinda
Flores. RN; Darlene Pembrook-Rogers. Michael G. Kienzle.
MD; Francis E. Marchlinski, MD. FACC; Alfred E. Buxton.
MD, FACC; Mark E. Josephson. MD. FACC. Hospital of the
University of Pennsylvania. Philadelphia. PA.
Propafenone hydrochloride {Prj is an experimental anti-
arrhythmic which effectively suppresses ventricular
premature beats. The effect of Pr on preventing induction
of sustained ventricular tachycardia (VT-S) by programmed
ventricular stimulation has not been assessed. We studied
the electrophysiologic properties and response to
programmed ventricular stimulation in 14 patients (pts)
with VT-S after intravenous Pr (1-2 mg/kg). Thirteen pts
were refractory to conventional antiarrhythmics. Pr did
not affect P wave duration (108t24 msec control (C).
106t23 msec Prj. PR interval (181t45 C. 194±53 Prj, AH
(122±31 C, 135±38 Prj or HV intervals (62±20 C, 65±18
Prj. QRS duration increased from 109±20 to 130±21 msec
(p-.OOO8) and ventricular effective refractory period
increased from 235t24 to 256t19 msec (p=.02). VT-S was
still induced in 13 of 14 pts. VT-S was initiated with
the same number of extrastimuli in 9 pts. with more
extrastimuli in 3 pts. and with fewer extrastimuli in 2
pts. Additional VT morphologies were seen in 7 pts. Cycle
length of VT was 303±73 msec before and 346±143 msec
after Pr (p-.15). We conclude: I)Pr has no effect on
intratrial. AV nodal. or His-Purkinje conduction; 2)Pr
prolongs ventricular conduction and refractoriness;
3)VT-S can be induced in most pts after Pr and mode of
initiation and VT cycle length are not predictably
affected; 4)additional VT morphologies are frequently
seen after Pr; 5)induction of VT-S is rarely suppressed
by Pr in pts with VT-S refractory to conventional drugs.
SAFETY AND EFFICACY OF PROPAFENONE 1:-.1
TREATMENT OF REFRACTORY VENT~CULAR
ARRHYTHMIAS. Lyle A. Siddoway, M.D., Katherine A.
Thompson, M.D., Robert H. Bergstrand, M.D., Ph.D., Ted
Wang, M.D., Dan M. Roden, M.D., F.A.C.C., and Raymond L.
Woosley, M.D., Ph.D. Vanderbilt University, Nashville, TN.
We studied propafenone (P) in 30 patients (pts) with stable,
high-frequency ventricular ectopic activity ('lEA) refractory
to at least two antiarrhythmic (AA) drugs. Cardiac diagnoses:
ischemic heart disease (17 pts), congestive cardiomyopathy (4
pts), mitral valve prolapse (3 pts), hypertension (2 pts), and
idiopathic ventricular arrhythmias (4 pts). Baseline "fA
frequency was established during placebo administration in a
48 hr pre-treatment period and in a 24-48 hr washout period
after dose-ranging. Pts received P 300 mg ql2h, increased
after 2-3 days to 300 mgq8h if necessary. Responders entered
chronic treatment (Rx) at the previously established optimum
dosage, with outpatient evaluation including serial 24 hr
ambulatory fCG monitoring to confirm continued efficacy.
Results: Inpatient Phase - Satisfactory "EA suppression was
seen in 22/30 pts (60-70% suppression - I pt; 70-80% - I pt;
30·90% -6 pts; > 90% -14 pts) without significant side-effects
(Sf). Complex ectopy, present in 16/22 responders, was
suppressed. 3/30 pts had serious SE (overt psychosis, sustained
ventricular tachycardia, and 20 AV block) which prevented
completion of dose-ranging. 2/30 pts had no AA response at
doses causing intolerable paresthesias, Chronic Rx: 21/22 pts
maintained a satisfatory AA response during 5.5 ± 3.2 mos Rx
(range 1-12). One pt stopped P due to intolerable paresthesias
at the effective dosage. Other SE were dose-related, mild,
and improved despite continued P administration; these
included dysgeusia, constipation, blurred vision, and dizziness.
Conclusion: P satisfactorily controlled refractory veA in 70%
of pts. Serious SE occurred in 1096 of pts and appeared early
in Rx, Dosages of 600-900 mg/day are effective and well
tolerated for most pts.
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INTRAVENOUS LORCAINIDE VERSUS LIDOCAINE FOR ACUTE THERAPY
OF COMPLEX VENTRICULAR ARRHYTHMIAS. RESULTS OF A RANDOM-
IZED, CROSSOVER STUDY
Jeffrey L. Anderson, MO, FACC; Maria Anastasiou-Nana, MO;
Steven L. Writer, MO; Joan R. Lutz, RN, LOS Hospital,
University of Utah, Salt Lake City, Utah
There is a need for effective, well-tolerated intravenous
antiarrhythmic agents. We compared effects of lorcainide
(Lor), a new class ICantiarrhythmic, with lidocaine
(Lid) in a randomized study in 20 hospitalized patients
(pts) with frequent (>l/min) complex ventricular arrhyth-
mias (PVCs). Pts were of median age 65 yr, and 19 had
organic heart disease (10 coronary disease, 5 valvular
di sease, 4 ca rdi omyopathy). Lor was gi ven as 2 mg/k 9 at
2 mg/min, with a supplemental dose, if needed, of 100 mg/
1 hr followed by 8 mg/hr. Lid dose was 1 mg/kg at 25 mg/
mi n, then 2 mg/mi n, with a supp1ement, if needed, of 50
mg/2 min, then 3 mg/min. Arrhythmias were compared for 2
hr before and after drug 1oadi ng. Fai ling pts were
crossed over to the opposi te drug (4 to Lor, 3 to Li d).
Total PVCs decreased by 42% after Lid (4515/hr to 2612/
hr, p<.Ol, n=9) and by 86% after Lor (p<.OOl, n=l1).
(Excluding 1 pt with sustained ventricular tachycardia,
PVC suppression averaged 74% after Lor (7893/hr to 2053/
hr, pc. 005). Response at 70% PVC suppress i on was 5/9
(56%) after Lid and 8/11 (73%) after Lor. Response at
90% PVC suppression was 2 (22%) after Lid and 5 (45%)
after Lor. In 7 pt crossing over, Lor led to greater PVC
suppress i on than Lid, averagi ng 256/hr (pc, 05). Pai rs
were suppressed 83% after Lor (182 to 31/hr, p<.Ol) and
83% after Lid (158 to 28/hr, p<.OI). Runs were sup-
pressed by 99.8% after Lor (47 to l/hr) and 81% after Lid
(24 to 5/hr). Adverse effects were minor with both drugs
and di d not Iead to interrupt i on of therapy. Lor is a
well-tolerated, efficacious antiarrhythmic when admini-
stered intravenously for therapy of complex PVCs and may
be superior to Lid.
ORAL LORCAINIDE FOR SUSTAINED VENTRICULAR
TACHYCARDIA AND FIBRILLATION
Debra S. Echt, M.D.; Miriam Shapiro; Janet Miller; Jay W.
Mason, M.D., F.A.C.C.; Roger A. Winkle, M.D., F.A.C.C.;
Stanford University, Stanford, California
Fifty pts underwent therapy with oral lorcainide (LOR). The
clinical arrhythmia was sustained VT in 33, VF in I, and VT!VF in
16 pts, Cardiac diagnoses were CAD in 39, myopathy in 7,
myocarditis in I, and no other heart disease in 3 pts. The
cardiac index was 2.4 + 0.6, ejection fraction 33 + 1496, and
NYHA functional class -2.4 + 0.8. Patients failed '7 + 2 other
drugs. Programmed stimulation (PS) both pre- and post-LOR
therapy was performed in 23 pts and VT was inducible in all with
VT cycle length increasing from 273 ! 65 ms to 388 ! 97 ms
(p~O.OOll. LOR was discontinued in 23 pts prior to hospital
discharge because of death in 4, side effects in 2, clinical failure
in 9, and VT induction in 8 pts, 27 pts were discharged on mean
LOR dose of 169 + 56 mg bid and follow-up of 10.5 + 10.0 mos.
Post-discharge LOR was discontinued due to death- in 7, side
effects in 3, clinical failure in 3, and other therapy in 2 pts,
Twelve pts are still on LOR after a mean of 19.9 + 8.4 mos. 15
pts inducible with PS were continued on therapy due to slowing
or tolerance of VT. Of these 15 pts, 5 expired from VT!VF and
I had non-fatal clinical failure. Of the entire 50 pts, II expired
on LOR, 9 in VT!VF; 6 of the 9 due to clinical inefficacy, 2 due
to combined drug toxicity, and I pt during LOR loading. Life-
table analysis revealed chances of successful therapy at 6 and 12
mos of 3896 and 3096 and overall survival of 8196 and 6396. Side
effects occurred in 8896 of pts, including sleep disturbances in
5696, tremor in 3696, gastrointestinal symptoms in 2696, ataxia in
1896, fatigue in 1896, and arrhythmia worsening, aggravation of
CHF and hyponatremia each in 1296, but necessitated drug
withdrawal in only 1096 of pts,
Clinical efficacy of LOR in refractory pts is low as with
other antiarrhythmic drugs. VT induced with PS may be slower
on LOR, but arrhythmia recurrences are often fatal.
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A NEW AND INDEPENDENT MEASURE OF THE VOLUME OF VIABLE MYOCARDIUM:
THE EFFECTS OF TRANSIENT ISCHEMIA.
Michael J. Shea, MD: Richard A.Wilson, M~' Christian M. de Landsheere,
MD: Ian Watson, MSc: Terry Jones, MSc: Andrew P. Selwyn, MD, FACC.
Cardiovascular Unit & MRC Cyclotron Unit, Hammersmith Hospital,
London, UK.
The tradi tiona! external assessment of tracer distribution in the
myocardium cannot take into account changes in volume and/or geometry
due to ischem~rf infarction or dyskinesia. To over-ccse this we used
rubidium-Bl ( Rb, t~=4. 7 hr, 65% positrons) to independently identify
the vol uae of viaijie myocardium. Six open chest anaesthetized dogs werl
given 1-3 mCi of Rb 2.5 hrs before recgrding positron tomograms
(through the mid left ventricle). The Rb in the potassium pool gave
target to background of 5.5-12:1 (range) and with decay correction (10%
change .over the following 2 hours. At the same tomograph~~ level
regional myocardial uptake (U, ml/gm/min x extraction) of Rb(t~.78sec)
was measured From equilibrium tOlllograms during infusion and myocardial
aymograms after an infusion giving) lQl times tb~ activity levels of
Rb. Sequential paired tomograms of Rb and Rb uptake were
recorded before, during and for 1 hour after 10 ",ins of occlusion of t h:
left anterior descending coronary artery (LAD). During control the
ratig 1between the LAD and nor~~l segments was O.91 :': 0.03 (mean:,: SO)
for Rb and 0.94 + 0.05 for Rb S Following occlusion of the LAD
there was a regional decrease in 2Rb (t~=78sec) uptake decreasing the
ratio between affeca!d and normal segment to 0.25:,: 0.1). However, th
volume signal from Rb showed a smaller change in ratio to 0.7B + 0.16
Hese results showed that wall thinning and dys ki nes i a detected using
Rb ~~counted for 21. 5 ~ 20% of the changes in the measure of uptake
from Rb indicating flow and extraction. Thus, wall thinning and
dyskinesia can account for up to 50% of the changes seen using tracers
and external detection; Sfherefore these effects lIIust be considered.
This new approach using Rb in the potassium pool of the myocardiUM as
a vol uae lIarker lakes it possible to express lIIeasurelllents of flow or
lIIetabolisll independent of any s i aul taneous changes in voluae or
geo.etry.
A tm-INVASIVE MARKER OF MYOCARDIAL VIABILITY
AFl'ER REPERFUSICN Bl\SED CN LEAKAGE OF RUBIDIlM-82
Richard A. Goldstein, M.D. ,F1\CC1 Jonathan C. MacLean
The University of Texas Health Science Center,
Houston, Texas
There are no methods available for the non-invasive
assessment of myocardial cellular viability.
Rubidium-82 (Rb-82) is a generator produced positron
emi.tter that can be used to measure regional flow
with a rrodel that includes rate constants for the
transfer of tracer into (k3 ) and out of (k4 ) the
cellular space. The hypothesis of this study is that
cell rneni:>rane function, measured as the net transfer
of Rb-82 (k3-~)' is related to myocardial viability.
Accordinglv, an IV bolus of Rb-82 was given to 15
open-chested dogs and regiooal tirne-activity
cw:ves \\'ere ootained with beta probes at baseline
and serially after coronary occlusions of 1-6
hours follaNed by reperfusioo. Hearts \\'ere then
stained with triphenyl tetrazolium chloride to
assess the viability of the epicardium under the
probe (corresponding to the range of positrons in
tissue). In viable ischanic regions, the k3-k4 was
positive (+3.32xlO-4/sec) Whereas in all non-viable
regioo it was negative indicating rneni:>rane leakage
(-2.1lxlO-4,p<.001). These data suqqest that the
rate constants of Rb-82 can be useful to assess
regional myocardial viability after reperfusioo using
positron emi.ssion tarography.
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THE MECHANISM OF THE ELIMINATION RATE OF 1231-
HEPTADECANOIC ACID FROM THE MYOCARDIUM.
Frans C.Visser,~D;Machiel J. van Eenige,PhD;
Ernst E. van der Wall,MD;Jan P.Roos MD.
Free University Hospital,Amsterdam,Holland
Conclusions:1)The elimination rate of 123I-HDA
does not correlate with beta-oxidation,but is
related to the disappearence rate of radioiodide
2)Under ischemic conditions beta-oxidation rate
is diminished and 123I-HDA is stored in the
lipid pool.This results in a slower myocardial
elimination rate.
16±3 min
123I-HDA
123I-Lipids
123I-Iodide
The myocardial elimination rate(T,) of 1231-
heptadecanoic acid (HDA) is thought to be
closely related to beta-oxidation. To verify
this hypothesis,we studied 10 dogs with and
without a coronary occlusion. (6 and 4 dogs resp)
Five minutes after i.v. injection of 123I-HDA
the relative contents of free radioiodide,radio-
labeled lipids and unaltered123I-HDA in pieces
of normal and ischemic myocardium were measured.
One hour earlier T! of the myocardium was
determined with 131I-HDA.
Results: 5 min. after 123I-HDA injection
Normal myocardium Ischemic M. T!
5% 8%
23% 52%
72% 40%
MYOCARDIAL EXTRACTION AND DISTRIBUTION OF
IODOPP.ENYLBENZYLDIMETHYLAMMONIUM, A ~lEW
L1POPHYLIC CATION.
Pierre ~o, MD, David V. Woo, PhD, T. Tanaka, MD,
DeanF. Wong, MD, Henry N. Warner Jr.,. MD, FA.CC,
Lewis C. Becker MD, FACC, Johns Hopkins Hospital,
Baltimore, Md.
Potassium analoos have been used for several years as
clinical ir-dicator s of myocardial blood flow, but the value
of thallium is limited by its lone half life and low enerpy
photons. We have tested !I-iodophenylbenzyldimethylammo-
nium (I PBDA) a radio-iodinated cation as a potential
thetlium substitute in a series of 7 monorel dor-s .
First pass myocardial and systemic extraction were deter-
mined us inc the double tracer technique, with technetium
albumin as r'eference . Tissue iodine 125 IPBDA distribu-
tions were compared to microspheres under a v~rie~y of
pathophysioloolcal conditions. (co~trol: myoca~dlal !nfarc-
tion, coronary artery stenosrs , Dipyridamole infusion).
First pass extraction averaoed 73% in normal cor,tr~ls
(3 determinations), 66.1% in dogs with LAD occlusion (!I
determinations) and !I0.1%in dogs raceivino persantine
(with or without coronary stenosis or occlusior.)( 5 deter-
minations). Tissue microspheres and IPBDA distribution
correlated in each doc (r = .75 to .85) but the relationship
was not linear IPBoA underestimatinr myocardial blood
flow at high flow.
Iodinated IPBDA is a potential thallium substitute due to
the better physical characteristics of iodine 123. It shares
however the biolooical limitations of potass.ium and analoqs :
a variable extraction and a non linear relation to flow.
R[GHT VENTR[CULAR FUNCTION FROM GATED XENON SCANS
Ann C. Tweddel, M.B. Ch.B.; William Martin, Ph.D.; Jain A. Simpson,
M.R.C.P.; lain McGhie, M.R.C.P.; James H. McKillop, M.R.C.P.;
[an Hutton, M.D.; Department of Medical Cardiology, Royal Infirmary,
Glasgow, G31 2ER, Scotland.
IN VIVO ASSESSMENT OF MYOCARDIAL AREA AT RISK IN PATIENTS
Andrew J. Feiring, MDj Philip M Bruch, Tarek S Husayni,
MDj Peter T Kirchner, MDj Carl WWhite, MD, FACC;
Melvin L Marcus, MD, FACC, Depts of Med & Radiol, CV
Center, Univ of Iowa Hosps, lows City, Iowa
Right ventricular function is of considerable interest in various
clinical conditions, especially ",yocardial infarction involving the
right ventricular wall. Gated Xenon133 (Xe133) offers a method of
assessing the right ventricle in isolation, without the problem of
overlying left ventricular activity. 4DOoIIBq of Xe133 were injected
intravenously over 30-40 seconds with iNges obtained by a Mobile
Ga_ Camera in the 300 left anterior oblique projection, with 60
caudal tilt, for opti..l separation of the right ventricle from the
lung fields. Acquisition is initiated as soon as right ventricular
activity becomes apparent and is terminated as activity leaves the
ventricle.
NOrllll right ventricular ejection fraction (RVEF) range of 40-551
was obtained from 10 volunteers. 10 patients with right ventricular
infarction had a mean E.F. of 231 (range 8-381). Serial assessments
of RVEF and wall OlOtion correlated well with haemodynallic and
clinical assessments. With rapid clearance frOli the lungs, the scan
can be repeated within 10 minutes to assess the effects of
intervention. [n comparison to technetium pertechnetate scans obtained
in the salle projection, septal wall OlOtion abnormalities were
identified IIOre readily by Xenon although total RVEF values were
similar (v • 0.94).
[n conclusion, gated xe133 scans offer a simple, reproducible
and non-invasive IIethod of assessing right ventricular function.
Delineation of area at risk (AR) is crucial for assess-
ing the efficacy of infsrct attenuating agents. We have
developed a new method for determining AR in dogs which
is germane to human studies. After coronary artery occlu-
sion (CAD) in 18 dogs (11 left anterior descending <LAD>,
7 circumflex <Cx», we performed intracoronary injection
(ICI) of 15 mCi of 99m technetium labelled albumin macro-
aggregates (TcMAA). Left anterior oblique and right lat-
eral gated nuclear images were acquired for LAD and Cx
CAO, respectively. Analyzing corresponding end-diastolic
images (EDI) the area of the cavity was subtrscted from
the area of the left ventricle (LV). The excised LV was
cut into six transverse slices parallel to the AV groove
and imaged on the camera face. Employing Simpson's fule
the post-mortem (PM) AR for the LV was determined.
AR EDI vs AR PM r-.95, y-.86x+2.7. The lnterobserver
correlation for AR EDI and AR PM was r-.98 and r-.99.
Five patients (Pts) have undergone AR analysis immediate-
ly prior to streptokinase thrombosysis. High quality AR
images were obtained after ICI of TcMAA. ICI of TcMAA
were unaccompanied by significant changes in heart rate,
rhythm, arterial, and LV pressures. Two Pts with s suc-
cessful thrombolysis had a 2 week followup arteriography
and AR evaluation. The AR deficits were completely re-
stored. We conclude that in vivo canine AR can be reliab-
ly and accurately determined. This technique should per-
mit assessment of AR in clinical studies of reperfu.lon.
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ACUTE MYOCARDIAL ISCHEMIA SUPPRESSES TRIGGERED ACTIVITY
IN VASCULARIZED HAMSTER ATRIAL TRANSPLANTS
Robert F. Gilmour, Jr., PhD; Douglas P. Zipes, MD, FACC,
Krannert Institute of Cardiology, Indiana University
School of Medicine, Indianapolis, Indiana.
Triggered sustained rhythmic activity (TA) has been
implicated as a cause of cardiac arrhythmias following
chronic myocardial infarction. However, the effects of
acute ischemia on TA are unknown. We have shown pre-
viously that automaticity and TA occur in apparently
normal blood-perfused hamster cheek pouch atrial trans-
plants and that acute ischemia suppresses automaticity.
The purpose of this study was to determine whether acute
ischemia suppresses TA. Neonatal hamster atrium was
transplanted to the adult hamster cheek pouch and studied
using microelectrodes four days later, after vasculariza-
tion had occurred. TA was initiated in 8 transplants by
spontaneous or paced action potentials. During control,
bursts of TA lasted 14.4 + 2.8 sec (mean + SEM) , had an
average cycle length of 439.5 + 40.2 msec-and terminated
following a subthreshold delayed afterdepolarization
(DAD) having an amplitude of 10.3 + 1.5 mV. Interruption
of blood flow to the transplants initially suppressed TA
induction by spontaneous action potentials, shortened TA
bursts induced by pacing, tended to prolong average TA
cycle length and reduced DAD amplitude. In two trans-
plants after complete suppression of TA DAD at control
amplitude no longer induced TA. TA could not be induced
after 15-72 minutes of ischemia. Suppression of TA
corresponded temporally with suppression of automaticity
and increased excitability threshold, as determined in a
separate group of transplants. These data indicate that
acute myocardial ischemia suppresses TA, possibly by
decreasing excitability and reducing pacemaker current.
C ACI0-
195±11#188±14
180±13*247±28
179±16#603±85
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C ACI0-
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186±141216±15
193±24*313±56
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N 6 133±5 140±4
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Basic Mechanisms of Cardiac Arrhythmias
CHOLINERGIC EFFECTS ON ELECTROPHYSIOLOGY OF ISCHEMIC
MYOCARDIUM AND ARRHYTHIIIAS
K. Chandrasekaran, MD; B.J. Scherlag, PhD, FACC; E.J.
Berbari, phD; L.A. Harrison, PhO, FACC; K. Friday, MD;
W.M. Jackman, MD; R. Lazzara, ~D, FACC, University of
Oklahoma, VAMC, Oklahoma City, OK.
Vagal stimulation (VS) prolongs the ventricular refractory
period slightly when sympathetic tone is high, but report-
ed effects on ventricular arrhythmias are inconsistent.
We studied the direct effects of VS on normal (N) and is-
chemic (1) myocardium in 6 Nand 14 infarcted dogs (2-10
days old) in vivo and of acetylcholine (AC), 10-6M and
10-5M on Nand I myocardium in epicardial preparations of
those hearts in vitro. VT/VF was induced in 5/14 dogs in
control and 0/14 during VS. VS prolonged refractory peri-
od (RP) significantly in I and Nmyocardium of infarcted
hearts in vivo without affecting conduction times (CT) or
electrograms (Eg). AC suppressed sustained reentrant fir-
ing induced in 2/14 preparations in vitro. AC greatly
prolonged refractoriness that extended beyond repolariza-
tion without effects on membrane potentials and Vmax, CT,
or Eg of driven action potentials. RP (msec, mean SEI1 in
N hearts (IN' Iy) are:
in vivo
THE EFFECT OF DIFFERENTIAL SHORTENING OF REFRACTORINESS
IN SUCCESSIVE SHORT CARDIAC CYCLES ON THE INITIATION AND
TERMINATION OF REENTRY IN THE ISCHEMIC CANINE HEART
Nabil El-Sherif, MD, FACC; William B. Gough, Ph.D.; Rahul
Mehra, Ph.D.; Robert H. Zeiler, Ph.D; Mark Restivo, MS,
Downstate and VA Medical Centers, Brooklyn, N.Y.
We correlated activation maps and effective refractory
period (ERP) maps in successive cardiac cycles (CC)
during reentrant excitation (R) induced by programmed
stimulation in the surviving epicardial layer in dogs 3-5
days post LAD ligation. When R was induced by a single
premature stimulus (S2) the activation map showed a long
arc of functional conduction block (ACB) and a figure of
8 circulating wave around both ends of the ACB. The ERP
map showed that the ACB developed at areas with juxta-
position of longer ERP (190-350 msec) in ischemic zones
and shorter ERP (140-190 msec) in border zones. When S2
failed to induce R there were fewer adjacent sites with
disparate ERPs and hence a shorter ACB. The circulating
wave reached the distal side of the ACB before ERP expir-
ed in areas proximal to the ACB. Introduction of an S3
further shortened ERP in normal and ischemic zones by 10-
40 msec. However, differential shortening at some border
zones (more in the normal than ischemic zones) resulted
in lengthening of the ACB. This forced the circulating
wave to travel longer, reaching the distal side of the
ACB after expiration of ERP in areas proximal to the ACB.
These areas were reexcited to initiate R. When R was
confined to a single beat this was again explained by
failure of ERP to shorten further in the central zone of
the ischemic layer resulting in conduction block and
termination of R. We conclude that differential shorten-
ing of ERP in successive short CC could modify the ini-
tial changes of ERP due to ischemia and explain both the
induction of R by multiple premature stimuli and the self
termination of R.
DEPENDENCE OF TRIGGERED ACTIVITY ON DIASTOLIC POTENTIALS
IN ONE DAY-OLD ISCHEMIC PURKINJE FIBERS, William B. Gough,
Ph.D.; Robert J. Zeiler, Ph.D.; Nabil El-Sherif, MD, FACC,
SUNY Downstate and VA Medical Centers, Brooklyn, N.Y.
Triggered activity has been previously reported to
occur in vitro in canine subendocardial Purkinje fibers
which have survived one day of myocardial infarction.
During the course of superfusion in vitro, the maximum
diastolic potential improves from the reduced -59mV±10
towards -87~4mV, and the ability to initiate or sustain
triggered activity is lost. Therefore, the effect of dia-
stolic potential on triggered activity was studied. Con-
stant current was passed through a Tyrode's-filled glass
suction electrode (0.5 mm in diameter) and transmembrane
potentials were measured simultaneously from nearby cells
using standard microelectrode techniques. In 10 prepara-
tions in which maximum diastolic potential had improved
and in which triggered activity could no longer be initi-
ated, depolarizing currents reduced the diastolic poten-
tial but did not directly initiate automaticity. However,
a train of stimulated beats during the depolarizing cur-
rent initiated triggered activity. In addition, when de-
polarizing current was not applied during the train of
stimulation, but was initiated during the last stimulated
beat of the train, triggered activity could be initiated
with a critical level of depolarization. In both cases
triggered activity stopped when the current stopped. In
5 other preparation in which triggered activity was sus-
tained, graded hyperpolarizing currents caused delayed
afterdepolarizations with diminishing amplitudes. There-
fore, triggered activity in ischemic Purkinje fibers de-
pends upon a critical range of diastolic potentials and
improves as the diastolic potentials "heal". This may
explain why triggered activity in ischemic Purkinje fib-
ers occurs during a limited time both in vitro and in
vivo.
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IN VIVO DEMONSTRATION OF DELAYED AFTERDEPOLARIZATION AS
A CAUSE OF VENTRICULAR RHYTHMS IN ONE DAY OLD INFARCTION.
Robert J. Hariman, MD, FACC; Ronald Holtzman, BS; William
B.Gough, Ph.D.; Rahul Mehra, Ph.D.; Joseph A.C. Gomes, MD,
FACC; Nabil El-Sherif, MD, FACC, SUNY Downstate and VA
Medical Centers, Brooklyn, N.Y. 11209
Delayed afterdepolarization (DAD) and triggered activ-
ity (TA) are important mechanisms of ventricular (V)
arrhythmias. However, in vivo recording of the phenomena
is not available. Recently we suggested that DAD and TA
are responsible for V arrhythmias in one day old myocar-
dial infarction (MI). To prove that this is the case, we
produced a small (range 2 to 4cm2) apical MI in dogs by
ligation of the multiple distal branches of left anterior
descending and circumflex coronary artery. Twenty to 26
hours post MI, 32 plunge electrodes were placed in the
endocardial surface of the area of MI. Unipolar electro-
grams were recorded using a multiplexer recording system
at high gains and through low pass filters. Suppression
of sinus activity by vagal stimulation produced monomor-
phic V rhythms with cycle lengths ranging from 450 to
1000 msec. The endocardial area of the earliest activity
during V rhythms showed a slow negative diastolic slope
and upstroke slope preceding each V complex. During spon-
taneous cessation of V rhythms or cessation induced by
intravenous propranolol (2 mg/kg) and verapamil (10 mg),
this area showed multiple rhythmic slow negative dias-
tolic potentials before the area became quiescent.
These rhythmic slow negative potentials are consistent
with subthreshold DADs that failed to propagate. V pacing
produced larger amplitude DADs or acceleration of V
rhythms. The results represent an in vivo correlate of
the in vitro demonstration of DAD and TA in one day old
MI in dogs. This study suggests that DAD and TA are
important in vivo mechanisms of V arrhythmias in the early
.phase of MI.
Monday, March 26, 1984
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Calcium Blockers in Congestive Heart Failure
VARIABLE, UNPREDICTABLE, AND DELETERIOUS HEMODYNAMIC
RESPONSE TO ORAL NIFEDIPINE IN SEVERE CHRONIC HEART
FAILURE: AN EXPERIENCE IN 32 PATIENTS. Uri Elkeram, MD,
Laura Weber, RN, Charles McKay, MD, Shahbudin Rahimtoola,
MD, FACC. USC School of Medicine, Los Angeles, CA.
Acute hemodynamic effects of oral nifedipine (ND)
(total dose of 20-SOmg) were studied in 32 patients (pts)
with severe chronic heart failure (CHF). At peak effecr
systemic vascular resistance (SVR) fell(~) from 1886 to
1410 dynes.sec.cm- S (P<.OI). Mean blood pressure (BP) +
from 96 to 85 mmHg (P<.OI), cardiac index (CI) increased
(t) from 2.06 to 2.48 L/min/m2 (P<.OI), stroke volume
index (SVI) t from 24 to 27 ml/m2 (P<.OI). No significant
change was seen in heart rate (HR) (89 vs 92 beats/min)
pulmonary artery wedge pressure (PAW) (24 vs 23 mmHg),
and stroke work index (SWI) (23 vs 24g.m/m2 ) .
Individual response to ND was variable. 10 pts showed
<15% t in CI (group A) and 22 pts showed >15% t in CI
(group B). 4 of group A pts showed significant + in CI
and/or t in PCW. Baseline (C) hemodynamic values and per-
cent change (%6) from control in the two groups were:
HR BP CI SVI SVR PAW SWI EF
Group A C 87 2.14 24 1678 24 22 0.19
%6 6 -II -5 -10 -2 9 -21
Group B C 99 2.02 23 1980 24 24 0.16
%6 2 -II 32* 30* -34* -4 12*
*·P<.OI from %6 in Group A; EF=efection fraction
In spite of significant difference in %6 in both
groups, clinical features, baseline hemodynamics and left
ventricular ejection fraction did not differ significant-
ly between the groups and could therefore, not be used to
predict the response of ND therapy.
Conclusion: 1.ND acts as a strong arterial dilator and
can t CI in pts with CHF. However, 10 of our 32 pts did
not respond and 4 of them even deteriorated hemodynami-
cally. 2. Unfavorable effect of ND cannot be predicted
from baseline hemodynamics or left ventricular function.
CIRCUS KOVEMENT IN THE TRICUSPID RING: AN IN VITRO KODEL.
Richard L. Page. BSj Lawrence H. Frame, MD. FACC; Brian
F. Hoffman, MD. FACC. Columbia University,
Department of Phatlllllcology, New York, NY.
NIFEDIPINE DOES NOT ALTER DIGOXIN LEVEL OR CLEARANCE
Janice B. Schwartz, MD, FACC; Philip J. Migliore, MD.
Sectlons of Cardlology and Pathology, 8aylor College of
Medicine, Houston, Texas.
CONCLUSION: Nifedipine administration does not alter
digoxin concentrations or clearance in healthy adults
in the absence of other drugs.
Because of the known influence of some calcium antagonist
drugs on serum digoxin concentrations and because the
findings of prior studies by us and others regarding the
effects of nifedipine are in conflict, we studied the
effect of oral nifedipine administration on stable serum
digoxin levels in healthy volunteers receiving no other
medication~ or interventions. Twenty males with a mean age
of 27±4 (x±SD) years completed an 8 week single-bl ind
study. They received open-label digoxin (Dig) O.375mg/day
throughout. After a 2 week digoxin only period, they took
digoxin combined with placebo for 2 weeks, then Dig and
nifedipine 18.5±O.4 (x±SD) mg po tid for 2 weeks, ending
with Dig and placebo for the final 2 weeks. Dig levels
were measured weekly and creatinine and digoxin clearance
every 2 weeks. Dig levels, Dig clearance, and creatinine
clearance during the initial and final placebo periods
were not significantly different. Importantly, no changes
were observed in digoxin levels or clearances during
nifedipine administration. Dig levels during the study
were:
Dig+Placebo
Week 2
Dig+Nifedipine
Week 1 Week 2
0.75
±.25
Dig+Placebo 2
Week 2
0.74
±.20
0.77
±.18
0.77
±.23
Serum Dig
nq/ml (x±SD)
We have described a canine model for reentrant (RE) tachy-
cardia (TACH), in which maps of excitation sequence
suggest the RE results from circus movement around the
tricuspid ring. We therefore attempted to induce RE in
isolated canine tricuspid ring. The preparation was super-
fused (70 ml/min) with Tyrode's containing 10-8 K norepin-
ephrine and 10-8 to 10-7 K acetylcholine, in a specially
designed tissue bath. Circus movement was induced in 6 of
6 preparations. lasting 15 to 80 min, with induction and
termination by either burst pacing or timed premature stim-
uli. The mean cycle length was 34StS2 mS at 33-340C and
27St7l mS at 37-38 0C. As for the RE in vivo, cycle length
was shortened by acetylcholine. The wave of excitation
travelled around the ring in either direction. Cutting the
ring abruptly ended the TACH and prevented reinduction.
Records of transmembrane potentials from the ring revealed
typical atrial action potentials. Histologic study of the
tissue revealed a circumferential orientation of atrial
fibers. Conclusions: 1) As was predicted by our in vivo
studies, circus movement around the tricuspid ring-ca-n---
cause sustained TACH; 2) This TACH satisfies the criteria
for RE; 3) The circus movement occurs in normally polar-
ized cells with fast responses; and 4) The model is suit-
able for simultaneous study of drug effects on atrial RE
and on action potential characteristics of cells in the
path for RE; 5) Histologic study revealed L circumfer-
ential orientation of the fibers above the tricuspid ring
aligned with the path of excitation during TACH that we
described in vivo and have now demonstrated in vitro.
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SVR -5
dyn/sec/cm
1815+571
1146+398*
1402+374
1009+379*
SVI 2
cc/m
24+6
37+8*
27+8
37+12*
HR MAP PCW CI 2
mmHg mmHg litres/m
PL-R 84+17 90+12 21+10 2.0+0.4
PN-R 78+11 77+12+ 18+6 2.7+0.5*
PL-Ex 113+21 107+14 32+3 3.0+0.1
PN-Ex 110+22 95+16* 24+3* 4.~1.3*
*~p<,Ol; + p<.05 for PL vS. PN
Compared to placebo PN reduced SVR by 39% at Rand 28%
during Ex. The increases in CI and SVI that were seen at
R were maintained during Ex along with a reduction in PAW
pressure. None of the 9 pts experienced side effects dur-
ing the acute drug trial.
These data demonstrate that PN 200-110 is a potent
vasodilating agent which substantially improves cardiac
performance in pts with CHF.
BENEFICIAL EFFECTS OF THE CALCIUM ANTAGONIST PN 200-110
IN PATIENTS WITH CONGESTIVE HEART FAILURE. David Broudy,
M.D., Barry Greenberg, M.D., F.A.C.C., Deirdre Siemienczuk
R.N. Oregon Health Sciences University, Portland, OR.
Preliminary studies with PN 200-110 (PN), a newly
available calcium antagonist, have suggested that its
predominant effect is on the peripheral vasculature. To
assess whether this drug might be of value in the treat-
ment of congestive heart failure (CHF) we administered PN
to 9 patients (pts) with New York Heart Association class
III-IV CHF. The 7 males and 2 females averaged 46 years;
ejection fraction was 0.32 (range 0.22 - 0.40).
Heart rate (HR). mean arterial pressure (MAP), pulmon-
ary artery wedge pressure (PAW), cardiac index (CI),
stroke volume index (SVI) and systemic vascular resist-
ance (SVR) were measured at rest (R) 3 hours after a
placebo (PL) was given and then 3 hours after 15 mg of PN.
In 5 pts measurements were also obtained during supine
bicycle exercise (Ex). The mean values + S,D. are shown
below: -
ACUTE EFFECT OF ARTERIAL VASODILATION WITH NIFEDIPINE ON
RENAL HEMODYNAMICS IN PATIENTS WITH SEVERE CHRONIC HEART
FAILURE. Uri Elkayam, MD; Laura Weber, RN; Vito Campese,
MD; saul Massry, MD; Shahbudin Rahimtoola, MD, FACC. USC
School of Medicine, Los Angeles, CA.
Renal blood flow (RBF) may be attenuated in patients
(pts) with severe chronic heart failure (CHF). Reducing
systemic vascular resistance (SVR) and augmenting cardiac
output (CO) with vasodilator therapy have shown variable
effect on RBF depending on the drug used. We evaluated
the effect of arterial dilation (>15% fall in SVR) with
nifedipine (ND)(20-50 mg) on renal hemodynamics in 8 pts
with CRF. Mean blood pressure (BP)(mmHg), CO(L/min),
SVR(dyn.sec.cm- S) , RBF (measured by p-aminohippurate
clearance in ml/min), renal vasculsr resistance
(RVR)(dyn.sec.cm-Sxl0 3, and glomerular filtration rate
(GFR) (measured by inulin clearance in ml/min) were
mesured at control (C) and at peak effect of ND.
(*-P<.05, **-P<.Ol)
BP CO SVR RBF RVR GFR
C 96!11 4.2!1.1 l753!466 607!126 l2!2 64!18
ND 86!6* 5.0!1.3** l295!3l2** 622!163 10!3 61!18
In addition a significant fall was seen in the ratio of
renal-systemic blood flow (O.15!0.02 to 0.13!0.03 P<.05).
In 7 pts the effect of ND on RBF was also compared in a
randomized crossover trial to that of 5-20mg of
intravenous hydralazine (Hyd). Initial hemodynamics prior
to administration of either drug were not significantly
different. Hyd resulted in only slightly greater decrease
in SVR than ND (-32% vs -26%, p-NS) but caused a marked
fall in RVR (11.9!3.1 vs lO.H2.6, P<.Ol) and rise Lu RBF
(572!165 to 644!188, P<.Ol). We concluded, therefore,
that: 1. Arterial dilation with ND in pts with CHF was
not associated with improved renal hemodynamics. 2. In
contrast Hyd in dose producing similar reduction in SVR
was associated with a significant increase in RBF.
HEMODYNAMIC EFFECT OF NISOLDIPINE IN CHRONIC CONGESTIVE
HEART FAILURE
WolfAlI!ll Thier, MDj Norbert Roewer, MD; Kurt P. Minderjlhn,MD; Peter Hlnrlth,
MD; Wllter Sllifelel, MD, FACC; Dept. of ClrdiolotY, Uni..nity Hospitll Hlmburg,
Welt Germony
COMPARATIVE VASODILATOR RESPONSES TO NIFEDIPINE,
HYDRALAZINE AND NITROPRUSSIDE IN PATIENTS WITH
CONGESTIVE HEART FAILURE. Gar~ W. Olson, M.D.; Joseph
R. LogIC, M.D.; and Patrick L. WltlOW, M.D., F.A.C.C.
University of Alabama in Birmingham, Birmingham, AL.
We compared the maximum hemodynamic effects of
nitroprusside (NTP), hydralazine (HYDZ), and nifedipine (NIF)
in 12 patients with both Class III-IV congestive heart failure
and coronary artery disease. Cardiac Index (CI) was
determined by thermodilution and ejection fraction (EF) by
standard gated nuclear methods. Values are mean! SEM.
~ NTP HYDZ NIF
8H4
81 ! 2*
18! 1* *
3.2! 0.2**
27! 3*
*41.6!4.1**
*96 ± 5**
82! 3*
17! 1* *
3.9! 0.3**
29! 2*
*46.5!:3.9**33.1!3.1
87! 4
77! 3*
14! 2*
2.7! 0.2*
27! 3*
87 t 4
97 ±3
21 ±2
2.2 ± 0.1
21 !,3
32.4±3.1
HR (bpm)
BP (mmHg)
PeW (rnrnrtg)
CI0/min/m"'2)
EF
Stroke Work
lndex t
*p < 0.05 compared to baseline; * *p < 0.05 compared to
nitroprusside; *' units = gram-meters/m2•
NTP and NlF caused no side effects but HYDZ caused angina
(4 patients), nausea (5 patients), and headache (5 patients). All
5 patients re-studied on NIF after 3 months showed sustained
improvement: EF = 31! 3* and CI = 3.0 ± 0.1.* In patients
with congestive heart failure and coronary disease we
conclude that: 1) nifedipine causes significant hemodynamic
improvement similar to hydralazine but significantly greater
than nitroprusside, even in those patients with severely
depressed EF; 2) nifedipine causes fewer side effects than
hydralazine and 3) nifedipine produces sustained hemodynamic
improvement over 3 months of chronic therapy.
The new calcium chlnnel blocker NilOldipine (NI hel been reported to hl.e I strong
.Isodillting effect in Inimol experimenll. In order to e..lulte ill .Iaodilltino effoct
in chronic congesti" hel" flilure, we ltudied 12 pelienll with lnoiOOrephicllly
proven coronary .nery di... (n-4) Or congestive Ardiomyopathy (n-8) with mo-
derlte to ..... left .entricullr dYlfunction (EF: 26±.11 %l. Left ventricullr per·
formlnee It rest Ind during otendlrdized (3 min 50 W) supine bicycle exerci.
WII e.llulted by SWln·Gln. thermodilution catheter. Sefore (e) Ind 14 dlYI
Ifter oral administrltion of 20 mg N per day helrt rete (HR), meln Irterill pressure
(MAPI, Itroke .olume index (SVn, Iyltemic II well al pulmonery .neullr reliltence
(SVR, PVRI Ind end-dilltolic pulmonlry Irtery prellure (EDPAPI wer. determined
Meen ;t.S.D.); 'p < .05,"p, < .02, + p < .01, ++ p < .001, N .1.C
T..... r_1ts show thet N hel I Itrong ocute Ind long stlndino .lIQdilltino effect
upon the Irterill end venoul sy.tem, which result. in en i....._t of left ven·
tricullr systolic II well II dieltolic perfo.-.
Rest Exerei.
C N C N
HR 83:1; 13 83:1: 11 124! 21 117! 14
Imin·1)
MAP a8! 13 1I6± 9 110:1: 14 107i 8
(mmHgl
SVI 35:1; II 45:1; 10' 381 11 481 1,··
(ml/m21
SVR 1346±271 1040±178+ 879±220 7201111'
dyn x I x cm-5)
PVR 149j.86 123;t. 66 159;t 75 116;t.61'
Idyn x I x cm-6)
EDPAP 241 a 20± 6' 37:1: a 28:1: 10++
(mmHgI
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Clinical Electrophysiology of Ventricular Arrhythmias
ENHANCED PERI OPERATIVE MORTALITY IN PATIENTS
WITH FASCICULAR CONDUCTION DISTURBANCES: HIGH-
RISK SUBGROUPS
Timothy Bateman, MD; Carolyn Conklin, RN; Mason Weiss,
MD; Lawrence Czer, MD; Morgan Stewart, MS; Robert Kass,
MD, F ACC; Jack Matloff, MD, F ACC, Richard Gray, MD,
F ACC, Cedars-Sinai Medical Center, Los Angeles, CA.
In pts with ischemic heart disease, left bundle branch block
(LBBB) and intraventricular conduction disturbances (IVCD)
are associated with increased martality rates. Enhanced
m orta Iity pers ists after coronary artery bypass surgery
(CABG): in 226 consecutive pts undergoing CABG, 8 of 21 pts
(38%) with LBBB or IVCD died during a follow-up period of
66:'14 months, compared to 4% of pts without LBBB or IVCD.
Further, we have identified a high-risk subgroup of pts with
LBBB/IVCD who died early postoperatively. Fourteen consec-
utive pts with LBBB/IVCD who survived >30 days postop
(Crp A) were compared to 10 consecutive pts with LBBB/IVCD
who died within 30 days of surgery (Grp B), drawn from our
computerized data base. Of the dying pts, 100% were cardiac
deaths, with heart failure the predominant cause in 7/10. Of a
large number of factors analyzed, the following were signifi-
cantly (p<.05) different (Crp A vs Grp B): Age (58:.7 vs 66:'9);
preop NYHA class IV angina (5/14 vs 9/10); preop ejection
froction (53:.18 vs 37:.16); preop left ventricular aneurysm
(2/14 vs 6/10); perioperative infarction (1/14 vs 7/10); postop
intra-oortic balloon pump (0 vs 5/10); and postop ventricular
tachycardia (1/12 vs 8/ I0).
In conclusion, in pts with LBBB or IVCD: I) there is an
augmented mortality post-CABG; 2) class IV angina, aneurysm,
older age, poor EF, and development of a periop MI identify a
particularly high-risk subgroup; and 3) the predominant mode
of death is cardiac failure, suggesting that the outcome is
related to poor left ventricular function.
BIFASCICULAR BLOCK ASSOCIATED WITH HYPERTROPHIC CARDIOMYO-
PATHY. CLINICAL, ELECTAOPHYSIOLOGIC AND PROGNOSTIC OBSERVA-
TIONS.
Fulvio Bellocci, MD; Pietro Santarelli, MD; Gerardo Ansalone, MD; Sandro Montene·
ro, MD; FrancoLoperfido,MD; PaoloZeechi, MD.
Catholic University of SacredHeart, Rome,ltaly.
Complete heart block (CHB) has beenreported occasionally in a few pts with hyper-
trophic cardiomyopathy (HCM), and nearly all pts exibited an ECG pattern of bifa-
scicular block (BB). However, little information is available regarding electrophysi-
ologic abnormalities in HCM. Ten consecutive pts (mean age39 yearsl with BB and
HCM underwent electrophysiologic 'study (EPSI. Five pts experienced syncope (S).
Repeated Holter monitoring(HM) revealed the causeof S in 4 pts (ventricular tachy-
cardia (VT) in 1 and transient CHB in 3). EPS, performed during sinus rhythm,
showed marked prolongation of H-V interval (> 70 msec.) in all pts, Atrial pacing
resultedin Mobitz type II block distal to H in 2 pts (in both HM had showntransi-
ent CHB). Ajmaline test produced II or III degree block distal to H in6 pts (includ-
ing the 3 pts with spontaneous transient CHB). All pts underwent pace-maker (PM)
irnplentation. During follow'tlp (mean 37 months). the pt with documentedVTdied
suddenly and 7 pts, including all 6 pts with previously documentedspontaneousor
induced heart block, developed permanent II or III degree block; no pt presented
recurrent S. Sudden death (SO) and S in HCM are usually attributed to ventricular
tachyarrhythmias, Our data demonstrate that BB in young adults with HCM is
associated with severe progressive involvment of distal conduction and suggest
paroxysmal CHB as cause of S. Obviously, in this unusual subgroup of pts beta-
blockers and calciumantagonists are not indicated,whileSand pO$sibly SO may be
avoided by PM implantation.
ABSENCE OF CARDIOVERSION INDUCED ARRHYTHMIAS IN DIGIT-
ILIZED PATIENTS NOT ON ANTIARRHYTHMICS
Douglas L. Mann, MD; Alan S. Maisel, MD; Gary Crossland;
J, Edwin Atwood, MD; Martin M. LeWinter, MD; Robert L.
Engler, MD, San Diego VAMC and UCSD, La Jolla, Cal if.
Previous studies concerning the incidence of cardiover-
sion (CV) induced ventricular arrhythmias in digitilized
patients have included large numbers of s~bjects ~ak~ng
antiarrhythmic drugs. Therefore, we studIed the IncI-
dence of CV induced ventricular arrhythmias in patients
with a therapeutic digoxin level, who were not on any
antiarrhythmics. All patients undergoing elective CV for
atrial fibrillation during a six month period were con-
sidered for inclusion in the study. Patients requiring
supranormal levels of serum digoxin for control of ven-
tricular response, or antiarrhythmics were excluded_ .
Fourteen patients were studied with ambulatory ECG monI-
toring for 21.4 hours (range 20-25) before and 5.6 hours
(range 4-8) after CV. The mean cumulative energy level
applied was 346 watt seconds (range 100-800). The serum
digoxin level drawn at the time of CV was 1. 1±?48 mcg/dL
(mean±SD). No patient developed complex ventricular ar-
rhythmias during the immediate 5 minute period post CV.
Pre and Post CV incidence of premature ventricular con-
tractions (transformed to IOgI0), couplets, triplets and
ventricular tachycardia was compared by t-test. There
was no significant (p>O,05) difference in the incidence
of premature ventricular contractions, triplets or ve~­
tricular tachycardia post CV; there was, however, a sig-
nificant (p<0.05) reduction in the incidence of post ~V
couplets. We conclude that patients with a therapeutIc
digoxin level may be safely cardioverted without the
concomitant use of antiarrhythmic agents.
RISK OF MAXIMAL EXERCISE TESTING IN PATIENTS WITH
MALIGNANT VENTRICULAR ARRHYTHMIAS
David Z. Young, MD; Steven Lampert, MD; Thomas B.
Graboys, MD, FACC; Bernard Lown. MD, FACC, Harvard
University. Boston. MA
While maximal exercise testing is useful for arrhythmia
detection and assessment of antiarrhythmic drug effi-
cacy. few reports have documented the safety of this
procedure in patients (pte) with malignant ventricular
arrhythmiae (MVA). We reviewed the complications (C)
of symptom limited exercise in 263 pts with MVA (mean
age 54 years; 197 men, 66 women) who underwent 1377
maximal treadmill tests (ETT). C was defined as need
for a medical intervention as a result of ETT. The
population studied consisted of 99 pts (38%) presenting
with ventricular fibrillation (VF), 95 pts (36%) pre-
senting with hemodynamically compromising ventricular
tachycardia (VT), 34 pts (13%) presenting with non-
-hemodynamically compromising sustained VT and 35 pts
(13%) presenting with non-sustained VT. One hundred and
sixty-four pts (62%) had coronary heart disease (HD),
32 (12%) had valvular HD, 29 (11%) had miscellaneous HD
and 38 (15%) had no HD. Results are as follows:
Total C No C
Number of pta""2"63 24 (9-:-1%) 239\90.9%)
Humber of ETT 1377 32 (2.3%) 1345 (97.7%)
C included VF (9). VT requiring cardiovereion (7). VT
requiring drug therapy alone (15) and bradycardia re-
quiring closed chest massage (1). There were no deaths
or myocardial infarctions. Of note. among pts free of
C 17 pts (6.5%) had an episode of sustained VT (>100
beats) which terminated spontaneously during 24 ETT's
(1.7%). Ve conclude that maximal exercise testing can
be conducted safely in pts with MVA.
ABSTRACTS
PROLONGED ELECTRICAL SYSTOLE IN LEFT VENTRICULAR ANEURYSM
Harisios Boudoulas, MD FACCj Larry Hromalik; Charles A.
Bush, MD,FACC; Stephen F. Schaal, MD,FACC; Carl V. Leier,
MD,FACC; Richard P. Lewis, MD,FACC, The Ohio State
University, Columbus, Ohio.
Electrical systole (QT) longer than electromechanical sys-
tole (QS2) and QT prolongation are associated with high
incidence of sudden death in patients (pts) with coronary
artery disease (CAD). Dissimilar depolarization-repolar-
ization in the left ventricular (LV) myocardium may pro-
duce QT >QS2 or long QT. In 61 unse lee ted pts wi th CAD
and LV aneurysm, 46 pts with CAD and a history of previous
myocardial infarction (MI) but no LV aneurysm (CAD-MI),
and 47 pts with CAD without previous MI (CAD-No MI), QT
and QS2 were measured simultaneously with a speed of 100
mm/sec within 48 hours after cardiac catheterization. Pts
on Class I antiarrhythmics were excluded. Pts with QT >
QS2, short QS2I and long QTI (QS2 and QT corrected for
heart rate are shown. *pcO.05 between aneurysm and non
aneurysm groups. QT 7 QS2 Short QS2 I Long QTI
(72SD) ( >2SD)
Aneurysm (n=61) 46 (75%)* 3 (5%) 25 (41%)*
CAD-MI (n=46) 10 (22%) 9 09.5'7.) 2 (4%)
CAD-No MI (n=47) 8 (l7'7.) 4 (8.5'/.) 1 (2%)
Pts with aneurysm had significantly higher incidence of
QT 7 QS2 and long QTI. The incidence of long QTI and QT >
QS2 was not statistically different between CAD-MI and
CAD-No MI pts. There was no significant difference in
the extent of vessel disease, age, sex or therapy among
the three groups. The QT >QS2 or long QTI in aneurysm
pts most likely is due to abnormalities of depolarization
or repolarization within or in the border zone of the LV
aneurysm. These results provide insight into the mecha-
nism of sudden death in pts with QT>QS2 and/or long QT
and help explain the high incidence of arrhythmias in
pts with LV aneurysm.
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Drug Therapy of Chronic Angina
LONG TERM EFFICACY OF D1LT1AZEM ASSESSED WITH
MULTISTAGE GRADED EXERCISE TESTS 1:-1 PATIE:-ITS WITH
CHRONIC STABLE ANGINA.
Michael J Bowles, MB, MRCPj Nardev S Khurmi, '1RRSj
Martin J O'Hara, MB, MRCP ; V Rala Subramanian, MD.
FACC; Edward R Raftery. MD, FACC. Cardiology
Department, Northwick Park Hospital & Clinical
Research Centre, Harrow, '1iddx •• England.
Seventeen patients were assessed with a placebo
controlled double blind dose titration protocol and
afterward all patients were put on diltiazem 120 mg
thrice daily. Exercise tests were performed at the
end of 2 weeks of placebo period and after 1'>, 18,
26, 40 and 52 weeks of diltiazem therapy. The mean
+ SEM exercise time of 5.8+0.7 mins on placeho
increased to 10.8+1.0 min after 6 weeks. 11.1+1.1
min after 18 weekS, 11.4+1.1 min after 21'> weeks
12.9+1.2 min after 40 weeks and 11.1'>+1.1 min afte;
52 weeks of diltiazem therapy. (p(O.-oOI vs placebo
at all stages). 17 patients were followed upto 8
weeks, II'> upto 21'> weeks and II up t o 52 weeks.
Similarly I mm ST depression time was prolonged on
diltiazem as compared to placebo (p(O.OOI vs
placebo). One patient was withdrawn because of
skin rash after 39 weeks, another patient developed
myocardial infarction after 8 weeks of diltiazem
therapy and died. Four patients showed transient
increase in CPK level. In conclusion diltiazem in a
dose of 360 mg daily possesses a powerful and
sustained antianginal effect and should be placed
amongst the first line antlanglnal drugs.
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CARDIAC AND SKELETAL MYOPATHY IN PATIENTS WITH
CARDIAC DYSRHYTHMIAS
Ann Dunnigan, MD; Mary Ella Pierpont, MD, PhD; Galen
Breningstall, MD; Stephen A. Smith, MD; David G. Benditt, MD,
FACC; D. Woodrow Benson, Jr., MD, PhD, University of
Minnesota, Minneapolis, MN.
We performed electrophysiologic studies, echocardiograms,
cardiac catheterizations, and histologic and biochemical analyses
of skeletal muscle biopsies in II patients (ages I day-37 years,
mean=19 years) who had dysrhythmias as the initial
manifestation of cardiomyopathy. Presenting symptoms and
signs attributable to dysrhythmias included: sudden cardiac
arrest (2/1 I), syncope (3/11), presyncope 0/1 I), palpitations
(2/ II), and congestive heart failure from bradycardia (1/1 I).
There was no clinical evidence of skeletal muscle weakness in
any patient.
Multicatheter electrophysiological evaluation established
diagnoses of ventricular tachycardia (6/ II), primary atrial
tachycardia (2/1 I), and second or third degree infraHisian heart
block (2/11). One patient (1/1 I) presenting with palpitations had
no inducible arrhythmia or conduction disturbance.
Echocardiographic, angiographic, and hemodynamic studies
demonstrated previously unsuspected dilated cardiomyopathy in
8/ II patients and restrictive cardiomyopathy in 3/ II patients.
Skeletal muscle histology was abnormal in 11/ II patients with an
increase in lipid droplets and endomysial fibrosis being the
characteristic findings. Serum free carnitine and short and long
chain acylcarnitine were normal in 10/11 patients. However,
skeletal muscle long chain acylcarnitine was reduced in 9/10
patients.
These findings support the concept that dilated or restrictive
cardiomyopathy presenting with dysrhythmias may be one
manifestation of a generalized myopathy.
LABETALOL IN THE MANAGEMENT OF ANGINA
James W Upward,MRCP, Fawaz Akhras,MD,Graham Jackson,MRCP
Cardiac Department, King's College Hospital,
London, SE5 9RS, England, UK
In this study the efficacy of the alpha and beta
blocking agent labetalol was evaluated in the treatment
of stable angina. Ten patients with angiographicalIy
proven coronary artery disease who were limited by angina
pectoris were studied. After a single blind 2 week
placebo period, labetalol was administered twice daily in
four 2 week periods. The daily labetalol dosage allocated
to these 4 successive periods was 200, 300, 400 and 600mg.
Diaries of angina attacks and nitrate (GTN) consumption
were kept. Maximal treadmill exercise tests,using the
Bruce protocol, were performed in the second week of each
period, 3 and 12 hours after dosage. One patient
required dosage reduction because of mild heart failure.
In 9 patients the exercise tolerance increased from 258
sec (!: 39 SE) to 300 : 49, 361 : 54 (p(0.05), 387 : 52
(p(0.005) and 399 : 54 sec (p(0.05) in the 4 successive
treatment periods (increases of 16,40,50 and 55% respect-
ively). These increases were accompanied by aslgniflcant
reduction in peak exercise rate-pressure product. In the
same periods angina attack frequencr decreased from
9,6 : 2,5 per week to 7.8 : 3, 5.7 - 3, 4.2 : 2 (p(0.05)
and 3.6 : 2 (p(0.05); and GTN consumption decreased from
7.3 : 2.8 per week to 6.3 : 3.6, 4.1 : 3.2 2.9: 2
(p(0.05) and 2.9 : 2.4 (p(0.05). Trough ~oint exercise
tolerance did not differ significantly from peak, at any
dosage level.
We conclude that labetalol is an effective well
tolerated anti-anginal agent. It can be given twice
daily and is most effective at 400 mg and 600 mg daily
dosage.
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COMPARATI VE EFFECTS OF NITROGLYCERIN AND NIFEDIPINE ON
COLLATERALS DURING EXERCISE IN PAT I~S WITH EFFORT
ANGINA
Koichi Tani ura, MD; Kazuhi sa Kodama , MD ; Shinsuke Nanto,
MD; Kiyomu Ishikawa , MD; Mi ch i t oshi I noue , MD ; Hiroshi
Abe, MO , FACC, Cardiac Inten s i ve Car e Uni t of Osaka
Police Hospital , Osaka, Japan .
The role of col latera ls in effort angina (EA) is consider-
ed impor tant because of relieving myocardial ischemia.
The effec t s o f nitroglyce rin (NG) and ni fedipine (NF) on
col l aterals remains unclear . To assess it direct ly and
cl i n i ca l l y , consecut ive supine exercise tests were per-
formed on 20 patients wi th EA unde r no medicat ion (con -
tro l , C), intravenous NG (0 .2 mg) and sublingual NF (10
mg ) . Si multaneous mean ar terial pressur e (MAP) , stroke
index (5 1) , pulmonar y arterial end- diastolic pr e ssur e
(PAEOP) and co r onar y blood f l ow (CBF) were measured and
co ron ar y angiogr aphy were performed at rest and at angina
dur i ng exerc ise (Max). Mean r e sponses were as follows:
Rest .-:..M;..:a:.:;xe-__
C NG NF C NG
MAP (mmHg) 104 99 94** 122 124
SI (m l / minl 44 43 47 53 54
PAEOP (mmHg ) 9 7** 10 24 21*
CBF (ml /min) 72 54** 68 164 184*
*p<0 . 005, **p<O.OOl ; C ve rsus NG & NF
In add i t i on, t he col l a t e r a l s visua l ized at r e st wer e
d i mi ni shed or disappea re d at a ngina dur i ng exercise i n C
but were rema i ned in NG as well as t hose at res t .
In NF, the co l l at er a l s o f 12 cases were remained , but
wer e diminished in 8 cases . These data suggest that NG
reduces i n preload and i ncreases i n regional f low t o is-
chemi c myocardium via collaterals but NF mai nl y t ends t o
suppres s the myocardial oxygen consumption due to reduce
in a fterload.
PROPRANOLOL ALONE AND IN COMBINATION WITH THREE CALCIUM
ANTAGONISTS: LEFT VENTRICULAR FUNCTION AND VOLUMES AT
REST AND DURING EXERCISE IN PATIENTS WITH ANGINA.
Donald L. Johnston, MD, Robert Lesoway; MD, Pam Mickle,
BScN; Dennis P. Humen, MD; William J. Kostuk, MD, FACC,
Universi ty Hospital, London, Canada.
Nineteen patients (pts) with exertional angina and normal
left ventricular (LV) function entered a
placebo-controlled, double-blind, randomized, crossover
trial. Pts received propranolol (P) 160 mg daily alone and
in combination (combo) with verapamil (V) 360 ~ daily,
diltiazem (D) 240 mg daily or nifedipine (N) 60 mg daily.
Each 4 week treatment period was followed by supine rest
(Rs)/exercise (Ex) radionuclide ventriculography.
Eje ction fraction (EF), end-systolic volume (ESV),
end-diastolic volume (EDV) and cardiac index (Cl) were
derived. Resting values are shown below. Values =mean ±
SD.
P P+V P+N P+D
EF (%) 62±11 58±10 61±10 60±10
ESVI (ml/m2) 39±25 45±26 40127 42127
EDVI (ml/m2) 92±34 102±31 92139 100136
SVI (ml/m2) 56±10 57±12 56111 57113
CIO/min) 3.6±0.8 3.4±0.6 3.8±1.1 3.2±0.7
Of the 3 calcium antagonists, V caused the greatest
increase in Rs cardiac volumes when combined with P. These
changes however, were slight and no changes occurred in EF
or symptoms. During Ex, EF and volumes were unchanged wi th
the combo's compared to P alone. Thus in pts with normal LV
function, the addition of V, D or N to P causes little
deterioration in Rs function and no improvement in Ex LV
function when compared to Palone.
THE BENEFICIAL EFFECT OF COMBI NED DILTIAZEM AND
PROPRANOLOL TREATMENT IN EFFORT RELATED ANGINA
PECTORIS
Jo hn Kenny, MRCPI; Peter Kiff, MRCP ; J oanna Holmes ;
David E. Jewitt, FRCP. Cardiac Department, King's
College Hospital, London, SE5, England.
The ant i angi nal effects of di lt i azem (D) 60 mgs three
t i mes a day, propranolo l (P) 80 mqs t hr ee times a day,
alone and i n combination, were i nve s t i ga t ed i n twelve
patient s with effort re lated angi na in a double blind
placebo controlled cross over t r i al , each treatment
period lasting four weeks . Time t o onse t of angina
was increased from 308 seco nds on pl ac ebo to 352 and
375 sec onds after P and 0 a lo ne (p<0. 05 ) , but increased
t o 438 seconds after 0 and P combi ned (p<O.Ol ) .
Simi larly the sum of the depre ssed ST segments in a
t welve lead ECG at peak exercise decreased from 7 mv in
t he placebo period to 5.4 mv after 0 and 5.5 mv after
P a l one , decreasing further to 4 .5 mv after D and P
combined (p<0.02). The total number of anginal episodes
decreased from 33 in the placebo period to 14 on 0 alone
and 7 on P alone, reaching 6 ep isodes during the combined
o and P treatment period . The peak rate pressure
product decreased from 24.8 mmHg beats/minute 10- 3 in
t he placebo period to 23.3 on 0 and 17 .5 on Palone
(p<O.Ol l reaching 14.7 mmHg beats/min/lO- 3 cn combina-
t ion t herapy (p<O.OOll . This study clearly demonstrates
the super ior value of combination treatment with 0 and P
i n effort related angina when compared with the use of
e ither drug alone .
THE TREATMENT OF ANGINA PECTORIS WITH CALCIUM CHANNEL
AND BETA BLOCKERS, EFFICACY AND EFFECT ON CARDIAC
FUNCTION.
lain N. Findlay Miep, Gerard Gillen BSc, Alex T. Elliott
PhD, .Henr y J. Dargie FRCP. Depart_nt of Cardiology
Western Infirmary Glasgow, Scotland U.K.
Although the combination of calcium channel and beta
blockers is effective in angina pectoris, concern exists
about possible depression of cardiac function. We
investigated the effect on left ventricular function
by radionuclide ventriculography of nifedipine 20mg
tds and atenolol 100mg/day and of verapamil 120mg tds
and atenolol IOOmg/day, singly and in combination, in 16
and 15 patients reapectively with stable angina pectoria.
Each study was placebo controlled and double blind. with
treatment periods Lasting 3 weeks. During nifedipine,
atenolol and that combination, exercise ST depresaion
decreased from 2.3±Q.5.. on placebo to 1.7~.4mm (NS),
0.929.3mm (p<0.02) and 0.7~.3mm (p<0.005) respectively.
Resting ejection fraction did not change on combination
from placebo (58tl v 6Q±2). During verapa.il, atenolol and
that combination, exerciae ST depression decreased from
2.6ZQ.4.. on placebo to 0.6jp.3am (p<O.OOI), 0.7tD.3mm
(p<0.OO5) and 0.3±O.2am (p<O.005) respectively. On this
combination 4 pat~ents withdrew because of profound
lethargy and I patient developed frank left ventricular
failure. In tho~e patie~ts completing the study, restina
ejectien fraction fell from ~2 on placebo to 53±3 on
combination (p<O.06). During ambulatory monitoring 4 pat-
ients developed significant bradycardia «40 ~eats/.in)
with periods of sinus arrest and A-V nodal escape rhythm.
We propose that the place of nifedipine is in combination
with a beta blocker; verapamil alone is an effective
anti-anginal agent but its co.bination with a beta
blocker can have significant effects on cardiac function.
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Arrhythmias in Children: Diagnosis, Treatment
and Prognosis
IMPROVH1ENTS IN THE TREATlIENT OF ATRIAL AUTOIIATIC
ECTOPIC TACHYCARDIA
Paul C. Gillette, 110, FACC; Arthur Garson, Jr., 110, FACC;
Co-burn J. Porter, MD, FACC; Pat McVey, RN; David Ott,
NO, FACC; Denton A. Cooley, 110, FACC, The Lillie Frank
Abercrombie Section of Cardiology, Department of Pedi-
atrics, Baylor College of Iledicine and Texas Children's
Hospital, Houston, TX
Chronic atrial automatic ectopic tachycardia (AlT) is
an uncommon form of SVT which has been considered benign.
The clinical characteristics of 13 of these patients
were: persistent tachycardia 13, repetitive tachycardia
0, variability of the tachycardia rate 10, and failure to
convert with: verapamil 8, cardioversion 4, overdrive
pacing and programmed stimulation 13. Nine patients had
abnormal ventricular function. One had severe cardio-
myopathy and was referred for transplantation. Each
patient had complete electrophysiologic study with endo-
cardial Mapping.
Surgical treatment consisted of cryoablatiun of a left
atrial focus in 5 cases, 3 with and 2 without cardio-
pulmonary bypass (CPO), removal of the right atrial
appendage in 5 cases and cryoablation and removal of
parts of the right atrial free wall in 2 cases with CPO.
One case had transcatheter ablation of a right atrial
appendage automatic focus with complete normalization of
her rhythm. Eleven of 12 surgical cases had complete
ablation of their AET with resumption of sinus rhythm.
Each successful case had improvement in cardiac function
as measured clinically by echocardiography and chest
chest x-ray.
An aggressive diagnostic and therapeutic approach is
warranted in these patients to prevent or treat cardio-
myopathy. Excellent results are possible.
SURGICAL MANAGI}!ENT OF REFRACTORY SlIPR\\l,\TRICUL\R T.\OIY-
ARRIIYTI r-1IAS IN CIII LDRE\;
David A. Ott, ~ID, FACC; Paul C. Gillette, ~m, FACC;
Denton A. Cooley, fID, FACC; Dan G. ~Ic\amara, sm, F.-\CC;
Arthur Garson, Jr., sm, FACC
Texas Heart Institute, Houston, Texas 7:030
Sixty-five children undeTh"ent attenJ!1ted surgical correc-
tion of refractory supraventricular arrhythmias us ing a
combination of intraoperative electro!,hysiologic mapoino.
followed by surgical division or cryoahl at i on of aberrant
conduction pathways. or atrial ectopic foci. Patients
ranged in age from 6 months to 18 years (mean 11.-1 years).
fifty-three patients had abnormal conduction patbwavs
crossing the atrioventricular junction (Kent bundle).
Thirty-five (66~) of these patients had classical 1I0lff-
Parkinson-White vi th a delta wave of pre-excitation on
surface EKG. Eight.cen (33~). however , dcmonstratcd only
retrograde conduction across the Kent bundle and had nor-
mal surface electrocardioerams when not in tachycardia.
Kent bundles were isolated to the following locations:
Right anterior or lateral 18 (33.9~), left posterior or
lateral 22 (4l.S~). posterior septal 9 (16.9~), anterior
septal 2 (3.:~), and both right and left 2 (3.7~).
follo~up extends to 89 months (mean 28.8 months) with 6
ilnmediate failures and 1 late reCUrrence. Recent refine-
ments in technique and the use of cryoablation for septal
lesions have improved our results. Twelve patients under-
went surgery for atrial ectopic foci by the followinp,
techniqucs: Cryoablation 7, excision 1, and both excision
and cryoablation 4. At 16.6 months mean followup there
was one late recurrence in the atrial ecto~ic focus group.
Children with refractory supraventricular tachycardia,
evcn in the absence of pre-excitation on EKG, should
undergo complcte elcctrophysiologic study to elucidate
the mechanism of tachycardia. Surgical treatment is safe,
predictable and offers the opportunity of a lifelong cure.
EVIDENCE THAT SOME "AV NODE REENTRY" INVOLVES TWO
ANATOMICALLY SEPARATE PATHWAYS
Richard T. Smith, MD; Paul C. Gillette, tV, FACC; Arthur
Garson, Jr., MD, FACC; Ali Massumi, MD; FACC; Pat
McVey, RN, The Lillie Frank Abercrombie Section of
Cardiology, Department of Pediatrics, Baylor College of
Medicine and Texas Children's Hospital, Houston, TX
Atrioventricular node reentry (AVNR) is one of the
most common mechanisms of supraventricular tachycardia
(SVT). It has been shown to be due to "functional longi-
tudinal dissociation" of the AV node in most cases. An
uncommon form of AVNR-SVT has been defined with a normal
PR interval and long RP interval during SVT. We studied
5 patients with this form of AVNR-SVT by electrophysio-
logic studies (EPS) and catheter ablative techniques.
Their ages were 2, 3, 8, 10, and 22 years. Three had
moderately severe cardiomyopathies.
In each case EPS defined retrograde dual AV node path-
ways and a reentry SVT using the fast pathway in the
antegrade direction and the slow pathway in the retro-
grade direction. Decremental conduction was present in
both directions in each patient indicating that both
structures had AV node-like properties. In 3 patients
the slow retrograde pathway was blocked for 4-6 hours by
a 2-4 joule/kg shock through the catheter. Antegrade
conduction persisted in each patient. In 3 patients the
bundle of His was permanently ablated by catheter tech-
nique and a pacemaker waa inserted. Retrograde conduc-
tion persisted in each. Thus, it is posaible to tempo-
rarily or permanently ablate conduction through either
pathway without affecting the other. Definitive surgical
treatment of the retrograde pathway should be poaaible
without need for a pacemaker.
THRESHOLDS FOR TRANSESOPHAGEAL ATRIAL PACING
IN CHILDREN
Macdonald Dick II, M.D., Robert M. Campbell, M.D., Janice
M. Jenkins, Ph.D., C.S. Mott Children's Hospital, University
of Michigan, Ann Arbor
Transesophageal atrial pacing has recently been reported for
acute conversion of supraventricular tachycardia (SVT) in
both adults and children. To determine the threshold in
milliamps and pulsewidth required for transesophageal atrial
capture in children, we atr ially paced 6 patients, aged 2 to
16 years (median 9 years) for 8 episodes of SVT (I SVT, 7
atrial flutter) through either transesophageal bipolar (2 rnm)
"pill" electrode (I) or tr ansesophageal standard bipolar
(JOmm) electrode catheters (4 French) in six. A step-wise
protocol, begining with initial pulsewidth 4 msec and current
5 mamps (constant current stimulator), was used,
incrementing the impulse strength alternately by I msec and
2 mamp until successful capture was achieved. Optimal
pacing site was estimated by the maximal esophageal P wave
amplitude detected as the electrode was slowly withdrawn.
Sedation with either morphine sulfate, benedryl, chloral
hydrate, or diazepan was used in five; general anesthesia
was used In our first' subject; one patient was converted as
an outpatient without sedation. Current and pulsewidth
duration required for capture were (x ± SD) 13.1 ± 3.8 mamps
and 6.1 ± 2.8 msec respectively, and were not related to
age or size. These leveIs were much lower than those that
produce mucosal hyperemia in experimental models (100
mamps, 20msecl. Successful conversion occurred in 6 of 8
trials. Although each patient experienced esophageal
discomfort ("heartburn") during successful pacing, no other
side effects were noted. These data indicate that successful
atrial capture can be achieved in children through the
esophageal route; the energy required is safe and produces
only transient esophageal discomfort.
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APPLICATION OF SIGNAL-AVERAGED ELECTROCARDIOGRAMS IN
PEDIATRIC PATIENTS
C. Elise Duffy, MD, FRACP, Milton H. Paul, MD, FACC.
82 signal-averaged ECGs (SAECG) were performed on 78 pa-
tients for one or more of the following reasons: (I)
research protocol, (2) congenital or acquired A-V or bi-
fascicular block, (3) complex ventricular dysrhythmia. A
clearly defined His potential was obtained in 51 patients
(65%), the main reason for failure to do so being in-
ability to separate the atrial and His electrograms in pa-
tients with a normal PR interval. In 17 patients, the HV
interval was obtained by SAECG (HVSA) and by intracardiac
recording (HVIC). There was a linear correlation such
that HVIC=0.71 HVSA + 16.66 msec, (r-0.74, SEE=3.95). In
16 of 18 patients with A-V or bifascicular block, an HV
interval was identified; failure was due to excessive
noise in one, but in the other, the SAECG was of good
quality. In this patient with postoperative 30 A-V block
and a wide QRS escape rhythm, the His potential may have
been related to the atrial electrogram (distal block), and
since there was no fixed relationship to the QRS, it would
have been averaged out. In patients with RV hypertrophy
or RBBB, a comparison was made between the longest ventri-
cular activation recorded by SAECG (VASA) and by RV endo-
cardial mapping (VAIC). There was a linear correlation
such that VAIC-0.91 VASA + 9.48 msec (r-0.98, SEE-7.64).
SAECG was applied to patients with RBBB following intracar-
diac repair of ventricular septal defect, tetralogy of
Fallot and related conditions. Patients with clinically
significant ventricular dysrhythmia tended to have longer
VASA (mean-176.25 msec, S0-39.1) than those without (mean
-152.23 maec, S0-26.01), p<0.05. SAlCe is a useful non-
invasive technique providing important prognostic infor-
mation in these patients.
SUDDEN DEATH IN PEDIATRIC CARDIOVASCULAR PATIENTS:
RELATIONSHIP TO PRIOR DYSRHYTHMIAS
Arthur Garson. Jr •• MD. fACC; Paul C. Gillette, MD, fACC;
Pat McVey RN; larry A. latson, MD; Dan G. McNamara, MD,
FACC; liilie frank Abercrombie Section of Cardiology,
Department of Pediatrics, Texas Children's Hospital and
Baylor College of Medicine, Houston, Texas
Sudden death (SD) is perhaps the most feared consequence
in medical practice because of the implication that ~he
SD might have been preventable. In order to det.ermfne
the possible relationship of pr-Ior dysrhythmias (D) to
subsequent SO and to determine if vigorous treatment of D
reduced the incidence of SO, we reviewed the records of
the 23,402 patients we have seendn the last 25 years;
101 died suddenly (SD defined: over 1 year old, sudden
event outside hospital, more than 1 ~nth sfter cath/
cardiac surgery patient not scutely 111). The .most
common diagnoses: cyanotic CHD PO shunt 12~, unop E1sen-
menger lB., PO TOf ll~, TOf unop 7', congestive cardio-
myopathy (CM) ~, PO AV canal 5~, PO Mustard 5~, long QT
5~. None had normal heart or mitral prolapse. Mean age
at death was 12.4 years (range 1.0-30.0). In the year
before death 72~ were NYHA class Ill-IV, 87~ had cardio-
megaly on C~R, 89' poor hemodynamics at ~ath. D we~e
present on routine ECG (taken 1 wk-lyr pr ror to SO) m
57': 22S of the 101 patients had PVC, 13% complete AV
block, 12% junctional rhythm, 8' atrial flutter, l' SVT,
a V tach. D were present in more than 50' of the
following: CM, long QT, PO TOf, PO AV csnal, PO Mustard;
D occurred in less than 50S of: unop Eisenmenger, TOf
unop cyanotic CHD PO shunt. Among the diagnoaes, D were
related (p<.Ol) to poor hemodynamics. SD oc~urred during
aports in 22S, at rest 50S t . asleep 28~. Pr1mary D ca~se
of SD was probable in 62:1i. Companng 1959-1978 nth
1979-1983 (and more agressive D management), incidence of
SD halved from .57' to .27' (p<.Ol). In conc.luafom 1)
SD was significantly related to poor hemodynamics and
prior D. 2) With improvement in treatment practicea, the
incidence of SD has been reduced significantly from
previous yeara.
Monday, March 26, 1984
4:00-5:15PM Ballroom A
Cardiovascular Epidemiology in Young People
and Childhood
RELATIONSHIP OF SERUM VERY LOW DENSITY LIPOPROTEINS TO
MEASURES OF CARBOHYDRATE INTOLERANCE IN CHILDHOOD.
BOGALUSA HEART STUDY
Gerald S. Berenson, MD, FACC; Sathanur R. Srinivasan, PhD;
Larry S. Webber, PhD, LSU Medical Center, New Orleans, LA.
Elevation of serum lipid levels and abnormalities in glu-
cose tolerance are considered indepemlent cardiovascular
risk factors. The relationship of VLDL-lipid (cholesterol
and triglycerides) levels to fasting and post-glucose
plasma glucose, insulin and FFA levels were examined in 4
subgroups of children (N-311, ages 6-18 yrs) from a total
biracial population whose earlier B- and/or pre-B-lipopro-
tein-cholesterol levels were in the extreme quintiles or
quartiles. High B-lipoprotein-cholesterol strata with or
without elevated pre-B-lipoprotein-cholesterol showed sig-
nificantly high levels of FFA and glucose response (mean,
30 and 60 min) to oral glucose load; whereas post-glucose
insulin responses were markedly higher in the high pre-B-
lipoprotein-cholesterol strata. VLDL-triglycerides re-
lated closely with fasting plasma glucose (r-0.53 to 0.60,
p<O.OOI) and to a lesser extent with post-glucose plasma
glucose response (r-0.37 to 0.44, p<O.OOI) in all cases.
For insulin and FFA, however, correlations were signifi-
cant only in certain subgroups. Similar relationships
were noted for VLDL-cholesterol. Measures of carbohydratE
tolerance, age and race accounted for 35-487. of the vari-
ability in VLDL-lipid. Surprisingly, fasting plasma glu-
cose rather than insulin was the predominant predictor
variable for VLDL-lipid in all sJbgroups except high pre-
B-lipoprotein-cholesterol and low B-lipoprotein-choles-
terol category, where age was the major determinant.
These results have practical significance; subtle metabol-
ic abnormalities in childhood might be exaggerated by
environmental factor(s), later in life leading to overt
hyperlipoproteinemia and coronary artery disease.
DISPARATE RESPONSE OF lDl CHOLESTEROL AND APOB TO
DIETARY TREATMENT IN TYPE II HYPERLIPOPROTEINEMIA IN
CHilDHOOD
Allan D. Sniderman MD, FACC; Babie Teng, MSc; Paul
5. Bachorlk, PhD; Jrank A. Franklin, Jr., MD; Simeon
Ma rgolis. MD; li I y Georgopoulos, MD; Peter 0.
Kwiterovich, Jr.. MD, Royal Victoria Hospital,
Montreal, Canada.
low density lipoprotein (lDl). the principal athero-
genic lipoprotein. is composed of several lipids.
chiefly cholesterol (C) and protein - almost all
apoB. Clinically, only lDl B is measured both to
di agnose Type I I hyper Ii poprotei nemia and judge the
adequacy of therapy in this disorder. We have pre-
viously shown that considerable changes in lDl compo-
sition may occur with apoB more faithfully reflecting
lOl particle number than lDl C. We therefore examined
the response of these two parameters of lDl level in
21 children (mean age 8) with primary Type II (13 with
Ila and 8 with lIb). lipoprotein levels were measured
using lRC techniques. plasma lDl apoB by radial
immunodiffusion both before and after appropriate
dietary therapy. Results of Therapy:
%Decrease after Dletary Thera Pt
Ila % -12 -14 -4 -11 +4
p <.001 <.001 NS <.002 NS
lib % -11 -11 -5 -6 -16
~ <.007 <.041 NS NS NS
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Can t he ECG be used t o detect ear l y lef t vent r i cu lar hy-
pertrophy in chi l dr en grouped by blood pressure levels?
After 24 blood pr es sur e (BP) measurements over 4 mo ., 134
children were selected from a total community study of
1604 yout hs. Race-sex-height specific percentiles (P) of
mean arterial pressure (MAP) were used to form 2 BP groups.
Those with MAP exceeding 90th P and others with MAP at 50-
60th P--the high (HBP) and midrange (MBP)--had average BP
levels 116/76 (104/64) mmHg. All (68 males, 60 whites. 74
blacks. 8-1 7 yr) had a 12-lead ECG . Measurement error
analyses showed the S-wave in leads aVR, Vi, V2 and the R-
wave in leads II, aVF and Vs are measured more precisely
in children. The S in lead III and Q-waves in lateral
chest leads are more difficult to measure. The R in leads
I (Ri) and V4 (RV4) and the S in Vi (SVi) and aVR were
greater in the HBP group (p <0.05) . Multiple regression
anal ysis of ECG variables on triceps skinfold (TSF),
weight (WT) and age explained 6-14~ and 12-20~ of the ECG
variabilit y in the HBP and MBP, respectively. A composite
index (Ri+SVi+RV4) was higher in males than females (p <
0 .05) . But r acial differences depended on the BP group .
For male s mean levels (±SD) for blacks in MBP group ex-
ceeded whites (38. 2±9.0 vs 29.8±6 . 3. p<0.05) . Discrimi-
nant analys i s of ECG variables and cardi ac axis found the
S-wave in Vi dif ferentiates the 2 BP groups (p<0.025).
This function assigned more whites than blacks to BP
groups correctly (70~ vs 55:). especially whites in the
HBP group (71. 4~). The results indicate that hypertensive
disease with target organ changes is already occurring in
early childhood.
SUBTLE ECG CHANGES IN CHILDREN WITH HIGH LEVELS OF BLOOD
PRESSURE
Theda A. Foster, MS; Gerardo G. Ari stimuno, MD, Antonie W.
Voors. MD, DrPH (deceased); Gerald S. Berenson, MD, FACC,
LSU Medical Center (SCOR-A) . New Orleans, Louisiana.
DOCUMENTED
AUTOPSY
CAD E..!..!!£1!. CBD .Q.
1-9 13 7 -0- 0 0 2 2
10-19 13 6 0 0 2 1 1
20-29 24 14 5 1 1 3 4
30-39 51 29 16 1 0 0 2
40-49 119.!!!..!i 2 1 0 .Q.
Total 220 146 65 "4 "4 6" 9
CAD-coronary artery diseasel DA-d!sBecting aneurys mI
HC M-hypertrophic cardlomyopathYI CHD-congenital heart
diseasel O-other cardiac disease
Thus, we founc!:
1) CVSD accounts foe 66' (146/220) of SD in young persollll age
1 tD 50 years.
2) As expectsd, docu mented pathologic autDpsy data available
in 60' (88/146) of CVSD showed CAD accounted foe 74'
\65/88) of CVSD and progre.m.vely increased after the second
decade.
3) CVSD.-ociatedwithBCM,CBD,andO lIostcommonly
occurs in the initial three c!ecade&.
CARDIOVASCULAR SUDDEN DEATB IN YOUNG PERSONS
B.L. KennedY, M.D., r.A.C.C., J.A. WhJtl.ock, B.S., T.A.
Buckingham, M.D.I Di-nalon of CardJolDgy, St. Louis University
Medical Center, St. Lou" M0-
To examine charactedat:l.cs of cardievuc:ular sudden death
(CVSD)in young per-ollJ, we reviewed the c!eath cert1ficates
(100 'I, autDPBY reporta (64 'I, medical examiners case inveetl.gat-
1011II (100'), and personal medical~ (100') of 220 suc!c!en
deaths (SD) of persollll aged 1 tD 50 yeU'll occurring during 1981
and 1982 in an urban (St. Lou County) population. The ag~
specific caU88 of CVSD was determined from docunented autDPBY
data, and probable CVSD fro m • edicallliBtcxy and circu IIstances
of death. Th_ data showec!:
AGE TOTAL.!.Q.!!.&
5 D .£.,J!!!;!.
PC
33(29\)
0(0 ')
SUDDEN DEATB IN YOUNG PERSONS - AN URBAN STUDY.
B.L. Kennedy, MD, FACC, J.A. WhJtl.ock, B.S.I Division of
Cardlology, St. Louis University Medical Center, St. Louis, MO.
To exa mine the incidence, type, and syste mic cause of sudden
death (SD) during youth, we reviewed the death cert1ficates
(100 'I, autDpsy reports (64'), medical examiner case investi-
gations (100 'I, and personalmed1cal history (100 ') of 220 SDs
occurring in 881 total deaths of persosm aged 1 tD 50 yeU'll
occurring during 1981 and 1982 in an urban (St. Louis County)
populatiOn of 703,462 persons (1980 cesmus). Analysis showed:
.!.Q.!!.& TOTAL AGE SPECIFIC SD RATE/100,000
DEATHS SD 1-9 10-19 20-29 30-39 40-49
1981 453 107 TI"""""2.4 6T 19.7 56.3
1982 428 113 8.5 5.3 7.9 16.0 53.6
The crude SD rate for 1981 was 14.9 and for 1982 was
15.6/100,000. The a9~adjusted SD rate foe 1981 was 18.2 and
for 1982 was 19.5/100,000. SD was interpreted as instantaneous
([na), within 1 hour (1 Hr) or within 24 hours (24 Bra).
TOTALSD INS 1BR 24BRS
1981 107 52(i9,) 16 (1st) 39 (36\)
1982 113 44 (39\) 19 (17') 50 (44')
When syste mic cause of SD as interpreted by docu mented
evidence (DE) oe probable cause (PC) was determined, the
frequency dilatdbution of InB 1 hr and 24 bra SD showed no
statistical difference foe ( 40 oe )40 yrs of age.
1981 1982
DE PC ~
Cardlovaacular 43(40') 25(23,) 45(40')
Cerebrovsscular 3(3\ ) 0(0 , ) 2(2 , )
Other 36(34 ') 33(29 ')
The_ data indicate 1) SD accounts for 25' of all deaths in
young parBOIlS aged 1 to 50 yrs, 2) InB SD (39 to 49 ') and 1 hr SD
(15 to 17 ') occurred proportionately in all age ranges and ac-
counted foe approximately 50' of all c!eatha, 3) cardlovasc:ular
c!iseue accounts foe approxi.ately 2/3'8 of all SD with DE
found in 40' and probable cause established in 23 to 29'.
UN; '1'ER'I FCLLO'HJP OF T1W&1EtnlS CARDIAC PACIN; IN
CHIIDREN Michael L. Epstein, MO: Daniel G. Knauf ,MO,
FACe: James A. Alexander, MO, FACe: U'liversityof
Florida, Gainesville, Florida
'lbe need for perroanent cardiac pacirg systems (I'M)
in children is increasirg primarily due to increased
frequency and cooplexity of surgery for oon:Jenital
heart disease. Transverous ('IV) leads are used
relatively infrequently for a nllllber of reasons in-
cluding: 1) large caliber leads relative to venous
IlIC'CeSS, and 2) lead dislodgment or fracture with
growth or trauma. we revie"ll!d our experience with 'IV
pacing in pediatric patients (pts) between 1973 and
1982 to evaluate the success of endocardial pacing.
Ten pts between 5 and 16 years (yrs) of age (mean
= 10.4 yrs) uOOer1llellt inp1antation of 'IV I'M. Nine pts
had structural heart disease and developed
dysrhythmias post-operatfvety, Iroications for Aol
included atrioventricular (AV) block (6 pts), sinus
none dysfunction (3 pts) and carbined sinus and AV
rode dysfunction (1 pt).
'IV pacing was the initial ntxle of therapy in 4 pts.
N:> subsequent revision has been necessary in 3 of them
16, 31 and 52 months (IIOS) following inplan-
tation. Five 'IV leads were placed because of failure
of epicardial pacing, but 2 have subsequently had
revision back to epicardial leads. 'lbe last pt had 'IV
lead to allow sequential pacing.
Since the TV lead placement, 10 hospital re-ad-
missions have been necessary OYer a oollective span of
35.9 pt years. All 10 pts are alive and have suffered
ro awarent adverse sequelae.
we conclude that 'IV endocardial pacing lead
systems can safely be inplanted in pediatric pts with
results that oonpare favorably with epicardial systems.
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Valve Surgery
INTRAOPERATIVE CONTRAST ECHOCARDIOGRAPHY FOR
EVALUATING VALVE COMPETENCY IN MITRAL VALVE
OPERATIONS.
Bruce P. Mindich MD FACC, Martin E. Goldman MD FACC,
Louis E. Teichholz MD FACC, Richard S. Meltzer MD FACC,
Karen Staville RN, Steven Horowitz MD FACC, Valentin Fuster
MD FACC Mt. Sinai Medical Center, New York, NY
Mitral commissurotomy or valvuloplasty is preferable to valve
replacement when possible. However, mitral regurgitation(MR)
which is difficult to detect intra-operatively(OP) precludes a
successful surgical outcome. We performed OP 2-D
echocardiography(2-D echo) on 16 patients(pts) undergoing open
heart surgery to determine the presence of MR pre and post the
operative procedure: 7 had mitral stenosis(MS), 4 severe MR, 5
had no mitral disease (controls). 2-D echo was performed by
applying a 5 MHz transducer directly on the heart during
agitated saline injections via an apical ventricular
sump,generating spontaneous contrast,with imaging in two
views. Baseline studies were performed following sternatomy
prior to cardio-pulrnonary bypass(CPB) and a second study was
done following the operative procedure,off CPB with
hemodynamic stabilization prior to chest closure.Baseline
imaging correlated with preoperative angiographic assessment
of MR severity.No control pt had contrast evidence of MR pre
or post CPB.AII 3 pts with mitral valvuloplasties and I of 3 with
commissurotomies required a second operative procedure prior
to chest closure due to persistant MR as detected by OP 2-
D echo contrast.None of the 5 valve replacement pts had
postCPB MR.2-D echo findings were more accurate than OP
pressure tracings in detecting MR. 2-D echo OP findings
correlated with postoperative clinical exams and 2-D echo-
Doppler studies. We conclude that 2-D echo with contrast is an
important intraoperative tool for assessing the presence and
relative severity of mitral regurgitation following mitral
commissurotomy, valvuloplasty, and valve replacement thereby
preventing a poor surgical outcome or early reoperation.
SURGICAL TREATMENT OF ACUTE ENDOCARDITIS WITH MULTIPLE
VALVE INFECTION
Norman Silverman, MD, FACC, Sidney Levitsky, MD, FACC,
Robert Mammana, MD, Univ. of Illinois, Chicago, Illinois
In 65 consecutive drug abusers surgically treated for
acute infective endocarditis from 1/76-8/83, 11 (17\)
patients (pts) required surgical procedures on 2 valves.
The predominant infecting organisms were pseudomonas
aeroginosa and staphylococcus aureus (36\ respectively).
In contrast to single valve infection, congestive heart
failure was the most common operative indication (82\ of
pts, p<.05) while persistent sepsis and embolism were
concomitant indications in 64\ and 36\ of pts respective-
ly. When only the left heart valves were involved, 7
aortic and mitral valve replacements were performed.
When both sides of the heart were infected, partial or
complete tricuspid valvectomy was performed in conjunc-
tion with 3 mitral and 1 aortic valve replacements.
Tricuspid competence was re-established by valve inser-
tion or annuloplasty in 2 pts. There was no early
«30 day) mortality. Surgery was performed 18+16 days
from diagnosis (7/11<14 days), yet 4/11 pts had peri-
valvular abscess formation. Long term follow-up revealed
a late mortality of 36\ due to prosthetic valve infection
(18%) or dehiscence (18%) at 3,4,6 and 18 mos following
primary surgery. These infectious complications were not
related to infecting organism, intracardiac abscess, or
prosthetic material in the tricuspid annulus. In 2 pts
who had surgically-induced tricuspid incompetence, 1 died
of recurrent sepsis and congestive heart failure and the
other required subsequent valve insertion for right heart
failure. The data indicate that (1) multiple valve
infection does not preclude successful early surgical
therapy (2) maintaining tricuspid competence is hemo-
dynamically preferable and (3) reinfection in this addict
population increases late mortality.
MITIGATION OF CALCIFICATION OF CARPENTIER-EDWARDS
BIOPROSTHETIC CARDIAC VALVES
Michael Jones, MD, FACC; Eloisa Arbustini, MD; Robert E.
Applebaum, MD; Elling E. Eidbo, BA; Victor J. Ferrans, MD.
National Heart, Lung, and Blood Institute, Bethesda, MD.
The effect of pre implantation preparation upon calcifica-
tion of Carpentier-Edwards porcine aortic (PAV) and bo-
vine pericardial (BPV) bioprosthetic cardiac valves was
studied. Standard glutaraldehyde prepared valves were
compared to valves that were prepared similarly, but in
addition were treated by elimination of phosphate from
all preparation and storage solutions, by addition of mag-
nesium chloride, and by sterilization using surfactant and
alcohol (American Edwards Laboratories, Santa Ana, CAl.
The valves were implanted in the tricuspid position in ju-
venile sheep and were explanted electively after an aver-
age of 20 weeks. None of the valves were infected. One-
half of each valve cusp was analysed for calcium by atom-
ic absorption spectrophotometry; the other half was evalu-
ated histologically. All data are expressed as mean
values ± S.E.M in mg of calcium per g of cuspal dry weighL
Standard PAY (n=9 valves) contained 74.9±8.9 mg/g;
whereas, treated PAY (n = 7 valves) contained 35.6 ± 3.2 mg/
g (p < 0.01). Standard BPV (n = 5 valves) contained 93.0 ±
20.2 mg/g; whereas, treated BPV (n = 6 valves) contained
15.6 ± 6.0 mg/g (p < O.OOll. X-rays of the valves confirmed
the quantitative findings. Histologic studies indicated
that the calcification was intrinsic, located within the
cuspal connective tissues. Thus, the method of prepara-
tion described above decreases calcification of PAY and
BPV in the sheep investigational model.
THE ST JUDE VALVE: A 5 YEAR EXPERIENCE
Lawrence Czer, MD; Aurelio Chaux, MD, F ACC; Michele
DeRObertis, RN; Timothy Bateman, MD; Morgan Stewart, MS;
Jock Matloff, MD, F ACC; Richard Gray, MD, F ACC,
Cedars-Sinai Medical Center, Los Angeles, CA.
Our 5 year (yr) experience with the St. Jude bileaflet valve
prosthesis was reviewed in 215 pts (256 valves) operated
between March 1978 and June 1982, with a minimum follow~
of one year. Total followup was 5375 patient-months <mean 26
months, 2 pts lost, 99% complete). The aortic valve was
replaced (AVR) in 73, the mitral (MVR) in 89, the tricuspid
(TVR) in 3, and multiple valves (XVR) in 50 pts; coronary
bypass was performed in 103 (48%). Preop NYHA closs was III
or IV in 206 (96%). Overall, early «30 day) mortality was
7.0%, and late mortality 15.8%. Postop NYHA c loss was I or II
in 84% of survivors. EmboliSTI (E) rate was 1.8/100 pt-vrs (8
events, 7 transient, I permanent visual field deficit; nane
fctcl), and was lower in AVR (0.6/100 pt-yrs) than MVR
(2.3/100 pt-yrs) or XVR (2.8/100 pt-yrs). Non~se of coumadin
(14 pts) doubled E risk (3.6/100 pt-yrs). No early or late
structural valve failure has occurred. Two pts developed a
per iva lvulor leak, one a valve erosion, and one a valve
throrrbosis (n; reoperation was successful in 3 of the 4 pts (I
valve-related death, 0.47%). Total failure rate from all causes
(E, T, perivalvulor leak, valve erosion, valve-f'elated death)
was 2.7/100 pt-yrs (12 events). In 50 consecutive outpts
studied at a minimJlTl of 2.5 yrs postop (22 AVR, 28 MVR),
none had significont hemolysis.
In conclusion, after 5 yrs of followup: I) St. Jude valve
demonstrates a low rate of failure (2.7/100 pt yrs) from all
causes; 2) structural valve failure has not occurred; 3) the
embolism rate is low (I .8/ I00 pt yrs) in properly ont icoagu-
lated patients; 4) no clinical evidence of hemolysis has
occurred.
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LATE RESULTS OF ISOLATED AORTIC VALVE REPLACEMENT IN
COMBINED AORTIC VALVULAR AND CORONARY ARTERY DISEASE
Anthony L. Picone, MD, Robert O. Bonow, MD, FACC, Charles
L. McIntosh, MD, Douglas R. Rosing, MD, FACC, Marguerite
M. Engler, MS, Mary B. Engler, MS, Stephen E. Epstein, HO,
FACC, NHLBI, Bethesda, Maryland
In a previous study, we observed that postoperative surv-
ival in pts with aortic valve and coronary artery disease
(CAD) treated with aortic valve replacement (AVR) alone is
similar to pts undergoing AVR who have no associated CAD.
To assess the late reaults of isolated AVR in such pts, we
studied the reaults of 275 pts undergoing isolated AVR
over a 10 yr period, including 58 pts with associated CAD
(>50% stenoais of at least one artery) and 217 pts with no
CAb. Both groups were similar in sex ratio, preop symptoms
and hemodynamics, type of valve implanted and pump time.
Perioperative myocardial infarction (Ml) rate was similar
in both groups. In-hospital mortality was 7% in CAD pts
and 3% in non-CAD pts (p-NS). The CAD group manifested
lower long-term survival by life-table analysis (57~8% vs
76+4% at 5 yrs, p<.005). Event free survival (EFS), de-
fined as the time from AVR to death, angina, congestive
heart failure (CHF), MI, or coronary artery bypass (CABG),
was also less for the CAD group (p<.005). Causes of death
were similar except for CHF, which was greater in non-CAD
pts (38% vs 8%, p<.Ol). Asaociated CAD did not affect sur-
vival in aortic regurgitation (AR) pts, but adveraly af-
fected survival in aortic stenosis (AS) and combined AS+AR
pts (p<.Ol and p<.05). CAD adversely affected EFS in both
AS and AR pta (both p<.Ol) . Hence, pts with aortic valve
disease and CAD undergoing isolated AVR have greater long-
term mortality and an increased risk of late complications
compared to similarly treated pts without associated CAD.
These results suggest that concomitant CABG may be indi-
cated at the time of AVR in pts with associated CAD.
A DECADE OF EXPERIENCE WITH BEALL VALVE REPLACEMENT
Axel W. Joob, MD; George B. Craddock, MD, FACC; Lockhart
B. McGuire, MD, FACC; Terry L. Flanagan, BA; David E.
Schneider; Irving L. Kron, MD, University of Virginia,
Charlottesville, Virginia.
Beall mitral or tr i cuspid valve replacement using model
103 or 104 has been associated with a high incidence of
malfunction requiring explantation . Seventy patients un-
derwent single valve replacement (6B mitral , 2 tricusp id)
with a Beall model 103 or 104 between 1972 and 1975. Of
the 57 late s ur vi vor s 22 patients required explantation
with an operative mortality of 27.3%. Major malfunction
occured in 4 patients: (2 occluder embolizations and 2
occluders fixed in the open position) . All 4 patients r e-
quired urgent s ur ge ry with an operative mortal it y of 50%.
The development of congestive heart failure sympt oms , a
systolic murmur, and hemolysis was used to justify card iac
catheterizations and possible explantation. Nineteen pa-
tients had late cardiac catheterizations. Fifteen of those
subsequently underwent explantation with an oper at i ve mor-
tality of 26.7 %. Three patients (15.8%) were cons i der ed
i noper abl e . Catheterization data revea led s ignificant
prosthetic regurgitation: Pulmonary Capillary Pressure
(PCP) 29.9mmHgt6.7SD, V wave 31.5mmHg±12 .0, Left Vent r i c-
ular End Diastolic Pressure (LVEDP) 18.0mmHg±7.8. Compar-
ison of hemolysis indicators in this group versus patients
not undergoing recatheterizations revealed significant el-
evation in LOH (p· .038) and lowered Hematocr it (p· .OI7) .
In conclusion awaiting changes in symptoms, worsening
hemolysis, or a change in murmur to justify reoperation
portends severe LV dysfunction, possible emergency explan-
tation, and a high operative mortality.
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Arrhythmia Surgery
THE RELATION OF ATRIAL BETA RECEPTOR DENSITY TO POST-
OPERATIVE ARRHYTHMIAS.
Francis C. KemQf, Jr., MD; Anders Hedberg, PhD; Perry
Moltnoff, MD; Mark E. Josephson, MD, FACC, University of
Pennsylvania, Philadelphia, PA ,
We obtained atrial tissue at the time of cardiac surgery
in 49 patients in order to assess the relationship of
beta-adrenergic receptors (BAR) density to post-operative
atrial flutter and/or fibrillation (AF). Surgery was for
coronary revascularizatlon in 3B, valve replacement in 6,
and ventricular arrhythmias in 5 patients. BAR con-
centration was determined by saturation binding of
[125I)-pindolol under equilibrium conditions from a
plasma membrane preparation. Patients were clinically
euthyroid. All patients were in sinus rhythm and had no
history of atrial arrhythmias. Patients were on beta
antagonists, calcium channel blockers, or both.Patients
were continuously monitored in the post-operative
period. AF persistinq >1 min developed In 22/49 patients
within 4B hours of surgery. These patients had a mean BAR
density of 134.4±37.5 f moles BAR/mg protein. The 27
patients without AF had a mean BAR density of 92.6±26.4 f
moles BAR/mg protein (p<.OOl). We conclude: l)AF is
frequent after cardiac surgery; 2)AF Is associated with
signif icantly increased BAR density on atrial myocardial
membrane; and 3)this association may explain the
previously demonstrated efficacy of propranolol in the
prevention of post-operative atrial arrhythmias.
PREDICTORS AND PROGNOSIS OF VENTRICULAR ECTOPY FOLLOWING
CORONARY ARTERY BYPASS GRAFT SURGERY.
David A. Rubin, MD, FACC; Karen E. Nieminski, RN, CCRN;
Judith C. Monteferrante, MD; Thomas Magee; George E.
Reed, MD, FACC; Michael V. Herman, MD, FACC. New York
Medical College, Valhalla, New York.
The incidence, risk factors and long term prognosis of
complex ventricular ectopy following coronary artery
bypass graft surgery is not known. Complex ventricular
ectopy is defined as Lown Grade IVa (couplets), IVb
(ventricular tachycardia) and V (R-on-T). We
prospectively evaluated gO patients with normal left
ventricular function who underwent elective coronary
artery bypass graft surgery. Ventricular ectopy was
documented by predischarge 24 hour ambulatory monitoring.
44% of patients had simple ventricular ectopy (Lown Grade
I, II, III) . 56% of patients had complex ventricular
ectopy. Risk factors analyzed include age, sex,
diabetes, hypertension, smoking, preoperative digoxin or
propranolol therapy, bypass time, aortic cross clamp
time, number of vessels bypassed, peak creatine
phosphokinase elevation and pericarditis . No risk factor
identified patients at higher risk for complex
ventricular ectopy. Patients were followed 6-24 months
(mean 16 months). Patients with complex ventricular
ectopy did not have a higher incidence of sudden death,
cardiac dea~ syncope, angina, myocardial infarction or
cerebral vascular accident . We conclude : 1. Complex
ventr icular ectopy is common follOWing coronary artery
bypass graft surgery. 2. No risk factors identify high
risk patients. 3. Complex ventricular ectopy following
coronary artery bypass graft surgery does not have a poor
prognosis. ---
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MECHANISM Of SUCCESS IN ENDOCARDIAL RESECTION IN VEN-
TRICULAR TACHYCARDIA
John M. Miller, MD, Alden H. Harken, MD, Mark E.
Josephson, MD, FACC, Univers ity of Pennsyl vania,
Philadelphia, PA 19104
Detailed intra-operative endocard ial mapp ing was carried
out dur ing 68 distinct ventr icular tachycardias (VT) in
28 consecut ive patients (pt s ) with coronar y disease. The
site of origin ( SO) for each VT (that site having t he
earl iest presystol ic electrical act iv it y in the latter
half of diastole ) was determined and the sequence of en-
docardial act ivation during VT was plotted (mean 41+28
s i tes for each VT ). The SO encompassed an area of 1~5
cm2 i n all pt s. Subendocardi al resection inc l uded the
SO and a 1 cm surrounding border. Centr ifuga l spread from
SO occurred in 53 VT (78%) ; the pat t ern of activation
made a complete loop around an aneur ysm border in 6 VT
(9%) ; and no specific pattern could be assigned in 9 VT
(6 pts;13%) due to lack of a sufficient number of mapping
sites « 15). All pts displayed centr ifugal spread from a
VT-SO in at least 1 VT. In all pts in whom a continuous
loop was observed, centrifugal spread was observed in
other VT . In pts with both patterns of activation in VT,
the SO of the centrifugal spread pat tern was unrelated
to the SO of the continuous loop pattern. There were 3
operat ive deaths. Post-operat i ve programmed st imulation
i nduced 6 VT in 5 pts . Of the 6 VTs, 2 had not been seen
pr ior to the post-operative study and mapping data in the
remaining 4 VT had shown centr ifugal sp read from the SO.
We conclude: 1) the act ivat ion pat t ern in VT i s usual l y
centr ifugal spread from a foca l SO 2) act ivation dur ing a
minority of VT demonstrates a continuous reentrant loop
around an aneurysm and 3) successful surger y is associ-
ated with removal of the SO in VT wi th a centrifugal
spread pattern, whereas in VT with a cont inuous loop pat-
t ern removal of onl y part of the circuit i s necessary.
SUST AINED VENTRICULAR TACHYCARDIA Of MULTIPLE
MORPHOLOGIES: SURGICAL EXPERIENCE
John M. Miller, MD, Michael G. Kienzl e , MD, Alden H.
Harken, MD, Mark E. Josephson, MD , fACC, Universit y of
Pennsylvania, Philadelphia , PA
We evaluated 93 pat ients (pt s ) with ventricular tachy-
ca rd ia (VT) and coronary disease who underwent sub-
endocardial resect ion for VT to determine the signi-
ficance of mult iple morphologicall y dist inct VT (VT-MM)
spont aneous or induced . Thirty-four pts ( 3 6~) had spon-
t aneous VT-MM (of whom 12 had other VT induced) ; 59 had
a s ingle spontaneous VT morphology (of whom 36 had other
VT i nduced) . Ten pts ( 1 1 ~ ) had VT (spont aneous or in-
duced) mapped to disparate s ites (>5 cm between s ites).
following surgery 21 VT i n 18 pts rema ined i nducible off
drugs (12 VT were spontaneous preoperat ively; 6 VT had
been induced-only; and 3 VT had never been seen pre- or
intraoperatively). There were 6 late VT recurrences (3 on
drugs ) and 3 late sudden deaths. pts with VT-MM spontan-
eous l y had: longer HV intervals (65 msec vs 53 msec);
more f requent disparate sites of VT origin, spontaneous
or i nduced (24% vs 5~ ); more frequent failure of surgery
alone to prevent VT inducibil it y (38%vs ~ ); and higher
spontaneous VT recurrence rate ( 2 1 ~ vs 2~ ); than pts with
a s ingle VT. pts with VT- MM spontaneousl y did not di ffer
from pts with a single VT wi th respect to location of
pri or myocardi al infarction, presence of left ventricular
aneurysm, or eject ion fraction. We conclude: 1 ) A high
per centage of pts with VT have MM . 2) VT- MM usually ar ise
from the same or adjacent s ites . 3 ) All VT require map-
ping to guide local ized surgery s ince 11% of pts have
disparate sites of VT or igin.
CRYOSURGICAL DENERVATION OF THE HEART. James M.
Dougl as , Jr. , M.D.; Mary E. Early, B.A.; Peter K. Smlth,
M.D. ; Jeffrey E. Hull, B. S .; James L. Cox , M.D., Duke
Un ivers ity Medical Center, Du rham, NC
This study was designed t o devel op a rapid, simple,
saf e and effective means for producing tot al cardia c
denerv at i on. Eleven adult mongrel dogs underwent
limi ted i nt raper ic ardi al di ssecti on of the gre at vess els
and i nt er atria l groove. Liqui d nit rogen was circula ted
th rough Tygon tu bing encirc l ing the great vessel s and
dors al wa ll of t he l eft atri um to c ryoablat e the
juxtaposed cardi ac surfaces. Efferent denerva tion wa s
te s te d by comparison of preoperat ive (pre-op) and
post ope rat ive ( post-op) s timul ation of 15 ca rdiac nerve s
i n each animal. Hemodynamic resp onses to direct
sympathet i c and par asympat het ic ner ve st imu lati ons were
elim ina ted post-op. Add i t ionall y , pre-op cardi ac ref le x
res ponses to nitroprusside (NP) induced hypoten s ion and
phenyleph r ine (PE) induced hypert ens ion we re eliminated
following cryosu rgery. The perce nt changes in systolic
blood pre ss ure (BP) and heart rate (HR) are tabulated .
in te rruption of di rec t and ref le x cardiac
to aut onomi c st imu lat ion confirm s this eas il y
procedure to be an ef fecti ve means of
acute total cardia c denerva t ion.
PRE-OP
POST-OP
The
resp onses
perfo rmed
atta ining
NP INFUSI ON
6BP 6HR
~ 44 ~ 5% 44 II ~
~ 47 ~ 3% 3 ~ 2 ~
PE INFUSION
6BP t>HR
31 ' 4' 14 • 2'
76 :': 10' 3 • J'.
INCIDFllCL AND NA'IU"AL HI STORY OF PERICA.~IATJ EFFUSIW
AF'rnR CARDI1\C S~Y
Lee ' eit zman , I'.n, Patrick Tinker , " .n., Itzhak !(ronzon,
!!.D . , F .A.C.C., Eohrairl Gl.assman , !' . D. , F .l\..C.C., Frank
C. &1encer, rl.n., 1".A.C.C. ')el., York Uni ver si t y !'ecUcal
center, New York, NY. .
!e prosoectivel v atud.ied the incidence ann nat ur al
history of peri.card.i.al. effusion (PEl occur r i rr- after
cardiac suroery. In 122 consecutive natients , echocardio-
nranhic studies were 11E!rforral :>rior to, and then 2, 5,
10, 20, and 30 days after suroerv, PE was observed in 4
'Xlt ient s !1reoneratively (nreon) , ' ann 103 (84%) 'X>stoner-
atively (~stoo) . PE was defined as sr'all (l to 'J m..
di as tolic senaration between the r,ericardiUl"' and the
heart), roderate (10 to 19 IT1) or lame (20rTl or rrore) •
The table lists the nUMber of nat ients for each PE si ze on
the various ooston c1ays . .
Preon day 2 day 5 day 10 day 20 day 30
N;) PE lIB 40 28 30 13 69
9'1all 4 57 43 26 10 14
'bderate 0 15 45 40 8 6
large 0 0 6 12 6 0
Absent or smal l PE on day 2 did not oredict the s i ze of
p~ in the fOllO\~irYt studies ; ho\.ever ; the absence of PE
on day 5 ~redicted no PE in all subseauent studies in
26/28 ~tients (93%). In 90% of the ~tients , PE reachec1
its raxinal s ize by day 10. In no nat ient did PC inc rease
after day 20. One nati ent had card.iac t aI"U'1Onade (day 3) .
Since late CXl"lnlications secondary to PE \;ere not seen,
serial echocardio-rans are not necessary in natient.s
with uncortolicated oostoo course. ..
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Laser Catheter Techniques
EFFECTS OF LASER RADIATION ON HUMAN BLOOD: RELATION
BETWEEN EXPOSURE AND DEBRIS FORMATION
George S. Abela, MD; Carl J. Pepine, MD, FACC; C. Richard
Conti, MD, FACC, University of Florida, Gainesville, FL
Use of lasers to recanalize stenosed arteries may re-
quire delivery of laser energy through blood. We investi-
gated the degree of hemolysis and structural changes to
blood cells induced by laser energy.
METHODS: Four ee's of citrated whole blood were placed
in 15 tubes and exposed to Argon laser radiation at I, 2,
and 3 watts (power) for varying duration (5,10,20,40 sec).
Temperature (T), hematocrit (Ret), hemoglobin (Hb) and
debris weight (OW) after laser exposure were compared to
non-lased blood (control). T was measured by thermistor
and debris was obtained by filtration through a 37~ mesh
and drying in air. Light microscopy and scanning electron
microscopy was done on filtered, lased blood for morpho-
logy.
RESULTS OF AVERAGE VALUES AT 3 WATTS
T(OC) Hb(gms/dl) Hct(%) DW(~g)
Control Sample (n-15) 24 1.7 41 0.8
Lased Samples (n-5) (n=7) (n=7) (n=6)
5 sec exposure 25 2.2 38 1.0
10 sec exposure 27 2.4 37 1.0
20 sec exposure 27 2.1 39 1.5
40 sec exposure 33 3.1 33 3.1
Compared to control at 3 watts, T, Hb and OW increased
and Hct decreased as duration of exposure increased. Im-
portant changes occurred only at 40 sec exposure and cor-
related with the rise in temperature. Microscopy of the
samples exposed at 40 sec showed clumps of red blood cells
(RBG) and perforated and deformed RBG.
CONCLUSION: The data suggest that to minimize blood
debris during in vivo lasing, the duration of exposure
should be kept-as short an interval as possible.
ACUTE AND CHRONIC COMPLICATIONS OF IN VIVO CATHETER LASER
ANGIOPLASTY IN ATHEROSCLEROTIC ANIMALS: VASCULAR WALL
DAMAGE AND ANEURYSM FORMATION--A WORD OF CAUTION
Richard M. Ikeda, MD: Garrett Lee, MD: Jerold H. Theis,
PhD, DVM: Ming C. Chan, MD: Daniel Stobbe; Claire Ogata,
as, Arnold Kumagai, SA, Dean T. Mason, MD, FACC, Cedars
Medical Center, Cardiovascular Laser Research Laboratory,
Miami, Florida.
Since there are little data about potential harmful ef-
fects of laser irradiation on the arterial wall, we
studied acute and chronic vascular responses of laser
exposure in atherosclerotic animalS. In 7 rabbits fed an
atherogenic diet for 3 to 5 months prior to study to
induce aortic atherosclerosis, a flexible 400 ~m diameter
quartz fiber attached to an argon ion laser was passed
antegrade or retrograde to the atherosclerotic ascending
aorta. The laser was turned on using power intensities
of 1-2 watts lasting 3 seconds. Following laser treat-
ment, the aortas were studied acutely (3 animals) and
chronically (4 animals) after recovery for 1-14 days. In
2 acute animals, argon laser produced a vapori7ed crater
within the atherosclerotic plaque at the endothelial Sur-
face: however, in the third animal there was also vascular
damage extending deep into the medial layer. In addition,
aortic aneurysm with muscular wall damage occured in 2 of
the 4 chronic animals. Thus, vascular complications may
arise when catheter laser angioplasty is randomly applied
without visualizing specific plaque targets and/or using
safe dose increments of power intensities and durations
of exposure. This study suggests caution in clinical use
of intensive phototherapy to cardiovascular lesions and
stresses need for further understanding of laser vascular
consequences prior to the application of laser angio-
pIasty in patients.
LASER IRRADIATION OF HUMAN THRO'1BUS: SELECTIVE ABSORPTION
OF RADIATION FOR RED BLOOD CLOTS BUT NOT WHITE CLOTS
Garrett Lee, MD; Daniel L. Seckinger, MD: Anthony Vazquez:
Daniel Stobbe; Phyllis Rosenthal; Ming C. Chan, MD:
Richard M. Ikeda, MD; Robert L. Reis, MD, FACC; Dean T.
Mason, MD, FACC, Cedars Medical Center, Cardiovascular
Laser Research Laboratory. Miami, Florida.
Laser irradiation to vaporize coronary atherosclerotic
plaques and vascular thrombosis has been reported from
our laboratory. tbreover. intravascular transmission of
laser energy is possible by a specially designed flexible
fiberoptic catheter system. Since human thrombus can be
separated into red clots (whole blood + fibrinogen +
thrombin) and white clots (fibrinogen + thrombin), we
investigated the ability of laser energy to penetrate
these clots. Red clot and white clot samples (n = 54)
ranging in volume from 0.3 to 0.9 cc were made. Each
clot was subjected to 3, 5, or 7 watt laser beam from
400 ~m diameter core quartz fiber coupled to an argon-ion
source which emits energy at 0.488 to 0.515 ~m. The
irradiation times needed to penetrate graded thrombus of
the two types of clots were determined. In red clots,
the greater the power, the shorter was the penetration
time; using 7 watts in 0.33 cc clots, it required 4.7
seconds. In 0.9 cc red clots using 3 watts, it took
293.3 seconds. In white clots, no penetration occurred
at any power level UP to 5 minutes. Spectrophotometric
studies showed that red clots (due to hemoglobin) but not
white clots absorbed argon laser energy. It is concluded
that argon laser provides the therapeutic modality for
lyses of human red clot thrombosis while, in contrast, a
different laser source is required for white clot dis-
solution.
ARGON LASER CORONARY ANGIOPLASTY: MASS SPECTROMETER
EVALUATION, TECHNETIUM 99 SCINTIGRAPHY, HUMAN INTRA-
OPERATIVE EVALUATION.
0.5. Choy, MD; S.H. Stertzer, MD, FACC; R.K. Myler, MD,
FACC; J. Marco, MD; I. Kaminow, MD; G. Fournial, MD;
San Francisco Heart Institute/Seton Medical Center, Daly
City, CA. and H~ital Purpan, Toulouse, France.
Since the previous work in animal and cadaver coronary
angioplasty with the Coherent 1000 Argon laser catheter,
work has proceded in three areas to more fully analyze
this promising therapeutic modality: 1. Mass spectro-
metry of vapor generated by in-vitro treatment of throm-
but (T) and plaque (P) have demonstrated the major com-
po~ents to ~e CO 2: (T)50%)(P29.6%), 02:. (T 1.16%)(P3.6%),HZ' (T 14.9%) (PIs. 3%), N2 (T 17.3%) (PZ4%) . The vaporiza-tion products are therefore chiefly CO 2 and H20, as wellas minute quantities of other non-toxic compounds that
are easily plasma soluble. Importantly, short chain (i.e.
4 carbon atom) hydrocarbons were the only significant
organic products of laser angioplasty, suggesting photo-
dissociation rather than thermal injury as the mechanism
of vaporization. 2. Technetium 99 labeled thrombi in
rabbit aortae and in cadaver coronaries demonstrated no
evidence of downstream emboli in the distal vascular bed
in-vitro experiments, respectively. 3. Five patients
undergoing coronary bypass surgery were highly selected
(after informed consent) for intraoperative laser coro-
nary angioplasty in conjunction with their myocardial
revascularization procedure. This represents the first
attempt to assess the safety and efficacy of the Argon
power source in the human coronary vasculature. Details
of the technique and followup an~iographic results will
be delineated.
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Coronary Angiography and Hemodynamic Responses
ANGIOGRAPHIC MORPHOLOGY IN UNSTABLE ANGINA
John Ambrose, MD, FACC; Stephen Winters, MD; Audrey
Stern, MD; Angie Eng; Louis E. Teichholz, MD, FACC;
Volentin Fuster, MD, FACe. Mt. Sinoi Medical Ctr, NY, NY.
216II60
SAP
30 pts
USAP
36 pts
In 39 patients, the "angina producing" coronary could be
localized by either angiographic assessment, or by the
distribution of transient ischemic ECG changes, Thallium
defects or gated wall motion abnormalities. Ec ulcerated
lesions were very common in USAP vs SAP (12/ 18 vs 4/21
respectively, p < .OD. The degree of stenosis in these 39
lesions was similar in USAP vs SAP (83.1 vs 79.2%
respectively). In all patients with USAP and SAP, the
incidence of one vessel and multivessel disease was similar.
Therefore, Ec ulcerated lesions are frequent in USAP; these
probably represent ruptured subintimal plaques which play on
important role as a source of the unstable ischemia.
The angiographic morphology of coronary artery obstructions
in angina pectoris has not been well studied. Therefore, in 66
patients with either stable (SAP) or unstable angina pectoris
(USAP), the morphology of coronary artery lesions wos
qualitatively assessed at angiography independent of
historical data. USAP was defined os rapidly progressive or
new onset closs '" or 'V angina pectoris. Coronary artery
morphology was classified as either concentric with smooth
borders, eccentric (Ec) with smooth borders, Ec ulcerated
when irregular borders or overhanging edges were seen or
multiple smooth and irregular lesions in series. Coronary
stenoses> 50% and < 100% were analyzed. Results
- Ec Ec
vessels concentric smooth ulcerated multiple
32 12 I I 8 I
p <.05
31
COMBINED INTRAVASCULAR ANGIOSCOPIC VISUALIZATION AND
LASER ABLATION OF VASCULAR ATHEROMA DOCUMENTED BY
ANGIOGRAPHY. James Forrester, MD, Frank Litvack, MD,
Warren Grundfest, MD, Robert Foran, MD, Miles Lee, MD,
Michael Fishbein, MD, George Berci, MD Samuel Meerbaum,
PhD, and Eliot Corday, MD. Department of Surgery and
Medicine, Cedars-Sinai Medical Center, Los Angeles,
Cal ifornia.
Nine cadaver aorto-iliac vessels were entered proximally,
using a 3.7mm o.d. prototype fiberoptic endoscope (Trime-
dyne Corp) specially designed for intravascular use. Ima-
ges were recorded on videotape. Atheroma on both the
aortic wall and at the iliac bifurcation were clearly
visualized during passage. After visualization, an Nd-YAG
laser catheter was inserted, and partially obstructive
iliac atheroma were lased under direct visual control.
Substantial reduction in %diameter stenosis (mean pre-
lasing 46%; post, 11%) was demonstrated by contrast
angiography. The angioscopic and lasing program was then
extended to in-vivo use. Femoral vascular detail was
readily recorded in both animals and man through through
the angioscope, but only after control of retrograde flow.
During cardiac surgery in man, we clearly visualized and
photographed important central structures such as the
left main coronary artery ostia, and individual cardiac
valves. Using a second prototype laser-angioscope in li-
ving dogs, we successfully delivered varying doses of Nd-
YAG radiation to femoral artery segments. Histologic eva-
luation at 28 days revealed a range of injury from inti-
mal proliferation through fibrous scar formation; the mag-
nitude of graded histologic injury was directly related
to laser energy. These data demonstrate the feasibility
of visualizing and recording of both intravascular and
intracardiac detail by fiberoptic angioscopy, and of res-
toration of vascular patency by laser energy delivered
through an intrasvacular catheter under direct visual
control.
LASER RADIATION OF ATIiEROSCLEROTIC LESIONS: DECREASED
INCIDENCE OF VESSEL PERFORATION WITIi A FIBEROPTIC LASER
HEATED METALLIC TIP
Timothr A. Sanborn, MD; David P. Faxon, MD, FACC:
ChrIstIan C. Raudenschlld, MD; Thomas J. Ryan, MD,
FACC. Boston University Medical Center, Boston, MA.
Laser radiation of atherosclerotic lesions can
effectively reduce luminal stenosis and vaporizes
plaques in live animals. However, a high incidence of
vessel perforation due to mechanical as well as direct
laser radiation is noted. Using a rabbit iliac model of
atherosclerosis and an argon laser source we compared
the effects of direct laser radiation employing a 1.0 mm
fiber to those of a new fiberoptic catheter (0.9 mm)
equipped with a laser heated metallic tip (Trimedyne,
Inc). A SF Swan Ganz catheter at the aortic bifurcation
permitted cineangiography, balloon inflation and saline
perfusion during laser radiation. Both fiberoptic
fibers were advanced fluoroscopically from a femoral
arteriotomy up to the iliac stenosis and multiple pulses
of 4-6 watts were delivered over l-Z seconds. Dye
extravasation was noted in 8/11 vessels (73\) with 10/43
pulses (Z3\) using direct laser radiation. In contrast,
no vessel perforation was noted with the laser heated
probe in four vessels which received 19 pulses
(p<O.02). Histologic examination revealed neointimal
vaporization with both types of laser energy; however,
less thrombosis was noted with the laser heated probe.
We conclude that this new catheter design employing
a laser heated metallic tip perai ts successful
vaporization of lesions with significantly less vascular
damage, perforation and intraluminal thrombosis
fOl'll8tion. Further refinements in fiber design and
flexibility will be necessary, however, prior to use in
more tortuous vessels.
CORONARY ANGIOSCOPY DURING CARDIAC CATHETERIZATION
J. Richard Spears, MD, FACC, Artur Spokojny, MD, H.
John Marais, MD, William Grossman, MD, FACC, Beth
Israel Hospital, Harvard Medical School, Boston, MA
Coronary angioscopy should permit direct inspection of
the lumen cross-section and identification of lesion
pathology. We therefore tested the feasibility of
introducing a #5F Olympus Ultrathin fiberscope into the
obstructed right coronary artery of 5 patients following
routine cardiac catheterization by the brachial approach.
An 8.3F USCI woven Dacron angioplasty guiding catheter
was modified to enlarge its lumen. After engaging the
right coronary ostium with the catheter, an attempt was
made to pass the angioscope coaxially to the tip of the
catheter. Visualization of the coronary lumen was then
achieved in 3 patients by manually injecting 5 to 10 cc
of a translucent crystalloid solution through the
guiding catheter at 2-3 cc/sec. White atheromatous
plaque could be demonstrated at the site of obstruction
in each case. In 2 patients, lack of sufficient flex-
ibility in the distal 2 cm of the angioscope prevented
passage to the catheter tip. Preliminary experience
with a videoendoscopic system suggests that this
monitoring modality is essential for the adequate
performance of angioscopy and for recording dynamic
changes during blood displacement. Geometric distortion
of the image and non-linearities in magnification and
light reflex with decreasing lens to object distance
make quantitative evaluation of the lumen difficult.
Lack of an angulation system further contributes to
this problem and, more importantly, restricts passage
of the angioscope to the proximal 1-2 cm segments of
coronary arteries. Although coronary angioscopy may
have research and clinical applications in the future,
these technical problems should first be addressed.
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POOR CORRELATION OF SAPHENOUS VEIN BYPASS GRAFT ANGIOGRAMS
WITH HISTOLOGIC CHANGES AT AUTOPSY
James B. Atkinson, MD, Ph.D.; Mervyn B. Forman, MB,MRCPj
Renu Virmani, MD, Vanderbilt University School of
Medicine, Nashville, TN.
Most studies of saphenous vein bypass grafts (SVBG) have
been either angiographic or morphologic, and few have
correlated premortem angiograms with postmortem angiograms
and histology. We studied 9 autopsy patients who had
received a total of 22 SVBG 12-120 months (mos) prior to
death (mean 73 mos). All patients had severe coronary
artery disease (>75% occlusion), with 3-vessel disease in
4 patients and 4-vessel disease in 5 patients. The %
cross-sectional area luminal narrowing of the SVBG at
autopsy was: 0-25% in 5 grafts, 26-50% in 5, 51-75% in 2
and >75% in 10, and of these 9 had total occlusion. Three
types of histologic changes were found: atherosclerosis in
3, fibrointimal proliferation (FIP) in 12 and total
fibrotic occlusion in 7. Angiograms had been performed
less than 6 months prior to death in 7 patients and
greater than 2 years in 2 patients. The premortem
angiograms showed 10 normal SVBG, 13 with 50% luminal
diameter reduction, and 9 with 90% reduction. In 15/22
SVBG there was excellent correlation between the
percentage of luminal narrowing found on angiography and
at autops'r: histologically 7 were fibrotic, 3 were
atherosclerotic, and 5 had FIP. In 7/22 (32%) SVBG the
angiograms over- or underestimated % occlusion and all had
FIP. Predominance of smooth muscle in FIP may be
responsible for spasm or relaxation of SVBG during
angiography which could cause errors in estimating the
degree of stenosis. Nitrates or calcium antagonists may be
useful both in assessing the degree of underlying
vasomotion in patients with stenotic lesions in SVBG and
as a therapeutic modality.
CDMPARISON OF DIGITAL AND ClNE'JItl;IOGRAPHY FOR DIJ\GtmIS
OF~y S'lnO)~
Jonathan 'l'PO.ik.1'lD~CC; Lloyd lseri, MO, FACC; Warren
Johnston, MO; Orhan Nalcioglu, PhD; Eric Castleman, MO;
Walter L. Henry, MO, FACC; University of California,
Irvine, CA.
Recent studies have demonstrated the feasibility of
quantitating coronary artery stenoses fran single frame
images of digital subtraction angiograms (angios) in
which lesions were preselected for the observ~~s. In
order to determine whether digital angios also are
adequate for the detection of coronary stenoses fran
unselected studies, 4 observers reviewed 30 digital
angios and 30 film-based cineangios. Each observer inde-
pendently measured percent diameter stenosis of sus-
pected lesions using calipers. Digital angios were 0b-
tained with intra-<:oronary injection of 4-6ml of con-
trast at 8 frames/sec and stored in an unsubtracted
format to permit post processing by mask mode subtrac-
tion, pixel magnification and edge enhancement. After
processing, digital images were transferred to 3/4 inch
videotape for review. 'lbere were 4 angios in which all 4
observers saw < 25% lesion on both digital and cine
studies. Of the 32 lesions which measured > 25% stenosis
by at least one observer on either the digital or cine
angio, there was 00 significant difference between the
mean steoosis measured fran digital (53.3 ± 30.7%) VB
cine (52.0 ± 31.1%). Interobserver variability was
assessed by the standard deviation (SO) between the 4
observers. 'lbe mean of the 32 standard deviation was
9.7 ± 7.7% for cine steooses and 10.4 ± 7.4% for digital
angi06 (p " tfl). we conclude that coronary angios ob-
tained and processed digitally and stored on 3/4 inch
videotape caJPUe favorably with cineangi06 for
detection and quanti tation of coronary stenoses.
EFFECTS OF ClGARETTF SMOKING ON REGIONAL CORONARY HEMO-
DYNAMICS IN PATIENTS WITH CORONARY ARTERY DISEASE
David Booth, MD, FACC, Mikel Smith, MD, Phil Dawson, MD,
Gale Kerns, MD, Anthony DeMaria, MD, FACC; University of
Kentucky and VA Medical Center, Lexington, KY
Although it has been shown that cigarette smoking in-
creases coronary blood flow in normal subjects, the ef-
fects of smoking have not been established in patients
with coronary artery disease or in those in whom coronary
anatomy is known. Therefore, we assessed hemodynamics and
estimated coronary flow for two myocardial regions by
measuring anterior and inferior myocardial flow (AMF and
IMF, respectively) using a multithermistor coronary sinus
catheter in 13 patients with coronary artery disease,
8(62%) with greater than 50% diameter stenosis of the left
anterior descending (LAD), left circumflex, and right cor-
nary artery, 4(31%) with two-vessel disease, and 1(7%)
with single vessel disease of the LAD. Of the 26 myocar-
dial regions assessed, 24 (92%) were found to be poten-
tially compromised by anatomically significant coronary
artery disease. Me:·.surements were obtained during control
and following smoking of one filtered cigarette of known
nicotine and tar content. In response to smoking, carboxy-
hemoglobin concentration (CO) increased from 3.6:': 3.0 to
6.6:':3.3% (P<.Ol), mean aortic pressure (MAP) increased
from 103:':16 to 120:':22 mmHg (P~.Ol), and heart rate(HR)
increased from 71:':5 to 79:':5 bpm (p~ .01). However, AMF and
IMF failed to increase; control valves were 66:':30 ml per
minute and 52:':39 ml per minute for AMF and IMF respective-
ly and were unchanged following smoking, 75:':35 ml per
minute and 47:':35 ml per minute (P=NS).
CONCLUSIONS: In cBntrast to the findings in normal sub-
jects, coronary blood flow is not augmented following
cigarette smoking despite an increase in the determinants
of myocardial oxygen demand in the presence of coronary
artery disease.
SYSTEMIC AND CORONARY HEMODYNAMIC RESPONSES TO SMOKING IN
CHRONIC SMOKERS WITH CORONARY ARTERY DISEASE. Pascal
Nicod, MD, Roger Rehr, MD, Srian G. Firth, MD, 0 Phi I,
FACC, Michael D. Winniford,MD, and L. David Hillis, MD,
FACC, U Texas Health Science Center, Dal las, TX.
Previous studies have provided conflicting data on the
effects of cigarette smoking (S) on coronary blood flow
(CSF), and some have suggested that S may inhibit an in-
crease (-) in CSF that should occur in response to t myo-
cardial oxygen demands. We assessed the acute effects of
S on systemic and coronary hemodynamics in 32 chronic
smokers (23 men, 9 women, aged 50:':9 {mearu Sll} years) with
coronary artery disease (CAD)(1 vessel in 9, 2 vessel in
5, 3 vessel in 18). Variables were measured before and
after (a)smoking of 2 cigarettes (within 5-7 mins)(n=19)
or (b )» 5-7 min period without 5 (n=13)(controls). From
baseline to repeat, no variable changed in the controls.
In contrast, in response to 5, there was an ~ (p<0.05) in
heart rate-systolic pressure double product (9.4:':2.6Xl0 3
to 10.5·2.8XI03), CO (4.9·0.9 to 5.6:':1.3 L/min), LV dP/dt
(1269'305 to 1441'470 mmHg/sec), and CSF (by thermodilu-
tion)(105'38 to 118'45 mlZmi n ) . To determine if the t in
CSF with S was of simi Jar magnitude to that induced by
other provocative maneuvers, 6 smokers with CAD (2 men,
4 women, aged 52'8 years) underwent (a)atrial pacing at
120/min for 5 min'. followed, 15 mins later, by (b lat r i a l
pacing at 120/min for 5 mins during 5. With pacing alone,
CSF increased 23'31 ml/min; with pacing and S, it in-
creased more (35-25 mJ/min, p<0.05). Thus, in chronic
smokers with CAD, smoking increases myocardial oxygen de-
mands and coronary blood flow. The magnitude of this
smoking-induced' in blood flow is greater than that
which occurs with other provocative maneuvers, demon-
strating that smoking does not inhibit an + in coronary
blood flow in response to + myocardial oxygen demands.
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New Clinically Relevant Echo Observations
SENSIBI LITY AND SPECIFIC ITY OF TWO DIME NSIONAL ECHOCAR-
CARD IOGRAPHY IN THE DIAGNOS IS OF AORTIC DISSECTION
EXPER IENCE WITH 115 CASES
R. Roudaut, M.A. Bi11es,P.Besse,M .Da11occhio, Hopital
Cardl0Joglque, avenue de Magellan, 33604 BORDEAUX PESSAC
France
The aim of this work is to specify the sensibility and
the specificity of two dimensional echocardiography
(2DE)in the emergency diagnosis of aortic dissection(AD).
607 patients(pts) were studied in our laboratory bet-
ween 1978 and 1983 for a suspected di agnos is of AD. In
115 cases the di agnos is of AD was confi rmed either by
angiography(angio) and or surgery, or in 16 cases by
autopsy or CT scanner(15 cases).They were 92 men and 23
women, with a mean age of 60+12. In all cases the 2DE
was performed with a systematfc approach of the aorta.
Thus parasternal(left and right, long and short axis
views),suprasternal, apical, subcostal, abdominal and
more recently dorsal views were systematically recorded.
In our experience two criteria are necessary for a defi-
ni te di agnos is of AD: an aort i c en1argmentand a typi ca1
i nt ima 1 fl ap (1i near, long, attached to the aorti c
wall ,constantly seen and mobile) .With these criteria
the accurate diagnosis was made in 59/68 type IAD(87%),
6/13 type II AD(46%), and only 10/33 type III AD(30%).-
Further more in 13 cases, the diagnosis of AD was
suspected by 2DE:in these cases , the intimal flap was
atypical, localized , transient,parallel to the aortic
wall, minimally mobile. In this group the diagnosis of
AD was confirmed in 7/11.
In conclusion :2DE is a practical and valuable method
for t he assessment of AD.The criteria(dilation of aor-
ta, intimal flap), were found to be reliable especially
in type I AD. In our group of 607 pts wi th suspected
AD, the sensibility of 2DE is 71 %, the speci f ici ty 99%.
IIEHODYNAMIC CORRELATES OF RIGHT VENTRICULAR DIASTOLIC COLLAPSE
IN CARDIAC TAMPONADE -- ECHOCARDIOGRAPHIC STUDIES WITH
PERICARDIOCENTESIS
Sanjay Singh, MD; Gregory H. Schuchard, HD; H. Sidney
Klopfenstein, MD, PhD; L. Samuel Wann, MD, FACC, Medical
College of Wisconsin, Milwaukee, Wisconsin
The echocardiographic finding of right ventricular diastolic
collapse (RVDC) has been proposed as a sensitive and specific
sign of cardiac tamponade. The precise hemodynamic
derangements associated with this finding have not, however,
been documented in man . We therefore performed
two-d imensional echocardiograms in 17 patients before and
after pericardiocentesis. Fourteen patients had RVDC, 3 had
none . lntra-pericardial pressure (IPP) was measured through
the needle; CO , RA pressure, and pulmonary capillary
wedge (PCW) pressure were measured with a thermodilution
floatation catheter.
Pre-Tap Post-Tap
RVDC
--IPP Z2.8 ± 6.6 DID Hg 3.6 ± 2.6 p < .001
CO 4.3 ± 1.6 l/min 7.5 ± 1.9 p < .02
RA 19.6 ± 8.1 DID Hg 5.6 ± 1.9 p < .005
Pew 22.6 ± 9.0 DID Hg 7.5 ± 2.5 p < .01
No RVDC
lPP 8 DID Hg 2 ns
CO 5 ± 1 l/min 5.8 ± 1.6 ns
RA 7.8 ± 4.8 l/min 6.3 ± 5.1 ns
Pew 11 ± 7 l/min 14.3 ± 0.6 ns
We conclude: 1) RVDC is accompanied by significant
hemodynamic derangement; 2) RVDC disappears with Unproved
hemodynamics following pericardiocentesis; 3) hemodynamics did
not improve following pericardiocentesis when RVDC was
absent .
EOiOCARDI<X;RAffiIC DESCRIPrION OF RIGHT VENrRIClJIAR
ANATCMY IN RIGHT vrnnuCUlAR TAQiYCARDIA: A INDICATOR <F
PR<X;NOSIS.
Rochey Foale MB, Edward Rowlam MB, Petra;
Nill:>yannopoulos MD, Dennis Krikler MD FACC, Royal
Poatgraduate Medical School, London, W12.
We have Sll:>1011 that some patients with ventricular tachy-
cardia (VI') aris~ fran the RV have adverse electro-
physiological (EP) features. These may be linked with
anatanical abnormal i t tes of the RV. Eleven patients
present irg with VI' hed the RV origin conf irmed by EP
study. Cross-sect ional echocardiograms (CSE) Ioo1:!re per-
formed in each with particular attention to RV cavity
size. RV inflow and RV outflow tract were measured fran
specific parasternal views am mid RV fran an apical 4
chatber view. Six patients (group 1) hal 1 or nore
adverse EP features sugJlleS t i~ poor prognos is: syncope,
multiple rorpll:>logies of RVVT or degeneration of VI' into
ventricular fibrillation. The renaimrg 5 (group 2) hal
none of these. All patients in grorp 1 hal obvious
dilatation of the RV in all r~ions. All patients in
group 2 all hal measuranents within our normal rarge ,
Table : Groop I Orcup II
(an) mean + SO (rarge ) mean + SO (rarge )
RV - inflow 7.1+0.5 6.3-7.5 5.3+0.8 4.2-6.1
RV - mid 4.9+1.2 3.5-6.5 2.8+0.2 2 .5-3.1
RV - outflow 3.4+0.4 2.8-3.8 2.4+0.5 1.7-2.6
In addition, all group 1 patients hal diastolic
distortion of the ventricular septum. 1\.10 hal r~ional.
dyskinetic zones in the RV inflow am outflow tracts.
CSE identify abnoDDalities of RV anatany in patients with
Rvvr. These abnotrnalities are lirked with alverse
electrophysiological features am may be useful as an
irxlicator of prcgnos ts,
POST VENTRICULOMYECTOMY ECCENTRIC SAM: FURTHER EVID!NCE
FOR THE VENTURI MECHANISM
C. Pollick HB, FACC, W.G . Williams MD, H. Rakowski MD,
E.D. Wigle MD, FACC, Toronto General Hospital, Toronto.
The mechanism by which ventriculomyectomy(VK) relieves the
pressure gradient(PG) in patients(pts) with muscular sub-
aort ic stenosis(MSS) is disputed. We studied 9 pts with
MSS by 10 and 20 echo pre and post VK.
Pre VM, 20 echo at short axis, mitral valve level, demon-
strated virtual obliteration of the LV outflow tract(LVOT)
at peak systole by severe SAM . Post VK, the VM site at
peak systole was located in the central LVOT in 4 pts and
lateral LVOT in 5 pts, and measured 1.36cm2 and 0.91cm 2
re spe ctively. In the 4 pts with central VM, SAM was con-
centric and mild(l) moderate (l) or absent(2) . In the 5
pts with lateral VK, SAM was eccentric and mild(2) moder-
ate(l) or severe(2) in the medial LVOT ; but absent in the
myectomised lateral LVOT(5)(fig: 2D(systole) and lD(medial
and lateral LVOT) at MY level) . Post VK hemodynamic stud-
ies in 3 ·of these 5 pts (including the 2 pts with severe
medial SAM) demonstrated no basal PG(vs. 78mm Hg pre VM).
)'11
•Conclusions: 1. The phenomenon of eccentric SAM supports
the concept that VM relieves the PG by widening the LVOT
thereby decreasing local Venturi forces that cause SAM.
2. Post VK echo studies of SAM severity may be misleading
unless both the medial and lateral LVOT are assessed.
ABSTRACTS lACC Vol. 3. No.2
February 1984:493
493
However, since one of the above usually was present, a positive
finding gave a combined sensitivity of 86%, specificity of 90%
and predictive value of 89%. In only I patient was a "typical"
echo-free cavity seen.
Thus, while echo-free cavities are rarely present in perivalvular
abscesses, attention to these other echocardiographic
abnormalities can make 20 echo an extremely useful technique
for the detection of this complication of endocarditis.
REUABLE DETECTION OF ENDOCARDITIS-ASSOCIATED
PERIVALVULAR ABSCESSES BY 20 ECHOCARDIOGRAPHY.
Stephen Ellis, MO; James Goldstein, MOj Richard L. Popp, MO,
FACC; Stanford University School of Medicine, Stanford, CA.
The presence of a perivalvular abscess (PA) associated with
infective endocarditis adds appreciably to the morbidity and
mortality of endocarditis, but PA are seldom recognized by
available non-invasive techniques. While occasional reports of
echo-free abscess cavities or echodensities with PA exist, we
have been impressed by the presence of more subtle findings in
patients later proven to have PA. Therefore, in a retrospective
but blinded study, we compared 20 echo findings in 26 cases of
endocarditis with PA documented at surgery with 28 cases found
not to have PA. 38 aortic and 16 mitral (41 prosthetic and 13
native) valves were examined. 4.0~2.4 days (range 0-7) elapsed
between echo and surgery. Echoes of interpretable quality were
obtained in 8.5%. Any single criterion seldom occurred, resulting
in:
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Doppler Echocardiography in Valvular Disease
NON-INVASIVE QUANTIFICATION OF MITRAL VALVE AREA USING
HIGH PULSE REPETITION FREQUENCY DOPPLER
Kent L. Richards, MD, FACC; Scott R. Cannon, PhD; Michael
H. Crawford, MD, FACC, Veterans Hospital &University of
Health Science Center, San Antonio, Texas.
High pulse repetition frequency (HPRF) duplex Doppler has
recently been developed to better quantitate very high
velocities associated with valve stenosis. To determine
the ability of Doppler to quantitate mitral valve area
(MVA) , 19 adults (9 with mitral stenosis & 10 with no
valve disease) underwent cardiac catheterization and ex-
amination with 3 MHz HPRF Doppler. Doppler spectral re-
cordings were obtained from the high ascending aorta us-
ing the suprasternal notch window; high velocity mitral
orifice records were obtained from the cardiac apex. As
real-time spectral display was used to orient the ultra-
sound beam parallel to the velocity vectors, the Doppler
angle was assumed to be 00 • The mean systolic peak aor-
tic Doppler frequency (FAs) & mean diastolic peak mitral
Doppler frequency (FMd) were obtained by integrating the
highest frequency spectral envelopes & dividing the areas
by the systolic & diastolic flow times, respectively.
The Gorlin equation was sim lified to:
MVA = Aortic Flow / Gradient & expressed in terms of
Doppler parameters: MVA = FAs/FMd. The ratio, FAs/FMd,
was used to identify mitral disease & quantitate its se-
verity. At catheterization, 9 patien~with mitral ste-
nosis had cardiac outputs of 3.8-8.5(5.9) L/Min, mean
diastolic gradients of 6-23(Tl)mmHg & MVAs of 0.7-2.5
(~)cm2. There was no overlap in FAs/FMd between mitral
stenosis & control patients. There was excellent corre-
lation between catheterization-determined MVA and that
predicted by Doppler where MVA = 4.1 FAs/FMd -.45 (r=.88;
SEE=.30). The study demonstrates the accuracy of HPRF
Doppler in quantifying MVA in patients in whom severe
aortic valve dtsease & mitral regurgitation are absent.
Specif ici ty
100%
86%
100%
80%
100%
Sensitivity
23%
27%
32%
40%
14%
anterior aortic root ~ 10 mm
posterior aortic root ~IO mm
valve rocking
sinus of valsalva aneurysm
localized density in septum ~14mm
INTER-TEST VARIABILITY OF ECHO AND X-RAY MEASUREMENTS:
IMPLICATIONS FOR DECISION MAKING IN PATIENTS WITH
VALVULAR REGURGITATION. B.Massie,M.D.,FACC, B.Greenberg,
M.D.,FACC, M.Cheitlin,M.D.,FACC, D.Thomas,Ph.D., J.D.
Bristow,M.D.,FACC. VAMC and University of California,
San Francisco, CA and University of Oregon, Portland ,OR.
Echocardiograms and x-rays are commonly employed for
serial measurements of LV size and function in chronic
aortic regurgitation (AR), and often form the basis for
therapeutic decisions. We undertook the present study to
determine the inter-test variability of these
measurements using ECHOS and x-rays performed 3 months
apart in 12 patients with significant but asymptomatic AR
without intervening clinical or therapeutic changes.
End-diastolic and end-systolic dimensions (EDD, ESD, in
mm), fractional shortening (%S), and x-ray CT ratio were
measured by the same reader, with the initial (I) and 3
month (3M) tests being read both individually (IND) and
together for comparison (TOG). The SD of the inter-test
differences was used as a measure of inter-test
variability, since 2SD defines the 95% confidence limits
of random changes.
EDD ESD %S CT ratio
Ivs3M6 SD Ivs3M6 SD Ivs3M6 SD Ivs3MA SD
lNO +1.2 5.4 +2.7 5.0 -2.8 5.2 +.01 .07
TOG +0.5 2.3 +0.5 2.3 -0.2 2.9 +.00 .03
The changes between the I and 3M were not significant,
but the SD's of the inter-test differences were
substantial, and moreover, they were significantly
greater (p (.05) if the tests were read IND vs
TOG. Thus, relatively large differences in heart size
(5mm for EDD and ESD •• 06 for CT ratio) and function (.06
for %S) must be present before they can be ascribed to
clinical changes, and if serial tests are not read
together. these differences must be twice as great.
CONTINUOUS WAVE DOPPLER ESTIMATES OF THE SEVERITY OF
STENOSIS FOR BIOPROSTHETIC VALVES IN THE MITRAL AND TRI-
CUSPID POSITIONS: STUDIES IN A CHRONIC LAMB MODEL
Lilliam M. Valdes-Cruz, M.D.,FACC, Michael Jones, M.D.,
FACC, Joan Main, Elling Eidbo, B.A., David J. Sahn,
M.D., FACC, Richard E. Swensson, M.D.,FACC., Iraj A.
Kashani. M.D., FACC, William Elias, Nat'l. Heart, Lung
and Blood Inst., Bethesda, MD and Univ. of Calif. San
Diego Medical Ctr., San Diego. CA.
We performed 2D Doppler echo exams on 22 sheep previous-
ly implanted with bovine pericardial or porcine aortic
valves in mitral (MV) (n=9) or tricuspid (TV) (n=10)
positions. Doppler exams, using an IREX scanner and
simultaneous hemodynamic studies were performed a mean
of 4.5 months post-op and just prior to sacrifice.
Doppler velocities (VEL) at rest and after Isuprel were
corrected for the angle between sampling and flow. Data
did not differ between valve types or locations, so
results were combined. Peak diastolic VEL(n=45) between
120-290cm/sec correlated well with peak gradients
between 6-43mmHg (r=0.90, SEE=16cm/sec). Using the
simplified Bernoulli equation (gradient=4xMax VEL2 )
Doppler VEL predicted actual peak gradients well(r=O.89,
SEE=2.6mmHg.) Doppler mean diastolic VEL, however,
predicted actual mean gradients poorly (r=0.56 SEE=
2.1mmHg). Peak VEL and gradients occurred late in
diastole, so pressure half time could not be determined,
but Gorlin valve areas ranging from O.31-2.87cm2 were
predictable with wide scatter by the formula A=0.003 x
Heart rate x Cardiac output/mean VEL (r=0.73, SEE=
O.3cm2 ) . Valve specimens showed leaflet thickening and
calcification similar to degenerated bioprostheses from
patients. The Doppler method, while predicting valve
area only marginally, appears promising for predicting
gradients across bioprosthetic TV's and MV's.
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MEASUREMENT OF PEAK FLOW VELOCITY IN ADULTS WITH VALVULAR
AORTIC STENOSIS USING HIGH PULSE REPETITION FREQUENCY
DUPLEX PULSED DOPPLER ECHOCARDIOGRAPHY. Catherine M.
Otto, MD; Carolyn Janko, RDMS; Robyn Prestley, RCVT;
A. Kim Saal, MD; Alan s. Pearlman, MD, FACC; Division of
Cardiology, University of Washington; Seattle, WA
In patients with aortic stenosis (AS), accurate measure-
ment of high blood flow velocities using conventional
pulsed Doppler (PD) has been limited by signal aliasing.
A new PD technique uses a high Dulse repetition frequency
(PRF) to avoid aliasing, and has promise for accurate
measurement of high flow velocities. We tested this new
method in 13 patients with suspected AS, in whom Dre-
catheterization PD studies of Deak aortic jet velocity
showed signal aliasing. Ten of these pts (8 males, 2
females), ranging in age from 27-82 (mean 62 years), had
technically adequate high PRF-PD measures of Deak aortic
flow velocity (v). The range in peak aortic flow velocity
was 1.3 to 4.9m/sec. The trans-aortic pressure gradient
(~P) was calculated from the modified Bernoulli equation:
~P=4v2. Cardiac catheterization was performed on the same
day as PD in 5 pts, within one week in 3 pts, and within
two weeks in 2 pts. The peak-to-peak ~P at catheteriza-
tion showed close agreement with peak instantaneous ~P
by high PRF-PD (~P Doppler = 0.96 ~P Cath + 7.8mm Hg, r=
0.92, SEE=II.Omm Hg). Aortic insufficiency was present
in 6 pts and was not associated with a systematic error
in ~P predicted by PD. One patient with an aortic valve
area less than I.Ocm2 had a low CO; ~P was less than
50mm Hg by both PD and catheterization. We conclude that
high PRF-PD can measure high flnw velocities in adults
with AS, and that predicted ~P by PD agrees well with
direct gradient measures at catheterization. However,
~P may not reflect the severity of AS when cardiac out-
put is low.
DOPPLER QUANTITATION OF STENOTIC SEMILUNAR VALVE AREA
Demetrio Kosturakis, MD, Hugh D. Allen, MD, FACC, Stan-
ley J. Goldberg, MD, FACC, David J. Sahn, MD, FACC, Lil-
liam M. Valdes-Cruz, MD, FACe, Univ. of Az, Tucson, AZ
Echocardiography and Doppler have allowed detection
of aortic and pulmonary valve stenoses and quantitation
of pressure gradients across stenotic semilunar valves.
However, no noninvasive techniques are reported which
evaluate the valve area of a stenotic semilunar orifice.
The purpose of this study was to assess area measure-
ments with a Doppler method and to compare results with
area determined by the Gorlin & Gorlin's cardiac cath
method. The Doppler area formula used in this study was
A=SV/(.88xV2XVET). This area formula can be derived fromthe Doppler cardiac output equation. Stroke volume (SV)
was calculated as SV=mean velocity per beat x vessel
area/the cosine of the beam/flow intercept angle (0). SV
was measured in the other great vessel which had a nor-
mal semilunar valve. In the area formula, .88 is a unit
change constant, V=maximal velocity of the jet beyond
the stenotic orifice, and VET=ventricular ejection time
which was measured directly from Doppler tracings. Four-
teen subjects (11 pulmonary stenosis, 3 aortic stenosis)
had cath and Doppler studies. Doppler exams were per-
formed within 24 hours of cath, 9 simultaneously with
cath. Area measured by cath (Gorlin) and by the Doppler
area formula correlated well (r=.97, SEE=.09, Y-.037
+.66X). The slope deviates from 1.0 because Doppler
slightly underestimates high pressure gradients. Fur-
ther, VET, PI-P2, and SV, measured independently by cath
and Doppler, also correlated well (r=.81, .94, and .96
respectively). This study demonstrates that the orifice
area of stenotic semilunar valves can be reliably pre-
dicted from noninvasive Doppler measurements.
ESTIMATION OF GRADIENTS ACROSS AORTIC COARCTATIONS BY
CONTINUOUS WAVE 2D ECHO DOPPLER: EXPERIMENTAL CANINE
STUDIES AND INITIAL CLINICAL EXPERIENCE
Suzana Horowitz, Lilliam M. Valdes-Cruz ,M.D. , FACC,
David J. Sahn, M.D., FACC, Douglas Larson, Ph.D., Kent
A. Young, Emmanuel Mesel,M.D. University of California
San Diego Medical Center, San Diego, CA
To evaluate a 2D echo Doppler method for estimating
gradients across coarctations (COARCTs), we created
COARCT like obstructions in 4 anesthetized dogs in whom
a ~-inch umbilical tape sewn to the descending aortic
wall was progressively tightened to produce an
hour-glass type obstruction while proximal and distal
pressures were measured with manometer-tip catheters. A
2.5 MHz Irex IIIB phased array transducer was placed on
the ascending aorta to image the descending aorta and
record continuous wave Doppler velocities. Angle
corrected maximal systolic velocities (MAX V) between
68-650 cm/sec correlated closely with 45 pressure
gradients between 8-174 mmHg (r=O.97, SEE=32 cm/sec).
Further, using t~e modified Bernoulli equation,
gradient=4xMAX V , Doppler estimated gradients also
correlated well with actual gradients (r=0.98, SEE=7.5
mm Hg). Fourteen patients with coarctation of the aorta
were studied prior to catheterization; 3 were status
post-operative for coarctectomy but had residual
gradients. Doppler overestimated gradients across long
COARCTs in 2 infants and distal velocity could not be
recorded in 1 infant, but for the other 8 patients with
discrete COARCT and the 3 with residual or re-COARCT,
Doppler estimated gradient was within 10% of the actual
gradient measured at cardiac catheterization. Our
results suggest that continuous wave 2D Doppler echo
provides a promising method for assessing gradients
across aortic coarctations.
HOW DOES EXTENDED RANGE DOPPLER COMPARE TO CONTINUOUS WAVE
IN RECORDING THE HIGH VELOCITY FLOWS IN STENOTIC AND RE-
GURGITANT LESIONS?
William J. Stewart, MD; Kathleen A. Galvin; Linda D.
Gillam, MD; David E. Guyer, MD; Arthur E. Weyman, MD, FACq
Massachusetts General Hospital, Boston, MA
Continuous wave (CW) Doppler echocardiography is of proven
utility in the non-invasive measurement of high velocity
(HV) flows associated with aortic stenosis and mitral
stenosis. In such HV lesions, normal pulsed Doppler (PD)
shows only aliasing, manifested by spectral dispersion
due to Doppler shift frequencies above the Nyquist limit
of one-half the pulse repetition frequency (PRF). Recent~,
PD instruments with extended range (EXR) have been devel-
oped which use a high PRF to discriminate directional HV
flow while maintaining range resolution. However, to date
no comparison has been made between the ability of the
EXR concept to actually record HV equal to those obtain-
able by CWo Therefore, we selected 41 patients (pts) with
echocardiographically significant valvular disease and
performed complete Doppler exams with both EXR and CWo 64
valve lesions were studied, including 16 mitral, 31
aortic, 11 tricuspid, and 6 pulmonic. In 39 (61%) of the
64 lesions, EXR depicted peak velocity (PV) above those
available with standard PD. However, EXR underestimated
PV compared to CW by> 0.5 meters/second rm/s) in 43 (67%)
and by )1.5 m/s in 16 (25%). A consistent underestimation
of PV by EXR was noted, which increases with higher PV. A
correlation between the difference in PV and the PV by CW
showed r=.62 and slope=.67. We conclude that EXR is a
useful tool, capable of adding significant HV information
not obtainable by standard PD. However, PV measurements
by EXR appear to underestimate PV compared to CW and this
underestimation increases at high velocities.
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Mapping and Signal Averaging in Cardiac Arrhythmias
EFFECT OF ANTIARRHYTHMIC THERAPY ON DELAYED POTENTIALS
IN PATIENTS WI TH VENTRICULAR TACHYCARDIA
A.R. Denn iss FRACP , D.L. Ross FRACP, FACC , D.V. Cody FRACp,
B. Ho MB, P.A. Russe l l FRACP, A.A. Young FRACP, FRCP,
J . B. Uther FRACP, Wes t mead Centre, Westmead, Austral i a .
Sign al-aver aging (SA) of the sur f ace ECG enables detect-
ion of l ow amplitude delayed potentials (DP) in the ST
segment in patient s with clinical ventricular tachycardia
(VT) . This study in ves tigated whet her the timing of DP
after QRS ons et was modi fied by antiarrhythmic dr ugs (AA ) ,
and whether any suc h changes corre l ated wi t h AA suppres -
s ion of clinical and inducible VT .
Thirty- two pat i ent s (36-7 0 year s ) wi t h sustai ned VT l at e
after myocar dial infarction had both VT in duci bl e at prog -
rammed st i mul at i on (PS) and DP >140 ms after QRS onset;
these pat ie nts had repeat PS and SA during 53 trials of
AA . Si gnal-averaged QRS durat io ns (QRS) measur ed in ms
f rom QRS onse t to the end of DP wer e : -
AA n QRS be fo re AA (M±SEM) QRS after AA
Quini dine 22 162 ± 18 158 ± 21 (NS)
Mexiletine 21 165 ± 21 166 ± 22 (NS )
Metoprolol 6 157 ± 9 154 ± 17 (NS)
Other 4 165 ± 17 177 ± 21 (NS)
DP were abolished in 5 trials of AA (9.4\) and VT was not
inducible after AA in 7 t ria ls (13.4\); abolition of both
DP and VT in ducibil i t y occu r red in onl y 1 tr ial . Si xteen
patients were treated wi th AA chronica lly on re gimes t es t-
ed at PS and AA , t he r emainde r being treated wi th sur gery
or amiodarone . The former group was fo llowed for a mean of
6 months and VT deve loped desp ite AA in 4 of 9 pat ien t s
with in duci bl e VT and 1 of 7 patients without i nduci bl e
VT; these 5 pa t i ent s had persistent DP on AA .
Conclusions: 1. Quin i dine , mexi l etine and metopr olol have
no consistent e f fect s on t i mi ng of DP. 2. Abolition of DP
by AA is uncommon. 3. Persistence of DP does not appear t o
predict clinical response to AA .
SIGNAL AVERAGED ECG IN PATIENTS WITH NONSUSTAINED
VENTRICULAR TACHYCARDIA: IDENTIFICATION OF PATIENTS WITH
POTENTIAL FOR SUSTAINED VENTRICULAR ARRHYTHMIAS
Alfred E. Buxton, MD, FACC, Michael B. Simson, MD, FACC,
Rita falcone, Carol Dresden, Fran cis E. Marchlinski, MD,
FACC, Harvey L. Waxman, MD, FACC, Ma rk E. Josephson, MD,
FACC, University of Pennsylvania , Philadelphia, PA
The signal averaged ECG has characteristic abnormalities
i n patients (pt s ) with sustained ventricular tachycardia
( VTS). Since pt s with nonsusta i ned VT (VTNS) have a high
r i sk for s udden cardiac death we used the s i gnal ave r -
aged ECG to attempt to i dent i fy a subgroup of pts with
VTNS at r isk for lethal VTS, and compare d th ese results
to t hos e of programmed s timulat i on i n 43 cons ecuti ve pt s
wi t h spont aneous VTNS . Programmed st i mulation i nduced VTS
i n 15 pts, 13 of whom had VTNS wi th the same morpholog y
i nduce d ; VTNS only in 16 pt s; and no VT i n 12 pts. Thir-
teen of 15 pts with induced VTS had coronary artery dis-
ease (CAD). On s ignal averaging pts wi th i nduced VT S had
a lon ger f iltered QRS durat ion ( 127 vS 100 ms , p<. 01 and
a higher incidence of l ate pot ent ials ( = < 27~ V in the l ast
40 ms of the fil tered QRS, 67% vs 25%,p=.01 ) t han pt s
without i nduc i bl e VTS. pts with i nducibl e VTS also had a
highe r i nc i dence of CAD (B7% vs 32% , p<.001) and lower
eject ion f ractions (41% vs 53%, p<.001 ) than pt s wi t hout
in ducibl e VTS. CAD pts with i nduci bl e VTS (13/22) had
higher inc idence of aneurysms ( 62~ vs 11%, p=.02) lo nge r
f il te r ed QRS ( 130 vs 107 ms, p<. 01), but a simil ar i nci -
dence of late potent ials (69% vs 67%) as CAD pts wit hout
in duc i bl e VTS. We conclude: 1) a subse t of pt s with VTNS
have i nducibl e VTS, most f requentl y i n association with
CAD, vent ricul ar aneurysms, and eject io n fractions <40%;
z) the s ignal averaged ECG may perm it noninvasive identi-
fication of pts with spontaneous VTNS havi ng the sub-
strat e to develop VTS.
PROS PECTIVE IDE NTIFI CATI ON OF PATI ENT S WITH INDUC IBL E
SUS TA INED VENTRICU LAR TAC HYC ARDIA WI TH FA ST FOURIER
TRANSFORM ANALYSIS OF SIGNAL AVE RAGED ELE CTROCARDIOGRAMS
Mi chael E. Cai n , MD; H. Dieter Ambos ; John A. Boerner,
MD; Thomas C. Mar ti n , MO ; Albert E. Fi scher , MS; Burton
E. Sobe l , MD, FACC , Washington Un iversity, St . Lou is, MO.
Pr ev io usly we reported relatively greater hi gh frequenc y
cont e nt in t he term i na 1 QRS and ST segmen t duri ng
arrhythm ia- free i nt e rv als i n patients known to manifest
su sta ined ve nt r icu lar ta chyc ard ia ( VT ) compared wi th
those without VT. To determine whether freque ncy doma in
analys is can pred ict i nduci bil ity with programmed
ven t ri cul a r stimulat ion, fast Four ie r trans form analys i s
( FFTA) of s ignal averaged XYZ ECGs was performed prospec -
t ivel y in 18 patients with organic heart disease and
suspected symptomatic dysrhythm ia. None had documented
sustained VT. With an RV st imulat ion protocol of single
and double extrastimuli at 3 cycle lengths and bursts of
rapid pacing to cycle lengths of 250 msec from 2 sites,
sustained VT was induced in 6 pat ients. The dB drop at4Q
Hz and the area under the curve f rom the fundamental
frequency to that at which the spectrum was 60 dB below
for t he termina l QRS and ST se gment in the 6 pat ients
with (Group A) and the 12 patients without inducible VT
(Group B) were (mean ! SE):
dB drop at 40 Hz 60 dB area
Gr oup Termi nal QRS ST Segment Terminal QRS ST Segment
A 19 .8!2. 7 43!4 .8 4377!405 3359±785
B 40!4 5B!2.4 20771350 18121491
p value <0. 0007 <0.01 <0. 001 NS
Thus, patients with inducible sustained VT have greater
hi gh frequen cy content i n ECG signals, especially the
term inal QRS, than those not i nduc i bl e . Accordingly, FFTA
offers promi se as a noninvas ive method of predicting
inducibility and the response to programmed ventr icular
st imulat io n in pat ients with suspect ed dysrhythmia.
LOCALIZATION OF THE SINUS NODE : COMPARISON OF CRYOTHERMAL
TECHN IQUES WITH ELECTRICAL MAPPING. Robert J . Hariman,MD,
FACC ; Rahul Mehra, Ph. D. ; William B. Gough , Ph.D.; Ronald
Holt zman,BS;Joseph A.C. Gomes, MD ,FACC ; Nabil EI-Sherif,
MD, FACC, SUNY Downstate and VA Medi cal Centers,Bklyn, NY
Loca l ization of the sinus node (SN) during cardiac sur -
ge ry may help prevent damage to t he SN. We used cryot herrn-
al mappin g (CM) to lo calize dominant (D) and latent (L)
SN pacemaker s (P) in 14 dogs and r eco rded 62 multiplexed
unipo lar e lec t ro gr ams f rom t he SN and right at rium us i ng
hi gh ampli f i cati on and low pass filte rs . Resul ts : CM
Method : In al l dogs , cooling (00 to - 100C for 15 sec)of
a l oca l i zed epica rdial area of 4 mm 2 (area I) close t o
sulcus terminal is r esul t ed in decreased hear t ra t e (HR)
and change in P-wave configuration. Simultaneous cooling
of an addi tional area a long sul cus termi nalis up to 22mm2
(area 11) r esulted in junct io nal rh ythm. CM req ui red <5
minutes in all dogs . The HR and P-wave conf ig ur ation re-
turned t o cont r ol fo l lo wing CM sugges t ing no adverse ef -
fec t to t he SN. Elec t r ical Mapp ing: In 5 dogs, HR was
) 120 bpm, pr ecluding re cognition of diastolic and upstroke
s lopes . In thes e dogs t he ea r lies t at r ial act ivat i on and
primar y negat i vity were re cor ded in an area of lD-1 8mm2
encompassing the enti re area I and a part of ar ea II of
CM . In 9 dogs, HR was (120 bpm which permi t ted id ent i f i ca-
tion of di as t ol i c and upstroke slopes . Elec t ro grams of
area 1 of CM showed di as t ol i c and upstroke s lo pes , com-
patible with t he area of DP, wher eas t he enti re area II
showed only dias to lic s lo pe compatible wi th an ar ea of LP.
Conclusions : 1) Reco r di ng of t he earliest a t r i a l ac tivi ty
does not adequately id enti fy t he enti re LP. 2) CM i s an
accurat e, quick and safe procedure for local i zat i on of SN
P and 3) unlike recording of SN elec t r ogr ams , CM can be
perf ormed i n the presence of rapi d HR. Cl i ni ca l applica-
tion of CM may decrease th e i ncidence of post-operative
SN dysfunction..
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BODY SURFACE POTENTIAL MAPPING-PARTIAL RIGHT BUNDLE
BRANCH BLOCK VERSUS RIGHT VENTRICULAR HYPERTROPHY WITH
TERMINAL RIGHT CONDUCTION DELAY
Jerome Liebman, M.D.; Yoram Rudy, PhD; Pedro J. Diaz,
PhD; Cecil Thomas, PhD; Robert Plonsey, PhD; Case Western
Reserve University, Cleveland, OH
Body Surface Potential Mapping (BSPM) with a 180
electrode system and color display was utilized in dif-
ferentiating RVH with terminal right conduction delay
(13 children with atrial septal defect) from partial RBBB
(10 children with varying anatomy, including 3 with
normal hearts, 6 with previous cardiac surgery, including
ventriculotomy, and 2 with heart disease and no cardiac
surgery). The differation often was not possible even
with vectorcardiography. All but one child with ASD had
clearcut right ventricular (RV) breakthrough, However,
as compared to normal (25 ms) the RV breakthrough was
delayed (30 ms), was over a broader front than normal,
and originated from the superior, rather than from the
right superior. In partial RBBB, RV breakthrough was not
present, but in 7 cases, LV breakthrough was judged to be
present, similar to that ~reviously described in patients
with advanced RBBB. The determining factor separating
the two groups was the presence of RV breakthrough in the
children with RVH and terminal right conduction delay and
the absence of RV breakthrough in children with partial
right hmd Le branch block.
LATE POTENTIAL-LIKE DEFLECT IONS IN THE ST -SEGf·1ENT IN
HEALTHY SUBJECTS
KorsukevJitz, J., f'1D; Erne, S.N., PHD; Hahlbohm,H.-D. ,PHD;
Lehmann, H.-P., PHD
Phys.-tech. Bundesanstalt Berlin and Free University
Berlin, Klinikum Charlottenburg, F.R.G.
Low amplitude deflections within the ST-segment of body
surface ECGs termed late potentials have been evaluated
as a means for identifying patients with ventricular ta-
chycardia. The purpose of this study was to determine the
incidence of late potentials in normal subjects. Body
surface high resolution ECGs of 22 healthy subjects
(25 : 3.2 years) were recorded in the Berlin magnetically
shielded room (B~lSR, noise level 0.4 uV rms for a band-
width from 0.01 Hz to 250 Hz and an electrode impedance
20 kOhm) with a patient limited noise level less than
2 uV peak to peak. Electrodes were placed at the second
intercostal space in the right parasternal and left mid-
clavicular lines, at V4 and V7. All bipolar electrode
combinations and lead II were evaluated. In unfiltered
beat to beat recordings in 16 subjects (group A) the
T-wave was smooth but in 6 subjects (group B) a deflec-
tion within the T-wave of maximally 15 uV was observed
in lead V4-V7. The occurence of these signals depends
on the position of the electrodes in relation to the po-
sition of the current dipole, calculated from magneto-
cardiographic measurements performed with a SQUID magne-
tometer in the BMSR. Thus, shifting electrode V4 syste-
matically (maximally 5 cm) is sufficient to cancel the
differences between group A and B. Consequently we ob-
served that the respiratory cycle influenced the de-
flections with pn increase during exspiration and a de-
crease during inspiration. We conclude that in healthy
subjects deflections which could be identified as late
potentials can be recorded in the T-wave depending on
electrode position.
Monday March 26, 1984
4:00-5:15PM Room E409/410
Arrhythmias and Ionic Changes
A NEW SITE OF ACTION FOR AMILORIDE ON THE CARDIAC SODIUM
CHANNEL: BLOCK OF INACTIVATION
Anne C. Marchese. MD; Pu-Di Xie, MO; Harold C. Strauss,
MO, Duke University, Durham, NC
Recent data suggest that amiloride, a diuretic that
inhibits Na transport and Na-H exchange, may also affect
Na-Ca exchange after prolonged exposure in erythroid
cells. Similar membrane transport mechanisms are present
in cardiac tissue, yet no data exist on possible inter-
ference by amiloride with ion transport in the heart.
We studied the electrophysiologic effects of 4 h expo-
sures to amiloride in canine Purkinje fibers using stan-
dard microelectrode techniques. Arniloride 10-6 - 10-5 M
led to a progressive lengthening of action potential
duration (APO) with a T of 1.8 ± 0.5 h (n=15).
Increase in APD was frequency dependent, so that for
10-5 Mamiloride at 2 Hz, APD increased by 65 ± 25 ms(21 t 8.0'1.), while at 0.5 Hz, APO increased by 366 ± 111
ms (76 t 36'1.) (n=6). At long cycle lengths (~2000 ms),
early afterdepolarizations and oscillations around the
plateau were seen. To determine the etiology of the
afterdepolarizations, Purkinje fibers treated for 2 h
with 10-5 Mamiloride were then exposed to tetrodotoxin
(TTX), manganese, and nisoldipine. 7.8xlO-7 MTTX, used
to block the Na channel, completely reversed all ami-
loride effects. 4 mM Mn increased the early after-
depolarizations, and arrest occurred at the plateau
potential routinely. 10-6 Mnisoldipine, a more selective
blocker of iSi, shortened APD somew~at but did not
reverse fully the effects of amilorlde. We conclude that
amiloride lengthens APO and causes early afterdepolariza-
tions ~ an effect on the Na channel, presumably by
blocking Na inactivation. This effect can be reversed by
TTX completely, while it is modu~ated by block of other
currents involved in repolarizatl0n.
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ELECTROPHYSIOLOGIC EFFECTS OF HIGH pH ON THE RABBIT
ATRIOVENTRICULAR NODE
Masao Nishimura, MD; Yasuhiro Tsuji, MD; Tadashi Nakanishi,
MD; Takakazu Katoh, MD; Yoshio Watanabe, MD, FACC,
Fujita Gakuen University, Toyoake, Aichi, Japan
We studied the electrophysiologic effects of high pH on
the spontaneously beating small (0.2xO.2xO.l rom) rabbit
atrioventricular (AV) nodal preparations using microele-
ctrode techniques. Raising pH from 7.4 to 8.1 by tris
buffer caused significant increases in action potential
amplitude from -70.9 to -74.0 mV, take-off potential from
-54.3 to -56.3 mV and maximal rate of depolarization from
15.5 to 19.3 V/sec, and a significant decrease in sponta-
neous firing frequency from 165 to 157/min (P<0.05, n=7).
These changes were exaggerated at pH 8.8, although other
action potential parameters such as overshoot, action po-
tential duration and rate of diastolic depolarization re-
mained unchanged even at this concentration. Voltage
clamp studies with double microelectrode method revealed
that elevation of pH from 7.4 to 8.8 shifted the holding
current outwardly by 4.2 nA at -35 mV, and increased the
peak slow inward current from -31.4 to -39.5 nA and steady
state outward current from 8.4 to 16.1 nA on depolariza-
tion to -5 mV. It also increased outward K+ current tail
from 2.5 to 4.3 nA on repolarization from +5 mV, and
hyperpolarization-activated inward current from -21.1 to
-24.5 nA at -85 mV (n=4). The steady-state activation
curve for outward K+ current tail showed a sigmoidal curve
between -50 and 0 mV at control pH of 7.4, which was
shifted by 9 mV to more negative potential levels at pH of
8.8. These results suggest that 1) high extracellular pH
exerts a negative chronotropic effect, but may improve
AV nodal conduction by increasing outward K+ current and
slow inward current, and 2) these ionic effects were
mediated by increased negative charges at the membrane
surface.
TEMPERATURE DEPENDENCE OF ELECTROGENIC SODIUM PUMPING IN
HUMAN ATRIUM.
Helge H.Ra8mussen, M.D.,FRACP: Robert E.TenEick.Ph.D.:
Donald H.Singer, M.D •• FACC; Renee S.Hart2, M.D.
Northwestern University. ChIcago IL.
The resting potential of Na loaded cardiac cells can
transiently hyperpolari2e to levels more negative than
the steady state resting potential (SRP). In order to
assess the temperature dependence of this hyperpolari2a-
tion, specimens of huma8 atrial appendage were Na loaded
by storage in cold (2-3 C) Tyrode's for 1 hr before
microelegtrode study~ Upon rewarming to 12, 17, 22, 27,
32 or 37 C in 20mM K (3 specimens at each temperature)
the resting potential became increasingly negative to a
maximal value (MRP) befgre slOWly declining to SRP.
Temperature 12bC 17 C 22°C 27°C 32°C 370C
MRP (-mV) 22-2~ 22-26 ~O-~5 63-67 68-72 62-65
SRP (-mV) 1~-17 1~ 2~-32 29-35 32-39 31-3~
We recently reported that acetylcholine during the period
of hyperpolari2ation induced a depolari2ation. indi~ating
polari2ation beyond the equilibrium potential for K and
thebefore the presence of an electrogenic current. MRP
(37 C) of specimens cooled In Tyrode's with LICI substi-
tuted for NaCl was -~3.2+3.~mV (mean+SD, n=6) while MRP
(37°C) was -65.7 + 3.3mV-when the same specimens had been
reincubate~ in cold NaCI containing T:rode's (p<O.001).
Because Ll can be substituted for Na but is not active-
ly transported i1 appears that the electrogenic current
is carried by Na • The ratio (Q 0) (mean MRP - mean SRP)
at 320CI (mean MRP - mean SRP) ~t 220C was 2.5 which is
similar to Q values reported for Na.K-ATPase in the
same temperalBre range. This similarity suggests that
Ne,K-ATPase is involved in electrogenic hyperpolari2ation
of human atrium. The findinga presented may have impor-
tant implications for the functional recovery of hearts
exposed to cold cardioplegia.
HOW DOES ACIDOSIS AFFECT SPONTANEOUS ACTION POTENTIAL AND
MEMBRANE CURRENT SYSTEMS OF THE RABBIT ATRIOVENTRICULAR
NODE?
Yasuhiro Tsuji, MD; Masao Nishimura, MD; Tadashi Nakanishi,
MD; Takakazu Katoh, MD; Yoshio Watanabe, MD, FACC,
Fujita Gakuen University, Toyoake, Aichi, Japan
Transmembrane action potentials were recorded from spon-
taneously beating small rabbit atrioventricular (AV) nodal
preparations (0.2xO.2xO.l rom) and the pH was progressively
lowered from 7.4 to 6.7 and 6.0 for 5 min by a phosphate
buffer (n=9). The rate of firing averaged 164/min during
control. Lowering of pH to 6.7 transiently increased the
rate to l87/min, and further lowering to 6.0 markedly re-
duced it to 142/min. Thus, all preparations showed a di-
phasic change. Perfusion at pH of 6.7 significantly
(P<0.05) decreased the action potential amplitUde from
98.8 to 92.6 mV, maximal diastolic potential from -74.6 to
-70.2 mV, take-off potential from -58.5 to -54.8 mV, and
maximal rate of depolarization from 20.1 to 12.0 V/sec.
The rate of diastolic depolarization was significantly in-
creased from 78.1 to 88.9 mV/sec. Action potential dura-
tion and overshoot were unaffected. Subsequent lowering
of pH to 6.0 further exaggerated these changes. The
transient acceleration of firing at low pH resulted from
decreased maximal diastolic potential and increased rate
of diastolic depolarization, whereas its subsequent slow-
ing was caused by a marked reduction in take-off potentiaL
Voltage clamp studies using double microelectrode techni-
ques showed that lowering of pH from 7.4 to 6.7 decreased
slow inward current by 9.1% and outward K+ current tail by
25.9%, and further lowering to 6.0 decreased these cur-
rents by 23.4 and 64.7%, respectively. These results sug-
gest that an acidotic milieu as during myocardial infarc-
tion depresses AV nodal conduction, but may exert variable
effects on its automaticity by reducing slow inward cur-
rent and outward K+ current.
EFFECTS OF CURRENT FLOW AND VAGAL STIMULATION ON
SUBSIDIARY PACEMAKERS IN THE LEAFLETS OF THE TRICUSPID
AND MITRAL VALVES
George J. Rozanski, Ph.D.; Jose Jalife, M.D.; Gordon K.
Moe, M.D., Ph.D., FACC, Masonic Med. Res. Lab., Utica,
NY and SUNY UMC, Syracuse, NY.
The electrical properties of tricuspid and mitral valve
leaflets from rabbit hearts were studied using micro-
electrodes. Tricuspid valve preparations were obtained
from regions far removed from the AV node. Leaflets
from both valves exhibited stable spontaneous automati-
city with intrinsic cycle lengths (650-950 msec) that
were longer than those of the SA node. Transmembrane
recordings from valve pacemaker cells exhibited more
negative diastolic potentials, larger overshoots and
faster upstroke velocities than the primary pacemakers
of the SA node. Application of long (2-3 sec) depolar-
izing current pulses with a suction electrode abbreviated
cycle length in a voltage-dependent manner. Brief
current pulses applied at different times during the
cycle accelerated or delayed the next pacemaker discharge,
depending upon their polarity, magnitude and timing.
Phasic effects were also observed in response to post-
ganglionic vagal stimulation. As in the SA node, the
effects of trief vagal stimuli on valve automaticity
depended on the timing, duration and intensity of the
stimulus. These experiments suggest that mitral and
tricuspid valve leaflets may represent a site of ectopic
pacemaker activity in the intact heart. This activity
may be modulated by electrotonic atrial input or by
repetitive, reflexly-mediated, vagal discharges.
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44.8±30.0
QUANTITATIVE COHPARISON OF ~IONOPHASIC ACTION
POTENTIALS RECORDED SI~roLTANEOUSLY WITH AN
INTRA- AND A NEW EXTRACELLULAR ELECTRODE
Hichael R. Franz, MDj Daniel Burkhoff; Myron L.
Weisfeldt, ~ID, FACC; Edward G. Lakatta, MD,
The Johns Hopkins Medical Institutions,
Baltimore, Md.
Recently, a new non-suction electrode has been
used for safe clinical recording of monophasic
action potentials (MAPs). Since a direct quant-
itative comparison of these MAPs and transmem-
brane action potentials (TAPs) has not been
performed, we recorded both TAPs and MAPs simul-
taneously from adjacent sites in isolated per-
fused rabbit septum preparations. To produce a
large range of TAP and MAP durations and confi-
gurations, recordings were obtained at varying
rCa] 0' [K] and drive cycle lengths. Recordings
were digit~zed at 1kHz sampling rate, computer-
-analyzed for duration at levels of 30, 60 and
9~ repolarization, and each TAP value plotted
versus that of the simultaneous MAP. The average
results (correlation coefficient and regression
line) from 7 experiments were:
Repol,level 90% 60%
r ,95+.04 .93+.07
slope ,90±,18 ,85±.17
intercept 31,5±63.7 33.2±56.8
(msec)
We conclude that MAP recordings with this extra-
cellular electrode indicate the TAP repolariza-
tion time course with reasonable accuracy and
can be used to assess the effects of pharmaco-
logic and electrophysiologic interventions when
intracellular recordings are not possible.
PROSTACYCLIIl SYlHHESIS BY CORONARY VASCULAR ENDO-
THELIUM
Georye E. Revtyak, MD; Al ice R. Johnson, PhD; Mary
Beth Santowski, BS; William B. Campbell, PhD, Uni-
versity of Texas Health Science Center, Dallas, TX.
Pros tacyc 1in (PG 1;1) present ; n the corona ry ci rc u1a-
t ion may reflecr prostagland in (PG) synthesis by
vascular endothelial cell s (ECs ) in response to
vessel wall injury and other vasoactive agents.
While PG production is well characterized in ECs
cultured from noncardiac vessels, there have been no
similar studies with coronary artery ECs. Therefore,
we cultured bovine coronary artery (BCA) ECs to
detennine which PG 's are released in response to
~~ecif ic stimul i. When BCA ECs were i ncubat ed with
C-arachi doni14ac id, t he only PG ide ntified by TLC
and HPlC was C-6-keto-PGF1 (s tab 1e metabolite of
PG1 2). As assessed by RIA, ~asal levels of 6-keto-PGF1 were 3-4 fgld 9reater than PGE~ (I.0±0.3 versus0.30~0.05 ng/10 cells). Under sinnlar conditions,
human pulmonary artery and umb i 1ica 1 venous ECs
produ5e at least 6-fold more 6-keto-PGF1 (6.4±0.7
ug/1 0 cells) and significant ~ounts orC> PGE and
PGF2 (2.4±0'~5and 6.5±0.8 ug/ 10 ce16s, respectively).HistRmine (10 M) and bradykin in (10- M) specifically
increased basaI" BCAEC 6-keto-F synthesis by 3.1-
and 4.8-fold, respectively, wh ifg mechanical disrup-
t ion, me11itin (2 ug/ ml ) and A23187 (10 llg/ml) all
increased both 6-keto-PGF and PGE production by
20- and 10-fold, respectiJe~y. Our ~esults indicate
that PG1 2 is the major PG synthesized by coronary
vascular endothelium and that i t s release may be
regulated by specific vasoactive agents. In contrast
to other tissues, however, it may have a reduced
capacity to produce PGI 2 in response to injury.
Monday, March 26, 1984
2:00-3:30PM Room 8412/413
Cardiovascular Pharmacology
TEE EF'FECrS OF TERClffiOXANE SYNrHEI'ASE INHIBITION H1
EYPERLIPEIMIP.. Bol"nie E. I'leiner, MO, FJI..cci Ira S. OCkene,
/.1J), FP.cci Marc Fisher, MO, Janes J. Hoogasian, John R.
l'r senaul t , Pnita M. Natale, Donald G. Love, Peter E.
Levine, MO, university of MIl. ~1edical School, \1orcester,
Massachusetts.
INFLUENCE OF NALOXONE ON VOLUME IN THE TOTAL CAPACITANCE
VASCULATURE
Leonard Bell; Edward Maratea ; David L. Rutlen, MD, Yale
University School of Medicine, New Haven, CT
The opiate antagonist naloxone, which i s associated with
prolonged survival in animal models of shock, has been
demonstrated to increase arterial resistance and cardiac
contractility. However, its influence on the total capa-
citance vasculature has not been described. Thus, the
present study examined the 'e f f ec t of naloxone on total in-
travascular volume (IV) in the capacitance circulation. In
1& anesthetized dogs, blood from the vena cavae was drained
into an extracorporeal reservoir and returned to the right
atrium at a constant rate so that changes i n total IVcould
be measured as reciprocal changes in reservoir volume. In
5 animals in which morphine ( 15- 30 mg iv ) had been previ-
ously administered, naloxone (2 mg/ml/min) was associated
with an increase in s ystemic arterial pressure from 58±3
to 66±3 mmHg (P<O.Ol) and a decrease in total IV of 74±29
ml (P<0.03) at 20 minutes. Directionally similar changes
were observed in 5 other animals in which exogenous opi a t es
had not been administered : arterial pressure increased
from &O ±S to &7±7 mmHg (P<0.05) and total I V decreased
l16±25 ml (P<O.Ol). In order to assess regional volume
effects, naloxone was examined in the absence of exogenous
opiates in 6 animals in which the splanchnic (SPL) and ex-
trasplanchnic (XSPL) vasculatures were separately perfused
and drained : total and SPL IV decreased &4 ±1& ml (P<O.Ol)
and lll±22 ml (P<O.Ol ), re spe ctively , and XSPL IV in-
cr eased 47±17 ml (P<0.05). Thus, naloxone, either in the
pr es ence or absence of exogenous opiates, is associated
wi t h a decrease in total IV. The decrease i n total IV is
due entirely to a decrease in SPL IV. In an animal not on
bypass, it would be expected that the naloxone mediated
total IV decrement would be as so ciated with increases in
both venous return and cardiac output.
P
.003
rc
US
.02
SM
5303.7+2788.3
--ill....9+104 8
p< 0 .001
HCHF
11153.6+3334.0
371 .0+93.0
p< 0 .001
PRE DRUG TxE2
PST DRUG TxE2
PRE DRUG PGI2
PST DRUG PGI2
'To evaluate the effect of UI08-485, a specific thron-
boxane synthetase inhibitor, in a hyperlipidemic rrodel,
10 senptes each fra] 10 male swine were obtained: five
sar.ples before and 4 during 7 days of treatr:'ent with
UK38- 485 lOmg/kg po qd. Five aninals were fed a high
cholesterol, high fat (FOP) diet for 3 weeks prior to
and during this study. The other five were fed standard
mash (SM). The total cholesterol in I:CHF was 511+1&9
rrq/dl and in el i was 91+13 rrq/dl. serum thr<rlJoxane
(TxE2) and prostacyclin IPG12) in pg/l.r:l1. were:
497.2+159.9 306.9+77. 3
762 2+107 4 474 3+103 8
p < o.ooi p< o.oo:
we conclude that: 1)HCHF' feeding increases TxE2i 2) UK38·-
485 decreases TxB2 in both HCI:F and 8M: 3) the absolute
TxB2 levels in both groups with drug treabrent are the
sar.e alti'Dugh the % reduction is I:1Uch greater in HCHF:
4) PGI~ does not change with HCHF feeding; 5) PGI2 rises
signifJ.cantly in both groups with treabrent Lut rore so
in HCHF.
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EFFECTS OF CALCIUM CHANNEL BLOCKERS ON BLUOD FLOW
DISTRIBUTION IN CONSCIOUS DOGS. Delvin R. Knight, Ph.D.
and Stephen F. Vatner, M.D. Depts. of Med., Harvard Med.
Sch. and Brigham & Women'5 Hasp., Boston, M~ and N.E.
Reg. Primate Res. Ctr., Southboro, MA.
Since Ca++ channel blockers are widely used
clinically to improve coronary(C) blood flow(BF), it is
important to know if these drugs act to redistribute BF
preferentially to that bed. To study this, the effects
of nitrendipine(NIT), 8~g/kg/min x 5 min, were evaluated
in 8 conscious dogs 3-6 wks after instrumentation with
an aortic(A) catheter to measure A pressure(P), an
electromagnetic flow probe to measure cardiac output(CU)
and left ventricular(LV) pressure transducer to measure
LV dP/dt. Doppler or electromagnetic flow probes were
placed around the circumflex C, renal(R), mesenteric(M)
and iliac(I) arteries to measure CBF, RBF, MBF and IBF
respectively. Following propranolol (1 mg/kg) and '
atropine (.1 mg/kg) to prevent reflex increases in heart
rate and LV dP/dt, which could cause a secondary in-
crease in CBF, NIT decreased AP by 24 ~ 2% from 96 ~ 3
mmHg while HR and LV dP/dt did not change from 143 ~ 7
beats/min and 2215 ~ 113 mmHg/sec, respectively. CO
increased by 38 ~ 2% from 2.~ ~ 0.2 L/min, RBF increased
by 6 ~ 2% from 150 ~ 21 ml/min, MBF increased by 15 ~ 5%
from 475 ~ 75 ml/min, IBF increased 92 ~ 18% from 93 ~ 7
ml/min while CBF increased 68 ~ 6% from 40 ~ 5 ml/min.
Nifedipine, 8~g/kg/min x 5 min, induced similar effects,
i.e., increasing CBF and IBF more than MBF and RBF.
Thus, in conscious dogs, Ca++ channel blockers re-
distribute CO preferentially to muscular beds. More
importantly, the C bed demonstrated significantly
greater (p<O.OI) vasodilation than the Mor R beds, even
when reflex increases in heart rate and contractility
were prevented.
Hyperem_i_a__
1:0 CX %DR
1.60±0.4 238±79
*1.15±0.2 *140±73
MBF During CAO Reactive
TM 1:0 TM MBF
BL 0.14±0.12 0.24±0.24 3.88±1.5
N 0.16±0.10 0.23±0.19 *3.26±1.2
*p<0.05 BL vs N
N did not affect myocardial oxygen consumption, resting
SF, extent of ischemic dysfunction, or rate of return of
SF following release of CAO. N reduces RH by a primary
vascular effect, and the resulting decreases in flow do
not impede recovery of SF following release of CAO.
EFFECT OF NIFEDIPINE ON TRANSMURAL DISTRIBUTION OF FLOW
AND SEGMENTAL FUNCTION FOLLOWING BRIEF CORONARY ARTERY
OCCLUSIONS.
David C. Homans, MD, Eugene Sublett, Debora Parrish, and
Robert J. Bache, MD, FACC, University of Minnesota Medi-
cal School, Minneapolis, Minnesota.
Nifedipine(N) is known to reduce reactive hyperemia (RH).
However, its effects on the transmural distribution of RH
flow and rate of recovery of ischemic segment function
(SF) are unclear. 30- and 60-sec. left circumflex (CX)
coronary artery occlusions (CAO) were performed in 8 open
chest dogs at baseline (BL) and 30 min. following N
(10 ~g/kg IV). SF was assessed by implanted ultrasonic
crystals (percent segment shortening). Flow was determined
by CX flowmeter and microspheres (MBF). N decreased peak
CX flow and percent debt repayment (%DR) following CAO. N
did not alter MBF at rest, or collateral MBF to ischemic
tissue during CAO. N did reduce mean transmural (TM),
endocardial, and endo:epi (1:0) MBF during RH following
30-sec. CAO.
DISSOCIATION OF MYOCARDIAL DIGOXIN CONCENTRATION AND
EFFECT DURING THE QUINIDINE-DIGOXIN INTERACTION
~:!.. Warner, MD, John T. Barnard, MD, J. Thomas
Bigger. Jr., MD, FACC, Elizabeth W. Uhl, BS, Richard
Einstein, BS, Columbia University, New York, NY
To study the relationship of myocardial digoxin (D)
concentration to 0 effect during the quinidine (Q)-D
interaction, we treated 18 dogs with 0 specifically la-
belled with tritium at the 12-alpha position. After a
steady-state serum digoxin concentration (SOC) of 1-
1.5 ng/ml had been obtained, each dog was randomly as-
signed either to receive Q or to continue on 0 only.
Two dogs treated with Q were not eligible for the study
because Q did not produce an increase in SOC of at
least 33%. In 7 dogs treated with Q, the SOC rose to
2.27~0.28 (p(O.OI vs pre-Q) over the next 5-7 days.
The SOC's of the 9 dogs treated with 0 only did not
change and were 1.15+0.15 (p(O.Ol vs. D+Q) after 5-7
days. Myocardial 0 concentration was 41.9+2.6 ng/g wet
tissue weight in dogs treated with 0 and 69.3+7.3 ng/g
wet tissue weight in dogs treated with 0 and Q
(p(O.Ol). The ratio of myocardial to serum 0 concen-
tration was 36.2~4.0 in dogs treated with 0 only and
30.5~8.l in dogs treated with D+Q (NS). We used inhi-
bition of 86-rubidium uptake to measure 0 effect on
myocardial monovalent cation transport. In dogs treat-
ed with 0 only, Rb uptake was 0.157± 0.043
nmole!mg/3Omin. (77% of control) and in dogs treated
with 0 and Q Rb uptake was 0.165+ 0.043 (81% of con-
trol, NS). Despite the fact that Q causes increases in
SOC and myocardial 0 concentration, it aoes not in-
crease the effect of 0 on myocardial monovalent cation
transport. We conclude that Q interferes with 0 bind-
ing or action at a specific myocardial receptor site.
Monday, March 26, 1984
4:00-5:15PM Room S412/413
Biochemical and Subcellular Myocardial
Responses to Exercise
EARLY CHANGES IN MYOCARDIAL MASS AND CORONARY RESERVE IN
EXERCISE INDUCED HYPERTROPHY
Peter M. Buttrick, MD; Thomas F. Schaible, PhD; Gary J.
Ciambrone; James Scheuer, MD, FACC, Montefiore Medical
Center-Albert Einstein College of Medicine, Bronx, N.Y.
We have previously shown that cardiac mass (CM) increases
and maximal coronary flow (MCF) decreases as early as 3-5
days after the creation of r~no-vascular hypertension (H)
in the rat. To study MCF and CM in exercise induced hyper-
trophy, adult female rats were exercised (E) by swimming,
75 min twice daily, and compared at various times with
age-matched sedentaries (S). Hearts were studied in a
Langendorf apparatus at 100 cm H20 aortic pressure and
paced at 5 Hz. MCF was determined by perfusing each
heart under two conditions: 95% N2:5% CO2 as gas; 12mM
adenosine (95% 02:5% C02)' Results are: (n-5-6 at each
point; Op<0.05 VB. matched S; +p<0.05 vs. S at day 0).
Exercise days 0 4 10 20 40
DHW/BW S .53 .52 .54 .55
(mg'g- l) E .5<1+.58+0 .70+0 .62+0
MCF* S 143 148 143 144
(ml'g-l/min) E 148 157+ 154+0 170+0
%6CF S 69 78 72 81
E 111+ 127+0 119+0 123+0
(DHW!BW - dry heart weight/body wt., *per g DHW; %6CF -
percent increase in flow with vasodilation). Body
weight was similar in all groups. These results show
that E, in contrast to H, increases both CM and MCF, and
that these changes occur within 10 days. A differential
response to vasodilators, evidenced by an increase in %6
CF, was seen after 4 days of exercise. We conclude that
changes in the microvascular capacity of the heart are
early events in the response to diverse hypertrophic
stimuli, decreasing with H and increasing in response to
exercise.
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THE EFFECT OF NONSELECTIVE a- AND SELECTIVE a I - ADRENERGIC
BLOCKADE ON CORONARY BLOOD FLOW DURING EXERCISE IN THE DOG
Xue-Zheng Dai, MD; Charles A. Herzog, MD; and Robert J.
Bache, M.D.,FACC; University of Minnesota Medical School,
Minneapolis, Minnesota.
BP during EX was decreased l7 ±5% after P (p<0.05) and
l3±4% after I (p <0.05) . HR was increased by P but not I .
CBF was increased after P in proportion to the increased
MV02 with no change in CS02' CBF, MV02 and CS02 were un-
changed by I. These data demonstrate markedly different
effects of selective and nonselective a-adrenergic block-
ade on coronary hemodynamics. Failure of I to increase
MaF during EX suggests that the greater increase in CBF
observed after nonselective a-blockade is not due to re-
lease of aI - medi a t ed tonic vasoconstrictor tone, but may
rather result from a2-adrenergic blockade.
Previous studies have demonstrated that coronary blood
flow(CBF) during exercise(EX) is increased following non-
selective a- adr ener gi c blockade; this finding suggests
that adrenergic vasoconstriction limits the increase in
CBF during EX. We compared the effects of the nonselective
a-adrenergic blocker phentolamine(P ) and the selective a l
blocker indoramin(I) on left c i r cumf l ex CBF during Kraded
treadmill EX in 9 chronically instrumented dogs . Heart
rate(HR), mean aortic pressure(BP), coronary sinus 02
(CS02), aortic-CS02 difference(A-V02), CBF and myocardial
02 consumption(MV02) were obtained at rest and during EX
under control conditions(C), after P (2 mg/kg, iv), and
after I (0.5 mg/kg, iv).
* p<0.05 for PRE vs. POST comparison
CONCLUSIONS : Cardiovascular tra ining effects can be pro-
duced desp ite a substantial level of a-I se l ec t i ve or non-
selective a-blockade. Adrenergic st imulation is not
required to produce exercise training effects.
116
42.3*
05 .2*
6C 61*
PROP
PRE POST
121
36.0
56.3
124
45.0*
84. 2*
131115*
70 65 66 59*
127
Rest Heart
Rate (H~)
Submaximal
Exer ci se HR
Peak V02 31.8 37.9* 38.1
Peak Lactate 46.9 61.5* 45.7
a-ADRENERGIC STlHULATION IS NOT NEEDED TO PRODUCE
CARDIOVASCULAR EXE~CISE TRAINING EFFECTS
William H. Savin, PhD; Elaine P. Gordon , tID; Steven 11.
Kaplan, BS; Barbara F. Hewitt , 'IS; Donald C. Harrison, lID,
FACC ; William L. Haskell, PhD , FACC, Stanf ord Universit y,
Stanford, California
Previous studies with a-agonists and nonselective a-
antagonists sUKKest that cardiovascular training effects
(CTE) are produced by a-adrenergic s t i Mul a t i on . However ,
we have previously shown that training effects can be
produced in the absence of car diac innervation (cardiac
t ransolant recipients). To further assess the role of a-
adrenergic stimulation in the develop~ent of CTE, 39
sedentary, normal men were assigned t o placebo (PLAC) ,
a t enol ol (ATEN), or propranolol (PROP) druK groups (r an-
dom, double-blind) and placed on an i nt ense , supervised
6 week exercise training progra~ (5 days/week, 45 min/day,
>757. peak heart rate). Drug doses were titrated indivi-
dually to produce Maximal chronotropic blockade during
exercise. (Dru~ dose ranges: ATEN: 50-200 mg/dav; PROP:
160-320 ~K/day). .
RESULTS: (PRE and POST are measurements made off drug
------ before and after tra ining).
PLAC ATEN
PRE POST ~ POST
HR(b/min) CBF (ml/min) MV02 (ml/min)
C I P C I P C I P
119 118 156*+ 32 32 51*+ J:8 3.6 ~
168 169 235*+ 42 44 84*+ 5.5 5.9 11.2*+
216 215 263*+ 61 58 104*+ 8.8 7.9 14.0*+
251 243 284*+ 83 70 117*+ 11.7 9.5* 14.9*+
*p<0.05 vs. C +p<0.05 vs. I
Rest
EX-l
EX-2
EX-3
·····,!!"IIIIIII
----CONCLUSIONS: 1) The magnitude of increase in V02m8 X forBB pts was similar to that of pts not on BB therapy. 2)
The l>V0 2max with training was independent of propranololdose.
IMPROVED MAXIMAL OXYGEN UPTAKE DURING PHASE 2 CARDIAC
REHABILITATION IS INDEPENDENT OF BETA-BLOCKADE THERAPY
Rudolph H. Dressendorfer, PhD, Joan L. Smith, MA, Seymour
Gordon, MD, FACC, Gerald C. Timmis, MD, FACC, William
Beaumont Hospital and Oakland University, Michigan.
Although increased maximal oxygen uptake (VO max) with
aerobic exercise training has been demonstrated in cardiac
patients (pts) taking beta-adrenoreceptor blockers (BB),
debate continues over whether BB attenuate this training
effect and, if so, whether the change in V02max (6VO max)is dose related. We measured V02m8 X in 88 pts, 71 at
whom were on BB, during maximal or symptom-limited tread-
mill tests conducted at 30±4 (mean ± SO) days after myo-
cardial infarction or coronary bypass surgery and again
following four weeks of a telemetry-monitored exercise
program (30 to 40 minutes of aerobic circuit training at
60% to 80% of initial V02max, two times per week) supple-
mented with home walking. Of the 71 BB pts, 40 were
taking propranolol in daily doses ranging from 10 to 300
mg/day. Mean VOZmax (ml / kg/ mi n) before and after train-
ing, and 6V02max in relation to propranolol dose were:
P
2p< . 05pl asma
DOES BETA BLOCKADE INFLUENCE VASOPRESSIN (VP) RESPONSE TO
EXERCISE (EX) TESTING IN ESSENTIA_ HYPERTENSION (EHTN)?
John P. ~icholson, MD, Jacek Preibisz, MD, Thomas G.
Pi cker inK, MD, John H. Lar agh , MD, FACC. Cardiovascular
Center. Cornell University Medical College, N.Y., N.Y.
VP has been implicated in the pathogenesis of EHTN and
has a physiological role in EX. Vasopressin's interaction
with ant i hyper t ens i ve therapy, however, is not well under-
s t ood . Therefore, we sought to determine the interaction
betwe en VP and beta blockade with AtenoloI (AT) 100 mg
dail y in 13 males (av. age 48±5) with EHTN average
sys to l i c blood pressure (SBP ) and diastolic blood pressure
(DBP) = l44±6/97!3 mmHg. During EX testing after one month
o f treatment VP was measured in both plasma and platelets .
Result s o f EX Testing (Ti me = 9 minutes)
Off AT P On AT
pre .73±.3 2p<.02 .37±. 2
post 2.0±4 2.2±.8
pl atelet pre l2.3+l .J 2p<.05 l2.4±1.5 2p<.001
post l3.7±1.I l4.5! I.8
There wa s no statist i ca l diff erenc e for both pre-EX
plasma and platelet VP be fore and after one month of
therapy. ~~en the pre-post EX change in VP platelet or
pl asma levels was compared on and off AT there was no
significant difference for both plasma and platelet VP
( ~ 1. 3 ! .5 vs . ~ 1 . 8 ± . 8 , t l . 4±. 7 vs. 62. l ±. 5 , ns). SBP and
DBP were significantly lower on AT and after 9 minutes of
exercise testing 200±6/ l l l ±3 vs. l16±7/96!3, p<.OOl) .
Plasma renin activity was significantly suppressed after
one month on AT therapy (J .5±1.0 vs . . 6±1.O, p<.OOl), and
rose 154% from baseline off therapy during exercise test-
ing, but only 54% during EX while on AT. These results
show that although AT was effective in lowering BP of
EHTN during EX, VP response remained intact, suggesting
that the mechanism by which VP reacts physiologically to
EX is independent of the beta adrenergic system.
f ,
.
'.
.
J. I •tt
i
, :.
t
t -
...
17.7+4 .6
20.8+3.0
+i8%
<.01
Non-BB pts
n=17
BB pts
n=71
17.8+4.3
21. 2+5.2
+19%
<. 01
Before
After
Xl>
P
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INC REASED PLASMA' CONJ UGATED DOPA/fIN E FOLLOWING EXERCISE
TRAINING IN DOGS
Alf red A. Bove, MIl , PhD, FACC; Gert rude M. Tvce , PhD;
Je r ry D. Dewey, BS , Mayo Clin ic , Rochest er , ~~
Conjugat ed dopamine (C- DA) i s an i nact i ve met abolite of
DA whi ch may act as a readily avai l abl e pool for ext ra-
adrenal conve rs ion t o norepinephrine (NE) and epinephri ne
(E) . Exercise training lowers f ree NE and E at res t (R)
and dur i ng exercise (Ex) , but no data are ava ilable on
t r a i ni ng e ffec ts on C-DA. We exami ned plasma C- DA, E,
and NE responses t o 8 weeks of t readmill exerci se t r a in-
i ng i n 8 dogs (T) . Si x cage-confi ned dogs (NT) we re used
as cont ro ls . All animal s had th e same die t t hroughout
t he study. Training res ponse was document ed bv a s tand -
ard s ubmaximal exe rc ise t es t (SSET) . Peak hear t rat e
(T: 157+14, NT: 206+6) and hea r t rat e at al l s t ap,es of
the SSE! were reduce-d in T ( p -: . 002). E and NE i n plasma
were measu red by high performance liq uid chromat op; r aphv
with el ect rochemi cal detection. Pl asma E (pg/ml) was
lower in the T group (p <.0 5) dur ing R (NT: 158+26; T:
76+14) and wit h Ex (NT: 200+26; T: 115+21). Plasma NE
(pg / ml ) showed a s imilar res ponse for R (NT: 246+56; T:
142+30) and Ex (NT : 424+105; T: 258+45) . C-DA (pg/ml)
showed a ma rked inc re ase- in T wi th R (NT: 1398+130; T:
11346+1291) and Ex (NT: 1410+189; T: 11137+1380, p<.00 05)
but w~s not affec t ed by acute Ex. No consIs tent in crease s
were detec ted in conj uga t ed E and NE. These data ind i-
ca t e ' t hat DA sulf ation i s augmented by exe rc ise trainin g.
As a resul t DA is pres umabl y di ve rted from direct sy n-
thesis of NE and E. These findings may exp l a i n th e ob-
servation t hat exe rc i se tra i ni ng aids in t he cont rol of
bl ood pres s ure in mil d hype r t ens io n. In addit io n, the
hig h pl asma C- DA l evel s in t he T dogs may act as a r apid -
l y avai l abl e pool f rom whi ch NE and E may be formed
allowing ci rc ul at ory adjus t ment s t o acut e exercise t o
occu r more rapidly i n t he t ra i ned stat e .
Monday, March 26, 1984
2:00-3:30PM Room S411
Coronary Flow Dynamics-Experimental
COHPARISON OF REFLOW BY SLOW REPERFUSION THROUGH A
CRITICAL CORONARY STENOSIS AND RAPID REPERFUSION THROUGH
A TOTALLY PATENT VESSEL
hJ:2JU. .E... GranatQ. 1m: Harry Her-ner-, HD, Ph.D.; Denny D.
WatsQn, Ph.D.; JQseph A. GaschQ, MD, FACC; GeQrge A,
Beller, HD, FACC: University Qf VA, CharlQttesville, VA
Clinical reperfusiQn with thrQmbQlytic agents is usually
under t aken in the settina or an underlying coronary
stenosis in the infarct vessel. Accordingly, experiments
were designed tQ CQmpare the effects Qf slQW reperfusiQn
(RP) thrQugh a critical stenQsis (CS) and rapid reflQw
through a tQtally patent vessel. In 16 dQgs (Group 1), a
CS was placed Qn the left anterior descending cQronary
artery (LAD) after which LAD QcclusiQn (OCC) was per-
fQrmed witb an adjacent hydraulic Qccluder. After 1 br
Qf OCC , reflQw through the CS occurred OTer 30 min by
gradual release Qf the OCC. In anotber 8 dQgs (Group 2)
rapid RP through a tQtally patent LAD was instituted by
sudden release Qf the OCC. In Group 1 dQgs, enodcardial
blQod flQW (ml/min/g) in the ischemic ZQne (IZ) rose
f rQm 0.Oh.•01 (SEH) tQ 0.69±.05 (p<O.OOOll and trans-
mural (TH) flQW rose from 0.23%.06 tQ 0.82%.09
(p<0.000 1) after RP. In grQup 2 dQgs undergQing rapid
and tQtal release of the OCC, IZ blood flQW rose from
0.06%.01 t Q 0.62%.OB (p<O.OOO1) and TH flQW rose from
0.3 BioI I to 0.BO±.13 (p<O.OOll after RP. The magnitude
of f low increase was cQmparable in bQth groups and slQW
RP thQugb tbe stenQsis did nQt reduce the degree Qf ·nQ
r ef l ow· tbat occurred.
These dats indicate that the increase in regiQnal flQW
witb slQW RP tbrQugh a critical stenQais ia similar tQ
tbat achieved witb rapid reflQw througb a tQtally patent
Yessel. The fQrmer model Qf RP simulates the cQnditiQn
Qf Qlinical RP with thrombQlysis in whicb a residual
stenosis exists after recanelizatiQ~
LEFT ANTERIOR DESCENDING OCCLUSION CAUSES SEVERE DE-
CREASES IN POSTERIOR HYOCARDIAL ENDOCARDIAL FLOW IN THE
PRESENCE OF SEVERE CIRCUHFLEX STENOSIS
..l2UIW. A..~ HA~ Hiare Hahanes, IU.; GeQrge
A. Beller, H.D. FACC, University Qf Virginia,
~harlQttesville, Virginia
We previQusly shQwed tbat in the presence Qf a mQderate
circumflex stenQsis (CxSt ) (gradient : 29mmRg), endocar-
dial flow and the endQQardial/epicardial (endQ/epi) flQW
ratiQ in the pQsteriQr myocardium (POST) fell by 15'
when the left anteriQr descending (LAD) was occ luded
(OCC). TQ assess tbe influence Qf tbe severity Qf the
cxSt (bydraulic ballQQn Qccluder) Qn POST perfusiQn
(8-10 ~ spberes) during LAD OCC, 9 Qpen-chest dQgs with
a se vere CxSt (gradient:50±1 mmRg) were stUdied. In
this setting, LAD OCC resulted in an increase in beart
rate from 113±7 (SEH) to 122±9 b/min (p=O.002) and left
atrial pressure (P) frQm 4.1±.O.7 tQ 6.9±O.B mmHg
(p<O.OOOll. Hean aQrtic (AQ) and Cx P fell from 113.:1:3 tQ
97±5 mmHg (p<0.0001) and 63±4 tQ Ii6:t.4 mmHg (p<O.OOll,
respectively. TQtal Cx flQW (CxF) by EMF and CxSt
resistance «AQP-CxP)/CxF) remained unchanged.
Epi flQW eo tbe POST myooardium did nQt fall signir1-
cantly with LAD OCC, but endQ flQW fell by 53'
(O.55±O.06 ee 0.26±O.07 ml/min/g (p:0.007» and the
endQ/epi rstiQ fell from 1.0~.1 0 to 0.1l8±O.13
(p<O.OOOl).
Henoe in tbe setting Qf a severe Cx stenQsis, LAD OCC
results in a marked deorease in POST elldQ perfusiQn
despite preservatiQn Qf epi flow. Sinoe the decrease in
endQ flQW was not, assooiated witb an increase in cxSt
resistanoe, the endQ flQW diminution did not appear ee
be oaused by .passive narrowing". Theae results may
bave clinioal relevanQe to patients with multivessel
disease experiencing aoute myooardial infarot1Q~
A RECENTLY DISCOVERED PEPTIDE ENDOGENOUS TO HUMAN CORO-
NARY ARTERIES, NEUROPEPTIDE-Y, CAUSES FUNCTIONALLY SIG-
NIFICANT CORONARY VASOCONSTRICTION IN DOGS
Mary F.Maturi, MD, Rodney Gr eene , BS , Wi l liam Schmidt,
BS , Randolph E.Pstterson, MD, FACC , NHLBI , Bethesda, Md.
A recen tly discovered pancreatic peptide, neuropeptide-Y
(NPY), has been demonstrated in cQronary artery, cardiac
muscle and conduction tissue from human autQpsy speci-
mens. The physiologic effects Qf NPY remain unknown, so
we assessed its effects in 14 chloralose-anesthetized
open-chest dogs. We recorded heart rate (RR), mean aor-
tic pressure (AP), circumflex (CFX) corQnary b1Qod flow
(CBF), cor onary vascular re sistance (CVR-AP/CBF), and
left ventricular e ject ion fraction (LVEF ) by gated blood
pool scintigraphy. The LV apex Waa paced to keep HR con-
atant aft er preliminary studies showed NPY-indu ced br ady-
car di a . NPY was infused into the CFX , 2 to 5xlO-8 moles
over 5-1 0 min. HR AP CBF eVR LVEF
Control 104 103 29 4.41 .368
NPY 104 105 22* 6.37* . 346*
(*p<. Ol f or control vs NPY ) . Reproducibility of LVEF in
paced, anesthetized dogs from repeated control studies
Was .004+. 004 (mean+SD, NS) . Although mean values are
shown, the degree of vaSQcQns t ric tion was dQse-related.
Higher doses of NPY inc reased AP , but we did not i ncl ude
these results. Three other dogs died Qf ventricular fib-
r i llation during NPY infusion . In CQnclusiQn, NPY causes
coronary vasoconstrict ion manifes ted by decreased CBF at
constant AP. This vasoconstr iction (44% increase in CVR)
sppears to be functionally significant, as judged by the
decreased LV func t i on. These phys iologic effects, com-
bi ned with the identifica tion of t his peptide in human
coronary arteries suggests the possibility that it may
playa role in angina due t o coro nary vaaQcQnstriction
in man.
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Pre P Post
93±5 NS 97±10
EFFECT OF D1LTIAZEM AND PROPRANOLOL ON SEGMENTU
DIASTOUC RELAXATION DURING TEMPORARY CORONARY
OCCLUSION IN CONSCIOUS. CHRONICALLY INSTRUMENTED
DOGS
Gregory D. Tilton. MD. Larry R. Bush. PhD, L. Maximilian Buja,
MD. FACC. James T. Willerson. MD. FACC, University of Texas
Health Science Center. Dallas, TX.
I hr Rep
88±13
168t27-
33tl0
74t1I-
74t13
106tII -
Class 2:TF
Class 2:RHEDT
Class I :RHEDT
In contrast to global diastolic function. little is known about LV
segmental relaxation (LVSR) during evolving myocardial infarction
or whether LVSR can be altered independently of systolic function
(SF). We characterized LVSR and determined the influence of
diltiazem (D). propranolol (P), and saline (S) on LVSR during 4
hours (hr) of coronary occlusion (CO) and I month (rno) reperfusion
(Rep) in 31 dogs. Up to 6 pairs of ultrasonic crystals. implanted
within and around the area of LV to be made ischemic in conscious
dogs. were used to measure mean rate to half end-diastolic
thinning (RHEDT) and the late diastolic thinning fraction (TF). At
I hr CO. LYSR was classified as mildly (Class J) and moderately
(Class 2) dysfunctional segments; then P (] mg/kg, I.Y.), an equal
volume of S. or 0 (20llg/kg/min X 5 hr) was administered.
Compared to S. P did not significantly al ter LYSR. The results for
S and D. expressed as percent of control ±S.E.M., were:
Group I hr CO 2 hi CO 4 hr CO
S 85±1 0 8~ 87l:6
o 96:t7 129±13- 180:t41-
S 30:!5 25±5 28±8
o 40l:6 53±10- 76t17-
S 76±8 70t9 65±16
o 78±8 I06±1 0- I 05:t7-
- =p at least <0.05 compared to S
D significantly increased LVSR at 2 through 4 hr CO and I hr Rep.
Furthermore. only 0 improved LVSR more than SF at these time
periods. Within 24 hr of stopping 0, LVSR fell to preinfusion
values and paralleled SF in all groups. Thus, 0 improves LVSR
independently of SF during CO and Rep while it is administered.
Diastolic 78±9 NS 79± 8 13±6 .003 20± 4
CIIC P
CIIC MBF 90±38 NS 9l±35 9±4 .09 16±1l
(Endocardial)
CIIC I/O L4±.3 NS 1.4±.3 0.4±.2 .007 0.6±.3
EVIDENCE FOR SlDRI'~ IMPRJIIEMI'Nl' IN COR:NARY
COLLATERAL BliXD F'f.1:Jfl BY ORAL DIPYRIIWoDLE
Richard w. Srnal~M.D. ,Ph.D. ,FJ\CC; Robert D.
Ekas,Ph.D., Richard L. Kukeeide,Ph.D., Patty M.
Richards; David J. Fisher, M.D.,FJ\CC, university of
Texas Medical SChool at Houston, Houston, Texas
we have studied the effects of oral dipyridaJrole (D) on
coronary collateral flow in 7 OOgs chronically
instrurented with circumflex(CIIC) flow prOOes, cuff
occluders, pressure (P) tubes, left' ventricular (LV), and
aortic{lID), P tubes and atrial pacing wires. After
recovery fran surgery, rneasurenents were made during
atrial pacing of lID, CIIC, and LV P and regional
myocardial blood flow (MBF) cc/grm/min using radioactive
uspheres during control and with CIIC occlusion. Animals
were then given oral dipyridermle 100 ng/day, for 10-14
days. Measurenents were repeated 1 day after last dose
of dipyridaJrole. Results are SI.IIlIlIarized below pre and
post dipyridaJrole.
Control
Pre P Post
AOP(mmHg) 96±5 NS 97±10
HR l16±8 NS l2l±16 l17±8 NS l2l±16
Conclusion: Short term administration of dipyridaJrole
inproved coronary collateral blood flow capacity as
measured by regiooal MBF and mean diastolic CIIC P
during CIIC occlusion.
BIPHASIC COROOARY FI:ru RESPONSE TO SUSTAINED
LEUKarRIENE D ALl-lINISTRATIOO
David Ezra, Md; Giora Feuerstein, MD; Jerel Erne;
Robert E. Goldstein, MD, FACe; USUHS, Bethesda, MD.
Intense coronary constriction and myocardial ischemia
occur after Ix>lus intracoronary (i.c.) administration of
leukotriene D4 (LID4) . To explore the consequences of
rrore sustained LTD4 exposure we infused LTD4 into left
anterior descending (LAD) coronary arteries of 12 anes-
thetized, open-chest darestic pig",. Mean pre-infusion
values were: total LAD blood flow (BF) 42 ± 2 ml/min
(SE),left ventricular end-diastolic pressure (EDP)11 ± 1
nm Hg, mean systemic arterial pressure (SAP) 91 ± 8 nm
Hg and heart rate (HR) 103 ± 5 beats/min. Continuously
infused LTD4, 1 uq/min Lc., produced the following:Time: 10 sec 2 min 4 min 8 min
~BF: -23%±6 -53%±9 -27%±12 +2%±22
Mean SAP and HR were unchanged during L, c. infusions.Thus
LID4- induced coronary constriction usually waned after 3-4 ll\lIl despite a constant rate of LID4 administration. Intwo instances constriction persist..ed without "escape",
and both pigs died in shock or ventricular fibrillation.
The rise in EDP (to 19 mn Hg ± 2) and ST segment shifts
seen at maximal decrease of BF resolved with return of BF
to baseline even tho.1gh LID4 infusion continued. Thesedata suggest that changes in EDP and the electocardiogram
are primarily consequences of LID -induced BF reduction
rather than indeperdent actions o~ LID4• Our results de-
ronstrate that normal coronary vessels usually "escape"
fran severe LID -induced constriction within a few min.
The occurrence ~f "escape" fran coronary constriction due
to L'Itl4 as well as vasopressin suggests physiologic an-tagonism to constrictor action. The efficacy of mecha-
nisms nediating such antagonism may be an inportant de-
terminant of clinical responses to coronary constrictors.
Monday, March 26, 1984
4:00-S:1SPM Room 8411
Alterations of Cardiac Contractility
LENGTHENING LOAD DETERMINES POST-LENGTHENING
fORCE DECAY Of RELAXING CARDIAC MUSCLE
Stanislas U. Sy~ ; Walter J. Paulus, MD ;
Victor A. Claes ; Dirk L. Brutsaert, MD, FACC.
University of Antwerp. Antwerp, Belgium.
Residual cardiac muscle force development after
mitral valve opening could potentially disturb LV
filling. We therefore investigated interactions between
muscle lengthening, lengthening load and
post-lengthening (p-l) force decay in isolated cat
papillary muscle (0=12).
An electronic length tracking system and precisely
timed load clamps allowed independent adjustment of
shortening and lengthening loads within one contraction
relaxation sequence.
Lf'or an identical shor tenlr.q history, lengthening
load influenced the time course of p-l force decay. At
a given p-l moment, residual force was smaller for a
lower lengthening load, i.e. a later onset of the
lengthening phase.
2.For an identical shortening history and an
identical lengthening load. the extent of muscle
lengthening or the final muscle length did not alter
p-I force development.
3.For an identical lengthening load, a different
shortening history shifted the p-l force decey, without
effecting its time course. The higher the shortening
load, the leter the p-l force decey.
The lengthening loed is the only determinent of the
time course of cardiac muscle force decay in thf p-l
phsse. Any analysis of LV filling mechanics should
incorporate a similar but dynamic interaction between
instantaneous LV wall streaa and residual cardiac
muacle force development.
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SUBEPICARDIAL COMPENSATION FOR SUBENDOCARDIAL POST-
EJECfION SEGMENT SHORTENING
Brian G. Bertha, B.S.; and John D. Folts, Ph.D., Uni-
versity of Wisconsin Medical School, Madison, WI.
Post-ejection segment shortening (PSS) has been described
only in subendocardial regions of the beating canine
heart with and without ischemia. In the present study
both subendocardial (SBN) and subepicardial (SBE) region-
al function in the basal circumflex myocardium was
studied during late systole and early diastole using the
ultrasonic crystal technique. Eleven open chest dogs were
instrumented with ECG, SBE and SBN ultrasonic crystal s,
aortic and LV pressure with LV dp/dt and a lso aortic
blood flow in four dogs. At control coronary flow heart
rate averaged 112±9.7. SBN segments exhibited a PSS
averaging 48.S±11\ greater than the systolic shortening
length before the nadir of LV dp/dt , Overlying SBE seg-
ments showed a significant compensatory increase in seg-
ment length before the nadir of LV dp/dt averaging 18.S±
18.2\ greater than the maximal SBE shortening distance
(p <0.005). This indicates that the SBE segment had
begun to lengthen while SBN segment shortening continued
after end systole. The PSS velocit y in SBN increases
343±82\ relative to pre-ejection shortening (p <0.0025).
These results demonstrate an asynchronous myocardial con-
traction pattern occurring across the left ventricular
free wall which may be related to redistribution of wall
tension (after load) occurring late in systole and dur ing
the rapid phase of isovolumetric relaxation. The rapid
increase in SBN shortening velocity preceding end systole
may be related to ventricular interaction with declining
ejection velocity late in systole. While myocardial
asynchrony is usually explained by contiguous series con-
tractile elements, the events described here involve myo-
cardial segments in different planes.
EFFECT OF CHANGES IN MYOCARDIAL CONTRACTION AND RELAXATION
ON DIASTOLIC MITRAL VALVE FUNCTION.
Daniel David MD, FACC; Eric L Michelson MD, FACC; Masahito
Naito MD; Leonard S. Dreifus MD, FACC; John Neilends,
Mark Schaffenburg. Lankenau Hospital, Philadelphia, Pa.
Atrial systole induces diastol ic mitral valve (MV) closu-
re. During prolonged diastolic periods the MV reopens. MV
reopening time (MRT) has been shown to be partially depen-
dant upon the accumulated left ventricular volume (LVV)
which in turn is influenced by myocardial wall properties
(WP) . To correlate diastolic MV function with changes in
WP, 6 heart blocked dogs were stud ied. Left atrial and
ventricular pressures (LVP LAP). myocardial tension (MT)
and echocardiogram were recorded during programmed pacing.
During prolonges pauses in ventr icular pac ing, atrial pre -
mature cont ractions were introduced at vary ing coupling
intervals (CI) . LVV and MRT were plotted for each CI du-
ring : control, administration of Ca·+ and verapamil (V) .
Velocities of septal contraction and relaxat ion (SCV SRV)
were determined. ~_ CA"
. a ./.aImII.
Iii-;,~.,.r;--R -~ · a / •
-. ~. :'~;:/~~
LYY ••• M .. LW.
In each dog and for each CI and LVV, Ca++ (mean MT 23gms/
cm2, SCV 196mm/sec, SRV 183mm/sec) prolonged MRT, whereas
V (mean MT 13gms/cm2, SCV IOOmm/sec , SRV 90mm/sec) short-
ened MRT. Thus, Ca++ and V have a marked effect on dias-
tolic MV mechanics. These alterations in MV mechanics
suggest that in addition to their effect on contraction
and relaxation, Ca++ and Verapamil have a prolonged
diastolic effect upon myocardial wall properties.
SYMPATHETIC NEURAL VERSUS MECHANICAL CONTROL OF
CARDIAC HYPERTROPHY. C Uboh, RL Kent, EW Thompson,
TA Marino &G Cooper, IV. Depts Med, Physiol &Anat,
Temple Univ, Phila, PA
Cardiac hypertrophy occurs in response to hemodynamic
overloads. Whether this hypertrophy is mediated by the
increase in load alone or instead by the accompanying
increase in sympathetic tone is controversial. The
chorda tendinae of a cat right ventricular papillary
muscle were cut while the pulmonary artery was banded
to create a model in which a segment of the myocardium
was unloaded in an otherwise pressure overloaded
hypertrophying ventricle. We have shown previously that
rapid atrophy of such an unloaded muscle occurs in a
normal, non-hypertrophying ventricle. Papillary muscles
were studied in pairs consisting of unloaded (U) and
adjacent control (C) muscles from the following right
ventricular types: sham-operated (S) and unloaded +
banded (UB) at 1 and 2 weeks. The right ventricle to
body weight ratio (RV/BW) and myocyte cross-sectional
area (XS) were measured as an index of hypertrophy and
the norepinephrine content (NE) of each muscle was
determined as an index of sympathetic activity.
Sham UB-lwk UB-2wk
~ C U e U
XS 125+ 9 167+17 121+20* 216+32 125+21*
(um2) *zp<.05 for U vs C
RV/BW 0.54+0.12 1.07+0.23** 1.36+0.14**
(g/kg) **·p<.05 for UB vs S
The increased XS of the loaded myocytes (C) in the
hypertrophying ventricles is absent in the unloaded
myocytes (U). In contrast, the HE in C muscles did not
increase over that of U muscles (1.1 nMlg wet wt). Thus,
this study identifies the increase in load rather than
in sympathetic tone as the pri.ary determinant of
cardiac hypertrophy.
MECHANISM OF THE NEGATIVE INOTROPIC ACTION OF LEUKOTRIENES
C4 AND D4 ON THE ISOLATED RAT HEART
John A. Bittl, MD; Marc A. Pfeffer, MD ; Robert A. Lewis,
MD ; K. Frank Austen, MD; Harvard Medical School and Brig-
ham &Women's Hospital, Boston, Mass.
Leukotrienes C4 and 04 produce a negative inotropic action
by decreasing coronary flow and/or by exerting a direct
myocar di al effect. To clari fy the mechanism of the nega-
t ive inot ropi c effect, we per fused an isovolumic rat heart
prepara tion at c o n s t a n t pressu r e a nd me asu r e d LV developed
pr essure (LVDP, mmHg), cor onar y flow (CF, ml/min), 02 ex-
tract ion (02E, %) , oxygen consumpt ion and 02 delivery
(MV02 and 020, ~moles 02/g ram dry weig ht / mi n) during per-
fus ion wit h f ive doses (pmoles/min) of C4 (N=IO) , 04 (N=
8) , angiotensin (AT,N=IO) , or with medi um which conta ined
half the st andard concent ration of ca lcium (l ow-Ca, N= 5).
DOSE LVDP CF 020 02E MV02
C4 - 0- 123±3 21±1 79±3 42±2 33±1
27 119±4 18±1* 69±3* 46±4* 32±2
270 106±4* 13±1 * 51±3* 58±2* 30±2*
04 0 119±6 21±1 78±3 43±2 34±1
32 109±8 18±1* 66±3* 52±3* 34±2
315 92±9* 13±1* 43±4* 65±2* 28±2*
AT 0 123±5 21± 1 80±4 43±3 34± 2
31 121 ±5 19±1* 71 ±4* 48±3* 34±2
307 11 2±6* 15±1* 52±4* 59±3* 31±2*
(Mean±SEM , *p <0. 05 vs . basel ine by 2- way ANOVA) . Like A4
C4 and 04 reduced CF markedl y as LVDP fe l l . At low dose s,
MV 02 was sus ta ined as increased 02E par tially offset the
decr eased 020. At hig her doses, 020 was so limited t hat
MV02 fell despite a further increase in 02E. The reduc-
tion in MV02 matched th e fall i n LVDP. In contrast, the
di rec t negative inotropi c act ion of low-Ca (LVDP fell t o
92 mmHg) produced no change i n 020 but decreased 02E (to
30'5%). Thus, C4 and 04 ar e potent coronar y vasoconstric-
tors which depress contractile ability by limiting 020.
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EXAC ERB ATION OF DO XORUBI CIN CARDI OTOXI CI TY BY DIGO XI N
Wi ll i am C. Reeves . MD . FACC; James W. Gr i f f it h. DVM ;
Mary A. Wood . BS; Lar ry Whitesell. BS. Cardi ol ogy,
Pennsylvania State Un iversity. Co l l ege of Medi cine,
Hershey. PA .
The effect of di goxin on t he devel opment of
doxo rubicin cardiomyopathy i s unc l ear. Some
inves ti gat or s have suggested a beneficial effect whil e
ot hers have reported no ef fect . Therefore. we deci ded
to evaluate this problem in a chronic rabbit model.
We document ed t he myocard ial pathol ogy by convent ional
hi stol ogic t echniques . Addit ional l y . myocard ial
f ibros i s was quant i f ied by hydroxyprol ine det ermina-
tions and myoc ard i al cel l ula r damage by 99m Tc
pyrophosphat e uptake.
Twenty - four ra bbits were studied: 6 control.
6 doxorubic i n. and 12 digoxin-do xorubicin.
Mortality in the digoxin-do xorubicin group was 50~.
All other rabbits lived throughout the entire
experi me nt. The severest grade of histologic lesion
wa s seen only in the digoxin-do xorubi cin group.
~yoca rdial hyd roxyproline cont ent wa s greater (p < .05)
in t he digoxi n-doxorubicin group than in the
doxor ubicin or cont rol groups. Myoc ard ial 99m Tc
pyrophosphat e cont ent wa s also si gni f icant l y greater
(p < . 05) in t he di goxi n-doxorubici n group than in
controls . The doxorubicin group 4i d not have
si gnificant ly greater (p > . 05) myocard ial 99m Tc
pyrophosphate cont ent than control s . We concl ude that
pretr eat ment and cont inued admi ni strat ion of di goxin,
toge t her with doxorubicin . increased t he sever i ty of
myocard i al damage and reduced lo ngevi ty in thi s
experi mental model of doxorubicin cardioto xicity .
Tuesday, March 27, 1984
8:30-10:30AM Grand Hall Meeting Room #2
Coronary Artery Surgery I
YOUNG ADULTS WITH CORONARY ATHERO SCLEROSIS: INFLUENCE OF
RI SK FACTORS ON THE TEN YEAR RESULTS OF MYOCARDIAL
REVASCULARIZATION
Bruce W. Lytle , MD, FACC, John R. Kramer, MD, Leonard A.R.
Goldi ng . MD. FACC. Delos M. Cosgro ve. MD, FACC, Judy A.
Borsh, RN. Marlene Goormastic. MPH, Fl oyd D. Loop. MD.FACC
The Clevel and Clinic Foundation, Cleve land . Ohio
To examine the atherogenic diathes i s of young adults with
coronary atherosc l e r os is 107 pat i ent s unde rgo i ng myocardi-
al r evas cular ization at age 35 or less (1971-1 975) were
r evi ewed . Follow-up (mean pos toperat ive interva l 115 mont hs)
documen ted 1 early and 15 l at e dea ths . 5 early and 23 l at e
non- fata l myocar di a l i nfa rctions , 13 cardiac r eope r a t io ns
and return of seve re angina in 10 pa tients. Surv ival a t
5 and 10 pos t oper a t i ve yea rs was 94% and 85%, and event-
f ree su rviva l 77% and 53%, r espective l y. Pos top erative
angiog raphic s tudies of 64 patients (mean interval 47
mo nt hs. r ange 2- 125 mo nths) showed saphenous ve i n p. raft
(SVG) .patency (49/88 , 56%) exceeded by i nte r na l mammary
ar t e ry graf t patency (25 /2 7. 93%) p( O.Ol . The pr eva lence
of SVG occlusion and pr ogre s s i on of atherosc le ros is i n
native corona r y ar t er i es in crease d with inc reasin~ pos t -
ope rative interval,but were not assoc iated with coro nary
ris k factors. Univar i ate and multivar i at e analyses we re
use d t o tes t preoperat ive cl inical and ang iographic and
operat ive variabl es for influence on surv i val and eve nt -
f ree sur viva l . Survival was dec r eased by mu 1t ivesse l di s-
ease (p=0.04) and i mpaired l eft ventricular fun ction
(p~O . OO l). Event-free sur vival was decreas ed by a fa mily
his tory of co ron a ry arter y disease (p=O .004) and c igare tte
smoking (p=O.Ol). Survival and event - f ree survival were
both decreased by diabetes (p<O.OOI. p=O.03) and elevated
ser um chol es t e r ol (p=O.02, p=O.002) . The prognosis of
young adults after myocardial revascular ization is
adversely influenced by coronary risk fac t or s .
H'tOCARDIAL REVASClLARlZATION IN rollNG PATIENTS
MacArthur A. Elayda, HD; Neil E. Striclau1, MD; Robert J. HaU,
MD, FACC; Albert G. Gray, Ph.D, En"ain Garcia, MD, FACC; Denton
A. Cooley, MD. Texas Heart Instiwte, Claytal FOLa'ldation for
Researcb-St. LIMe's Episcopal Itlspi tal, Houston, Texas
Isolated corornry artery bypass grafti~ (CAB) _ perfonlled
in 890 patients (pts) aged 10 to 39 years (yrs) dlring the peri-
od 1970-1981. There were 45 pts \.Mer 30 yrs and 845 pts under
40 yrs. Overall early mortality (EM ) lollS 1.61(14/890) . Group I
pts (1970-1975) canprised of 292 pts hal lI'I EM of 2.41(71292)
1Il1le group II pts (1976-1981) CXIlIp'ised of 598 pts had .... EM of
1.21(71598). Positive fllllily history of cardiovascular disease
was p'esent in 671. hypertension (81'>140/90) in 40.OS. diabetes
mellitus in 29.81, hyperlipidllDia in 491. and obesity in 30.41
(20 pounds cr more CNerweight). Cigarette snoking lollS fOU'ld in
92J an:! history of prior myocardial infarction was elici ted in
431. Cardiac catheterization Slo~ triple vessel disease in
53.7'S(478/890) , ~vessel disease in 31.7'S(282/890) and single
vessel disease in 14.61(130/890). Forty~e percent had normal
left ventricular (LV) fllllCtiOO, 4llS twj mild to lDOderate LV i~
painnent lI'Id UI had severe LV dysfla1ction. Majori ty of the pts
in group I (60.4$) had 1 to 2 bypllss grafts while majority of
group II pts (63.3$) had 3 to 4 saphenous vein grafts implanted.
There has been "If late deaths (13.11). The OCCLrrence of a~ina
CXIlIlBred tD ltle p'eop state lollS lesser in 15,1$. the :5iIIIe in
1.61. IlIOn! frequent in 4.1$. stopped therl recurred in lOS and no
qina IllS recorded in 68$. Acwarial life srvival clrve anal-
ysis revealed a 5-year SUl"Vival (lS) of 90.61 or lI'I average
lI'Inlllll attrition (AA) rate of 1.6$ lI'Id a 10 lS of 68.61 tr ....
aver. AA of 2.98$. Seventy-five percent of the pts retlrned
to 1\111t1IIe work. One Iuldred and fifteen (12. 9S) pts were kno~
to hBVe repeat CAB pr1urily due to provession of disease in
ltle native ooronaries. The reoperation rate is significantly
hl.&her calpared to the total instiwtion rate of 2.llS(622/22.284)
nido CAB. This study SloIlS that ~dial revascularization ClIlI
be La'ldertaken in YOIq plltients lI1th low operative risks, s.
stantial sr-ptc.atic lIIp'ov_t IIld FOCI lon& tel'll resul ts.
REVIEW OF OUR EXPERIENCE WITH DOUBLE AND SEQUENTIAL
MAMMARY ARTERY GRAFTS IN MYOCARDIAL REVASCULARI ZATION
M. Laxman Kamath, HD; Lorna Hendri x; Shanti la1 Patel MD;
Tom Lassar, HD; Donald H. Schmidt, MD , Universit y of
Wisconsin, Milwaukee, WI
In our center, internal mammary arter y grafts (IHAG)
have been the preferred conduit for coronary artery by-
pass graft surgery (CABGS) based on long term patency and
the ir ability to provide the same coronary reserve as
saphenous vein grafts (SVG). IMAG are partiCUlarly use-
ful in patients who lack adequate veins due to poor qual-
ity or previous CABGS. The purpose of this study was to
assess the frequency of use and the relative patency of
both double (dbl) (right and left I l~G) and sequential
(seq) (two or more anastomoses) IMAG . Over a period of 40
months , 692 patients (pts ) were operated on with 299
(43\) haVing at least one IMAG placed. 134 of these 299
pts had dbl or seq IMAG. Of these 134, 61 had dbl, 40 had
one seq, 7 had two seq, and 26 had dbl IMAG with at least
one be ing a seq. IHAG are usually placed to the left an-
ter ior descending (LAD), diagonal or marginal branches
with seq IMAG usually placed to two diagonals, two mar-
ginals, or a diagonal and t he LAD. Of these 134 pts, 53
were recatheterized within t he year. The results of
patency, with comparison to SVG, are as follows:
No. pts No. Cath(\) \Patency
ObI IMAG 61 26 91.5\
One seq IMAG 40 11 90.0\
Two seq IMAG 7 2 100.0\
One IMAG/one seq IMAG 26 14 100 .0\
Total lMAG 134 53 (40\' 94.3\
SVG 128 48 (38\' 93.6\
The data show that i t i s feas ible t o perform dbl and seq
IMAG during CABGS, and the relative early patency of
these grafts is not significantly different from the
patency of: SVG.
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ACUTE EVOLVING MYOCARDIAL i NFARCTION
REVASCULARIZATION: ANALYSIS OF RESU LTS WITH AND
WITHOUT PREVIOUS STREPTOKINASE REPERFUSION.
Antonio Carvalho, HD; Jose Andrade, HD; Jose Su£
Cl, Ho; Expedlto Sllva, HD; Renato Du~rat, MD ; .-
Joao Branco, HD; Enio Buffo10 , MD; Unlcor HOSpl -
tal, Sao Paulo, Brazil.
We performed myocardial revas cu1ar iza tion in 86
patients (pts) with acute evolving myocardial
infarction (AEMI) with and without previous
streptokinase (SK) infusion to try to determine
if there was any difference between the two
groups . The pts constituted a consecutive sample
studied from December 81 to July 83 and the
criteria for AEMI were the usual ones. There was
total occlusion of the vessel in the infarcted
area in 54 pts (group I); SK was performed and
in a period of 2 hours to 6 days the pts
underwent complete revascularization. In the
remaining 32 pts (group II) SK was not performed
and revascularization was performed r ight away
with in 6 hours of onset of symptoms. The average
number of grafts per patient in both groups was
2.4 . The total i n- hospi t al mor t ali t y rate was
8 .1 %; however 6 out of 7 deaths were i n grou p I,
all of them when surgery was performed less t han
72 hours after SK i nf us i on; all dea ths were
related to coagulation problems . In group II the
mortal ity rate was only 3.1 %. Out of 79 pat ien ts
who were discharged 78 of them remain stable .
Revascularization during AEMI can be safely
performed when there is not a orevious SK
infus ion; we now only perform surgery at least
72 hours after a SK infusion and based in our
exper ience we do not recommend early surge ry in
AEMI just after SK reperfusion .
INTRA- AORTI C BALLOON PUMP INSERTION: A RANDOMIZED STUDY
COMPARING PERCUTANEOUS AND SURGICAL TECHN IQUES
Mark J. Gol dbe r g, M.D., L A. C.C.; Adr i an Kant ro wi t z , 11. 0 .,
F.A. C. C. ; Melvyn Rubenfire, M.D. , F.A. C.C .; Gary Goodman ,
11 . 0 . j Paul S. Freed, M.S.; Leonard Hallen, M.D.; and
Paula Reimann, R.N. Sinai Hospital of Det ro i t and Wayne
Sta t e Unive r s i t y , Detroit, Michigan .
101 patient s (pts.) referred f or intra-aortic balloon
pump ( IABP) coun t er pul sa t i on and agr ee ing t o participate
in a r andomized study were assigned t o e i t he r the percu-
taneous (Perc ) or surgical (Surg ) techn ique of insertion.
In sertion us ing the designated t echnique was succes s fu l
i n 45 of 51 (88%) of Perc pts. and 48 of 50 (9&%) of Sur g
pt s . (diff er ence not signifi can t ) . Time f rom be ginning
of inse rtion t o i ni t ia tion of count e r pul sa t ion was 13 ~ 8
minutes f or Perc pts . vs 31 t 16 minu tes for Surg pt s .
(p<. OOI) . In the Perc gr oup 1 pt . had seve re le g
ischemia requ iring immedi a te t erminat i on of IABP assis t -
ance while 10 pt s. r equired Fogar t y thrombectomy fo l lo w-
i ng elect i ve IABP re moval. In the Surg group , 2 pt s. de -
ve loped l eg ischemia r equiring surgical inte rvention , 3
pts . had se pticemi a (inc l udi ng 1 pt . who requ ired vein
pa tch repa i r ), and 1 pt. had a cerebral embo l us. Aortic
dissect i on , ao r to -i l i ac per f orat i on or amputa tion did no t
occ ur i n ei t he r 1r ouP. Vascula r complica tions occ ur red
in 11 (2 2%) of Perc vs 3 (6%) of Sur g pt s . (p<.05). The
dec rease i n hematoc r i t f r om pre- i ns ert i on t o 24 hours
post - i nsertion was 2. 3 t 3. 0% for Pe r c vs. 5.2 ~ 3.3% f or
Sur g pt s . (p<.005) . Blood trans f us i on was req uired in 4
Perc pt s . (8%) and 18 Surg pts. (36 %) (p <. OI) ( t ra ns -
fusion following ope n heart surgery excluded ). We
conc l ude th at while the Perc t echnique fo r IABP insertion
is fa s t e r t han t he Surg techn i que , and t echnically easy,
i t is as socia t ed with a higher i nc i dence of va scul a r
complica t ions .
FLOW CHARACTERISTICS OF GRAFTS TO INFARCTED MYOCARDIUM:
AN IMPORTANT POTENTIAL COLLATERAL SOURCE
Alexis Sokil, MD; Harry Schwartz, MD; Benjamin L. Aaron ,
MD, FACC; Mltchell Mills, MD, FACC; Richard J. Katz, MD,
FACC; Roy H. Leiboff, MD; Alan G. Wasserman, MD, FACC; P.
Jacob Varghese, MD, FACC; George B. ~ren,.MD; Alla~ M.
Ross, MD, FACC; George Washington Unlverslty, Washlngton,
DC
In an effort to provide complete surgical revasculariza-
t ion vessels to zones of previous infarct ion (I) areofte~ grafted in order to perfuse reSidual .viable muscle
and to possibly serve as flow sources to dlstant myocar-
dium via collaterals . As flow characterist ics of grafts
to f ibrot ic areas are unknown , and as flow is a deter-
minant of graft patency, we compared flow rate~ in grafts
to infarcted distributions with grafts to non-lnfarcted
zones and grafts encompassing both run-off beds. Ninety-
one post infarction pts. received: 23 end to end grafts
to I zones, 28 end to end grafts to non-I zones, 39 skip
grafts to both I and non-I beds, and 110 skip grafts to
only non-I areas. Mean electromagnetically ~asured flow
(cc/mintSE) without vasodilators and off cardlopulmonary
bypass was not different in end to end grafts to I or
non-I zones (59t8 vs 68±6 respectively, p=ns). There was
also no difference in flow in skip grafts to only non- !
zones vs. skip grafts to both I and non-I zones (84t6 vs
80±S, p=n~). In 25 patients given Papavarine, flow
augmented equally to I and.non-I zones (7S%t8 and ?6%t9
respect ively) . Thus bypasses to I zones carry equIvalent
flow to those into non-I beds, both as single grafts and
incorporated into skip grafts. Conclusion : The viability
of revascularized myocardium has little or no effect on
graft flow rates . So far as flow preserves patency,
these grafts presumably remain patent and may serve as
important potential collateral conduits to non-infarcted
myocardium.
Tuesday, March 27, 1984
10:30AM-12:00PM Grand Hall Meeting Room #2
Percutaneous Transluminal Coronary Angioplasty-
Vascular Effects
PERCUTANEAOUS ARTERIAL PERFUSION OF ACUTELY OCCLUDED
CORONARY ARTERIES IN DOGS
Bernhard Meier. MD; Andreas R. Gr ue nt zi g , MD; FACC; Jo e
E. Brown, RT, Emory Universit y School of Medicine,
Atlanta, GA.
In sud den c lo sur e of coronary arteries (CAl t i me unt il re-
perfu s i On 15 essenti a l f or preservat i on of myocar dium. I n
sea rch Of a prac t ical method to perfus e acu t el y occl uded
CA unti l def i nit i ve revascularizat i on a new ro ller pump
was tested i n 11 hepari nized dogs . It was fed f rom t he
f emor a l a r t e r y and connected to the ce ntra l l umen of a
bal l oon catheter. Occl usion of a majo r CA was ac hi eve d
through susta i ned ba l l oon inf lation .
Mean f l ow ra t es were 66 a t begin and 52 ml/mi n at end of
pe r fusi on. Mean perfusion pressu re s at pump ex it remained
a t 56 PSI . Perfusion pr eve nted majo r i s chemia for > 60 mi n
i n 9 dogs. Six dogs were sacri fi ced a t SD- 12Omi n. Three
dogs died duri ng perfus ion af t er 60 min [110- 150 min ,
t hr ombos ed catheter ) and 2 bef ore 60 mi n (sys t em f ailureJ .
Plasma hemog lob in as measure for hemoly sis rose f rom ba-
s e l ine mean of 20 mg/d l t o 29 aft er firs t passa~e t hrouKh
r o l l e r pump. At 30 and 60 min it was 108 and 87. Wi t hout
ba lloon catheter it averaged 26 aft er 60 ~i n Gf pas s age
t hrough ro ll er pump.
In conclusion, distal coronary perfusion wit h arter ia l
blood using a roller pump connected to a balloon ca the t er
proved effective to temporarily prevent ischemia during
acute occlusion of CA. Hemolysis occurs mainly due to t he
small lumen of the balloon catheter but does not exceed
threshold for hemoglobinuria. This system could bridge
time between onset of acute infarction (e.g., as compli -
cation of angioplasty) and definitive revascularization
(t hr ombol ys i s , further angioplasty , or bypass surgery).
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In conclusion, both CABG and PTCA provide significant im-
provements in maximal coronary blood flow as measured by
CFR. Although neither returns CFR to normal, both pro-
vide comparable improvements on a chronic basis. This
technique demonstrates a new physiologic approach to
measuring the outcome of coronary revascularization and
is now available on a real-time basis during cardiac
catheterization.
COMPARATIVE EFFECTS OF PERCUTANEOUS TRANSLUMINAL CORONARY
ANGIOPLASTY AND CORONARY ARTERY BYPASS SURGERY ON CHRONIC
CORONARY FLOW RESERVE
Fred Aueron, M.D.; Robert A. Vogel, M.D.; Eric R. Bates,
M.D.; William W. O'Neill, M.D.; Bernhard Meier, M.D.;
Spencer B. King Ill, M.D.; John E. Douglas, M.D.; Michael
T. LeFree, B.S.; Bertram Pitt, M.D., FACC; Andreas R.
Gruentzig, M.D., FACC, Veterans Administration Medical
Center, Ann Arbor, Michigan
Coronary artery revascularization can be accomplished by
either coronary artery bypass surgery (CABG) or by percu-
taneous transluminal coronary angioplasty (PTCA). To
evaluate the success of each technique, we have measured
regional coronary flow reserve (CFR) by a new technique
utilizing digital computer enhancement of standard coro-
nary arteriograms. The myocardial contrast appearance
time of hyperemic and resting angiographic studies was
used to assess regional CFR. Patients prior to PTCA and
CABG had regional CFRs of 1.11+0.2 and 1.05+0.1, respec-
tively. Following revasculari~ation, the f;llowing data
were obtained:
EFFECT OF ACUTE CORONARY OCCLUSION ON HEMODYNAMIC RE-
SPONSES IN AN ADJACENT CORONARY ARTERY.
Robert G. Macdonald, MD; Robert L. Feldman, MD, FACC;
Wilmer W. Nichols, PhD, FACC; C. Richard Conti, MD, FACC;
Carl J. Pepine, MD, FACC, University of Florida,
Gainesville, Fl.
Effects of acute occlusion of 1 coronary artery on flow
(F) responses in another were studied in 16 open chest
dogs. Circumflex(Cx) F was measured with and without Cx
narrowings(N), before and during reactive hyperemia(RH).
In 12 dogs the left anterior descending artery(LAD) was
occluded and measurements repeated after 1 hr (ischemic
group). Extent of ischemic LAD region was quantitated.
4 dogs without LAD occlusion comprised a control group.
In the control group no systemic, LV or coronary hemo-
dynamic changes were observed after 1 hr. In the ischemic
group 1 hr after LAD occlusion heart rate and AD pressure
were not changed but stroke volume had decreased (22~20%,
mean+SD) and LVEDP increased (4+3 mm Hg) both p<0.05.
Basaf CxF was not changed by CxN <90%; 90% CxN decreased
CxF both pre and post LAD occlusion. During RH without
CxN, CxF decreased post LAD occlusion in 11 of 12 dogs
(144+66 to 133+70 ml/min, p<0.05). With 60% and 80% CxN,
CxF during RH decreased before LAD occlusion (108~46 and
69+30 ml/min, respectively), but fell further (both p<
0.05) after LAD occlusion (89+41 and 54+27 ml/min). A
significant relation (r=.69) was found between %reduc-
tion in RH CxF and %LV made ischemic.
These data suggest that acute coronary occlusion dimin-
ishes flow reserve in an adjacent coronary artery. The
magnitude of flow reduction is related to the size of the
injured region.
Chronic PTCA
Chronic CABG
Normal Vessels
Pre-Revas.
N % Stenosis
i"i 77.9+14
9 77.0~14
11
CFR
1.56+0.1
1. 50~0. 2
1.94~.41
Follow-up
(mo. )
6.2+0.3
3.1~0. 2
BALLOON ANGIOPLASTY: EFFECT OF PLATELET-INHIBITOR DRUGS
ON PLATELET-THROMBUS DEPOSITION IN A PIG MODEL
Peter M. Steele, MBBS (Hons); James H. Chesebro, MD, FACC;
Anthony W. Stanson, MD; David R. Holmes, MD, FACC; Lina
Badimon, Ph.D.; Valentin Fuster, MD, FACC, Mayo Clinic,
Rochester, MN, and Mount Sinai Medical Center, New York,
NY.
Balloon angioplasty is associated with a high incidence of
occlusion and restenosis probably related to early plate-
let-thrombus deposition. Angioplasty of the common caro-
tid artery was performed in heparinized normal pigs (mean
weight 32 kg)--lO control (C) and 48 treated as follows:
Aspirin (ASA) 40 mg/day (ASAl), ASA 650 mg/day (ASA2), di-
pyridamole (DIP) 200 mg/hr IV, DIP 100 mg/90 min IV and
ASA 650 mg/day (ASA/DIP), prostaglandin El (PGEl) 100 ng/
kg/min IV, PGEI 100 ng/kg/min IV and DIP 100 mg/90 min IV
(PGEI/DIP), dextran (DEX) 250 ml IV immediately prior to
procedure (DEXl) and DEX 250 ml IV 4 hrs prior to proce-
dure (DEX2). Pigs were sacrificed 1 hr after angioplasty.lllIn-labeled platelet deposition and macroscopic mural
thrombus formation are shown below.
No. Platelets (mean) Mural
Pigs xl06/cm2 Thrombus
C 10 45 7/10
ASAI 7 19 1/7
ASA2 5 69 3/5
DIP 7 60 5/7
ASA/DIP 7 18 1/7
PGEI 10 53 5/10
PGEI/DIP 4 245 4/4
DEXI 4 33 2/4
DEX2 4 42 4/4
With this overwhelming stimulus for platelet-thrombus
deposition, treatment with ASAI and ASA/DIP resulted in
less mural thrombus formation (P-0.05), and platelet
deposition was reduced. This may have important implica-
tions for clinical trials.
INTRACORONARY THROMBUS: ROLE IN CORONARY OCCLUSION COM-
PLICATING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY
(PTCA)
Thomas A. Mabin, MB.ChB; David R. Holmes, Jr., MD, FACC;
Hugh C. Smith MD, FACC; Ronald E. Vlietstra, MB.ChB,
FACC; Alfred A. Bove, MD, FACC; James H. Chesebro, MD,
FACC; Guy S. Reeder, MD; John F. Bresnahan, MD, FACC;
Thomas A. Orszulak, MD, Mayo Clinic, ROChester, MN
Complete occlusion is the most common serious complica-
tion in patients (pts) undergoing PTCA. In that coronary
artery thrombus (CAT) is a frequent finding in some pts
with spontaneous coronary occlusion, e.g. infarction, the
role that preexisting CAT plays in acute occlusion during
PTCA was evaluated in 238 pts at Mayo Clinic prior to
March 1983. CAT was present prior to PTCA in 15 pts (6%)
and absent in 223 pts (94%). There was no significant
difference in pts with and without CAT for mean age, dur-
ation of angina, unstable or variant angina, severity of
stenosis, distribution of disease or number of diseased
vessels. There was a higher incidence (p<O.Ol) of prior
and recent infarction in the group with CAT present prior
to PTCA, 66% versus 28% and 40% versus 14% respectively.
All pts had received dipyridamole ± aspirin pre-PTCA and
5,000-10,000 units heparin during PTCA. Complete occlu-
sion requiring emergency coronary bypass surgery oc-
curred during or within 4 hours after apparently suc-
cessful PTCA in 10 of 15 pts (6,%) with preexisting CAT
versus in 18 of 223 pts (8%) without CAT (p<.OOOl). In
no pt with CAT who occluded was major intimal dissection
seen. Of the 18 pts without preexisting CAT in whom oc-
clusion occurred during ?TCA, occlusion resulted from
major intimal dissection in 12. In conclusion, the pre-
sence of CAT prior to PTCA identified a subset of pts at
high risk for total coronary occlusion during attempted
?TCA. In the absence of CAT, total occlusion is infre-
quent and most often caused by major intimal dissection.
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8.5+3.1*
6.5+2.3
4.4+2.3*
AP
AVP
VP
DISADVANTAGEOUS EFFECTS OF VENTRICULAR PACING ON CARDIAC
FUNCTION AND MYOCARDIAL ENERGETICS
Yukihiro Koretsune, MD; Kazuhisa Kodama, MD; Michitoshi
Inoue, MD; Shinsuke Nanto, MD; Koichi Taniura, MD;
Masatsugu Hori, MD; Masayoshi Mishima, MD; Hiroshi Abe,
MD, FACC, Osaka University Medical School, Osaka, Japan
To evaluate the physiological significance of atrial
contraction and ventricular asynchronicity in different
pacing modes, comparative study of atrial(AP), ventricu-
lar(VP) and A-V sequential pacings(AVP) was performed in
25 patients with sinus bradycardia. Coronary sinus flow-
(CSF) and oxygen extraction were measured by using coro-
nary sinus thermodilution catheter along with mean aortic
pressure (mAP) and CO(thermodilution) before and during
each pacing for three minutes. After these measurements,
left ventriculograms were obtained with a simultaneous
high fidelity LV pressure. We assessed the myocardial
energy efficiency(EE) as the ratio of LV pressure-volume
area to myocardial oxygen consumption(MV02: O2 extraction
X CSF). Results are:
H R mAP C 0 C S F MV02
(/min) (mmHg) (l/min) (ml/min) (ml/min)
66+5 107+15 4.~1.0* 75+48* 7.7+5.6*
66+5 107+16 4.6+1.0 90+57 8.8+6.0
66+5 101+16* 4.1+0.9* 94+59 9.5+6.7
mean+S.D. *p 0.01 vs AVP
A lower CO in VP than AVP indicates that atrial kick
could augment CO substantially. However, AVP resulted in
a lower CO and higher MV02 than AP though atrial contrac-
tion similarly functioned in both pacing modes. This
indicates that ventricular asynchronicity in AVP is
unfavorable to cardiac hemodynamics. Moreover, the mean
EE was highest in AP and lowest in VP. Thus, we conclude
that a lack of atrial contribution and ventricular asyn-
chronicity in ventricular pacing may be disadvantageous
in cardiac function and myocardial energetics.
Control 88+ 9 8+3 152+76
II 30 sec 85+ 8* 12+5* 93+45*
60 sec 87+10 16+5* 98+45*
Incldence of anglna and pvc's was comparable at 30 and
60 sec. In conclusion, the results indicate that pBI can
be performed wlthout major risks even when the balloon
interferes with the MLCA; however, additional monitoring
of PCP is recofOOlendab1e since rapidly evolving ischemia
may not be reflected by simple measurement of AOP.
CORONARY BLOOD FLOW AND HEMODYNAMICS DURING PROLONGED
BALLOON INFLATION IN CORONARY ANGIOPLASTY
RUdiger Simon, MD, Ivo Amende, MD, Paul R. Licht1en, MD,
FACC Hannover Medical School, Hannover, FRG.
In o;der to test the safety of prolonged (p) balloon in-
flations (BI), w~ continuously monitored ECG, aortic
(AOP) and pulmonary wedge pressure (PCP) and blood flow
in the great cardiac vein (GCVF; thermodi1~tion) through-
out 60 sec BI in 26 patients (pts) undergolng coronary
angioplasty (CA). In 10 pts (group I) the inf1a~ed bal-
loon occluded the main left coronary (MLCA) durlng CA of
the MLCA (3 pts) or the proximal LAO (7 pts). In,16 pts
(group II) with CA of the mid LAD, ~he balloon dld not
interfere with the MLCA. Results: Wlth BI, GCVF de-
creased markedly in both groups, reached a minimum at
15 sec and then stayed stable throughout pBI. AOP fell
slightly during pBI, whereas heart rate did not alter.
In contrast, pBI was associated with a sustained ~ncrease
in PCP indicating ischemia; this was more marked ln group
I than in group II. Mean values at 30 and 60 sec BI for
both groups are given in the table (*: p<.0.05 vs. con-
tro l ; +: pc 0.05, I v~. II).
AOP PCP GCVF
(fOOlH~) (mmHg) (m1 Imi n)
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Hemodynamics of VVI and Physiologic Pacing
OPTI~AL LEFT ATRIOVENTRICULAR SEQUENCE IN DUAL CHA~8ER
PACING - LI~ITATION5 OF PROGRA~~EO A-V INTERVAL
~ark Wish, MO; Ross O. Fletcher, MO, FACC; John 5. Gottdiener, MO, FACC;
Andrew 1. Cohen, PlOt FACe; D. Joshua Cutler, MO, FACe; Herman Rogers,
CPT; Veterans Administration & Georgetown University Medical Centers,
Washington, D.C.
Left cardiac output is dependent on optimal left atrioventricular se-
quence (LAV5). In our study discrepancies between LAV5 and prograrrmed AV
interval (AV) t which determines the right atrioventricular sequence, were
measured by recording the left atrium (LA) with a bipolar esophageal
electrogram. Right heart pressures and cardiac outputs were obtained
during prograrrmed AV intervals of 25, lSD, 200 and 250 msec in OVl and
during atrial sensing in ODD.
Inter-atrial conduction time (atrial spike to LA) was 123'52 50 msec,
range 90-250. The LA-V spike (LA-V) at a prograrrmed AV of 150 msecs was
27.52 msec (range 60 to -100). The optimal cardiac output (av 6.9'1 II
min) was obtained at a prograrrmed AV 185.38 msecs , with an LA-V of B2±3B
msec , SUbstantially less than the LA-V (116±42 msec , p<..05) recorded
during the worst cardiac output (av 5.4±1. 7 l/min) obtained at a pro-
gramned AV of 207±44 msec , During atrial sensing in ODD the LA-V interval
of 160.56 msec was 7B msec greater than the LA-V interval of 82'19 msec
(p<.05) recorded in OVI mode. Cardiac outputs at this increased LA-V
interval showed a 21~ decrease from 6.9.1.1 to 5.2'1.9 (p<.05). In one
patient with markedly prolonged atrial conduction (A-LA 335 msecs) the
optimal cardiac output occurred at a proqreemed AV interval of 25 msec ,
since other available intervals placed the LA in early systole.
We conclude: 1) longer available prograrrmable AV intervals would allow
optimal placement of LA-V, even with markedly prolonged intra-atrial con-
duction times; 2) the optimal LA-V established in OVl mode irrmediately
extends with atrial sensing to produce significant hemodynamic deficits.
Pacemaker design allowing automatic decrease in AV interval lotith pro-
gra"",able ranges 40 to 110 msec is required to maintain optimal LAV5;
3) 000 pacemaker pts who depend on VOO rode for pacing should have
optimal AV intervals established in OVI decreased by the measured exten-
sion of LA-V due to sensing or by the 75 msecs mean value established in
this study.
A RANDOMISED CONTROLLED TRIAL OF DDD AND
INCREMENTAL VVI RATE RESPONSIVE PACING.
Perrins EJ, Hudson WM, Lahiri A,
Raftery EB, Sutton R. Westminster Hospital and
Northwick Park Hospital, London England.
10 patients with complete heart block DDDM pacemakers
were studied in a randomised double blind rest and
exercise protocol comparing DDD pacing and VVI rate
responsive (VVIRR) pacing. They underwent symptom-
limited upright bicycle stress tests with a Swann-Ganz
thermodilution catheter in situ. 8 patients in addition
underwent a semi-upright exercise test with non-imaging
nuclear probe assessment of LV function. On the day
prior to study patients underwent a standard graded
maximum stress test. Atrial rate was measured at 1
oinute intervals. These values were subsequently used
to determine the programmed VVI rate during each
successive minute in VVIRR pacing. There was 3 hours
rest between modes. All programming was blind to the
observer. In DDD mode exercise time was 7.7 minutes and
workload achieved 2406 kpm. In VVIRR mode exercise
time was 6.5 minutes, workload 1790 kpm (p < 0.001).
Pulmonary capillary wedge pressure (PCWP) was
significant ly lower in DDD then in VVIRR both at rest
(8 't 5 DDD, 13 't 7 VVIRR, P < 0.01) and at peak
exercise 20 + 5 ODD, 24 + 8 VVIRR, P < 0.01). Cardiac
output was equal at rest, but was significantly
greater in DDD mode at peak exercise (~9 + 1.6 DDD,
8.2 't 1.7 llmin VVIRR, p < 0.02). There were no
significant differences in heart during exercise in the
two modes. Dyspnoea was the limiting symptom in 8
patiens in VVIRR mode but only 1 in DDD. Radionuclide
assessment of LV function demonstrated that the end
diastolic volume was significantly greater during DDD
mode. In addition a highly significant correlstion was
shown between resting ejection fraction and the
increase in maximum work load achieved in ODD
compared to VVIRR modes. DDD pacing was haemo-
dynamically superior to VVIRR pacing both at rest and
during symptom limited exercise.
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DOPPLE~ DETECTION AND QUANTITATION OF MITRAL REGURGITA-
TIOlI DURIllG VENTRICULAR AND ATRIOVENTRICULAR SEQUENTIAL
PACU1G
Frederick T. Zugibe, MD; Navin C. Nanda, MD, FACC; Toshio
Akiyama, MD, FACC; S. Serge Barold, MD, FACC, University
of Rochester Medical Center, Rochester, New York
HEMODYNAMIC EVALUATION OF DIFFERENT RATE RESPONSIVE PA-
CINGS DURING EXERCISE
Paolo Rossi, MD; Giorgio Rognoni, MD; Eraldo Occhetta, MD:
Maria D. Prando, MD: Marco Minella: Dean J. McCarter, Ph.
D., Divisione di Cardiologia, Ospedale Maggiore, Novara,I
These data show that the highest cardiac performance du-
ring ST in rate responsive pacing was obtained by respi-
ratory triggered PM in comparison to the other ones; the
loss of A-V synchrony is not a limiting factor in the ma-
jority of patients. * P <. .01
In patients in chronic complete AVB cardiac output (0) by
paired thermodilution, oxygen uptake (VO ), A-V 0 diffe-
rence, working capacity (WC), left ventrfcle stro~e work
index (LVSWI), sinus Prate (P) were recorded in supine
and standing position, during multistage treadmill tests.
All pts worked until they reached the anaerobic threshold:
10 pts performed stress test (ST) with fixed cardiac pa-
cing (VVI). The same pt performed a ST with rate responsi-
ve pacing: 5 with a P triggered PM (VAT), 4 with RS
4PM(CPI), 7 with a respiration triggered PM (VRT, Biotec).
All ST were pacing dependent. 0 decreased from supine to
standing position in VVI', VAT and RS
4
, unchanged in VRT
pacing. The basal values (B) and at maximum of ST (means)
were:
1236 3.9 10
1100 4.4 12.8*
1050 4 12*
1535* 5 14*
A-V02 PrateMax B Max
150
131*
130*
150
87
82
80
82
11
5*
12
LVSWI
B Max
52 137
54 77
50 73
63 121
3.2 16' 25
3 8 28
2.8 9 26
3.5 12.3 30'
O/ulse WC
B Max MaxMax
VO 0Ma~ B
WI
VAT
RS
VA~
Twelve patients (pts) with dual chamber pacemakers were
studied during VVI (9 pts), DVI (8 pts), AAI (2 pts),
and/or VDD (2 pts) pacing modes (depending on capability
of each pacer) utilizing continuous and pulsed Doppler
echocardiography (DE) to analyze left atrial (LA) flow
patterns. Each pacing mode was maintained for at least
1 minute and presence and severity (graded 0 to 3+) of
mitral regurgitation (MR) was determined by mapping
extent of LA systolic reversed flow and by assessment of
maximum amplitude (grey scale), and duration of systolic
flow. In 7 of 9 pts with MR (1+ to 3+) during VVI, MR
disappeared in 2 pts during AAI or DVI pacing, MR
decreased in severity in 1 pt during DVI (2+ to 1+) and
was unchanged in the remaining 4 pts. Five pts (3 DVI,
2 VDD) with MR were studied at different AV intervals
and 3 showed maximum reduction in MR (to 1+) at AV
interval range of 140-160 msec compared to VVI and/or
shorter (25-100 msec) and longer (200-250 msec) interval
lengths. MR was unchanged in the other 2 pts at all AV
intervals. Interestingly, 1 VVI pt without MR developed
1+ MR during DVI at 200 msec AV (fixed interval, could
not be varied). DE is useful in not only assessing the
presence and degree of MR in pts with dual chamber pacing
but may also help select the pacing mode and AV interval
producing the least MR.
postop S
postop ~S
24 hr 5
24 hr NS
48 hr S
48 hr NS
72 hr S
72 hr ~S
1C1'M'lY-SBNSID, RAft: RfSPOOSIVE PACIN:;: 'mEAOOLL
PERf'()IfWCE AND HlHlMWUC CHARACTERISTICS
[)emis P. HIIIIen, K>j William J. Kostuk, MD, FACe; George
J. KleIn, K>, FACe, thiversity Hospital, I.cindon, Qltario.
A MW p8C8IIllIker incorporating a special sensor to detect
body activity has been developed. '!be electrical output
frOlll this sensor is P'ocessed to P'oduoe an increase in
pacing rate in response to PJysical activity. Five
patients (JDHrI age 71, range 44-82 years) underwent
perJllUlent iDplantation, 4 paced in the WI IOOde and 1 in
the AAI mode. A single-blinded, randcmized, crossover
study was carried out to assess exercise capacity by
treecllaill perfonence and~c function using
qLWntitative radionuclide ventriculograPlY.
CoIIpred to fixlecl rate denlIInd IOOde (D) pacing, the
activity-lllDdu1.ated mode (A) did not result in any
sic~lificant iqr<Well8\t in total exercise C1Iration, VOoz
lIIIIX, or VCO:2 lIIIIX. However, there was significant
iqlI'~t in anaerobic threshold (AT ml.OgImin/kg).
FurthclllDCe, A WI U80Ciatee:l with an increased cardiac
index (eI 1/min/~) mdiatee:l by an increased heart rate
(HR bpD) It 8IIlller cardiac vo1llllls (end-diastolic vollllle
[EDT all.), stroke volLllle [SV 1IIl/m2), end systolic
vol~ [ESV alIm2), index [I) Wlen CCIIPled to D
without any cbange in left ventricular ejection fraction.
EllKciee R88ults (man±SD)
AT EWI ESVI SVI "cr HR
A 13.41;t2.26** 106;:30* 60±26+ 4fi;!:1l* 4.2~1.1* 92!.5.3'
D 11.85+2.2 122+38 64+30 56+13 3.75+.83 69+3
** P cO:01, * p c'lf.os, -+ p cO.l'; • p < .001 -
In~, althc:iiJh f\mcticNI capacity-loU not altered
in tbu _tully papllation, A pacing does iqxove left
ventricular~ f\.nctic:n cming exercise ..tlicb
-.y lZ'0V'e to be t.eficial in~ patients.
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Transplantation, Mechanical Heart, Balloon Pumps
srcnr AND LEF" HEART FUNCTION IN SURVIVING AND NON-SURVIVING
PATIENTS REQUIRI~r. INSERTION OF A LEFT HEARl ASSIST DEVICE
fOLLOWING CARD LAC SURGERY.
D.M. Rose, M.D., S.B. Colvin, H.D., J.N. Cunningham, Jr.,
M.D., 0.\1. Isom, M.D., FACC, K.Il. Krieger, ~I.D., E. Glassman,
M.D., FACC, and F.C. Spencer, M.D., FACC, New York University
Medical Center, ~Y, NY
Since July, 1978 we have inserted a left atrial to ascending
aorta, roller pump left heart assist device (LHAD) in 39
patients. All patients had cardiac failure following cardiac
surgery that was unresponsive to pharmacologic agents and
intra-aortic balloon pump. All patients required insertion
of the L1~\D to provide adequate systemic perfusion. Nineteen
patients regained satisfactory ventricular function and
were weaned from the assist device. The assist device was
employed in surviving patients (S) for 16-92 hrs (mean 42±
5), and was employed in non-surviving patients (NS) for
4-92 h r s (mean 36: 7). All non-surviving patients died
either as a result of refractory cardiac failure or coag-
ulopathy. Post-operative hemodynamic results are summarized:
Cl LVSIH SVR
JlJ~~/J~_ ~G1!-M) (dyne-sec-cm-S)
1.75:0.4 25.7±2.5 2485±120
1.63+0.6 20.8±4.5 2593±110
2.34+0.3 40.2±4.5 l605±102
1.72:0.4 23.5±1.9 2S08±234
2.95:0.3 46.7±2.7 l248±120
1.67:0.2 22.7:0.8 2133±208
2.87:0.3 45.8:3.1 1232±11S
1.70:0.7. 21.4:0.5 2410±125
SurviVing patients demonstrated significantly improved
ventricular function within 48 hours while non-surviving
patients did not. These hemodynamic improvements can
provide early prognostic indices for survival with the
use of this type of assist device.
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AFFERENT REINNERVATION OF CANINE CARDIAC AUTOTRANSPLANT.
P.K. Mohant~, MD, FACC; J.R. Capehart, MD; R.R. Lower,
MD; B.J. Sa lon, BA; M.D. Thames, MD, Med Co11 of
Virginia and VA Med Center, Richmond, Va.
Recent reports of angina in patients with cardiac trans-
plantation suggest afterent reinnervation even though
efferent denervation persists. Our previous study in
dogs indicated that afferent reinnervation is uncommon
in the first 2 years post transplant. The purpose of
this study was to determine if afferent reinnervation of
the heart occurs in the long term. We assessed the de-
creases in arterial pressure(AP) and renal nerve activity
(RNA) resulting from chemical stimulation of left ven-
tricular sensory receptor~,with vagal afferents with
cryptenamine (veratrum alkaloids) in 3 dogs 8-12 years
post cardiac autotransp1antation(AT), and in 6 sham dogs
(thoracotomy and pericardiotomy 6-8 weeks before study).
RNA responses to physiologic stimulation of cardiac re-
ceptors by volume expansion also were determined.
Results: LV cryptenamine inhibited RNA by 73±S% in AT
and by 94±5% in sham dogs. Decreases in AP were 30mmHg
and 50mmHg for AT and sham dogs, respectively. Volume
e~p~nsion inhibited RNA in AT (43%) and sham (48%) dogs
s1m1lar1y for comparable increases in cardiac filling
pressure. One of 3 AT dogs had large decreases in AP
and RNA after cryptenamine but no change in heart rate
during electrical stimulation of the vagi. Conclusions:
Ther~ is ex~ensiv~ afferent reinnervation (evidenced by
chem1ca1 st1mulat10n) of the AT heart which results in
relatively norma~ cardiopulmonary baroref1ex responses
to vo1~me expans10n. Vagal afferent reinnervation may
occur 1n the absence of vagal efferent reinnervation.
Afferent reinnervation may account for the reported
occurrence of angina after cardiac transplantation.
EXCELLENT SUP.VIVAL IN MORBIDLY ILL CAPnIAC TRANSPLANT
RECIPIENTS SUPPORTED BY INTRAVENOUS DRIPS AND INTRAAORTIC
BALLOON
Bartley P. Griffith, KIl, Robert L. Harrlesty, lID, FACC,
Alfredo Trento, MD, ~Ark E. Thompson, MD, FACC, Jerome M.
Itzkoff, MD, Henry T. Bahnson, MD, FACC, University of
Pittsburgh, Pittsburgh, PA
Since llarch of 1981, 25 of 56 patients treated by
heart transplantation were morbidly ill preoperatively.
Sixteen required intravenous infusions of dopamine and
dobutamine while the additional 9 had an intraaortic bal-
loon inserted prior to emer~ency transfer (3 oatients) or
during in-hospital candidate evaluation (6 patients).
Intravenous and/or balloon support were initiated rela-
tive to the degree of systemic hypoperfusion to avoid pro-
gressive obtundation or renal and hepatic failure. A
serum creatinine persistin~ above 2.5 m~% was considered
a contraindication to transplantation. The median wait-
ing period for a donor or~an was 5 days. Immune suopres-
sion was provided by cyclosporine and low malntenance
dose prednisone (20 ms). Since July of 1982, antithymo-
cyte globulin was added as rescue therapy from severe or
persisting rejection.
The cumulative year survival in this ~roup of 27
morbidly ill recipients was 85%. One of the 16 patients
with intravenous support and 1 of the 9 with the intra-
aortic balloon device died during the operative admission
from intracerebral hemorrhage and embolism, respectively.
It is concluded from these morbidly ill recipients
that if intravenous drug or mechanical balloon support can
sustain or improve vital or~an function, excellent results
can be achieved by cardiac transplantation. Advanced sup-
port measures do not by themselves incur an additive risk
and should be used prior to the occurrence of irreversible
organ damage.
LONG-TERM HEMODYNAMIC FOLLOWP OF CARDIAC TRANSPLANT
PATIENTS TREATED WITH CYCLOSPORINE A AND PREDNISONE
Barry F. Uretsky, MD, FACC; M. Greenberg, MD; P. S.
Reddy, MD, FACC, R.L. Bernstein, MD; B.P. Griffith, MD;
R.L. Hardesty, MD; M.E. Thompson, MD, FACC; University
of Pittsburgh, Pittsburgh, PA.
To evaluate long-term cardiac function after heart
transplantation(TX) in patients(pts) treated chronically
with cyclosporine A(CyA) and prednisone, 15 pts underwent
cardiac catheterization and endomyocardial biopsy(BX) 10
months after cardiac TX (mean 12.8+2.9 months). Mean CyA
dose was 6+2 mg/kg/d and prednisone 21+9 mg/d. All pts
developed postoperative hypertension(dTastolic >100 mmHg)
requiring treatment. One pt( NYHA Class III) had hemody-
namic findings of constrictive pericarditis. The preva-
lence of hemodynamic abnormalities in the 14 asymptomatic
pts are listed below:
Mean + SE Criterion for Abnormal Pts
Abnormality Number %
RA(mmHg) 5 + 3 > 6 mmHg 2 (14%)
PA(mmHg» 19 + 5 > 21 mmHg 3 (21%)
LVEDP(mmHg) 13 + 6 > 15 mmHg 5 (36%)
DBP(mmHg) 97 + 14 > 96 mmHg 8 (57%)
AV02(vol%) 4.9 +.6 >5.5 vol% 2 (14%)
CI(L/min/m2) 2.3 +.5 (2.0 L/min/m 2 3 (21%)
EF(%) 51 + 10 <50% 5 (36%)
Fibrosis on BX 0.7 + 1.1 >1+ 5 (36%)
Infl on BX 1.0 + 1.0 >1+ 5 (36%)
DBP-diastolic blood-pressure, AVOz-systemic arteriovenous
oxygen difference,EF-ejection fraction, Infl-Inflammation
BX abnormality scoring system(0-4+).
All 15 pts had normal coronary arteriography. There was
no relationship between BX and hemodynamic abnormalities.
Conclusion: Hemodynamic abnormalities are often found
10 months or later after TX in asymptomatic heart TX pts
being treated with CyA and prednisone.
CIRCULATORY VERSUS RESPIRATORY LIMITATIONS TO EXERCISE
BEFORE AND AFTER HUMAN HEART-LUNG TRANSPLANTATION
James Theodore, M.D.; Conor Burke, M.B.; Keith Dawkins,
~4.B.; Stuart W. Jamieson, H.B., FRCS, FACC; Edward B.
Stinson, t1.D., FACC; A. Van Kessel, B.S.; Norman E.
Shumway, M.D., FACC; Eugene O. Robin, M.D.,Stanford Univ.
Human heart-lung transplantation provides a model
for assessing the role of circulatory versus respiratory
limitations in pulmonary hypertension. We studied 7
patients pre- and post-transplantation during maximal
exercise attainable by each. The results show that exer-
cise limitation both pre- and post-transplantation is
largely circulatory.
Pre H-L Tx Post H-L Tx
~ + 1 SO x + 1 SO
H.R. (Beats/min) 1l1.3±Z6.5 135.7±10.5 < .05
%Predicted. Max. H.R. 58.8±13.6% 7l.9±5.5% < .05
VOZ (ml/kg/min) 10.5±3.1 l8.79±Z.39 <.001
% Predicted, ~·1ax. VOZ Z5,7±8.3% 46.0±7.7% <.001
OZ-Pulse, (ml/kg/Beat) .098±.037 .139±.015 <.OZ5
%Predicted,Max. OZ-Pulse 46.7±Zl.8% 64.0±9.0% <.OZ5
PaD Z (Torr) 36,7±15.1 97.3±8.Z <.001Pa02 increased from 3?±15.1 (SO) to 97±8.Z post-transplant. O2 pulse and VO Z were low but did not corre-late with PaOz. Post-transplant HR increased and the
maximal attainable \10 Z i ncreased, Despite normal post-
transplant Pa02' 02 pulse and V02 improved but
were less tnan predicted values. These studies indi-
cate that in pulmonary hypertension the major limitation
to maximal exercise is circulatory. Following heart-lung
transplantation, circulatory perfo~ance improves as
shown by an increased 02 pulse and VOZ' but not to pre-
dicted values. This may be related to deconditioning and
also to altered regulation of the circulation following
heart-lung transplantation. Despite circulatory impair-
ment, exercise tolerance is well maintained.
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VEINGRAFT ATHEROGENESIS: EFFECT OF DIFFERENT PLATELET
INHIBITORS
Lawrence E. Boerboom, PhD; Gordon N. Olinger, MD, FACC;
Lawrence I. Bonchek, MO, FACC; Ilhan I. Gunay, MO; Ahmed
H. Kissebah, MO, PhD, Medical College of Wisconsin,
Milwaukee, Wisconsin
We previously showed that the accelerated uptake of chol-
esterol (Chol) and B-apoprotein (B-apo) observed in auto-
logous vein grafts placed into arteries of normolipemic
macaques could be dramatically ameliorated by Rx with
aspirin (A) plus dipyridamole (D). This study tests the
effect of these agents in this model when used separately.
Cephalic veins were interposed in femoral arteries of 23
macaques maintained on a normolipemic diet. Eight ani-
mals served as controls. Ten animals received a graft in
alternate legs in alternate phases of the study. They
were Rx with A (80 mg/day) during one phase and with D
(50 mg/day) during the other. Five animals received A
+ D. Chol and B-apo were measured in grafts and in
ungrafted veins 3 months later. Chol and B-ape contents
in grafts were similar for each Rx, and for each Rx were
markedly reduced from control (p<.OOl). Data are R + SD.
Chol(mg/lOOmg) B-apo(ug/lOOmg)-
Vein Graft Vein Graft
.08+.02 .20+.02 2.0+.3 18.5+2.5
.06+.02 .09+.02 1. 8+. 4 1. 6+ • 3
.06+.02 .09+.04 1.8+.5 1.8+ .5
•06:!::.02 .07:!::.03 1. 8:!::. 6 1.9:!:: .4
In this model at 3 months, Rx with either A or D alone is
as effective as the combination in reducing graft lipid
accumulation.
Tuesday, March 27, 1984
8:3O-10:30AM Ballroom C
Nuclear Magnetic Resonance Imaging
NlIR UlAGING OF EXPERIIlENTAL IlYOCARDIAL INFARCTIONS WITH
AND WITHOUT IlYOCARDIAL PARAMAGNETIC CONTRAST AGENTS
George E. Wesbey, MD; Charles B. Higgins, MD, FACC,
lIartin J. Lipton, lID, FACC; Robert C. Brasch, lID; Barry
L. Engelstad, MD; Hans J. Weinmann, lID; Richard Siever~,
lID; Richard Ehman, lID; Jeffrey Lovin, MD, University of
California, San Francisco, CA.
A variety of paramagnetic agents have been employed for
enhancing contrast of specific tissues. In the current
study, two agents, nitroxide spin label (NSL) and gado-
linium (Gd-DTPA), were administered to 17 dogs with 24
hour old myocardial infarctions (LAD ligation). Hearts
were excised at 1.5 and 5 minutes after I.V. administra-
tion of NSL or Gd-DTPA (0.35 ~1/kg) and NMR ima~es were
obtained with a small bore 0.35 Tesla (15 mHz) resistive
unit. Jearts with infarctions were also imaged without
the use of contrast agent (n=8). Tissue samples of nor-
mal and infarcted myocardium were also analyzed with a
10.7 mHz Nlffi spectrometer.
Without contrast media, infarcts displayed increased sig-
nal intensity (I), Tl and T2 relaxation times compared
to normal myocardium. Gd-DTPA caused a greater increase
in intensity and decrease in Tl (p ~ 0.05) of normal (TI =
134 msec) compared to infarcted myocardium (TI = 22e
msec) in hearts excised at 1.5 mins (perfusion phase). On
the other hand, at 5 mins (infarct enhancement phase)
significantly greater (po< 0.0l) Tl shortening occurred in
infarcted (147 msec) vs. normal myocardium (211 msec).
Contrast intensity of myocardial regions increased with
decreasing Tl time.
Thus, infarcted myocardium can be differentiated from nor-
mal myocardium using Nlffi imaging. The intensity differ-
ence between the two can be altered by paramagnetic con-
trast agents.
CLINICAL NllR WAGING OF TilE IIEART
Charles B. lIigginsL MD, FACC; Benjamin F. Bvrd , ~ID; Peter
Lanzer, MD; David Stark, ~; Elias II. Botvinick, ~U, FACC;
Nelson B. Schiller. MD, FACC; Lawrenc(' Crooks, PhD; Leon
Kaufman, PhD, Vniversity of California, San Francisco, CA
Gated NMR images of the heart were obtained with the spin
echo technique in 40 patients and normal volunteers using
a 3.5 kGauss superconducting maBnet in order to define
the role of N~ffi imaging in heart disease. Multisectional
imaging encompassing the entire heart was obtained at
echo delays (TE) of 28 and 56 msec. Each 5 slice gated
series was obtained in approximately 8 minutes. The pa-
tient group consisted of 10 patients with chronic myocar-
dial infarctions, 4 patients with cardiomyopathy and 9
patients with pericardial a~normalities. All ~~R studies
in patients were correlated with cineangiograms and/or
sector scan echocardiograms. Magnetic relaxation times
of Tl and T2 were measured for the septal and lateral myo-
cardial walls, as well as for skeletal muscle and subcu-
taneous,periaortic fat. The T2 values of myocardium were
higher Lhan skeletal muscle while these values were near-
ly identical for various myocardial se!1ments.
Gated images displayed myocardial wall thickness, inter-
nal morphology such as valves, chordal-papillary muscle
apparatus and moderator band. Regional wall thinning,
mural thrombus, and antero-lateral and posterior aneur-
ysms were demonstrated at sites of chronic infarctions .
Asymmetric and global hypertrophy and dilation of the
left ventricle along with pericardial abnormalities such
as effusions, pericardial inflammation and thickening
were clearly discerned.
Thus, gated Nlffi imaging is currently an effective method
for evaluating a variety of left ventricular and peri-
cardial abnormalities.
PROTON NUCLEAlt MAGNETIC 'tES'lNANCE 'tELAXATION TIllES IN TilE
ASSESSllENT OF PE'tFUSION RESULTING F'tOlI 'IYOCARTJIAL
ISCHEllIA AND ,\EPERFUSION
Adam ~ :latner, ~ '\obert TJ. Okada, lID, FACC; Gerald 'I.
Pohost, MD, FACC. ttass • General Hospital, Boston 'lA.
Preliminary studies in our laboratory suggest that proton
nuclear magnetic resonance (N!IR) imaging techniques are
capable of mapping the intrinsic differences in the pro-
ton relaxation tiMes TI and T2 that result from myocardi-
al ischemic danage. The present study was undertaken to
assess the relationship between proton relaxation times
and changes in myocardial perfusion resultinp, from dif-
f er i.ng ischemic insults. 1)ogs unde rwen t occlusion of the
left anterior descending coronary artery (LAD) for 30min-
utes (n=5) and 60 minutes (n=5). Additional dogs under-
went LAD occlusion and reperfusion of 30 minutes and 15
minutes (n=5) and 60 Minutes and 15 minutes (n=5), re-
spectively. ~adiolabelled microspheres were administered
to assess regional myocardial perfusion. After sacrifice,
each heart was divided into 2 normal and 2 ischemic zones
and subdivided into epicardial and endocardial halves. In
the endocardium of the occlusion-only groups, Tl and, to
a lesser extent, T2 elevation correlated significantly
with reductions in ischemic flow and in the ref low groups
correlated with reperfusion flo,", as shown below:
Occlusion Reflow TI T2
30 min ~ r=.75 p<.0005 ~S.
30 min 15 Min r=.85 p<.OOOl r=.63 p<.0l
60 Min none r=.67 p<.OOl r=.62 p<.005
60 min 15 min r=.9l p(.OOOl r=.83 p<.OOOl
The correlations were less prominent in the epicardial
rep,ions. In conclusion, proton relaxation times which may
be estimated from imap,ing studies provide an indication
of reeional myocardial perfusion and accordinp,ly should
be of considerable value in the assessment of ischemic
heart disease.
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ELECTROCARDIOGRAPHIC SYNCHRONIZATION IN CARDIAC NUCLEAR
MAGNETIC RESONANCE IMAGING: METHOD AND EVALUATION
Peter Lanzer, MD; Elias Botvinick, MD, FACC; Frank Stucki,
MSEE; Nelson Schiller, MD, FACC; Lawrence Crooks, PhD;
Leon Kaufman, PhD; Charles Higgins, MD, FACC, University
of California, San Francisco, Calif.
To synchronize gradient pulses and improve anatomic res-
olution of in vivo nuclear magnetic resonance (NMR) card-
iac imaging, a NMR compatible ECG sensing device (SD)
which converts the electrical ECG signal into an optical
signal has been developed. It consists of 3 low-resistance
electrodes (LRE), nonmagnetic cables (NMC) , fiber optic
cables, a pre-amplifier and an amplifier recorder located
outside of the m1R imaging housing. Within the imager LRE
and NMC did not increase the noise level. Filtering the
high frequency currents induced in the electrodes by
changing magnetic fields produced an ECG signal identical
to the control. SD ECG gated cardiac NMR imaging was per-
formed without complications in 35 patients (pts) and 10
dogs, totaling 85 and 51 imaging sequences (IS), respec-
tively. A 0.35T superconducting NMR imager and 2D Fourier
transform image acquisition at two spin echoes (28 and 56
msec) was employed. In each IS 5 0.7cm thick sections
were acquired from base to apex. Image quality (IQ) was
assessed by 2 independent observers as 2+ when optimally
resolved, 1+ with partial anatomic resolution and 0 if
without resolution of cardiac structures. In pts, 62 IS
(73%) were 2+, 11 (13%) were 1+ and 11 (13%) were graded
O. In dogs, 25 IS (44%) were 2+ and 32 (56%) were graded
O. The major determinant of IQ was R-R interval variation
during imaging. Respiration, anatomic level and acquisi-
tion in end-diastole reduced IQ to a lesser degree. Gated
NMR imaging with this ECG SD appears safe and relatively
reliable. Improved IQ can likely be achieved by limiting
data to cycles of specific length and respiratory gating.
CHANGES IN VENTRICULAR EXCITABILITY AND VULNERABILITY IN
NMIl FIELDS
Glenn J.R. Whitman, MD; John U. Doherty, MD; Murray
Rob1nson, BA; John Hazelgrove, PhD; Michael B. Simson,
MD, FACC; Mark E. Josephson, MD, FACC; Alden H. Harken,
MD, University of Pennsylvania School of Medicine,
Philadelphia, PA.
Theoretical concern exists that the currents generated
during NMR studies may induce cardiac arrhythmias in
susceptible patients. The purpose of this study was to
determine if a strong, static external magnetic field
(BO, 4.7 Tesla) associated with radiofreQuency pulsing(81, 5 Gauss) alters ventricular excitability or vulne-
rability to arrhythmias. Langendorf perfused rabbit
hearts (12) were equipped with pacing wires for recording
the ECG and measuring strength-interval (51) curves, and
determining the repetitive ventricular response (RVR) and
ventricular fibrillation threshold (VFT). 51 curves were
determined from 0.5-10mA. RVR and VFT (the current
required for> 3 and> 10 repetitive responses, respec-
tively) were assessed-using a 100 HZ, 14 pulse train
spanning the T wave of the ECG. RVR was 72.2124.8in and
68.31~2.4 mAo~t of the magnet (p=NS). VFT likewise did
not d1ffer (83.2in120.5 vs. 73.1out121.1 mA, p=NS).
Ventricular refractory periods measured at threshold
(193.8in123.6 msec, 195.50ut126.2 msec) the midpoint of
the 51 curve (164.6in119.5, 168.30ut116.3) or at 10 mA
(157.6int23.O, 161.7Qutt16.6) did not differ. Nodifference was seen 1n the change in refractory period
from threshold to 10 mA (35.0int24.6, 30.8outt20.5). We
conclude: l)NMR spectroscopy at field strengths far
exceeding those used for human studies does not increase
ventricular excitability or vulnerability in the isolated
rabbit heart; 2)further studies are necessary to deter-
mine the safety of the technique in humans.
DETECTING MYOCARDIAL ISCHEMIA AND EFFECTS OF REPERFUSION
USING PROTON NMR RELAXATION PARAMETERS
Donald Johnston, MD; Robert Okada, MD;FAAC; Adam Ratner,
Buckley terPenning, Donna Lutrario, Gerald Pohost, MO,FACC
Massachusetts General Hospital, Boston, Massachusetts
NMR imaging may provide a method of quantitatively aSsess-
ing the effects of myocardial ischemia and early reper-
fusion. Vital to the production of an NMR image, relax-
ation parameters Tl and T2 were measured in this study to
determine the effects of coronary occlusion and reperfu-
sion. Five dogs underwent 3 hrs of LAD occlusion (3/0)
and 5 dogs underwent 3 hrs of LAD occlusion followed by
1 hr of reperfusion (3/1). After sacrifice epicardial and
endocardial samples were removed from the central ische-
mic (CZ), peripheral ischemic (PZ), and normal zones (NZ)
and Tl and T2 measured (20 MHz). Microsphere technique
showed incremental reductions in blood flow from NZ to PZ
to CZ for all dogs with a return to normal after reper-
fusion. Results (msec) for the endocardial samples are
shown below. The only epicardial change was an increase
in Tl for the 3/1 group.
UO Ul
Tl T2 Tl T2
NZ 675'!'16 49'!'1 664'!'24 ~
PZ 731!22*** 53!4* 720!49 ** 52!2
CZ 747!26*** 54!S** 767!27 *** SS!S**
Values are mean: SD; *Pc.OS; **p~.Ol; ***p~.OOl vs NZ.
The increase in Tl for CZ was greater (p~.OS) for the 3/1
group than the 3/0 group. Also, for the 3/1 group, a
further increase (p~05) in endocardial Tl occurred from
PZ to CZ. Thus, after a brief period of coronary occlu-
sion significant changes in Tl and T2 occur. These find-
ings demonstrate the potential of NMR for imaging early
ischemia. An incremental increase in endocardial Tl from
PZ to CZ suggests NMR may grade the severity of ischemia
and serve as a useful tool to assess reperfusion.
Tuesday, March 27, 1984
10:30AM-12:00PM Ballroom C
New Approaches and Electrophysiology
RAPID DETERMINATION OF THE ENDOCARDIAL ELECTRICAL ACTIVA-
TION SEQUENCE DURING VENTRICULAR TACHYCARDIA USING A SPE-
CIALLY DESIGNED MULTIELECTRODE BASKET CATHETER IN THE DOG
Donald A. Chilson, MD, Lorna Linda University Medical Cen-
ter, Loma Linda, CA
The purpose of this study was to determine if a specially
designed, conical-shaped basket catheter deployed in the
left ventricle could rapidly determine the electrical ac-
tivation sequence (EAS) in dogs with pleomorphic or uni-
form ventricular tachycardia (VT). The catheter consis-
ted of a high torque, 9-fr, braided catheter with four
limbs that when deployed from its collapsed position in-
side a sheath, expanded symmetrically, formin~ a conical-
shaped basket contacting the left ventricular endocard-
ium. Electrograms were simultaneously obtained from 13
electrodes, three electrodes on each limb and one on the
catheter tip. Myocardial infarctions were produced in
each dog by two-stage LAD occlusion/reperfusion procedure.
VT was induced by programmed left ventricular stimulation
seven to 21 days, mean 12, following infarction. The
catheter was easily positioned inside the left ventricle
via the femoral or carotid arteries and did not alter
mean arterial pressure. EAS was determined durin~ VT
from 13-49 fluoroscopically documented sites within two
minutes of VT induction. Three dogs with uniform VT
showed identical beat-to-beat EAS and identical site of
earliest electrical activity. Four do~s with pleomorphic
VT showed dissimilar beat-to-beat EAS but similar ~egion­
al site of earliest electrical activity. Postprocedure
gross examination of the heart revealed no catheter-in-
duced damage. In conclusion, a multi-electrode, conical-
shaped basket catheter provided safe and rapid hiy,h reso-
lution left ventricular endocardial maps and demonstrated
differences in the EAS and site of earliest electrical
activity between uniform and pleomo~phic VT in the do~.
51 2 l ACC Vol. 3. No. 2
February 1984:512
ABSTRACTS
NEWCATHETER SYSTEM FOR RECORDING ACCESSORY AV PATHWAY
POTENTIALS FROM THE CORONARY SINUS
War r en J ackman,MD ;Karen Fr i day,MD ;Gabri el Bizouati,MD;
Eliot Schechter , MD,FACC;Edwin Olson, MD ;Edwar d Berbari,PhD,
FACC;Lura Har rison,PhD,FACC;Benj amin Scherlag,PhD,FACC ;
Ralph Laz zara,MD,FACC, Unive rsi t y of Oklahoma and VA
Medical Center, Oklahoma City , OK
We pos tula ted that l ef t-s i ded accessory AV pa thway po-
t ent i a l s(AP)had not been r ecorded from ca the ter el ec t ro des
i n t he corona ry s i nus(C S) because wid e l y spaced linear elec-
t rodes maximize a trial(A)and ven t ricular potentials(V)and
minimize AP pr opagating perpendi cul ar t o CS. We designed a
#6F cat het er with 3 se ts( lOmm apa r t)of 4 elec trodes or ient -
ed a t 90° arou nd the ca t he ter pr edi c ting t hat l ow ga in r e-
cordings between adjacent e lec t rod es on a set ( l mm spac i ng)
woul d enhance AP and minimi ze the mo re dis tant over lap i ng
A and V. We sought and found disc re te AP dur i ng retrograde
conduc t io n along 1.5-10mm of CS a t t he s i te of earliest r e-
trogr ade A in 3/3 pts with le ft la t eral AP(l overt,2 con-
ceal ed). AP amplitude unfiltered= .07-.48mV,10cal V-AP=25,
10, 40msec, and AP-A=25,15,20msec. Retrograde block occurred
bet ween V and AP" in all 3 pts af te r s light increase in
l ocal V-AP. In the pt with overt AP,ant egr ade conduction
interval s were same as retrogr ade (l ocal A-AP=25,AP-V=25
msec) and ant egra de block occur r ed between A and AP after
i nc rease i n l ocal A-AP. Evidence of .ant egrade penetrat i on
of AP with block between AP and V was present i n 1 pt with
concea led AP ;n o evidence of antegrade penetration was pr e-
se nt i n the ot her pt,but th at pt r ecentl y r ece ived amioda-
rone . We conc l ude t hat fo r lef t -sided AP:l)AP can be con-
sistently re corded f rom CS us ing a close bip olar electrode
orient ed perpendicular t o CS axis;2 ) r etr ogra de bl ock occ ur s
on ventr i cular s id e of AP;3) ant egr ade penetration of AP can
occur i n concea l ed AP; and 4)variabi l ity in the sites of
bl ock may be explained by variation in geomet ry of AP in-
sert ions,reducing the sa fet y f actor f or pro paga t i on into
and out of AP by di f fering degr ees.
ELECTRODE-CATHETER ABLATION OF REFRACTORY VENTR ICULAR
TACHYCARDIA: CONTINUED EXPERIENC E.
Geoff rey O. Hartzler, M.D., FACC; Lee V. Gio r gi , M.D.
Mid-America Heart Institute, St . Luke' s Hospital
Kansas City, Missouri
The pr eve ntion of recurrent ventricular tachycardia
r emain s a treatment dilemma. A unique th erapy, that of
e lec t rode -cat het er "ablation" has bee n succ ess ful l y
att empt ed i n 4 pt s , each hav in g multipl e VT r ecurrences
desp ite ex tens iv e antidysrhythmi c dr ug th erapy and
add i tiona l ope ra t ive mapp ing wi th surgi cal exc is io n in 2
pts. Aut omat i c RV t achyca r di a was present in a 32-y-o- f .
Ind ucible, reentrant VT was present in 3 ma les ages 57,
60 and 65 , eac h with pr i or myocard i al infarc t io n and
bypass su rge r y , 2 wi t h aneur ys mectomy, and al l with poor
LV fu nc tion (EF - 18%, 26%, and 35%) . Electrophys io log ic
studies inc l udi ng pace mapp ing and in tracav i tary elec-
trode ca t he te r mapp ing l ocal i zed VT t o t he RV out f l ow
t ract - 1 pt , vent r icular septum - 2 pts , and pos t ero -
basal zone - 1 pt. Wi th pentothal anes thes ia, 3 t o 6
300- J shocks were di r ec t ed f ro m an adjacen t e lec t ro de of
a 7- F cathe t er t o an externa l ches t wall paddle . Tr ansient
seq uelae inc lu ded s i nus br adycard i a, r i ght bundl e branch
bl ock, and spontaneous ly t e rmin at in g VF. Following abla-
tion, VT coul d not be reinduced . Post-pr ocedur e crea t i ne
kinase r anged 1200 t o 6000 mIU/ mI without ECG cha nge . In
foll ow-up , I pt required a seco nd abla tion at 2~ mos
with no VT recurrence fo r 3 subse quent mos pr i or t o dea t h
from pump failure . Three pts r ema in free of sus t a i ned VT
a t 12 mos, 5 mos , and 2 mos. VT could not be reinduce d
in 2 pt s undergoing late s t udy (2 mos ).
Conclusion: Electrode catheter ablat i on of both auto-
matic and reentrant VT is fe asible. The pr ocedur e merits
continued c l i ni ca l investigat i on.
ATRIOVEKSION - MECHANISMS OF ATRIAL FLUTTER IN HAN
AND ELECTRICAL TREATMENT USING A NEW TECHNIQUE
A.David Cunningham, B.Sc., John A.Kennedy, FKCP,
Cardiac Department, Western Infirmary, Glasgow, Scotland
Atrial flutter (AFl) was treated using Atrioversion,a new
techniqu~ in which a single, constant current stimulus
with a pul.se width exceeding the tachycardia cycle length
is delivered. Using conventional ( 2ms pulse width) and
long stimuli, spontaneous AFl was investigated in 51
patients. Duration of AFl ranged frOD I day to 5 years.
Using one atrial premature beat (APB) induced during AFl,
an atrial site was cla s s i f i ed as Type I if the post-
stimulation cycle did not exceed the AFl cycle length by
more than 20 ms, and Type II if the return cycle was
longer or fully compensatory. One or more conventional
st imuli caused conversion to sinus rhythm (SR) in 5
patients, and to atrial fibrillation (AF) in 1.
Atrioversion was attempted in the remaining 45 cases.
Mean atrial cycle length was 208 ms, mean stimulus pulse
width 253 ms, mean amplitude 11.9 mA, and mean energy 3.1
mJ. Conversion to SK occurred in 26 cases (58%); to AF in
14 cases (31%) and in 5 the rhythm was unchanged. SR was
regained in 75% of Type I sites, compared to 42% of Type
II (p(0.03). AF occurred in 8 out of 17 patients on
digoxin, and in 6 out of 28 not on digoxin (p(0.025). 16
patients not on digoxin had Type I sites; 13 (81%) were
converted to SR. 47 patients had common AFl,with negative
P-waves in 11,111 and aVF. In 4 patients an impulse
caused conversion to atypical flutter, with +ve P-waves
in I and II. In one patient the two forms could be
interchanged repeatedly. Two Type I sites with activation
times differing by 60 ms were found in another patient.
These observations support macro-reentry as the mechanism
of human AFl and we believe that conversion to SR using
Atrioversion occurs by premature depolarisation and
"clamping" of a point in the reentry circuit, preventing
propagation of the next circulating impulse. With careful
catheter placement, the technique is highly successful in
converting AFI to SR.
THE STRENGTH-INTERVAL RELATION IN NORMAL AND INFARCTED
HUMAN LEFT VENTRICLE
Michael G. Kienzle, MD, John U. Doherty, MD, Dennis M.
Cassidy, MD, Norman H. Marcus, MD, Harvey L. Waxman, MD,
FACC, Alfred E. Buxton, MD, FACC, Francis E. Marchlinski,
MD, FACC, Mark E. Josephson, MD, FACC, University of
Pennsylvania, Philadelphia, PA
We characterized refractoriness in normal (N) and in-
farcted ( I ) left ventricles by endocardial bipolar
catheter stimulation in 6 N pat ients and at N and I
s ites in 7 patients. The effective refractory period
(ERP) was determined at diastolic threshold and 0.5 rnA
increments to 10 rnA with extrast imul i delivered in 5 ms
decrements during ventricular paced cycle lengths of 600
and 400 ms. The current of the dr ive st imulus was held
constant (2 X diastolic threshold ) . The ERP curve shape
and diastolic threshold were similar at N sites in pa-
tients with and without prior I. Diastolic threshold was
higher at I sites than N sites (1. 8+1.1 vs 0.9+0.8
mA , mean+SD, p<.05 ). The effect of paced cycle-length
on shortening of ERP at 10 mA was equal in I (34Z10 ms)
and N (32+12 ms) sites. The change in ERP from diastol-
ic threshold to 10 rnA was greater at I than N sites i n
6/ 7 pat ients with prior I ( r ange 15-90 ms at Nand 5-255
ms at I sites). The lowest rnA producing the shortest ERP
was s imilar at N and I sites at all paced cycle length
(range of mean 4.8+2.5 to 7.3+2.3 rnA ). We conclude:
1) Exc itability and refractorIness at N sites is similar
i n N and I patients. 2) Excitability is reduced at sites
of I. 3) Paced cycle length has similar effects on ERP
in I and N tissue. 4) Increasing mA has a greater effect
on ERP at I than N sites.
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COKFLICTING CONTRAST AGENT REQUIREMEKTS FOR MYOCARDIAL
CONTRAST TWO DIMEKSIONAL ECHOCARDIOGRAPHY
Shuji Kondo~ MD; S.au.l Me.rb.ua, PhD, FACC; Chuw. Tei,
Mb, rlcc; Iiot Cord.y, MD, FACe ; Kenn.th Ong, PhD;
Pravin M. Shah, MD, FACC , C.dars-Sin.i and Wad.worth VA
M.dicsl Centers, LoB Angeles, Csli fornia
~oronsry !low (CF) response and ayocardial contrast echo
washout were stud i.d in 7 op.n chest and 8 clos.d
chest doga, uains 4 different hand-asitBted echo con-
traat asents (CA) which prOVided reprodUcible regional
~yocard1.8l delineat ion in two di.enaional echo (ZDE)
1.ase. during subaelective coronary CA injectiona (2 .1
bolua). ZO cona.cut iv. poatinjection LV .nd-diastolic
fr.aea of 2DE short axia cross-sections were co.put.r
analyz.d to derive a .yocardial CA waahout i ndex (T
liz). Th. course of coronary flow reapona. (duration-d)
eXhibited an i n i t i . l reduction (%R), followed by in-
cre.ae to a hypereaic p.ak (%HP),and Bub••quent decay
tow.rd control.
RESULTS (ae.a +SD, p<.05 va 6% dextr.~:
--n- - %R %HP d aec
61 dextr.n ~ ~ +
30% renosrafia 26+31 11~78 31+98
30% aucroa. 62+22 119+488 23+5e
3~ sluco.e 70021e 174+388 28+88
6% dextraa CA had the loweat- -
%HP and Bhortest d, but ita
coaputed T 1/2 w.a el.v.ted.
CO.CLUSION: In addi tiOD to
•• t.tT and .dequate
echoseDicity, .s.e••••nt of
true .yoc.rdial perfuaioa
vith .yoc.rdi.l cODtr••t 2DE
viII require th.t aev .,.ats CF
f •• tur. both rapid
aToc.rdial w.shout
(con.i.tent with phys iolo,iC
aicrocircul.tory tr.n. it)
.nd ainiaal hypereaic
.lter.tion or the blood flov .
7ilE "LIlIKIlIG PIlEllOHEllOll" : All ELECTRO?HYSIOLOGIC
HECH,\11I SH WHICH CREATES PERSI STENT FUNCTIONAL
?RE F!:REIl7 IAL ROUTES OF HlPULSE PROPAGATIOll
Michael Lehmann, MO: Rehan Hahmud, 110 : John Oongas,
HO; Jog ind er Soni, HO; Stephen Oenker , HO; Hasood
,\khtar, HO , FACC , Uni versit y of Wiscons i n-Hount Sinai
1·ledical Cent er , Hil waukee , Wiscons i n
Sust a i ned f unctional an tegrade bundle branch block
1 S only one example of a more gene ral "linki ng
phenomenon" in which there is persistent functional
preferentia l conduct i on a long one of two potent i al
avenues of propagat ion, due t o repeti ti ve concea led
conduction f r om the oppos ite dir ec t i on. We wish to
repor t t he occ urence of t hi s phenomenon in othe r
se tti ngs as well : 1) Four cases of persis t ent
contralateral retrograde activat ion of the His bundle
dur i ng r ig ht ven'ricular pac ing at rapid ra tes
(sus ' a i ned f uncticnal retrograde r ight bundle branch
block): 2) Four patients with Wolff-Parkinson-White
syndrome in whom functional persistent preferen tial
conduction a l ong eit her ' he normal or acce ssor y
pat hway was obser ved dur ing atrial or ventr icular
pacing: and 3) One case of repe t i t i ve ret r ograde
activat ion of the His bundl e by right ventr icular
paced-impulses dur i ng macro- ree ntrant ventri cular
tachycardia. The unifying mechanism i n all th es e cas es
in volves creat i on of a f unc'ional l y commi . t ed rou te of
impulse propaga tion; dur ing successive beats, this
preferred pa'hway is maintained and "linked" via
concealed conduction t o electrophysiologic sequelae of
each preced ing bea t. The "l inking phenomenon" , mos t
clear l y eviden t in human models of macro reentr y
circuits, suc h as those i nvol vi ng t he bundle branches
or a Kent bundle, could potentially occur i n micro-
ren t rant circui t s as well .
Tuesday, March 27, 1984
8:30-10:30AM Ballroom D
Contrast Echocardiography Myocardial Perfusion-
New Agents and Methods
~CATICN OF MYOCARDIAL PERroSICN BY a:NI'RAST
EX::fD:AIlDIOGRAPHY: CllMPARISCN WITH 'mE TRPCER MIOVSPHERE
'ImiNI<;UE
Giancarlo Biamino, M); K.J. Henrichs, M); 1. Krock, M);
H. Matsuoka, M); B. Winkler, M); R. SChrMer, M);
W. SChaJ?E!l', M)
Dept . of EX'r:ler1lre1ta1 cardiology, Kerckhoff-Institute,
Bad Nauheim and Dept. of Cardi~logy, I<linikum
Steglitz, FU Berlin, Gennany
In 8 i solated, fibrillating canine hearts perfused with
arter ial blood fran a donor d:>g at a ccnstant flow, the
short axis of the left ventricle at the level between
mitral valve and papillary 1lUSC1es was visualized bv 2-0
echocardiogrdI?hY (2-DE); Toshiba SSH 40. .
After intracoronary injectioo of 600-800 m;J/dnl SH U 454,
a susoenston of saccharide microbJl:i>les, l:x1Tr:lgeneoos
opacificatioo of the myocardium lasting 10-20 sec was 00-
served. After t:enp:>rary curonary cxx:lucioos at different
sites and levels , the resulting perfusion defects were
visualized by 2-DE and quantified by planimetry in the
short axis view. The 2-DE data were ex:tnPared with those
obtained by the use of tracer microsph&es, whid'l were
injected at the same time as the echo exmtrast aqent. A
correlation coefficient of r = 0.89 (a = 0.92, b = 3.37)
between both techniques IoaS OOtained.
Apart fran a transitory snaIl coronary dilatatioo no
s ide effects were OOserved after IlU1tiple injections of
the agent. Electron ndcrosoopdcal, analysis of the my0-
cardial tissue of the investigated hearts did not reveal
any structural ~nnent after injectioo of SH U 454.
Conclusioo: The use of SH U 454 prCIII'ides a reproducible
quantitative visualizatioo of myocardial perfusioo de-
fects, which correlates closely with that by the tracer
microslilere technique.
SYSTOLIC EXPANSION OF INFARCTED MYOCARDIUM EXPLAINS THE
OVERESTIMATION OF INFARCT SIZE BY WALL MOTION ANALYSES
Willi.. F. Armst rona ,M .D. , FACe ; Mary J. Conley;
J..ea C. Dillon, M.D., FACC; Harvey Feigenbaum, M.D. ,
FACC; Krannert Institute; Indi.na Univeraity School of
Medicine; Indianapolia , Indiana
Systolic "tethering" of adjacent no~l myocardium
i. frequently .dv.nced '8 an explanation for
overeatiaation of infarct aize by echocardiographic wall
aotion .nalyai.. Lengthening of infarcted or ischeaic
.yocardium in ay.tole haa been vell documented with
.everal previous techniquea. In this .tudy we u.ed
contr••t enhanced tvo-diaen.ional echocardiography to
aep.rate perfuaed from non-perfuaed ayoca rdium and
undertook analy.is of the systolic behavior of the
non-perfuaed region of myocardium in 15 ahort-axia scana
froa 9 cloaed cheat doga.
The length (L), the ratio of L to ventricular
circumference (L/C), and the ana Ie (0) .ubtended by the
nonperfuaed .ea-ent vere aeaaured at end-di.atole and
end-ay.tole by two independent obaervera. A ayatolic
increaae in L, Llc .nd 0 waa aeen in 13/15 atudie.
analyzed by ob.erver I and in 14/15 by ob.erver 2.
L increa.ed by 2-18%, LIC by 8-25%, and 0 i ncr eaaed by
6-46%. The increaae in Land Llc repeaent. lengthenin,
of the non-perfuaed aegaent. The widening of 0 ie due
to both the incre.ae in Llc and to .av...nt of the
ceater of the ventricular contour toward t he non-per-
fuaed relion in ayatole . The iacreaae in L, LIC and
videning of 0 reault. in coapariaon of non.naloloua
relion. of myocardium in di••tole .ad .y.tole. Region.
of norael border aone myoc.rdium 1n diaatole .re c~
p.red to the po.ition of inf.rct.d ayoc.rdium in .y.tole
c.uaiag .a overeatiaatioa of iaf.rct aize by endoc.rdi.l
.ation or w.ll thickening .naly••• •
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INCREASED REGIONAL END-DIASTOLIC WALL THICKNESS AND
SUBENDOCARDIAL ECHO INTENSITIES EARLY AFTER REPERFUSION :
RELATIONSHIP TO ULTIMATE MYOCARDIAL NECROSIS
Roberto V. Haendchen, MD; Kenneth Ong. PhD; Frederick
wood, BS; Shigeru Yamazaki, MD; Michael Fishbein. MD.
FACC; Samuel Meerbaum, PhD, FACC; Eliot Corday, MD.
FACC, Cedars-Sinai Med. Ctr., Los Angeles, CA
Increased regional end-diastolic (ED) wall thickness
(EDWT) and myocardial echo intensities (INT) have been
observed in the first hour of reperfusion (R) following
acu t e coronary occlusion (0) . To investigate the
sequent ial changes in EDVT and INT after R, 7 closed-
ches t dogs with 3 hr. LAD-O wsre examined up to I hr. R
by computerized tvo-dimensional echo (2DE). Short-axis
sections at the mid-LV level wsre iaaged in control, ,
hr. LAD-O, and 5. 15 and 60 min. post-R, using constant
gain settings and linear echo signal processing. 2DE ED
images were digitized and subdivided into 16
subendocardial (endo) and subepicardial (epi) regions.
Mean INT. skewness and kurtosis were calculated from
histograms in each region. Sub-epi snd sub-endo
myocsrdial biopsies in ischemic (I) and non-I (HI) zones
of a Ilid-LV transverse slab were obtained for
measurellents of water content, and % necrosis (H) was
evaluated by triphenyl-tetrazol1um (range 0 to 37.2%).
2DE lind excised LV sections were matched and subdivided
with atandardized referencing. RESULTS: Out of 112
segments, 34 had N>20% of the wall. Significantly
increased EDWT (>30% above pre-R) was found in 28/34,
31/34 and 29/34. at 5. 15 and 60 Ilin post-R (sensitivity
82.4, 91.2 and 85.3%; specificity 96.9 . 96.9 and 95.8%.
respectively). The sensitivity for increased endo-INT
(>20% above pre-R) was 83.6, 75.3 and 59.0%, and
specificlt)' 90.4, 88.0 and 86.4%. I zone sub-endo wster
content nceeded thst io HI (85.2% vs 79.5%).
CONCLUSION: Increased regional EDWT or endo-INT.
detected aa earl)' as 5 min after R••ay reflect
irreveraibly da.aged .yocardium, associated with
increased poat-R .yocardial wster content and presu.ably
rapid interstitisl and cellular accumulation of calcium.
2DE-C Method 2DE-E Method
R/S H202 R/S H202
56±3 bE9 b5±4f m9* 59±13
* = p<.05 . E method vs. C method.
Conclusion: Contrast-enhanced 2DE estimates of risk area
agree well with angiography. C method. which assumes
transmural extent of perfusion. yields a larger risk area
than E method. which exactly measures the transmural
extent of intramyocardial opacification.
USE OF CONTRAST-ENHANCED 20 ECHOCARDIOGRAPHY TO ESTIMATE
CORONARY RISK AREA: COMPARISON OF IMAGE ANALYSIS METHODS
Anne Taylor. MD; Robert Kieso; Jeffrey Melton; Natesa
Pandian. MD; Richard Kerber. MD. FACC. University of Iowa
Hosp ital. Iowa City. Iowa
Contrast-enhanced 20 echocardiography (2DE) may permit
in-vivo delineation of coronary risk area by selective
injection of contrast agents into the coronary arteries.
To define the risk area. 7 dogs had Judkins catheters
placed in the left coronary ostium. Two contrast agents
were studied: agitated 1:1 Renografin/saline (R/S) and
0.15% H202 . Short-axis. papillary muscle level images
were obtained during left main contrast injection while
the circumflex artery was occluded. permitting deline-
ation of the risk area of the left anterior descending
(LAD). The risk area was defined in each image by 2
ways: the "circumferential" (C) method. which considered
the whole transmural extent of any region to be opacified
even if only the subendocardial region brightened with
contrast. and the "exact" (E) method in which the precise
intramyocardial area opacified by contrast was measured.
Risk area thus obtained was compared to anatomic risk
area measured by postmortem an9iography of papillary
muscle level slices. Results (LAD risk area expressed
as mean %LV ± SO):
Angiography
DET!IlHINATION OF INFARCT SIZE I!'lKEDIATELY AND FOUR HOURS
POST CORONARY OCCLUSION: SUPERIORITY OF DIGITAL SUBTRAC-
TION CONTRAST EClOCARDIOGRAPHY TO WALL HOTION ANALYSIS
Steven R. West, MD; William F. Armstrong, MD, FACC;
James C. Dillon, MD, FACC; Harvey Feigenbaum, MD, FACC;
Indiana University School of Medicine; Krannert
Institute of Cardiology. Indianapolis, Indiana.
The purpose of this study was to compare the accuracy
of digital subtraction contrast echocardiography (DSC)
to wall motion analysis for determining infarct size.
Myocardial thickening (MY) and endocardial motion (EM)
were analyzed at 32 regions of the short axis scan of
the LV . Fifteen different level short axis scans from 9
closed chest dogs were studied immediately (/1) and 4
hours (/4) after coronary occlusion. Ultrasound contrast
was produced by aortic root injection of agitated reno-
grafin and saline. Echocardiograms were digitized in a
256 x 256 x 6 bit matrix. DSC was created by subtracting
the average of 3 pre-contrast field s from the average of
3 post-contrast fields. Total and non perfused myocar-
dial areas were determined by electronic planimetry.
Echo parameters (DSC, EM. MT) were compared to percent
infarct by nitro-blue tetrazolium (NBT) staining of the
corresponding slice of left ventricle. Results:
NBT vs DSC/I DSC/4 MY/I MT/ 4 EM/I EM/4
r D."9r o:"9r 0:57 0:2'8 0:68 0:38
SEE( r.) 5.93 5.03 12.4 14.5 11.1 14.0
p (.001 <'001 NS NS NS NS
There was no significant difference between the estima-
tion of infarct size by DSC immediately after coronary
artery occlusion and 4 hours post occlusion (r-0.94 ;
SEE-6.29%; p-(.OOI). We conclude that DSC accurately
determines infarct size and is more accurate than either
EM or MT. Furthermore, DSC performed immediately after
coronary occlusion accurately predicts eventual infarct
size.
Tuesday, March 27, 1984
lO:30AM-12:00PM Ballroom D
Echocardiography: Cardiac Function
COMPARISON OF NUCLEAR MAGNETIC RESONANCE AND ECROCARDIO-
GUPRY IN DETERMINATION OF CARDIAC DIMENSIONS IN NORMALS
Bruce J. Friedman, MD. John Waters. MD. Oi Ling Kwan. BS,
Anthony N. DeMaria. MD. FACC University of Kentucky,
Lexington. Ky.
No data exist regarding the ability of nuclear magnetic
resonance imaging(NKR) to assess cardiac size and
performance in man. Therefore. we compared the measure-
ments of cardiac dimensions by NKR to those obtained by
two-dimensional e~hocardiography(2-D) in 10 normals(BSA
ranges 1.37-2.11m ). NKR transverse cardiac sections were
obtained during ECG gating using a 90· radio frequency(RF)
pulse followed in 30 msec by alSO· RF pulse to elicit a
spin echo signal. The average time required to perform an
NKR study was 2 hours . Cardiac dimensions measured in
diastole includsd: aorta(AO). left atrium(I.A). left
ventricle(LVD). right ventricle(RVD). posterior wall
thickness(PWT). and septal thickness(ST). An LV systolic
dimension(LVS) and shortening fraction were also obtained.
Results in cm (mean~sd):
AO LA - LVD LVS RVD PWT ST
NKR 3.1~.5 2.9~.4 4.1+.7 3.2+.6 3.3+.5 1.1+.2 1.0+.2
2-D 2.9-:;.5 2.6-:;.5 4.6-:;.7 3.(!:.6 2.S!:.3 0.9!:.1 0.9!:.2
r .91 .94 .S5 .61 .SO .56 .61
LV shortening fraction calculated from these data was 20
+4~ for NKR and 35+5~ for 2-D. r =.61. Thus. in normal
subjects NKR yields a range of values for cardiac
dimensions of similar standard deviation to that of 2-D
echo. Heasurements by NHR correlate well with those
obtained by echocardiography for cardiac challber
dimensions. but less well for wall thickness. Failure of
NHR values for shortening fraction to correlate closely
with those of echo are probably related to the limitations
of ECG gating especially the difficulty of determining the
LV end systolic fr.... These data indicate that. although
technically cumbersome. NHR represents an alternate non-
invasive technique for the assessment of cardiac anatomy.
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FACTORS INFLUENCING ACCURACY OF TWO-OIlffiNSIONAL EC~OCARDIO­
GRAPHIC LEFT VENT:l.ICULA.1. IIASS ASSESSilENT
Benjamin Byrd, Ill, lID ; Iialter Finkbeiner, lID: Alain
Bouchard, lID ; Norman Silverman, 1m; Nelson !l. Schiller, lID,
FACC, University of California, 5an Francisco
To examine factors i nfluencing t he acc uracy of LV ~~ss
measured from clinically acquired (non-quantitative ) two-
dimensional echocardiograms (20E), hearts from 195 adult
autopsies over a one-year period were prospectively col l ect -
ed. Thirty patients were found who had 2DE within six
months of death and whose hearts were suitable for we igh ing.
Weights ranged from 69 to 535 g. 20E were grouped according
to technical quality, temporal proximity t o death and seg-
mental abnormalities. A previously val i da t ed algor ithm
based on a truncated ellipsoid was used to calculate LV
mass. Measurements were made by a senior echocardiographer
(OBS I) and a less experienced fellow (035 2). Of the 30
20E 7 studies were judged technically excellent, 7 good, 14
fair and 2 poor. Segmental wall motion abnormalitie s were
found in 7. Twelve studies were performed within 10 days of
death, 10 between 10 and 20, 3 between 20 and 30, 3 between
30 and 40, and 2 between 50 and 180.
20E measured by OBS I were highly predictive of aut opsy
mass (r=0.95, SEE-+/-IO.6g) for the entire group, whi l e
those measured by OBS 2 were less predictive (r=.83). £li·-
mination of technically poor and fair studies considerab l y
improved predictions of 035 2 (r=0.95) and slightly i mprov-
ed those of OBS I (r=O.9a). :urther elimination of 20E with
segmental abnormalities or 20E done more than 30 days before
death did not improve predictive accuracy.
~Ie conclude that LV mass can be accurately estimated from
cl i ni cal l y acquired 20E. Furthermore , measurements ftom
technically difficult 20E can be made accurately but requ ire
an experienced echocardiographer. Segmental abnormal ities
and remoteness of 20E from time of death did not adversely
influence predictive accuracy.
ACCURATE MEASURES OF CANINE LEFT VENTRICULAR VCl.UME DURItli
THE CARDIAC CYCLE BY THREE DIMENSIONAL ECHOCARDlOORAPHY
K1ll1im ~ Moritz, fhn; Alan S. Pearlman, MD, FACC;
Douglas K. Medema, MSEE; Donald W. Franklin, BA,
University of Washington, seattle, WA.
We have developed a method to measure the LV vol.une (LVV)
throughout the cardiac cycle using a series of two
dimensional echocardiographic (2DE) scans, and applied
this method to open chest, instrumented dogs during
cardiopulmonary bypass. To make accurate real time
measuremenb of actual LVV, we constructed a custan voll.Ule
chamber. The left atrium is opened, the mitral leaflets
excised, and a thin walled latex balloon inserted into the
LV. External pacing insures a constant heart rate.
Approximately 20 nonparallel transepicardial 2DE unages
are recorded with the simultaneous ECG. A transducer
locating system defines the position and orientation of
each 2DE scan plane relative to an external reference
coordinate system. Using the EGG for timing, 2DE images at
a given point in the cardiac cycle are chosen fran each of
the scan planes. The LV endocardium in each of these
images is then digitized to generate a series of data
points that describe three dimensional (3D) LV cavity
geometry at that instant in the cycle. LVV is then
calculated automatically. In a single dog paced at a rate
of 10, three observers digitized the 2DE images 3 times
each at 15 points during the cycle. Calculated LVV (CV)
fran the 3D echo reconstructions closely paralleled actual
LVV, (AV), which ranged from 48.0cc (end diastole) to
10.1cc (end systole). Linear regression was used to
cClllp8re s1JllJltaneously determined CV and AV. Analysis of
variance showed no significant interobserver differences.
In the 135 total studies, CY = 0.89 AV +3.2cc, r=0.966,
SEE=3.1cc. Of the individual CY':!, 114 (841) were wi thin
5cc of the AV. We conclUde that our method estimate:! LVY
accurately throughout the cardiac cycle.
RIGHT VENTRICULAR VOLUME IN-VITRO BY TWO-DIMENSIONAL ECHO-
CARDIOGRAPHY USING A NEW MATHEMATICAL METHOD
Jay C. Buckey. MD ; James M. Beattie, MD; F. Andrew
Gaffney, MD , FACC; J.V . Nixon, MD, FACC; C. Gunnar
Blomqvist, MD. FACC . University of Texas Health Science
Center, Southwestern Medical School, Dallas, Texas
A new mathematical method for determining ventricular vol-
umes has been described by Watanabe et al . Volumes are
estimated from multiple two-dimensional echocardiographic
views recorded from a single point at sequential angles.
To determine volume the product of sectional cavity area
and center of mass for 'each view is summed over the range
of angles us ing a trapezo idal rule. We tested this meth-
od on 10 normal formalin-fixed human hearts suspended in
a mineral oi I bath. Multiple (10 to 12) short axis RV
views at 5.0 0 intervals were videotaped. The images were
digitized by two independent observers ( leadi ng- edge to
leading-edge technique) and analyzed using a graphics
tablet and microcomputer. Actual RV volumes (x) were de-
termined by filling the chamber with water. These data
were compared to the mean of the two echo measurements
(y) . Mean volumes for the series were 57.8 ml actual and
55.9 ml by echo; the regress ion equation was y-.98x-0.7.
SEE=3.9 ml, r=.93. p<O.OOl. The slope and intercept did
not differ s ignificantly from I and 0 respectively.
Analysis of views obtained every 2.5 0 did not improve
accuracy. The indi vidua l volume (ml) data were :
Heart # 1 2 3 4 5 6 7 8 9 10
Actual 44.061.6 58.6 44.6 58.065.063.6 53.3 75.3 53.6
Echo 40.4 60.3 54.5 44.360.2 55.1 65.8 49.2 74.354.6
Interobserver variations were small (r-.85. SEE-5.5ml:
linear regression). The results show good accuracy over
a fairly narrow range of volumes despite the Irregular
shape and trabeculations of RV.
SUPERNORMAL LEFT VENTRICULAR FUNCTION IN ESSENTIAL HYPER-
TENSION : EVIDENCE FOR INCREASED CONTRACTILITY.
Subhendu Narayan, BS; Richard B. Devereux. MD; Elizabeth
M. Lutas, MD; Marianne C. Spitzer, Katherine Fleischmann,
BS ; Michael A. Zullo , MD; Jeffrey S. Borer, MD. FACC ;
John H. Laragh, MD, FACC. Cornell Medical Center , New
York, N.Y.
Supernormal resting LV function has been reported in some
patients wi t h essential hypertension. To eluc idate the
responsible factors, we used simultaneous echocardiography
and cuff blood pressure (BP) to as sess LV end-systolic
st ress (ESS) , end-systo! ic dimensi on (LVIDs) relationships
at rest and dur ing unloading by nitroglycerin . Since
these mea su rements incorporate LV after load and hyper-
trophy. and are independent of preload, an increased ESS/
LVIDs ratio and upward displacement of ESS-LVIDs lines
would provide evidence of increased LV contractility.
Seventeen as ymptomatic pat ie nts with uncomp licated essent-
ial hypertension (HTN) (BP 161 r Z(·/103.!. 15 IlIll Hg, age 4H
13 years ) were compared to 16 normals (NL) (BP lISt 14176
!6 mm Hg; age 311: 11 years. both p ~0.005 vs HTN). The
ESS/LVIDs rat io was higher in HTN than NL (24.3~ 5.8 vs
19.4:t 3.6 , p <.0.01 ) and 8 of 17 HTN (47% group A) had ES5/
LVIDs greater than any of the 16 NL (p~O.OOl). The slope
of the ESS-LVIDs line during nitroglycerin unloading was
also higher in group A hypertensives than in the remaining
9 hypertensives (group B) 09.6 x 103 dynes/cm3± 27. 1 vs
47. t-z: 20.1. p l..0.005 ) or in /1Ls (56. 7! 32.5). Group A
hypertens ives were similar to group B hypertensives in age
(43! 9 years vS 45 :t16 years, N.S .) and had sl ightly high-
er BP (l74t.32/108:t 19 mm Hg vs 149! 12/98 ! 9 mm Hg) in-
dicating that the results are not due to comparative youth
or mildness of HTN. We conclude that a subset of pat ients
with essential hypertension has evidence of increased LV
contractility at rest . which may be due either to intrin-
sic myocardial adaptation or an effect of humoral factors.
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YEAR- TO-YEAR VAR IA8lLl TY OF ECHOCARO t OGRAPH IC I1EASUREI1ENTS
IN NORMAL SUBJECTS.
Richa rd B. Deve reux, 110; Isaac ~!. Hammond, PhD; Eli zabeth
H. Lutas, HO; Marianne C. Spitzer, Michael H. Alderman MO;
John H. Laragh, 110, FACC. Cornell Medical Center, New
York, N.Y.
Echocardiography (ECHO) is commonly used in long-term
follow-up of patients with cardiac disease, but little is
known of the normal year-to-year variability of ECHO
measurements. To address this issue we studied 53 normal
subjects (31 male, 22 female) aged 19 to 64 years twice,
at a mean interval of 17 months. ECHOs were read blindly
to measure diastolic interventricular septal and posterior
wal I thickness (IVSd and PWTd) , left ventricular internal
dimension (LVIDd), LV Mass (LVll) and fractional shortening
of LVID (~ALVID). Systolic and diastolic blood pressure
(SBP and DBP) and heart rate (HR) were measured as hemo-
dynamic indices. Mean values of all measure~nts were
similar on Echo-I and Echo-2 but correlations between
paired measurements differed, being highest for LVll and
LVIDd and lowest for LV wall thickness and %ALVID (all
p40.01 to p40.OOOI).
ECHO-l ECHO-2 r MEAN DIFF. 95% LIMIT
SBP 119! 12 126:[ 13 0.58 II (9%) ,,20 mm Hg
DBP 77!:.8 78.1 8 0.57 6 (8%) !12 mm Hg
HR 70t. 12 66 t 10 0.79 6 (9%) rl2 beats/min
IVSd 0.9!' 0.2 1.0 i 0.2 0.38 0.1 (15%) !.0.3 cm
LVIDd 4.9!0.6 4.3tO.6 0.76 0.3 (5%) 1:0.5 ern
PIlTd 0.8! 0.2 0.3~ 0.1 0.49 0.1 (12%) ~0.2 em
LVM 162! 57 164~ 53 O.Cl 26 (16%) t.51 g
%ALV ID 35.t 6 36 t 6 0.46 4 ( 12%) t. 8 %
Analysis of the difference between measurements yielded
95% confidence limits to detect significant changes in
individual subjects. These confidence limits take into
account variability in echo technique and interpretation
as well as the effects of hemodynamic fluctuations.
Tuesday, March 27, 1984
8:30-IO:OOAM Room E4091410
Autonomic Effects on Arrhythmias
THE DYNAMICS OF QT INTERVAL CHANGES DURING VALSALVA
MANOEUVRE IN NORMALS AND LONG QT SYNDRl»lE
Ghazwan S Butrous, MB; David E Ward, MO, FACC; Anthony W
Nathan, MB; A John Camm, MD, FACC, St. Bartholomew's
Hospital, London, England.
The Valsalva manoeuvre (VH) at 20 mmHg for 20 sec was
performed in 18 control subjects, 3 index cases (2
familial) with long QT syndrome (LQTS) and 11 of their
first degree rel~tives. Beat to beat QT intervals were
measured from lead II of the ECG recorded at 25 mm/sec
during control and all four phases of VH. In control
subjects the measured QT (QTm) revealed a significant
decrease (356+40 to 331+32 ms, p<0.001) during phase 2
(sympathetic predominant) and a slight but significant
increase (361+32 ms, p<0.05) during phase 4 (para-
sympathetic predominant). After intravenous propranolol
(0.2 mg/kg) there were no significant changes in the QTm
during phase 2 (390+46 to 318+34 ma) but a significant
increase during phase 4 (406+39 ma, p<0.01) persisted.
Corrected QT (QTc) intervals-(control: 398+32; phase 2:
437+35, p<0.001; phase 4: 373+36 ma, p<0.005) closely
followed the pattern of RR interval changes during all
phases of VH (control: 807+180, phase 2:585+134 phase
4:991+180 ma). In the patients With LQTS the QTm
increased during phase 2 (467+18 to 500+20 ma). In the
relatives of familial LQTS there was a similar increase
in QTm during phase 2 despite a normal QT interval at
rest (430+10 to 445+30 ma), but in all 6 relatives of
the patient with idIopathic LQTS the QTm shortened
during phase 2. Beta-blockade normalized the VH induced
QTm changes in patients and their affected relatives.
The trend of changes in QTm (but not QTc) during phase 2
of VM are extremely useful in the diagnosis and follow
up Of patients with LQTS. VM detects latent cases of
LQTS among relatives of affected patients.
THE LONG QT SYNDROME
Emanuela Locati, ~IO; Arthur J. Moss, '10, FACC; Peter
Schwartz, MD, FACC; Richard Crampton, MD, FACC; Eric
Carleen, University of Rochester tledical Center,
Rochester, NY, Institute of Clinical Physiology,
University of Milan, Milan, Italy, and the University
of Virginia School of Medicine, Charlottesville, VA.
During the past four years we have enrolled and followed
prospectively 187 patients (pts) with the idiopathic
long QT syndrome (LQTS). This international registry
was undertaken to better understand the clinical
course of this unusual repolarization disorder with its
potential for malignant ventricular arrhythmias. The
criterion for LQTS registration was an idiopathic QT
(Bazett) > 0.44 sec.; 44% of the pts were identifiedc
during family evaluation of a propositus with LQTS
and 38% during investigation of a pt with unexplained
syncope. The average pt age was 24 yrs, mpdian 20 yrs,
with 64% female. Prior history included syncope 56%
(median age 1st episode 12 yrs), torsades de nointes
(TdP) or ventricular fibrillation (VF) 21%, mitral
valve prolapse 9%, and congenital deafness 5%. During
an average follow-up of 20 months per nt, the combined
syncope (n=26) and arrhythmic death (n=4) event rate
was 10% per yr. Six baseline clinical characteristics
were associated (p < 0.05) with post-enrollment
syncope/arrhythmic death (odds ratios): prior
syncope (6.5), VPB pairs (6.4), history of TdP (4.0),
absence of a family history of LQTS (3.8), QT > 0.46
(3.5), and multiform VPBs (3.4). Full dosageCof beta
blocking drugs or left stellectomy for refractory
TdP/VF generally provided effective therapy in the
management of high risk LQTS pts.
ELECTROPHYSIOLOGIC TESTING IN THE UPRIGHT POSITION:
IMPROVED EVALUATION OF PATIENTS WITH CARDIAC RHYTHM
DISTURBANCES USING A TILT TABLE
Stephen C. HammillRBMD~ FACC; David R. Holmes, MD, FACC;
Bernard J. Gersh, ch, FAcc; Douglas L. Wood, MD;
Michael J. Osborn, MD, FACC; Christopher McLaran, MS;
Declan D. Sugrue, MS, Hayo Clinic, Rochester, HN.
Patients are traditionally evaluated in the supine posi-
tion in the electrophysiology (EP) laboratory, although
symptoms due to a cardiac rhythm disturbance are usually
present clinically when upright. Assuming the upright
position results in dependent displacement of blood fol-
lowed by prompt vasoconstriction to maintain arterial
pressure. This normal response may aggravate tachyar-
rhythmias due to an increase in catecholamines or may
precipitate vasodepressor syncope if the vasoconstrictor
response is absent. We evaluated the use of a tilt table
during EP testing over 12 months in 104 patients, age 60
years (range 37-81), with supraventricular tachycardia
(SVT) (59 patients), vasovagal syncope (6 patients), and
carotid sinus hypersensitivity (CSH) (39 patients).
Twenty-three patients (22%) had significant abnormalities
upright that were not present supine: 1) Eight patients
with SVT had their clinical syndrome of palpitations and
syncope reproduced upright with minimal symptoms supine.
Two patients with SVT had sustained atrioventricular re-
entry upright with only 2-8 beats of tachycardia supine;
2) Six patients with syncope and a normal cardiac eval-
uation prior to EP testing had their typical spell only
after being placed upright during a vasovagal event; and
3) Seven patients with CSH had their clinical syndrome
reproduced with carotid sinus massage only when upright,
developing hypotension despite maintaining their heart
rate with sinus rhythm or pacing (vasodepressor response).
In 22% of patients, EP testing in the upright position
provided clinically important information not available
with standard testing in the supine position.
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CAROTID SINUS HYPERSENSITIVITY : EVALUATION OF THE
VASODEPRESSOR COMPONENT
Adrian Almquist. MDj Charles Gornick. MD; D. Woodrow
Benson.,Jr. MDj David G Benditt. MD, FACC; University of
Minnesota. Minneapolis. Minnesota
Carotid sinus hypersensitivity (CSH) comprises both
cardioinhibitory and vasodepressor components. Muscarinic
blockade (atropine. AT) usually reverses bradycardia. but
does not prevent hypotension. This study assessed whether
CSH vasodepressor effect is due to active a- ad r e nerg i c
wi thd rawal resulting in unopposed a -adrenergically-
mediated vasodilation. and whether hypotension can be
attenuated by the orally absorbable a - adr energ i c agonist,
Ephedrine. Five patients with predominant CSH vaso-
depressor component were studied supine at a fixed heart
rate (atrioventricular sequential pacing. rate: 80/min)
under the following conditions: 1) control; 2) AT alone:
0.04 mg/kg i.v.j 3) Combined AT and a- adr ene rg i c blockade
(propranolol. PROP: 0.2 mg/kg i.v.). and 4) Ephedrine
alone: 120 mg p. o , daily. Intra-arterial pressure was
monitored prior to and during 10 sec carotid sinus
massage. Maximum carotid sinus massage-induced changes
in systolic (SP). di~Stol1c (DP) and pulse pressure (PP)
are tabulated (mean~D).
Control ~ AT AT-PROP ~ Ephedrine
SP -41 18 -37 ± 8 -31 t 3 ( -17 ± 5'"
OP -23 t 9 -26 ± 3 -21 t 6 -13 t 6
PP -18 11 -11 t 8 -10 ± 2 -2 t 2'"
*p<O.OS vs Control (Student's t-test)
Both AT alone and combined AT-PROP failed to reverse
CSH induced hypotension. Thus. our findings indicate
that unopposed B- adr ener gi c vasodilation does not
account for CSH vasodepressor component. but that the
a -adrenergic agonist. Ephedrine effectively diminishes
hypotension. Consequently orally absorbable a- adr energ i c
agonists may be useful in attenuating vasodepressor
responae in CSH patients.
FOLLOW UP STUDY OF PATIENTS WITH SICK SINUS SYNDROME BY
PHARMACOLOGIC TOTAL AUTONOMIC BLOCKADE
Iwao Yamaguchi, MDi Takeo Kurusu, MD ; Tosh ihito Togo, MDj
Kaname Iida , MD; Yasuro Sugi shita, MD ; Iwao Ito, MD,
Uni ver s i t y of Tsukuba, Ibaraki, J apa n .
Thi s study was designed to evaluate significance of the
intr ins ic hea r t rate determination by pharmacologic total
auto nomi c blockade (TAB) (atropine 0.04 mg/kg and
propranolol 0.2 mg/kg, Lv.) in prognosi s of patients
with s i ck s i nus syndrome (555). In t his way 120 555
pat ient s were classified into 47 patient s with intrinsic
s i nus node dysfunction (group 1) and 73 pa t i ent s with
di sturbed autonomi c regulation of s i nus node function
(gr oup II)( the 1st study). Thirty eight!1 3 months
(mean±SD) later, the intrinsic heart rat e de terminati on
was repeated in 13 patients of gr oup I and 8 patient s of
group II , i n whom pacemaker had not been implanted ( t he
2nd study). All patients of group I and group I I in the
1s t s tu dy belonged to group I and group II r espe ctive l y
by t he i nt r i ns i c heart rate determinat ion in the 2nd
s t udy . In gr oup I corrected s i nus node r ec over y time
(CSNRT) and s i noa t r i a l conduction time (S t r auss ' s me t hod)
(SACT) of the 2nd study exceeded th eir r espective va l ues
of the 1st s t udy (before TAB: CSNRT 1256!3 24 msec -
2871±986 msec , p<0.0005; SACT 2l2 ±17 rnsec - 253±2l msec,
p<O.Ol ; a f te r TAB: CSNRT 2208±546 msec ~ 3268±508 msec,
p<O.Ol ; SACT 22l ±20 msec ~ 267±27 msec, p <O.Ol) . In
cont r as t , CSNRT and SACT of group II were unchanged .
Pacemaker implantation was required at t he period of th e
2nd study in 10 of 13 cases (77%) in group I because of
increasing frequency of intolerable central nervous
sys t em symptoms, but not 1n group 11 . In conclusion, SSS
due to i nt r i ns i c sinus node dysfunction is progressive
and t he i nt rins i c heart rate determination by TAB Is
useful to predict prognosis of SSS patients.
AUTONOMIC DEPENDENCE OF VENTRICULD-ATRIAL CONDUCTION .
James L. Pasquariello, MD; Robert J. Hariman, MD, FACC;
J oseph A.C. Gomes, MD, FACC: Philip Barreca, BSj Nabil
El - Sher1f, MD,FACC,SUNY Downstate and VA Med Ctrs,Bkl ynN~
Ret r ogr ade vent r iculo- a t r i a l (VA) conduction has been
shown t o be an i mpor t ant determinant of pacemaker-induced
" endl es s l oop" tachycardias and certain paroxysmal supra-
vent r i cul a r tachycardias (PSVT). We observed that pa-
t i en ts (pts) with no demonst r able VA con duction prior t o
i mpl anta tion of ce r t a i n t ypes of pacemakers may develop
" end l es s l oop" tachycardias due to ac qu i Si t i on of VA con-
duct i on afte r t he procedure. We tested the hypothesis
th at t he pr esen ce of VA conduc t i on is largely dependent
on autonomi c tone . We studied 18 mal e pts (52-75 yrs),
wit h no demons t r abl e VA conduction during ventricular
pacing a t cyc l e lengths (CL) s l i ght ly shorter than the
Si nus CL (range 600-920 msec) . I . V. atropine (A) 0.5-2. 0
mg and isoproterenol (I) 0.5-4.0 ug/min were given until
a maximal dose of the drug was given or a 20% increase in
heart ra te was observed. Injection of A produced 1:1 VA
conduc t i on in 44% (8/18) pts up to paced ventricular CL
of 4l 2±49 msec (range 310-500 msec). Infusion of I re-
su l t ed i n 1:1 VA conduction in 56% (10/18) pts up to ven-
t r i cular CL of 367!52 msec (range 250-430 msec). VA in-
t erva l s i n t hes e pt s wit h revers i bl e VA conduc t i on rang-
ed f rom 190 t o 290 msec . All patients who showed VA con-
duct i on following A s howed VA conduc t i on during infusion
of I , but not a l l pt s t hat responded to r responded to A.
Conc l us i ons : 1. The presence of VA condu ction is depend-
ent on autonomic t one in certain pt s . 2. Since VA condu c-
t i on may not be manifest under resting conditions, pts in
whom cer t a i n t ypes of pacemakers are contemplated, or
have sus pec t ed , but not inducible, PSVT should have stud-
ies whi ch in clude autonomic manipulation. 3. Infusion of
I shou l d be tr ied t o compl e t e l y rule out reversible VA
conduct i on.
Tuesday, March 27, 1984
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Clinical Factors in Hypertension
POSSIBLE r.OL E OF INCREAS ED BL OOD VISC OSITY IN TH E HEMO-
DY NAtl lCS OF HY PERTE NS IO N.
Richa rd B. Oev e re ux , MD; David B. Cas e , I'D; Michael H.
A l derm~ n , MO; Thomas G. Pi cke r in g , MO, PhD; Joan Lind, BS;
Holli s D. Kleinert, MO; Shu Ch ie n , rID; John H. Laragh,
MD , FACC. Co r ne l I Medical Cent e r , New York, N.Y.
~hol e bl ood v is cos i t y has bee n re po rte d t o be ele vated i n
_e l ec t ed pa t ie nt s wi t h ess e nt ial hype r tension . but the
app licabil ity o f t hi s fi nding to unsel ec te d pati e nt s o r
it s re la t ion to t he hemodynami cs o f es sen t i a l hyper t e ns ion
have no t been _t ud i ed . Accor di ng ly , we measured who le
b lood v i s cos i t y at s hea r ra t es f rom ~O t o 450 sccr l , and
~ s ti ma t ed ca rd i ac i ndex (CI) and to t a l pe r ip he ral re si st -
ance (TPR) f ro m echocar di ogr am and simul taneo us b lood
pre s s ure (BP) . Subj ec ts i nc lu ded 37 pa t ien t s with es sent -
ia l hype rt ensi on ( 70.' men) and 4C nor rno t e ns i ves (651 men)
dr awn f ron a large. we i I-c har ac t e ri zed adu l t emp loye d pop-
u la t ion. P<Jt ie nt s w i th hypert ens i on had h ighe r whol e
bl ood v i sco s i t v a t 450 seC
'
(4 . 1! . 5 vs 3 . 8 !. 6 cP o
p < O.OI ) , 225 sec r l (4 . 4 ±. 6 vs 4 .0 ~ .7, p <0.00 2) and 90
seC I (5. 5 1 . 6 vs 5.2 !.7, P <'O.OS) . Hema t ocr i t was no
h ighe r in hype rt ens iv e pa t ient s (44. 6 1 4. 0 /) t han i n nor m-
o t ens i ves (44. 3! 3.5 ) indi ca ti ng th a t i ncreased v i scos i t y
was due to o t he r fac t or s . Pat i ent s wi t h hype r tens i on had
s i gn i f i can t ly h igher BP ( 1 5 5 ~ 14/ 93 :1: 8 mm H'1 vs 12(, ~ 11 /7:;
!'7 , p<.O . OOl l and CI (J . 3 ! 1.0 Limin/ m2 vs 2. 8! O. B,
p <.0.02 ) I'd th four per cen t h i gher TPR . ~e conc l ude th at
I ) uns el ec t ed pa t i ent. wi t h ess en t i a l hypertens io n f rom
t he gener a l popu l a t ion have inc reased whol e bl ood Vi SC05 -
i t v : 2) t h i s is i nde pendent of hema to c r i t ; and 3) the mao-
n i t ude o f increase in who le bl ood v i s cos i t y is similar t ~
th at i n TPR in pa t i e nt s wi t h e ss en t i a l hypertension.
The re fo re, increased bl ood v is co si t y ma y playa sionifi-
cant rol e in mi Id essential hypert e nsi on . .
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ECHOCARDIOGRAPHIC LEfT VENTRI CULAR MASS TO DIFFERENTIATE
CHRONI C HYPERTENSION FROM PREECLAMPS IA DURING PREGNANCY
James A. Thompson, MD ; Ki ran B. Sa9ar, MD, FACC; Patri cia
M. Hays, MD ; Dwight P. Cruikshank, MD, Med ica l Col lege
of Vi roinia, Richmond, Viroinia.
Di fferent iat ion of preeclamps ia f rom chronic syst em ic
hypertension during pre9nancy remains an impor t ant
diagnosti c dilemma. Since chronic hypertension lea ds to
an increas ed left vent r icul ar mass , we post ula t ed that
pat ients with chronic hypertension durino preonancy
shoul d have an elevated left ventr icular ma ss, whereas,
pat ients wi t h preeclampsia wou ld have a norma l left
ventr icular mass. Therefore, we measured left ventri cular
mass with M-mode echocardiooraphy in 13 patients wi th
normal preonancy , 18 pat ients with chronic hypertens ion
(blood pressure> 140/90 in first t rimeste r ), and 11
patients with preeclampsia dur ino pregnancy (blood
pressure> 140/80 in third trimester ) . Sequent ial
measurements of left ventricular mass were made in each
trimester in chronic hypertens ives and normals; and in
the third trimester preeclamptics. All measurements of
left ventricular mass were made bl i ndl v without the
knowledge of the patients' cli nical status. Left
ve~tricular mass of 159 ± 16 r. (mean ± standard error of
mean) in patients with preeclampsia wa s simi l ar to left
ventricular mass of 150 ± 26 r. i n normal pat ient s. Left
ventr icular mass of 226 ± 44 G in patients with chronic
hypertension was s i9nificantly hioher than in pat ients
with preeclampsia and normal preonancy (P < 0.05) . In
chronic hypertension , the i ~c reas e in l eft ventri cule r
mass was noted in the first tr imester and pers isted
throuQh the postpartum per iod whereas in normals le ft
vent ri cul ar mass remained t he same t hroughout pre9nanc.".
We conclude that an elevated left ventricular mass in
the third trimester may be used to differentiate chronic
hypertension from preeclampsia durin9 pre9nancy.
CARDIOVASCULAR ADAPTATION IN ELDERLY HYPERTENSIVE
PATIENTS. Franz H. Messerli, MD, FACe; Kirsten Sund~aard­
Riise, BS ; Hector O. Ventura, HO; Francis G. Dunn, MD,
FACC; Edward D. Frohlich, MD, FACC; Ochsner Clinic and
Alton Ochsner Medical Foundation, New Orleans, La.
Cardiovascular function and structure were evaluated
with M-mode echocar-dfogr-aphy and by measurinp: systemic
hemodynamics (indocyanine green) as well as intravascular
volume (iodine 131-albumin) in 12 patients older than 6~
years of age with essential hypertension. These subjects
were matched with regard to mean arterial pressure (MAP),
race , sex , body height, and weight with 12 corresponding
SUbjects who were younger than 40 years of age. Results
were as follows : (mean + lSD)
Elderly - Young E<
MAP (mmHg) 114.4+16.7 113.0+16.2
HR(beats/m~n) 67.1~10 72.4~8.4 .02
CI(L/min/m ) 2.60+.48 3.38+. 52 .00001
SV (ml) 70.7~18.3 RB.3~23.2 .001
LVDD (em) ~.14+1.05 4.Q3~.72 NS
LVWT (cm~ 1.20+.14 .97+.23 NS
LVMI(g/m ) 169.2+~3 123+45 .02
RIPT 224.2+54.9 243.2!Q 6. 1 NS
HAP=mean arterial p;:-essure; HR=heart rate; CI=cardiac
index; SV=stroke volume; LVDD=left ventricular diastolic
diameter; LVWT=wall thickness; LVHI=mass index; R/PT=
radius/wall thickness ratio.
In t he elderly patient, cardiac adaptation to arterial
hypertension is characterized by left ventricular hvper-
trophy of the concentric type associated with a low car-
diac output resu1tinll: from reduced heart rate, stroke
volume, and impaired ventricular compliance. Since simi-
lar chan~es (althoup:h to a lesser degree) occur with ap:e
also in normotensive subjects, arterial hypertension seems
to act as a time accelerator and to reset the biolo~ical
clock . .
IS THERE A SEX DIFFERENCE IN VENTRICUIAR RESPONSE TO THE
SAKE SYSTOLIC BLOOD PRESSURE?
Allen, J.W., MD, FACC; J iao, P.H., MD ; Brooks, S.H.,
Ph.D.: De Quattro, V. , MD; Kim, S.J., MD, U.S .C., White
Memorial Medical Center, Los Angeles, California.
Epidemiologic studies have noted lower mortality in women
than men with the same pressure (P). It is not clear if
this difference is related to sex alone or other differ-
ences associated with sex. This study evaluates ventri-
cular differences associated with sex . 24 paired
observations between males and females with comparable
(P) were carried out. We obtai ned the following results :
MALES FEMALES DIFFERENCES PVALUE
ESF 394;::'110 304 + 90 88 ;::'171 0.017
=SBP 147 + 25 147 + 25 0.3;::'1.8 0.3
11.6 f2.2 =PWT 10.3;::'1.8 1 + 2 0.006
ESS 49! 12 45 + 15 4 f 2l 0.23
=AGE 54 + 10 53 + 15 1.2;::'9.6 0.3
numbers represent means;::. 1 S.D.
ESF~ End Systolic Force (P x ~end systolic radius2)
dynes x 103
SBP~ Systolic Blood Pressure (rom Hg)
PWTc Posterior wall Thickness (rom)
ESSe End systolic Stress ( dynes x 103)
C1112
Hales with similar (P) have larger ventricles with
greater intracavitary force leading to i ncr eased compen-
satory wall thickening to normalize wall stress. This
difference in ventricular response may account for some
of the differences in mortality and morbidity between
sexes and suggests that intracavitary force may be a
more fundamental predictor of complications of hyper-
tension.
HIGH PREVALENCE OF RENAL ARTERY STENOSIS IN HYPERTENSIVE
PATIENTS WITH CORONARY ARTERY DISEASE.
G.W . Vetrovec, MD, FACC; M.J . Cowley, MD, FACC; D.N.
Landwehr, MD; V.E. Parker, RN, FNP, Medical College of
Virginia, Richmond. Virginia .
To assess the frequency of renal artery stenosis (RAS) in
patients (pts) with hypertension (HBP) and/or renal in-
suffi ciency (RI) undergoing coronary angiography, screen-
i ng abdominal aortography was performed in 118 pts with a
history of HBP and/or RI. Single plane cine abdominal
angiography was performed immed ia tely following routine
coronary ang iography ut i l iz ing 20-40 ml of 76%reno-
graf in. Abdominal angiography was adequate for inter pre-
tat ion in 116 of 118 (98%) pts . One hundred and two pts
had HBP. 2 had RI (creati nine >1.5 mgs%) and 12 pts had
both HBP and RI (HBP/RI) . RAS ( > 50%) was present in 26
of 116 pts (23%) ; 18 of 102 (lB%) HBP pts , 1 of 2 RI pts
and 8 of 12 (67%) HBP/RI pts . Signif icant (s ign) RAS was
present in 22 of 73 (30% ) pts with sign coronary ar tery
disease (CAD) wh ile only 4 of 43 (9%) pts without CAD had
sign RAS. Associated sign decreases in ki dney size were
seen uni l aterally in 3 pts whil e 2 pts had bi la tera l ly
decreased kidney size with associated bilateral s ign RAS .
In conclusion: (1) Sign RAS was identi f ied in 30%of
pts with HBP and/or RI suggesting that more vigorous con-
sideration of RAS may be appropriate in HBP pts wi t h CAD .
(2) Abdominal ang iography i n conjunction with coronary
angiography appears to be a useful screen ing test for RAS
i n pts with HBP and/or RI.
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ASSESSMENT OF LEFT ATRIAL FUNCTION IN PATIENTS WITH
HYPERTENSIVE HEART DISEASE
Yasue Matsuda,MD; Yeichi Toma,MD; Kohshiro Moritani,MD;
Hiroshi Ogawa,MD; Takashi Fujii,MD; Michihiro KOhno,MD;
Toshiro Miura,MD; Masako Matsuda,MD; Reizo Kusukawa,MD,
Yamaguchi University, Ube, Japan
The simultaneous left atrial (LA) pressure recording
and LA and left ventricular (LV) cineangiograms were
obtained with a catheter-tip micromanometer. In 7 pa-
tients with hypertensive heart disease (HHD) , the ratio
of LV filling volume before LA active emptying to LV
stroke volume was significantly lower than that in 8
normal subjects (65±13 vs 76±7~,P<O.05), while the ratio
of LV filling volume during LA active emptying to stroke
volume was significantly higher than that in normal sub-
jects (35±13 vs 24±7~,P<O.05). The ratio of flow volume
(LV filling volume before LA active emptying - LA empty-
ing volume before LA active emptying) to stroke volume
in patients with HHD was significanly lower than that
in normal subjects (43±13 vs 57±9,P<O.05). LA work during
LA active emptying was calculated from LA pressure-volume
curve. LA work in patients with HHD was significantly
larger than that in normal subjects (274±lOl vs 94±42mmHg
·ml,P<O.OOl). The LA work also showed a significant line-
ar correlation with LA volume before active emptying
(r=O.73,P<O.Ol). The ratio of LV flow volume to stroke
volume correlated inversely with LA work (r=-O.57,P<O.05).
Thus in patients with HHD, the LV filling before LA ac-
tive emptying is impaired, which results from the de-
creased blood flow from the pulmonary veins to the left
ventricle, In these SUbjects, the LV filling volume dur-
ing LA active emptying is augmented. The LA function
during active emptying can be attributed to the Frank-
Starling mechanism. As a consequence, the atrium does
more work, the more blood is transported to the left
ventricle during LA active emptying.
IS CARDIAC FLUOROSCOPY OR THALLIUM SCINTIGRApHY A BETTER
DIAGNOSTIC TEST FOR CORONARY DISEASE THAN EXERCISE
ELECTROCARDIOGRAPHY IN WOMEN? Joseph Hung, MD, Bernard
Chaitman, MD, FACC, Jules Lam, MD, Jacques Lesperance,
MD, Georges Dupras, MD. Montreal Heart Institute,
Montreal, Quebec.
Cardiac fluoroscopy (CF), exercise-reperfusion thallium
(Tl) scintigraphy and exercise electrocardiography (SECG)
are common diagnostic tests for coronary artery disease
(CAD) in women. However, few data evaluate initial test
and order sequence which may determine the need to
perform more than one test. We performed each test in 92
symptomatic womenj the prevalence of CAD ~70' was 30'
(28 pts) and 16' (15 pts) had multivessel disease (MVD).
The predictive value of a positive or negative test is:
Pretest Post-Test Risk of CAD
vs pretest risk Risk of Test positive Test Negative
.p<0.05; tp<O.Ol N CAD SECG CF Tl SECG CF Tl
Typical angina 25 .60 .79 .81 .92 0* .22 .25
Probable angina 27 .30 .29.73* .80* .30 .12.11
Nonspecific pain 30 .07 .09 .17 .25 .06 .04 .04
Total 92 .30 .45 .67t.78t .16 .10t .11t
The risk of MVD increased from 16' to 30' with a posi-
tive SECG (NS) vs 65' and 73' when ~2 vessels were calci-
fied or ~2 Tl segments were abnormal (p<O.OOl). However,
<2' of pts had MVD if the SECG, CF or Tl were normal. A
stepwise discriminant analysis selected an abnormal Tl
scan, coronary calcification, and type of chest pain as
significant (p<0.05) predictors of presence or absence of
CADj fluoroscopic score, Tl score and extent of ST
depression in 14 leads were predictive of MVD.
Thus, SECG or CF provides sufficient diagnostic infor-
mation regarding disease presence and severity to pre-
clude further testing in women With typical angina. In
women with probable angina or those with nonspecific
pain, CF or Tl would be more useful.
Tuesday, March 27, 1984
8:30-10:00AM Room 8412/413
Exercise Physiology and Testing: The Ischemic Heart
EFFECTS OF SUSTAINED-RELEASE NITROGLYCERIN, DILTIAZEM, AND
THE COMBINATION ON INVASIVE HEMODYNAMIC RESPONSES TO MUL-
TISTAGE EXERCISE TESTING: Robert A. Bruce MD, Kenneth F.
Hossack MD, Fusako Kusumi MS, Barbara Day BS, and Toshiko
Kannagi MD, University of Washington, Seattle, WA 98095
FUNCTIONAL TRANSLATION OF EXERCISE RESPONSES FROM GRADED
EXERCISE TESTING TO EXERCISE TRAINING
Carl Foster. Ph.D.; Michael L. Pollock, Ph.D., FACe;
Sheila M. Sennett, B.S.; John Hare, B.S., University of
Wisconsin Medical School (Milwaukee Clinical
Campus)-Mount Sinai Medical Center, Milwaukee, WI
SRN increased aerobic capacity and lowered peripheral re-
sistance and systemic pressure more than D. Additional
fall in resistance and pressure without further increase
in cardiac output with C demonstrated interaction. Two
patients receiving C and 1 patient receiving D had sympto-
matic hypotension which stopped the study with this treat-
ment regimen. In conclusion, excessive lowering of blood
pressure by combined vasodilator therapy did not relieve
myocardial ischemia or improve ventricular performance.
The prescription of a target heart rate (THR) for
exercise training (ET) from graded exercise testing
(GXT) is an accepted practice. The estimation of steady
state pace for level ground ambulation during ET based
on responses during incremental uphill exercise from GXT
is, however, less systematized. The purpose of this
study was to evaluate the relationship between THR
observed during GXT and the ET pace reqUired to elicit
THR. Forty-one participants in a preventive/
rehabilitative ex~rcise program performed a total of 77
exercise procedures consisting of GXT (Bruce protocol)
and ET (20-45 min) performed within 1 week. The
relationship between the pace during ET and the time
during GXT that the ET THR was observed was evaluated
using regression analysis. Resting, maximal and ET HR
was 74 + 19, 163 + 23 and 135 + 21 beats/min. ET HR
represented 67 + 22 %of maximum heart rate reserve. ET
pace (min/mile)-was well correlated (r =0.83) with the
time during GXT that THR was observed and could be
predicted from the equation:
ET Pace(min/mile) = 20.8-0.97 (Time (min] Ouring GXT)
The results of this study indicate that, in addition to
allowing computation of a THR, the results of GXT may
also be used to prescribe a pace for level ground
ambulation during ET that will yield this desired THR.
This functional translation of GXT response may improve
the precision of exercise prescription and allow for
improved safety and compliance in ET based preventive/
rehabilitative programs.
C(4)
+20
+18
-32**
-42**
-7
D(5)
+4
+6
-4
-9
-8
SRN(4)
~
+17
-23*
-32***
-2
Acute effects of placebo (PS), sustained release nitrogly-
cerin (SRN) , diltiazem (D) capsules, and the combination
of both drugs (C), were monitored in 9 stable angina pa-
tients. They were randomized to receive either PL or 13mg
of SRN, orally (double blind). This was followed in an hour
by 120mg of D orally, given to all patients (unblinded).
Invasive hemodynamic measurements were made before and
after each treatment at supine and sitting rest, 2 levels
of submaximal, and at maximal exercise and twice in recov-
ery. Age and systemic pressure differences in patients
receiving PL or SRN prompted evaluation of percentage
changes at maximal exercise (from control values to treat-
ments). Significance was determined by unpaired t tests.
(*p <.05, **p <.01, ***p <.001).
(n) PL(5)
Oxygen uptake -3
Cardiac output -3
lIean systemic pressure +2
Peripheral resistance +5
Mean pulmonary artery pressure 0
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IMPROVED ACCURACY OF THE EXERCISE ELECTROCARDIOGRAM:
ANALYSIS OF PEAK RATE-RELATED CHANGE IN ST SEGMENTS
Peter M. Okln, MD; Paul Kllgfleld, MD, FACC; Harvey
Goldberg, MD; Jeffrey S. Borer, MD, FACC, Cornell Medical
Center, New York, N.Y.
'1REAIJULL S'lRmlS 'lES'l'DI; IN GBUA'1RIC PATIEN1S
&-opel Yasilgmoolokis. MD, Andrei DIImian, MDI
Gregory Mahan, 11)1 Dicran Baron, MOl Myrvin Ellestad,
MO, FAa:. Img Beam Memorial Hospital, tbiversity of
California, Irvine, CA
we concluae that in both age groups the above para-
_tars carry sJailar sensitivities and specificities
foe CAD. 'Ibe only exception is a low specificity
(high false positivity) of Sf S8CJIeIlt depcession in the
~ 65 grc:q». '!be other uained parllEters being more
specific~ permit correct classification of patients
with abnomal gr~ respcnse in the geriatric
population.
22\
841
26'
m
ApgiQlQ
25t
lOOt
40t
91\
7C1t
67\
sensitivity
Sp!C1 ficitv
sensitivity 63' 2llt
Srw;ificit.y 2ft llfit
TreacDill stress testing (TST) in evaluating coronary
artery disease (CAD) is well established for young and
middle-eged populations. In order to assess its role in
o1dIr populations, we CCJlPIed the IBKilun TST and
coronary arteriogr.. of 70 pta aged~ 65 years (mean
69 years) with 85 pta aged < 65 years (mean 49 years) •
1tI:IIomal par-.eters eamined were: ~ lID Sf Ile(JlIl!I1t
depcession (ft), increase in R wave height (R),
decrease in o--w hei~t (0), and presence of ~ina
with exercise. '!be results are:
9>65 ST R
9 < 65
When conventional diagnostic criteria are employed, exer-
cise electrocardiography has relatively poor specificity
and predictive accuracy for three vessel and left main
coronary artery disease (CAD). However, ECG evaluation
using linear regression analysis of the peak rate-related
change In ST segment depression (ST/HR slope) recently
has been reported to accurately distinguish patients with
no disease from those with CAD, and to accurately separate
patients with one, two, and three vessel CAD. To assess
the applicability of this method, and to compare It with
conventional Interpretation, we retrospectively evaluated
50 patients In whom exercise ECGs and coronary cineangi-
ography had been performed for suspected CAD. We used a
modified ST/HR slope analysis limited to leads V5, v6, and
aVF. There were 18 patients with three vessel (3v) or
left main (LM) CAD (> 75% luminal narrowing), 22 with two
vessel, 6 with one vessel, and 4 with no CAD. Standard
ECG criteria (> O.lmV horizontal or downsloplng ST
depression) IdentIfied 3v-LM CAD with a sensitivIty of
78%, specifIcity of 56%, and positive predictive value of
only 50%. Peak ST/HR slope crIteria (~6.0~V/beat/mln)
Identified 3v-LM CAD with a sensItivity of 78%, specifici-
ty of 97%, and positive predictive value of 93%. Overall
test accuracy using measured peak ST/HR slope was 90%,
compared with 64% for standard ST segment depression
criteria. We conclude that analysis of the peak ST/HR
slope can markedly Improve the diagnostic accuracy of
exercise electrocardiography, and that further prospective
study of this method Is IndIcated.
Tuesday, March 27, 1984
10:30AM-12:00PM Room 8412/413
Myocarditis
Conclusion: In chronic myocarditis, clinical and hemody-
namic improvement can occur on immunosuppressive therapy
without histological improvement on biopsy, suggesting
that inflammation may not be the direct cause of
myocardial dysfunction in chronic myocarditis.
DISCORDANCE OF CLINICAL AND HISTOLOGICAL RESPONSE TO
THERAPY IN CHRONIC MYOCARDITIS. Janet E. Strain, MD;
Richard M. Grose, MD, FACC; Cary L. Hirsch, MD: David
C. Kramer; Sangho Cho, MD; Stephen M. Factor, MD, FACC,
Montefiore Medical Center, Bronx, New York.
Endomyocardial biopsies(B), clinical, and hemodynamic
data were compared in 7 patients(pts) with chronic myo-
carditis(M) before and during immunosuppressive therapy
(1ST) with prednisone and azothioprine. B were initially
performed for worsening idiopathic congestive myopathy
of 4m to 4yrs duration (mean 11+15m). Band cath were
repeated after 7+2 wks of 1ST, ;ithout changes in other
medications. At-repeat study 5 of 7 pts had marked im-
provement in NYHA class (NYHAC) and LV ejection fraction
(LVEF). Despite functional and hemodynamic improvement,
there was no corresponding B-evidence of lessened infIam-
mation(I) with 1ST. Neither a numerical index(NI) of the
activity of I, which examined number of I cells, degree of
cells necrosis, and interstitial edema(score 0-4 for each,
max score=12); nor the number of mononuclear celIs(MC)
per high power field averaged from 5 HPF changed signifi-
cantly on 1ST in responders or non-responders. (mean ~ SD,
*:p 0.05)
Non-Responders
pre-1ST on-1ST
3.3+.3 3.3+.3
16+ 4 15+ 3
Io±: 3 8.3~ 2
49~19 47~ 5
Responders
pre-1ST on-1ST
2.8+.4 1.4+.5*
24+ 9 43+17*
6.4+.5 6.6+2.3
4o±: 9 43~19
NYHAC
LVEF
NI
MC
The extent of ST-segment depression (ST.) relative to the
increment in heart rate (tHR) during exercise electro-
cardiography (ExECG) was recently reported to accurately
predict the presence of coronary artery disease (CAD) in
angina patients (pts), including those on beta-blockers
(BB). We studied the effect of 6HR on the sensitivity of
ExECG in 65 patients, all with a history of exertional
chest pain. The prevalence of CAD (> 70% narrowing of
one or more major vessels on contrast angiography) in this
subset was 69% (45/65). Chest pain occurred during tread-
mill testing (Bruce protocol) in 44% (20/45) of pts with
CAD and in 25% (5/20) of non-CAD pts, and was attributed
in 3 of the latter 5 cases to documented coronary spasm or
mitral valve prolapse. Seventeen CAD pts (38%) and 8 non-
CAD pts (40%) were on BB during ExECG. Results were:
INDEX CRITERION SENSITIVITY
(+) ExECG Total pts BB pts non-BB pts
ADJUSTING FOR HEART RATE INCREMENT IMPROVES SENSITIVITY
OF EXERCISE ELECTROCARDIOGRAPHY IN EXERTIONAL CHEST PAIN
Chongxuan Gao, MD, Rudolph H. Dressendorfer, PhD, Seymour
Gordon, MD, FACC, Gerald C. Timmis, MD, FACC, William
Beaumont Hospital and Oakland University, Michigan.
ST. > 1.0 mm 76% 53% 89%
ST./6HR > l3xlO- 3 93%* 94%** 93%
ST integral > 10 ~V.sec 58% 29% 71%
ST integral/tHR > 7.5xlO- 2 91%** 82%** 96%*
*p<.05, **p<.Ol vs index without 6HR.
The use of 6HR did not significantly alter specificity,
which was 50% for ST./6HR and 60% for ST integral/6HR.
CONCLUSIONS: 1) In this subset, exertional chest pain was
a less sensitive predictor of CAD than ST.. 2) Adjusting
for 6HR significantly improved the sensitivity of ExECG,
especially in pts on BB therapy. 3) The computer-derived
ST integral yielded no diagnostic advantage over
conventional ST-segment analysis.
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COMPUTER ASSISTED QUANTITATION OF MYOCARDIAL FIBROSIS
IN HISTOLOGIC SECTIONS OF HUMAN HEARTS
Robert H. Hoyt, MD; Elizabeth E. Ericksen, BSEE; Steve
M. Collins, PhD; David J. Skorton, MD, University
of Iowa and Iowa City VA, Iowa City, IA.
Histologic characterization of abnormal myocardium
may require estimation of the collagen (C) content
of the specimen. Methods of quantifying C include
hydroxyproline (H) assay and measurement of the relative
areas of C and muscle from histologic sections (HS).
We developed a computer-assisted method for deter-
mination of C from HS which also allows assessment
of the spatial distribution of C. Full thickness
segments of normal or fibrotic left ventricular myocar-
dium from 10 human hearts were divided into portions
for H assay or for trichrome-stained HS. The HS were
analyzed using a computerized microscopic video analysis
system. The sections were transi11uminated using
a green filter and digitized into a 512x512 pixel
matrix with 256 gray level quantization. The images
were segmented into C and muscle regions using a gray
level thresholding technique. The percent C by image
analysis was compared to that from H assay.
Results: Awide range of C, from normal (5 ~q H/mg
dry weight) to fibrotic (38 ~g/mg) myocardium was
studied. C from analysis of HS strongly correlated
with H (r=.98, p<O.OOI), with excellent intra- and
interobserver concordance (r=.99 and .99 respectively).
Results were unaffected by variations in histochemical
staining. We conclude that accurate quantitation
of myocardial C may be obtained from HS using image
analysis techniques. This approach also allows the
characterization of the spatial distribution of collagen
in histologic sections and may be useful in the patholo-
gical study of abnormal myocardium.
~ CI' IJft W!WIlDIR 1IbIMi:mM lIIIml~ MD!I aIaSIC
DDJIIlI"'S D,.-.s IIIIIr
Jc.o~~ !!!i. AlIa &a1ft8D, IUl; SeDdra Lima; iklbert Adua, M;
iklbert a-l, 1lVK; A1.lIIJ. a-.r, IUl; 'DIau8~ FtlD;~ L.
Ve_, IUl, PJa:, JoID IIopdm thiW1'llitiY, llIlt1Jlol'll, mI RIAID, llDI,
Bett.da, Ii!.
Recent studies Sll(p8t that intracellular T. cruzi invuion with
re~ of int;..,.llular~ III1t1411m dur1JIg 1. cruzi infection
18 CNCia! to the pathopllesl8 or chronic Chapa myocarditis.
IIowenr, in anu tIIldeaic tor Chapa di_, the incidence of
clinicel Ballll QlIpe ~t1a ill low ucag intect.! iD1ivicluala
wbile the 1.ncidIIIoe or chranic a..- ~t1a ill h1&ho 'DuI.
either &alta a..- ~t1a~ coaplicata T. crun infectiOll
and 18 not i_portaDt to the pathopneel8 of chronic Chapa
..,ooarditill, or Balta 0lIllII8 a,yocard1till~ iapail'll IX f\mctiOll
III! 1hef8tol'Il ca.- IlD~ To thill ~tion 118
inDoculated T. cruzi fro- • buaan Chapa dilltue cue into the
llUbconjuntive ot 6 RhltllUS aonDTs (7.5 x 1C)] parasites each).
Puuit.ia ..ntored intectia1 mi neIdy 2Il~ (enHIilllltolic
and trectiOllal chaDp in area, EllA lUId PCA) quantified global LV
fllllctiOll tor 10..... BIcUml IX f\mctiOll ... ....c by visal
~ ot 2D -=!IDee. Ed&t ot aculll ~it1a ....tabl.illlwd at
lW~. All...a,. bill tM ltluiia s1gn mI detectable s-r-i.tamia
in tala 2nd.... PaJm~ rme in ell by1he 9th ... (_ • 1.8
x 10' pBnBi-..'al); 4 ....,. la.t ..14ltJt (_ • -13), :5 died mI :5
1IWN e-critiald. 2D echo DlA. mi Jl:l -u.d~~ OllIItrol
to tbe lut atvdy witlW1 12 houra ot d.th (EDA • 2.6 + .9 to 2.7 +
1.0 ca2, PCA· eo + 6.8 to 74 + 7.6~, lIS). At autoJlll1' 2"had linen;
801111~t1a TlU bill belii IIllCr'1t:I.c.t 111Ul IlD~ lc8) 111Ul
aNIImt inu-llular 1'. crus1. (1 _t or 1'. e:ru&i/aI- ot II,JOCardiIa
nctionad). Two had lIOden.te lUId 2 aUd acute _;yocardiU.. In
olDihwlen cute a..- ~t1a IIII;J be -.roe after 'l:. crun
intecti.oD, Jet _ IlD in IX 1\mction dlBpita~
inu-llular 'l:. Cl'UBi imMkII.
TREATMENT OF CHRONIC ACTIVE MYOCARDITIS WITH
IHHUNOSUPPRESSIVE THERAPY.
George A. W1lliama, MD, FACC, Hartin W. Schwarze, D.O.,
Harold L. Kennedy, MD, FACC, Diane Palaer, MD, Charles C.
Tsai, MD. St. Louis University, St. Louis, HO.
We evaluated 6 pts with chronic cardi~opathy during
the course of their illnesses of 1-9 years duration who
were found to have chronic ·act i ve myocardit1s diagnosed
by lymphocytic 1nfiltration and cell destruction on
endomyocardial biopsy. Subsequently, theae pts were
treated w1th Imuran/Prednisone for 6-16 months. Sequen-
tial biopsies were performed at 1, 3, 6 and 12 months to
evaluate response to therapy. Clinical status, right
heart pressures and echocard1011'1III8 were IIOnitored.
Results: Five patients had increases of at least one
funct10nal class. Reduction of diuretics was possible
w1th a simultaneous fall in wedge pressure. The biopsies
of all 5 showed a marked reduction ot the infl....tory
1nfiltrate and no further active necrosis. Two of the
five had sudden deterioration and died at 10 and 16
IIOnths. Their biopsies showed progressive myocardial
hypertrophy and fibrosis and were ind1stinguiahable from
congest1ve cardiomyopathy. One patient deteriorated
progressively and treatment was stopped at 6 months.
Repeat b10ps1es did not 18prove in th1s pat1ent.
Baseline echocardiogrU18 showed enlarsed, diffusely
hypok1netic LV's. Echocardiographic LV aize and function
did not improve with therapy but docu.ented deteriora-
tion.
Conclus10ns: 1) r.aunosuppression can iaprove the
funct10nal status of patienta with chronic active
myocarditis, but it My be transient. 2) Noninvuive
par_ters were not as uaet\ll as sequential biopay and
h8lllOC1ynulics for monitorina of progreaa. 3) Sequential
biopa1es imply that low grade myocarditis MY be a
precursor of end stage congestive cardia.yopathy.
T1OM:NI)1A DOaD (')R)llJoff1PA1l!Y: A 1£VERS1ll.E RJlM IF LEFT
VOORIQI.JR DYSFIICTIlK
~ h Packet", 14); Qlst H. 8a1~, 14); Jdr1 J. Gall~", 14l,
rtIOtley, 14); Mallt S. SmiU1, foil; LawleIU D. Getman,
MD. ~ ~ivet'Si1;y Med1ca1 eentet", IM_, N.C.
we plesent 9 petients (age 5-57) wUtl clinically signiffcant LV
~fwtctian pteslllld til be ,elated til lftXIlttolled ~tanatic
t.actDat~1 of 25-41 (Elrl 14) yeats a..ticn. Ef~ of 9 had
incessant taet\ycal'dil fOI' 0.5 to 6 hllean 2.6) yea,"$. One had
ectopic atl"ia1 tacllYcll'dia, 7 hid accessolY aU"ioventl"iculal"
p.lthways, and 1 had ventl'fcula," ~~L Seven InIetlllellt
SUt9!tY, a.1ng which a focus rK ~ic 1:actl)Cal~a was ablated
in 2, and ., ltCl!SSOly pa~ was divided in 5. Two InIetlllellt
ab1atilll of 1tle AV cxnb;tilll ~ta Six of 9 Ml ~1l1al
biqlSies, IlCIlI! of wtlich yie1d1d a specific pathological diagnosis.
Racltoru::licle angiC9W was pefat.t III all patients iMedfately
befol1! and 11-51 (IlIeIn 24) IIOIlthS aftet· sul-geIY. LV function
iqllvved .,bdly fn 7 of 9 at lest and in ., adltftiCNl patient
cb1ng ecetcise. Ovet.ll, 1tle ejectflll n'lCtflll ,ose nan 19 + 9
It.. 10- 35) in 1tle baseline state to 44 + 14 It.. 22-58lat
late follOll\4l (p<.(m). Ei91t patients 18IllIfn ~tanatic 11-51
(1llIall 24) IIlIlU1s 1Iftl!l. Ule conect1~ lllueQlle .., ha'tIe IfllIlled
1lCt1la1 actiYities. we QlIlC1ude 1tlIt significant LV ~fIItct1l1l
~ follow chtUlic lIlCalttolled tlICttatdta .., is 'evet'Sib1e in
sc.e cases aftl!l . lXIItlol of Ule atltt'bill.
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MULTIPLE FORMS OF PLASMA CREATINE KINASE INDUCED BY
PLASMA EXHIBIT MARKEDLY DIFFERENT PLASMA CLEARANCE RATES
Samuel George, M.D., Yuichi Ishikawa, M.D., Robert
Roberts, M.D., FACC, Baylor College of Medicine, Houston,
TX
Creatine kinase (CK) isoenyzme MM exists in tissue as a
single form (MMi~' but upon release into plasma exhibits
3 forms and MBl.l\ exhibits 2 forms. We noted previously
that purified tissue CK has a much shorter plasma ti than
plasma MMCK. To further characterize the conversion and
determine whether plasma clearance of CK is altered, the
3 plasma forms of MM were purified by alcohol extraction
(25%), fractionation on Sephace l-DEAE followed by chroma-
tofocusing. Purified canine myocardial CK (M~t) incu-
bated with plasma (l hr) exhibited 3 forms, MM'"-3, MM-2
and MM-1. Peptide mapping showed MM to be identical to
MM-3. but MM-l and MM-2 were differeht from MM-3 and each
other by at least one amino acid. Separation of MM-2 into
subunits by 4 M urea and random reassociation led to 3
forms: MM-l, MM-2 and MM-3. Bolus intravenous injections
of purified tissue MM (MM-3) into the dog exhibited a tl
of 1.8 hrs due primarily to sequential conversion into
MM-2 and MM-1. In contrast, bolus intravenous injections
of MM-l exhibited a tl of 3.8 hrs and remained in the
form of MM-1. Serial blood samples were analyzed for
multiple CK forms before and after coronary artery occlu-
sion in the dog . MM-l and MM-2 (>90%) predominated in
control samples . After coronary occlusion, MM-3 markedly
increased (>80%) and over 4-6 hrs converted into MM-2 and
MM-l . Thus, loss of a positively charged amino acid from
1 subunit results in MM-2 and from both subunits, MM-1.
This alteration prolongs the plasma ti and must be taken
into account in estimating infarct size from plasma CK.
Since release of MM-3 reflects recent injury, its detec-
tion and quantification provides an objective marker to
indicate onset of infarction.
Pt. 3Pt. 2Pt. 1
an- eu ocy e 0 6 29
OKT 11 (Pan-T) 0 6 22
OKT 4 (T-Helpers) 3 5 9
OKT 8 (T-Suppression) 2 1 32
B1 (B-Iymphocyte) 0 0 1
Ba1 (B-lymphocyte) 0 0 1
HNK 7 (Natural-killer) 3 6 11
The IPX technique allows more accurate identifi-
cation of lymphocytes in EMB. Long-term studies
of larger pt. populations may define lymphocyte
sUbpopulations with prognostic implications.
IMMUNOPEROXIDASE FOR THE IDENTIFICATION OF
LYMPHOCYTES IN ENDOMYOCARDIAL BIOPSY
SPECIMENS
Bruce M. McManus, James Linder, Thomas D. Sears,
william C. Rogler. Cardiovascular Registry,
University of Nebraska Medical Center, Omaha, NE.
Counting inflammatory cells in endomyocardial
biopsy specimens (EMB) is difficult and unless
electron microscopy is used, requires subjective
interpretation. Considering the therapeutic im-
plications of such counts, accurate counting
methods are paramount. We have applied the im-
munoperoxidase (IPX) technique with monoclonal
antibodies to lymphocyte surface antigens to
accurately enumerate the number and subclasses
of lymphocytes in EMB from 3 patients (pts) with
clinically suspected myocarditis. These data are
summarized in Table 1.
Light Microscopic Count
Total Section 17 17 25
m oc e nt en
Tuesday, March 27, 1984
8:30-10:00AM Room S411
Experimental Myocardial Infarction: Assessment of
Infarct Size
KINETIC PROPERTIES OF CK ISOENZYME SUBFORMS (ISOFORMS)
RELEVANT TO DATING THE ONSET OF IRREVERSIBLE INJURY
Hidekazu Hashimoto, MD; Ann M. Grace, MA; Richard W.
Gross, MD, phD; Arnold W. Strauss, MD; Burton E. Sobel,
MD, FACC, Washington University, St. Louis, Mo.
To determine whether subforms of individual CK iso-
enzymes (isoforms) detectable in plasma after myocardial
infarction are present in myocardium itself and whether
the kinetics of their formation in plasma are consis-
tent enough to render plasma isoform analysis amenable
to dating the onset of necrosis, we developed a chro-
matofocusing procedure that permits quantification of
isoforms free from distortion due to denaturation en-
countered with conventional analytical techniques.
Contrary to the case when denaturing methods are used,
MM CK from normal or necrotic dog heart was found to
consist of essentially one isoform, MMA (PI = 7.91 ±
.01 [SEJ) (> 95S). When purified MMA (400 IU/kg) was
injected i.v. in conscious dogs (n = 4), peak activity
(average = 7 IU/ml) and disappearance rates corresponded
closely to those after infarction. Two subforms, MMB
(PI z 7.74 ± .02) and MMc (PI = 7.51 ± .02) appeared as
a function of time. Thus, for example, MMc at 1, 2, 6,
and 10 hr increased from 0 to 4, 16, 63. and B3S (SE( 5S for each) in vivo; values similar to those during
incubation for the same intervals i n vitro (B, 25, 77,
and 93S). Incubation at 370 of MMA with plasma from
each dog (B IU/ml) resulted in parallel curves for each
dog in vivo and in vitro of sequential and irreversible
conversion (MMA first to MMB and then to MMC)' Specific
activity (IU/mg of RIA detectable protein) was the same
for all 3 isoforms. Thus, kinetics of isoform formation
in plasma are suitable for dating the time of onset of
irreversible injury associated with initial and re-
current infarction.
F OllOWING EARLY REPERFUSION, All THE CREATINE
KINASE DEPLETED FROM THE NECROTIC MYOCARDIUM
APPEARS IN THE BLOOD
Yuich i Soto? MD; Toshiyuk i Degawa, MD; Kazush ige lsojirm,
MD; JOCOb -Rlt. MD; Michael C. Fishbein. MD. FACC; David
L Korsbner, William E. Shell, MD. FACC; William Ganz, MD.
F ACC, Cedars-Sinai Medical Center. los Angeles. CA
Previous studies suggested that only 15-30% of creatine kinase
(CK) depleted from the necrotic myocardium appeared in the
blood while the coronary artery rerroined occluded. Recent
studies reported that CK release into the blood was markedly
enhanced by reperfusion. In this study, we explored the effect
of reperfusion on CK release. In 14 anesthetized dogs, the
coronary artery was occluded for 4 hours and reperfused for 20
hours. Blood samples were obtained hourly for CK determina-
tion. The heart was cut into I em slices and biopsies Vl'ere
taken perpendicular to the cut surfoce from both the necrotic
and nor I'T'Q I subendocardium. The biopsies showed a 96% CK
depletion. Infarct size (IS) was determined by the triphenyI
tetrazolium chloride staining method and corrected for a 34%
increase in water content. Total myocardial CK depletion was
determined by multiplying IS by the CK content in the norl'T'Ql
tissue. The amount of CK appearing in the blood was
determined using the one-compartment model with a CK
disappearance constant of -0.OOJ9/min. The constant was
determined in 6 dogs following injection of CK rich plasma
harvested fram donor dogs. Plasma volume was measured with
99mTe-Iabelled red cells. A near identity of the amount of
CK depleted from the myocardium with that appearing in the
blood was found in 14 dogs with a correlation coefficient of
0.96. Tbos, all the CK depleted from the necrotic myocardium
-is washed out by early reperfusion into the blood without any
detectable inoctivation. This should allow accurate measure-
ment of IS following reperfusion.
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THE EARLIEST APPROPRIATE TIME TO ASSESS MYOCARDIAL
SALVAGE FOLLOWING REPERFUSION BY MEASUREMENTS OF
REGIONAL CONTRACTION ABNORMALITIES
Roberto V. Haendchen, MD; Daniel T. Lang; Jan loordsij,
BS; Michael C. Fishbeln, MD, FACC; Samuel Meerbaum, PhD,
FACC; Eliot Corday, MD, FACC, Cedars-Sinai Medical Ctr.,
Los Angeles, CA
Slow recovery of LV function following reperfuaion (R)
preclUdes early assessment of myocardial salvage through
studies of regional contraction abnormalities. To
evaluate at which post-R time the extent of regional
contraction abnormalities reflects the extent of
myocardial necrosis (I), the LAD coronary artery was
occluded for 3 hours in 15 closed-chest dogs followed by
7 days R. Two-dimensional echo short-axis sections at
the mid-LV level yielded measurements of systolic wall
thickening (WTH) in 16 subsegments during control, 3 hr.
OCClusion, and 15 min., 1 hr., 24 nr,; 72 nr.; and 7
days post-R. At the end of the experiments, 1 was
evaluated by triphenyl-tetrazolium in an equivalent mid-
LV tranverse alice (range 0-36.1% I). Results of
regression analysis between the circumfersntial extent
(CEXT) of impaired WTH (WTHC 10%) at different times
after R vs. the CEXT of ultimate 1 (1)25% of regional
wall thickness) were (SEE-standard error of sstimate):
r SEE E~uation
15 min. R ~ IT:"; y. O. 8 x + 37.0
1 hr. R 0.56 20.3 Y~ 0.48 x + 34.0
24 hr. R 0.79 14.9 y= 0.62 x + 29·2
72 hr. R 0.93 7.4 y. 0.72 x + 24·5
7 day R 0.92 7.5 Y- 0.79 x + 20.6
At 15 and 60 min poat-R CEXT of impaired WTH grossly
overestimated (by 19.3% and 21.3% respectively) the CEXT
of N, but overestimation was significantly less at 24
hr., 72 hr., and 7 days post-R (14.3%,4.5%,and 2.9%).
It is concluded that the extent of myocardium which
eihrblts severe impairment of function at 3 days post-R
prOVides a satisfactory indication of the extent of
myocardium with more than 25% wall necrosis.
IS RATE OF FUNCTIONAL RECOVE1~ AFTER TRANSIENT CORONARY
OCCLUSION RELATED TO SEVERITY OF ISCHEMIA?
Ricky M. Schneider, MD; Kenneth B. Roberts; Frederick R.
Cobb, MD, Duke and VA Med Ctrs, Durham, N.C.
Recovery of left ventricular (LV) function following
transient myocardial ischemia occurs at a variable rate.
This study tests the hypothesis that the recovery rate is
determined by the severity of ischemia. Occlusion of the
mid left anterior descending artery followed by reperfu-
sion after 1 hr was performed in 11 chronically instru-
mented, awake dogs. Ejection fraction(EF) was measured by
multigated equilibrium radionuclide angiography before and
during acute occlusion and 3 and 6 hrs and 7 days follow-
ing occlusion. Regional myocardial blood flow(MBF) was
measured in 1-2 gm samples of the entire LV with 9~ micro-
spheres before and during acute occlusion, and following
release of occlusion to document reperfusion. The sever-
ity of LV ischemia was estimated by determining the MBF
deficit resulting from each occlusion and also by deter-
mining the mass of myocardium with greater than 25\ reduc-
tion in blood flow from normal region flow.
The acute decrease in EF correlated linearly with MBF
deficit(r=0.B4) and ischemic mass(r=0.B4). The data were
analyzed as 2 groups based on the rate of EF recovery. In
7 dogs that had full EF recovery by 6 hr, the ischemia was
mild; the mean MBF deficit was 10\, range 4-20\; the mean
ischemic mass was 14\ LV weight, range 4-27\. In 4 dogs
that had little or no EF recovery by 6 hr (but full reco-
very by 7 days) the ischemia was severe; the mean MBF
deficit was 29\, range 24-30\; the mean ischemic mass was
37\, range 30-41\. The extent of infarction was small in
both groups, mean 3\, range 0-9\ of LV weight and was not
related to recovery rate.
In conclusion, the rate of EF recovery following 1 hr
coronary occlusions is related to the severity of acute
ischemia.
Linear regression analysis for non-transmural MI (TE< 80%)
showed an inverse relation between TE and %SWT, (%SWT=45-
.56TE, r=-.75). However, when compared to transmural Mis,
infarcts of TE 60-80% had no higher %SWT, as the relationship
between TE and %SWT became non-linear for TE >approximately
65%.
Therefore: J) An inverse linear correlation exists between
myocardial contractility assessed 14 days after MI by %SWT and
TE, for TE less than approximately 60%. 2) Because infarcts of
TE> 60% have %SWT no better than transmural infarcts, salvage
of greater than 40% of the jeopardized myocardium may be
required to improve rnyccardial contractility compared with that
seen with transmural infarcts.
RELATION OF MYOCARDIAL SALVAGE WITH CORONARY
REPERFUSION TO FUNCTION AT 14 DAYS: IMPORTANCE OF
TRANSMURALITY OF INFARCTION
Stephen Ellis, MDr Joshua Wynne, MD; Claudia Henschke, MD,
PhD; Tomas Sandor, MD, PhD; Robert A. Kloner, MD, PhD,
FACC. Brigham and Women's Hospital, Boston MA and Stanford
University Hospital, Stanford, CA.
Many clinical studies of early coronary reperfusion in acute
myocardial infarction have shown modest improvement in later
contractility, suggesting that either the window for salvage is
smaller in man than experimental animals, or that salvage of
small amounts of myocardium has little functional consequence.
To investigate the second possibility, 11 mongrel dogs were
studied 14 days after 2 hr cccluslon-reperfustcn. Transmural
extent of infarction (TE) determined at necropsy measured along
endocardial to epicardial radians was correlated with % systolic
wall thickening (%SWT) as determined by computer-assisted 20
echo for 600 arc segments. TE ranged from 11-100%. Results of
the relation of TE to %SWT were:
TE
%SWT
1-20% 21-40% 41-60% 61-80% 80%-100%
38!;I 74!;5 19!;11 9+4 8+6
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DIFFERING EFFECTS OF ANGIOTENSIN II AND PHENYLEPHRINE ON
END-SYSTOLIC PRESSURE-VOLUME RELATIONSHIP IN CONSCIOUS
DOGS
Tsukasa Tajimi, MD; Thomas F. Widmann, MD; Masunori
Matsuzaki, MD; Kirk L. Peterson, MD, FACC, University of
California, San Diego, La Jolla, Calif.
When used to increase left ventricular (LV) afterload,
angiotensin II (AGT) or phenylephrine (PE) may cause
direct or reflex alterations in contractility. Thus, in
6 awake dogs (1-5 weeks post micromanometer and sonomi-
crometer implantation) we compared the end-systolic (ES)
pressure (P)-volume (V) relation determined by PE (20-25
ug/kg/min) as opposed to AGT (0.6-0.8 ug/min). LV peak
P reached with PE ~ AGT for each pressor intervention.
Afterload was also decreased using Nitroprusside (NP,
2.0-2.5 ug/kg/min). Heart rate was controlled at 120
beats/min by atrial pacing. ES was determined as the
maximum ratio of P to V. LV volume was calculated with
long and short axes (ellipsoidal geometry). Linear re-
gression was applied to the ES points for 4 series of
interventions: (control-NP-AGT) and (control-NP-PE).
each with and without Propranolol (P). The slope (Emax)
and volume intercept (Vo) were compared at each series.
Without P the linearity of (control-NP-PE) relation was
less than that of (control-NP-AGT). (Mean r=0.67 vs.
0.97, p<O.OOl), and PE shifted the P-V loop to the left.
With P, Emax and Vo did not show significant differences
between AGT and PE series (mean r: 0.96 vs. 0.97; Emax:
6.8!2.5 (SO) vs. 6.9!1.8; Vo: 12.0!10.4 vs. l2.9!9.3).
We conclude: 1) without adrenergic e-blockade, PE shifts
the ES P-V relation leftward; 2) the response to PE is
likely secondary to S,-adrenergic stimulation of the
myocardium; and 3) without S-adrenergic blockade, a PE
pressor stress test is not appropriate for determining
Emax in a clinical setting.
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COLD 19~m RADIONUCLIDE VENTRICULOGRAPHY IN
THE ASSESSMENT Of TIlE CXlLD PRESSOR TEST
lain N. findlay MRCP, Gerard Cillen BSc, John
Wilson BSc, Alex T. Elliott PhD, Henry J. Dargie
fRCP, Department of Cardiology, Western Infirmary
Clasgow, Scotland.
Such variable ejection fraction responses to cold
pressor stimulation (CPS) have been reported in
patients with coronary heart disease that its place
as a diagnostic test is now in doubt. Possibly, the
long acquisition time of gated radionuclide ventricul-
ography (RNVC) obscures significant changes in cardiac
function during CPS. The use of the short lived radio-
nuclide, COLD 19~m, with a multi-crystal gamma camera,
enabled us to perfon. sequential first pass RNVC before,
during the f1 rat 30 seconds, at 2 minutes and af ter 2
minutes recovery fraa the CPS. We studied normals (n-IO),
patients with angiographically proven coronary artery
disease who had normal LV function with no history of
myocardial infarction (n-IO) and patients with impaired
LV function due to congestive cardio.yopathy and who
had noraal coronary arteries (n-IO). The maximum rise in
systolic blood pressure occurr~d at one .inute in
normals and ischaemics (31±~..Hg, p(O.OOI and 39%8..Hg
p(O.OO~ respectively) and at 2 minutes in cardiomyo-
pathics (44Z7),p(0.001) in whom blood pressure did not
return to control 2 minutes after CPS. Ejection fraction
did not change during CPS in normals (~7±2 to ~2±I,NS) or
ischaemics (~7~4 to ~~4, NS), while in cardio.yopathics
there was a consistent fall (27i~ to 22~. p<O.OO~) at 2
.inutes. The cold pressor test does not distinguish pat-
ients with coronary heart disease from normals; it should
be regarded as an afterload stress during which subjects
with normal LV function can ..intain their ejection
fraction while those with impaired LV function cannot.
AFTERLOAD-SHORTENING RELATIONS BEFORE AND AFTER SURGICAL
CORRECTION OF CHRONIC LEFT VENTRICULAR VOLUME OVERLOAD.
Michael R. Zile, MD, William H. Gaasch, MD FACC Herbert
J. Levine, MD, FACC. Tufts University Sch~ol of'Medicine
and VA Medical Center, Boston, MA .
To define the patterns of systolic wall stress (a) and
the a- short eni ng relations before and after surgical
correction of chronic LV volume overload, we examined pre
and I-year postop echocardiographic data from 20 patients
(pts) with mitral regurgitation (MR) and 32 with aortic
regurgitation (AR). All 52 had preo p LV enlargement
(LVE). Based on postop data, 2 subgroups were defined for
each les ion; pts in A achieved a normal end diastolic
dimension « 3.3 cm/m2), wh ile pts i n B had persistent
LVE . Meridional a (dynes/cm2XI03) was calculated from LV
echo data, calibrated carotid pulse reco rd, and BP.
Data below are mean ± SEM ; * = p <0. 05 (preop vs .
postop) ; t = P < 0.05 (vs. normal) . PS = peak systolic ;
ES = end systolic. PS a: ESa:
Preop Postop Preop Postop
Normal 209±9 65±3
MR group A 244±13 187±4* 63±4 63±4
group B 232±24 236±22 114±20t 150±16t
AR group A 295±IOt 185±11* 63±5 72±15
group B 386±13t 290±33t 91±9t 99±19t
In MR(A) and (B), changes in mean a we re minimal while
fractional shorten ing (FS) fell in both (A: 36±5 to
29±2X* ; B: 27±5 to 17±J%*) . In AR(A) mean a decreased
and FS was unchanged (J4 ±1 to JO ±2%) ; i n AR(B) mean a
was unchanged and FS fell (27±2 to 18±4%*).
Thus, i n Group B pts (MR and AR), pers istently abnormal
a may contribute to postop decline i n FS (afterload ex-
cess). However, in MR(A), despite correction of the "low
impedence left atrial leak," there was no significant
change i n a; in these pts the postop decline in FS cannot
be explained on the basis of afterload excess.
LEft VENTRICULAR CONTRACTILITY IN THE POSTOPERATIVE PATIENT :
An Evaluation of the Force-Interval Relationship. James D.
Sink, M.D.; Page A. W. Anderson, M.D., FACC ; Andrew S.
Wechsler, M.D., Duke University Medical Center, Durham, NC
The force-interval relationship--the dependence of card iac
contractility on the rate and pattern of stimulation--was
evaluated for its potential use in monitoring patients i n
the immediate period following heart surgery. Six patients
were studied for 3 days following coronary artery bypass
graft ing. The instrumentation introduced during surgery
was a) a catheter-tip micromanometer i nt o the LV b) a pair
of ultrasonic transducers onto the LV epicardium t o monitor
minor axis dimension , and c) pac ing electrodes onto the
right atrium. Heart rate (HR) was cont r ol l ed by atrial
pacing at the basic rate. After every 20th systole (the
control systole), a pause in the HR was introduced during
which an extrasystole (SE) and a post-extrasystolic (SpES)
were elicited at test intervals tE and tpES' respectively,
following the control systole . The intervals, tE and tPE&
were experimentally manipulated. When the test intervals
w~re increased, the peak first derivative of LV pressure
(Pmax) of SE and SPES increased monotonically. To elimi-
nate the effects of LV end-diastolic volume dimension (EDD) ,
ve used only SPES and control systoles with the same EDD's
in construction of PES ratio curves (Pmax of SPES/Pmax of
the cont rol .ystole as a function of tPES)' The PES ratio
rose monotonically with an increase in tpESi these curves
were well fitted by an exponential relationship. The PES
ratio exceeded unity at long tpES's. This ratio , denoting
post-extrasystolic potentiation , vas inversely dependent
on tEo No complications to the patients occurred. These
findings, identical to those found in isolated myocardium
and the isovolumically contracting isolated heart, suggest
that the force-interval relationship can be used to safely
and easily monitor postoperative ventricular contractilit~
TIlE END SYSTOLI C PRESSURE/VOLUME RATIO IS INDEPENDENT
OF PRELOAD IN INTACT MAN IMMEDIATELY FOLLOWING CARDIAC
SURGERY
George T. Daughters, MS; Geraldine C. Derby, RN;
Edwin L. Alderman, MD, FACe; Anne Schwarzkopf, BS;
Carol W. Mead, BS; Neil B. Ingels , Jr ., Ph.D; Edward B.
Stinson, MD, FACC; D. Craig Miller, MD, FACC;
Palo Alto Medical Foundation, Palo Alto, CA 94301
Response of the LV end systolic pre~sure/volume ratio
(P/VR) to preload augmentation (by blood or plasma
expanders) was studied in 8 pat ients during the first 24
hours following coronary artery bypass graft surgery
(CABG). LV pressure was monitored with a catheter tip
manometer, and LV volume was obt ained by computer-aided
ana ly sis of i mages of surgically implanted radiopaque
markers outlining the LV in RAO projection . Heart rate
was ma intained constant at 100 beats/minute by atrial
pacing. Vol ume infusion adequate to increase the preload
(End Diastolic Volume; EDV) resulted in no change in
mean P/VR for the group . In 2 patients there was a
significant P/VR increase (p< O. OS) and i n 2 others a
modest i ncr ease (p<O.IO). LV pressure vs. volume loops
showed that in all four of these cases, after load had
also changed, systolic pressure increasing more than end
systolic volume (ESV). In most cases, P/VR was unchanged
despite EDV augmentation, because ESV and pressure were
invariant. We conclude that : I ) preload augmentation
( increased EDV) can be accompanied by afterload changes .
2) P/VR i s independent of preload in the early period
following CABG surgery if there i s no change in
afterload. 3) If afterload is unchanged, P/VR can be a
useful assessment of postoperative LV function.
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CARDIAC FUNCTION IN PATIENTS WITH AC~lR!D IMMUNE
DEPlClENCY SYNDROME (AIDS) llt AIDS PRODROME
John Reitano, ~; Marjorie King, MD; Howard Cohen, MD;
Wafaa EI-Sadr, MD; Shirley Rubler, MD, FACC;
Jonathan Steinberg, M.D.; Vincent Fisher, MD,
Cardiology & Infectious Disease Sections VAKC, NY, NY &
Depts. of Medicine & Physiology, NYU School of Medicine.
Acquired I-.une Deficiency Syndrome (AIDS) involves
1DUltiple organ .ysteu. Our goal was to investigate
cardiac function. Twenty-five patients (21 with diag-
nosed AIDS, 4 with AIDS prodrae) have been evaluated by
baseline EKG, K-Kode and 2D echocardiography. Nine
patienta alao had resting radionucllde angiography.
Patients were male, aged 27 to 67 years; mean 40.7 +/-
11.0 yean. The 4 prodrcae patients all had normal
studies. · Four of 21 AIDS patients (19%) had baseline
EKG abnormalities - 2 right uis deviation, 1 diffuse
ST segment elevation, 1 low voltage, and 1 repolarization
abnormalities with Type I 2nd degree AV block. Ten AIDS
patients (48%) had abnoraal echocardiograma - 3 had LV
end diastolic dimell8ion >6511_, 2 had fractional shorten-
ing <28%, 6 had RV end diastolic dimension >25mm, and 7
had pericardial effusion. Four of 6 AIDS patients (66%)
had abnormal re.ting radionuclide angiograms - 4 with
decreased RV ejection fraction and 3 with decreased LV
ejection fraction; and 2 with dilated RV and 1 with
dilated LV. Of the 21 AIDS patient. only 5 had no evi-
dence of cardiac dysfunction. Seven (33%) had abnormal-
ities blvolving the right ventricle alone; 3 (14%) had
evidence of biventricular dy.function; 7 (33%) had
pericardial effusion &lid two of these (l0%) developed
taaponade which required drainage. Abnormalities of
cardi..: flJllction occurred frequently in our AIDS
patienu. Cardiac function .hould be evaluated in
patient. diagnosed as having AIDS.
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Coronary Thrombolytic Therapy
Mt. Sinai/New York University Randomized Reperfusion Trial:
Pilot Phase. P. Rentrop, F. Feit, R. Schneider, H. Blanke, P.
Stecy, and the Reperfusion Study Group, New York, NY.
One hundred twenty-four patients with ~30 min of ischemic pain
and ECG changes suggestive of acute infarction were
randomized at <12 hours into 4 groups: I Intracoronary(lC)
Streptokinase(SK), 2,000 U/min; II: IC SK+IC nitroglycerin
(.Olmg/min); III: IC nitroglycerin; IV: Conventional therapy, no
acute angiography. In I, II, III duration of IC infusion was 45-90
min; II, III were maintained on IV nitroglycerin for 3 days; I, II,
III, IV were fully anticoagulated and hod endpoint angiography
day 10-14. Results: Prior to intervention 60/89 vessels were
completely obstructed. Acute recanalization rates were: I:
12/19; II: 19/23(NS); III: 1/18(p=.000J). Endpoint angiography
revealed delayed recanalization: I: 0/4; II: 2/3; III: 10/13.
Endpoint patency rates were: . I: 15/21; II: 21/24; III: 17/21;
IV: 16/24(NS). Analysis of , variance of gated blood pool
ejection fraction change (l1EF) from preintervention to day 10
showed a significant effect of preintervention obstruction(total
obstruction l1EF=-.02(n=21); subtotal obstruction
liEF =+.07(n= 12); p=.05), but not of treatment. l1EF
1=+.05(n=12); l1EF IV=-.03(n=13), p=.07. Four manth mortality
was: I: 6/29; II: 7/28; III: 4/26; IV:2/28(NS). Conclusions:
I.IC infusion of SK results in significantly higher acute
recanalization rates than infusion of nitroglycerin. 2.lnfusion
of nitroglycerin combined with long term anticoagulation is
associated with a high rate of delayed recanalization.
3.Patients treated with IC SK, nitroglycerin, or conventionally
treated patients show no differences in chronic potency rates.
4.Svbtotal lesions are associated with significantly better
functional improvement than complete obstructions. 5.Failure
to show significant treatment effects upon function and
mortality may be due to the smoll sample size.
INTRACORONARY VS INTRAVENOUS STREPTOK INASE IN I:YOCAROIAL
INFARCTION
And ris Saltups, FRACP, FACC, John Boxall, FRAC P, Betty ~o,
MB, Simon Bower, MB, Nicholas Balazs, FAACB, Peter Oennls,
FRCPA, Prince Henry's Hospital, Melbourne, Victoria,
Australia .
A prospect ive , ra ndomi zed trial compared the efficacy of
i nt racorona ry (IC) and intravenous (IV) Streptokinase (SK).
Thirty-one patients (pts) hospitalized <3 h after onset of
transmural myocardial infa r c ti on (HI) rece ived ICSK (16
pts) or IVSK ( IS pts) after baseline coronary arter io -
graphy (CA ) . Thrombotic occlus ion of the infarct-related
artery (IRA) was evident in 15/16 pts given ICSK and 13/15
pt s who rece ived IVSK . Thr ee pts had sub-total occlus io n
without thrombus . ICSK dose was 2 ,500-5,000 U/min fo r 75-
90 mins. IVSK pts received 500,000 U/30 min (12 pts) or
1.5 million U/60 min (3 pts),
Of the 28 IRAs with thrombus 14/15 reopened with ICSK and
9/13 with IVSK (N.S.) in 10-60 min (av. 25) after starting
SK. Reperfusion (complete, rapid contrast filling of dis-
tal IRA branches followed by cha racteristic cardiac iso-
enzyme concentration/time curves) ensued in 13/15 ICSK but
i n only 4/13 IVSK recipients (p <O.OI) and was established
i n 2 .5-6.5 h (av , 4.2) after onset of MI. Earlier appear-
ances of CK?~B peak levels - mean 10.9 ± 1.67 vs 18 .7 ± 2.3
h (p<O.OOI), linear decay 12.9 ± 2 .4 vs 23.5 ± 5,7 h (p <
0 .001) and heat-stable lact ic dehydrogenase peaks 22.5 ±
5 .9 vs 38.7 ± 6,1 h (p <O.OOI) related to onset of symptoms
of HI were associated with reperfus ion. Review CA av , 2.8
days post-SK showed reocclus ion of 4 reopened IRAs (ICSK -
3, IVSK - 1). Eight weeks post -sx, ang iographic ejection
fraction had improved in 13 pts with persistent IRA paten-
cy and deteriorated in 10 pts with unsuccessful reperfu-
sion or reocclusion (mean ~ 6 + 9.6 vs -13.9 - P < 0.01) .
CONCLUSION: ICSK was superior to IVSK for myocardial
reperfusion .
RANDOMIZED TRIAL OF INTRACORONARY VERSUS
INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL
INFARCTION. William J. Rogers~ MD, FACC; William P.
Hood, Jr., MD, FACC; Russell C. eev., MO; Patrick L
Whitlow, MD. UAB Medical Center, Birmingham, AL
To determine the relative merits of intracoronary (IC) and
high-dose intravenous (IV) streptokinase therapy in patients
(pts) with acute myocardial infarction (AMl), we randomly
allocated 30 pts with suspected AMI to IC ([) pts) or IV
streptokinase ([) pts). IC pu underwent coronary angiography
and then received 240,000 IU streptokinase IC over I h. IV pts
received I.' million IU of streptokinase IV over 4) min without
antecedent an!!,iography. Both groups had IV heparin for 10
days. CK-MB at I.' - 3.0 h intervals for 72 h, and follow up
angiography on day 10. CK-MB evidence of AMI evolved in 14
pts in each group. Interval from onset of AMI symptoms until
beginning streptokinase was similar in Doth groups (mean < 6 h)
but interval from hospital admission until be!!,inning therapy was
shorter in IV pts (IV = 0.7 + .1, IC = 1.8 + 0.2 h, p < .000.
Interval from AMI symptoms Until peak CK-MB averaged I) .! I
h in IV pts and I' + 2 h in IC pts (PNS). CK-MB peaked < 16 hrs
from onset of symptoms in 64% (9/14) of IVpts and in 64% (9/14)
of IC pts (PNS). Patency of the infarct - related artery on
angiography 10 d post-MI was found in 86% ([2/14) of IV pts and
in 64% (9/14) of IC pts (PNS). Bleeding re~iring transfusion
occurred in 21% (3/14) of IV pts and in 29% (4/14) of IC pts
lpNS). Two IC pts sustained cardiac arrest during treatment,
one of whom died, whereas no serious morbidity occurred in the
IV pts. At I wk post-MI, radionuc1ide ejection fraction had
improved over baseline in 62% (8/13) of IV pts vs 23% (3/13) of
IC pts (p< .0').
Tt-us. high-dose IV compared to IC streptokinase in AMI
resulted in nearlier treatment; 2) similar hemorrhagic com-
plications but less overall morbidity; 3) similar CK-MB evidence
of reperfusion and similar late angiographic patency rates; and
4) significantly greater improvement in ejection fraction.
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There was no significant difference in either the early
or late mortality of SK and C patients. SK patients more
frequently had coronary angioplasty and revascularization
surgery.
CONCLUSION: There was no meaningful effect of intra-
coronary SK on the survival of patients with inferior
HI within the first 15 months even when angioplasty or
revascularization surgery were added to their therapy.
SHOULD INTRACORONARY THROMBOLYTIC THERAPY BE PERFORMED IN
ACUTE INFERIOR INFARCTION ?
Renato G. Ramos, MD, Cheruku Reddy, MD, V. Gangadharan,
MD. FACC, Andrew M. Hauser, MD, FACC, Douglas C. Westveer.
lID. FACC, James R. Stewart, lID , FACC, Seymour Gordon, MD.
FACC, Gerald C. Timmis , 110, FACC. William Beaumont
Hospital. Royal Oak and Oakland Uni ver s i ty , Rochester, MI.
15
5
Bypass
(i:)
20
o
Angioplasty
(i:)
11. 2
8.1
Total
Mortality
(i:)
2.4
o
Followup
Mortality
(i:)
8.8
8.1
SK
C
Reduced mortality has been proposed as a possible benefit
of thrombolytic therapy in acute myocardial infarction
(HI). To test this hypothesis in inferior MI, we studied
the early and late mortality (14.3 months; range 2 to 28
months) of 91 patients presenting within 6 hours of symp-
toms who were treated with intracoronary streptokinase
(SK) and 37 control patients who were retrospectively
selected and consecutively matched by 111 site, candidacy
for SK and the time interval from sympt om onset (6
hours).
RESULTS:
Hospital
Mortality
(i:)
A RANDOHIZED TRIAL OF INTRACORONARY VERSUS INTRAVENOUS
STREPTOKINASE IN MYOCARDIAL INFARCTION. PRELIHINARY RE-
SULTS
Jeffre~ L. Anderson, HD, FACC; Hiram W. Harshal1, HD;
Joan • Lutz, RN; sherman G. Sorensen, 1'10; Jack C.
Askins, 1'10; Arthur O. Hagan, LOS Hospital. University of
Utah, Salt Lake City. Utah
38 patients (pts) wi th acute myocardial Intarcti on (HI)
were randomlzed 2.5 :!: 1.2 h after pain onset to lntraco-
ronary streptoklnase (IC-SK), nal8, or lntravenous strep-
tokinase (IV-SK), n-20. SK dose averaged 200,OOOU for IC
and 750,0000 for IV pts. IC-SK was applied at 4.1 ± 1.5
h but IV wlthln 2.7 :!: 1.1 h (p<.05). Time of peak enzyme
release was slmilar1y early after admission in IV-SK and
IC-SK: CK-HB 9.7 :!: 3.7 h versus 11.1 :!: 6.1 h. and LOH-I
29.9 :!: 10.6 h versus 26.7 :!: 13.0 h. Summed ST segment
elevations were slmi1ar on admission and diminished
abruptly after therapy in both groups. R wave loss and Q
wave evo1utlon were also slml1ar ln both groups. Conval-
escent (day 10) radlonuc11de ejectlon fractlons (EF) were
55 :!: 15~ after IV-SK and 53 :!: 15~ after IC-SK (NS).
Change in EF, day 1-10. tended to be greater after IV-SK:
6.4~ (p<.02) versus 1.4~ (NS), due to lower lnHla1 EF.
Semiquant1tathe echocardlographl c wa 11 mot1on 1ndex on
admlsslon and dlscharge did not differ by group, however,
and improvement (day 0-10) was slgnlflcant after IC-SK
(p<.02). Arrhythmias and heart failure dld not differ.
Infarct patn was dlmlnlshed similarly In both groups, as-
sessed by morphine requirement. Recurrence of Ischemic
pain (5 versus 2) and bypass surgery (6 versus 2) tended
to be more frequent after IC-SK (NS). Hlnor b1eedlng was
more common after IV-SK (5 versus 1). 1 pt dled lnhospl-
ta1 in each group. Predischarge eva1uati on 1ndl cated
significant coronary reperfusion to the infarct zone ln
751 of IV-SK and 721 of Ie-SK pts (NS). IV-SK and IC-SK
cOlllPlrab1y affect the hospital course of I'll, and IV-SK
hiS the advantage of earlier and easier application.
EFFECT OF INFARCT LOCATION AND REPERFUSION
SUCCESS ON OVERALL MORTALITY WITH
INTRP.CORONARY STREPTOKINASE THERAPY
Richard W. Smalling,M.D.,Ph.D.,FACC: Francisco
Fuentes,M.D.,FACC: Charles H. Hicks,M.D.,
Margaret W. Matthews,R.N.,CVNS: Gregory
Freund,B.A.: K. Lance Gould,M.D.,FACC,
University of Texas Medical School at Houston,
Houston, Texas.
During the past 2~ years we have prospectively
studied 257 consecutive patients(PTS) with
myocardial infarction(MI). Of these, 175 were
enrolled in our intracoronary streptokinase
protocol (SK) and the remaining PTS(C) were
treated similarly except for emergency
catheterization on admission. Total mortality
in the SK group was less (13%) than Group C
(28%, P=.003) during the study period (average
follow-up > 12 mos). There was no difference
in mortality between anterior (13%) and
inferior (10%) MI's in the SK group. SK PTS
without successful reperfusion had a simi liar
mortality (35%1 compared to C(28%, P=NSI. SK
PTS with anterior MI had improved mortality
compared to C (13 vs 36%, P =.0061. PTS with
inferior MI did not demonstrate a clear
difference in mortality (10% vs 16%, P = NSI
compared to C. Mortality in PTS with patent
coronary arteries on CCU admission was much
less than mortality in PTS with persistent
coronary occlusion (6.5% vs 35%, P < .0011.
Conclusions: 1) SK results in improved
mortality in MI, especially in PTS with
anterior MI, 2) Unsuccessful SK does not
appear to decrease chance of survival.
Tuesday, March 27, 1984
2:00-3:30PM Grand Hall Meeting Room #2
Effect of Thrombolytic Therapy on Regional Function
EFFECT OF SEVERE RESIDUAL STENOSIS ON RECOVERY OF
FUNCTION AFTER STREPTOKINASE
Florence H. Sheehan MD, B.Greg Brown MO PhD, Oet1ef
G. Mathey'MO, Harold ~ Dodge 1'10 FACC. University of
Washington, Seattle WA
The effect of residual stenosis (resid) after
streptokinase (S) reperfusion (Rperf) in acute myocardial
infarction (MI), of failure to Rperf(nonRperf), and of
rethrombosis after Rpferf, on regional LV wall motion
(WM) was determined from the contrast angiograms of 32
patients (pts) studied acutely and 2-12 wks later. WM
was measured at 100 chords perpendicular to a centerline
midway between the end diastolic and end systolic contours
and expressed in standard deviations (SO) from the mean
of 64 normal pts. Change in mean WM (SO/chord, see
Table) in the most hypokinetic part of the MI region was
compared with minimum cross-sectional area (minA) of the
MI artery resid following 5 infusion quantitated by a
com uter- ass 'sted method. Results: Chan e in WM N:
min .3mm min <0.3 rethrombosis nonR erf
O. +1. 1 - . +0. -0.6+0.8 5 . +0. 6
p<,.005 0.3 vs <0. ,pe02 >0.3 vs rethrombosis •
p<..01«0.3+rethrombosis vs nonRperf),1 way analysis.
All 6 pts whose WM improved >1 SO/chord had minA>0.3 mm2.
Of 7 pts who had bypass surgery after 5 and patent grafts
WM improved only in the 6 pts whose minA had been >0.3mm2.
Thus WM does not improve without Rperf and may not
improve after Rperf if resid stenosis is severe. The
worsening of WM in pts with severe resid stenosis or
rethrombosis suggests that limited Rperf may be more
deleterious than permanent occlusion. Measurement of
resid stenosis should be performed to determine the need
for additional revascu1arization procedures.
ABSTRACTS JACe Vol. 3. No.2
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EFFECTS OF CORONARY THROMBOLYSIS ON REGIONAL tlYOCARDIAL
PERFUSION AND METABOLISM ASSESSED WITH POSITRON EMIS-
SION TOMOGRAPHY
Steven R. Bergmann I PhD; Kei th A. A. Fox, ~1B ChB; Robert
M. Knabb, PhD; Mary A. Burnes, BS; Burton E. Sobel. MD,
FACC; Washington University, St. Louis, Mo.
Although it is well established that macrovascular
patency can be restored with thrombolytic therapy,
beneficial effects of the intervention on nutritional
perfusion and myocardial metabolism have been more dif-
ficult to define. lIe used positron emission tomography
(PET) to evaluate myocardial perfusion and metabol ism
in response to occlusion and reperfusion in 8 closed-
chest dogs subjected to LAD coronary thrombosis. One to
2 hr after induction of thrombus, perfusion was eval-
uated with H2l50. and metabolism was assessed after
i .v , injection of llC-palmitate (llC-p) f ol loved by
dynamic acquisition PET (2 min scans). In normal re-
gions, llC-p accumulated within 2-4 min, and the
turnover of llC-activity from 5-15 min lias monoexpo-
nential with a tl/2 of 13 ± 5 (SO) min. In the region
supplied by the LAD, perfusion was diminished to 22 ±
l4~ of normal. In 50~ of dogs, llC_p clearance from the
ischemic zone was reduced (tl/2 = 43 ± 24 min) while in
the others, llC_p in the Ischemic zone accumulated
throughout the entire 20 min period, reflecting de-
creased a-oxidation. In 4 dogs with persistent occlu-
sion, myocardia1 perfusion remained depressed (21 ± l8~
of norma1) at repeat tomography 90 min after initia1
PET, and diminished llC_p clearance persisted. After
thrombolysis, myocardia1 HZ150 content in the region at
risk at least doubled and the clearance of llC_p in-
creased (tl/Z = Z6 ± 4, p < .05) indicating substantial
recovery of metabolism. These resu1ts indicate that se-
quentia1 PET permits prompt assessment of the responses
oT metabolism and perfusion to coronary thrombolysis.
SUSTAINED ANAEROBIC METABOLISM AFTER RECANALIZATION OF
CORONARY ARTERY IN ACUTE MYOCARDIAL INFARCTION
Jun Tarnai, MD; Kazuhisa Kodama, MD; Shinsuke Nanto, MD;
Masashi Naka, MD; Masayoshi Mishima, MD; Michitoshi
Inoue, MD; Hiroshi Abe, MD, FACC, Cardiac Intensive Care
Unit of Osaka Police Hospital, Osaka, Japan.
To evaluate the effects of percutaneous trans luminal
coronary recanalization (PTCR) on coronary circulation
and myocardial metabolism, we studied in 15 patients
(pts) with acute antero-septal myocardial infraction
before and after PTCR. Regional lactate extraction ratio
(RLER) and regional coronary arterio-venous oxygen
difference (RAVD02) were derived from analyzing lactate
and oxygen content in arterial and great cardiac venous
blood. Great cardiac venous flow (GCVF) was measured by
continuous thermodilution method and regional coronary
vascular resistance (RCVR) was defined as mean aortic
pressure/GCVF. RLER and RAVD02 showed 5.8'2.1% (mean SO)
and 11.5 2.0ml/dl in pts with total occluded state before
recanalization. After recanalization spontaneously or
by successful PTCR, RLER turned to negative value (-25+
9.0%). RAVD02, however, showed no significant change
before and after PTCR. RCVR was decreased by 10% with
recanalization. Moreover, these condition were recogniz-
-ed to sustain for more than 24 hours after recanaliza··
tion.
(RLER and RAVD02 showed -28'12% and 11.O'3.lml/dl after
24 hours in 6 pts.) Thus, we conclude that the impaired
myocardium may be salvaged by PTCR but the myocardial
metabolism could not be restored to aerobic state within
24 hours.
DISCORDANCE BETWEEN EJECTION FRACTION AND REGIONAL
HYPOKINESIS IN ACUTE AND CHRONIC MYOCARDIAL INFARCTION
Florence Ii. Sheehan MD, Andraa Szente MD, Detlef G.
Mathey MD, Harold T. Dodge MD FACC, University of
Washington, Seattle WA
Correlation between ejection fraction (EF) and regional
hypokinesis (hypo) in the infarct (MI) artery territory
(territ) was analyzed from the contrast left
ventriculograms of 84 patients (pts) studied during acute
MI. Motion was measured at 100 chords perpendicular to a
centerline drawn midway between end diastolic and end
systolic LV contours. normalized for heart size, and
expressed in standard deviations (SO) from the mean of 54
normal pts. Hypo calculated as mean chord motion in the
least contractile 50% of the MI territ correlated poorly
with EF:r-.46. EF was ~55 in 15 pts with severe hypo
(below -2SD/chord) and <55 in 6 pts without severe hypo,
a discordance of 25% (21 of 84). Motion averaged over
75% or 100% of the MI territ correlated little better
with EF:r=.54,.58, and raised discordance to 26%,27%,
respectively. Therefore hyperkinesis (hyper) was
calculated as mean motion in the moat contractile 50% of
the nonMI wall and algebraically summed with hypo. The
resultant measure of net abnormality correlated well with
EF:r=.84. On the follow-up study of 46 pts performed
2-12 wka after MI hypo correlated better with EF (r=.79
vs .41 acutely) because nonMI wall motion was less hyper
(0.3~1.2 va 1.0~1.3 SO/chord acutely, p<.OOI).
Thus the sensitivity with which the EF reflects the
severity of hypo in the MI territ of the LV differs in
acute and chronic MI according to the magnitude of hyper
on the nonMI wall. Since hyper falls following acute MI.
interventions to salvage myocardium should be assessed by
measuring regional hypo in the MI territ.
EFFECTS ON LEFT VENTRICULAR FUNCTION OF STREPTO-
KINASE THERAPY IN ACUTE MYOCARIAL INFARCTION
William P. Hood,Jr., MD, FACC; William J. Rogers,MD, FACC;
Russell Reeves,MD; Patrick L. Whitlow,MD; William A. Baxley,
MD, FACe. University of Alabama in Birmingham, Birmingham,
AL
To assess effects of thrombolytic therapy of acute myocardial
infarction (MIl on left ventricular (LV) function, biplane cine-
angiography (RAO/cranial LAO) was performed before and 15(t8)
days after administration of either intracoronary (240,000 U) or
intravenous (up to I million U) streptokinase (SK) in 34 patients.
Global LV function was assessed by biplane volumetric ejection
fraction (EF) and regional LV function by segmental ejection
fraction (SEF), representing percent area change (average of
both views) in the zone of the MI or in the non-MI zone. Results
were as follows:
Follow-up
Successful SK (23)
EF(%) 47.8 ± 10.2 49.1 ± 7.2 (NS)
SEF, MI(%) 13.4 ± 13.1 17.8±13.2 (p <0.05)
SEF,non-MI(%) 48.1 ± 10.7 47.2 ± 7.6 (NS)
Unsuccessful SK (J I)
EF(%) 47.1 ± 6.7 41.5 ± 11.0 (NS)
SEF, MI(%) 19.4 ± 11.2 22.8 ± 14.6 (NS)
SEF,non-Ml(%) 44.6 ± 10.4 36.5± 11.8 (p=o.o5)
CONCLUSIONS: I. Two weeks after SK therapy for MI, a) global
EF is unimproved despite successful thrombolysis, b) SEF in the
MI zone is improved slightly if SK was successful, c) SEF in the
non-MI zone tends to be worse. 2. To assess adequately the
effects on LV function of SK therapy in MI, regional rather than
global parameters must be measured.
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EXERCISE-INDUCED ISCHEMIA IN THE STREPTOKINASE REPERFUSED
MYOCARDIUM: RELATIONSHIP TO EXTENT OF SALVAGED MYOCARDI-
UM AND DEGREE OF RESIDUAL CORONARY STENOSIS
Teddy ~ Weiss, MD; Jamshid Maddahi, MD; Ivor Geft, MD;
Ana Becerra, BS; AI Ian Lew, MD; Daniel Berman, MD,
FACC; HJC Swan, MD, PhD, FACC; Wi liam Ganz, MD, FACC;
Cedars-Sinai Med Ctr., Los Angeles, CA
Although streptokinase thrombolysis (SKT) in acute myo-
cardial infarction results in a variable extent of sal-
vaged myocardium (SM) and residual coronary stenosis
(RCS), the frequency and determinants of exercise-induced
ischemia (EI I) in the SM are not known. Thus we evalu-
ated 38 patients (pts) by exercise (Ex) TI-201 and/or Ex
radionuclide ventriculography within 6 months of SKT, of
whom 35 were successfully thrombolysed. In al I pts the
size of the initially jeopardized myocardium (IJM) and
the SM were defined and quantified on TI-201 studies ob-
tained immediately before and 7 days after SKT. EI I (re-
versible TI defect or worsening of wal I motion) in the
IJM developed in 21 pts (Group I) and was absent in the
remaining 17 pts (Group II). Ex chest pain and Ex ST de-
press ion (ST·j.) were not sens it ive markers of EI lin Group
I patients (sensitivities 19% and 28% respectively). The
relationship between the development of EI I and size of
the IJM and SM, and %RCS was assessed:
Results IJM SM %RCS
Group I 725+365 458+240 84m
Group II 422'+217** 147+178** 93+10*
*p< 0.05, **P< 0.005. EII was frequent (18722 pts ) when
SKT resulted in a large SM ()250) and was rare (3/16 pts)
when SM was <250. In conclusion: 1) Ell is frequent in
the reperfused myocardium; it is related to the size of
IJM and SM, and cannot be predicted by Ex CP, Ex ST. ,or
severity ot % RCS, and 2) management ot RCS In SKT pts
can be guided by radionucl Ide evaluation ot the extent ot
SM and Ell.
Tuesday, March 27, 1984
4:00-5:15PM Grand Hall Meeting Room #2
Coronary Artery Surgery II
SURVIVAL IN HIGHEST RISK PATIENTS WITH CORONARY ARTERY
DISEASE: BENEFITS OF BYPASS GRAFTING
John R. Holmes, MO: James B. Wallis, MO: Jeffrey S. Borer,
MO, FACC: Jeffrey W. Moses, MD, FACC: Harvey Goldberg, MD,
FACC: Jeffrey Fisher, MO: Valavanur Subramanian, MD, FACC;
William Gay, MO, FACC: Stuart Calle, BS, Cornell Medical
Center, New York, NY
We previously showed that prognosis in pts with coronary
artery disease(CAD) can be inferred from left ventricular
ejection fraction(LVEF) at resteR) and exercise as deter-
mined by radionuclide cineangiography(RNCA). To determine
if coronary artery bypass grafting (CABG) can mitigate poor
prognosis in the highest-risk pts (those with EF <30%) ,
we assessed survival in 181 non-selected pts, 25Rtreated
surgically, and 156 treated medically. The groups were
comparable by age, sex, duration of exercise, double prod-
uct at exercise, and, among pts catheterized, prevalence
of left main or proximal 3-vessel CAD. Lifetable analysis
showed a trend toward improved survival in CABG pts (78%
vs 55% at 3 yrs, NS): overall mortality was 6/25 (24%) in
CABG pts and 53/156 (34%) in non-CABG pts over mean fol-
lowup intervals of 16 and 23 months, respectively.
Overall Mortality
EFRest 0-29% 16-29"/. 0-15".
Non-CABG 53/156(34%) 28/113(25%)-p(.001-- 25/43(58%)
NS NS NS
CABG 6/25(24%) 2/19(11%) -p(.005- 4/6(67%)
Moreover, lifetable analysis revealed that among CABG pts
with EF>15%, 3 yr survival is 94%, while 3 yr survival in
non-CABG pts is 60%. All CABG deaths were immediately
post-op; lifetable analysis of perioperative survivors re-
vealed significantly improved survival compared to non-
CABG pts (p<.02). We conclude that while mortality risk
is quite high in CAD pts with EFR<30%, CABG tends to im-
prove survival in this group, and clearly reduces mortal-
ity among pts surviving the perioperative period.
K>RTALITY, MORBIDITY AND COST-EFFECTIVENESS OF CORONARY
ARTERY BYPASS GRAFT SURGERY IN 'l1IE ELDERLY.
Arthur J. Roberts, M.D., Daniel G. Knauf, M.D., James A.
Alexander, M.D., C. Richard Conti, M.D., Dennis D..
WUoQdha11~ M.D'A1De~nard Wi E11i,on, Ronald Fisher.niversi~y of r orida, Ga nesville, Florida
In 143 patients (pts.) undergoing coronary artery bypass
graft surgery analysis of clinical results and cost-effec-
tiveness was undertaken at a university hospital (UR) and
its affiliated VA center. The pts. were divided into 4
groups based on pt. age and hospital location: Group I,
UR<60, N.36; Group II, VA<60, N-41; Group III, UR>65,
N-35; Group IV, VA>65, N-31.
Pre-op Group I Group II Group III Group IV
Age (mean) 51.30 50.36 71.5 69.5
, CABG (mean) 3.69 2.76 3.06 3.29
Ejection fraction 55.08% 50.55% 50.76% 52%
Post-op
Mortality 0 1 4# l'
Arrhythmia 11 14 26#' 19#'
Neural deficit 2 1 2 2
Wound infection 4 1 6' 3'
Septicemia 1 0 6# 0'
Re-operation 0 2 2' 6'
Psychosis 0 7 17" 12"
Respiratory failure 2 0 4' 2'
Inotropic support 1 5 10' 6'
lABP 1 1 6' -.}:'
Peri-op HI 1 1 3 O'
Liver failure 0 1 1 1
Kidney failure 0 0 5" 2"
, days SICU 3.56 2.35 11.97', 3.32'
, days post-op 10.75 11.25 19.03 14.42'
Hospital charge $20,288 $20,682 $47,784' $25,947'
IP<0.05, #I P<O.Ol for Groups I and II vs III and IV
Co-p1icatiQna, late mortality, duration of hospitaliza-
tion and expense are greater in the elderly.
UNSTABLE ANGINA PECTORIS: TEN YEAR SURVIVAL IN 1,012
PATIENTS TREATED BY CORONARY ARTERY BYPASS SURGERY.
Marcus A. DeWood, MO; Ronald P. Grunwald, MD, FACC:
William P. O'Grady, MD, FACC: Gerald R. Hensley, MD, FACC:
William F. Stifter, MD: J. Paul Shields, MD, FACC,
Deaconess and Sacred Heart Medical Centers, Spokane, WA.
Coronary artery bypass surgery has been shown to relieve
angina in the majority of patients with chronic angina.
Although comparisons of medical and surgical forms of
therapy for unstable angina pectoris have shown little
difference in short term studies, there are few long term
studies of the outcome of coronary artery bypass surgery
for unstable angina pectoris. Accordingly, we reviewed
our operative results from 1973-83 in 1,012 patients with
unstable angina pectoris defined as progressive rest pain
and ST and T-wave changes on ECG. Short (30-day) and
long term mortality (1-10 years, mean 4.8 years) were
evaluated with reference to 1, 2, or 3 vessel disease and
were dichotomized by ejection fraction (EF) < or ~ 50 per
cent. Patients lost to followup (N=40) were not included
in long term analysis. Results included:
# Vessels 30-Day Mortality Total Mortality(Mean 4.8 yrs)
1 2.1% (5/231) 9.8% (21/215)
2 1.2% (4/332) 11.5% (37/322)
3 or 3+ 2.9% (13/449) 16.3% (71/435)
Overall 2.1% (22/1012) 13.2% (129/972)
Over the 10-year period, reoperations were necessary in 63
(6.5%) cases. When dichotomized by ejection fraction:
E.F. 30-Day Mortality Total Mortality
< 50% 1.2% 11.2%
.:: 50% 3. 6%::::::>N.S. 20.0%'>P < .05
Thus: (1) Coronary artery bypass surgery is associated
with acceptable short and long term mortality in patients
with unstable angina pectoris. (2) Left ventricular
function at the time of coronary artery bypass surgery
for unstable angina pectoris is highly predictive of
short and especially long term outcome.
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CONDUCTION ABNORMALITIES FOLLOWING CORONARY BYPASS SUR-
GERY: PREDICTIVE ROLE OF CORONARY LESIONS. G.V.R.K.
Sharma, M.D.; J.A. Kirdar, M.D.; E.D. Folland, M.D.; M.
Josa, M.D.; S.F. Khuri, M.D.; and A.F. Parisi, M.D. V.A.
Medical Center, West Roxbury, Brigham & Women's Hospital,
and Harvard Medical School, Boston, MA.
Conduction abnormalities (CA) following coronary ar-
tery bypass graft surgery (CABG) are not infrequent but
have received little attention. Of 200 consecutive CARG
patients 36 (18%) developed new persistent CA. These
were: left anterior hemiblock in 26 (72%), left bundle
branch block in 4 (11%), intraventricular conduction
delay in 4 (11%), Mobitz type I in 1 (3%) and complete
heart block in 1 (3%).
To elucidate the potential role of pre-operative angi-
agraphic lesions in the development of post-operative CA,
significant stenosis (i.e., 75% or more) of the left main
coronary artery, the left anterior descending (LAD) coro-
nary artery before the origin of the first septal perfor-
ator (S1) and Sl itself were evaluated. Although arte-
rial supply to the conduction system is derived both from
the LAD (to the bundle of His, the left bundle and its
anterior fascicle) and the A-V Nodal artery of the right
(to the right bundle and the left posterior fascicle),
since we did not encounter right bundle branch block or
left posterior hemiblock 1IIl0ng the post-operative CA, we
did not evaluate right coronary lesions. Correlation of
angiographic abnormalities to post-operative CA in 137
patients showed:
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Rl\NIXMISED TRIAL OF THE EFFErI' OF ASPIRIN AND
DIPYRIDAM:lLE 00 OJ~y VEIN GRAFI' PATE:CY.
Nicholas Brooks K>. , John E.C. Wright FR:S.,
Marvin F. Sturridge FR:S., RaFtJael Baloon MD., FNX.
lDndcn Chest Hospital, lDndcn, UK.
The canbination of aspirin and dipyridarrole is
believed to improve vein graft patency. A dooble
bliIrl randanised trial was performed adding 99()tg. of
aspirin and 225mg. of dipyridarrole daily to the
routine managanent of 159 patients, and placebo, 161
patients. The 2 groups were CIOOlpaI'able in tenns of
age, sex, symptanatic state, and angiographic findings.
253 patients underwent angiography at one year. 27
patients in each group, were oot reinvestigated. 38 of
these withdrew their oonsent, 21 in the placebo and
17 in the treated group, and 16 were surgical or late
deaths. 627 of their 717 grafts (87.5%) were patent,
and 190 (75%) of patients ha:i all grafts patent.
The patency rate in the placebo group was 86% and in
the treated group 89% (ns). Patency of grafts to
vessels after endarterectany was 71% in the placebo
group and 74% in the treated group (ns) • All grafts
were patent in 74% of the placebo groop and in 76% in
the treated group (ns}, In these patients with high
graft patency rates aspirin and dipyridalrole had 00
significant effect.
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Significant lesion s
in LMCA and/or LAD
before 81 and/or Sl
*P.<0.025
Lesions proximal
with a significant
CA TOTAL
without with
without 60 13* 73
with 41 23* 64
101 36 137
to or involving Sl were associated
incidence of post-operative CA.
AHGIOGRAPHIC FEATURES OF SAPHENOUS VEIN AORTOCORONARY
BYPASS GRAFT ATHEROSCLEROSIS
Karc Enjalbert. lID; Lucien Cupen. lID, FACC; Jacquu
Lesperance, lID; Claude K. Grondin, lID; K.rtial G.
Bour••••• lID, FACC. Kontreal Heart In.titute. Kontreal.
Canad•.
Postoper.tive ansiosr.phic e:umin.tion. vere performed
in 82 unselected patient. (pts) at about 1 yr and 11
yr.. Of the 132 patent sraft. (ItS) at 1 yr. 93 re-
m.ined patent at 11 yrs (70.5~). Chanles noted in theae
patent Its after the first yr vere observed in 35/82
pts (/13~) and in 45/93 Its (4R). In our 8llperience.
th ••e ch.nle. vere .lvay. found .t reoperation to rep-
resent cla•• ic atherosclero.i. (35 pts). In 16 sts anI,
one Belment vas involved: prollillal in 13, lIid in 1 and
di.tal in 2. Ch.nles in aeveral selllent. vere .ore fre-
quent, observed in 29 Its. includinl S vith narrovinl
at one of the .na.to~.e•. In 23 It•• only one type of
Ie. ion v•••hown: eccentric .teno.i. in 7, pl.que in 6.
concentric .tenosi. in 5, vaU irrelularitiu in 4 and
cauliflower-like illase in 1. Several Ie. ion. of various
type. vere seen in 22 st•. A .pur-like le.ion .een in 5
It•• ulcer.tion noted in 6 and dil.t.tion in 2 were al-
way....ociated with other 1•• ion•. The.e chanse. vere
.i.Uar in st. to the variou.coronar, arterie. ezeept
for isolated involve..nt of the prod..l .e&Mnt which
va. ~re frequent in st. to the left anterior de.cend-
ins .rtery. All st••howed l.te chanse. in 24/51 (.7~)
pt. with .ulUple sts. The l~n of the.. "athero.cle-
roUc" sts was reduced b, Ie.. th.n 5~ in 12 sts, b,
50 to 7~ in 14. and by ~re th.n 7~ in 19. We con-
clude that late sraft ch.nse. are 1) frequent. 2) uau-
all, involve .ultiple .ite., 3) .how variou. ansio-
Ir.phic pattern., 4) frequent1, produce .evere ob.truc-
tion .nd 5) .re .lw.,. c.u.ed by atherosclerosis.
Tuesday, March 27, 1984
2:00-3:30PM Ballroom A
Clinical Coronary Blood Flow and Cardiac Function
TRANSLUMINAL SUBSELECTIVE MEASUREMENT OF CORONARY BLOOO
FLOW VELOCITY AND CORONARY VASODILATOR RESERVE IN MAN
Robert,F. Wilson
A
M.D.; Craig J. Hartley, Ph.D.; Donald E.
Laugh"n, MSEE; elv,n L. Marcus, M.D., FACC; Carl W.
White, M.D., FACC, CV Ctr, Univ of Iowa &VA Hosps, Iowa
City, IA.
Assessment of coronary blood flow velocity (CBFV) and the
reserve capacity of individual coronary vessels in the
catheterization laboratory has been hampered by methodo-
logical limitations. Such data, if obtainable, could
provide a means of assessing the physiologic significance
of coronary obstructions and of studying coronary reserve
in conscious man. aecause previous Doppler catheters were
too large to place beyond the coronary orifice, we
developed and extensively validated a small coronary
Doppler catheter (3 F tip) which can measure instan-
taneous changes in CBrV in individual coronary vessels at
the time of cardiac catheterization. Validation studies
were carried out in 7 calves in whom CaFV was varied from
0.1-5.7 x resting CaFV. CBFV measured by the catheter
correlated well with simultaneous measurements of time-
volume collections of coronary sinus flow (r=0.97, n=68,
range 52-924 ml/min). We have measured subselective CaFV
in 5 normal patients (2 LAD, 3 RCA). A prolonged stable
caFV signal was obtained in all patients. Resting C8FV
increased a mean of 5.3 fold (range 3.8-7.5 x resting
CaFV) after 0.56 mg/kg IV dipyridamole (DP) infused over
4 minutes. Onset of infusion to peak C8FV was 422 sec.
(mean, range 275-604 sec.). Mean maximal response to
intracoronary Renografin (R76) injection (2-4 ml) was 3.7
x resting C8FV (range 2.9-5.0). In nonmal conscious man
DP produces a yreater increase in C8FV than R76. This
method of measuring CBFV in individual coronary vessels
and assessing coronary vasodilator reserve in the cathe-
terization laboratory should greatly facilitate studies
of the coronary circulation in man.
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REG IONAL HETEROGENE lTV OF NORMALLY PERFUSED HUMAN
MYOCARDIUM
Pamela Douglas MD, Nathaniel Reichek MD, Kenneth Franklin
MD, Erwin Mermelstein MD, Joel Raich1en MD, Theodore
P1appert, Ali Muhammad, Martin St. John Sutton MB FACC,
Alden Harken MD FACC, Cardiovascular Section, University
of Pennsylvania, Philadelphia, PA
Regional differences in myocardial thickness and func-
tion exist in the normal canine left ventricle. To
assess myocardial heterogeneity in man, we performed
intraoperative myocardial mapping using epicardial M-mode
echocardiography at normally perfused sites in 22 sub-jects during coronary bypass surgery (n=15), mitral
(n=5), or aortic valve replacement (n=5). Mapping was
performed with a sterile 7.5 mHz fingertip transducer in
the distribution of normal coronary arteries (13 left
anterior descending (LAD), 15 posterior descending
(PDA)). Each vascular territory was divided into 5 tiers
from base to apex and digitized diastolic wall thickness
(T) and % systolic thickening (XT) determined in each
tier. Results were: (mean+s.d.; *p<.05 vs base, T in
cms)
Base 2 3 4 Apex
LAD T '2":"lY±.7 T:"S±:"5' T:"!f:"3* ~~
%T 34±17 46±25 68±30* 56±27* 57±28*
PDA T 1.4±.4 1.3±.3 1.2±.3 1.2±.4 1.0±.3
%T 44±24 49+22 57±27 69±38 51±29
Comparison of LAD and PDA territories showed no differen-
ces in regional %T although T was greater in the 2 basal
LAD tiers than in the 2 basal PDA tiers (p<.05). Thus,
myocardium becomes thinner and systolic percent
thickening increases from base to apex in the LAD ter-
ritory. In contrast, similar trends are not significant
in the PDA territory. We conclude that regional hetero-
geneity of normal myocardial thickness and systolic func-
tion exists in man.
ABSENCE OF LEFT ATRIAL BRANCH ARTERY, POSSIBLE ETIOLOGY
FOR NORMAL LEFT VENTRICULAR END-DIASTOLIC PRESSURE WITH
SEVERE LEFT VENTRICULAR SYSTOLIC DYSFUNCTION
Israel Tarnari, MD; Jeffrey S. Borer, MD, FACe; Jeffrey W.
Moses, MD, FACC; Harvey L. Goldberg, MD, FACC; Jeffrey
Fisher, MD, Cornell Medical Center, New York, NY.
Hemodynamic study of patients with coronary artery disease
(CAD) and with severe left ventricular(LV) systolic dys-
function reveals two subgroups, one group with high LV
end-diastolic pressure(EDP) and the other with low LVEDP.
Though several explanations for these findings are possi-
ble, one potential contributing factor may be that pts
with high LVEDP have normal left atrial(LA) function,
thus more completely filling their poorly compliant ven-
tricles at ED than do pts who lack the normal LA contrac-
tion, whose LVEDP thus might be expected to be relatively
lower. To evaluate this possibility, we reviewed coronary
angiograms of 50 pts with severe CAD with LV ejection
fraction(EF)~30% and without valvular heart disease or
hemodynamically important CAD-induced MR. LA branch(LAB)
(originating from the circumflex artery) was normal in
42/50 pts; 8/50 pts had inapparent or occluded LAB. Groups
were similar in age (65 vs 61 yrs,NS) and sex distribu-
tion; all were in normal sinus rhythm. Global systolic
function (EF=20% vs 23%,NS), regional systolic function
and anatomic extent of CAD were similar in the 2 groups.
Of the 42 pts with patent LAB, 40/42 (95%) had high LVEDP
(~ l6mmHg). Of the 8 pts who had inapparent or occluded
LAB, only 2/8 had high LVEDP (p(.OOl). We conclude that
LA ischemia or infarct, suggested by absence of LAB, may
be an important contributor to normal or low LVEDP seen
in some pts with severe LV systolic dysfunction; lack of
a normal left atrial contraction at end-diastole in such
pts may lead to relative underfilling of the poorly com-
pliant ventricle.
IMPROVED DIASTOLIC AND SYSTOLIC LEFT VENTRICULAR
FUNCTION DURING EXERCISE AFTER TRANSLUMINAL CORONARY
ANGlOPLASTY
Jannet F. Lewis, MD; Francisco A. Tortoledo. MD; John M.
Lewis, MD, FACC; Lawrence R. Poliner, MD, FACC; Albert
E. Raizner, MD. FACC; Mario S. Verani, MD, FACC, Baylor
College of Medicine, Houston,. Texas
To assess the effects of transluminal coronary
angioplasty (TCA) upon LV diastolic and systoliC
function during exercise, we performed radionuclide
angiograms in 30 consecutive patients before and s!2
(mean ! SD) days after TCA. The f oLlovf.ng parameters
were measured at rest and at the same exercise double
product before and after TCA: LV volumes; peak diastolic
filling rate (PDFR); global and regional LV ejection
fractions (EF). After TCA, significant decreases
occurred during exercise in end-diastolic volume (ls3!36
pre vs 127!ss ml post-TCA. p < .05) and end-systolic
volume (60!36 to 49!32 ml, p < .05). Rest PDFR was
unchanged (2.4!.8 pre vs 2.4!.8/sec post) but exercise
PDFR was improved (2.1!.7 pre vs 2.s!.7/sec post.
p<.Os). Patients with left anterior descending artery
stenosis (n=22) with abnormal exercise EF response pre
TCA «5% increase from rest to exercise), improved the
exercise global EF (+ 12%), regional septal EF (+ 24%)
and apical EF (+ 11%) post-TCA (all p < .001). Percent
coronary area stenosis was reduced from 90!9% to 41!19%
(p < .001) and transstenotic pressure gradient from
49!17 to 9!9 mmRg (p < .001) post-TCA. Thus. successful
TCA leads to early improvement of global and regional
systolic LV function during exercise. Furthermore,
diastolic properties during exercise are also favorably
influenced by TCA, an effect not previously
demonstrated.
PLATELET AGGREGATION AND PLASMA THROMBOXANE B2 LEVELS IN
ACUTE MYOCARDIAL INFARCTION
Yoshiki Takatsu, MD; Yoshiki Yui. MD; Ryuichi Hattori,
MD; Kazunori Kadota, MD; Hirofurni Kambara, MD; Tomoyuki
Murakami, MD; Keishi Sakaguchi, MD; Chuichi Kawai, MD.
FACC. Kyoto University Hospital, Japan
We studied the changes of platelet aggregation and plasma
thromboxane B2(TXB2) levels in 7 patients with acute myo·
cardial infarction. Intracoronary thrombolysis(IT) was
performed within 5 hours from the onset. The obstructed
left anterior descending arteries were reperfused by uro-
kinase( 240,OOO-600,OOOIU ). Blood samples from the aorta
(A) and the coronary sinus(C) were analyzed before, imme-
diately after. and 4 weeks after the IT.
ADP1~M(i.) AA(mM) TXB2(pg/ml)
Before A 18!10~ 3'14±1.3S~ 184'94~
IT C G 2S±13 G3.14±1.3S ~161'S3After A 31'20: 3.11'1. 4 11 : * 125'38 J :IT C: 26± 7:: 3.18±1.30j* * 261'90 :4 weeks A 51±16 : 0.67±0.23 : 74±11
after C 51±13 0.75±0.32 102±17
( ADP1~M(i.)=percentages of aggregation induced by I~M
adenosine diphosphate; AA=the lowest concentration of
arachidonic acid which produce platelet aggregation; nor-
mal range of plasma TXB2 is 60-100pg/ml; values are mean'
SD; * peO.05 ~ P<O.OI )
In conclusion. platelet aggregation in A & C before IT
was reduced as compared with those of 4 weeks after IT.
The reduced platelet aggregation showed no essential
change immediately after IT, although elevated plasma
TXB2 levels before IT further increased in C immediately
after IT probably due to wash out effect. However. these
elevated plasma TXB 2 levels decreased to normal levels 4
weeks after IT.
ABSTRACTS lACC Vol. 3, No.2
February J984:531
531
LVEDP-Rest LVEDP Post-Pacing
HCM (n-ll) 15+5** 31+6*
C (n-9) 10+3 11+3
(*-p(0.005, **-p(0.05 vs respective C; ***=p(0.05 vs HCM
rest; +-p(0.05 vs HCM mid-pacing). Peak pacing produced
AP in 12/13 pts and diminished lactate consumption in 9/13
pts with HCM. No C pt experienced AP and all increased
lactate consumption. Thus, pts with HCM have high GCV-f10w
at reat, probably due to septal hypertrophy, and achieve
.az1gua vasodilator reserve at low paced HR. The decline
in coronary flov at high paced rates may be due to eleva-
tion of LVEDP, due either to ischemia or to abnormal in-
trinsic diastolic relaxation exacerbated by tachycardia.
INFLUENCE OF VASODILATOR RESERVE AND LEFT VENTRICULAR
FILLING PRESSURE ON CORONARY BLOOD FLOW IN HYPERTROPHIC
CARDIOMYOPATHY
Richard O.Cannon, MD, Douglas R.Rosing, MD, FACC, Martin
B.Leon, MD, Rita M.Watson, MD, Stephen E.Epstein, MD,FACC,
NHLBI, Bethesda, Maryland
Angina pectoris (AP) occurs frequently in patients (pts)
with hypertrophic cardiomyopathy (HCM). To study the mech-
anism of myocardial ischemia in HCM, great cardiac vein
flow (GCV-F,ml/min) and lactate were measured at rest and
during intermediate (HR 120-130) and peak (HR 150) pacing
in 13 pts with HCM, and in 29 pts (C) with normal M-mode
echos. Cardiac index (CI) and GCV MV02 were measured at
rest and peak-pacing, LV filling pressure (LVEDP) at rest
and immediately post-pacing. Values - mean +SD.
Rest Mid-Pacing - Peak Pacing
BP GCV-F BP GCV-F BP GCV-F
HCM (n-13) 97+19 mll* 103+21 140+34* 105+24 119+29t
C (n-29) 97+12 70+22 101+13 107+34 100+14 126+37
CI MV02
HCM (n-13) 3.2+0.5 11.5+4.5
C (n-13) 3.0+0.5 9.2+3.5
CI MV02
2.9+0.8*** 13.1+4.0
3.1+0.7 15.1+4.4
PERCUTANEOUS BALLOON COARCTATION ANGIO-
PLASTY
Zuhdi Lababidi, Jiunn-Ren Wu, Pediatric
Cardiology. Univ. of Missouri. Columbia. Me
Percutaneous balloon coarctation angioplasty
(BCA) was successfully performed to treat our
first 9 consecutive patients with coarctation
of the aorta (C/O). The patients were 2 weeks
to 27 years of age.
The balloon was positioned across the ridge
of the C/O and inflated for 5-10 seconds to
pressures of 100-120 psi. The balloons were
5-18 mm in diameter (DIAM). chosen according
to the aortic arch DIAM.
The ascending aortic pressure (AsAo).
descending aortic pressure (DsAo) and coarcta-
tion gradient (fiP) were measured in mmHg
before and after BCA.
Pre-BCA Post-BCA
AsAo DsAo fiP AsAo DsAo fiP
Mean 160/85 95/73 64 122/73 109/70 11
!SD 25/19 23/20 14 11/11 14/13 6
Angiographic DIAM of the C/O increased (from
4.4 t 1.6 to 8.4 t 3.0 mm) after BCA. This
represents a 91 ! 21% increase in the C/O
DIAM, resulting in an 82 t 10% decrease in AP.
No morbidity or mortality was observed in
any patient. The femoral pulses, which were
weak, became strong and equal to the radial
pulses immediately and remained so during the
1-10 month follow-up period. BCA offers an
alternative to surgical treatment of C/O.
Tuesday, March 27, 1984
4:00-5:15PM Ballroom A
Catheter Therapy and Techniques
BALLOON ANGIOPLASTY OF COARCTATION RESTENOSIS: CLINICAL
AND ANGIOGRAPHIC FOLLOW-UP
Jean S. Kan, MD; Robert 1. White, MD; Sally E.
Mitchell, MD, Johns Hopkins Hospital, Baltimore, Md.
Six patients had successful percutaneous transluminal
balloon angioplasty (PTA) for coarctation restenosis 10
months to 17 years after the surgical repair by primary
reanastomosis (4 pts), Gore-tex patch angioplasty (1 pt),
and bypass graft (l pt ). Outpatient digital subtraction
angiography (DSA) was performed 5 to 15 months after the
procedure. Arm and leg blood pressures were measured
seri ally.
Systolic pressure gradients (SPG) indicate persistence of
hemodynamic improvement.
SPG
Post INTERVAL
angio- SINCE
Initial plasty Follow-up ANGIOPLASTY
(mmHg) (mmHg) (mmHg) (months)
60 12 0 22
32 0 0 20
60 8 2 12
64 25 8 10
68 20 0 8
66 8 6 12
In al1 patients DSA confirmed persistent relief of the
obstruction. Two of the patients had further remodeling
of the stenotic site at follow-up. There was no evidence
of aneurysm formation at the angioplasty site.
PTA appears to be an effective method for the treatment of
coarctation restenosis.
PERCUTANEOUS BALLOON AORTIC VALVULOPLASTY
Zuhdi Lababidi. Jiunn-Ren Wu, Pediatric
Cardiology, Univ. of Missouri, Columbia. MO
Percutaneous balloon aortic valvuloplasty
(BAV) was successfully performed to treat our
first 15 consecutive patients with congenital
valvular aortic stenosis ~AS). The patients
were 2-19 years of age.
After the balloon was positioned across the
aortic valve (AV) and the venous~atheter tip
was positioned in the right atrium (RA), the
two catheters were connected together outside
the groin. The balloon was then inflated to
100-120 psi for 5-10 seconds. During the
inflation the left ventricle continued to
pump through the catheters to the RA. The
balloons were 10-15 mm in diameter, chosen
according to AV diameter.
The left ventricular pressure (LV), aortic
pressure (AD), and systolic AV gradient (fiP)
were measured in mmHg before and after BAV.
Pre-BAY Post-BAV
LV AO fiP LV AO fiP
Mean 215/11 106/66 109 149/11 115/77 34
!SD 48/8 21/10 46 17/8 15/10 15
Only one patient required surgical valvu-
lotomy after BAV. At aortotomy there was
evidence of stretching and minor tearing of
the aortic cusps.
No morbidity or mortality was observed in
any patient. BAV offers an alternative to
surgical treatment of AS.
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DILATION ANGIOPLASTY OF POSTOPEPATIVE "CAVAL" OBSTRUCTIONS:
PP.ELl!!INARY RESULTS. J.E. Lock,FACCjB.P. Fuhrman;~i.J.
Rashkind; J. 1. Bass, Univ. of i1innesota, !linneapol is, !'iN
Five children(I-12 yrs) with postoperative SVC(n=2) or
IVC(n=3) obstruction underwent dilation angioplasty (DA)
2 mos to 6 yrs after operation (i~ustard,n=3; Shumacker ,
n=l; liver transplant,n=l). Caval pressures exceeded 17
~~g in each child(mean=24~:g); symptoms included viscer-
omegaly(n=3),ascites(n=l), pulmonary edema(n=2), and hy-
drocephalus(n=l).Catheters were advanced percutaneously
from femoral or jugular veins;progressively larger bal-
loons were inflated to 2 atm until a waist was seen; in-
flation was then increased until the waist disappeared.
All obstructions were very compliant:l to 5mm(mean=3mm)
diameter(D) obstructions(gradient of 7-28mnfr:g, mean=lS)
required 6-20mm balloons for DA. In one child, 2 balloons
(15 to 20mm) were used together. DA was well tolerated
despite 20-30 sec of caval occlusion. In 4 children with
fixed anatomic obstruction,DA was acutely successful;the
mean gradient fell (15 to 3mmP.g) and the mean D rose (3 to
8mm).Clinical improvement(decreased liver size,edema,etc)
has persisted for 2-4mos in all 3 survivors.A fifth child,
dilated 2-4 mos after a Shumacker repair, had "dynamic"
caval obstruction:severe tricuspid regurgitation(V wave =
34mnfrlg) compressed the superior baffle,causing marker sys-
tolic narrowing(2mm) but minimal diastolic obstruction. In
that child,DA caused no improvement in D or gradient. No
complications of DA were observed in any child.
Operative relief of 4 of these obstructions would have
required cardiac bypass;the IVC obstruction after liver
transplantation was inoperable.Although late hemodynamic
and angiographic results are not yet available,we conclude
that DA of fixed postoperative "caval." obstructions is
effective short term,although large balloons are needed,
and offers a reasonable alternative to operative manage-
ment. However, dynamic baffle obstruction appears to be
unaffected by DA.
CHRONIC PERCUTANEOUS PERICARDIAL DRAINAGE WITH KODIFIED
PIGTAIL CATHETERS. J.E. Lock, FACC; J.L. Bass;T.J.Kulik;
B.P. Fuhrman, Dept.Pediatrics, Univ. of Minnesota, Mpls.
Seven children(~ to 16 yrs) with pericardial effusions
of varied etiology(l leukemic, 1 hemorrhagic,lpostperi-
cardiotomy, 1 autoimmune, and 3 infectious) underwent
placement of pigtail catheters into the pericardial sac
for chronic drainage.All effusions were exudates(protein
3.6-5.3gm%). Catheters were placed percutaneously under
local anesthesia with fluoroscopy.After entering the peri-
cardium a curved guidewire was advanced to the posterior
pericardium,the skin and fascia were dilated using stan-
dard techniques, and a pigtail catheter was advanced over
the guidewire into the posterior pericardiac space. Cathe-
ters were then continuously drained until drainage ceased.
In the first 3 children,we used unmodified 5-6F angio-
graphic catheters with 0.032-0.038" endholes and 0.025"
side holes. In 2 children, drainage ceased within 24 hrs
despite residual pericardial fluid,necessitating surgical
drainage. In the third child, repeated heparin infusions
were required to maintain catheter patency.In the next
4 children, 8F catheters were modified by placing 0.050"
holes in the catheter shaft near the tip. All holes were
placed in the same plane as the pigtail curve, to avoid
abutment of holes against pericardium or epicardium after
catheter placement. In all 4 cases, pericardial drainage
ceased 3-7 days after catheter placement, no effusions
were present by echocardiography at catheter removal, at
least one hole was patent at catheter removal,and no fur-
ther pericardial drainage or heparin infusions were re-
quired.No complications were associated with catheter
placement or removal in any child, despite significant
coagulopathies in 4 of 7 children. The use of modified
pigtail catheters to drain pericardial effusions appears
safe and,at least in some children, effective. This tech-
nique may reduce the risk of late tamponade, and reduce
the need for operative drainage of some effusions.
COMBINED FLUID-FILLED AND MILLAR CATHETER SYSTEM
FOR HIGH-FIDELITY PRESSURE RECORDINGS IN INFANTS.
Steven Colan, Children's Hosp. Boston, MA 02115
Study of diastolic function in infants and young child-
ren has been limited, in part due to technical difficul-
ties in obtaining high-fidelity pressure recordings.
standard fluid-filled catheter systems have a limited
frequency response, typically deteriorating above 10-20
Hz with resonant frequencies of 30-60 Hz. Catheter-tip
pressure transducers are not suitable for intravascular
maneuvering in this age group. Therefore, a system was
investigated whereby a 5.0 Fr Millar catheter-tip
pressure transducer was connected directly to a standard
pigtail catheter using silicone rubber-seal luer-fitting
plastic domes. A sine-wave pressure generator was used
to determine the frequency response of this combined
system using 3.2 Fr-40 em, 4.0 Fr-50 cm, and 5.0 Fr-80 cm
pigtail catheters. The analysis was performed on three
catheters of each size, and no difference was found using
different catheters of the same size.
Findings were: (1) the 3.2 Fr system demonstrated a flat
line (100\) response to 90 HZ, rising to 160\ response at
the resonant frequency of 130 Hz; (2) the 4.0 Fr system
was 100\ accurate to 60 HZ, rising to a 175\ response at
the resonant frequency of 85 Hz; (3) the 5.0 Fr system
had a 100\ response to 35 HZ, rising to a 200\ response
at the resonant frequency of 60 Hz. Thus, this system
provides high fidelity tracings and the 3.2 Fr system is
suitable for determination of diastolic function in neo-
nates and infants.
Tuesday, March 27, 1984
2:00-3:30PM Ballroom B
Exercise Physiology: The Failing Heart
IS ST SEGMENT ELEVATION DURING EXERCISE DUE TO
CONCOMITANT VENTRICULAR DYSSYNERGY?
Roxann Rokey, MD; Robert Vaccarino, MD; Mario S. Verani,
MD, FACC, Baylor College of Medicine, Houston, Texas
A proposed mechanism of ST segment elevation during
exercise (EX) is the development of new or worsening LV
dyssynergy in the area of ST elevation. To test this
hypothesis, we performed rest and EX radionuclide
ventriculograms in 27 patients with ~ I mm EX-ST
elevation (GR I) and 37 control patients (GR II) with ~
I mm EX-ST depression. Global LV ejection fraction (EF)
was computer calculated. Ventricular dyssynergy was
assessed by measuring the regional EF of dyssynergic
segments. Each wall was also graded on a numerical
scale (normal 3 to dyskinesis -I) and a total
dyssynergy score obtained by adding individual scores
(normal score = 15). Results on table below (mean t
SD)•
GLOBAL EF(%) REGIONAL EF(%) DYSSYNERGY SCORE
REST EX REST EX REST EX------
GR I 47tl9 4S!19 32!18 29tl7 9.6t5 8.6t5
GR II 55tl3t 49t13* 39tl4t 29t18* 13t3t 11.3t4*
* p < 0.05 vr. GR II REST t p < 0.05 vs GR I REST
Severity of coronary disease, EX duration, peak heart
rate and double product were similar in both groups.
Prevalence of EeG infarction was greater in GR I vs GR
II (66% vs 35%, p < 0.05). GR I patients had no
significant deterioration of global EF, regional EF, or
dyssynergy score during EX, in contrast to GR II. Thus,
despite worse global and regional function at rest,
patients with EX-ST elevation had no significant
deterioration of global EF, regional EF, and total
dyssynergy score when compared to EX-ST depression
patients. Ventricular dyssynergy alone cannot
adequately explain ST segment elevation with exercise.
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THE EFFECT OF POSTURE ON HAEMODYNAMIC MEASUREMENTS OF
CARDIAC PERFORMANCE
Neville C. Jackson, S.P. Verma, G.I.C. Nelson, B. Silke,
S.H. Taylor, Dept. Med. Cardiology, General Infirmary,
Leeds, U.K.
For practical reasons, haemodynamic evaluation of cardiac
function is often performed in supine subjects although
most treatments for cardiac disease are for use in the
ambulant patient. This study assessed the haemodynamic
consequences of postural change at rest and on exercise
in 16 male patients with ischaemic heart disease and
either normal (NHF group n=8) or severely impaired
(HF group n=8) LV function. Intravascular pressures
were externally transduced, CO was by thermodilution and
LV filling pressure was from the PA occluded (PAOP)
trace. Supine and upright measurements were obtained
at rest and during 4 minutes bicycle exercise at an
individualised, fixed workload. Resting supine PAOP was
>19 mmHg (mean=25 mm) and Ejection fraction <30% in all
the HF group. In the NHF group restin~ supine PAOP was
<16 mmHg (mean 9 mm) and Ejection fraction >35%. In
the upright posture, PAOP fell sienificantly (NHF
9 - 3 mmHg; HF 25 - 13 mmHg p<0.005), as did CO, and
the peak exercise induced increments in mean BP and
PAOP in both groups were reduced, the peak CO beine
unchanged (NHF - 4.6 L/min/m2 ; HF 3.6 L/min/m2 ) . This
was despite a reduction in exercise tachycardia in the
upright HF group (103-94 bpm p<O.Ol), presumably
related to improved LV function followine a fall in
exercise PAOP from 41 mmHg supine to 25 mmHg upright
(p<O.OOOl). Apart from this, haemodynamic changes with
posture were qualitatively the same in both groups.
With impaired LV function therefore, haemodynamic
effects of therapy may be accentuated in the supine
position.
RELATION OF PUillONARY AND SYSTEMIC HEMODYNM1ICS TO
EXERCISE CAPACITY IN LEFT VENTRICULAR FAILURE
Joseph A. Franciosa,IID,FACC; Bonnie J. Baker, MD,
Veterans Administration Medical Center and University of
Arkansas for Medical Sciences, Little Rock, Arkansas
Exercise (E) capacity in LV failure (LVF) does not corre-
late with measures of LV performance. We recently report-
ed that E capacity correlates with RV ejection fraction
(EF) but not LVEF in patients with LVF suggesting an im-·
portant role of the pulmonary circulation during E in
LVF. We measured hemodynamics (Swan-Ganz catheter; intra-
arterial cannula; CO by Fick) at seated rest and during
upright bicycle E to symptomatic maximum in 34 patients
with chronic LVF. Maximal 02 uptake (VOmax) averaged only
12+5 (SD) ml/min/kg as respiratory quotient rose signifi_
cantly to indicate achievement of anaerobic threshold. PA
wedge pressure (PAW) rose from 20±10 to 37±9 mmHg during
E while PA mean pressure (PAM) rose from 30±13 to 52±13
mmHg (both p<.OO[). Resting CO of 4.4±2.4 L/min and rest-
ing systemic arterial mean pressure of 100±19 mmHg did
not correlate with VOmax (r=.29 and .39 respectively).
VOmax did correlate with PMI (r=-·.43, p< .02), PAW (r=-.54,
p<.O[), and total pulmonary resistance (TPR, r=-.48, p
<.01) measured at rest.VOmax did not correlate, however,
with resting systemic vascular resistance (SVR), r=.004,
or resting pulmonarv arteriolar resistance (PAR), r=-.15.
During E, TPR remained unchanged at 7±4 units, while SVR
fell from 23'8 to 15±6 units (p<.OO[). These results are
consistent with our previous observation that RVEF
correlates with E capacity in LVF. The presently
observed relation between TPR and E, and failure of TPR
to fall during E suggest that after load on the RV may be
an important determinant of E capacity in patients with
chronic LVF. Pulmonary venous hypertension during E
may be important as a contributor to TPR in LVF.
Increased levels of plasma renin activity (PRA) and anti-
diuretic hormone (ADH) are present in congestive heart
failure (CHF) at rest (R). In order to evaluate the
neuroendocrine response to exercise (Ex) in CHF, we
studied 12 patients with stable, chronic New York Heart
Association Functional Class 2-3 CHF and [[ age matched
normal controls (Nls). Both were on low sodium diets
and were studied upright at R, moderate Ex (50 watts) and
strenuous Ex (100 watts) with a bicycle ergometer. CHF
patients had higher R heart rate (mean ± SEM 88 ± 4 vs
72 ± 3 beats/min, p<.OI), but similar Ex heart rates and
blood pressures. Both ADH and PRA were elevated at rest
in CHF (3.6 ± [.3 vs 0.5 ± 0.1 pg/ml, p<.05 and 4.7 ±
0.8 vs 2.8 ± 0.3 ng/ml/hr, p<.02 respectively. Both
groups had normal serum sodium and osmolality. With Ex,
PRA and ADA increased in both groups. PRA remained
higher in CHF subjects than Nls both at moderate Ex (4.7
± 1.2 vs 3.4 ± 0.1, p=0.26) and strenuous exercise (9.4 ±
2.0 vs 3.2 ± 0.03, p<.03). ADH increases were greater in
CHF patients than Nls at moderate Ex (3.6 ± 1.[ vs 0.4 ±
0.2, p<.03) but not significantly greater at strenuous Ex
(3.9 ± 2.1 vs 2.6 ± 2.3, p>0.6). These findings suggest
that these neurohumoral responses (PRA and plasma ADH
level) are more activated in CHF than in Nls not only at
rest, but also with Ex. PRA remains several fold higher
with strenuous Ex in CHF, but ADH differences are less
pronounced with strenuous Ex.
NEUROENDOCRINE ACTIVATION IN RESPONSE TO EXERCISE IN
CONGESTIVE HEART FAILURE
Philip Kirlin MD, FACC; Roger Grekin, MD; Elaine Ballor,
BS, SuniY-D~Mo; Bertram Pitt, MD, FACC, University of
Michigan, Ann Arbor and Michigan State University, East
Lansing, Michigan.
SVRdyn/sec/~~
1706+438
2069+ 737*
SVI 2
ml/m
26+7
22+8*
STATIC EXERCISE I~ CONCESTIVE HEART FAILURE AND THE
RESPO~SE TO VASODILATORS. David Broudy, MD, Barry
Creenberg, MD, FACC, Deirdre Siemienczuk, RN, Steven
Reinhart, MD, Henry DeMots, MD, FACC, Cynthia Morris, MS.
Oregon Health Sciences University, Portland, Oregon.
In patients (p t s ) with congestive heart failure (CHF) ,
[eft ventricular (LV) performance is strongly influenced
bv changes in afterload. In normal subjects static exer-
cise (S-Ex) produces a variable cllange in systemic vas-
cular r e s t s t an c e (SVR); however, the effects of S-Ex in
pts with CHF are not well defined. Consequently, we eval-
uated the response to sustained handgrip at 50% of max-
Ima[ voluntary contraction in 24 pts with CHF. Ejection
fraction in these pts averaged .30 (range .16 - .40).
~1ean values + standard deviations for mean arterial
pressure (~L\P) ,-heart rate (HR), pulmonary artery wedge
pressure (PAW), cardiac Index (CI), stroke volume index
(SVI), and SVR at rest and during S-Ex were:
~=24 HR ~IAP PAW C[
bpm mmllg mmHg L/min/m2
Rest 87+[6 93+15 20+10 2.2+.5
S-Ex 101+17* 109+[7* 29+11* 2.2+.7
, = p < ~05; * = p < .005
Changes in CI that occurred during S-Ex were inversely
correlated with changes in SVR (r=-.62, p < .01).
S-Ex was repeated post vasodilator (V) therapy in 8
pts. Values for S-Ex pre and post V (S-ExV) were:
:\=8 HR MAP PAl, CI SVI SVR -5
bpm mmHg mmHg L/mm/m2 ml/m2 dyn/sec/cm
S-Ex 107+19 115+19 33+[1 [.9+.6 18+4 2430+944
S-ExV 112+32 102+16r 27+8 3.3+1.2* 32+8* 1199+407*
l,e conclud;;- that S-Ex causes ch ange s in after load-that
adversely effect LV performance in pts with CHF. Vaso-
dilator drugs are able to blunt the increase in SVR and
thus are able to substantially improve LV performance
during S-Ex.
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EF <33%
EF ~3370
RELATIVE PROGNOSTIC VALUE OF FOUR COtWETING TESTS ONE
MONTH AFTER UNCOtWLICATED MYOCARDIAL INFARCTION
Charles A. Dennis, MD, Joseph Hung. tID. Helena Kraemer,
PhD, Michael L. Goris. tID, PhD, Deborah Barnes, BA,
Robert F. DeBusk, MD, FACC, Stanford University School of
tledicine, Stanford, California
Although treadmill exercise testing, quant~tative exercise
thallium perfusion scintigraphy (TPS), rest and exercise
radionuclide ventriculography (RVG) and 24-hour ambulatory
ECG have prognostic value in post-infarction patients,
their comparative value is not well established. To
evaluate this issue, 81 men aged 55~G years underwent all
4 tests 28±10 days after clinically unco~plicated infarc-
tion; this cohort accounted for 50% of infarctions in the
referring centers. Within the next 6 months 11 recurrent
events occurred: 1 fatal and 1 nonfatal infarction, 1
nonfatal cardiac arrest and 8 coronary artery surgeries.
Significant univariate predictors of recurrent events
(p< 0.05) were maximal treadmill workload, magnitude of
perfusion defect on exercise TPS, rest, peak and maximal
change in ejection fraction (EF) on RVG and number of
couplets on ambulatory ECG. Only peak exercise EF signi-
ficantly discriminated by stepwise logistic regression
analysis between patients with and without recurrent
events. All univariate predictors except peak TIl workload
correlated significantly (p< 0.05) with peak exercise EF.
EVENT + EVENT-
7 8 Sensitivity 7/11 = 64%
4 62 Specificity 62/70= 89%
li- -ro Accuracy 69/81 = 85%
CONCLUSION: Within this clinically low risk population,
peak exercise ejection fraction <33% was the best single
predictor of recurrent cardiac events, subsuming most
of the prognostically important information from the
other three tests.
CARDIOVASCULAR RESPONSE TO DYNAMIC EXERCISE IN
SYMPTOMATIC PATIENTS WITH CHRONIC SEVERE AORTIC
REGURGITATION. David T. Kawanishi, MD, Charles R.
McKay, MD, P. Anthony N. Chandraratna, MD, FACC,
Michele Nanna, MD, Cheryl L. Reid, MD. Uri Elkayam, MD,
Michael Siegel, MD, Shahbudin H. Rahimtoola, MD, FACC.
USC School of Medicine, Los Angeles, California.
Cardiovascular responses to supine bicycle exercise
(EX) were measured in 12 patients (pts) with chronic
severe aortic regurgitation (AR). Radionuclide left
ventricular ejection fraction (EF) was .51±.03 (mean
±SEM) at rest and .55±.03 with EX; 7 of 13 pts had less
than a .05 increase in EF from rest to EX.
Heart rate (HR) , mean arterial pressure (MAP), mean
pulmonary artery wedge pressure (PAW), and thermo-
dilution cardiac index (CI) were measured simul-
taneously with continuous Doppler measurement of total
left ventricular output index (LVI). Regurgitant volume
index (RgI)=LVI-CI, regurgitant fraction (RgF)=RgI/LVI,
and systemic vascular resistance (SVR) were calculated.
HR MAP PAW SVR CI LVI RgI RgF
(beats/min) (mm Hg) (dyne-sec/emS) (L/min/M 2 )
REST 78 88 15 1297 3.06 6.43 3.38 .51
EX 97 102 24 1040 4.34 7.33 2.99 .38
p <.001 <.001 .002 <.001 <.001 .01 NS .002
A fall in RgF contributed to increase of CI in all pts,
even in those with large increases of PAW, and regard-
less of the EF response. The SVR tended to fall more
in pts with a poorer EF response, r=.80, SEE=119 dynes,
pCOOI.
CONCLUSIONS: In symptomatic pts with AR during supine
dynamic EX: 1) PAW increases significantly; 2)
Reduction of RgF helps to augment CI; and 3) Reduction
of SVR is greater in pts with a poor EF response, but
the reduction of RgF is independent of change in EF.
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Exercise Hemodynamics in Aortic Regurgitation
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*p < .01 by ANDVA
These data show that the EF response to ex is unrelated
to echo evaluation of LV chamber size or pump function.
However, pts whose EF + during ex had a larger V:M ratio
suggesting that compensatory hypertrophy had been inade-
quate for the degree of volume overload.
ASSOCIATION BETWEEN ECHOCARIDIOGRAPHIC VARIABLES AND THE
EXERCISE EJECTION FRACTION RESPONSE IN AORTIC INSUFFIENCY.
B. Greenberg, MD, FACC, B. Massie, MD' FACC, D. Bristow,
MD, FACC, M. Cheitlin, MD, FACC, D. Broudy, MD, B.Kramer,
MD, G. Krishnamurthy, MD, D. Cox, D. Loge, D. Thomas,Ph.D.
Oregon Health Sciences University, Portland, Oregon.
A reduction in ejection fraction (EF) during exercise
(ex) may be an early marker of left ventricular (LV) dys-
function in patients (pts) with aortic insufficiency (AI).
Increased (t) LV end diastolic dimension (EDD), end sys-
tolic dimension (ESD), and decreased (~) fractional short-
ening (%FS) by M-Mode echo cardiography (echo) may also
predict subsequent LV dysfunction. We performed radio-
isotope angiography at rest (R) and during maximal ex
and echo at R in 55 minimally symtomatic pts with iso-
lated chronic AI in order to determine the relationship
between echo variables and the EF response to ex.
Pts were divided into 3 groups (gp) based on the EF
response to ex. Gp I increased (t) EF ~.05 units; Gp II
either t or decreased (~) EF < .05 units; Gp III ~ EF>.05
units. For all 55 pts EF at R was 0.64 +0.09 (mean + S.D),
there were no differences in EF between groups. -
Echo measurements of EDD, ESD, %FS, posterior wall
thickness (PWT) , and volume/mass (V:M) ratio (normalized
for systolic blood pressure) are shown below:
N EDD ESD PWT %FS V:M
PCW
15
32***
.'.PCW
-.43
-.63*
Rest
EX
EXERCISE HEMODYNAMIC RESPONSES IN ASYMPTOMATIC AORTIC
REGURGITATION. Barry Massie,M.D.,FACC, Barry Kramer,M.D.,
Nina Topic,R.N., Barry Greenberg,M.D.,FACC, Debra Loge,
B.S., Melvin Cheitlin,M.D.,FACC, J.David Bristow,M.D.,
FACC, Randy Byrd,M.D.,FACC. VAMC and University of
California, San Francisco, CA.
To examine LV function during supine exercise (EX) in
isolated aortic regurgitation (AR), we performed
simultaneous hemodynamic measurements and scintigraphy
in 12 asymptomatic and 2 mildly symptomatic patients
(PTS) with LV dilatation. Mean hemodynamic values and
EF at rest were normal. EX tolerance was preserved
(mean 767 ! 327 kp-m/min). Although EX EF was normal in
10/14 PTS, the mean EF fell slightly with stress due to a
rise in end-systolic volume (ESV) and an unchanged
end-diastolic volume (EDV). The severity of AR as
measured by LV /RV stroke counts ratio decreased with EX
in all PTS. While CI rose significantly with EX, PCW
pressure also increased to > 20 mmHg in every °T.
Correlations of maximum EX load and EX CI with changes
(~) in other indices during EX were examined.
EF EDV ESV CI SI
67 264 91 2.8 42
61* 252 109* 8.0*** 61***
Correlations (r) with rest-exercise changes
6EF I.EDV ."ESV I.CI 'SI
Workload .45 .46 .40 .71 .29
EX CI .73** -.43 -.60* .90*** .72**
*p<.05 **p<.Ol ***p<.OOI
Thus, PTS with asymptomatic AR and LV dilatation
usually do not have a normal hemodynamic response to EX.
Despite preserved EX tolerance and ability to increase
CI, as well as normal rest and EX EF, PCW often rises
precipitously. EX capacity seems to ref lect ability to
increase forward CI, and this correlates with the EF
response and inversely with the rise in PCW.
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Thus. in AR, redistribution of f l ow (because of a decrease
in RF) and tachycardia contribute to increase in CO during
EX. The TSV does not change despite a decrease in ESV
because of a concomitant decrease in EDV.
REGULATION OF CARDIAC OUTPUT DURING E(ERCISE IN AORTIC
REGURGITATION
Abdulmassih S. Iskandrian. MD. FACC ; A-Hamid Hakki. MD.
FACC ; Angelo Amenta, NMT ; Je ff Mandler. NMT; Sally A.
Kane. RN. Likoff Cardiovascular Irst itute. Hahnemann
Univer s i ty and Hospital. Phi ladelpnia. Pa.
Radionuclide ang iographic ~.a~u remen t of the regurgi-
tant f r ac tion (Rn). based on d Lf ierences in stroke volume
(SV) count s of the 2 ventricle&. permits eva lu a tion of the
cont ribut i on of SV to net car~ i ac outpu t (CO) in aort i c
re gurgita tion (AR). We stud ~ed 10 normal s ubj ec t s
(gro up I ) and IS patients (rts) with chroni c AR (gro up II)
a t re st (R) and upr ight ex~rcise (EX). In both group s.
in creases i n heart rate a~d forward SV (FSV. ml / M2 ) con-
tributed to the increase in CO during EX. but the compen-
satory mechanisms were ';l f fer ent. In gro up I the increase
i n FSV paralleled the ~ncrease in tot al SV (TSV, ml/M2 ) ,
with no change in tfid-diastolic volume (EDV, ml/M2 ) , a
decrease in the en=~systolic volume (ESV, ml/M2)(PzO.OOOI)
and no change in RF. In group II. the EDV decreased
(P-O.02), the ESV decreased (P-0.003), the TSV did not
change . and the RF decreased (P-0 .03) ca using an increase
in FSV. (Table). The left ventricular ejection fraction
was significantly lower at rest and dur in g exercise in
group II than group I (P-O.OOOL).
I
II
R
79t27
IS3t61
EDV
EX
82t23
132t39
ESV
R EX
31tl6 23tl5
8St47 6St3S
TSV
R EX
48t13 59tl0
68tl9 66tl 4
RF (%)
R EX
9t7 9t6
53t IS 45t l 5
LIMITATIONS OF QUALI TATI VE ANGIOGRAPHIC GRADING IN
PATIENTS WITH AORTIC OR MITRAL REGURGITATION
Charl es H. Croft, MD. Kirk Lipscomb . MD, FACC, Kennet h
Ma th i s, BS, Pascal Nicod, MD, Gregory Tilton, MD , Brian
G. Firth, MD, FACC, Michael D. Wi nni f or d , MD, L. David
Hillis, MD, FACC. University of Texas Health Science
Center, Dallas, TX
This study was performed (a) to assess the accuracy of
qualitative ang iographic grading (1-4+) of aortic (AR) or
mit ra l reg urgitation (MR) and, (b) to determine factor s
that might influence t he reliability of such grading .
Accord ingly, i n 399 patients (pts) (278 men, 121 women,
mean age 52:!: 13 [meantSD] years) , forward cardiac index
( FCI) (L/ mi n/ m2) was measured by Fick and/or indicator-
dilution and LV angiographic index (ACI) by the area-
length method, from which the regurgitant index (RI) was
cal culated (ACI-FCI). Of the 399 pts, 124 had no regur-
gitat ion; in these, there was good agreement between ACI
and FCI (r=O.84). In 119 pts with AR , those with 1+ an-
giographic AR had a RI of 0.68tO.65 L/min/m 2 ; 2+, I.S8 ±
LiS; 3+. 2 .96±1.45; and 4+, 4 .86t2.15. In 156 pts with
MR , RI was: 1+. O.60tO.63 L/min/m 2 ; 2+, 1.lltO.85; 3+,
2.17 ±1.26; and 4+, 4.60t2.31. With both AR and MR. there
was considerable overlap of RI in grades 2+, 3+ and 4+.
In pt s with an LV end-diastolic volume index (EDVI) ?
120 ml/m2 , the qualitative grade was especially likely
to underestimate the severity of regurgitation (RI). The
reliability of angiographic grading was not impaired by
an enlarged LV end-systolic volume index. depressed LVEF
or elevated LV end-diastolic or LA pressure. Thus, in
pts with AR or MR, the angiographi c grading of regurgita-
t ion often is at variance with the regurgitant index,
especially in those with large LV EDVI . Therefore,
quantitative assessment of valvular regurgitation is
needed before valve replacement i s recommended.
CARDIOVASCULAR ADAPTATION TO I SOLATED AORTIC I NSUFFICIENCY
Robert L. Feldman, ~ID. FACC ; Wi l mer W. Nichols , PhD, FACC;
C. Richard Cont i . ~ID, FACC; Carl J . Pepi ne . MD . FACC,
University of Florida, Gainesv ille, FL
To evaluate adaptative re sponses to iso la t ed aort i c i n-
su f f i ci ency (AI). systemic and coron ary hemodynamic
re sponses at rest and during exercise (EX) were evaluated
in 6 foxhounds with chronic AI (pr esent > 2 yrs) and 4
littermates with acute AI (present 2- 3d) . Dogs were in-
s t r ument ed with ascending aortic (Ao) and circumflex (Cx)
ar t er y flow (F) probes (EMF) and le f t ventricular (LV)
and Ao pressure (P) transducers . EX was performed on a
treadmil l at the same workload.
RESULTS *p<.OS acute vs chr oni c , mean t SO
CHRONIC AI ACUTE AI
Res t EX Rest EX
HR (b/mi n) I lOtiO 28Lt L9 L26tL4* 229±L 9*
CO (l/min) 2. 4±. S 7. HI. 7 2. 2±.6 S. 6±1. 6*
SV tota l (ml) 37:!:7 34t6 29±3 31±4
CxF (ml/min) 4 L±6 l3St2 7 32t9* 67t20*
AoP (mmHg) LLOt8 IS6t 23 92±13* LL3t LL*
LVEDP (mmHg) - 2 7t 2 14t 2 L3t S* 22t 8*
dP/dT (mmHg- sXIO_2) 28t4 83t 3 29t3 60t 1O*LV wor k (gm-mXIO ) S9t l 4 194t 71 43t5* L03t18*
LV fun ct i on at re st was pr es erved in chronic but not
acute AI . During EX chronotropi c and in otropi c r esponses
wer e depressed in acute compa red to chr onic AI. Car dio -
vascu l ar adapt at io n to chronic AI is complex but preserves
LV hemodynamic function .
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New Antiarrhythmic Approaches
CLINICAL EXPERIENCE, COMPLICATIONS AND SURVIVAL IN
50 PATIENTS WITH THE AUTOMATIC IMPLANTABLE
DEFIBRILLATOR (AID)
Debra S. Echt. M.D.; Kaylyn Armstrong, Paula Caltagerone; Phil
E. Oyer. M.D•• F.A.C.C.; Edward B. Sti nson. "I.D., F.A.C.C.;
Roger A. Winkle, M.D•• F.A.C.C.; Stanford University, CA
Five original AID devices ut illzlng morphology criteria and 47
using only bipolar rate sensing for VT/VF detection were
evaluated in 50 pts, The primary arrhythmia was sustained VT in
22, VF in 18, and VT and VF in I I pts. The underlying cardiac
disease was CAD in 34, myopathy in 7. other disease in 7, and no
structural disease in 3. The mean NYHA funct ional class was
2.2. mean card iac index 2.6. and mean e jection fract ion 38%.
Pre-AID. the pts survived 3.3 + 2.4 arrhythmia episodes and 1.9 +
1.8 cardiac arrests and fa iled 4:0 + 2.3 drugs. Insuff icient energy
for defibr illation required intr aop-erati ve repos it ioning of spring-
patch and/or use of pat ch-patch lead conf igurations in 11 pts
(22%). with 7 ult imately rece iving 2 patches. '\her a 8.0 ! 7.4
mos follow-up (range 1-33 rnos), 25 pts received a total of 300
shocks for VT, VF, sinus tachycardia (ST). SVT. or atrial fibril -
lation (AF). It was difficult to determine the rhythm init iat ing
each shock. Shocks caused discomfort in most pts and severe
emotional problems in 5 pts (10%), 3 of whom received a total of
143 shocks. 28 pts received concom itant drug therapy to reduce
frequency of shocks. No synchronous shock in ST. SVT, or AF is
suspected of inducing VT or VF. Lead complications included
fra ctures in 2. insulation breaks in 2. and lead migration in 2 pts ,
The device was explanted in 4 pts ; due to shock acceleration of
VT to VF during pre-d ischarge testing in 2, due to poor sensing of
VT by a morphology type unit in I, and late pocket infection in 1.
One pt expired peri-operatively and 2 expired in follow-up, one
in VF and the other not due to arrhythmia. Life table analysis
indicates (,.. and 12-month cardiovascular survival of 94.5% and
88.6%, and VT/VF survival of 97.2% and 97.2%. These survival
rates are superior to all other forms of treatment we have
utilized for patients with refractory VT and VF.
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IMPLANTATION OF AUTOMATIC DEFIBRILLATORS VIA THE MEDIAN
STERNOTOMY
Richard Brodman, MO; Seymour Furman, MO; John Fisher, MO,
Montefiore Medical Center, Bronx, N.Y.
Seven patients (pts) (all alive) received 9 automatic
implantable defibrillator (AID) units during 1-15 months
(48 patient months). Six have coronary artery disease and
one, cardiomyopathy. Two also have implanted pacemakers.
One AID discharged appropriately for documented ventri-
cular tachycardia (VT). Problems were: five discharges
occurred in one pt because of rapid atrial fibrillation
(AF) above the rate limit of the AID; requiring closed
chest ablation of AV conduction. During induced ventri-
cular fibrillation (VF) this AID failed to defibrillate
on the first discharge requiring use of a higher output
(24.5 to 31.5 joules) unit. Failure to sense VT required
a rate only sensing AID in another pt. One of five pts
with superior vena cava and right ventricular apex trans-
venous leads developed transient (3 days) venous
insufficiency of the upper extremity. The present implant-
ation route is: for pts undergoing endocardial resection
via median sternotomy, one defibrillator patch is placed
over the left ventricular apex, the other over the lateral
right atrium; two sensing leads are placed on the left
ventricle and all four leads insulated and brought to
subcutaneous tissue of the left upper quadrant. For pts
with refractory VT and left ventricular dysfunction, all
four leads are placed via median sternotomy. For pts
requiring a pacemaker implant and an AID, all six leads
are placed via median sternotomy. If a pacemaker (PM) is
implanted (2 patients) a bipolar PM with both leads
widely separated from the defibrillator sensing bipole
is used. A unipolar PM may trigger the AID and be injured
by the electrical discharge. There have been no
complications of sternotomy which is safe and rapid.
EFFECTS OF NEODYMIUM:YAG LASER ON MYOCARDIAL AND VALVULAR
TISSUE. DOSIMETRY AND GROSS AND MICROSCOPIC ANATOMY
G. Michael Vincent, MD, FACC; Kirk Knowlton; John A.
Dixon, MD; Randy G. lee, MD, University of Utah, Salt
Lake City, Utah
Laser i rradi at i on (LI) causes thermal injury. Arrhythmia
source ablation or interruption of conduction may be pos-
sible using LI. We studied the effect of Nd:YAG LI on ca-
nine myocardial and valvular tissue. LI was applied to
epicardium and valve leaflets in vitro, and in 5 anesthe-
tized dogs to endocardium and valve leaflets in vivo via
a fiberoptic wave guide inserted through a cardiac cathe-
ter. Gross and microscopic studies were performed after 8
days. Inspection showed cup-shaped focal hemorrhage and
necrosis. Microscopically, necrosis and hemorrhage were
present, surrounded by 0.5 to I.Omm zone of active granu-
lation tissue. An intense necrotizing vasculitis was seen
in the RV. Transmural lesions from endocardial LI were
seen in RA, RV, and LV lesions. No perforation occurred.
Lesion size was related to energy. 30 watts(W) for 1 sec-
ondts ) (800 joules/cm2) to LV produced 2111I11 depth and di-
ameter. 40-50W for 5s (1270-1590 j/cm ) produced 4-SnIn
depth and diameter. At 80 to 90W and >ls, cavitation oc-
curred. Valve perforation, and chordal-shortening but not
rupture, occurred in vitro with 80W for 3s. Aortic cusp
LI in vivo at similar energy produced necrosis of under-
lying myocardium but little effect on valve. Multiple LI
at 40-6(1,1 and 3-4s to the same LV region produced trans-
mural Injury of 1-2cm diameter. All animals had unevent-
ful a-day post-LI course. We conclude that 1)several LI
to same area produces injury which might be appropriate
for arrhythmia ablation or conduction interruption, 2)the
injury extent and depth can be controlled by the energy
delivered, 3)valve leaflets and chordae may not be in-
jured at energy levels appropriate for myocardial le-
sions, and 4)LI appears to be well tolerated.
lRANSCAlHETER ENDOCARDIAl AIUTION-A C[J!IlARISON OF LASER PHOTOAIlLATION
AND ELECTRODE SHOCK ABLATION
Benjamin I. Lee, I'll; Ross O. Fletcher, I'll, FACCI Andrew I. Cohen, MO,
FACC; O. JoshuaCutler, I'll, FACC; Albert A. DelNegro, I'll, FACC; Steven
N. Singh, I'll, FACC. Veterans Administration and Georgetown University
I'Iedical Centers, Washington, o. C.
7.7 9.0
6.0 6.0
7.6 7.0
Intact Dogs
L E
40 320
E (IJISEC)
200 320
3.0 3. 0
2.6 1. 0
1.7 1.5
L (Watts X Sec)
20 40 BO 100
3.0 3.2 4.0 4. 5
2.0 2.8 3.2 3.8
1.4 2.4 3.7 6.8
lranscatheter electrode shock (E) has been used for ablation of His
bundles and arrhythorogenic foci. This study coroares the effects of
transcatheter laser irradiation (L) with E on canine enclocardiun.
Unipolar electrical energy in a L""", wave form was delivered via the
tip of a luninal bipolar electrode catheter. Laser irradiation was pro-
vided by a Nd-YAG laser coupled to a 0.9 ... fiberoptic core within the
electrode catheter IlJlllln. A total of 57 L and 22 E doses were delivered
to the endocardial surfaces of 2 isolated hearts and the hearts of 5
intact anesthetized dogs. Catheter position was fluoroscopically
validated and heart rhythns recorded. Gross lesion size as a function of
energy delivered is shobl!'l below.
Isolated Hearts
Length
Width
Depth
(nm)
L induced lesion size in the isolated heart increased as a function of
energy delivered. 40 "",ttsec of L achieved by 20 watts at 2 seconds
created larger lesions (3.9X2 .9X2.8 lM1) than those created by 80 watts
at 0.5 seconds (2. 5X2X1. 6 mn ). At any given energy level for L or E.
lesions in intact animals were 2-3 X larger t han those in the isolated
heart. E required 2.5-4X more energy than L to achieve lesions of com-
parable size. In intact dogs E produced freQUent episodes of sustained
ventricular tachycardia lllhile L at energy levels causing similar lesions
produced ectopy only within 1 second of delivery. Transcatheter laser
irradiation can create comparable lesions at lower energy levels, and
with less arrhythmias than transcatheter electrode shock.
Internal low energy cardiovers ion via an endocardial
electrode situated at the apex of the RV has been srown to
be successful in terminating ventricular tachycardia (VT).
We examined the stability and accuracy of sensing of the
electrogram using a prototype of an implantable cardio-
verner (Medtronic 2342, refractory period 20~s) in 12
patients with vr. We have also assessed the synchron-
isation of the right ventricular electrogram to the
surface QRS in these pat ients during 25 episodes of VT.
Electrophysiological study srowed that 14 episodes \¥ere
right ventricular and 11 left ventricular (RR 105-76Qns,
mean 372ms) in origin. Early sensing of the electrogram
(within 4~s of onset) occurred in 22 episodes (RR 250-
670, mean 37fJns), trough during these episodes occasional
canplexes \¥ere missed. In one episode (RR 700ns) sens irg ,
trough delayed 8Qns, still fell within the first half of
the QRS. In another (RR 15Qns) only alternate canplexes
\¥ere sensed with variable delay. In a third (RR 19<h1s) a
Wenckebach response caused sensing to fall outside QRS.
Sensing of the electrogram was equally ~od for right or
left VT, trough it occurred later W1en arising fran the
LV. We conclude that appropriate sens ing for VT can be
achieved with a RV apical electrode irrespective of the
origin of tachycardia and will avoid synchronised enerRies
being delivered outside the QRS conplex , Ibwever, rapid
tachycardias with RR intervals srorter than the refractory
period of the device may cause malsens ing and result in
the delivery of non-synchronised energfes ,
'!HE ASSES9-IElIT OF A PRarO'IYPE IMPIlINTABlE CARDIOJERTER
(MEUrRONIC 2342) FOR vmrRICUIAR TAOiYCARDlA.
Edward Rowland, MB; Michael Perelman, MB; Robin Barclay,
BSC; Dennis Krikler, MD, FACC, Cardiovascular [hit,
Hammersmith Hospital, London.
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LASER MICRO TRANSECTION OF THE HIS BUNDLE: A PERVENOUS
CATHETER TECHNIQUE
Onkar S. Narula, MD, FACC; Saroja Bharati, MD, FACC;
Ming C. Chan, MD; Abraham A. Embi; Maurice Lev, MD, FACC,
Cedars Medical Center, Miami, Florida
This study reports a laser catheter technique for tran-
section of His bundle (BH). Experiments were performed
in adult mongrel dogs anesthetized with Nembutal admin-
istered intravenously. Electrode catheters (SF) were
inserted via a femoral vein and positioned in the high
right atrium for atrial pacing (AP) and in the BH region
for recording of His bundle electrograms. The A-H and
H-V intervals were measured during NSR and AP. Through
another femoral vein, a laser fiber was inserted via
a lumen catheter (7F) with a preformed curved tip. Under
flouroscopic control, the laser fiber tip was positioned
immediately next to the BH electrode catheter. During
continuous BH recordings and flouroscopic monitoring,
a short burst (30-60 sec) of argon laser was delivered
(2.5 watts) resulting in instantaneous complete heart
block (CHB). Escape of a BH rhythm (CL=IIOO msec) with
a QRS morphology and duration similar to that of NSR
was noted. "SPLIT" His bundle potentials were recorded
with an unchanged A-H (50 msec) and a H'-V interval of
20 msec. In the sacrificed dogs heart, serial sections
of the conduction system have validated "SPLIT" His
bundle potentials by revealing complete micro transection
of the BH into a superior and inferior bundle with a
gap measuring 0.3 mm in depth. The A-V node, the branch-
ing portion of BH and the bundle branches were unaffected.
In conclusion: Our study demonstrates that BH can be
precisely transected with a pervenous laser technique.
These findings are of great clinical significance in
the management of cardiac arrhythmias with laser induced
micro lesions.
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TRANSIENT ENTRAINMENT AND INTERRUPTION OF PAROXYSMAL AV
NODAL TACHYCARDIA
Pedro Brugada, MD; Albert Waldo., MD, FACC; Hein JJ
Wellens, MD, FACC. Depts. of Cardiol., Univ. of Limburg,
Annadal Hospital, Maastricht, The Netherlands, and .Univ.
of Alabama at Birmingham, Alabama.
The possibility to transiently entrain and interrupt AV
nodal tachycardia (AVNT) by overdrive pacing was studied.
tn 14 pts with AVNT pacing was performed during tachycar-
dia from the right atrium and the right ventricular apex
with trains of 20 stimuli starting at a rate 10 beats/min
(b/min) faster than the tachycardia rate. Thereafter the
pacing rate was increased in steps of 5 b/min until AVNT
was terminated. Overdrive atrial pacing increased the
ventricular rate during AVNT~he pacing rate with an
increase in anterograde conduction tillle over the slow
pathway. Overdrive ventricular pacing increased the
atrial rate to the pacing rate with lIlinimal changes in
the V-A interval. Continuous resetting of the re-entry
circuit during pacing vas demonstrated in all patients
frOli the atrium and the ventricle. However, at the fas-
test atrial pacing rates not terminating AVNT variations
in the anterograde conduction time prevented demonstra-
tion of entrainment of the last paced beat. Localized
block in the slow pathway with reversal of circuit during
atrial pacing was observed in 3 patients. Fusion at the
atrial level during atrial pacing could not be demon-
strated, nor at the ventricular level during ventricular
overdrive pacing. Conclusionl: 1) The ability to de.on-
strate tranl1ent entrailllent of AVNT luggests that re-
entry is the underlying .echani.. of thil arrhythaia. 2)
Continuoul resetting of the re-entry circuit during over-
drive 11 nlpon.ible for the phenOlllenon of entrait.ent.
3) The inability to lhow atrial or ventricular fulion
during entraiaaent luggelts a true intranodal location of
the re-entry circuit.
HUMAN VENTRICULAR REFRACTORINESS: INTERDEPENDENCY OF
DRIVE TRAIN DURATION, CURRENT STRENGTH AND HEART RATE
Eric N. Prystowsky, MD, FACC: William M. Miles, MD,
Krannert Institute of Cardiology, Indiana University
School of Medicine, Indianapolis, Indiana.
The purpose of this study was to determine the effect of
drive train duration (OTO) on ventricular effective re-
fractory period (VERP) , and to test the hypothesis that
DTO, heart rate and current strength of premature stimulus
(52) have interdependent effects on VERP. Ten patients
(pt.s) had VERP determined at the RV apex with bipolar
stimuli of twice diastolic threshold (2 DT, ~1.6mA) for
basic drive train (51) and either 2 DT or 6.0IIlA via a
separate current output for S2' DTD of Sl from 2 to ~
150 beats shortened VERP from 263±21 to 228±18 msec (mean
± SO) (p<.05) with 52 of 2 DT (n-6) , and from 250±13 to
212±20 msec (p<.05) with S2 of 6.0 mA (n-3). For S2 of
2 DT and 6.0mA 60\ of VERP shortening occurred at DTD 50
beats. In four pts VERP was determined at pacing cycle
length (PCL) 600 and 400 msec at DTD of Sl of 2,4,8,12
and 50 beats using 52 of 2 DT and 6. 0mA. CUrves of VERP
(msec) versus DTO 2 to 50 beats were made and all curves
shortened (p<.OI): 284±31 to 264t21 (PCL 600,522 DT),
273±34 to 250±24 (PCL 600,52 6.0mA), 268±19 to 240±13(PCL 400, 52 2 DT) and 251±18 to 225±IS (PCL 400, 52 6.0
mA). VERP curves differed for 52 of 2 DT versus 6.QInA
at PCL 600 1llSec (p<.OS) and at PCL 400 .ec (p<.OOI).
However, at each PCL the VERP with DTD 50 beats and 52
2 DT did not differ from VERP with DTD ~12 beats and 52
6. 0IIlA. Further, a1thou9h VERP curves PCL 600 uec, 52
2 DT versus PCL 400 lIlSec, 52 2 DT differed (p<.OS), in-
creasing 52 to 6.0IIlA at PCL 600 .ec abolished this dif-
ference. We conclude that DTD has a ..rked effect on
VERP, and DTD, PCL and stiaulus .tren¢h are interde-
pendent factors for VERI' deteraination.
ELECTROPHYSIOLOGIC EVALUATION OF THE EFFICACY OF
ETHMOZINE IN PATIENTS WITH VENTRICULAR TACHYCARDIA.
David E. Mann, MD; Jerry C. Luck, MD, FACC; Craig M.
Pratt, MD, FACe; Sharon A. Magro, PAC; Valerie Sakun,
PAC; Stewart J. Katz, MD; Christopher R. Wyndham, MD,
FACC. Baylor College of Medicine, Houston, TX.
To define electrophysiologic (EP) effects of oral eth-
mozine (E) and predict outcome during E therapy, EP test-
ing (EPT) was performed control (C) in 30 patients (pts)
with ventricular tachycardia (VT) and after ~3 (mean 12)
days of oral E (mean 11.1 mg/kg/day) in 25/30 pts. E pro-
longed A-H (C vs E, mean±SD msec): 83±29 vs 100±28, and
H-V interval: 53±14 vs 66±17, QRS duration: 109±25 vs
124±27, all p<.OOI and QTc: 418±41 vs 444±47, p<.OI with-
out affecting atrial (260±41 vs 249±41, p=NS) or ventric-
ular refractory periods (238±23 vs 244±27, p=NS). Group I
(GrI) (12 pts ) with sustained (sus) VT and GrlI (18 pts)
with nonsus VT had VT induced at EPT as follows:
INDUCIBLE VT: N SUS NONSUS NONE
GrI C 12 10 1 1
E 11 7 2 2
GrI I C 18 2 4 12
E 14 3 1 10
VT cycle length increased on E (260±38 vs 313±48, p<.OI).
Prospective follow-up (1 to 624, mean 104±141 days) was
conducted in 28 of 30 pts on E (11 GrI, 17 GrII pts). VT
recurred in 6 GrI (5 sus, 1 nonsus) and 4 GrII (1 sus, 3
nonsus) pts. Death occurred in 2 GrI pts (2 sudden) and 3
GrII pts (1 during VT, 2 non-SUdden). Fourteen pts (3/11
GrI, 11/17 GrII) had no recurrent VT or death. EPT pre-
dicted outcome in 6/10 GrI and 3/13 GrII pts restudied on
E. We conclude: Ethmozine prolongs A-V nodal and infra-
nodal conduction without affecting cardiac refractory
periods and prolongs cycle length of induced VT. Ethmo-
zine may be more effective against nonsus VT than sus vr.
EPT on ethmozine may predict outcome in pts with sus vr.
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THE DEGREE OF SYMPATHETIC COUNTERREGULATION DETERMINES THE
OCCURRENCE OF REBOUND IN HEART RATE AFTER SUDDEN WITHDRAWAL
OF CHRONIC EETA - BLOCKADE
Burkhart Kramer,MD; Gabriele Kramer,MD;Michael Hausen,MO;
Wolfgang Maurer,MD;Wolfgang KUbler,MD,FACC
Medizinische Universitatsklinik 1ll,Heidelberg,W-Germany
Rebound phenomena after sudden withdrawal of chronic B-blok-
kade have been explained by changes in the number and/or sen-
sitivity of B-adrenergic receptors during chronic B-blockade.
Changes in circulating catecholamines have not been noted. To
re-investigate this question 14 healthy volunteers were sub-
jected to 8 identical submaximal bicycle exercises :(a) 3 exer-
cises at intervals of 4 days before chronic B-blockade, 1 of
these exercises was repeated after an acute B-blockade with
0.6 mg metoprolol/kg Lv., (b) 3 exercises at intervals of 4
days during chronic B-blockade (4-6 weeks) with 200 mg meto-
prolol daily p.o.,24 hours after the last dose, (c) 1 exercise
72 hours after sudden withdrawal of metoprolol.Heart rate,
blood pressure,plasma adrenaline and noradrenaline were mea-
sured before and at the end of every exercise. Results: 7 aub-
jects had a rebound in heart rate on exercise after sudden
withdrawal of metoprolol (group I), in 7 subjects there was no
rebound (group II). After sudden withdrawal of metoprolol
group I reached higher levels of adrenaline compared to the 3
exercises dur-ing chronic B-blockade; group II reached about
the same levels.Noradrenaline showed the same tendency but
without statistical significance. On 0.6 mg metoprolol/kg I ,v,
the B-blocking effects on heart rate dur-ing exercise were less
pronounced in group I than in group II. - Conclusions: After
sudden withdrawal of chronic B-blockade with metoprolol a re-
bound in heart rate on exercise could be shown in 7/14 subjects.
Subjects with rebound differed from those without (1) in their
enhanced sympathetic counterregulation after sudden withdra-
wal of chronic B-blockade with metoprolol, (2) in their reduced
hemodynamic response to an acute B-blockade.which indicates an
enhanced sympathetic response even to an acute B-blockade.
EFFICACY OF NONINVASIVE ELECTROPHYSIOLOGICAL TESTING IN
PATIENTS WITH IMPLANTED PACEMAKERS TO CONTROL ARRHYTHMIA
Ross Fletcher, MD, FACC; Andrew Cohen, MD, FACC;
Randolph Cohen, M.D.; Benjamin Lee, M.D.; D. Joshua
Cutler, M.D., FACC; Albert DelNegro, M.D., FACC; Steven
Singh, MD, FACC, Robert DiBianco, MD, FACC; Veterans
Administration and Georgetown Medical Centers, Washington,
D.C.
In 3 years 54 pts received implanted pacemakers (8 atrial,
22 ventricular and 24 dual chamber) capable of performing
non-invasive serial electrophysiological testing. 30
Medtronic Spectrax SX or SXT, 15 Versatrax 7000A-2449 and
9 Gemini 415A were used by triggering pacemakers with
chest wall stimulation in AAT, VVT or modified DDT or by
synchronized direct programming.
18 pts without clinical arrhythmia had 1 induction of
polymorphic VT at high output and rapid burst pacing. 11
of 12 pts with sustained VT and 16 or 16 pts with
sustained SVT had clinical tachyarrhythmias induced. Only
1 of 10 pts with non-sustained high grade ventricular
ectopy had sustained VT induced. After treatment with
drugs or surgery 7 of the VT pts were not induced and
have had no clinical recurrence. 11 of 12 non-inducible
pts with SVT have had no clinical recurrence. Mean
follow-up is 14.4 mos. During studies, 82 of 86 episodes
of VT and 96 of 96 reentrant SVT and 25 of 28 episodes
of atrial flutter were reverted by pacing with cardio-
version being reqUired in 4 VT and 1 SVT patient.
Serial noninvasive testing correlates with successful
clinical therapy in patients with pacemakers and clinical
arrhythmias.
SOTALOL-PROPRANOLOL COMPARISON: RELATIONSHIPS AMONGST
ANTIARRHYTHMIC EFFICACY, CLASS III ELECTROPHYSIOLOGIC
ACTION AND BETA BLOCKADE. H.J. Duff, MD., D.G. Wyse,
MD, FACC, R. Bond, RN, K. Hillier, RN, L.B. Mitchell,
MD. Dept. of Medicine, Univ. of Calgary, Calgary, CAN.
Sotalol is a beta blocker which also has Class III
action (prolongation of repolarization with little
change in phase 0). To assess whether Class III
effects, beta blockade (BB) and antiarrhythmic efficacy
are interrelated, a comparison of sotalol (Class III +
BB) and propranolol (BB) was made in 5 patients with
baseline sustained inducible VT (Ind VT). Serial pro-
grammed electrical stimulation (PES) studies were done
during gradually increasing dosages of sotalol. On the
third day of each dosage level, BB was evaluated by %
reduction in maximum exercise heart rate (Bruce Proto-
col), and plasma concentrations and OTc were measured.
In the same patients, PES was done during infusions of
propranolol at concentrations known to produce a high
degree of BB (136 ± 79 ng/mL and then 716 ± 380 ng/mL).
Results: (6 from baseline, x ± SD, * = p(0.05).
Sotalol Daily Dosage (mg)
320 640 1280
VERP (msec) 25±7 i7Ifl* 70± 7*
OTc (msec) 24±30 78±44* 98±10*
BB (%) 21%16 40± 4* 44± 4*
Conc (l.Ig/mL) 1± 1 4± 1 6± 2
Less than 8 beats of Ind VT was seen in 3 patients with
sotalol. Spontaneous Torsade de Pointes occurred in the
other 2 patients (both at 640 mg/day) and precluded com-
plete evaluation. Prolongation of VERP and OTc parallel
ed beta blockade. However, BB with propranolol was
associated with shortening of OTc and VERP and all
patients continued to have Ind VT. Class III activity
appears to be dissociated from BB and contributes to
antiarrhythmic efficacy and Torsade seen with sotalol.
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New Techniques in Myocardial Imaging:
NMR-CT-PET
ALTEUATIONS OF THE PROTON NUCL~~ I~GNETIC RESONANCE
SPIN-LATTICE r.E~{ATION TIME (Tl) IN ~EJECTING CARDIAC
ALLOG~AFTS
Adam V. Ratner, BA; Leslie V. Barrett, RN; David L. Gang,
lID. MassachusettS-General Hospital, Boston, 'Iassachusetts
To assess the ability of proton nuclear map,netic
resonance (NlW.) techniques to detect cardiac allograft
rejection, studies were performed using the rat hetero-
topic carcliac t r ansp l.ant at t on model. Hearts from Brown
Norway rats were transplantecl into the abdomen of Lewis
rats. In addition, cardiac isografts were produced in
both strains and used as control groups. After 7 days,
the donor hearts were visually assessed for function.
Hearts that ..ere not beating were excluded frOM further
study. The rats were sacrificed and both the donor and
the native hearts were removed. A section frOM each
heart was set aside for pathologic ana~ysis and measure-
Ments of Tl were obtained. Grossly all allograft donor
hearts appeared abnormal ..hile all other hearts appeared
normal. Reci?ient hearts in all ~roups and donor hearts
in the control groups had Tl values that were not sig-
nificantly different. Allograft hearts demonstrated Tl
elevation of 15.5% (n=5; p(.005) when compared to the
native hearts in the experimental group. There was 12.6%
elevation (n=7; p(.OOI) of Tl when the alloBraft hearts
were compared to Brown Norway isografts and 16.3% (n=6;
p(.02) when cOMpared to Lewis isografts. All allograft
hearts had siBnificant histologic evidence of rejection.
This spectroscopic study suggests that W!? iMaging tech-
niques which eMphasize Tl may allow assessment of cardiac
alloBraft rejection.
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THE INFLUENCE OF A 0.35T STATIC MAGNETIC FIELD ON THE
ELECTROCARDIOGRAMS OF HUMANS
Peter Lanzer, MD; Elias Botvinick, MD, FACC; Nelson
Schiller, MD, FACC; Charles Higgins, MD, FACC; University
of California, San Francisco, CA.
The application of nuclear magnetic resonance (NMR) in
medicine implies an exposure to static and rapidly chang-
ing magnetic fields. Static magnetic fields (Bo) less
than 2 Tesla (T) appear to have no harmful biologic eff-
ects. In primates at Bo of 0.1 to 7T, electrocardiogra-
phic ST-T changes have been describeJ, but no data on
human subjects is available.
We studied the electrocardiograms (ECG) of 15 patients
prior to, during, and immediately after exposure to a Bo
of 0.35T. Three low-resistance electrodes were placed on
the chest and the ECG's recorded using a specially desi-
gned NMR compatible device. From all ECG tracings the
heart rate (HR), rhythm, and amplitudes of P,R,S and T
waves were assessed and the ECG's formally analyzed. The
results were compared by a paired-sample t test. We found
a significant increase in T wave amplitude (~0.05) during
the Bo exposure. Changes in HR, P, and QRS amplitude were
not statistically significant, and there were no rhythm
changes. Upon formal analysis, 13 patients demonstrated
alterations in ST or T configuration, producing biphasic
or inverted T waves, depressed and, in one case, elevated
ST segments. Only 1 patient demonstrated an apparent de~
ay in R wave inscription. All ECG changes were immediat-
ely reversible after the cessation of the Bo exposure and
were accompanied by no complaints or complications.
The exposure to a Bo of 0.35T may alter the ECG pattern
of a human subject. Whether these changes are due to
electromotive forces associated with blood flow through
the Bo or to changes in the ventricular pattern of acti-
vation and repolarization remains to be determined.
QUANTITATIVE ASSESSMENT OF NMR RELAXATION PARAMETERS FROM
IMAGES OF ISCHEMIC MYOCARDIUM
Donald Johnston, MD; Robert Okada MD, FACC; Buckley ter
Penning, Bruce Rosen MD; Thomas Brady MD. Massachusetts
General Hospital, Boston, Massachusetts
A technique has been developed to determine corrected Tl
from a series of NMR images. Tl values were calculated
by fitting measurements taken from saturation recovery
(SR) images at 6 different pulse intervals. Correction
was made for gaussian selective excitation and spin echo
data acquisition. This technique was validated using flu-
id phantoms with known Tl values. In order to determine
how this technique could be used to assess Tl in the in-
tact heart, we studied 6 dogs; 3 underwent 3-hr LAD
occlusion (3/0) and 3 underwent 3-hr LAD occlusion fol-
lowed by l-hr reperfusion (3/1). Technetium-99m labeled
microspheres were given into the LA during occlusion and
gamma camera images of the sliced heart obtained to con-
firm the presence of ischemia. After sacrifice the ex-
cised intact heart was placed in an 8cm diameter bore
1.44 tesla (61.4MHz) superconducting magnet and imaged.
Using inversion recovery with pulse intervals of 200-
300 msec, central and peripheral ischemic zones (CZ, PZ)
were visualized as bright areas (long Tl) on cross sec-
tional tomograms. Although abnormalities were not as
clearly visualized with serial SR images, marked changes
in endocardial Tl were calculated using our technique.
Tl increased from 914 ± 70 msec in the normal zone to
1044 ± 86 msec in the PZ (p4.01) and to 1166 ± 84 msec in
the CZ (p~.OOl). The difference between PZ and CZ was
Significant (p<.05). Differences in Tl between groups
3/0 and 3/1 were not significant. Thus, the technique
described allows a quantitative assesment of regional Tl
changes from NMR images. Incremental changes within the
area of ischemia suggests that NMR may be able to iden-
tify an ischemic border zone.
ANALYSIS OF VARIATION IN VASCULAR LUMINAL NUCLEAR MAGNET-
IC RESONANCE SIGNAL INTENSITY DURING THE CARDIAC CYCLE
Peter Lanzer, MD; Elias Botvinick, MD, FACe; Nelson
Schiller, MD, FACC; Leon Kaufman, PhD; Charles Gooding,
MD; Robert Brasch, MD; Charles Higgins, MD, FACC, Uni-
versity of California, San Francisco, Calif.
The signal intensity of moving blood assessed by proton
nuclear magnetic resonance (NMR) imaging using the spin
echo (SE) technique has been related to the magnitude of
flow, with measurable intensity at flow rates below 20 cm/
sec. To determine whether such intensity changes appro-
priately parallel flow during the cardiac cycle, 6
patients were studied using ECG synchronized NMR imaging
employing a 0.35T superconducting magnet and 2D Fourier
transform acquisition at 2 SE delays of 28 and 56 msec.
In each patient, 2 imaging sequences, each comprised of
5, 0.7 em thick section, 100 msec apart, were acquired
over the cardiac base with a delay of 0-500 msec from the
ECG R wave, covering the length of the cardiac cycle. In-
tensity was measured in the lumina of visualized segments
of the aorta and cardiac chambers, in all patients, and
in the pulmonary artery, in 2 patients.
In each study, the lowest signal intensity in great artery
lumina corresponded to early systole, where blood flow
velocity may be expected to be greatest. Intensity was
maximal at end-diastole, measuring a mean increase of
246% compared to systolic intensity, in parallel with ex-
pected flow deceleration. Signal intensity in cardiac
chambers was low and demonstrated less impressive diastol-
ic increase (30%), suggesting persistent blood flow at
rates near or just above detectable levels.
Serial changes in NHR signal intensity appear to reflect
changes in blood flow velocity during the cardiac cycle.
For measurement of specific flow rates, particularly those
>20cm/sec, more sophisticated pulse sequences are needed.
REAL TIME CARDIAC CT SCANNING USING A MILLISECOND FOCUSED
ELECTRON BEAM (CINE/CT) SCANNER: INITIAL RESULTS IN PA-
TIENTS AND ANIMALS
Martin J. Lipton, MD, FACC; Charles B. Higgins, MD, FACC:
Donald W. Farmer, MD; Robert G. Gould, PhD; sandy Napel,
PhD; Douglas P. Boyd, PhD, UC San Francisco, CA.
Results from a prototype ultrafast cardiovascular CT scan-
ner (CVCT) are reported. Two simultaneous CT scans, each
0.8 em thick, were obtained with 50 millisecond (msec) ex-
posures through the hearts of a series of dogs (n=9) and
patients (n=12) with ischemic heart lesions. Two scanning
mode options were chosen. Myocardial wall thickening and
motion were studied by obtaining eight 50 msec CT exposures
during one heartbeat within 0.5 second (cine CT). Blood
flow was measured by obtaining approximately 20 scans at
the same level after intravenous administration of con-
trast media (0.15 g/kg). Each exposure was of 50 m/s but
in this mode a one-half to one second delay was chosen
between each sequential scan; utilizing ECG triggering,
each scan corresponded to the same cardiac phase. Dogs
included ischemic models with hydraulic occluders on the
left anterior descending coronary artery (n=4) , 3 week
old antero-septal infarcts (n=3) and controls (n=2). The
patient population comprised 3 patients with coronary by-
pass grafts, 4 with remote and one with a 3 week myocar-
dial infarction, and 2 patients with hypertrophic cardio-
myopathy_ The images obtained were presented in the cine
CT mode and also in the conventional format (hard copy
photographs). Image quality was comparable to that of
present whole body scanners. The rapid exposure time and
speed of repeatability were striking. Bypass grafts, wall
thinning and dynamics were identified and correlated with
conventional studies in patients and with autopsy findings
in the dogs. Preliminary results indicate exciting diag-
nostic potential for cardiac cine CT tomography.
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A SLICE BY SLICE COMPARISON OF SINGLE PHOTON EMISSION
COMPUTERIZED TOMOGRAPHY AND TECHNETIlm MACROAUTO-
RADIOGRAPHY IN THE DETERMINATION OF "RISK AREA" AFTER
ACUTE CORONARY OCCLUSION.
Sanjiv Kaul, M.D.; Robert D. Okada, M.D., F.A.C.C.;
Natesa G. Pandian, M.D., F.A.C.C.; Donna Lutrario,
Martha Barlai-Kovach, Arthur E. Weyman, M.D., F.A.C.C.;
Gerald M. Pohost, M.D., F.A.C.C.; H. William Strauss,
M.D., F.A.C.C., Mass Gen Hosp, Boston, MA.
A tomo~Taphic technique for assessing perfusion risk area
on a slice by slice basis would be clinically useful.
Accordingly, 8 dogs were studied using single photon
emission computer1zed tomography (SPECT) followed by
technetium macroautoradiography (TA). After coronary
ligation of either the left anterior descending or left
circumflex coronary artery, 1 million microspheres labeled
with technetium-99m were injected into the LA. Fifteen
minutes later, the heart was removed, placed on a holder,
and imaged with SPECT using a 360 degree sweep. The LV
was then cut into multiple slices perpendicular to its
long axis and TA performed. Myocardial area and ischemic
area were digitized for each level using both SPECT and
TA. Risk area was calculated as ischemic area/myocardial
area x 100% for each slice and the total LV. Risk areas
for each level usin both methods were as follows:
Regress on
Level E uation
mitral va ve y=. x+.
chordal y=0.96x+1.10
mid papillary y:1.16x+1.36 .92 ~P<.OOl)
low papillary y-O.98x-4.73 .77 p~.03)
a ical =3.06x+6.84 .94 .001)
The correlation between SPECT and MA was excellent at all
levels. SPECT tended to underestimate the risk area at
the apical level. The correlation for estimation of total
LV risk area was excellent (r=.98).
In conclusion, SPECT accurately estimates risk area for
the left ventricle at multiple levels except for the apex.
As the apex constitutes a small part of the total LV
myocardium, this does not significantly alter the estima-
tion of total left ventricular area by SPECT.
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Radionuclide Ventriculography-Use in Coronary
Artery Disease
E.VAli.IATICfi CF IEFT VENl'RIaJIAR REIAXATICN BY~ INIEX
U:;IN; B;JUILIBLItJ4 RADICfiOCLUE ANGlOORAPHY
T. Ilce2!'l!'lQ.MP,M. ozaki,MP, T. Yamagishi ,MD,T•Shimizu ,MP,
Y.nn-utani ,MD,M.Matsuzaki,MD, Y.MatslXla,M:>,fll£X::,T,Kumada,MD
, and R.Rusukawa,MD. Yanaguchi Univ., Ube, Japan.
'Ib assess left ventricular(LV) relaxation, EXX; gated
equiliblil.lll blood pool study was perforned in 108 patients
[18 l'lQl'llBl (N),33 angina pectoris (AP) ,42 ~al
infarction(MI),6 H04,9 CCMI. The ratio of i.Jx:renent of LV
volune fran miniJral volune to 100msec to the end diastolic
LV volune was expressed as early filling volure ratio(%EfV
). The tiJne calStant (T) of LV pressure during iSOllOlumic
relaxatioo was measured in 60 patients by weiss netrod,
The oorrelatioo beboieen %EFV and T was significant (Y=36+
49.6/X.r=0.56.p<0.001). carpa red with NUl. 3:!:L3) , %EfV
was significantly(p<O.OOl) lower in AP(6.5±l.8) , MI(5.8±
l.8), HCM(4.6±l.1) and CCM(4. 7:1:0.1). The peak filling rate
(PFR), the filling fractioo during first third of diastole
(1/3FF) and mean first third filling rate U/3FRn), now
used as the indices of LV diastolic perfontanee, Io'lere not
oorrelated with T, In additioo, in PFR, 1/3FF and 1/3FRn,
IlDre than 25% of the patients with diseased heart had
overlap with N, 00 the other hand, there Io'lere ooly 5%
overlap in %EfV. iltlreouer, 1/3FF(r=0, 74) and 1/3FRn(r=O.57)
Io'lere afected by heart rate but %EfV was not influenced by
heart rate. These result indicate that %EfV can reflect
LV relcucatioo and is a sensitive f.rTI:-=-sli~--,,-. :-
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GEOMETRY DEPENDENCE OF RADIONUCLIDE EJECTION FRACTION:
EFFECTS OF DIFFERENTIAL ATTENUATION DURING REGIONAL
HYPOKINESIS
Ricky M. Schneider, MO; Ronald J.Jaszczak, MO; R. Edward
Coleman, MO; Frederick R, Cobb, MO, Duke and VA Medical
Centers, Durham, North Carolina
This study evaluates geometric effects due to photon at-
tenuation on global ejection fraction(EF) measurements by
radionuclide angiography(RNA) during regional hypokinesis
(RH). Studies were performed in a 2-compartment left ven-
tricular(LV) model that allowed simulation of global hy-
pokinesis or anterior or posterior RH in a torso chamber
with heart to background activity comparable to clinical
studies. RNA accurately measured EF during global hypokin-
esis but progressively underestimated true EF during in-
creasing anterior RH and overestimated true EF during
posterior RH. When RNA EF(Y axis) was plotted against true
EF(X axis) for a 240 ml model, linear regression equations
were Y=l.51X - 26 for anterior RH and Y=0.60X + 25 for
posterior RH; slopes and intercepts were significantly
different, p<0,0005. Disproportionate effects of RH were
a direct function of LV size but were not affected by dis-
tance of the LV from the detector or changes in background
activity.
The experimental data confirmed mathematical models that
predicted that differential effects of RH resulted pri-
marily from differential attenuation of counts due to dis-
tance. The primary role of attenuation was further con-
firmed in the LV model by the calculation of accurate RNA
EF during RH from absolute end-diastolic and end-systolic
volumes determined using an attenuation-compensation pro-
cedure, Thus the disproportionate effects of RH on RNA EF
were corrected by considering differential photon attenu-
ation.
DIFFERENCES IN DIASTOLIC FILLING IN CORONARY DISEASE AND
HYPERTENSION: PATHOPHYSIOLOGIC IMPLICATIONS.
Alan Hirsch,M.D., Isao K. Inouye, M.D., Barry M,
Massie,M.D.,FACC, Debra Loge.B.S •• Julio Tubau.M,D ••
Paul Simpson,K.D.,FACC. VAMC and University of
California, San Francisco.CA.
Diastolic filling is abnormal in coronary disease,
hypertrophic cardiomyopathy and hypertension, but the
sensitivity of different indices of diastolic filling
varies between diseases. To determine the pattern of
abnormalities, we measured peak filling rate (PFR. in
EDV/sec), time to PFR (TPFR, in msec) and normalized
first-third filling fraction (FF1/3) by blood pool
scintigraphy in normals, untreated hypertension patients
and coronary patients. FF1/3 was defined as (LV cts
after 1/3 of diastole minus end-systolic cts)~(stroke cts
times RR interval in sec); this differs from similar
indices described by others. Only subjects with normal
ejection fractions were included.
EF PFR TPFR
Normals (n-ll) .65t.07 2.63t.39 158t27
CAD (n=l 1) .60t.09 2.03t,63* 160t22#
HTN(n-37) .64t.08 2.29t.49 190t47*#
*p<.05 vs NLS; #p<,05 CAD vs HTN
45%, 0% and 55% of coronary patients and 27%, 32%, and
89% of hypertension patients had abnormal PFR, TPFR and
FF1/3. respectively. Published reports indicate that PFR
is most often reduced in coronary disease while TPFR is
more consistently prolonged in hypertrophic
cardiomyopathy. Our findings confirm this differing
pattern of diastolic filling changes in coronary disease
and hypertrophic states. FF1/3 appears to have the
greatest overall sensitivity for abnormal diastolic
filling. We speculate that PFR is affected primarily by
relaxation changes, TPFR is determined by chamber
stiffness, and FF1/3 reflects both.
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RADIONUCLIDE LEFT VENTRICULAR EJECTION FRACTION AT REST
AND AT MULTIPLE WORK LOADS IN NORMAL SUBJECTS: INTER AND
INTRA DAY REPRODUCIBILITY
Udho Thadani, MR, FACC; Robert Burow, Kim Sung; Ronald
Lee; Don Kellerman; Dwight Reynolds, MD, FACC; Michael
Wilson, MD, FACC, OURSC and VAMC, Oklahoma City, Oklahoma.
ln the same subject, the values during two studies on the
same day varied by -5 to +5 at R, by -3 to +19 in the R
Ex position, by -11 to +3 at 200 kpm, by -25 to +5 at 400
kpm, by -24 to +3 at 600 kpm, by -7 to +4 at 800 kpm. On
two different days values varied by -5 to +3 at R, by -5
to +7 in R Ex position, by -5 to +7 at 200 kpm, by -10 to
+2 at 400 kpm, by -4 to +4 at 600 kpm, and by -10 to 0 at
800 kpm. Conclusions: Group values for EF at R and at
multiple work loads were highly reproducible on the same
and on two different days. However, in a given subject,
values during two studies varied widely. These results
should be taken into consideration when effects of ther-
apy are being evaluated in subgroup of patients labelled
responders and non-responders based on two studies.
13
3
43
5
11
2
Stenoses
3
No. Arteriographic
EXECG OF n 0 1 2
Nondiagnostic >1 55 10 15 17
n=8l -0 26 14 8 1
Normal >1 53 7 21 14
n=76 -0 23 17 3 1
Ischemic >1 102 1 22 36
n=136 -0 34 8 8 13
EXERCISE RADIONUCLIDE VENTRICULOGRAPHY: ITS ROLE IN
INTERPRETATION OF THE EXERCISE ELECTROCARDIOGRAM.
F. Earl Fyke, MD; Ian P. Clements, MD, FACC; Raymond J.
Gibbons, MD, FACC; Alan R. Zinsmeister, PhD; Manuel L.
Brown, MD, Mayo Clinic and Foundation, ROChester, MN
In 293 consecutive patients with chest pain (231 male,
62 female) who underwent coronary arteriography and supine
rad i onuc l i.de ventriculography (RVG) at rest (R) and
maximal exercise (MEX), stepwise linear discriminant
~nalysis identified from 22 RVG variables a discriminant
function (OF) employing 2 variables at R (left ventricular
ejection fraction and end-diastolic volume index) and 4
at MEX (heart rate, systolic blood pressure, left ventric-
ular ejection fraction and rate-pressure product) that
optimally djst~nguished significant arteriographic
stenosis (> 70% luminal diameter narrowing) of 1, 2 or 3
major vessels (DF>1) from no significant stenosis (DF=O).
Utility of this RVG OF as an adjunct to the exercise
electrocardiogram (EXECG) was assessed in subgroups with
normal, ischemic and nondiagnostic EXECG's obtained at MEX
during RVG (Table).
In this selected population, the RVG OF was of little
additional diagnostic value if the EXECG was ischemic; was
sensitive (88%) and specific (71%) when the EXECG was
normal; and was sensitive (79%) but less specific (58%)
when the EXECG was nondiagnostic although multi vessel
stenoses were rare (14%) if DF=O. This study has clear
implications for use of RVG after an EXECG.
64±8
66±7
66±4
62±4
64±6
65±5
Day I, Study 1
Day I, Study 2
Day 14, Study 3
Radionuclide ventriculography(RVG) is widely utilized to
assess left ventricular function and effects of therapy.
It is often assumed that in a given subj ec t , values of
ejection fraction(EF) are similar on a given day or on
different days. We evaluated the reproducibility of EF de-
rived by gated RVG at rest(R), at R in Ex position and
during multistage supine bicycle exercise(Ex) on the same
day and on two different days in 8 normal subjects. Stu-
dies were carried out in a fasting state at the same time
on different days. Group results (Mean ± SD) are shown.
R R-Ex P Ex kg meter /min
200 400 600 800
69±5 70±5 71±5 72±5
69±9 74±8 73±7 74±6
71±5 71±6 74±7 75±9
ACCURACY OF RADIONUCLlDE VENTRICULOGRAPHY IN THE DIAG-
NOSIS OF CORONARY DISEASE
James D. McMeekin, HO, Jeanne Copp, MPH, Jack E. Juni, MD
Andrew J. Buda, MD, James H. Thrall, MD, Bertram Pitt, MD
University of Michigan, Ann Arbor, HI
Recent reports have shown a lower specificity for the
detection of CAD than in initial reports. This study
reviews our experience in 383 pts with supine radionuclide
ventriculography (RVG) and coronary angiography within 6
months of each other. Of these 341 pts with a chest pain
syndrome form the study group. 151 pts had a myocardial
infarction. Significant CAD was defined as >70% stenosis
or >50% left main coronary st~nosis. Adequate exercise
(ad-ex) was defined as a pressure-rate product> 25000,
angina, or 1 mm ST depression. RVGs were graded for
ejection fraction response and wall IllOtion.
Results: Sensitivity Specificity Prevalence
1. Study group RVG .86* .33 .60
(n-34l) ECG .30 .68
2. Group w/ad ex RVG .91 .39 .64
(n-205) ECG .41 .70
3. Group w/o ad ex RVG .75* .22 .54
(n-136) ECG .14 .67
4. Group w/o HI and RVG .88** .41 .47
w/ad ex ECG .50 .70
5. Group w/o HI and RVG .60** .22 .34
w/o ad ex ECG.13 .66
*p<.05 Sensitivity of 1 vs3;**p-.005 Sensitivity of 4 vs5
ECG-Exercise Electrocardiogram
Specificity of RVG was low in all groups. For sll groups
the lensitivity of RVG was significantly greater than ECG
and the specificity of ECG was greater than RVG (p<.005).
Sensitivity of Rve was significantly improved in groups
With ad ex. These data indicate than ave is a highly
sensitive diagnostic test but demonstrates a low specific-
ity for the diagnosi8 pf CAD in thi8 patient population.
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Antiarrhythmic Drug Effects in Canine Models of
Myocardial Infarction
COMPARATIVE EFFICACY OF LIDOCAINE AND A NEW CLASS OF ANTI-
ARRHYTHMIC AGENT (BRB-I-28) ON VENTRICULAR TACHYCARDIA AND
SUDDEN ARRHYTHMIC DEATH
Benjamin J. Scherlag, Ph.D., FACC; Johannes Brachmann,
M.D.; Ralph Lazzara, M.D.; Bruce R. Bailey, Ph.D.; K.
Darrell Berlin, Ph.D., VA Medical Center, Oklahoma City,
OK and Oklahoma State University, Stillwater, OK
In the 24 hour infarcted dog heart sustained ventricular
tachycardia (VT) at rates above 300/min can be consis-
tently induced. If mean blood pressure (MBP) falls below
40 mmHg for 1-2 min, ventricular fibrillation (VF) and
sudden death (SD) occurs. We tested the comparative
efficacy of BRB-I-28, a member of a new class of anti-
arrhythmic drugs, 3,7 diheterabicyclo-nonanes, and lido-
caine in the suppression of VT and prevention of SD. In
6 dogs lidocaine (L) 2-6 mg/kg caused a decrease in MBP of
5-10% in sinus rhythm, slowed induced VT in 3 by an aver-
age of 40/min, caused no change in induced VT in 1 and
allowed induction of VT in 2 dogs in whom VT could not be
induced prior to L. In contrast, 6 dogs given BRB-I-28,
3 and 6 mg/kg intravenously, showed a 10-15% increase in
MBP. Induction of VT was suppressed in 3, (p<0.05, com-
pared to L) slowed in 2 by an average of 100/min and VT
was induced in 1 only after BRB-I-28. Electrical record-
ings from various sites showed a marked loss of amplitude
and conduction block only in abnormal tissues involved in
the presumed reentry; normal electrograms were unaffected.
We conclude that BRB-I-28 significantly decreased lethal
reentry compared to L since it suppresses or markedly
slows induced VT yet raises MBP particularly during VT
(50-60%). Although L does slow VT it further depresses
MBP and does not prevent SD, BRB-I-28, has potent and
selective depressant action on electrical properties of
abnormal tissues from which reentrant rhythms can origi-
nate.
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EFFECTS OF PACING AND DRUGS ON ARRHYTHMIAS IN 24 HOUR
CANINE MYOCARDIAL INFARCTION.
Hervi Ie Marec, M.D., Peter Oanilo , Jr., Ph.D., Michael
R. Rosen, M.D., Columbia University, New York, N.Y
Recent studies have generated cont r ove rsy about the
mechanisms responsible for arrhythn~as in the dog 24
hours post coronary occlusion. Both triggered activity
(TA) induced by delayed afterdepolarizations (DAD) and
automaticity have been proposed as the mechanism.
Therefore, we studied the response t o pacing, lidocaine
(L) and ethmozin (E) of ventricular tachycardia (VT) in
cons cious dogs 24 hours after LAD coronary artery liga-
t ion, and of sustained rhythmic activity (SRA) identified
with microelectrodes in endocardium isolated from
infarcts. In conscious dogs 24h after infarction, spon-
taneous VT cycle length (CL)=357+26ms (X+SD). Single
extrastimuli (S2) reset VT. Overdrive pacing for 60 sec
did not decrease or increase VT CL . Plasma L concentra-
tions (L)~2-5~g/ml had no effect on VT. In the presence
of (L) 6-10~g/ml, overdrive pacing suppressed VT in 1 of
7 dogs . (E) 1-5~g/ml, converted VT to sinus rhythm and
when VT recurred, it was overdrive suppressible in 6 of
dogs. These results are more consistent with the known
effects of both drugs on automaticity at low membrane
potentials than DAD. In isolated infarcted tissue SRA
CL=714+150ms. MVP was -64+6mV. DAD were seen in 10%
of infarcts and only at HOP -70 to -75mV. (L) 5~g/ml,
increased SRA CL to 901+240ms. (E) 2~g/ml, increased
SRA CL to 1527+471ms in-6 and terminated SRA in 3 of 9
experiments . In the 10% of experiments with DAD, Land E
both decreased DAD amplitude and suppressed TA. In sum,
infarcted myocardium showed automaticity at low HOP. DAD
were seen rarely, occurred mainly at higher HOP, and did
not explain most SRA. Our results suggest that the
arrhythmia in 24 hour infarcts is automatic, although TA
can be induced in some insta~ces .
ANTIARRHYTHMIC EFFECTS OF SOTALOL ON VENTRICULAR
ARRHYTHMIAS FOLLOWING CHRONIC MYOCARDIAL INFARCTION IN
THE DOG ARE DUE TO PROLONGATION OF REFRACTORINESS
Robert F. Gilmour, Jr., PhD; Phillip J. Ertel, as;
Douglas P. Zipes, MD, FACC, Krannert Institute of
Cardiology, Indiana University School of Medicine,
Indianapolis, Indiana.
The purpose of this study was to determine whether the
antiarrhythmic effects of sotalol, a S-blocker that also
prolongs the ventricular effective refractory period
(ERP) , are due primarily to prolongation of ERP. We com-
pared the effects of sotalol on ERP and inducibility of
ventricular tachycardia (VT) and fibrillation IVF) with
a sotalol derivative that prolongs ERP but does not have
S-blocking or local anesthetic properties. Open chest
dogs anesthetized with a- chl or al ose were studied 6-8 days
after 2-stage occlusion of the left anterior descending
coronary artery for two hours, followed by reperfusion.
Sustained VT or VF was induced by progr ammed electrical
stimulation of the infarcted zone and ERPs were deter-
mined in normal and infarcted zones using premature
stimuli . In 16 dogs, 32 episodes of VT and 24 episodes
of VF were produced . Sotalol (2-4 mg!kg iv bolus)
suppressed VT or prevented VT induction in 9/ 15 trials
(60\) (p<.Ol). The sotalol derivative (5-1 0 mg!kg) was
effective in 8/17 trials (47\) (p<. 05) . Neither drug
prevented reinduction of VF. Infarcted zone ERP in-
creased more (p<. 05) than normal zone ERP after sotalol
(2 .5 mg!kg) (24.1 versus 15.9 msec, respectively; n=9
and 18) and after the sotalol derivative (5 mg!kg) (14.6
versus 5.7 msec; n=ll and 20). These data suggest that
the antiarrhythmic effects of sotalol are due primarily
to increased ERP and that sotalol and a sotalol deriva-
tive may be useful to treat recurrent VT.
MECHANISM OF LIDOCAINE ACTION ON REENTRANT VENTRICULAR
RHYTHMS IN THE CANINE ISCHEMIC HEART. Rahul Hehra, Ph.D;
William Gough, Ph.D.; Robert Zeiler, Ph.D.; Nabil
EI-Sherif, HO, FACC, SUNY, Downstate and VA Hedical Center
Brooklyn, N.Y.
The mechanism by which Lidocaine (L) can prevent the i~
duct ion of reentrant ventricular arrhythmias (RVAs) is
not adequately understood. We attempted to study the ef-
fect of L on RVAs induced by premature electrical stimuli
(PES) in 10 dogs 3-5 days follOWing left anterior descend-
ing coronary occlusion. Isochronal activation maps were
drawn from 62 bipolar electrodes and correlated with re-
fractory periods (RP) and excitation thresholds (ET)meas-
ured at each electrode site pre and post L infusion (4mg/
kg + 50 ug/kg/min IV). Isochronal maps showed that RVAs
occured when the two circulating wavefronts around the
arc of conduction block joined into a common wavefront(CW)
within the ischemic zone (IZ) and then reexcited the nor-
mal myocardium. L had the following effects 1) in all dogs
it prolonged the RP at most sites within the IZ and in-
creased ET with some sites becoming inexcitable 2) RP and
ET of normal myocardium was not significantly altered. 3)
For the premature beat, the conduction time from the nor-
mal to the IZ was prolonged in all dogs. 4) In 7 of 10
dogs, L was able to prevent RVAs at long coupling of PES
but not at shorter coupling intervals. At long coupling,
the CW was blocked in the IZ where RP had prolonged signi-
ficantly. At shorter coupling of PES, there was further
increase of conduction delay with the IZ and the CW was
not blocked. In the remaining 3 dogs L did not prevent in-
duction of RVAs. Conclusions: 1) The antiarrhythmic effect
of L is prt.arily caused by its ability to block the CW
secondary to the increase in RP and ET within the IZ. 2)
In all experiments L dhd not completely abolish RVAs in-
duced by PES because of the unfavorable interplay between
conduction delay and increase of RP within the IZ.
ANTI-VENTRICULAR TACHYARRHYTHMIC EFFECT OF
ORAL CLOFILIUM IN A CHRONIC CANINE MYOCARDIAL
INFARCTION MODEL
Hideo Mitamura, MD, Eric L. Michelson, MD, FACC, Charles
Kasiewski, BS, Charles Sauermelch, BS, Leonard S. Dreifusv ,
MD, FACC, The Lankenau Medical Research Center;
Philadelphia, PA
To evaluate the ability of oral clofilium (CF), a quaternary
compound with reported class 3 antiarrhythmic activity, to
prevent initiation of ventricular tach yarrhythmias (VTs), 20
dogs with 3-8 day old myocard ial infarction were studied
closed chest using programmed st imulation. After inducibility
of VT was demonstrated in each dog, either 5 mg/kg
(GrI: n=IO dogs) or 10 mg/kg (Gr2: n=10) of CF was
administered orally . Initiation of VT was prevented in 6/ I0
Grl dogs and in 7/10 Gr2 dogs. Anti-VT efficacy was evident
at 1-2 hrs after both doses of oral CF. Notably, the duration
of effect was > 3 hrs in 3 Gr I dogs, incl uding > 24 hrs in I
dog. In comparison, efficacy pers isted for > 3 hrs in 5 Gr2
dogs, including >24 hrs in 2 dogs. In addition, slowing of the
sinus rate was observed which was still evident at 24 hrs
(GrI: -19%, p < 0.01; Gr2: -28%, p < 0.01). However,
conduction times including the PR interval and QRS width
were unchanged by either dose. The mean ventricular
refractory period (VRP) of normal t issues showed a dose-
related prolongation: Grl: .21 msec (p < 0.001), and Gr2:
.33 msec (p < 0.001). Infarct t issues showed even more marked
prolongation of mean VRPs (Grl: +34 msec, p< 0.05; Gr2:
.40 rnsec, p < 0.00 I). VRP prolongation persi sted for as long as
> 48 hrs in Gr2 dogs. We conclude that oral CF is highly
effective in suppressing VT initiation in this model. After a
single oral dose of 10 mg/kg, both antiarrhythmic and
electrophysiologic effects are prolonged. The major
electrophysiologic effect of oral CF is to prolong VRPs,
although sinus slowing is also evident. Oral clofilium warrants
further investigation as an anti-VT agent.
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SALUTARY COMBINED ANTIARRHYTIiMIC EFFECTS OF
PROCAINAMIDE AND PROPRANOLOL IN A CHRONIC
CANINE MYOCARDIAL INFARCTION VENTRICULAR
TACHYARRHYTIiMIA MODEL
Hideo Mitamura. MD. Ole-Jorgen Ohm, MD, FACC, Eric L.
Michelson, MD, FACC, Charles Sauermelch, BS, Hans Haupt,
BS, Leonard S. Dreifus, MD, FACC, The Lankenau Medical
Research Center, Philadelphia, PA
Clinically, Class I antiarrhythmic drugs are often used in
combination with a beta-adrenoceptor blocking agent,
particularly in patients with ischemic heart disease. To
compare the antiarrhythmic and electrophysiologic effects of
procainamide (PA) and propranolol (P), used alone and in
combination, 34 chronically infarcted dogs susceptible to
sustained ventricular tachyarrhythmias (VTs) were studied
using programmed pacing. Dogs received PA (20 mgJ1<g, lv)
alone (N = 27), P (0.2 mgJ1<g, iv) alone (N = 30), and the two
drugs both singly and in combination (N =23). PA prevented
VT initiation in 6/27 (2296) dogs and P in 8/30 (2796, P = NS)
dogs. Of 23 dogs studied on both drugs singly, 8 (3596)
responded to either PA andlor P; however, only 1123 (496) dog
responded to both drugs used alone. Notably, of the 15 dogs
failing both drugs used singly, the combination of PA and P was
effective in 6 (4096). Moreover, measurements of ventricular
refractory periods (VRPs) at multiple sites revealed that P
increased VRPs predominantly in normal tissue (mean 17 vs
6 msec, p < 0.01), whereas PA increased VRPs more markedly
in infarct tissue (mean 24 rnsec) than in normal tissue (mean 14
msec, pc 0.001). The combination of P and PA resulted in
more uniform prolongation of VRPs (37 vs 32 msec, p = NS) and
decreased dispersion of refractoriness between normal and
infarct areas, respectively. Effects on ventricular conduction
were minimal. Thus, the combination of PA and P has salutary
effects in preventing ventricular tachyarrhythmia initiation in
this model. An electrophysiologic mechanism for this
favorable interaction is suggested.
Tuesday, March 27, 1984
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Clinical Studies in Congestive Heart Failure
ABNORMAL AUTONOMIC CONTROL MECHANI SMS IN HEART FAILURE.
Adam TiMmis MD, John Kenny MB, Paul Smyth MB, Stephen
Campbell BSc, Stephen Kerkez MSc, David Jewitt FRCP.
King's College Hospital, Denmark Hill, London, SES 9RS UK
The mechanisms underlying the abn ormal r esponses to
orthostatic stress in heart fa ilure are i l l defined and
little is known about the effects of t he rapy . In t hi s
study, ther e fo r e , haemodynamic and adrenerg i c responses
t o uprigh t tilt were measur ed i n 9 pa tients with hea r t
fa ilure (NYHA grade III) treated for 4 week s with
felodipine , a new vasodilating ca l c i um antagoni st. Be fore
treatment tilt produced significant reductions in
pu l monary wedge pressure (19±3tc5±3 mmHg) and car d iac
i ndex (2 . I ±O. 1 t o 1. 8±0.1 l / min/m' ) but or thos t a t ic
reflexes wer e not act ivated: nor ad r e nal i ne and hea r t rate
r emain ed unch anged and blood pressure fell f r om 98±3 t o
93±4 mmHg (p<O. OS ) . Felodipine 30 mg daily r ap i dly
improved left ventricular(LV) function but res toration of
orthostatic reflexes was delayed 48 hours. Thereafter
tilt-induced reductions in LV filling and cardiac i nde x
pr oduced normal r ises i n noradrenaline (212±46 to 360±78
pg /ml ;p<O .OS) and heart rate (82± 3 to 91±4 bpm;p<O.OOll
but postural hypotension persisted because the vascular
effects of felodipine prevented i nc re ments in s ys t emic
resistance. Drug withdrawal caused prompt haemodynami c
deterioration. Orthostatic reflexes, however, were still
intact 48 hours later when tilt e l i c i t ed a completely
normal pattern of responses. Thus the abnormal
orthostatic responses in heart failure are due to
impairment of autonomic control mechanisms and not to
absence of venous pooling. Importantly the autonomic
dysfunction is reversible with felodipine therapy. There
is pronounced temporal dissociation between the changes
in reflex responsiveness and the changes in LV function.
THI RD HEART SOUND IN PATIENTS WITH CLINICAL CONGESTIVE
HEART FAILURE AND NOID~ LEFT VENTRI CULAR SYSTOLIC PER-
FORMANCE
Danie l \lohl ge l e r nt e r , MD; Rober t Soufer , MD; Nes t or Vita,
MD ; Ma r cos Amu chastegui , tID ; H. Di rk Sostman, MD; Harve y
J. Berger, MD, FACC; Bar r y L. Zare t , MD, FACC , Ya l e
Un ive r s i ty , New Haven , CT
The th ird hear t s ound (53 ) i s regarded as a mani festa tion
o f left ven t r i cul a r (LV) sy s t ol ic dys fun ction i n conges t -
i ve heart f ai l ure ( OiF), and has been adv ocated as an i m-
portant cl i n i ca l i nde x o f s ui t ab i l i t y fo r digitalis ther-
apy . Ove r a one yea r period we prospectively identified 21
pa tien ts (pts) with an 53 ga l l op , c l i ni ca l CHF, and normal
LV e ject i on fraction (mean ~ SD: 60~1 2% ) . The S3 in ea ch
pt was noted on auscultat i on by two i ndependent observers.
CHF was documented by an obj ec t i ve clinical and radio-
graph ic i ndex and was 10+2 (maximum s cor e- 13) . A high tem-
poral r e so l ut i on nuclear-probe study was used to measure
peak f illing rate (PFR) , an index of diastolic function.
Abnormal diastolic function (PFR <2. 5 EDV/sec and/or pul-
monary capi l l ar y wedge pressure >18mm Hg) was present in
8 o f 21 pts . PFR was at the lower limits o f normal (2.5-
3. 0 EDV / s ec) in 3 pts with no other evi den t mechanism for
CHF. CHF and 53 were attr ibuted to vol ume overload /renal
f a ilu re in 3 pts, and t o "s ilent" mitral regurgitation
( docume nted by angiograph y) i n 2 pts. Mechanisms were un-
known i n 5 r ema i ni ng pts.
Thus, an 53 may be pres ent in pts with CHF and normal sys-
t olic LV fun ction. In ce r t a i n cases, this may reflect LV
diastoli c dysfunction. An 53 is not always an indicator of
systoli c dysfunction and may not be the most reliable in-
dividual c r i t e r ion for institut ing conventional CHF thera-
py such as d igitalis.
EXERC ISE IN ~OLE RANCE IN PATIE NT S \>l ITH CHRONIC HEART
FA ILURE: ROLE OF IMPAIR ED SKELETAL NUTRITIVE FLOW
John R. Wilson, MD; Jack L. Mart i n, MD, FACC;
Nancy Ferraro, RN; David Schwartz, MD , FACC, Uni vers i t y
of Pennsyl vani a, Philadelphia, PA.
The maximal exercise capacity of patients with chronic
heart failure (HF) is frequently reduced. To investigate
whether this exercise intolerance is due to inadequate
skeletal muscle nutritive flow, we compared cardiac
outputs, leg blood flows and leg metabolism during
maximal bicycle exercise in 7 patients with normal
maxima l V02 (>20 ml/min/kg; Group A) and in patients with
HF and either moderately (15-18; Group B; N=8) or
markedly « 14; Group C; N=8) reduced maximal V02 ' In
al l 3 groups , exerc ise incr eased systemic and leg blood
flow l i near ly with increas ing workload. In Group A,
cardi ac output= .085 watts + 5.6 L/min and leg flow =
.039 watts + . 79 L/min . Syst em ic and leg flow responses
were s iQnifi cant ly lower in both Groups Band C, consis-
t ent with reduced skeletal muscle perfusion; flow
reduct ions averaqed 20~ in Group Band 40% in Group C.
Th ese flow abnormalities were assoc iated with heightened
leg 02 ext r act ion (A:72t6%; B:8Ot8%; C:85t7%), support ing
a decrease in muscle flow, and with early leg lactate
release (A :60±16 watts; B:37t21 watts; C:20±0 watts ),
suggesting a compensatory increase in muscle anaerobia-
s is . Al l pat ient s discont inued exerc ise due to leg
f ati gue . At exhaustion, pat ients in Groups Band C
exhi bi t ed siqnificantly higher leg 02 extraction and
femoral venous lactate levels than noted in non-exhausted
patients exercising at equivalent workloads, suggesting
that exhaustion was due to achievement of a critical
level of muscle underperfusion . These data suggest that
the reduced maximal exercise capacity of patients with
chronic heart failure is primarily due to impaired
skeletal muscle nutritive fl9w.
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CORRELATION BETWEEN HUMAN MYOCARDIAL BETA
RECEPTOR DENSITY AND LEFT VENTRICULAR FAILURE IN
HEART TRANSPLANT RECIPIENTS.
Michael B. Fowler, MB, MRCP; Michael R. Bristow, MD, PhD;
Wayne A. Minobe, BS; Robert Ginsburg, MD; Jeffrey A. Laser,
MD; Stanford University School of Medicine, Stanford, California
We have previously described decreased J3 -adrenergic receptor
density (BRD) in failing human left ventricles. To establish the
relationship between BRD and left ventricular performance
polynomial regression analysis was used to correlate BRD
(maximum [3H 1 DHA binding in fmol/mg) and the ratio of
maximum isoproterenol to maximum fluoride stimulation of
adenyl cyclase O/F-AC) with the severity of left ventricular
failure in 19 patients whose hearts were removed for cardiac
transplantation. The severity of heart failure was assessed from
cardiac catheterization data, NYHA functional class, and a
quantitative clinical heart failure score derived from signs,
symptoms, and radiographic data (HFS). Resting cardiac index
(mean+ISD = 1.7+0.5 L/min/m2), NYHA class (mean 3.4+0.6), and
heart failure score were found to correlate with BRD (mean
31.6~15.1 fmol/mg; value for normals 60.4:<:6.1 fmol/mg) and
I/F-AC (mean 61~22%). The correlations are:
BRD !/F-AC
r p r p
C.I. 0.83 0.01 0.59 0.05
NYHA -0.58 0.01 -0.73 0.01
HFS -0.56 0.01 -0.49 0.10
Conclusion: B-receptor "down-regulation", a marker for
exposure to catecholamines, correlates with the severity of
heart failure and may be important in its pathophysiology.
IMPROVED HEMODYNAMICS,BUT REDUCED ARTERIAL P02,AFTER
ORAL PRAZOSIN IN PATIENTS WITH COR PULMONALE
H.Vik-Mo,MD,N.Walde,MD,H.Jentoft,MD,F.J.Halvorsen,MD.
Depts.Clln.Physiol.& Pulm.Diseases,Haukeland Hospital,
Unlv.of Bergen,Norway.
Eight patients with chronic obstructive pulmonary disease
(COPD) and heart failure were evaluated for acute and
longterm response to oral prazosin {PZ).Right heart
catheterization was done before,after one week and after
two months of treatment with PZ {2-10 mg/day).Measure-
ments were done at rest and during bicycle exercise.At
re~t PZ reduced_mean pulmonary artery pressure (PA) from
26+4 mmHg (Mean+SD) by 16% after one week (**)(**=p<O.Ol
vs before) and by 9% after two months (*)(*=p<0.05 vs
before) ,increased cardiac output (CO) from 4.0+1.0 I/min
by 11% (*) and 17% (*),reduced pulmogary vascular resi-
stance (PVR) from 289+45 dyn.sec.cm- by 33% (**) and 32%
(**) and reduced sys!emic vascular resistance (SVR) from
1563+404 dyn.sec.cm- by 16% (**) and 23% (**),res~ective­
ly.Heart rate (HR) was unchanged.Arterial pO ,7.7+1.0
kPa before PZ,fe11 by 7% (*) after two months~but was not
changed after one week.During exercise similiar signifi-
cant changes were observed in PA,CO,PVR and SVR both
after one week and two months,with unchanged HR.Arterial
pO? fell by 8% (*) after two months,but not after one
week.Lung function tests were not changed by PZ.None of
the patients had left ventricular dysfunction.
The above data suggest that oral PZ have an acute and
longterm hemodynamic effect in cor pulmonale due to COPD
with reduction in PVR and elevation of CO.However,since
arterial P07 is reduced during longterm treatment,caution
IS adVised Tn the use of PZ in these patients.
LOW DOSE DOPAMINE ADDED TO INOTROPIC DOSE DOBUTAMINE
IMPROVES RENAL HEMODYNAMICS IN LEFT VENTRICULAR FAILURE
Gary J. Rogal, MD; Rufino C. Pabico, MD; Barbara McKenna;
J. Franklin Richeson, MD, University of Rochester Medical
Center, Rochester, New York
Tuesday, March 27, 1984
2:00-3:30PM Room 5412/413
Factors Affecting Myocardial Ischemia
%ofPre-lsc NS IOO.O.:!:,O.O 46.1.:!:,9.3 71.1+4.3
Strain (0)020 AIR 100.0+0.0 71.2+4.4* 104.3+14.0*
. (values are mern+SE, *p< 0.05 AIR vs NS) -
Increased ATP levels resulted in improved diastolic compliance (a
right-ward shift in the static stress-stmin curves). Oor data
suggest: (I) ATP levels will recover more rapidly with AIR
infusion. (2) The return of ATP levels and diastolic compliance
correlate temporally. (3) Diastolic compliance can be improved
by increasing myocardial ATP levels following rn Isc insult.
48 hrs post-Isc
2.70+0.37
4.15+0.26*
RELATIONSHIP BETWEEN RECOVERY OF MYOCARDIAL ATP
LEVELS AND CARDIAC FUNCTION FOLLOWING ISCHEMIA
Herbert B. Ward MD, Jolene Kriett, MD, John A. St. Cyr, MD,
David Alyono, Mh, Richard W. Bianco, BA, Stonley Einzig, MD,
PhD, Robert W. Anderson, MD, FACC, John E. Faker, MD, PhD,
Lkliversity of Minnesota, Minneapolis, MN
Recovery of ATP levels and cardioc function following 20 min of
normothermic global ischemia (lsc) on cardiopulmonary bypass
were studied in 13 awake, chronically instrumented dogs. Saline
(NS, n=8) or adenine (A, 20 mM) plus ribose (R, 80 mM) (n=5) was
infused (I rnl/rnin) into the RA for 48 hrs starting at the end of
lsc, Infusions were stopped one hr before measurements. We
measured axis diameters and wall thickness by sonomicrometry,
LV transmural pressures and dP/dt by micromanometry and CI by
microspheres. Endocardial septal bi?f,sie1were token via an RVcannula. Static stress (r:I , dynes x 10 Icm )-strain data and
maximum LV pressure-volume ratio (Emax, mmHg/ml) were
obtained ciJring transient vena caval occlusion. While no
relationship could be established between ATP levels and Emax,
dP/dt or CI, ATP levels correlated with diastolic compliance
(r=0.59, p< 0.01l. Systolic function indices returned to normal
more quickly thrn ATP levels in both qroips.
Pre-Isc 4 hrs post-Isc
NS 5.0(>+0.18 2.43+0.20
AIR 4.32~0.24 2.91~0.30
ATP
(nmol/mg)
CI 1.85±.15 2.77±.32* 3.05±.34*
PCW 25±2 l7±2* 19±2*
TPR 4038±438 2646±359* 25l8±353*
U 59±11 68±6 110±9*t
GFR 69±13 68±2 79±7
RPF 2l5±46 220±19 3l3±53
FF .33±.03 .32±.03 .28±.03*t
FENa .56±.39 .6l±.37 .74±.39*
RVR l5847±2800 l2957±1345 10028±12l7*t
Table shows mean±SE; *p<.05, vs. Period 1; tp<.05, vs.
Periods 2&4; FF = filtration fraction
In no pt did arrhythmia, blood pressure or tachycardia
worsen with addition of Dp. We conclude: 1) Beneficial
hemodynamic effects of Db are preserved without increased
toxicity with addition of lo.-dose Dp; 2) Beneficial
renal hemodynamic and excretory effects occur when low-
dose Dp is added.
We tested the hypothesis that addition of low-dose dopa-
mine (Dp) improves renal hemodynamics in patients (pts)
receiving dobutamine (Db) for left ventricular failure
(LVF). Cardiac index (CI L/min), pulmonary wedge pressure
(PCW rnm Hg), peripheral and renal resistances (TPRdyn '
sec'cm- s, RVR dyn'sec'cm- s), urine flow (U cc /H}, glomer-
ular filtration rate (GFR cc/min), renal plasma flow (RPF
cc/min) , fractional sodium excretion (FENa) were measured
in 6 pts during five sequential periods, starting with
the drug free state (Period 1); measurements were repeated
while on Db alone (Periods 2&4; 911g/kg/min, mean), and
with Dp (Periods 3&5; 311g/kg/min) added to the Db regimen.
PARAMETER PERIOD 1 MEAN 2&4 MEMI 3&5
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ENHANCEMENT OF FUNCTIONAL RECOVERY OF "STUN-
NED", REPERFUSED MYOCARDIUM BY A NEW ULTRA-
SHORT-ACTING BETA-BLOCKER.
Rudiger Lange, MD; Robert A. Kloner, MD, PhD, FACC;
Eugene Braunwald, MD, FACe, Harvard Medical
School/Brigham and Women's Hospital, Boston, MA
Reperfused, nonnecrotic myocardium is known to exhibit pro-
longed depression of regional function following short periods
of experimental coronary occlusion ("stunned myocardium").
We investigated whether a new ultra-short acting beta-blocker
(ASL-8052) enhances functional recovery when given prior to
and during coronary occlusion but not during reperfusion.
ASL-8052 allows short-term beta blockade because its action
ceases within 16 min following discontinuation of its admini-
stration. Anesthetized open-chest dogs instrumented with
ultrasonic crystals to measure epi-and endocardial percent
segment shortening (%SS) were subjected to a 15 min LAD
coronary occlusion followed by 240 min of reperfusion. Treat-
ed dogs (T) (n=12) received an infusion of ASL-8052 (l0D-150
I!&fkg/h) starting I h preocclusion and ending at onset of
reperfusion. Control dogs (e) (n=12) received saline. Regional
myocardial blood flow was similar in e and T during occlusion,
and during reperfusion. ASL-ll052 caused an 18% decrease of
heart rate and LV dP/dt prior to occlusion (p < .005). Baseline
values for endocardial %SS were 21 ~4% (~SD) in e and
23 ~ 7% in T dogs. During occlusion endocardial %SS was
-1I~6% in e and -8~5% in T dogs. However, by 240 minutes
of reperfusion endocardial %SS had recovered to II 1:12% in T,
but only to 0 ~9% in e dogs (p < .05). Recovery of epicardial
%SS was 0 t 3% in e and I t 6% in T (NS). We conclude that
ultrashort acting beta blockade with ASL-8052 protects ische-
mic subendocardium when given prior to and during occlusion
and accelerates functional recovery during reperfusion.
DOES FLUOSOL-DA llfPROVE PERFUSION DISTAL TO CORONARY
STENOSIS IN ANESTHETIZED DOGS? J.G . Kingma, Jr., Ph.D.;
J.R. Rouleau, MD, FACC; J. Magrina, MD; M. Harvey and
G.R. Dagenais, lID, FACC, Laval University, Quebec, Canada.
FLUOSOL-DA(FDA) is a suitable oxygen carrier to myocar-
dial and cerebral tissues. To examine the effect of FDA
on the coronary pressure-flow relation (PFR) during
maximal coronary vasodilation and intact autoregulation,
FDA was infused (25ml/kg, i.v.) in 11 anesthetized dogs.
Arterial paZ was maintained above 300mmHg throughout the
experiments. lIyocardial blood flow was measured with 8
different 15~m radioactive spheres injected at 4 diffe-
rent diastolic circumflex artery pressures (Pcd) before
and after FDA. During vasodilation, the PFRs for the
entire LV posterior wall, or for the subendo- and subepi-
cardial layers were linear (r>0.90) before and after FDA.
FDA did not modify the slopes of the PFRs or the pres-
sure intercepts at zero flow in these regions. During
intact autoregulation, at control Pcd, posterior wall
blood flow (PBF), posterior:anterior (P:A), and subendo:
subepicardial blood flow ratios/gram (1:0) remained
unchanged after FDA. However, after FDA the autoregula-
tory curve was shifted to the left enabling a further
Pcd (mean±SD) decrease of 19±3mmHg at control PBF and of
12±7 and 8±6~Hg at 0.75 and 0.50 control PBF respectively
while preserving subendocardial perfusion as shown here
for 0.50 control PBF:
Hct Fct Ped PBF P:A 1:0 m02 MLE
FDA- 45 0 26 49 0.50 0.31 6.31 36
FDA+ 34* 2.9+ 22* 57 0.53 0.55+ 6.62 25
*: p<0.05; +: p<O.OOlj ANOVA. IILE: myocardial lactate
extraction (%); Ped= mmHg; PBF, ~W02= ml/min/lOOg.
Thus, FDA does not modify the PFR during vasodilation; how-
ever, FDA extends the lower end of the coronary autoregu-
latory range and preserves subendocardial perfusion by
itrreasing the 1:0 from 0.31 to 0.55 at the lower Pcd level.
PREVENTION OF MYOCARDIAL INJURY AND CIRCULATORY COLLAPSE
IN SHOCK YITH FRUCTOSE 1-6 DIPHOSPHATE
Angel K. Markov, MOi Joe Terry, BS; Ralph Didlake, MDi
Patr,ck H. Lehan, MD, FACC; Harper K. Hellems, MD, FACC,
University of Mississippi Medical Center, Jackson,
Mississippi
The heart plays a central role in every known type of
circulatory shock, either in the terminal stages or i n
the be~inning of decompensation of the circulatory
system. This study was designed to verify whether
fructose 1-6 diphosphate (FOP) will prevent cardiac
damage and circulatory failure in two types of lethal
hemorrhagic shock. In 140 do~s shock was induced either
by fixed volume (FV) blood withdrawal (n • 72) or by
maintain ing MAP of 35 mm Hg for) hours and 15 min
(n • 68) . The controls received 10% glucose or 2.5%
NaCI while treated animals received lOX FOP from 1.25 mg
up to 12 mg/kg/min. Treatment was initiated up to 2
hours after exsanguination. Some dogs (n • 70) were
sacrificed for ATP, CP, FDP, lactate and pyruvate
content of the hearts while the rest were allowed to
recover. FOP prevented EKG ischemic changes and
improved cardiac output (p < 0.01), dp/dt (p < 0.01) and
MAP (in FV p < 0.01). The myocardial ATP and CP were
significantly higher (p < 0 .005 and p < 0.01) in the FDP
treated animals as well as other intermediates of gly-
colysis. The survival rate in the FDP treated group was
88% and for the controls 18% (p < 0.0005). Conclusions :
(1) Administration of FDP to dogs subjected to severe
hemorrhage prevents myocardial damage and circulatory
collapse. (2) The therapeutic effect of FOP appears to
be metabolically mediated by intervening in glycolysis
both as a metabolic regulator and high energy substrate.
CORONARY FLOW RESERVE AND HEART FUNCTION IN EXPERIMENTAL
HYPERTROPHY: COMPARISON OF AORTIC STENOSIS AND STENOSIS-
REGURGITATION
Qian 'Sufan, MD; Jose M. Brum, MD; Alfred A. Bove. MD,
PhD, FACC, Mayo Clinic. Rochester, MN
Coronary blood flow (CBF) and heart function were studied
in 6 dogs with subcoronary aortic stenosis (AS) produced
by suturing teflon masses into the sinuses of Valsalva;
in 4 dogs undergoing aortic leaflet suturing which
resulted in aortic stenosis and insuf fic iency (AS- AI ) and
in 6 dogs undergoing heart-lung bypass with aortic cross-
clamp and aortotomy only (C). Study was car r i ed out 2
months after operation. The result s were as follows :
C AS AS-AI
LV-AO gradient (mmHg) a 56.6+27. 5 32.0+10.5
LV weight (gm) 91. 3+3.6* 126.8+15.1 145. 2+ 15.2
LV/body (gm/kg) 4. 24+0. 27* 6.38+0 .90 7.18+0.50
EF 0.68+0.08 0.72+0.04 0.78+0.05
Stroke vol (ml) 45.8+5.7 51.8+5.1 77.1+1 2.9*
Stroke work (J) 0.2 2+0.08 O.3l±o.04 0.69+0.10*
p<0.05 compared to other gr oups . -
CBF/gm was examined using 15 ~ radioactive microspheres .
There was no difference at rest in the three groups.
During maximal vasodilation induced by adenosine and
pacing, CBF increased 571% i n C. 317% in AS. and 314% in
AS-AI. Endocardium CBF increased 383% in C, 271% in AS.
and 234% in AS-AI. Epicardium CBF increased 762% in C,
356% in AS, and 383% in AS-AI. In l eft ventricular
hypertrophy without failure subs t ant i a l CBF reserve
remains in pressure overload and combined pressure/
volume overload, however. CBF reserve is less than normal
when resting function is s t i l l normal. There appears to
he no difference in CBF reserve between AS and AS-AI.
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nI:CREASEr> FLOW RESERVE FOLLOWING TRANSIENT
MYOCARDIAL ISCHEMIA
John M. Nicklas, M.D.; Sanford Gips, Cynthia A. Von
Heynlnqen, 8.S., University of Michiqon Hospitals, Ann Arbor,
Michiqon
Serial measurements of coronary flow reserve (CFR)
assessing the functional siqnificonC1! of coronary stenoses con
now be easily performed durinq anqiography usinq digital
tecmiques. Since these meosures may be mode ofter
episodes of ischemia, we studied the effect of a transient (/5
min) period of regional ischemia OSCH) an CFR in 14 open
chest doqs.
Coronary flow was quontitated with electromagnetic flow
probes, and CFR was determined during reoctlve hyperemia
ofter 30 sec. coronary occlusions and durinq intracoronary
infusions of adenosine. Meosures of CFR ofter ISCH were
mode after coronary flow returned to basal levels and
monitored for one hour.
All measures of CFR were significantly reduced after ISCH
(p <.05): hyperemic/basal flow ratios ~ 15%, peak hyperemic
flow ~ 20%, peak adenosine flow ~ 15%, mean duration of
reactive hyperemia ~ 37%, repayment/debt flow ratio ~ 52%,
and minimal coronary resistance durinq reactive hyperemia
andadenosi ne +17 and +13%.
Thus, a transient period of myocardial ischemia decreases
ern for at least 1 hour and may overestimate the functional
significance of a coronary stenosis, and alter conclusions
drown from serial studies.
G§
14.0± 1.7
27.5± 5.5**
mmHg/mllmin
105.4 ±10.6
84.2+ 8.9
mean ndo: pi.t
mllminlg
Resting: CTL .94±.11 1.38 ± .09
AVS 1.20 ±.20 1.09 J: .09**
MYOCARDIALBLOOD FLOW IN LEFT VENTRICULAR
HYPERTROPHY FROM AORTIC VALVULAR STENOSIS
David Alyono MD; Robert J. Bache MD FACCj Arthur J.
Crumbley MDj Joseph R. Schneider MDj Debora G. Parrish BS;
Robert W. Anderson MD FACC, Univ. of Mim., Mimeopolis, MN
We studied the charocteristics of regional left ventricular (LV)
myocardial blood flow (LVBF)with 15 ).ITl radioactive microspheres
in 6 normal dogs (CTL) and in 7 dogs with LV hypertrophy
praduced by plicating the noncoronary aortic valve cusp at 6-8
weeks of age (AVS) (gradient 110 121 mmHg). The dogs were
studied during resting awake state andduring maximum coronary
vasodilation produced by intravenous infusion of adenosine
(I mg/kg/min). AVShoda significant (p <.01) increase in LV
wei t to wei t ratio 7.61.54 vs 4.3 1.2 k •
Adenosine: CTL 6.17 ± .39 1.06 ±.17
AVS 3.27 ±.60*** 0.72±.18*
t Endocardial to epicardial blood flow ratio
§ Coronary vascular resistance per gram of LV myocardium
"p <.10 ~<.05 ***p <.01 as compared to respective control
At rest meCli'lVBF was not significantly different between con-
trol and AVS; however, during adenosine infusion mean LVBF was
signiflcontly less in AVS, with control increased by 656% and AVS
by 273%. During resting state as well as during adenosine infu-
sion endo:epi was lower in AVS. CVRPG was not significantly
different during resting statej however, during maximum coronary
vasodilation, CVRPG was significantly higher in AVS, with control
decreased to 13% and AVS to 32%. Thus relative blood flow to
endocCll'dium is significantly less than normal, both at rest and
during adenosine infusion, in dogs with LV hypertrophy from sub-
coronary aortic stenosis. The impairment of minimum coronary
vascular resistance suggests thot growth of the coronary vascu-
lature did not keep pace with hypertrophy of the myocCll'dium.
Control
AVP
(*p<.Ol; compared
pH changes in the
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CAN CORONARY VASOCONSTRICTION INDUCED BY VASOPRESSIN
CAUSE MYOCARDIAL ISCHEMIA IN DOGS?
Mary F.Maturi, MD, David Markle, PhD, Rodney Greene. BS,
Edith Speir, BS, Young Moo Ro, MD, Dino Vitale, MD.
Stephen L.Bacharach, PhD, Michael V.Green, MS, Seth R.
Goldstein, PhD, Randolph E.Patterson, MD, FACC, NHLBI
Bethesda, Ksryland
Whether the competition between vasoconstrictor stimuli
and intrinsic autoregulation can actually result in myo-
cardial ischemia remains unknown. ThUB we studied the ef-
fect of vasopressin (AVP) on coronary blood flov (CBF)
in normal arteries and determined whether these effects
were functionally significant. We recorded CIF and aortic
preaBure (AP) before and after intracoronary AVP (10-10
molea) in 16 chloralose-anesthetized dogs. Radionuclide
left ventricular ejection fraction (LVEF) waB uBed to
assesa functional significance of CBF changeB (n-6).
HR AP CBF LVEF
131 106 56 .472
129 103 33* .393*
to control). Iachemia v.. confiraed by
AVP-infuBed resion (n-10).
HR AP CBF pHlRep pHIlen pHNa
Control 128 95 42 7.40 7.39 7.40
AVP 122 94 22* 7.31* 7.33* 7.41
(*p<.Ol; pHlRen-infused region subendocardiua; pHlRep-IR
Bubepicardiua; pHNR-remote normal region Bubendocardiua).
AVP decreased CBF by 41%, LVEF by 18%, and decreased pH of
the infused region without changing Hl, AP, or pH of the
normal region. In conclusion an endogenous peptide, AVP,
can cause coronary vaBoconBtriction d~natrated by a de-
creaBe in CBF vith unchanged AP and HR. More i~ortantly,
thia vaBocoDBtriction can override coronary autoregula-
tion to produce ~ocardial ischeai., .. BhoWD by both
-rocardial contractile dYBfunction and tiaBue acidoBiB.
REDUCTION OF EXERCISE-I NDUCED ISCHEMIA BY THE COMB I NATION
OF ATENOLOL AND DILTIAZEM I N DOGS WI TH CHRONIC CORONARY
ARTERY STENOSIS
Masunori Ma tsuzak i,M. D., Bri an Guth , Ph .D. , Tsukasa
Tajimi, M.D. ,Scot t Kemper,M.S .E. E. , Jo hn Ross, J r . ,M. D. ,
FACC, Uni ve r s i ty of Cal i f ornia , San Die go , La Jolla, CA .
The effec t of the combinat i on of a t enolol(A) , a beta-
blocke r , and the calcium ant agoni st, diltiazem(D) on
exe rcise- i nduced regional myocard i al ischemi a were
examined in 8 dogs with chroni c coro nary s t enos i s by an
ameroid cons t r i c t or placed around the l eft circumflex
coro na ry ar te ry . We measured l ef t ven t ricul ar pressure
(LVP:mi cromanometer), sys tolic wal l th i ckening( %WT: sono-
micromet r y) ,cor onary blood flow veloci ty(CBFV :Doppler
f lowmeter) , and myocardial blo od fl ow(MBF :microsp heres )
a t cont ro l r est(CR), during cont rol treadmill exe rcise
(CE), and during exerci s e wi t h A(l mg/kg PO) and D(O.3mg
/kg, IV) (ADE, i dent ical exercise bout ) . Ei ght een days
(average) postoperativel y , CBFV of LCX was red uced t o 55
%(aver age) of 7 days pos t opera tion in 4 dogs(p . Ol), and
r emainin g 4 dogs LCX was completely occluded , but %WT
and MBF a t r est i n t he i s chemi c a rea( I A) wer e normal .
ADE was car ried out 3 hour s afte r A and 15 min after D.
The t abl e summar i zed da ta :
HR LVP %WT (% ) MBF in IA
(b /min) (mmHg) I A CA ENDO TMBF
CR 102±14 143±10 26±7 27!6 .9 6!. 08 1. 03!. 06
CE 227±31* 161±15* 3±2* 33!5* .1 5! .08* . J6!. I3 *
ADE 1 55~14 *+ IJ9~7t l 4±6*t 26±4+ . 53±. 24*+ . 75±.lJ*+
TMBF=mean transmural bl ood f l ow, CA=cont ro l a rea ,
ENDO=sub endoca rdial blood f l ow, *p . 01 vs CR,tp . 01 vs CE
MBF was shown as a deci mal f r action of CA bl ood f low.
Thus, i n th i s model, th e comb ina tion of A and D i s
markedly effec t ive to impr ove exer ci se - i nduc ed i s chemi a
by l es s ening HR and LVP dur ing exer cise .
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Other physiologic data were as follows:
After each current application, serum CK-MB increased 12.2 MIU/l ±
4.6 S.D. (p<.Ol) and ischemic ECG changes were consistently present.
After an average of 10.7 current applications, all animals were tachy-
pneic on mild exertion.
SEQUENTIAL PRODUCTION OF IlYOCARDIAL ISCHEMIA IN CONSCIOUS OOGS
Tarlk Waslie. MD; Jerzy Polanski, MD; Paul S. Freed, KS; Gerald
Kandel I , MD; Paul Stein, MD, FACe; Adrian Kantrowitz, MD, FACC, Sinai
Hoopital of Detroit and Wayne State University School of Medicine,
Detroit, Michigan
No significant changes from normal were observed in 3 control
animals. The animals were sacrificed electively 101 days (av.) after
surgery. Pre-sacrifice cineangiography and PM examination disclosed
coronary artery occlusions, stenosis, recanalizations, and collaterali-
zation in the distributions expected on the basis of time elapsed since
electrode activation. In all cases the myocardium exhibited multifocal
patchy local scarring due to ischemia, as well as occasional dense
fibrosis.
184 ± 26.6
45.2 ± 12.8
16.9 ± 3.0
Fluid
At Rest Challenge
After Completion of
Electrode Activation
178 ± 21
33.2 ± 4.7
11.1 ± 2.4
Fluid
Challenge
124 ± 21
64.0± 4.7
11.8 ± 2.4
Before Electrode
Implantation
HR 116 ± 12.4
SV 38.1 ± 6.1
PCWP 6.0 ± 1.4
At Rest
The practicability of creating ault1focal ischemia in conscious,
unanesthetized dogs leading to lV functional impairment was tested. In
each of 10 male mongrel dogs, 5-a (total 74) silver electrodes were im-
planted into the lumina of multiple branches of the left coronary artery
and exteriorized. FollOWing the animal's recovery from electrode place-
ment, aOQl.lA anodal current was applied for 3 hours to an electrode in
each of 7 dogs. Three to seven days later, an additional electrode was
activated. This procedure was followed until all electrodes had been
activated (some, 2 or 3 times).
PERSISnm: ~ ,IC AINllHAI ,ITIES OF RUBIDIl.tl-82 EX11lACTICX'I IN
M'I'OCARDIlti REaM:RY FlOl 1llANSIENl' IsatailA
Richard A. Wilson, KJ; Michael J. Shea, KJ; Olristian h. de landsheere,
KJ; Terry Jones, lflc; Andrew P. Selwyn, KJ, FNX, Ii<IlnErsmith Hos:>ital
and If\C Cyclotron lliit, London lJ(
Prolonged recovery of myocardial function and cation ~take (8~)
have been described in dogs and IlBn folloo'lJ short periods of ischEmia.
The folloo'lJ experiments were intended to see if lIIetabolic disturbances
apart fran abnonnalities of transnural perfusion are involved in these
prolonged disturbances. Seven anesthethed open chest dogs were studied
folloo'lJ stenosis of the left anterior descendi'lJ coronary artery (lAD)
§<l prevent reactive hyperemia. The regional myocardial (RM) uptake of
'~ (ml/lfn/min x extraction) loBS rreasured usi'lJ positron tarography and
flow loBS rreasured usi'lJ the left atrial injection of reference carbon
lIIicrospheres before, duri'1l and a9r one hour after 10 mins of lAD
occlusion. The RH extraction of ~ loBS calculated as uptake divided
by reference flow. In nonnal sepnts there loBS an inverse relation
between flow 8(.pver a raJ1le of 0.3 ml/min/wn to 4 ml/min/!Jl') and
extraction of '<rib (extraction; -0.45 (In flow) +Q.46, t=O.93). lMri'll
recovery after lAD release the ischEmic area showed a persistent and
abnonnal decrease in cation ~take. In these regiOl'~ there loBS a
distortion of the relationship between extraction and flow as described
above by the regression equation for nonnal areas. This distortion loBS
due in part to a 10 ! )"!, re<b:tion in extraction (p ; <0.00. In these
experiments, prol~ abnonnalities of cation ~take follOjji,'lJ
transient ischEmia were cUe in part to a netabolic abnonnality of vilb
extraction (t ,e, cation transport and trappi'll). This stro'lJly suggests
a persistent disturbance of cell menbranes Wlich is central to nontRl
electlqlhysiological and mechanical flR:tion of the myocardium.
This method reliably brings about multifocal myocardial ischemic
changes in dogs and may be useful in the development of a model of
chronic LV failure.
Tuesday, March 27, 1984
2:00-3:30PM Room S411
Ambulatory Monitoring-Sudden Death
806 patients recruited at 9 different enrolling hospitals
as part of the MPIP Risk Stratification Study had Holter
recordings obtained 2 weeks post AMI and were followed for
at least 1 year following their AMI. 72 of these patients
died during the first year. The patients were grouped
according to the SDANN. 57% of the patients had a SDANN
of 50-100 ms and a relative risk of 2.5 compared with
those with SDANN >100. 15% had a SDANN < 50 ms and had a
7-fold increase in mortslity risk. This relationship waa
stronger than, and was independent of such indices of
ectopic ventricular activity as presence of runa,
couplets, multiformed PVC, R on T, bigeminy, PVC rate, as
well as heart rate on the Holter, ejection fraction as
measured by RVG, type of infarct, and demographic
characteristics. This striking relationship between an
eaaily measured variable and mortality increases our
ability to identify high risk post infarct patients.
HEART RATE VARIABILITY: A VARIABLE PREDICTING
MORTALITY FOLLOWING ACUTE MYOCARDIAL INFARCTION
Robert E. Kleiger, MD, FACC; J. Phillip Miller;
J. Thomas Bigger, Jr., MD; Arthur J. Moss, MD; and
The Multicenter Postinfarction Research Group,
Jewish Hospital of St. Louis at Washington University,
St. Louis, MO
Most variables obtained on Holter Monitoring to assess
risk following an acute myocardial infarction (AMI) have
been indices of ectopic ventricular activity. We have
examined the utility of the standard deviation of average
N-N intervals (SDANN) (the average being calculated for
each 5 minute epoch over the length of a 24 hour
monitoring period). This variable indexes the variability
of the heart rate over time but is not sensitive to stable
ventricular or atrial arrhythmias.
24
88+9
118+10
104+2
97+8
ES 10+7* 74+9* 73+7* 86+7* 91+10
M 15+7* 82+7* 103+7 97+15 103+2
L 115+3* 108+3* 112+4* 106+4 102+1
AO 6+4* 60!12* 57!14* 62!9* 70!7*
Data are shown as % control! SEM (*p<.05 vs control)
QUANTIFICATION OF REGIONAL MYOCARDIAL FUNCTION
AFTER ACUTE ISCHEMIC INJURY
Donald D. GIower, MDj John A. Spratt, MD; George S. Tyson, MD;
Joseph R. Newton, BA; J. Alan Wolfe, BA; J. Scott Rankin, MD
Duke University Medical Center, Durham, N.C.
Assessing changes in intrinsic myocardial performance during
acute regional ischemia is difficult due to concurrent changes in
afterload and diastolic fiber length. To clarify this issue, left
ventricular (LV) pressure (P) was measured with a micromano-
meter, and myocardial segment length (L) was obtained with
intramyocardial ultrasonic crystals in 8 conscious dogs during
pharmacologic autonomic blockade. Preload was varied with
vena caval occlusions during control conditions, after 15 minutes
of coronary occlusion, and at varying intervals during 24 hours of
reperfusion. Segment stroke work (SW) was computed as the
area of the LVP-L loop. Acute ischemia decreased ejection
shortening (ES) and shifted the linear relationship between SW
and end-diastolic length (EDL) rightward, diminishing the slope
(M) and increasing the x-intercept (L ). The area (A) under the
SW-EDL curve represented preload ricruitable work and reflec-
ted changes in both M and L • ES, M, L , and A all returned to
preischemic values over 24~ours of r Bperfusion, although A
required the longest time and appeared to be the most sensitive
measure of ischemic dysfunction. Thus, by accounting for chan-
ges in LVP and EDL, A is a sensitive measure of intrinsic
myocardial function during ischemia and may be useful in
quantifying interventions designed to modify functional recovery
after acute ischemic injury.
Reperf (hrs) 0 .25 1 4 12
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DIURNAL VARIATION OF THE r;,r INTERVAL IN THE INNERVATED
AND THE DENERVATED HUMAN HEART.
Rodney Bexton, BM; Hans Vallin, MD; Thomas Cochrane, PhD;
John Camm, MD, FACC.
St. Bartholomew's Hospital, London, England.
Twenty four hour ambulatory ECG monitoring was performed
in 6 pacemaker dependent patients (pts) with constant rate
ventricular demand pacemakers and in 6 cardiac transplant
recipients with anatomically denervated hearts. 10 QRS
complexes were recorded at a paper speed of 50 mm/sec at
hourly intervals and the r;,r intervals measured blind by 2
observors. The QT intervals of the transplant pts were
corrected by Bazett's formula. OT intervals were
normalized (QTn) by dividing by the mean r;,r for the 24
hours in each pt and expressed as a percentage.
In the denervated heart diurnal variation of normalized
QT was present but 'blunted' with slightly longer r;,rn
during sleep than during waking hours (5.00 hrs vs 17.00
hrs: 101.5\ vs 98.5\, NS). In the innervated heart the
diurnal variation was pronounced with significant
differences between sleep and waking hours (5.00 hrs vs
17.00 hrs: 103.4\ vs 98.1\, p e o.ot ) , The most marked
changes in this group occurred at the time of waking
(5.00 hrs vs 8.00 hrs: 103.4\ vs 95.9\, p<O.ool). No
changes in QTn occurred in the transplant pts during these
hours. There was no significant difference between QTn for
the 2 groups during sleep (3.oohrs: 101.1\ vs 101.2\, NS)
but was shorter in the innervated hearts during active
waking hours (9.00 hrs: 95.4\ vs 102.2\, p<O.Ol).
Diurnal variation of the QT interval may be marked in the
innervated heart. This variation is dependent on both
changes in autonomic tone and in levels of circulating
catecholamines.
AMBULATORY ELECTROCARDIOGRAPHIC MONITORING IN PATIENTS
WITH PROLONGED QT INTERVAL
Chien-Suu Kuo, MD, FACC; C. Pratap Reddy, MD, FACC; and
Borys Surawicz, MD, FACC; University of Kentucky Medical
Center, Lexington, KY
Available evidence suggests an association between pro-
longed (t) QT interval and ventricular(V) tachyarrhy-
thmias(T) in patients with congenital tQT interval, and an
association between tQT interval and sudden death in sur-
vivors of myocardial infarction. To further evaluate the
role of tQT interval in VT, we performed ambulatory elec-
trocardiographic monitoring in 28 patients(pts) (18 female,
10 male, age 48.7±16.6 years) with acquired tQT interval
[QTc by Bazett formula 0.528±o.058(0.44-0.66) sec] and 28
age and sex matched pts with normal QT interval [QTc 0.404
±o.018 (0.37-0.42) sec]. None of 56 pts had heart disease,
serum electrolyte abnormalities, or was receiving anti-
arrhythmic drugs. Twenty-four of 28 pts with tQT interval
had central nervous system pathology or acute neurologic
event and 4 pts had no apparent cause. The incidence of
ventricular arrhythmia(VA) was as follows:
No VA VPC< VPC~ Complex
l00/24hr l00/24hr VA
tQT 13 pta 9 pts 1 pt ~
Normal QT 11 pts 5 pts 5 pts 7 pts
VPC.Ventricular pre.ature complexes.
Com~lex VA5 V couplet, 3-S VPC in-a-row with rate <l00/.in
VTa- 3 VPC in-a-row with rate~ l00/min.
There was no dif~erence in the incidence of VA in two
groups of pts (X .5.79, P>0.10). AIIong pts with tQT
interval, there was no difference in QT or QTc between pts
with or without VA, between pta with VPC<100/24hr or ~
l00/24hr, and between pta with simple or complex VA. We
conclude that acquired tQT interval in the absence of
structural heart disease is not associated with increa.ed
incidence of VA.
CLINICAL PREDICTIVE VALUE OF BASELINE HOLTER MONITORING
IN PATIENTS WITH RECURRENT VENTRICULAR TACHYCARDIA OR
VENTRICULAR FIBRILLATION. Edward V. Platia, MD; Colin K.
Phoon; Philip R. Reid, MD, FACC; Lawrence S.C. Griffith,
MD, FACC. The Johns Hopkins Hospital, Baltimore, Maryland
We carried out 48-hour baseline Holter monitoring in 77
patients(pts), referred for recurrent ventricular tachy-
cardia(VT) or fibrillation(VF), in order to assess the
value of quantitative Holter monitoring in predicting
subsequent outcome in this high risk pt group. There were
60 men and 17 women, whose ages ranged from 13 to 84
years, mean 54 years. Fifty had coronary disease, 11 car-
diomyopathy, 4 mitral prolapse, 3 long QT syndrome, and 11
no structural heart disease. Baseline Holter monitoring
at time of admission was carried out for 4l±23(mean ± Sn)
hrs. Following treatment with antiarrhythmic drugs, pts
were followed in clinic for a mean followup time of 19±12
months. Good clinical response was defined as absence of
sudden death or syncope in followup. Life table analysis
showed thatJ,lOOO PVC's/24hr was associated with a signi-
ficantly decreased survival(p=.013) compared to a PVC
count under 1000/24 hr. The presence of couplets (p-.008)
and the presence of VT (pa.03) were associated with sig-
nificantly decreased survival compared to their absence.
Overall predictive accuracy of each of these Holter find-
ings was 55-60%. Such analysis also showed that maximal VT
rate exceeding ISO/min was associated with a significantly
decreased survival compared to a rate below ISO/min
(p=.013). The highest predictive accuracy, 70%, was obser-
ved when VT was present at a rate above ISO/min. In
summary 1) baseline 48-hour quantitative Holter monitoring
can predict the probability of medical success in pts with
VT/VF; 2) presence of frequent PVC's, couplets, or VT on
Holter provide moderate predictive accuracy, but 3) the
presence of VT with a rate above ISO/min is the best
predictor of outcome.
VENTRICULAR ARRHYTHMIA ANALYSIS AND MORTALITY RISK
STRATIFICATION IN CONGESTIVE CARDIOMYOPATHY.
John Holmes, MD, Spencer H. Kubo, MD, Robert J. Cody, MD,
FACC, and Paul Kligfield, MD, FACC. Cornell Univ~rsity
Medical College, New York, NY.
To test the hypothesis that ventricular arrhythmias
detected by ambulatory electrocardiography can stratify
mortality risk in patients with comparably severe
congestive cardiomyopathy, we evaluated clinical,
hemodynamic and neurohormonal findings in 31 patients.
Ventricular and supraventricular arrhythmia profiling
revealed no significant frequency or complexity
differences between the 16 ischemic and 15 nonischemic
patients. By Kaplan-Meier analysis, there was a 51%
survival rate at 12 months and a 19% survival rate at 25
months for the total population. Subgroups based on
ventricular arrhythmias included 9 patients with simple
VPCs (peak Lawn grade 1-3) and 22 patients with complex
VPCs (peak Lown grade 4-5). Clinical parameters,
hemodynamic indices and baseline catecholamines and renin
angiotensin system activity were similar in simple and
complex arrhythmia groups. Survival was strikingly
related to arrhythmias: mortality was 11% (1/9) in the
simple VPC group and 59% (13/22) in the complex VPC group
(p<0.025 by log rank test). There were 12 episodes of
sudden death while 2 patients died in circulatory
failure. Survival was not significantly influenced by
etiology. Thus, we conclude that ambulatory
electrocardiography can independently stratify mortality
risk among patients with severe congestive
cardiomyopathy. Furthermore, the high mortality rate in
patients with complex ventricular arrhythmias,
independent of ventricular function, suggests that
antiarrhythmic interventions may be particularly
warranted in this group of patients.
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PREVALE:N::E AID SIGNITICAOCE OF VENffiICUIl\R PREMATURE
BFATS IN 1698 OO'IDYED MEN
G. De Backer, MD, F1'CC; J .P. Van Durme, MD; M. Korni t ze r,
Kl; M. Dramaix, MSc; F. Kittel, MSc, Dept. Cardiology,
State university Qlent, Belgitml.
Ventricular premature beats (VPB) were studied by 24 hr
Holter rronitoring in 1698 enployed men aged 40-55 yr.
A pos itive angina pectoris questionnaire or ischemic-like
OCG changes were present in 170 (CHD +) . '!he preval ence
of any VPB/24 hr , ~ 10 VPB/24 hr and a peakfrequency of
)10 VPB/hr i s presented by age for QID + and CHD nega t i ve
(CHD -) subjects (n=149l).
Age % any VPB/24hr %~ 10 VPB/24hr % p:!akfrequency~O/hr
CHD - QID + QID - CIlD + CHI) - CHI) +
40-44 -16 2.-. 31 12 9
$f l~ l~] $45-49 $l2O _ 0 38]$ $[ 15 22]$
50-55 28~ 51 23 30 · 19 18
x $
: p< .05; 0 : p< .01; : p < .001
'!he prevalence of frequent VPB increases with age while
the prevalence of sporadic VPB increases with the pre-
sence of 0-:0.
Arrong the CliO -, no relation was found between VPB and
cholesterol, arterial bloodpressure, srroki.nq, obesity,
leisure tine activity, Plysical capacity, soci. corofess.io-
nal class and job stress; independent of age a positive
correlaticn (p < .05) was found between the frequency of
VPB and the job involvement scale of the Jenkins Activity
Survey. a measure of the type A behavior pattern.
During a follow-up of 4 years 20 o-D - develc.ped a fatal
or non-fatal myocardial infarction. Preliminary results
suggest that VPB do not carry any prognostic significance
in CliO - subjects.
Tuesday, March 27, 1984
4:00-5:15PM Room 8411
Risk Factors for Coronary Disease
NON-SPECIFIC S-T + T-~IAVE ABNORMALITY AND RISK OF
CLINICAL MANIFESTATIONS OF CORONARY HEART DISEASE: THE
FRAMINGHAM STUDY
William B. Kannel MD. FACC, Heir Stampfer, MD,
Daniel L. McGee, Ph.D., Boston University, Boston, MA
Major manifestations of ischemic myocardial involve-
ment can occur in the absence of symptoms (e.g.• silent
myocardial infarction and a positive exercise test). The
T-wave and S-T segment of the ECG reflects ventricular
repolarization, which may be altered by myocardial
ischemia or damage. This report examines the risk of
developing clinical manifestations of coronary heart
disease (CHD) in asymptomatic subjects who developed
"non-specific" ECG S-T + T-wave abnormalities. (NSA-ECG)
Over 26 years of follow-up 664 men and 452 women
developed CHD. NSA-ECG increased in prevalence from
about 2 to 16%from ages 30-62 with only a slight male
predominance: 2.7% for men and 2.0%for women overall .
Risk of developing some clinical manifestat ion of CHD
was 2-fold greater in those who exhibited NSA-ECG than
those who remained free of it. All clinical manifesta-
tions of CHD including myocardial infarction, angina
pectoris, coronary insuffic iency (unstable angina)
occurred in excess. Only the excess risk of sudden death
failed to reach statistical si ani f i cance in one sex or
the other. The excess risk associated with NSA-ECG was
noted at all ages from 37-74 years and in both sexes. It
persisted on taking into account associated hypertension .
RI SK OF VASCULAR DISEASE IN THE ELDERLY : THE BRONX AGING
STU DY
Bru ce Kimme l MD, Sh l omo Cha r l a p MD, Miriam Aronson Ph .D,
Lewis Gi dez Ph . D, Robe r t Katzman MD, Howa rd Ede r MD,
William Fr ishman MD, FACC, Albert Einstein Col l e ge of
Medicine, Br onx , New York .
To determine r i s k f actors which predict vascul a r di s e as e
(VD) i n t he ex t re me e l de r ly , we under t ook a 5 year pros -
pe c t i ve NIH-sponso re d s tu dy of 400 healthy ambu l atory
s ubj ec ts ( 5) ag ed 75 t o 85 ye a r s . All S unde rwent bas e -
line evalua t ions with yearl y f ollow-up of ca r di opulmona ry
and ne ur ops ych i a t r i c he a l t h , includin g lipo pro t e i n ( L)
pro f il i ng and 24 ho ur ambula t o ry ECG examS (Holters ).
At baseline, 35% had br adya r r hyt hmi as , 3% a tr i a l f i b-
r il l a t i on , 7% RBBB and 2% LBBB. Ven t ricula r arrhythmi a s
were e xt re mely common wi t h 18% hav ing gr eater than 5
VPCs pe r 1000 be ats , and 3% ven t r icula r tachyc a rd ia . HDL
level s i n th e e l de r ly were s i gn i f ic ant ly lowe r than our
referen ce popu l a t i on . At 3 years, 19 dea t hs were attr ib-
u t able t o ca r di o- ce r ebr ovasc ul a r dise as e. In all but 3
S who di ed, HDL, HDL2 an d HDL3-c holeste r o l were below
t he median for t his e l de r l y population . No associa tion
be t ween o t he r L fract i on s and risk of VD wa s seen.
Hyper t ension was not assoc iated wit h i nc reased r i sk of
VD. Pe r iods of bradycardia were r ecorded i n al l S with
non-fa t a l CVA; 75% havin g prolonge d e pis ode s . Fr om
t hese da ta , i t wou ld ap pear that sp ecific ri sk fact ors
may e xis t for pred i cting VD i n the elderl y. Inciden c e
da ta fo r ca rd io -ce re br ovasc ul a r complica t ions in th is
e l der l y popula tion is being ga t he re d. Lon ger f ol l ow-up
(whi ch i s on-go i n g) wil l he l p c l a r i fy the impact of
medi cat i on s and other med i cal intervention s on this r i sk.
THE LElDEN INTERVENTI ON TRIAL: DIET, SERUM LIPIDS AND
CORONARY ATHEROSCLEROTIC LESION GROWTH
Alexande r C. Artnzenius , MD; Enno A. van de r Vel de, PhD;
Hans C. Reiber , PhD; Noes Kempen; Coen M. van Gent, PhD;
Udo M. T. Hout smuller, PhD; Daan Kromhout , PhD; Beert Buis, MD,
Leiden Uni versity, Leiden, Netherlands .
A prospecti ve 2 year interve nt i on tri al i s ca r r i ed ou t in
whi ch r ep etitive coronary angiogr aphy was car r i ed out t o
measure change s o f c o ronary l e sions . Diet wa s vegetarian,
r i ch in poly-unsaturated fat, low in dietar y cho l est e r o l
an d low calori c if ne e d be . Of 53 anginal patients (pts)
with a t least 50% obs t ruction in at least one vessel, 4
died , 7 r e ce i ve d bypasses , 2 mal i gnancie s developed and 1
patient r e f us ed r epe a t angi ography . Data of 39 are given .
Changes o f co rona ry l esion s we r e assessed by computer pro-
cessing o f arter iograms. The mean of percentage na rrowing
of a l l obstructions per person i s taken as his (her) score .
Resul t s show that in 17 o f 39 pts no coronary lesion grow th
or e ven r egre s sion was seen t o occur. Li nol eic acid con-
tent of ch olest e r y l est ers increased from 52 . 4 to 60.8%
(P < 0 . 00 1) and S. ch olestero l / HDL-C rati o (cho l / HDL) de-
cr eased f r om 7 . 07 t o 6 . 44 (P < 0 .01) . Pts who at base line
had chol / HDL ratio > 6 . 5 and r emai ned high (hh group) are
compa r e d t o those whose ratio decreased du ring tri al from
high t o l ow « 6 . 5) (hI group ) and those who were l ow and
rema i ned l ow (11 group) . One pt went from l ow t o high .
cho l/HDL mean no l esion gr owt h
group n Baseline 2 ye ars or regression
hh 16 8.66 7 .89 (- 8 .7%) 2/ 16 (12 .5%)
hl 6 7.60 5 .64 (- 14 . 0%) 3/ 6 (50 .0\ )
11 16 5 . 38 5 .25 (- 2 .3%) 11/1 6 (68 . 5\)
The dif f erences between hh , hI and 11 gr ou ps are s ignifi -
cant. Re s ul t s suggest t ha t low chol/HDL r at i os res ulting
from dietary recommend at i on may help t o retar d atheroge-
nic l esion growt h .
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In conclusion, this may indicate that the more active T3
hormone plays a regression inducing role in CAD.
Multivariate analysis showed a significantly higher T3 in
the regression group as compared to the progression group
independently of T4, T3-resin and the lipids.
DOES THYROID METABOLISM, INDEPENDENTLY OF LIPIDS, PLAY A
ROLE IN REGRESSION OF CORONARY ATHEROSCLEROSIS?
Jacques D. Barth, MD; Johan H.C. Reiber, PhD; Paul G.
Hugenholz, MD, FACC; Jan C. Birkenhager, MD; Alex C.
Arntzenius, MD, Thoraxcenter, Erasmus University,
Rotterdam, The Netherlands
As thyroid metabolism influences lipids, and several lipid
fractions are related to coronary artery disease (CAD)
development, studying Thyroxine (T4), Triidothyronine (T3)
and Triidothyronine-resin uptake (T3-resin) in progression
(P) and regression (R) of CAD is of particular interest.
CAD patients who participated in a vegetarian diet inter-
vention study were recatheterized after 2 years. Progres-
sion or regression of CAD were assessed by coronary arte-
riograms and quantitated with a computer based analysis
system (automated contour detection). P. and R. were de-
fined on the basis of coronary scores derived from abso-
lute (rom) measurements. R. was found in 14, P. in 23 men.
Results:
T3-resin (%)
27.8 ± 2.5
27.1 ± 2.9
T4 (nmol/l)
102.9 ± 16.2
111.2 ± 17.3
T3 (nmol/l)
2.34 ± 0.41
1.78 ± 0.28
HDL-cholesterol total cholesterol triglycerides
0.96 ± 0.11 5.80 ± 1.03 1.59 ± 1.14
1.00 ± 0.19 6.43 ± 1.55 2.02 ± 1.04
R.
P.
(umol!l)
R.
P.
The relationship between ansiosraphic prosression of
coronary artery disease (CAD) and the presence of 3
known rislt factors - hypertension, >160 IIIIlIIS systolic
or 95 diastolic, smoltins habit in the year precedins
catheterization and cholesterol serum level - was stud-
ied in 364 non operated pts catheterized twice, a mean
of 40±25 months apart. Prosression was defined by a
consensus of 3 observers as a 2OY. or more decrease in
lumen di ...ter in coronary artery sesments initially
stenosed by 5OY. or more or as a 3OY. or more decrease
with initial stenoses 5OY. or less.
Prosression occurred in 19 of the 51 pts with less than
5OY. stenosis on the first ansiosram (no or mild CAD),
in 18 of the 35 pts with initial stenosis between 50
and 69~ (moderate CAD) and in 121 of the 278 pts with
stenosis 7OY. or sreater (severe CAD). The 19 pts with
no or mild CAD at the first evaluation who prosressed
differed from the 32 who did not by hisher cholesterol
level (250±42 ms/d1 vs 2l7±47, ps.02), smoltins hab-
it (16/19 pts vs 16/32, ps.Ol) and number of rislt fac-
tors (1.6±.7 vs l±.9, p=.007). In pts with moderate
or severe CAD, the rislt factors and their number were
not related to prosression, (cholesterol level 237±38
ms/d1 with prosression vs 239±53 without, smoltinS
habit 108/139 pts vs 129/174 NS, hypertension 41/139 vs
50/174 NS).
Conclusion: The role of rislt factors in prosression of
coronary artery disease appears important at the early
stase of the disease and less important when the dis-
ease is more advanced.
THE IIIPORTAJICE OF RISK FACTORS AT VARIOUS STAGES OF
S!V!RITY OF CORONARY ARTERY DISEASE
Pierre Th'roux. 80. FACC; Alain Moise, 80j Yves
TaeJlllans, 80; David D. Waters, 80, FACC; Ihor Dyrda,
80, FACC, Montreal Heart Institute, Quebec, Canada
'mE INCIDENCE OF VENl'RICULAR PREMA'lURE IEATS IN '!HE
MULTIPLE RISK FAcroR INTERVENTION '!RIAL.
Jerane D. Cohen, 1'10; James D. !'eaton, MS; R:>nald J.
Prineas, MBBS; for the MRFIT JEsearch Group.
St. IDuis university ScOOol of Medicine, St. IDuis, MJ.
The annual resting ECGs cbtained in the MRFIT ~re
exemined for VPB and the data were as follows:
Special Usual JElative Risk*
Intervention (%) Care (%) (SI!tJC)
Nbn-HT 6.6 8.0 0.83
Hypertensive 10.5 9.2 1.14
(*p<.Ol for difference between relative risk estimates.)
'!he association of the incidence of VPB and hypertensive
status did rot depend on the presence of resting ECG
abnormalities at baseline. For SI men there was en
increased risk of developing VPB anong those taking
diuretics oompared to those rot taking diuretics,
relative risk = 1.23, p = .03. Among UC men the
relative risk of VPB for the group taking diuretics was
1.19, p = .08. '!his increased risk ancng diuretic users
also was rot dependent upon the presence or eosenoe of
baseline resting ECG abnormalities. A vulnerability
index, VI, (QI' interval x cycle length/QI' interval + TR
interval) was used as the criterion for early VPB. A
higher incidence of early VPB was roted for both SI and
l.JC hypertensives oompared to their respective
non-hypertensive groups. These data provide
oonfirmation of the higher incidence of VPB ancng
hypertensives treated with diuretics.
Wednesday, March 28, 1984
8:30-10:00AM Grand Hall Meeting Room #2
Angina Therapy-Calcium Blockers
EFFICACY OF CALCIUM ANTAGONIST THERAPY IN PATIENTS WITH
ANGINA PECTORIS, NORMAL EPICARDIAL CORONARY ARTERIES
AND ABNORMAL VASODILATOR RESERVE
Richard O.Cannon, MD, Rita M. Watson, MD,
Douglas R.Rosing, MD, FACC, Stephen E.Epstein, MD, FACC,
NHLBI, Bethesda, Maryland
Abnormal vasodilator reserve of the coronary microcircu-
lation has recently been demonstrated to be a frequent
mechanism of angina pectoris in patients with "normal"
coronary arteries. To assess the effect of calcium anta-
gonist drugs known to be potent coronary arteriolar vaso-
dilators, 25 patients previously demonstrated to have an-
gina pectoris on the basis of abnormal vasodilator res-
erve underwent an outpatient randomized double-blind,
placebo controlled, crossover study. An unblinded lead-
in phase determined the best dose of verapamil or nif-
edipine for each patient. The period of treatment for
placebo or drug during the study was 28 days, during
which time diaries were kept to record episodes of chest
pain and TNG consumption. Exercise testing using bicycle
ergometry was performed at the end of each treatment
period. 15 patients received verapamil 160-640 mg/d;
10 pts received nifedipine 40-120 mg/d. Values represent
mean + SD. ETT=exercise tolerance testing.
Episodes of TNG ETT ETT
Chest Pain Consump. Duration Chest Pain
Placebo 35+28 40+53 4'30"+2'30" 16/21
Drug 2i~22* 22+28* 5'13"+2'20"** 9/24+
(*·p(0.005, **~p(0.025, +.p(O.Ol vs respective placebo)
Four patients interrupted the study during the placebo
phase; one patient interrupted the study during the drug
phase.
Thus calcium antagonist therapy appears beneficial in
controlling anginal symptoms and improving exercise
tolerance in patients with angina pectoris, "normal"
coronary arteries and abnormal vasodilator reserve.
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NIFEDIPINE VERSUS CONVENTIONAL THERAPY FOR UN-
STABLE ANGINA PECTORIS: A RANDOMIZED DOUBlE-
BLIND COMPARISON.
James Muller, MD; Zoltan Turi, MD; David Pearle, MDj John
Schneider, MD; David Serfas, MD; John Morrison, MO; Peter
Stone, MD; Robert Rude, MD; Bernard Rosner, Ph.D.; Ellen-
jane Scheiner, B.A.; Robert Roberts, M.D.; Burton Sobel, MD;
Charles Hennekens, MD; Eugene Braunwald, MO. Brigham and
Women's Hospital and Harvard Medical School, Boston, MA.
Nifedipine (N) may have a valuable role in the therapy of
unstable angina (UA). We screened 1,388 patients with ische-
mic pain of less than 45 minutes duration and randomly
assigned 126 to a titrated schedule of N (10 mg po q6h) or
conventional (C) therapy (propranolol 20 mg po q6h, if not
contraindicated, and isosorbide dinitrate 20 mg po q6h).
There were no differences between N and C-treated patients
in the time to relief of pain, or in the following endpoints:
N C P
n=63 n-63
Change in anginal
attacks/day
Day a-Day 2 -2.8+0.3 -2.5+0. 4 NS
NTG tablets/day
Day a-Day 2 -2.1+0.4 -2.0+0 .5 NS
Morphine use (Day 1) 21% 13% NS
Infarction within
2 weeks 14% 14% NS
Of 20 patients who di~ not respond to either N or C, 50ClE-
became pain free when the opposite therapy (either C or N)
was added. N relieved pain more rapidly than did C only when
added to prerandomization beta blockade. Thus, N alone is
equivalent to C for UA, but may be more effective when
added to beta blockade.
FUNCTIONAL INTERACTION BETWEEN VASODILATION INDUCED BY
DILTIAZEM AND NITROGLYCERIN: A POTENTIALLY USEFUL COM-
BINATION?
Karl F. Cremer, Pharm D, John A. Pieper. Pharm D; Michel
Joyal, MO; Robert L. Feldman. MD, FACC; John Gelman, MD;
Carl J . Pepine. MD. FACC. University of Florida.
Gainesville, Fl.
Calcium blockers and nitroglycerin (NTG) probably relax
vascular smooth muscle by different mechanisms (NTG
acting predominantly uPon large vessels and calcium
blockers upon arterioles). Accordingly. we investigated
the influence of vasodilation elicited by diltiazem (DTZ).
0.25 mg/kg bolus followed by 1.4 mcg/kg/min IV infusion,
given alone and in combination with NTG (20-100 mcg/min
IV infusion) on coronary and systemic hemodynamics in 13
patients with coronary disease. Heart rate (HR).
systolic pressure (SP). CO and total LV blood flow (CSF)
were measured before (control) and during DTZ infusion
alone and with NTG.
MEAN + SD
RESULTS CONTROL DTT DTZ &NTG
HR(b/min) 80+12 75+10 83+15
SP(rrrnHg) 145+13 132+14* 116+20+
CO(l/min) 7.5+1.8 8.3+2.1 7.9+1.9
CSF(ml/min) 143£44 152+53 155+76
*p<O .05 DTZ vs Control ; + p<O.05 DTZ vs DTZ &NTG
Although DTZ-induced vasodilation reduced SP. CSF was
maintained. With further vasodilation induced by addi-
tion of NTG, SP declined more but CSF was still main-
tained. The combination of IV OTZ and NTG appears to
offer profound vasodilation potential without reflexly
mediated increases on HR or decreases on CSF.
ANTIANGINAL EFFICACY OF BEPRIDIL. A NOVEL CALCIUM
ANTAGONIST: DOUBLE-BLIND EVALUATION BY QUANTITATING
flYOCARDIAL ISCHErtIA BY C0I1PACT HOLTER A.'lALOG TECHNIQUE
IN CHRO~IC STABLE ANGINA
Koonlawee Nademanee ~D. FACC; Bramah N. Singh MD. FACC;
nartha Piontek RN; Vanida Intarachot RN; Cora11 ee Yale t-lS.
Wadsworth VA Hospital. Los Angeles. Ca.
Bepridil(B). a new Ca++-antagonist. prolongs cardiac
repolarization but its anti anginal efficacy is unknown.
Thus, 16 pts(all 11, mean age 65 yr) with documented
chronic stable angina(CSA) with +ve ETT, underwent blinded
13w~ ~acebo cross-over study with B, 30Omg/day .End points
uere: NTG use, angina frequency(AF), onset of ischemia(lnm
ST~) and of chest pain(CP) and exercise duration(ED)during
ETT. ECG recordings(24hr), analysed for ischemia duration
(ID) by compact Holter analog(CHA) included all periods of
ETT. Results( Means + S.D.):
Placebo- Bepridil p value
NTG use/wk 3.67 + 4.4 4.17 + 5.8 NS
AF/wk 3.82 + 4.2 3.83 + 4.7 NS
1nmST4(sec) 204.5 +' 128.6 293.1 + 175.4 ~0.01
CP (sec) 301.6 + 119.1 387.6 + 192.7 ~0.01
ED (sec) 362.8 + 133 .0 440 .1 + 207.3 40.05
ID/24hr(min) 84.8 + 130.9 62 .3 + 162.2 (D.01
HRxBP(x10-3) 18.2 + 4.1 15.8 + 3.8 <0.01
The pattern of ischemia on ETT was identical to that
occurring spontaneously; over 60% of episodes were pain-
less and about 90% were not preceded by increase in HR .
Conclusions:(i) B exerts significant antianginal effect
by reducing HRxBP product and probably by reducing
coronary vasomobility inCSA;(i;) ETT&CHA parameters are
superior to AF and NTG use as end points with less
variability; (iii) the use of ETT and CHA can markedly
reduce pt sample size for evaluating antianginal drugs.
EFFECT OF BEPRIDIL IN CHRONIC STABLE ANGINA: A MULTICENTER
PLACEBO CONTROLLED DOUBLE-BLIND RANDOMIZED CROSSOVER TRIAL
J.Hill, M.D.; J.Alpert, M.D.; R.Zusman, M.D.; G.Vetrovec,
M.D.; J.Borer, M.D.; R. Conti, M.D.; C.Pepine, M.D.;
University of Florida, GaineSVille, Fla.
Bepridil, a calcium antagonist with a half-life of approxi-
mately 58 hours, was compared to placebo in a double-
blind randomized crossover trial. Forty-four patients (39
men, 5 women) with exercise-induced angina pectoris and an
ischemic ST segment response with exercise testing (modi-
fied Bruce protocol) were studied. Overall, bepridil (400
mg once a day) increased total exercise time (1.6 + 1.7
min.,p<.OOl) time to angina onset (2.3 + 1.9 min.,-p<.OOl)
time to lmm ST segment depression (1.9 + 1.8 min., pz.001)
time to 2mm· ST segment depression (1.6 +1.4 min., pz001)
and total work achieved (1.1 ± 1.4 KPM,-p<.OOl) compared
to preceeding placebo phase (all mean change + SO). Order
of administration, placebo vs. bepridil, was not found to
be a aignificant (p-NS) factor in any parameter measured.
Both angina frequency (3.3 + 8.6 attacks/week) and nitro-
glycerin consumption (2.3 +-6.5 tablets/week) decreased
during bepridil compared t~ placebo but this was of border-
line significance (p-0.06 & 0.09 respectively). Rate-
pressure product at end exercise was not significantly
changed comparing bepridil to preceeding placebo phase
(-0.50 + 4.3, p-NS). This suggests a decrease in oxygen
demand as the primary mode of action. Minor side effects
occurred during both bepridil and placebo phsses. Only
gastrointestinal and CNS related complaints appeared signi-
ficantly more frequent with bepridil (p-.02 & pzO.06).
four patients had side effects limiting therapy (dizzi-
ness in 3 and +LFT's in l)and one patient died during
bepridil therapy. In summary. this study suggests that
bepridil is effective for the treatment of exercise-
induced myocardial ischemia.
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'nIE EFFECT OF MlSOLDIPINE OM EXERCISE LEFT VEMTRlCULAR
PERFORMANCE IN COROMARY ARTERY DISEASE ASSESSED BY FIRST
PASS RADIOMUCLIDE ANGIOGRAPHY AND GOLD-195m.
Jllles C.O'I_fe, FRACP; Duncan S. DYII\ond, HD; John L.
Caplin, HB; William Flatman, HSo; Seamus BaniJII, HB. st.
Bartholomew I s Hospital, London, England.
The effeots of Misoldipine (MIS), a new caloium
antaaonist drua, on exercise (Ex) LV function were
investisated in 10 patients with ooronary disease and
anaina pectoris. First pass radionuclide angiogralDS
(FPIIA) were performed at rest and peak Ex pre-MIS and at
rest, identical workload, and new peak Ex 1 hour post-MIS
lQags orally, using gold-195m (half life, 30.5 seconds).
Pre-NIS, mean LV ejeotion fraction (EF) decreased from
58.3+6.3' to 37.5+10.6' (p<0.005), and at same Ex load
poat:IIS fro. 59.2+6.0' to 47.8+15.0' (p<0.05). The
improvement in mean ExLVEF post:NIS was significant
(p<0.005), with no signifioant change in mean heart rate,
blood pressure or double product. 6/8 patients had
coap~ete relief of angina post-MIS, 6/10 patients
increased ExLVEF by at least 10', and 10/24 Ex induced
regional LV abnormalities normalised post-MIS. TiJlle to
peak Ex inoreased fro. mean 246+91 seoonds pre-MIS to
325+112 seconds post-MIS (p<0.005). At new peak Ex, LVEF
was-42.2+11.6' (p<0.025 versus peak pre-MIS) and 4/24 Ex
induoed regional abnormalities pre-MIS remained normal.
In conclusion, Ex performanoe, duration and LV function
improve after MIS in patients with coronary disease.
Funotional improvement is seen even at higher workloads
than pre-treataent and these effects are independent of
heart rate and blood pressure response to Ex.
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Predictors of Survival After Acute
Myocardial Infarction
REGION!\L 1o«00000IAL BLOOD FLOW AND W'.LL MJrION STUDY IN
PATIENTS WI11l DESIGN!\TED ACIJl'E "SUBENDOCARDIAL INFAICTION".
Oberdan Parodi, ~, Markus Schwaiger, MD, Janine Krivokapich,
MD, Heinrich R. Schelbert, MD, FACe, lI:1A School of Medicine,
Los Angeles, CA.
Clinical definition and location of subendocardial infarction
(SI) are based on a COIIIIIOn misconception of the &:G
findings. In 9 patients (pts) with designated acute SI, >e
evaluated regional myocardial blood flow by N-13 8IIIIlOnia (N-
13) and positron computed tomography (lCT) and regional wall
motion (liM) by echocardiography or radionuclide angiography.
Both studies were performed the 88IIIe day and within 1 to 6
days after the acute episode. N-13 study was preceded by Cl}-
15 blood pool imaging for defining the inner LV margins
(transmission milUl8 blood pool). Regional myocardial N-13
activity ll88 determined from IIIl1tiple regions of interest in
the postero-lateral (PL) and antero-septal (AS) walls. An N-
13 defect ll88 considered transmural if the mean radioactivity
through the entire wall was less than 10% above background.
Of the 5 pts with lateral 51's by K:G, 2 had N-13 defects in
tIE AS and 3 in tIE PL wall. TIE site of 10M abnormalities
(WIt') (hypo- or altinesis) ll88 concordant with the N-13 defect
~ R:T. Of the 3 pts with AS location of 51 by K:G, 2 showed
an N-13 defect in the PL and 1 in the AS wall. No IOH\ were
fOlmd in the latter pt while posterior hypo- and dyskinesis
_ observed in the 2 former pts , One pt with inferior
location of 51 by K:G showed perfusion and WH\ in tIE PL
walls. In 3 pts, N-13 defects >ere found to be t ransmrra.l ,
All 6 angiographically evaluated pta had severe triple vessel
disease. We conclude that a) presence or absence of Q waves
does not permit distinction between translll.lral and 51, b) the
location of ST-T changes does not predict the site of
infarction, and c) pts with this &:G syndrome exhibit a wide
spectrum of IOH\ and usually diffuae coronary atherosclerotic
lesions.
SIGNIFICANCE OF RIGHT VENTRICULAR DYSFUNCTION FOR SEVERE
VENTRICULAR ARRHYTHMIAS AFTER MYOCARDIAL INFARCTION.
Matthias Pfisterer, MD, Roman sieber, MD, Markus Soler,MD,
Hans Emmenegger, MD, Felix Burkart, MD, University Hospi-
tal, Basel/Switzerland.
To assess the significance of right ventricular (RV) dys-
function after a first myocardial infarction (MI) for
severe ventricular arrhythmias (Lown >111), a consecutive
series of III pts was studied prospectively. At hosr'tal
discharge, 24 hr Holter monitoring and radionuclide en-
triculography were performed for determination of le t(LV)
and RV ejection fraction (EF) and wall motion (WM) abiorma-
lities. In 59 pts with transmural inferior MI, RVEF was
31.9f9.7% (depressed in 47/59 pts), whereas LVEF was 52.0f
13.7%. In contrast, RVEF was 41.5fll.6% in 22 pts with
transmural anterior MI (~ in 9/22 pts), but LVEF was redu-
ced to 3B.lf16.7% (p<.OOl between groups).In 30 pts with
subendocardial MI, RVEF was 40.7f6.5% (. in 15/30 pts)
and LVEF 57.6fl1.7%. RVEF values correlated well with an
independently assessed WM-score: 41.2fB.5% for normal,
31.2f6.4% for hypokinetic and 20.3f5.1% for akinetic RV
contraction (p<.OOl between groups). 24/111 pts (22%) had
Lown >111 arrhythmias, 14% with anterior, 27% with infe-
rior and 17% with subendocardial MI. Results relating
these arrhythmias to LV and RV function showed:
LVEF ).40 LVEF >.40 LVEF •• 40 LVEF'.40
RVEF >.35 RVEF •. 35 RVEF >.35 RVEF'.35
n 53 33 9 16
Lawn >III 4 (8%) 8 (24%) 2 (22%) 10 (63%)
We conclude that (1) RVEF is significantly depressed in
patients with a recent inferior MI but rarely in pa-
tients with anterior MI and (2) the incidence of Lown
)111 arrhythmias was similarly increased in patients
with either isolated severe RV or LV dysfunction and
highest in patients with depressed LVEF and RVEF, in-
dicating an independent contribution of ~dysfunction
for the occurrence of severe arrhythmias after MI.
PROGNOSTIC SIGNIFICANCE OF ANGINA AFTER HOSPITAL
DISCHARGE FOLLOWING MYOCARDIAL INFARCTION: RELATION TO
OTHER PREDICTORS OF SURVIVAL
Xavier Bosch, KD; David D. waters, KD, FACC; Alain
Moise, KD; Alain Bouchard, KD; Pierre Theroux, MD,
FACC, Montreal Heart Institute, Montreal, Canada
The prognostic significance of angina during the first.-
year after myocardial infarction (MI) was assessed in
225 consecutive pts who underwent a predischarge exer-
cise test limited to 5 MErS or 70" of age-predicted
maximal heart rate. pts older than 70 yrs, or with an-
gina or overt heart failure wi thin 4 days of the test
were excluded. MI was anterior in 97 pts (43") and 47
(21") had a non-Q wave MI. A previous MI was present in
57 pts (25"). QRS score, and index of infarct size, was
calculated for each pt (mean 4.2±3.9). During hospi-
talization 52 pts (23") had angina. The exercise test
induced ST depression ~ 1 mm in 70 pts (32"), ST ele-
vation in 28 (12"), a 1Ol0 mm increase in systolic BP
in 20 (9") and PVC's in 44 (20"); 59 (26") did not
reach the target endpoint.
Angina after discharge appeared in 107 pts (48"), at a
mean of 1. 5 months. During the first year post-dis-
charge 25 pts (II") died, 17 of them suddenly. Cox re-
gression analysis identified 2 clinical and 3 exercise
test variables as independent pt'edictot's of mot'tali ty:
exercise ST depression (p<0.005, relative risk 4.4),
post-discharge angina (p<0.005, t'elative risk 3.8), QRS
score (p<O.Ol), poor exercise tolerance (p<0.05) and
PVC's dut'ing exercise (p<0.05).
Thus, in addition to clinical and exercise test vari-
ables available at the time of hospital discharge post-
MI, angina during the first year is a strong, indepen-
dent predictor of 1 year mortality.
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POST-MYOCARDIAL INFARCTION SURVIVAL: A REAL IMPROVEMENT
OVER 9 YEARS.
Peter L. Thompson, ME, FACC; Jan L. Eccles; Yvonne K.
Vandongen, RN; Jan D. Watt, RN; Nicholas H. de Klerk,
MSc. Dept of Cardiovascular Medicine, Sir Char les Gaird-
ner Hospital, QEII Mejical Centre, Perth, Austr~lia .
Trends in survival from 29-365 days were examined i n 1233
consecuti ve patients who had survived 28 days after acute
myocardial infarction (AMI). The period 1973-81 was
examined; consistent WHO criteria for definite AMI were
used. The case fatality rate declined from 13 .3\ in 1973
to 3.2\ i n 1981 . To assess whether this decline was due
to a real improvement in survival, the trends were re-
examined after correction for the severity of infarction.
The , index of severity was based on the Perth Coronary
~egJ.ster (PCR) , a community-wide study of AMI performed
J.~ 1971. The PCR index was based on age, sex, previous
hJ.story of AMI, diabetes, hypertension, heart rate
>104/min, blood pressure <115 mmHg on admission and major
cardiac arrhythmias. The 29-365 day case fatality rate
?enerally ran parallel with the severity of cases admitted
J.n t~at year. Nevertheless, the risk of death after cor-
rectJ.on for severity in 1981 was only 40\ that of 1973 .
The rate of coronary artery bypass surgery in the year
post-AMI rose from 1.1\ of cases in 1973 to 14.8\ in 1981
The down-trend in case fatality was well established be-
fore the rapid increase in post-AMI surgery occurred in
1~79; multivariate analysis showed that cor onar y surgery
dJ.d not ,expl~in improved survival when sev~rity and the
trend wJ.t~ tJ.me were considered. Thus : (1) A distinct
trend to 1.D1proved post-AMI survival was observed even
~ter c~rrection for severity. (2) This trend could not
att~J.bu~ed to post-AMI coronary surgery. (3) If this
~rend J.S wJ.despread, estimates of the impact of post-AMI
J.nterventions will need substantial revision.
1seHm.1IA scrs INDEPENDmlTLY FRad VEN'IRIClJLAR
F..NCI'lm AND ARRHYIHMIA IN PATIOO'S wrm a:R:NARY
AJmm' DISEASE
1llLlt:. Es1liJ4 MoD.., Joel Morganroth, M.D., FACC,
Scott Spielman, M.D., FAlX, Leonard N. Horowi tz,
M.D., FAlX, Harold Kay, M.D., Hahnemann Univers i ty
Philadelphia, PA.
To assess the relat ionship of ischemia to pump
function and ventricular arrhythmias (VA) 74
patients (pts) with coronary artery disease (CAD)
underwent radionuclide angiography and within 7
days Holter monioring (HM) and rest Tl-201
scintigraphy. lIM data were scored from 1-7: for
increasing frequency only (1-4) and the presence of
complexity with increasing frequency (j-7). TI-201
scans were scored by the number of segments
(total=15) with determination of : fixed defects
(scar) and transient defects (ischemia).
Pts with low ejection fractions (EF<30%)
compared to pts wi th higher EF's (~30%) had
significantly more scar segments (4.5 vs 2.8 p<O.l)
and worse mean HM scores (4.3 vs 3.0 p<.OI);
however, there was no difference in the number of
ischemia segments (1.4 vs 1.0 p=NS). In pts wi thout
and wi th ischemia there was no difference in the
mean EF (38% vs 36% p=NS). Further, pt s wi th
complex arrhythmias had no more ischemia than pts
wi thout complex arrhythmias (1.1 vs 1.1, p=NS).
thus, ischemia is independent of ventricular
function and arrhythmias; prognostic stratification
and therapy of pts with ~ must include a separate
consideration of ischemia.
INFARCT EXTENSION ~TRUNGLY PKEDICTS 1 YEAR MORTALITY
AFTER NONTRANSMURAL BUT NOT TRANSMuRAL MYUCARDIAL
INFARCTION
Alan S. Maisel, MD, Elizabeth A. Gilpin, Ary L. Go1d-
oerger, MD, Harmut Henning, John Ross, Jr., MD, University
of Ca 1ifornia at San Diego. San Diego, CA
Myocardial infarct extension is associated with high hos-
pital mo-talt ty and decreased one year survival, but the
influence of infarct location on 1 year mortality in
patients who survive hospita lization has not been exam-
ined. A prospective study was undertaken of 726 con-
secut ive hospital survivors of myocard ial infarction en-
te r ing our data base. The patients were classified by
ECG into the following infarct groups: nontransmura1
n=131, transmural-anterior n=237, and transmural inferior
n=322. Infarction extension was diagnosed by any 2 of
the following: 1) recurrent chest pain (24 hours or more
after adm1ssion); 2) new persistent ECG changes; 3) ele-
vation or reappearance of CK. 53 patients (B% of total)
had infarct extens ion: nontransmura 1-11%, transmural
anterior-7%, transmural inferior-6% tnontransmure l vs.
transmural: p<.03). Of the nontransmura1 patients who
died within 1 year, 32% had infarct extension compared to
on 1y 6% of survivors (p<.001), and infarct extens ion in
nontransmura1 infarction carried a higher mortality than
in nontransmura1 infarction alone (64% vs . n% p<.OO6).
Of 50 variables exam ined for prognostic significance, in-
farct extension was the strongest univariate predictor of
1 year mortality in nontransmura1 infarctlon out was not
a pred ictor in transmura 1 anteri or or transmural inferior
infarction . Conclusion: Increased mortality in hospital
surv ivors of myocardial infarction after inf arct extension
occurs in nontransmura1 but no in transmural anterior or
transmural interior 1nfarction.
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Cardioversion Methods and Effects
IMPLANTABLE TRANSVENOUS CARDIOVE RTER
Douglas P. zipes, MD; Eri c N. Prystowsky, MD; John W.
Brown, MD; William M. Mil e s, MD, James J. Heger, MD,
Indiana Univ. School of Medicine, Kr anne r t Inst. of
Cardiology, Indianapolis, Indiana.
Pr evi ous studies in dogs and humans have demonstrated that
a synchronized truncated exp one nt i a l shock of < 2.0 J de-
l i ve r e d vi a a catheter e lect rode t e rminates su;tained ven-
tri cu l ar t achyc ar di a (VT) . Based on those data, an im-
pl antab le device (Mode l 7210 , Medtroni c , In c) we i gh i ng 95g ,
powered by 2 i ndepende nt li th ium sources, was developed .
TWo devices have been implanted unde r l ocal anesthesia in
2 ma les, 54 and 67 ye a r s ol d , with coronary artery disease
and recurrent sustained VT. The unit de live rs sy nchronized
shocks(0 .06-2. 0 J) dur i ng VT au tomatica l ly or on command .
Programmab le pa c i ng capab i l i t i e s inc l ude VVI(30- l00 PPM)
for br adyc ardi a , VOO (30-400 PPM) and ext r as t i mulus pacing
(Sl - S2- S3- SN) fo r VT initiation and t ermination us i ng a
sp eci ally des i gned progr amrne r(Model SP6000) . Pacing rates ,
se nsitivi t y, pulse wi dth , car diove r sion ene rgy , and VT de-
tection crite r i a (cycle length of tachycardia , chan ge i n
cycle l e ngth from normal t o tachyc ardia, n~r of i nter-
vals t o trigge r) are prog r ammab l e via bidi rec t iona l t ele me-
try t hat a lso provi des marker pulses, e lectrogr ams , de vi ce
se t tings and end of l ife i ndicators . The device connects
t o a ti ned l ead (Model 6882, Medtroni c,Incl wi th 2 distal
e lectrodes i n the right ve ntricular apex for sensing and
t o serve as the cathode dur ing the shock and 2 proximal
electrodes in the superior ve na cava for the anode. Both
uni t s have fun ctioned normally t o da t e . Using the implant-
ed unit, VT was initiated in 1 patient during SlS2S3 pa c-
i ng . VT then was sensed appropriately and was terminated
by a syn chronized shock of 0.5 J. Transient bradycardia
after the shock resulted in VVI pacing. Neither patient
has ye t had spontaneous VT but the f ollowup period is
short « 1 month).
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PJlCIN:i THRESHOlD CHAN:;ES AFI'ER~ CA'lliETER
a:xJNl'ERSHOCK IN MAN
RaY!)XXld Yee, MD; Douglas L. Jones, PhD; GeOrge J.
KleIn, MD., FOCP (C), FNX, university Hospital, loodon,
cntario.
we have recently reported the use of a new transvenous
catheter system ('lC) for transvenous defibrillation and
cardioversion in an intensive care setting. An
inportant feature of this catheter is its ability to
serve as a pacing catheter in the event of bradycardia
or asystole following countershock. Consequently, we
examined the ser ial d1anges in pacing threshold and R
wave amplitude following insertion of the rc in 12
patients with recurrent ventricular tacl1yarrhythmias.
Imnediately after countershock (N=6) pacing threshold
utilizing the tip electrodes of the rc increased
(1.4+.2 vs 2.4+.5 volts, mean+SEM, p < .05).
concUrrently, the R wave amplitude reCorded through the
tip electrode decreased (bipolor R wave - 5.9+1.1 vs
3.4+.7 rrW, P <.01; unipolar R wave recorded from the
distal ventricular electrode - 8.9+1.8 vs 4.6+1.2 mY,
p <.01; and proximal ventricular electrode - 7./+1.5 vs
5.0+1.0 rrW, P < .01) • A return to control -values
occUrred within 10 minutes of countershock. In one
patient, ventricular capture through the 'lC could not
be obtained at the maximum temporary pacemaker output
of 20 volts after countershock, Iotlile no changes in
pacing threshold occurred using a second catheter at
another right ventricular site. Pacing threshold
increased by 154.3+30.2% during the first 7 days that
the catheter was in-situ.
we conclude that countershock through the 'lC causes an
acute increase in pacing threshold and decrease in R
wave amplitude. A catheter used for countershock may
not be acceptable as a backup pacing catheter.
THE ELECTROPHYSIOLOGIC EFFECTS OF HIGH ENERGY ELECTRICAL
DISCHARGES IN THE VENTRICLE
Francis C. Kempf, Jr., MD; Rita A. Falcone, MA; Francis
E, Marchllnskl, MD, FACC; Mark E. Josephson, MD, FACC,
University of Pennsylvania, Philadelphia, PA.
We studied 20 dogs to: 1) determine the potential of
catheter delivered cardioversion (CDCV) to produce a
substrate for arrhythmias, and 2) characterize the
effects of CDCV on left ventricular refractoriness,
epicardial electrograms, and surface electrocardiograms.
Five dogs each received one CDCV of either 50, 100, 200,
or 300 joules at the left ventricular apex. Acutely, one
dog died with ventricular tachycardia (VT), 9 dogs had
nonsustained VT, and 5 dogs had an accelerated fascicular
rhythm, which terminated spontaneously. Programmed
stimulation (PS) was performed prior to and 2 weeks after
CDCV . No reproducible VT was initiated by PS (1 to 3
extrastimuli and burst pacing) and no change in left
ventricular refractoriness was observed (168.9±125.1 vs
165.2±21 .7 ms). Acutely, 10 dogs developed ST segment
elevation in leads 2, 3 and aVF which returned to
baseline before the chronic study. At the chronic study,
no abnormalities were noted in local epicardial electro-
grams or the surface electrocard iogram. At post-mortem
all dogs exhibited focal necrosis at the site of CDCV.
We conclude CDCV: 1) is frequently associated with
transient acute electrocardiographic changes; 2) produces
no chronic changes in the surface electrocardiogram or
epicard ial electrograms, and 3) is acutely arrhythmogenic
but chronically does not produce a substrate for indu-
cible tachyarrhythmias.
EFFICACY OF TRANSVENOUS CARDl OVERSI ON IN VENTRI CULAR
TACHYCARDIA: A PROSPECTIVE RANDOl!IZED STUDY
Sanj eevSaksena , lID, FACC; JohnCicc one , lID; St ephenRo t hbar t , lID
Ka ther i neLip tak ,RN ; ~i l liamCrae l iu s ,PhD ,Newark Beth I srael
11edi ca l Center, Newark , New J ersey
Facto rs influenc ing the efficacy of t r ansv enous card iover -
s ion(TC) fo r t ermination of vent ricular tachycardia (VT )
ar e cur rent ly debat ed . lie performed a prospec t i ve random-
ized s tu dy t o evaluat e 2 in cremental TC protocols in l 4pts
with VT & organic hear t disease , aged 67±6yr s & LV ej ec -
t i on frac tion 27±141 , using a ~ed tronic 6e80 l ead in the
RV apex. Gro upA(7pts ) r ecei ved 8 synchronized shocks of
0.03-2 .2j oul es & Gro upB(7pts) 0 . 5-l0j oules. Pts underwent
id entical protocol s durine cont rol (C) e l ec t ro phys iologic
s t udies( EPS) & af t er 1-3 antiarrhyt hmic dr ugs(AD) during
ser ial EPS. Variables analysed i nc l uded ej ect i on fracti on,
VT cyc le length(CL), morphol ogy, i nduct io n mode, AD, ECG
intervals, ventricular effective r efractory period, lead
threshold & time interval t o TC.
RESULTS: GpsA&B were comparable for al l variables. There
were 46 VT episodes(E) (GpA-26,GpB- 20) & 178 shocks(GpA-119
GpB- 59) for VT termination. TC successfully terminated 62%
of VTE i n GpA & 50% in GpB. In t he CEPS TC terminated 40%
of VTE i n GpA & 55% in GpB . Af t er AD TC terminated 75% of
VTE in GpA & 44% in GpB. In 10pts with uns uccess ful TC i n
CEPS & success f ul TC after AD , VTCL i ncr ea sed from 254±35
ms (CE?S) t o 308±59ms(AD EPS)( p<.025) . A multivariate ana-
l ys is corr e l at ed succe ssful TC wi t h VTCL (p<.05 ) with no
significant r e lat ionshi p t o ot her va riabl es . VT accelera-
t i on wi t h TC was signif i cant ly less i n GpA as compar ed t o
GpB at CEPS( 11vs57% p<. 005) but not af t er AD (11vs 28% p>.l )
COnCLUSIONS: I-Te successfully t ermin at ed 57% of all VTE.
2-Successful TC is rela ted to VTCL . 3- AD enhan ces eff i cacy
of TC by i ncreasing VTCL . 4- High energy TC does not i n-
crease ef ficacy but r educes therapeutic t olerance. 5-VT
accelerat io n wi t h TC is more f r equen t at higher energies &
r equires avai l abi lit y of transthor aci c defibr il l at ion .
TRANSTHORACIC ELECTRICAL IMPEDANCE BY FOURIER ANALYSIS IN
A CANINE MODEL
~ .Ih. 1&I::UJ4 HIl.i Henry R. Halperin, MD; Joshua E.
Tsitlik, PhD; Kenneth Brin, MD, PhD, Johns Hopkins Hospi-
tal, Baltimore, Maryland.
Peak delivered current has been shown to be the best
electrical parameter for achieving defibrillation and in
theory is dependent on the resistive and reactive ele-
ments of impedance. We calculated these two components by
Fourier analysis of delivered pulses in 5 dogs. Stored
energy (30-400 Joules) was administered by a standard
defibrillator to closed-chest dogs (20-25kg). Voltage
and current were simultaneously displayed on an oscil-
loscope using a 1000:1 voltage divider and a 0.11 ohm
shunt, respectively. Fourier analysis was performed on
digitized voltage and current data. Ratios of voltage
and current moduli (impedance) as well as differences in
phase angles were calculated for each harmonic. Total
impedance was not dependent on frequency since it was
accounted for by impedances below the second harmonic.
As shown below, reactive energy(out of phase) was negli-
gible compared to resistive energy(in phase) but im-
pedance was dependent on the magnitUde of delivered ener-
gy (p<.02 ANOVA).
Stored energy (J) 30 100 200 300 400
Delivered energy (J) 23 78 147 214 289
Resistive energy (~) 97 96 96 96 96
React!ve energy (~) 3 4 4 4 4
Impedance (ohms) 54±5 51±4 49.t3 46±3 4at5
Thus, transthoracic electrical impedance of the canine is
predominantly resistive and is inversely proportional to
the magnitude of delivered energy. This has important
implications since prospective measurement of re-
sistance by a small amplitude pulse may allow deter-
mination of the minimum energy reqUired for cardioversion
or defibrillation.
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SELF-ADAPTING OVERDRIVE DEMAND PACING AS A METHOD FOR
TERMINATING VENTRICULAR TACHYCARDIA
Charles Haf fajee, MD, FACC; George Charos, MD; Augus t i ne
Castellanos, MD, FACC ; Berouh Berkovits, FACC.
Univ. of Mass. Medical School , Worcester, MA and Univ . of
Miami School of Medicine, Miami, FL
A new external self-adapting demand pacemaker (SSI) whi ch
initiat es over dr i ve pacing (00) foll owing the r ecogni tion
of vent r i cular tachycardia (VT) from intrins i c car di ac
signals was evaluated as a me tho d (SSI MX) for termi nat i ng
i nduc i ble VT in 9 patients (pt s) undergoi ng progra mmed
vent ricular s t i mul a t io n and serial drug test i ng. The SSI
pacemaker i ni t i a t es anti tachycardia 00 th er apy at t he on-
se t of VT automatically by shortening its es cape i nt er val
so that i t is identical t o th e cycl e l ength (CL) of t he
VT. The SSI pacemaker then s tarts t o over dr i ve t he VT by
beat to beat shortening of i ts CL for a prog r ammed prede-
t ermined number of beats. The beat t o beat CL decrement is
pro grammable from 1 to 25 msec.
Termin ation of 84 VT episodes i n 9 pt s was attempted by
SSIMX pacing employing 00 bursts of 5 t o 50 beats (mean
13.2) of 00 with beat to beat decrement s of 1 to 25 msec
(mean 8 .2 ) for each 00 attempt. The VT- CL of the 84
episodes r anged from 430 t o 220 msec (mean 340). Cardi o-
ve r sio n or DC shock was th e only succes s f ul met hod of
t erminating the 38 VT episodes not r espondi ng to SSIMX
pac ing. In one pt two VT epi sodes (CL 220 msec) were ac -
cel era t ed by SSIMX pacing . No cons is tent change i n VT
responsiveness to SSIMX pacing was obs erved dur i ng co n-
comitant an tiarrhythmic therapy.
In concl us i on , SSIMX pacing appea r s t o be a safe and pro-
mi s i ng method of 00 pacing for termi nating VT . Fur t he r
cl i ni cal eval uat i on of t his method i s encour aged .
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Morphologic Changes: Pulmonary Vascular Disease
IJENI'RICULAR SEPTAL DEFEX:!' WIlli Pl.JI.M:lNARY V1ISClJIAR OBSrRUC-
TIVE DISFASE:~ FOI..U:'M-UP AND PREDIcrION OF <X1r-
CCME AF'I'ER SUR:;ICAL CORREX:TIOO
Peter M. Steele, MBBS (Hems); Valentin Fuster, M.D., FAC.C,
William H. weidman, M.D.; Donald G. Ritter, M.D., FAC.C;
Dwight C. McGoon, M.D., FAC.C, Mayo Clinic, Rochester, MN.
~ 1954 and 1976, 124 patients (pts) had an isolated
ventricular septal defect (VSD) with a total pulmonary
resistance (RP) of ~7 Un2. Fifty-four pts (Irean age 6.6
years, Irean RP 11.1 um2) had surgical treatIrent (ST) and
70 pts (Irean age 13.3 years, mean RP 24.2 Un2) had roodica1
treatlrent (MT) . Patients were follC1w'ed for a median of
20 (5-29) years. Nine (17%) ST pts died at operation and
the 10 and 20 year survival for ST pts was 88% (34 pts)
and 53% (14 pts), cx:rrpared with 84% (50 pts) and 60% (19
pts) respectively for MT pes, Of the 28 ST pts alive at
recent fol.Iow-up, 18 (64%) were asyrrptanatic corpared
with 8 (17%) of the 47 surviving MT pts. 'Thirty ST pts
had a subsequent cardiac catheterization at a mean of 4
years after operation and the RP was o:rrpared to that at
the time of operation. Of the 11 clinical and harodyn-
amic variables tested as predictors of change in RP, only
the age at operation was progmstically significant
(P=0.02). Of the 13 ST pts .::.3 years of age at operation,
11 (85%) had a decreased RP a:npared with 8 (47%) of the
17 ST pts >3 years. After 20 years' follow-up, 8 (74%)
of the ST pts .9 years were alive cx:rrpared with 6 (41%)
of the ST pts >3 years. Of the 28 MT pts who had a sub-
sequent catheterization, 23 (82%) showed an increased RP.
'Thus, these pts with VSD and high RP had a shortened sur-
vival regardless of treatIrent. Ha.leVer, despite the
level of RP at the time of operation, ST pts <3 years
were often asyrrptanatic at fol.Iow-up , had improved hero-
dynamics and a better long-term survival.
TRl'NCl!S ARTERIOSPS lHTH SINGLE PULMONARY ARTERY: THE
INFLUENCE OF PULMONARY VASCULAR OBSTRUCTIVE DISEASE ON
EARLY AND LATE RESULTS I N SURGI CALLY CORRECTED PATIENTS.
Der ek A. Fyfe , M.D . , David J . Dri sco l l, M.D. FACC ,
Rober to Di Donato , M.D. , Francis co J . Puga , M.D. FACC,
Gor don K. Danielson , ~!.D. FACC, Dougl as D. !Ia i r , I-' .D.
FACC, Mayo Cl i ni c , Roches ter , MN
Ni net een pa t i ents wit h truncus ar t eriosus and s i ngle
pul mona ry ar t e r y (TASPA) had cor r ec t i ve opera t i on at the
Mayo Cl i ni c s i nce 1969 . Pre-oper a t ive pulmona r y res i s-
t ance divi ded by 2 (Rp/2) was used t o predic t the de~ree
of pul monary vas cul a r obs t r uc t iv e di sease (PVOD) a t op-
e ra t ion. Six of 19 pa t ients (32%) died peri operat i ve ly .
Three wi t h Rp / 2 of 6 .2 t o 9 .2 unit s m2 had irreve r s i ble
(Hea th -Edwards Gr ade 4) PVOD . His t ology a t operation
i n 2 patient s wi th Rp/ 2 of 2.7 t o 3. 2 uni t s m2 had
Gr ade 1 and 2 l es i ons . Of 7 pat ients dying 45 to 100
mont hs pos t - oper at i ve ly , 4 had pr e-operat i ve Rp/2 of
5 . 1 t o 7. 5 units m2 and p r o ~res s ion t o sever e PVOD was
documente d. Two patient s dyin g lat e wit h pre-operative
Rp/2 < 5 uni ts m2 did not have sev er e PVOD . One surviv-
i ng pa t ient wi th a pr e- operative Rp / 2 > 5 units m2 has
had no progress iv e PVOD 147 months pos t -o perat iv e . Five
patient s wi t h Rp /2 < 5 uni t s m2 r ema i n wel l f rom 13 t o
133 month s pos t -o pe ra t ive l y . Pati ent s with TAS PA wi t h
pre -ope ra tive l y Rp/ 2 > 5 uni t s m2 have bot h a hi gh
operative (4 / 10 patient s ) and late (5/6 pa t i ents ) mor ta-
l it y assoc iated wi t h pr ogress i ve PVOD . In cont r as t ,
pa tients wi t h Rp/2 < 5 uni t s m2 had no pro~ressive PV2D.
In conc l us io n , i t appea rs t hat an Rp/ 2 of > 5 uni t s m
pr ed i c ts prog r ess i on of PVOD and poor outcome f ollowing
ope ra t i on in patien ts wi th truncus ar t er i os us and s i ng le
pulmonar y artery .
3-D ANATOMY OF PtJU40NARY ARTERIES IN PULMONARY ATRESIA
Yun-He Liu, M,D .; Michael Block, M.D. ; Donald J. Hagler,
M.D., FACC; Paul R. Julsrud, M.D. ; Douglas D. Hair, ~.D.,
FACC; James B. Seward, M.D., FACC; and Erik L. Ritman,
M.D ., Ph.D .; Mayo Foundation, Rochester, Minnesota
Measurements of pulmonary artery vessel lumen cross-
se ctional area, length of branches, and branching angles
were obtained in children with first stage repair of con-
genital pulmonary atresia. Patients were scanned in the
Dynamic Spatial Reconstructor (DSR), high-speed CT scan-
ner, during injection (0.7 - 1 .2 ml/kg) of contrast agent
into the pulmonary artery conduit . Accuracy of measure-
ments of vessels was first established using a glass
model of the vascular tree and with pulmonary arterio-
gr ams of dogs. Based on the model, it was determined
that the cross-sectional area of a I mm diameter 'vessel'
could be measured within 60% of the truth, a 2 mm vessel
within 10%, and a 5 mm vessel within 5%. We compared
direct measurements and DSR measurements for all
'vessels' between 1 and 19 mm diam~ter (r • 0.99 for
cross-sectional area (SEE· 2.5 mm ), branching angle
(SEE = 20 ) , and segment length (SEE· 1 mm». Based on
the dog studies, cross-sectional a2ea of vessels (1.5 -10 mm diameter) had a SEE· 2.2 mm , SEE· 1.8 mm for
segment length and SEE = 4.50 for branching a9gle. In
a patient with 12 mm2diameter conduit (113 mm area) D~Rvalue was 115 ± 5 mm and 2cineangiogram was 94 ± 13 mm .In a pati~nt with a 50 mm area conduit DSR ~alue was
47 + 5 mm and cineangiogram was 55.5 + 9 mm. The DSR
sca; (8 sec) involved 0.63 - 0.95 R/sec exposure at ster-
num whereas the biplane cineangiogram (3 - 5 sec)
involved 0.8 R/sec . Based on these data, we conclude
that a single DSR scan provides accurate measurements of
pulmonary artery anatomy and vessel dimensions.
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FUNCTIONAL ROLE OF MAJOR SYSTEMIC-TO-PULMONARY
COLLATERAL ARTERIES IN PATIENTS WITH TETRALOGY
OF FALLOT AND PULMONARY VALVULAR ATRESIA.
Pui-Kan Liao, MD; Paul R. Julsrud, MD; William D.
Edwards, MD, FACC; Robert H. Feldt, MD, FACC,
Mayo Clinic, Rochester, Minnesota.
In patients with tetralogy of Fallot and pulmonary
valvular atresia, major systemic-to-pulmonary collateral
arteries (SPCA) are frequently present and supply
variable portions of lung for gas exchange; the possible
role of SPCA for bronchial nutrition has not been
thoroughly studied. In 19 such patients, we studied the
major SPCAs by angiography (angio) during life and by
histology (histo) postmortem (by sequential section and
selective serial section) to identify branching patterns
and nutritive branches that might indicate a dual
functional role. Of 63 (30 right, 33 left) major SPCAs
identified by angio, 22 (35%) joined the central
pulmonary arteries or their lobar or segmental branches,
and 41 (65%) did not. Within the lungs, branches which
originated directly from the SPCAs travelled with
airways and resembled normal pulmonary artery branches
by angio; 88% were elastic and indistinguishable from
pulmonary arteries by histo. In 29 selective SPCA angio
injections, 12 (41%) had bronchial (9) or intercosto-
bronchial (3) branches. Moreover, small muscular twigs
arising from major SPCAs or their hilar branches entered
the bronchial submucosa as nutritive bronchial arteries
in 6 of 8 SPCAs studied by serial histo section. Our
studies support the hypothesis that major SPCAs are
probably derived from fetal intersegmental arteries and
may therefore retain a dual function for alveolar gas
exchange and bronchial nutrition. Accordingly, surgical
ligation of a major SPCA may produce pulmonary infarction
in some cases.
ANGIOGRAPHIC MORPHOLOGY OF VENTRICULAR SEPTAL DEFECT IN
DOUBLE OUTLET RIGHT VENTRICLE
P.H. Nath, /10; Beni cno Soto, /10, FACC; Lionel M.
Bargeron, Jr., MD, FACC: Roberta M. Bini, MD; Albert D.
Pacifico, MD, University of Alabama, Birmingham, AL.
Morphology of the ventricular septal defect (VSD) is a
major determinant in choice of technique for surgical
repair of double outlet right ventricle (DORV) and its
prognosis. To evaluate the VSD and its anatomic bound-
aries, angiocardiograms of 26 patients were reviewed.
Perimembranous VSD has anterior portion of the atrio-
ventricular (AV) valves in its margins, thus possessing
fibrous continuity between tricuspid and mitral valves;
in muscular VSD the fibrous continuity between their
annuli is absent. When the defect involves the inlet
septum and a common AV valve was present AV septal
defect was diagnosed. These features were seen best in
left ventriculogram obtained in 4-chamber projection.
The relationship of the VSD to the aortic and pulmonary
valves was seen equally well in elongated right anterior
oblique projection and 4-chamber view. Location of VSD
was muscular in 14 (55%), peri membranous in 10 (30%) and
AV canal in 2 (6%). Since the conduction system is
known to be related to the central fibrous body, peri-
membranous and AV canal type VSD have conduction system
in their margins while muscular VSD is safe. Muscular
VSD was the most common type encountered in DORV. Eight
of 14 muscular VSDs were committed to pulmonary valve
and 7 of 10 peri membranous VSDs to aortic valve. There
was no predictable relationship between location of VSD
and position of ascending aorta. Thus preoperative
angiography utilizing axial projections provides accu-
rate information about the morphology of VSD in DORV and
predict its relationship to the conduction system.
QUANTITATIVE ASSESSMENT OF RIGHT AND LEFT VENTRICULAR
GROWTH IN THE HUMAlI FETAL HEART: A PATHOANATOMIC STUDY
~~rtin G. St. John Sutton, MD, FACC, Dale S. Huff, MD,
University of Pennsylvania, Philadelphia, PA
The right ventricle (RV) has been considered the domin-
ant ventricle in the human fetal heart. This concept has
derived from autopsy studies in which RV weights were
greater than left ventricular (LV) weights. In these
studies however, varying proportions of the septum were
arbitrarily designated as RV and LV, resulting ina multi-
phasic RV growth curve. The different RV and LV weights
and growth curves are inconsistent with their common vas-
cular resistance, and unexplained by changes in the fetal
lung; this stimulated us to compare the RV and LV in 30
normal fetal hearts of gestational ages (GA) from 15-40
weeks (wks). GA was assessed by biparietal diameter. In
each heart, the great vessels were excised at the semi-
lunar valves and the hearts weighed. The atria were re-
moved and the RV and LV free-walls detached from the ven-
tricular septum. Measurements were made of 1) total heart
weight, 2) RV and LV free-wall weights and their contri-
butions to total heart weight, 3) RV/LV weight ratio and
4) RV and LV free-wall thicknesses. The effect of GA upon
each of these was assessed by linear regression analysis.
Total heart weight increased from 0.8 g at 15 wks to 14.5
gat 40 wks (r =.95). RV and LV free-wall weights did
not differ at any point in gestation (r =.97), and in-
creased with GA (r =.95, r =.94) so the RV/LV weight ra-
tio was consistently 1.0. The contributions of RV and LV.
free-wall weights to total heart weight were 29 ! 2% and
30 ! 2% and did not vary with GA. RV and LV wall thick-
nesses were similar throughout (r =.96), and increased
with GA (r =.72, r =.74). We conclude that the similar
RV and LV weights, wall thicknesses and contributions to
total heart weight throughout gestation, do not support
the presence of RV dominance in the human fetal heart.
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New Antiarrhythmic Drugs II
LONG-TERM ANTIARRHYTHMIC EFFICACY OF HEXILETINE: RESULTS
FROM 24-HOUR ELECTROCARDIOGRAMS
Presented by Jean-Pierre Van Durme, H.D. for the
International Hexiletine and Placebo Antiarrhythmic
Coronary Trial Research Group, Akademisch Ziekenhuis De
Pintelaan, Gent, Belgium
IHPACT was a randomized, dOUble-blind, placebo controlled
trial designed to evaluate the antiarrhythmic action of
the long-acting formulation of mexiletine (Hexitil-Perlon-
gets, 360 mg b.i.d.) during one year after myocardial
infarction (HI) irrespective of arrhythmias at baseline.
A total of 317 patients were treated with mexiletine and
313 with placebo. Treatment was initiated 3 to 25 days
after hospital admission. Ambulatory 24-hour ECG record-
ings were obtained at baseline and Months 1, 4, and 12
and analyzed centrallY. The primary response variable was
"frequent or complex cardiac arrhythmia" (FCCA) defined as
the occurrence of 30 or more single premature ventricular
contractions (PVCs) in any two consecutive 3D-minute
blocks or one or more runs of two or more PVCs in the
entire 24-hour ECG recording. The incidence of FCCA was
lower in the mexiletine group at Honth 1 (36.5J) than in
the placebo group (58.0J). This difference is highly
statistically significant (z = -5.04, P < 0.0001). This
effect persisted at Month 4 but at Month 12 although in
the same direction was not significant. With regard to
the component parts of FCCA, mexiletine was particularly
effective in reducing the incidence of runs of three or
more PVCs (9.4J compared to 21.61 in the placebo group;
z = -3.92). Hexiletine was also effective at Months 1
and 4, but not significantly at Month 12, in reducing the
incidence of bigeminy, trigeminy, and multiform PVCs, and
the median percentage of 30-minute blocks with one or
more PVCs. In conclusion, mexiletine was effective in
preventing or supressing ventricular arrhythmias at least
over the first four months following acute HI.
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TREATMENT OF REFRACTORY VENTRICULAR TACHYARRHYTHMIAS WITH
A COMBINATION OF MEXILETINE AND A CLASS IA ANTIARRHYTHMIC
DRUG
Brian McGovern, MB; Hasan Garan, MD; Christodulos S.
Stavens, MD, Mark H. Schoenfeld, MD. N.A. Mark Estes. MD.
Maureen P. Fallon, Jeremy N. Ruskin, MD. FACC. Massachu-
setts General Hospital, Boston. MA
A combination of Mexiletine and quinidine or procaina-
mide was evaluated in 76 patients (pts) in whom mexile-
tine, quinidine or procainamide alone had failed to
control ventricular tachyarrhythmias. All pts had docu-
mented spontaneous and electrically inducible ventricular
tachycardia (VT) or ventricular fibrillation (VF). The
age of the pts was 59+9 years (mean + 1 SD); ischemic
heart disease was pre;ent in 70/76 pts; the mean ejection
fraction was 31+14, and the number of previously failed
drug trials was-4.8+2. The results of programmed cardiac
stimulation performed on mexiletine combined with quini-
dine or procainamide are expressed based on the present-
ing clinical arrhythmia:
Presenting Number Percent
Arrhythmia Number Suppressed Suppressed
Nonsustained VT -1-3- 6 46%~Sustained VT 38 6 16% 11
VF 25 9 36%
TOTAL ~ rr 28%
We conclude that a combination of mexiletine and quini-
dine or procainamide may effectively suppress inducible
ventricular arrhythmias where each agent alone has fail-
ed. The combination is more likely to be effective in
pts presenting with nonsustained VT or with VF than in
pts with recurrent sustained VT.
THE ANTIARRHYTHMIC ACTION OF BETHANIDINE
Vilma Torres MD, David Flowers MD, Brenda Butler BA,
Jonathan Wynn MD, Deborah Keefe MD, Dennis S. Miura MD &
John C. Somberg MD. Albert Einstein College of Medicine,
Bronx, NY.
Bethanidine (B) a chemical analog of Bretylium was
studied to determine its efficacy as contrasted to
procainamide in preventing programmed electrical stimula-
tion (PES) induced ventricular tachycardia (VT). Eigh-
teen patients who underwent PES because of symptomatic VT
received protriptyline (P) 15 mg orally 24 hours and 1
hour prior to B testing. Sustained VT (VT not spontane-
ously stopping) was induced in 5 and nonsustained VT (10
beats or greater that terminated spontaneously) was
induced in 13. These patients had failed an average of 3
drugs in prior PES testing. B (5 and 10 mg/kg) was
administered IV and PES repeated. Following B 8 out of
18 patients (44%) had VT prevented. B 5 mg/kg protected
7 and 10 mg/kg protected 1 patient. P failed to
influence inducibility, but attenuated the acute hype~ten­
sive and orthostatic effects of B. After B there were no
significant changes in PR, QRS, QTc, and refractory
periods of the right ventricle. Procainamide (Pr) 1000
and 1500 mg IV protected 7 out of 15 patients (46%).
Mean Pr serum level was 7±0.79 ug/1iI1. B protected 50% of
patients not protected by procainamide. Thus B may be an
effective antiarrhythmic in patients in whom class I
agents are ineffective. Four patients with symptomatic
VT have been on B for an average of 7.8 months without
any VT clinically or on Holter monitoring. Concommitant
administration of P attenuates the orthostatic and acute
hypertensive action of B. These studies show B to be
effective in preventing VT induction and thus, its use
may not be restricted to cases of primary ventricular
fibrillation.
No VTA, su~tained or non-sustained, was inducible in
10/26 \38') pts on the combination of Mx and a IA
agent. All 10 pts successfully treated with the
combination had inducible sustained VTA on each agent
alone at plasma levels comparable to those achieved
with the combination. In the remaining 16 pts who were
still inducible, each of the 3 drug regimens prolonged
VTA cycle length: IA agent by 37+21' control; Mx by
27+26' controlj IA agent plua Mx-oy 49+28' control. We
conclude that 1n pts with inducible sustained VTA re-
sistant to IA agents rlrne and Mx alone, the combination
of Mx ,nd a IA agent 1 suppresses inducible VTA in more
thsn 1 3 of pts, and 2 more effectively prolongs VTA
cycle length than either agent alone.
EffICACY Of COMBINATION THERAPY WITH HEXILETINE AND A
TYPE IA AGENT fOR SUSTAINED VENTRICULAR TACHYARRHYTHMIAS
Allan M. Greenspan. ~~i Scott R. Spielman, MD.
~~arles R. WebD, MU, tACC; David T. Lowenthal,
MD, rACC; Leonard N. Horowitz, MD, fACC. Likoff
Cardiovascular Institute, Hahnemann University,
Philadelphia. PAt
Because the efficacy of stand~rd anti-arrhythmic
agents in treating sustained l>30 s~c or causing syn-
cope) ventricular tachyarrhythmias lVTA) is lim1ted, we
studied the effects of comb1natt'o1 therapy with Mextle-
tine (Mx) and et'ther Quinidine Q or procainamide( PAlin 26 patients pts) with inducib e sustained VTA 22
with uniform morphologr ventricular tachycardia and 4
with ventricular fibr1 lation). VTA rema1ned inducible in
all 26 pts receiving Mx alone and a Type IA CIA) agent
alone. Each pt then received a combination of the IA
agent and Mx. The doses of Mx and the IA agent when given
in combination did not differ significantly from the
doses of either agent when given alone. The plasma levels
achieved for each drug were:
ALONE
COMBINATION
P VALUE
Mx
1.1+.43
1.1±.48
NS
PA
12.6+4.8
lO.3±6.0
NS
Q
3.2+1.5
2.9±1.4
NS
CLINICAL USE OF INTRAVENOUS FLECAINIDE FOR ACUTE
ATRIAL, JUNCTIONAL AND VENTRICULAR TACHYCARDIAS
Anthony WNathan, MBj Kevin J Hellestrand, MB;
Rodney S Bexton, 1M; A John Caam, MD, FACC.
St BarthOlomew's Hospital, London, England.
Intravenous flecainide (2 mg/kg) was given during acute
onset tachycardias to 61 patients. Ten had atrial flutter
and 10 atrial fibrillation (inCluding three with
preexcitation). Fifteen had atrioventrioular reentrant
tachycardia, nine AV nodal tachycardia and 17 ventricular
tachycardia. The results were as follows:
Arrhythmia Terminated Tachyoardia iate
Pre • Post. p value
Atrial flutter 2/10 (20J) 120~12. 86~5. <0.001
Atrial fibrillation 9/10 (90J) 156+10 120+8 <0.05
Atrioventricular 12/15 (80J) 183:;31 141:;28 <0.001
Intra AV nodal 8/9 (89J) 184:;29 139:;21 <0.001
Ventricular 13/17 C76J) 175:;11 112:;14 <0.01
, =immediately before termination, .-= ventrIcular rate.
In those with atrioventricular tachycardia, termination
was in the retrograde 11mb (accessory pathway) in 11 and
anterograde limb (AV node) in only 1; in those with AV
nodal tachyoardia 7 terminated in the retrograde "fast"
pathway and only 1 in the anterograde "slow" pathway.
Three had proarrhythmic effects. One, with AV nodal
tachycardia, developed ventricular fibrillation, and
another with ventricular tachycardia degenerated into
fibrillation - both had received other antiarrhythmic
drugs, and one, a patient with atrial flutter, developed a
faster ventricular rate. All 3 responded to external
countershock. Minor side effects included oral
paresthesiae, transient dizziness and visual blurring.
Flecainide is a very effective and relatively safe drug
for the termination of recent onset paroxysmal atrial,
junctional and ventricular tachyarrhythmias of all types
except for atrial flutter.
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ANTIARRHYTHMIC ACTION OF BEPRIDIL: A LONG ACTING
CALCIUM BLOCKER WITH ANTIARRHYTHMIC PROPERTIES
Vilma Torres, MD; David Flowers, MD; Brenda Butler, BA;
Dennis Miura, MD; John C. Somberg, MD, Albert Einstein
College of Medicine, Bronx, N.Y.
Bepridil (B), a long acting calcium entry blocker is an
effective antianginal agent that may possess anti-
arrhythmic properties. Since B prevented programmed
electrical stimulation (PES) induced ventricular tachy-
cardia (VT) in an animal model, we hypothesized that B
may be effective in preventing PES induced VT and thus we
planned to compare the effectiveness of B to procainamide.
Twelve patients, 7 men and 5 women, average 64 years with
hemodynamically significant VT underwent PES. After
failing an average of 2.25 drugs; sustained VT (VT not
stopping spontaneously but requiring termination) was
induced in 5 and non-sustained VT (10 beats or greater
that terminated spontaneously) was induced in 7 patients.
B administered (1 mg/kg increments) by constant infusion
prevented VT in 7 out of 12 patients (58%). The mean
protective dose was 2 mg/kg, with serum B level at PES of
632 ± 77 ng/ml (M ± SEM). Following B there were no
significant changes in HR, PR, QRS, and QTc. Right ven-
tricular refractory periods were prolonged, 16% (p<0.05).
Six patients had His bundle recordings prior to and after
B at the protective dose. Mean AH and HV intervals were
100 ± 12, 48 ± 3 msec, and after B 98 ± 12, 49 ± 4 msec.
Pharmacokinetic studies showed the apparent plasma elimin-
ation half life of B to be 22.5 hours. Procainamide,
1000 mg IV protected 10 of 12 patients (83%) from PES
induced VT, serum concentration of 6.5 ± 0.76 Vg/ml. In
no patient did B facilitate VT induction. These studies
suggest that B may be an effective antiarrhythmic agent
and combined with its anti-ischemic action, may make it
an ideal agent in selected patients.
LASER PHOTOABLATION OF AORTIC VALVE CALCIUM: EVALUATION
OF ARGON VERSUS CARBON DIOXIDE LASERS USING EXCISED SUR-
GICAL AND POST-MORTEM SPECIMENS
Jeffrey M. Isner, MD, FACC; Harold Michlewitz, MD; Richard
H. Clarke, PhD; Roberta F. Donaldson, BS; Deeb N. Salem,
MD, FACC, Tufts-New England Medical Center, Boston, MA
Previous surgical experience has demonstrated that hemody-
namic improvement can be achieved by gross debridement of
calcific deposits (Ca) from the aortic valve (AV) leaflets
of patients with aortic stenosis. We therefore investigat-
ed the use of laser photoablation (LP) to perform debride-
ment of AV ca. Surgically excised, heaVily calcified AV
leaflets from patients with aortic stenosis were treated
with either carbon dioxide (7 leaflets) or argon (8 leaf-
lets) LP. Carbon dioxide LP consisting of either continu-
ous exposure or multiple 500 msec pulses (cumulative ex-
posure <4 minutes) of 5-8 watts power eliminated >90% of
AV Ca seen on pre-treatment x-rays of 7/7 leaflets; one
0.8mm perforation occurred in 1 leaflet. In each case, LP
also reduced thickening due to fibrosis. Similar results
were also achieved with 6 leaflets from AVs that had been
preserved intact on post-mortem specimens; gross inspec-
tion of post-LP specimens suggested that AV leaflet com-
pliance and competency were nearly normal. Argon LP (4.3
watts, cumulative continuous exposure 2-8 minutes) vapor-
ized some portion of CA from 8/8 leaflets; the extent of
debridement achieved with carbon diOXide, however, could
not be duplicated, probably because the typical white hue
of the AV surface limited absorption of the argon (454-
514nm) light.
We conclude: 1) near-total debridement of AV Ca can be
achieved using LP; 2) carbon dioxide LP is more effective
for this purpose than argon LP; 3) in selected patients
with calcific aortic stenosis, it may be possible to per-
form intra-operative LP of AV Ca in o~der to preserve the
native AV and thus avoid prosthetic valve replacement.
Wednesday, March 28, 1984
10:30AM-12:00PM Ballroom B
Aortic Stenosis-Mitral Incompetance
NON-INVASIVE EVALUATION OF SEVERITY OF AORTIC STENOSIS BY
A POINT SCORE SYSTEM AND A CLINICAL ALGORITHM.
Mario Romero, MD, Toru Nakamura, MD, Julio Milanes, MD,
Herbert Hultgren, MD, FACC, Stanford University School of
Medicine, Palo Alto, California.
SEN 42% 51% 55% 50% 68% 35%
SPE 80% 78% 75% 82% 78% 97%
p< .025 .005 .005 .005 .005 .005
A total score >5 occurred in 85% (46/52) of patients with
severe AS compared to 15% (6/41) with mild AS. In 43
patients with a score <5, 28 were symptomatic and 6 (21%)
had severe AS. Fifteen patients with a low score were
asymptomatic and only two had severe AS. The use of six
non-invasive variables plus an evaluation of symptoms
permitted the identification of nearly all (52/54)
patients with severe AS.
DEMONSTRATION OF THE IMPORTANCE OF LEFT VENTRICULAR END-
DIASTOLIC VOLUME IN DETERMINING THE MAGNITUDE OF MITRAL
VALVE PROLAPSE UNDER DIFFERENT HEMODYNAMIC CONDITIONS
Randal W. White,MD; K. Wray Amon, BS; Michael H. Crawfor~
MD, FACC; University of Texas Health Science Center and
Veterans Administration Hospital, San Antonio, Texas
The volume of the LV in relation to the size of the mitral
valve is believed to be important in determining the mag-
nitude of mitral valve prolapse (MVP). However, this re-
lationship has not been demonstrated during bedside ma-
neuvers used to detect the auscultatory features of MVP
and the value of such maneuvers in the 2-D echocardio-
graphic diagnosis of MVP is unclear. Therefore, we stu-
died 21 subjects; 11 with definite auscultatory evidence
of MVP and 10 normals. 2-D echocardiography was perform-
ed during hand-grip (HG) exercise (50% maximum grip) and
amyl nitrite inhalation. LV volumes were measured from
biapical views (Simpson's rule) and maximum systolic MVP
area was measured from the annular plane by a video 1ight
pen. In the MVP subjects, HG increased heart from 70±15
(SD) to 88±22 beats/min (p<.005) and systolic blood pres-
sure from 113±lO to 130±42 mrnHg (p<.OOl), but did not
change EDV (81±36 vs 82±22 ml) or MVP area (.73±.48 vs
.78t.53cm2 ) . Amyl increased heart rate from 73±12 to
103±21 beats/min (p<.OOl); decreased systolic blood pres-
sure from 116±23 to 98±24 mmHg (p<.05) and EDV from 91±31
to 69±!7ml (p<.005);and increased MVP area from .51±.31
to 1 .05±.42 cm2 (p<.OOl). Similar hemodynamic and vol-
ume changes were observed in the normals, but no normal
developed MVP during HG or amyl. We conclude that: 1)
only maneuvers that change LV size alter the magnitude of
MVP; and 2) the increase in MVP observed after amyl nit-
rite inhalation may be of value in the 2-D echo diagnosis
of MVP, whereas handgrip exercise is not.
Ejection
Time
T-
Time
Q to
Peak
Faint
Severity of aortic stenosis (AS) in elderly patients is
difficult to assess and the disease is frequently
progressive. Non-invasive methods of detecting severity
or progression would be useful in reducing the need for
invasive procedures. We employed 6 non-invasive variables
and a point score system combined with a clinical
algorithm to evaluate severity of AS in 95 patients (mean
age 63 yrs, range 42-87). All had coronary arteriography
and determination of aortic valve area. Variables and
scores [ ] were: Valve calcium on chest x-ray [2]; LV
hypertrophy by ECG [2]; Faint A2 [2]; Q to peak of murmur
>0.28 sec. [3]; T-time of carotid pulse >0.06 sec. [2];
and corrected ejection time >0.46 sec. [3]. The
sensitivity (SEN), specificity (SPE), and p-val~e for each
variable in patients with a valve area 20.80 em (severe
AS) are shown below:
Valve LV
Calcium Hypertrophy
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MYXOMATOUS MITRAL VALVES, MITRAL VALVE PROLAPSE AND
PROGRESSIVE MITRAL REGURGITATION
Albert J. Kolibash, Jr., MD, FACC, Charles A. Bush MD~James Kilman, ~~,~eph M. Ryan, MD, FACC:
Charles F. Wooley, MD, FACC, Ohio State University,
Cohmbus , Oh.
The progression of mild mitral regur gi t ati on (MR) , mos t
commonly associated with mitral valve prolapse (MVP)
and myxomatous mitral valves (MMV) , to clinically symp-
tomatic severe MR is not well def ined. Seventy-six pa-
tients (pts) ages 26-82 yrs (mean 59) presented with
cardiac symptoms and/or significant MR. The mean dura-
tion of symptoms was < 1 yr but a murmur was known in
70 pts from 1-57 yrs (mean 25). Atrial fibrillation
was also seen in 40 pts. Cardiac catheterization
(cath) in 75 pts showed significant MR in all pts and
MVP in 65. Serial caths in 14 pts at 3-16 yr intervals
(mean 8) showed progression from mild MR with MVP to
severe MR with ruptured chordae. Serial clinical ex-
ams, chest x-rays and/or echocardiograms in 10 other
pts, 6 with documented MVP, showed progressive cardio-
megaly over 5 yrs. Mitral valve surgery (MVS) in 69
pts comprising 53~ of 131 pts haVing MVS for MR of mul-
tiple etiologies during the same period demonstrated
floppy mitral valves in all pts and ruptured chordae in
38. Pathological exam showed extensive myxomatous
changes .in all valves. Thus, (1) pts with MMV and mild
MR remain asymptomatic during most of life ; (2) acute
deterioration with symptomatic severe MR occurs in
later life and is frequently related to atrial fibril-
lation (53~, 40/76 pts) and ruptured chordae (50~,
38/76 pts); (3) MMV is the most common etiology of se-
vere MR in pts having MVS for pure MR at our institu-
t!on ; (41 the fr~quency of documented MVP i n the 24 pts
With serial studies suggests that ·MMV with progressive
MR is an important subset o~ the MVP syndrome.
MITRAL VALVE PROLAPSE:EVIDElICE OF BAROREFLEX AB I10RMALl TY
WITH IIlTRAVASCULAR VOLUME MAIIEUVERS
Jon M. Rogers, MD; Haris ios Boudoulas, MD, FACC ; Char les
F. Wooley , MD , FACC, The Ohi o State Unive rs ity , Columbus,
Ohio
Inappropriate changes in hear t rat e i n symptomatic pat-
i ent s (pts) with mitral valve prolaps e (MVPS) may reflect
baroref1ex disease. In 8 MVPS pts and 7 cont r ol s (C)
graded phenylephrine (P) infusions were performed (0.5-
2.5 ~g!kg!minute) supine under basal (B) condi t i ons (day
I), a f t e r volume depletion (VD) with intravenous furosem-
ide (day 2) and after rapid volume expansion (VE) with
0 . 9% saline (3000cc!10 hours ) (day 3) . VD and VE were
equ al for MVPS and C. With each amount of P i nf us ed mean
a r t eria l pressure (MAP) was equa l l y inc r ea sed i n MVPS and
C. i n B, VD and VE. The decrem en t i n hea r t r at e (HR) was
gr ea t er in MVPS compa r ed to C in B, VD and VE . Slopes of
t he regres sion lines related chan ges i n HR as a funct i on
of MAP ( .1I1R! .1MAP) and were signif icantly dif fe rent i n
MVPS compared t o C at any leve l of hydra t ion .
*p< . 05 C ve r su s MVPS; ± 1 S .E .
LONG-TER~ SIGNIFICANCE OF THE LEFT VENTRICULAR DYS-
FUNCTION THAT OCCURS IMMEDIATELY AFTER MITRAL VALVE
REPLACEME NT FOR MI TRAL RE GURGITATION
J oann Ur quha r t , MD, Robert O. Bonow, MD, FACC, Barry J.
Mar on , HD, FACC, Douglas R. Rosing, MD, FACC, Lewis C.
Lipson. MD, FACe, Stephen E.Epstein, MD. FACC, NHLBI,
Bet hesda, ~la ry land
Previous s t udi es have demonstrated that the LV ejection
fraction (SF) of patients (pts ) with mitral regurgitation
(HR) det eriorates significantly foLlovfng valve replace-
ment (HVR) . However, the long term c l t atca l significance
and ef f ec t on long-term LV function of this finding are
unknown. We therefore studied the effects of MVR on early
pos t op (6 rno t o 2 yrs) and late postop (3 to 5 yrs, mean
3 .5 ) LV fu nction in 23 MR pts using radionuclide angio-
graphy . Before ~WR, EF was 48+8% (mean+SD); EF early af-
te r MV R decreased to 35+13% (p(O.OOl) with 12 pts demons-
trating >5% decrease in-SF. The only pt who died during
subsequent follow-up was the pt with the lowest EF early
pos t -op (1 3%, compared to 35% preop). All remaining pts
are al i ve; 19 of 22 have persistant improvement of >1
fun ctiona l c l as s compared to preop values. At 3-5 yrs
EF wa s 39~14% , a significant increase (p(.005) from the
earl y post - op studies; in 9 pts EF increased >5%. All pts
with EF >30 on early study remained stable or showed an
i nc rease i n EF on late s tudy ( 43+9% to 50+10%, p(. 05) .
However , of 8 pts with EF(30% on-early study, 1 pt died,
two had no change i n EF between early and late
stud ies, and 3 had a progressive decrease in EF of >5% .
Hence , early pos t - op det erioration in EF does not
genera lly cor r e l a t e with subsequent clinical or LV
fun ct i onal cour se ; most pts with substantial early
dec rease i n EF man i f es t i mproved long-term LV func tion ,
with good cl i nic a l results 3-5 yrs postop. However, pt s
with pr of oundly decreased EF post-op «30%) appear to
const itute a gr oup at risk of persistant LV dysfunction.
Wednesday March 28, 1984
8:30-10:00AM Ballroom C
Treatment of Congestive Heart Failure: I
ROLE OF THE RENIN-ANGIOTENSIN SYSTEM IN THE
DEVELOPMENT OF TOLERANCE TO PRAZOSIN IN SEVERE
HEART FAILURE. Milton Packer MD, FACC, Norma Medina
RN, Madeline Yushak RN. Mount Sinai Hospital, New York, NY
Tolerance to the hemodynamic effects of prazasin (PZ) in
severe heart failure (CHF) has been attributed to activation of
the renin-ongiotensin-oldosterone (RAA) system. To verify such
a role, we treated 21 CHF patients (pts) with PZ 15 mg daily for
3-12 wks. Cardiac index (CI, l/min/m2 ) , mean arterial (MAP) and
pulmonary wedge pressure (PCW, mm Hg), systemic vascular
resistance (SVR, d-s-c) and plasma renin activity (PRA, ng/cc/hr)
were measured before (C), after 1st doses of PZ (DI), after 4Bh,
during long-term PZ (LT), and 48h after PZ withdrawal (W);
digoxin and diuretics remained unaltered. Seven pts received the
aldosterone antagonist, spironolactone, during the trial (group 11),
whereas 14 pts (group J) did not. * =p <.05 vs C, t = p <.05 vs DI
CI MAP PCW SVR PRA
AHR! .1MAP was not significant l y different after VE com-
pared to B in MVPS and C but changed s ign i f icant ly (p <
.05) in MVPS and C from B to VD.
Mitral valve prolapse patients have abnormal barore flex
sensitivity compa r ed to controls at basel ine, volume de-
pletion and volume expansion whi ch may, in part, exp-
lain their inappropriate chang es in heart rate.
MVPS
C
B
1.96 + .29*
1.13 :+ .13
VD
2.44 + .33 *
1.53:+ .12
VE
1. 73 + .2 7*
1.04 :+ . 14
C 1.95 84.9 27.2 · 180 1 2.4
DI 2.66* 65.9* 17,4* 1038* 5.9*
4Bh 2.14t 74.8*t 21.7*t I444*t 6.5*
LT 2.05t 75.8*t 22.4*t 1536*t 2.9t
W 1.92 85.4 25.9 1755 2.3
II C 1.55 83.9 28.4 2261 5.7
DI 2.09* 66.4* 20.0* 1457* 11.6*
48h 1.75t 77.4*t 22.7*t 1969*t 8.4
LT 1.8ot 74.0*t 25.9t 180B*t 6.8t
W 1.72 80.1 27.4 2054 4.6
After 48h, tolerance developed to the initial effects of PZ on CI,
MAP, PCW and SVR, and this was associated with a significant
increase in PRA. However, tolerance persisted during long-term
PZ therapy, even though PRA declined to pre-PZ values.
Spironolactone did not prevent tolerance: the responses in groups
I vs II were similar. Weight did not change in either group.
These data indicate that hemodynamic tolerance to PZ in pts
with CHF is not the result of activation of the RAA system and
cannot be prevented by treatment with aldosterone antagonists.
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DOES BLOCKADE OF THE RENIN-ANGIOTENSIN SYSTEM I N HEART
FAILURE ALTER THE REN AL RES PONSE TO ORTHOSTAS IS?
John C. Burnett, J r . , MDj J ames H. Cheseb ro , t1D , FACC;
Denni s R. Bresnahan, MD j Robe r t L. Fr ye, MD, FACC,
Mayo Medi cal Schoo l , Rochester , MN.
We have pr evious l y repor ted t ha t t he functional in teg-
r i t y of the kidney i n contro l of volume homeostas i s is
i ntac t in ch ronic conges tive hear t failu r e (CCH F) . I n
CCHF t he ki dney r es ponds physiologi cally wi t h an i ncreas e
in t he t ubul ar r eabsorpt i on of so di um dur in g the refl ex
stimul ation of or thostasis . A critical ro le has been
pr oposed for t he renin-angiot ens i on s ys t em (RAA) as t he
med iator of the increased reabs orp tion of sodi um during
t he s tres s of quiet s t andi ng. To test t his hypothes i s, we
studied 8 pat ients with NYHA Class I I I CCHF char ac t erized
by hyper reninemia (7 . 2+2 .2 ng/ ml /min ) befo r e and f ol lowing
t wo weeks of capt opr i l- (C) ther apy (18 . 75+3. 1 mg t.i.d. ).
Measurements were obtained fo r glomerul ar-f i l t r a t i on rate
(GFR) , r enal plasma flow (RPF) and f racti onal reabsorption
of sodium (FRNa+) in the supine and upright positions (U).
GFR (ml/min) RPF(ml/min ) FRNa+(%) MAP(mmHg)
Before C (S) 69+6 262+34 96 .3 +0.9 93.0+3. 3
(U) 56~8+ 202~37+ 99 .4~0 .2+ 9 3 .6~3 .8
Durin g C (S) 87~1l 388-:;:61++ 97 .5-:;:0 .8 ++ 79 . 1~3 .9++
(U) 64~4+ 244~26 99. 1~O.4 + 78.8-:;:4.2
+,++ p<. 05 (+ S vs U), (++S vs S)
The present s tudy establ i shes that blockade of the RAA
system r esul t s i n (1) t he pred i cted dec rease i n mean
art erial pres sur e (MA P) and (2 ) an i ncrease i n t he tubu lar
reabsorpti on of s odi um despite an i ncrease i n renal pl asma
f l ow. The rena l response to orthos tas i s is not a l t ered
by captopr i 1. Thus, the i nc rease in t he t ubul ar re-
absorption of sodium during r ef lex ac t i vat i on can occur
i nde pendently of t he RAA system.
CONTRASTINr. EFFECTS OF HYflRALAZINE ANf) CAPTOPRIL ml
SYMPATHETIC NERVOUS ACTIVITY IN PATIENTS HIT'i IMPAIREfl
LEFT VE~H~ ICULAR FUNCTI orl
Joachim Manthey, Mf); Rainer Dietz, Mf); Norhert Rohrig, Mf);
Albert Schomig, MD; Franz Schwa rz , Mf); Wolfgang Kiihler,
MD, FACC; Med. IJniv.-Klinik, Heidelberg, West Germany
Vasodilator administration in pat ients (pt s ) \~ith heart
failure may produce not only peripheral vasodilation hut
also a reflex increase in sympathetic nervous activity
(SNA) especially in patients with only mildly elevated
systemic vascular resistance (SVR). This increase in SN ,~
may limit the clinical benefit of many pts receiving vaso-
dilator drugs. In this stUdy we compared the vasodilators
hydralazine (H) and captopril (Cpt) for their effects on
SNA in 17 pts with severely impaired left ventricular
funct ion (LVEF~0.30) but with only mildly elevated SVR
« lQOO dyn.s.cm- 5). Hel!lOdynamic data and plasne norepine -
phrine (NE) were measured before and 4 weeks after chroni c
treatment either wi~h H (150 - 300 mg/1ay; group A) or
with Cpt (150 - 300 "g/day, group R). Control values (e)
and values after treatment iven as means were:
SVR SV HR NE
Group A: C 1508 33 R9 477
(~;8) H 1232* 39* Hl4* 731'*
Group R: C 1568 31 R7 468
(N;9) Cpt-!i 1014* 45'" 78*§ 259*§
SVR ; dyn.s.cm ); SVI ; stroke volume index, ml/m';
HR ; heart rate, beats/min); NE ; pg/ml ; '" p<n.05 ( C vs
H or Cpt; § p< 0.05 group A vs group R.
Conclusions: In pts with severely impaired LV function but
only mildly elevated SVR chronic H administration is ac-
companied hy a marked rise in SNA indi cat i ng a question-
able value of H for the long term nanagement of these
pts. In contrast, in similar pts receiving Cpt SNA is
attenuated during chronic therapy suggesting the useful-
ness of Cpt for the chronic treatment of these pts.
ADRENERGIC INHIBITION IN CONGESTIVE HEART FAILURE:
HEMODYNAMIC, NEUROHUMORAL AND RECEPTOR RESPONSE
PhillP. Kirlin, MD, FACC; Roger Grekin, MD; C.B. Smith, MD,
Ph.D .; Sunil Das, MD; Jack Juni, MD; Milton Gross, MD;
Robert Weiss, MD; Bertram Pitt, MD , FACC, Uni ver s i t y of
Michigan , Ann Arbor and Mi chi gan St ate University, East
Lans ing, ~lichigan .
Adrenergic i nhi bi t i on i n conges t i ve heart failure (CHF) is
cont r over s i a l . In order to study chr onic adr ene r gi c
inhibition , we randomized 13 normotensive patients (pt S)
with stable New York Heart Associat ion Functional Class
2-3 CHF for 3 weeks t o either methldopa (MD) (500 -1000 mg/
day, n=7) or to placebo (PI , n-6 ) . Mean! SEM LV ejection
fraction (EF) was 23 ! 4%. Radionuclide ventriculography
at rest (R) and upright exercise (Ex) was used. MD
reduced heart rate (HR) at R (85 ! 4 to 80 ± 6 beats/min,
p<.03) and mean blood pressure at rest (98 ± 3 to 88 ± 3
mm Hg, p<.05) and Ex (117 ± 7 t o 102 ± 3 mm Hg, p=.07).
Pressure rate product was lower both at R and Ex (both
p<.OS) . Ex stroke volume was hi gher (p=.08) and Ex
systemic vascular resistance lower (p=. 07) with MD.
Clinical status, Ex duration and R and Ex CO, LV volume
and LV EF were unchanged by MD. PI pts had only higher
HR at R. MD reduced R and Ex plasma norepinephrine (by
r adioimmunoassay) insignif i ca ntly (p=0 . 15 and 0.10).
Plasma ant i di ur e t i c hormone was unchanged but upright
plasma renin activity increased with MD (7 . 2 ± 2.3 to
12.5 ± 3 . 4 ng/ml/hr, p<.04 ) . Pl atelet a l pha-2 r eceptor
dens ity and affinity , by yohi mbi ne radioligand technique)
were unaltered despite hemodynami c cha nges. These
f i ndings suggest that adrenergic i nhi bit i on with MD 1n
CHF I) may not be harmful 2) may improve cardiovascular
efficiency (s ame Ex capacity and CO at lower HR, blood
pressure and pressure rate product ) and 3) increases
plasma renin ac t i vi ty .
PLASMA NOREPINEPHRINE REMAINS HIGH DURI NG LONG TERM VASO-
DILATOR THERAPY OF CONGESTIVE HEART FAILURE REGARDLESS OF
OUTCOME.
Leon Stein, MD, FACC; Indiana University Medical Center,
Krannert Institute of Cardiology , Indianapolis, Indiana.
Plasma norepinephrine(NE)is elevated in patients(pts)with
Severe congestive heart failure(CHF). This reflects incre-
ased sympat he t i c neural activity to provide inotropic sup-
port and raise systemic vascular resistance (SVR) to maint-
ain perfusion pressure when systemic flow falls. There-
fore,NE should decline when SVR is lowered and flow rises
with VD t her apy of severe CHF. We r eport 17 CHF pts, NYHA
Class III and IV whose NE remained high during acute and
long term therapy with the direct arteriolar VO minoxidil
(M)or hydralazine(H)despite cl inical and hemodynami c imp-
rovement . Before therapy heart rate (HR)was 91+16 beats/min
left ventricular filling pr es s ur e 22+6mmHg , car d i ac index
(CI) 2.08+ .47 1/min/m2,stroke volume (SV) 43+19 ml,systemic
vascular-resistance(SVR)1936+742 d/ s /cm- 5-;-and NE 787+463
P9/ml(normal~ 320). After acute drug t esting,pts wer; t it-
rated to a mean daily dose of 23mg of M or 300mg of H.
Repeat invas i ve studies were done after 1 month,and after
1 year of ambulatory t herapy(mean M dose 34mg and H 400reg)
Results were as follows (mean + SO) :
N HR CI - SV SVR
Acut e 17 95+18* 3.09+.85** 61+24** 1200+482**
1 Month 14 93+13 3.03+.71** 59+18** 1355+454*
1 Year 9 80+16 3.45+.68** 83+22** 1202+355"'*
"'p <. .05 and up,- . 01 compare d t o control.
Control NE correlated positively with HR,r=.53(p(. 05)and
negatively with SV,r= -.69(p(.001 ) . After 1 year,9 surviv-
ors advanced to NYHA Class I Or II. There were 8 cardiac
deaths,4 of them sudden ;NE did not differ between surviv-
ors and those who died. Conclusion-In pts with severe CHF
NE did not predict outcome,and remained high during VD
therapy inspite of clinical and hemodynamic improvement.
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VASOPRESSIN RESPONSE TO IMPROVED CARDIAC OUTPUT WITH
MDL 17,043 IN PATIENTS WITH HEART FAILURE
Barry F. Uretsky, MO, FACC; J.G. Verbalis, MO;
T. Generalovich, MD; A. Valdes, RN; P.S. Reddy, MD,
FACC, University of Pittsburgh, Pittsburgh, PA.
The stimulus for increased plasma vasopressin(AVP) in
heart failure(CHF) patients(pts) is unknown but has been
attributed to a "low flow" state.To determine if improve-
ment in cardiac index(CI) decreases AVP,18 CHF pts under-
went right heart catheterization in the control(C) state
and after incremental intravenous(iv) doses(mean 5.8+2.9
mg/kg) of MOL l7,043(MDL) to peak(P) increase in CI~
CI(L/min/m2) MAP(mmHg) RA(mmHg) PAW(mmHg) AVP(~U/ml)t
C 1.9 +.4 81 + 11 14 + 7 24 + 5 4.0 + 1.5
P 3.3 + .6* 67 + 9* 9 + 5* 14 + 6* 5.6 + 4.1
*p<.Ol P-vs C, MAP=mean arterIal pressure, PAW=PA-wedge
tAVP in non-eHF catheterization pts 2.0+ .9 ~U/ml
Despite a marked increase in CI, AVP did not change
significantly. Pts were divided into those Who increased
AVP after iv MDL (Group I,n=ll) and those who decreased
AVP after MOL(Group II,n=7). Baseline hemodynamic param-
eters were not significantly different between I vs II.
AVP rose in group I pts from 3.7+1.7 to 7.1+ 4.7 ~U/ml
and it fell in group II from 4.4+1.1 to 3.3+.7 ~U/ml.
In group I vS II decreases in systolic AP (~2l+l4 vs -8+6
mmHg) and MAP(-18+7 vs -7+9 mmHg) were greaterTp<.025).-
There were no significant-differences in response to MOL
in diastolic AP, CI, heart rate, PAW, RA, plasma renin
activity, or norepinephrine level.
In group I, AVP rose in spite of an increase in CI,
possibly because of the moderate fall in AP. In group II,
however, where the fall in AP was minimal, an increase in
CI was associated with a decrease in AVP. The data sug-
gest that the response of AVP to MDL may be a net result
of an increase in CI tending to decrease AVP and a fall
in AP tending to increase AVP.
PERIPHERAL INTERACTION OF SYMPATHETIC NERVOUS SYSTEM AND
RENIN-ANGIOTENSIN SYSTEM IN PATIENTS WITH HEART FAILURE.
Mark A. Creager, MD, FACC; David P. Faxon, MD, FACC;
Susan M. Rockwell, BA; Haralambos Gavras, MD; Jay D.
Coffman, MD, Boston University Medical Center, Boston,MA.
In patients with congestive heart failure (CHF), both
the sympathetic nervous system (SNS) and the renin-angio-
tensin system (RAS) may be stimulated. Excessive SNS
activity may limit the limb vasodilatory response to
captopril (C). Since orthostasis normally increases both
plasma renin activity (PRA, ng/ml/hr) and p~asma norepin-
ephrine concentration (NE, pg/ml), we compared the forearm
hemodynamic response to 600 head-up tilt in 11 sodium
depleted normal subjects (NS) and 7 patients with CHF
before and after C, 25 mg. p.o. To eliminate alpha
adrenergic effects, 6 additional supine (sup) CHF patients
were pretreated with intra-arterial phentolamine (50-100
~g/min) and then given C. Venous occlusion plethysmography
was used to determine forearm blood flow (FBF, ml/IOO ml/
min) and forearm vascular resistance (FVR, units).
FBF FVR PRA NE
tilt sup tilt sup tilt sup tilt
1.6* 52 61 5.7 9.5* 180 330*
2.1 42 38t 3l.lt 40.9*t 230t 400*
NS
pre-C
post-C
CHF
pre-C 2.2 2.3 56 49 10.4 10.4 320 470
post-C 2.2 1.7 57 55 38.5 55.6*t 300 440
* P < 0.05 sup. vs. tilt t P < 0.05 pre-C vs. post-C
In contrast to NS, tilt did not decrease FBF nor increase
PRA or NE in CRr. C decreased FVR during t 11t in NS but
not in CMF. Phentolamine decreased FVR from 47.3 to 17.5
units (p < 0.05). The addition of C decreased FVR further
to 14 units (p < 0.01). Conclusions: In patients with CHF,
FVR and NE are elevated when supine and not altered by
tilt or C. The contribution of the RAS to FVR is apparent
only after SNS blockade.
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Treatment of Congestive Heart Failure: II
DOES VASODILATOR THERAPY ALTER PROGNOSIS IN
PATlENTS WITH SEVERE CHRONIC HEART FAILURE?
COMPARATlVE EFFECTS OF HYDRALAZINE AND
CAPTOPRIL ON CLINICAL OUTCOME AND SURVIVAL IN 175
PATIENTS TREATED OVER A 6-YEAR PERIOD. Milton Packer
MD, FACC, Wai Hung Lee MD, Jeffrey Bair MD, Norma Medina
RN, Madeline Yushak RN. Mount Sinai Hospital, New York, NY
Much is known about the differing effects of vasodilator drugs
on hemodynamic variables in patients (pts) with severe heart
failure (CHF), but little is known about their comparative
effects on clinical outcome and survival. Over a 6-yr period, we
treated 175 pts with severe CHF with either hydralazine (HYD,
120 pts, 150-3000 mg daily) or captopril (CPT, 76 pts, 75-450 mg
daily); 21 pts received both drugs at different times. All pts
underwent invasive testing during initiation of therapy to
confirm hemodynamic efficacy; clinical responses were assessed
after 3-6 wks of treatment on constant doses of digoxin and
diuretics. Long-term follow-up was obtained in 166pts (95%).
Both HYD- and CPT-treated groups were similar with respect
to etiology of CHF and pretreatment hemodynamic variables.
However, clinical improvement (t by> I NYHA class) was
observed more frequently in pts treated-with CPT (44/76 pts,
58%) than those treated with HYD (37/120 pts, 31%), p<.OOI.
Moreover, within the 1st 2 wks of therapy, adverse reactions
requiring drug withdrawal occurred in 22 of 120 pts (18%)
treated with HYD (e.q., nausea and vomiting, ischemic events),
but in only 2 of 76 pts (3%) treated with CPT (p<.OI). Most of
adverse effects requiring CPT withdrawal (e.q., rash, dizziness,
azotemia, dysgeusia) were delayed (in 7/76 pts, 9%)and occurred
after clinical benefits had been realized (after 1-8 months).
Despite the marked differences in clinical response, life-table
analysis showed that survival rates in the 2 groups were similar
at 1 yr (53% vs 46%)and at 2 yrs (31 % vs 30%), CPT vs HYD.
In conclusion, clinical benefits are seen more consistently with
CPT than with HYD in pts with CHF, but this contrast in clinical
outcome is not translated into a difference in long-term survival.
THE RESPONSE OF THE FAILING LEFT VENTRICLE TO THE
CARDIOTONIC AGENT MOL 19,205
Warren K. LaSkeR' MD; SG Shroff, MD; JL Martin, MD, FACC;
Jp Kleaveland,O; MJ Likoff; KT Weber, MD, University of
Pennsylvania, Philadelphia, PA and the Cardiovascular
Institute, Michael Reese Hospital and Medical Center,
Chicago, IL.
We measured the improvement in resting hemodynamic and
hydraulic performance following the acute intravenous
administration of the phosphodiesterase inhibitor MOL
19,205 (M) in 9 subjects (S) with severe left ventricular
(LV) dysfunction (mean LV ejection fraction 19±9%).
Catheter tip sensors were used in all 9 S for deter-
mination of aortic (Ao) and LV pressure (P,mmHg) and peak
+dp/dt (mm Hg sec-I) while in 5 of the 9 S measurement of
electromagnetically-derived simultaneous Ao b190d flow
ve10cit~ allowed for derivation of pulsatile (Wo) and
total (~t, mWatts) hydraulic power. At the peak cardiac
output (C.O., l/min) response (M=105±50 mg), we found
(*=p<0.05, Mvs. control):
C.O. AoP LVP +d~~gt wo/Wt
Control "OJ ~ ~ 88/680
(±SD) 1.2 8.2 8.1/6.1 61 35/155
M 5.5* 81 101/16* 1235* 195/1146*
(±SD) 1.0 15.6 7.6/9.0 119 107/447
Each component of hydraulic pQwer was increased after
inotropic stimulation and ~o/~t also increased (12.8±1.6%
control; 16.3±1.3S M; p<0.05). Thus, MOL 19,205 acutely
improves LV dp/dt in the settin9 of decreased preload and
unchanging after10ad and is therefore consistent with a
positive inotropic agent. The increased fraction of
pulsatile aortic input power reflects both the increase
in C.O. and a decrease in peripheral resistance.
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HEMODYNAMIC EFFECTS OF FORSKOLIN. A NEW DRUG WITH COM-
BINED POSITIVE INOTROPIC AND VASODILATING PROPERTIES
Thomas Linderer. MD; Giancarlo Biamino. MD; Thomas BrUg-
gemann; Karln Pes]ln. MD; Rolf Schroder. MD. Dept. of
Cardiology. Klinikum Steglitz. Free University. Berlin.
FRG .
Forskolin (F) is extracted fromt he roots of coleus for-
skohlii. Chemically. it is a diterpene derivative. Ex-
perimentally. it showed a strong positive inotropic as
well as a vasodilating action in isolated heart prepara-
tions. animals and volunteers and. at higher dosages, a
positive chronotropic action. The primary step of F ac-
t ion may be activation of adenyl ate cyclase. To assess
hemodynamic effects of F in patients. F (32 ~g/kg in 10
min) was given to 6 pts with CAD and 6 pts with COCM dur-
ing routine cardiac catheterization (Group A); 8 pts with
COCM were studied using the "nuclear stethoscope" (Group
B). Results: Group A: F decreased LVEDP by 30% and SVR by
41 %; it increased dp/dt by 55% and dp/dt/p by 85%. CI
rose from 2.0 to 3.1 1/min/m2 • This increase of CI had to
be ascribed to an increase of HR in pts with CAD and nor-
mal LVEDP, but, since heart rate did not change signifi-
cantly, to a significant increase of SVI (from 14 to 24
ml/m2 ) in patients with COCM (LVEDP > 18 mmHg). Measuring
coronary blood flow (argon method) revealed a decrease
of MV02 by 13%, probably due to vasodilatory action.
Group B: EF increased by 17%. peak rejection rate by 25%,
peak filling rate by 26%. Conclusion : This study con-
firmed experimental findings on the action of F in pts
with heart disease. F is a drug with potential benefit
for treating pts with congestive heart failure.
HEMODYNAMIC AND CLINICAL LIMITATIONS OF LONG-
TERM AMRINONE THERAPY IN PATIENTS WITH SEVERE
HEART FAILURE. Milton Pocker MD, FACC, Norma Medina
RN, Madeline Yushok RN. Mount Sinai Hospital, New York, NY
Amrinane (AMR) produces acute hemodynamic improvement in
patients (pts) with severe heart failure (CHF), but its long-term
clinical utility remains controversial. We treated 21 CHF pts
with AMR 600 mg daily for 2-10 wks, while digoxin and diuretics
remained constant. Cardiac index (CI. l/min/m2 ) . heart rate
(HR. min-:), mean arterial (MAP), left ventricular filling (LVFP)
and right atrial pressures (RAP. mm Hg), and systemic vascular
resistance (SVR. dyn-s<m-S ) were determined before (C). on the
Ist day (01), after 48 hrs, during long-term AMR (LT). and 48 hrs
after AMR withdrawal (AMR-W). Nine pts did not undergo a LT
study because of adverse effects. Results in 12 pts: * <.05 vs C:
CI HR MAP LVFP RAP SVR
C 1.89 87 87.8 27.3 11.1 2066
01 2.65* 89 74.7* 15.4* 4.3* 1360*
48h 2.71* 92 79.3* 16.3* 4.6* 1359*
AMR-LT 2.42* 103* 77.0* 19.4* 4.6* 1525*
AMR-W 1.62 92 85.7 24.3 8.5 2362
Overall, acute and LT AMR significantly increased CI and HR
and decreased MAP, LVFP, RAP and SVR; these returned to C
levels upon AMR-W. Yet, only 8 of 12 pts had LT hemodynamic
benefits. of whom only 6 pts improved clinically. Four pts
showed progression of underlying CHF during AMR: values during
AMR-LT were similar to C, followed by deterioration below pre-
AMR levels upon AMR-W; none improved clinically. Four of the
8 pts who improved also hod evidence of CHF progression.
Adverse effects in 21 pts were anorexia, nausea and diarrhea
(12), fever (2), worsening angina (2), ventricular fibrillation (2),
rnylogias (J), worsening CHF (2) and thrombocytopenia (6). Only
3 of 21 pts could tolerate AMR-LT and were cl inically improved.
In conclusion, despite marked early and late hemodynam ic
effects, drug-related progression of CHF and frequent adverse
reactions limit the usefulness of AMR in pts with CHF.
THE ACUTE AND CHRONIC RESPONSE TO ORAL HDL 17,043 IN
PATIENTS WITH SEVERE HEART FAILURE
Barry F. Uretsky. MD, FACC ; T. Generalovich, MD; R.
Spangenberg, HO; P.S. Reddy, MD, FACC; A. Valdes, RN; R.
Salerni, MD, FACC, University of Pittsburgh , PA.
To determine the potential utility of oral MDL 17,043
(HDL)in heart failure. the acute hemodynamic and hormonal
responses to a single dose were studied in 20 pts ( l O pts
each on either 3mg/kg or 6mg/kg) for 8 hours(hr) by right
heart catheterization. Plasma renin activity(PRA,ng/ml/
hr) and norepinephrine(NE,pg/ml) were measured at 0,1 and
4 hr . Compared to baseline(O hr) hemodynamic changes were
s i gn i f i cant at 1,4 and 8 hr(p<O .Ol).
Time(hr) 0 1 4 8
HR(beats/min) 90+19 94+15 97+15 95+13
MAP(mmllg) 80+9 75+9 72+9 71+1
PAW(mmllg) 25+8 17+8 16+9 15+6
CHL/min/m2) 1.9+.4 2 .3+.4 2.5+.5 2.6+.7
SVR(dynes-sec-cm-5) 1634+358 1338+357 1195+305 1206+304
HRgheart rate, MAP=mean arterial pressure, PAW=PA wedge,
SVRgsystemic vascular resistance .
Neither PRA(O hr 8.9+8.6, 1 hr 8 .1+7.3, 4 hr 13.6+
12.8) or NE(O hr 869+500, 1 hr 797+415, 4 hr 748+372)
changed significantly. To date, 4 pts, 3 of whom-improved
subjectively, returned for repeat study at one month:
Time(hr) 0 1 8
HR 107+17 105+14 105+11
MAP 78+11 73+6 65+4
~ 2~ lffi l~
CI 2.1+.3 2.4+.4 2 .5+.4
SVR 1454+263 1228+213 1072+138
These data cemonstrate that oral-MOL produces a sig-
nificant and sustained acute hemodynamic improvement
without further stimulation of PRA or NE. These data also
suggest that hemodynamic respons iveness is maintained for
at least one month after drug institution.
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New Investigative Methods in Echocardiography
and Doppler
INTRACARDIAC FLOW VECTOR MEASURED BY A NEW PULSED DOPPLER
TECHNI QUE
Toshio Morita, MD; Akira Kitabatake, MO: Masato Asao, HO;
Jun Tanouchi , MD: Ken Ishihara . MD; Kenshi Fujii, MD;
Tohru Masuyama, MD; Hiroshi Ito, HO; Masatsugu Hori, MD;
Michitoshi Inoue, MD, Hiroshi Abe, MO, FACC, The First
Department of Internal Medicine, Osaka University Medical
School, Osaka, Japan.
Fl ow vectors ( velocity and direction ) have not been
meas ur ed with any conventional method ; thus, instanta-
neous changes in intracardiac blood flow vectors are
still unknown in beating hearts . We examined intracar-
diac f l ow vectors in open chest dogs by a newly developed
pulsed Doppler system provided with three transducers and
a micro-computer unit. Ultrasound transmitted from a
transducer was simultaneously received by three trans-
ducers and three different f l ow vector projections a t a
sample volume were measured. Those were utilized to
determine the vector. One transducer was used for 2D
echo-Doppler; therefore, the lo cation of sample volume
was indicated on the 2D echo i mage. The time resolution
was 12 msec; in the preliminary model study, the magni-
tude and direction of vectors were measured with errors
less than 10% and 8 degrees, respectively. In the left
ventricle, diastolic inflow vector, initially directing
toward the apex of the heart during rapid filling phase,
gradually changed in its direction anteriorly and to the
left with decreasing its velocity during slow filling
phase, followed by a flow toward the apex with a secon-
dary increment in its velocity during atrial contraction
phase. Ejection flow vector held its direction toward
the base of the heart throughout systole. Thus, the
present system allows us to quantitatively evaluate
intracardiac flow in its magnitude and direction in
beating hearts.
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SPLIT SCREEN SIMULTANEOUS DIGITAL IMAGING OF REST AND
STRESS ECHOCARDIOGRAKS-A NEW KEnlOD FOR EVALUATION
EXERCISE INDUCED WALL MOTION AlNOXMALITIES.
Steven R. West, KD; Harvey Feigenbaum, MD, FACC; William
F. Armstrong, MD, FACC; Deborah Green, BS; James C.
Dillon, KD, FACC; Indiana University School of Medicine;
Krannert Institute; Indianapolis, Indiana
Two-dimensional echocardiography can accurately
assess changes in regional wall motion with or immedi-
ately after exercise. The practicality of the examina-
tion is limited by analysis of an image filled with
excessive respiratory interference. We used digital
imaging to improve the quality, the ease, and the accu-
racy of exercise echocardiography in assessing wall
motion abnormalities. Two-dimensional echocardiograms
were performed at rest and immediately after treadmill
exercise examination. Standard long axis, short axis, 4
chamber and 2 chamber views obtained both at rest and
immediately following exercise were "digitized" in a
256 x 256 x 6 bit matrix. This was done by viewing the
prerecorded analog image until a technically good
cardiac cycle was observed. A cursor was placed on the
corresponding electrocardiographic R wave. The record-
ing was then replayed and the desired cardiac cycle was
captured in digital format. The "digitized" image con-
sists of 8 fields 50 msec apart displaying systolic
cardiac motion. Both the corresponding "digitized" rest
and stress views can be viewed simultaneously on a split
screen in a continous loop in real time, slow motion, or
frame by frame. The "digitized" studies may be stored on
a hard disk, floppy disk, or videotape. This new techni-
que greatly facilitates the ease, quality, and accuracy
of analyzing exercised induced wall motion
abnormalities.
QUANTITATIVE MYOCARDIAL PERFUSION STUDIES WITH A NEW SAFE
ECHO CONTRAST AGENT
M. Schartl, MDj Th. Fritzsch, DVM; W. Friedmann, MDj
L. Lange, MD;
Research Lab., Schering AG, Berlin and
Klinikum Charlottenburg, Free University Berlin, FRG
The new echo contrast agent SH U 454 consisting of a sus-
pension of sacharide microbubbles and being safe in toxi-
cological studies after left heart administration, was
tested to show whether it can reproducibly opacify the
myocardium after aortic root injection in 10 closed-
chested beagles.
Myocardial opacification was performed with 4 ml SH U 454
i n the normal and hyperperfused (dipyridamol i.v.) state
of perfusion and during RCX occlusion by balloon cathe-
ter. Cont ras t enhancement was evaluated by videodensito-
metr y synchronously in the two regions of interest per-
fused by LAD and RC X. Contrast intensity was uniformly
and significantly raised i n both regions afte: dip yrida-
mol (p < 0.01). After RC X occlusion contrast ~ntens~ty
was always significantly lowered (p< O.OU whereas the
LAD region exhibited reproducibly th e same cont ras t ~n­
tensity as before. Aortic and pulmonary pressure as well
as heart rate remained constant after 4 ml of SH U 454
i n all instances. In 50 % of the animals slight ST and T
depressions occurred for max. 20 sec ~n the ~ormal.and
hyperperfusion conditions. The area w~thout ~ntens~ty
rise after RCX occlusion correlated well ( r (5) = 91)
with the area at risk estimated anatomically with Evans
blue. Also nonperfused areas too small to lead to wall
motion abnormalities were clearly indentified by th~s
agent. . " .We conclude that aort~c root lnJectlons of SH U 454 pro-
vide quantitative analysis of the state of myocard~al
perfusion in vivo without hemodynam~c consequences.
CONTRAST ECHOCARDIOGRAPHIC QU~~TITATION OF AORTIC INSUF-
FICIENCY: STUDIES IN AN ANIMAL MODEL USING A STAND-
ARDIZED EXPERIMENTAL ECHO CONTRAST AGENT
David J . Sahn, M.D., FACC, Lilliam M. Valdes-Cruz, M.D.,
FACC, Mi chael Jones , M.D., FACC, Joan Main, Richard E.
Swensson, M.D., FACC, William Elias, Elling Eidbo, B.A.,
Kenne t h H. Gerber, M.D., Natl. Heart, Lung, and Blood
Institute, Bethesda, MD, and Univ. of Calif. San Diego
Medical Ctr., San Diego, CA.
In thi s s t udy aortic insufficiency (AI) was produced
acut ely in 3, 25Kg open chest lambs by resecting an
aortic valve leaflet in order to explore contrast echo
quantitation of regurgitation. Calibrated electro-
magnetic (EM) flow meters were placed on the pulmonary
ar t ery (PA) to measure effective cardiac output (CO),
and on the ascending aorta (AO) to determine total for-
ward AO fl ow (FF). The difference between FF and
CO=r ever se AO flow/min, so that regurgitant fraction
(RF) could be calculated. RF was varied with a Neosyn-
ephrine drip to yield 22 EM RFs 14-58%(CO 1.3-3.1
l /min). 20 echos were recorded with an IREX scanner in
api cal views to image the AO with constant time gain
compensa t i on and instrument gain. Left atrial inject-
io ns of 0.2 5cc (75mgs) of SH U 454, an experimental gas
pr oducing echo contrast agent (Berliscan,Inc.) , filled
the left vent r i c l e and AO uniformly (202-220 video den-
sity (V- DENS) units). AO time V-DENS dilution measure-
ments were fitted to exponential curves. The exponential
V- DENS deca y constant, Nlheart rate, showed a linear
relationship ( r =- .84 , p<0. 001) to EM RF. The time to ~
of peak AO V-DENS/RR' interval was also correlated
(r - O. 81) with RF. Our study suggests that V-DENS
s t udi es with a standardized echo contrast agent may
allow quantification of valvular insufficiency when CO
i s normal.
CLINICAL UTILITY OF A COMPLEX a:x-tPUTER AImRI'lliM(CA) ill
DEI'ECT LV ENOCCARDIAL BORDERS IN 2-D OCHOCARDIcx;RAMS (2-DE)
Eberhard Grube, Jobst Nitsch, Bernd Backs.
university of Bonn, Departement of Cardfo.loqy, FRG.
PURPOSE: To test the clinical value and application of a
corplex CA for LV border extraction in 2-D echocardiogra-
IDic 2-and 4-chamber views in a routine patient population
MEmiOD: 128 consecutive patients(pts) with various heart
diseases were examined in 2-D apical projections and gra-
ded according to the quality of endocardial definition
(grade I being the best,grade IV being the worst iIrage) .
The CA uses a radial gradient method(2 windows with vari -
able size,360 radiants)with a variable filter matrix and
an autanatic closing algorithm;the CA suppresses artefacts
and closes endocardial strings by a probability classifi-
cation.The CA was applied to the 2-DE of all pts and the
results~ with manual border extraccton.vouaestv) ,
regional contraction (RC) were calculated and~ bet-
ween the two methods and observers.fuus the reproducibili-
ty of data could be assessed.RESULTS: fue CA was success-
fully applied to all grade I and II 2-DE, in 39 out of 45
pts(86%) with grade III and in 9 out of 20 pts(45%)with
grade IV echos. V and RC calculated on the basis of auto-
matic and manual border extraction correlated favourably:
ESV r= .9318.3 ml,EDV r= .90~ 11.1 ml,EF r= .9315.1 %, RC
using 5 areas in a floatinJ axis system shoeed a 91% agree
ment;reproducibility of data increased using the CA(varia-
tion coefficient of .32 manual data vs .24 autorat.ic data) .
CCNCLUSICN: A cctll'Uter algorithm based on a radial gra-
dient definition and a variable filter matrix can accura-
tely and reliably be applied to all good quality 2-D echo-
cardiograms and to the majority of pts with minor iIrage
qualities in a routine patient pop..1lation.fureover the
reproducibility of data increases by using this CA and
thus potentially increases the diagnostic safety.
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Intraobserver Without Computer: 6.5% 10.8% 14.0%
% Variation With Computer: 4.5% 7.0% 11.9%
% Change: -31% -35% -15%
In all cases, the computer defined borders showed less
variation than manually defined borders. Analysis of
variance confirms the significance of these differences at
the .05 level. Furthermore, the area correlation between
observer and computer was .985, and the computer produced
borders at a rate of 3.1 minutes per cycle.
EVALUATION OF AN AUTOt~TED BORDER DETECTION ALGORITHM IN
2D ECHO IMAGES OF VARYING QUALITY: OBSERVER VS COMPUTER
VARIABILITY. Leslie Oliver, PhD, Edward Geiser, MD, Liang-
fu Zhang, Julius Gardin, MD, Alfred Parisi, MD, FACC,
Nathaniel Reichek, MD, Arthur Weyman, MD, FACC, Jeffrey
Werner, MD, FACC, Richard Kerber, MD, FACC, Richard Conti,
MD, FACC. University of Florida, Gainesville, Florida.
Each video frame from one cycle of 30 2D short axis
studies was selected for digital analysis by 5 observers.
On Day 1 each observer traced the endocardial border (EnB)
on alternate sequential frames using a joystick. On Day 2
only end diastolic (ED1), end systolic (ES), and closing
end diastolic (ED2) borders were traced by hand. On both
days, the computer used the ED1, ES and ED2 traced borders
to define an area of interest for automatically generating
borders. The computer located the EnB for all frames in
each cycle for each observer both days. Both inter- and
intraobserver variation were measured as mean absolute
area percentage differences for each image quality. The 30
images were rated as 5 excellent, 7 good, 9 limited, and 9
non-processable by consensus of the observers.
CARDIAC CATHETERISATION GUIDED BY ULTRASOUND
Ivo Cikes, MD, Branko Breyer, PhD, Aleksander
Ernst, MD, Fedor Custovic, MD
University Hospital Rebro, Zagreb, Yugoslavia
To avoid known disadvantages of conventional x-
ray guided cardiac catheterisation (CC) we have
developed a system for ultrasonically guided CC.
A small piezo-electric transducer mounted on the
catheter tip with associated external triggering
or timing electronics acts as an ultrasound emit-
ter (active mode) or receiver (passive mode). As
a result a well-defined blinking marker pointing
to ~ catheter tip can be seen in the 2-dimension-
al echocardiographic (2DE) image. It allows easy
identification of the catheter tip and its pre-
cise placement in the desired position for pres-
sure recording, sampling the blood for oxymetry,
ultrasound contrast angio~raphy and myocardial
perfusion studies.
The efficacy of the prototype system was tested
in water-bath, 8 cadaveric hearts and 6 beating
dog hearts. In all cases easy identification of
the catheter tip with blinking marker and its
precise positioning in the desired site was pos-
sible. It is believed that after clinical trial
this method may open up a new field of clinical
application of 2DE. Besides prOViding unique mor-
phological data 2DE could be used in obtaining
additional data as with conventional CC, making
it a possible method for complete cardiac diag-
nosis. The same system has been used for intro-
ducing pacemaker electrodes and electrodes for
electrophysiologic studies.
16.2%
13.9%
-14%
13.0%
8.7%
-33%
9.9%
6.9%
-30%
Excellent Good Limited
Without Computer:
With Computer:
% Change:
Interobserver
% Variation
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Intraoperative and Invasive
Echocardiographic Methods
USE OF TWO-DIMENSIONAL ECHOCARDIOGRAPHY (2DE) IN THE PER-
FORMANCE OF LEFT VENTRICULAR MYOPLASTY BY LASER PHOTOTHE-
RAPY IN A BEATING HEART. EXPERIMENTAL STUDIES IN INTACT
DOGS. N. Pandian, MD, J. Isner, MD, FACC, R. Clarke, phD,
R. Donaldson, BS, J. Bonin, BS, E. Lojeski, BA, D. Salem,
MD, FACC, D. Payne, MD, R. Cleveland, MD, FACC. Tufts-
New England Medical Center, Boston, MA.
Previous in-vitro work in our laboratory in post-mortem
hearts of IHSS patients has suggested that a well-defined
myoplasty (MP) could be accomplished by laser (L) photo-
therapy. The aim of the present study was to explore whe-
ther 2DE could aid in the performance of such MP in a
beating heart. To assess this, in 5 anesthetized dogs,
continuous 20E imaging was used to image an argon L fiber
encased in a special catheter as it was introduced into
the LV cavity after earlier fluoroscopic guidance. By
utilizing long-axis, short-axis, and 4-chamber 20E views,
we were able to manipulate and position the L on to the
ventricular septum. Fluoroscopy alone was insufficient
for precise positioning. 20E further aided in evaluating
the adequacy of L-septal contact: no microbubbles were
seen in LV caVity when the L was turned on in the pre-
sence of adequate contact, but vigorous microbubbles ap-
peared if the tip was free in the cavity vaporizing the
blood. Pathologic examination revealed that the success
of MP and the exact location of MP could be prospectively
predicted by 2DE in 3 of the 5 dogs in whom L-MP was suc-
cessfully accomplished. In the 2 dogs in whom pathology
disclosed no lesions, 20E showed excessive bubbles during
L phototherapy presumably due to poor L-septal contact.
Serial 2DE before and after MP in all dogs indicated no
adverse effects in myocardial function. We conclude that
20E imaging is a critical requirement in the performance
of laser myoplasty in intact subjects. 20E is useful in
(a) guiding the L fiber to the desired site in the ven-
tricle (b) assuring the adequacy of L-septal contact and
(c) assessing the effects of L-MP on myocardial function.
'flm USE OF T:tJ DTI'fllSICf.llI.L roKX:APDICC,FAPHY DURnf;
TRANSSEPTAt. CARDIlIC CA'ffiETERIZATIC1"
Itzhak ,{ronzon, ~.n., F.A.C.C., Eohrain GlasSMan, r.n,
F .A.C.C., t1Jrray L. Cohen, r.o., Howarrl E. Piner, z.o.
F .A.C.C., Barbara Peisinoer, !'.D. New York University
r\edical Center, te' York, tlY
Inadvertent puncture of the intranericardial aorta is
a serious cx:inolication of transseptal catheterization.
Two diJ!ensional echocardiooraohv allows delineation and
soat.Lal, resolution of the aorta- and interatrial serytUl'l.
Thirteen natients underwent, transsental catheterization
with s:im.lltaneous ronitorincr of neeClle and catheter
oosition usinq fluroscoov and t1No di"lensional cchocardio-
errantlv. The interatrial sentUl'l was deronstra~ on the
Sho'i:t< axis and four c.~r vi~<'S, an(l_ clearly senarat~
fnn the ascending aorta. 'ihe transsental needle an(l_
catheter were vfsual.dzed by ec~ioqra'lhy"!hile ~
needle tin was nanioulated into the fossa oiralis avoi"'··
ino nuncture of the aortic root. In sere cases, unc'\er
oressure fnn the needle tin just before puncture, the
interatrial sentun aooears to buloe towards the left
atznm. saline contrast ecbocardiocramv helned to
confirn the needle position in t1le riqht- atri\l'\, "IiI in
the left atriUl'l after rxincture, '!his <:l.ata SI.lC'tTests that
0..0 dimensional eclxx:ardiOC'ranhy is a useful adjunct to
flurosoop<j duri.n:J transsental cat.heterization, MaV
irprove its safety, and orevent its ClCmJlications.
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EVALUATION OF THE CORONARY ARTE RIAL WALL AND LUME N BY
HIGH-FREQUENCY 2- DIMENSI ONAL EPI CARDI AL ECHOCARDIOGRAPHY:
COMPARISONS WI TH HI STOLOGIC MEASUR EMENTS . David
Mc Pher son, MD; Mark Armstrong, MD; Melvin Marcus , MD,
FACC; Rober t Kieso; Marge Megan; Richard Kerber , MD, FACC
Uni vers i ty of Iowa, Iowa Ci ty , Iowa
Although angiog raphy provi des silhouet t e informati on
on th e coronary ar t eri al lumen, i t has not been possib le
to direct ly measure coronary ar te ri a l wa ll thickness and
lumen di ameter for ident i f i cat i on of athe rosc lerosis
antemortem. Our purpose was to evaluat e the accuracy of
a recent ly devel oped hi gh-f requency ultrasonic device for
t he measurement of arteria l l umen and wall . We compared
in -v ivo canine coronary echocardiographic images (echo)
t o histologic (hist) measurements. In 11 open-chest
dogs, coronary art ery echos we re obta i ned by epicardia l
placement of a 13 MHz probe (Biosound Surgiscan) over t he
left anterio r descending and circumf l ex ar t eri es. Subse-
quent ly th e coro nar ies we re pressure-fixed at syst ol ic
ar t er i al pre ssure and hi st sections preoar ed. Result s
(me an- Sll) :
Lumen Di ameter (mm ) Wall Th icknes s (mm)
Echo Hi st Echo H1St
2.4::. 5 2.0::.4 0. 4::.1 O. I~O.O
The lumen diameter/wall thickness rat i o on echo was 6.2::
2. 1. Si mi l ar resul t s were obtai ned on directly exposed
l arger per i phera l arterie s (carotid and femoral ) . Proxi -
mal coronary occl us i on caused the coro nary l umen area t o
decrease by 40% (p<.OOI) ; wall t hickn es s showed no
change . Concl us ion: Epicardia l echo measurements of
coronary arteria l l umen dia met er and wal l th i ckness are
accurate and sens i ti ve to changes i n l umen s i ze caused by
arteri al occlusion. These res ul ts sugges t that hi gh-
frequency epi cardial echocardiography used duri ng open-
heart sur gery coul d effect ively evaluate coronary wall
thi cknes s and lumen dia meter and th us improve present
assessmeDt of ath erosc l erotic disease.
AULICATION OF INTRAOPERATIVE TWO-DIMENSIONAL ECHOCARDI-
OGRAPHY TO PATIENTS WITH OBSTRUCTIVE HYPERTROPHIC CARDI-
OMYOPATHY UNDERGOING VENTRICULAR SEPTAL MYOTOMY-MYECTOMY
Barry J. Maron, MD, FACC, Charles L.McIntosh, MD, Yvonne
E.Wesley, Javier Arce, MD, NHLBI, Bethesda , Md.
Ventricular septal myotomy-myectomy (VSMM) is recommended
to patients (pts) with obstructive hypertrophic cardiomy-
opathy (HCM ) who do not benefit from medical ther apy.
VSMM is per formed to rel ieve subaor tic obstruction through
an aortotomy which prohibits the surgeon from directly
visualizing the entire operative site. Thus, precise know-
ledge of ventricular septal (VS) anatomy is crucial to
successful operation. In order to better define septal
morphology, we utilized a sterilizable Diasonics 5MHz two-
dimensional (2D) echo transducer for intraoperative
studies in 9 pts with HCM; echos were performed by plac ing
the transducer directly on the anterior surface of right
ventricle. In 6 of 9 pts, preop transthoracic M-mode and
2D echos did not provide definitive assessment of VS thick-
ness. In each of these pts, measurements of VS thickness
varied by S-llmm (avg 7) due to subopt imal visualization
of VS endocardial sur faces. However, in each pt intra-
operative echo ( IE) prOVided a clear definition of endo-
cardial borders and more accurate definition of VS t hi ck-
ness. In 1 other pt transthoracic echo underestimated VS
thickness by Smm; in the remaining 2 pts VS thickness by
transthoracic and IE were similar. IE performed after
resection of VS muscle also provided direct morphologic
assessment of depth, le ngth and width of VSMM. In 8 pts
IE showed VSMM to be adequate and mitral systolic anterior
motion (SAM ) was abolished or greatly reduced; in the
other pt, VSMM was narrow and shallow and SAM persisted.
Hence, intra-operative 2D echo is a rapid and easily
performed procedure which constitutes a valuable aid and
guide to the surgeon performing VSMM.
Wednesday. March 28, 1984
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Autonomic Effects on the Heart and Vasculature
COMPARISON OF BETA RECEPTOR DENSITY ON HUMAN LYMPHOCYTES
AND ATRIA
Francis C. Kempf , Jr. MD ; Hendrick M. Ecker, MD; Anders
Hedberg, PhD; Perry Mollnoff, MD; Mark E. Josephson, MD,
FACC, University of Pennsylvania, Ph iladelphia, PA .
Lymphocyt e BAR
22.78±3.78
31.86±9. 79
Group 1
Group 2
We compared beta adrener gic receptor (BAR) concentrat ion
on atr ia l t issue at the t ime of cardi ac sur gery with the
BAR concentrat ion on simultaneously obtained lymphocytes
i n 24 patients (pt s ) undergoing cardiac surgery. Total
concentrat ion of BAR was determined by saturation bind ing
of (1125)-lodop indolol under equil ibrium condi t ions on a
preparat ion of plasma membranes. Seven pat ients were on
no chron ic therapy known to affect BAR (Group 1) . Gro up
2 included 17 pts treated with e antagonists, calcium
channel bloc kers or combination treatment. Pts were not
receiving exogenous sympathomimetics and were clinically
euthyroid . Data for the two groups is described in f
moles BAR /mg protein:
At ri al BAR
113. 17±15.46*
149.67±20.8*
*p<O.1
Li near regression analysis revealed peor correlation
between BAR concent r ation on lymphocytes and atria
(r=O.35) . We concl ude: 1) Pts treated with B antago nists
and calc ium channel bloc kers have incr eased BAR on both
lymphocytes and at r ia compared to control pts. 2) Ther e
i s poor correl ation between the BAR concentration on
atria and lymphocytes . 3) This may l imit the utility of
lymphocyte BAR determinat ions to predict cardiac receptor
physiology .
During cardiac ultrasound scanning of the septum with a
13MHz scanner in human subjects undergoing aortic valve
replacement surgery , we observed a textural change whi ch
sugges t ed we mi ght be imaging card iac conducting tissue.
Accordingly, in this study,S f r esh dog hear ts , were
r emoved after hypothermic cardioplegic arrest, and kept
at 4°C. in an i ce bath, while right and l eft vent r i cl es
were opened and right and left sept al surf aces were
scanned systematically with the 13MHz water path scan-
ner . A textural change consisting of a band of echos
brighter t han the septal musculature was imaged cons i s-
tently, in fer ior to the coronary sinus extending anter-
iorly, and inferior to the membraneous sept um, 3mm deep
to the right septal surface . On the left septal sur-
face, a similarly defined bundle of tissue was imaged
extending inferiorly from the non-coronary aortic valve
cusp, 1.5mm under the septal surface. The l ocations at
which these changes were seen were marked with pins
al ong both septal surfaces . Conduct i ng tissue was the n
visualized after staining the left septal sur face with
Lugol's iodine, and the AV node, bundle of HIS and right
bundle were dissected out. All pins (N=52) for the 5
hearts lay within 2mm of the anatomically i dent i f i ed
conduct i ng tissue. OUr st udy suggests that very high-
frequency ultrasound may potentially be used to locate
and ident ify the AV node, bundle of HIS and right and
left bundle branches during cardiac surgery.
ULTRASONIC LOCALIZATION OF THE CARDIAC CONDUCTING SYSTEM
IN HYPOTHERMIC (4°C) CANINE HEARTS: A POTENTIAL NEW
APPLICATION FOR INTRAOPERATIVE ULTRASOUND DURING SURGERY
David J. Sahn, M.D., FACC, Veena Raizada, M.D ., Colin
Bloor , M.D. , FACC, Jack Copel and, M.D ., FACC, William
Elias , University of Calif . San Diego Medical Ctr., San
Diego, CA.
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[5.TI-. ~ECEFTCP. I~CUi'[(r : I'ND FAHIf.L
CFAFACTEF.IZATIr::1" FRO. F/I.: CJI."Ue.C ~ : YCCYTES.
Jeone Eo lIT', F-h.r .j 5teve ". Fuckett, Ph. r . ; Fazel R.
Eowdon, LA.; William J. Posers, 11.r-, FI'.CC; and Hyun D.
Kirr , Hi.D, Eeot s. of Pharrr-acolovy and ~edicine, UAB
Medical Center, Eirminanam, I'.L.
We report results of isolation and partial characterization of S-
receptors of rat cardiac myocytes. Cardiac myocytes were
preoarec frorr norrral acul t rat hearts. r: em Drane proteins
were extracted from myocvtes with 1% Triton X-102. The
extracted rrerr Drane oroteins were fractionated by eEAE-
Seohacel ion exchange column cnrornatozraphy. Two major
orotein peaks were obtained. C'ne of the protein peak sarrples
contained S-receptors to which 12'1-1'-(4'-azido-3'-iodObenzyll-
carazolol (12'I_ABC) was specifically bound' . This s~mple was
covalently labeled with 12'J-ABC by UV Irradiation. The
radiolabeled sample was applied to a Seoharose CL-6B ~el
column. Two radiolabeled protein oeaks, one with a lv', r = 01'
'7(',000 anc the other with a />'r = 01'9',000 were found. When
the '70,OOO-['alton complex was subjected to
SrS-polyacrylamide ~el electrophoresis under. reducing
conditions it was dissociated into a component with a ~\r
66,000. The 9' ,OOO-£"1a1ton complex was dissociated into a
'8,OOO-Dalton component upon SDS-polyacrylamide ~el
electrophoresis under reducing conditions.
An excess amount of isoproterenol .and ~ropranolol depressed
pnotolabeltng of the S-receptors With I 'I-ABC by 60% and
40%, respectively.
The information about S-receptor molecules will be useful for
the delineation of the mechanism of action of B-blockers via B-
receptors in heart cells.
EFFECTS OF CARVEDILOL ON HUMAN ISOLATED BLOOD VESSELS.
R.F.W.Houlds, Ph .D., FRACP,H.J.Stevens,H.Phann., S .Lipe,
B.Sc(Hons), R.L. Medcalf, B.Sc(Hons), V.lwanov,B.Sc(Hons).
Department of Clinical Pharmacology,The Royal Helbourne
Hospital, Parkvil Ie 30S0, Victoria, Australia.
Carvedilol (C=BHI4.190) is a new beta-adrenoceptor ant-
agonist with vasodilator properties. To determine in more
detail the mechanism of the vasodilatation in man, we have
studied the effects of C on contractile responses of
human isolated digital arteries and metatarsal veins,
obtained post mortem, to norepinephrine (NE) S-hydro-
xtryptamlne (SHT) and barium chloride. Its effects on
neurotransmitter outflow after nerve stimulation in
digital arteries has also been assessed . C shifted con-
centration-effect curves to NE to the right, but also
slightly reduced the maximum responses to NE. Calculated
pA values were 7.S for arteries (n-6) , 7.2 for veins(n=6)Th~ effects of NE were antagonized to a greater extent
than the contractile effects of SHT, but significant in-
hibition of concentration-effect curves to SHT was pro·
duced tn both arteries and veins by C at a concentration
of 10· mol/I. C had no effect on concentration-effect
curves to barium chlor~de except at the highest con-
centration tested (10- mol/I). Neurotransmitter outflow
was ng~ enhanced significantly by C ~n a concentration
of 10 mol/I (n-S) . It is concluded firstly, that the lack
of antagonism of responses to barium chloride suggests C
does not act by antagonism of calcium ion entry into the
smooth muscle cell. Secondly that the act ion of C is
partly mediated via a-adrenoceptors, but the inhibition
of responses to SHT suggests possible blockade of a post-
receptor mechanism. Thirdly that C, as a beta-adreno-
ceptor antagonist with vasodilator activity in both
arteries and veins, may be useful for the therapy of
hypertension and angina pectoris.
BETA-ADRENERGIC RECEPTOR BINDING IN HUMAN
ENDOMYOCARDIAL BIOPSY TISSUE
Jeffrey A. Laser,MDj Michael R. Bristow,MD,PhDj Wayne
A. Minobej Michael B. Fowler,MD, Stanford University
Medical Center,Stanford,California
UNCHANGED CARDIAC SYMPATHETIC TONE DESPITE MARKED IMPROVE-
MENT IN LEFT VENTRICULAR FUNCTION WITH MDL 17043
Christian Viquerat, MD ; Dean Kereiakes, MD ; William W.
Parmley, MD, FACC; Kanu Chatterjee, MB, FACC. Univers ity
of Cal iforni a, San Francis co, Calif.
B=base1ine; pEpeak; *p<O .Ol
As ART NE did not change (pr e MDL:846~744 pg/ml. post
MDL :787+526 pg/ml, mean ~SD), improved LV function with
MOL 17043 is not associated with de creased systemic
sympathetic activit y. Furthermore, as TmR NE also re-
mained unchanged, cardiac sympathetic tone is not altered
by MOL 17043 despite marked improvement of LV fun ction.
4699
-7226
TmR DOP
(pg/min)
46668
32559
TmR NE
(pg/m in)
-1639
- 208
TmR E
(pg/min)
86
118*
CSF
(m1/min)
2.1 25
3.5* 14*
To evaluate the relationship between ca r di ac sympathetic
tone and improved LV functi on, we determined changes in
hemodynamics, cor onary sinus flow (CSF) , arterial (ART)
and coro na ry sinus (CS) ep inephrine (E), norepinephrine
(NE) and dopamine (DOP) following intravenous MOL 17043
in 17 patients with severe chr onic heart failure. The
marked increase in card iac i ndex (CI) and decrease i n
pulmonary capillary wedge pressure ' (PCWP) , r eflecting
improvement in LV fun ction, were not cor re l a t ed to any
change in ART, CS or transmyocardial release (TmR ) of the
three ca t echo1ami nes .
CI 2 PCW?
(L/min/m ) (mmHg)
B
P
Beta-receptor density (BRD) has been shown to be a potential-
ly important var iable in the course of heart muscle disease
and heart failure. Previous measurement of BRD in human
hearts has been hampered by limited access to the gram quanti-
t ies of tissue required to assay BRD with previously available
radioligands. We report the use of the high specificity, high
specific activity radioligand (RL) (-) [1 2 5 I lcyanopindolol (ICYP)
to measure BRD in milligram quantities of cardiac tissue obtain-
ed by RV endomyocardial biopsy. Nine patients with end-stage
congestive heart failure (CI=I.7:t 0.2) and 9 normal patients
(CI=3.l± 0.3) underwent RV endomyocardial biospies. Biopsy
tissue consisted of 3 to 5 pieces totalling 11 to 42 milligrams.
Membrane preparations were made by extracting contractile
proteins and washing a 50,000 x g pellet. Assay conditions
included 20 mM Tris/DO mM NaCI buffer at pH 7.5 and incuba-
tion at 30 0 C for 120 minutes, by which time equilibrium was
reached. Specific binding defined by bound ICYP displaceable
by I uM (-)propranolol averaged 80.6 4.096 at low ICYP concen-
trations, was saturable, stereospecific, and linear with protein
concentration. Myocardial BRD was decreased in heart failure
patients (2l! 5 fmol/mg) as compared to normals (55 :tI l fmol/
mg,p <.02). The dissociation constants were the same for both
groups (23 ;5 pM). These BRD values are quite similar to our
previously reported data for gram quantities of normal and
failing human heart. Conclusions: J)BRD can be reliably mea-
sured on human endomycardial biopsy tissue using ICYP as
a RL. 2) BRD is significantly decreased in failing human hearts.
3)ICYP binding in human endomyocardial biopsy tissue is a
potentially powerful tool for investigating beta receptor regula-
tion in the intact heart.
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EFFECTS OF ACETYLCHOLINE ON ARTERIAL VASOMOTION DEPEND
UPON PRE-EXISTENT ARTERIAL TONE
Jubran B. Habib. MD; Ray Lekich. MS; Robert Roberts. MD.
FACC; Philip D. Henry. MD. FACC. Baylor College of
Medicine. Houston. Tx.
Cholinergic vasorelaxation may require the release of an
endothelial factor and contraction of isolated vessels
in response to acetylcholine (AC) may reflect endothe-
lial injury. To evaluate effects of AC on intact
arteries in situ. we infused AC into the femoral artery
of dogs and monitored internal arterial diameter (10)
noninvasively with a newly developed high resolution
ultrasonic imaging technique. Continuous intra-arterial
infusions of AC for up to 5 min evoked dose-dependent
constrictions. and at no dose level was relaxation
elicited. AC. 70 \lg/kg. min. decreased 10 by 14 ± 6%
(SD;n-l0;p<0.0l). After withdrawal of AC. there was a
reactive vasodilation with an increase in ID of 12 ± 6%
compared to pre-AC control (p<O.Ol). Pretreatment with
atropine (60 \lg/kg.i.m.) abolished the responses during
and after AC. In other experiments. the femoral arter-
ies were preconstricted (mean reduction in 10 of 20 ±
5%) with a continuous intra-arterial infusion of phenyl-
ephrine (0.2 \lg/kg. min). AC. 70 \lg/kg. min. increased
ID by 12 ± 5% (SD;n=14;p<0.01). and after AC. ID
increased further to 31 ± 6% (p<O.Ol). Relaxation during
and after AC were blocked by atropine. Scanning EM of
monitored arterial segments revealed an intact endothe-
lium. Thus. in dog femoral arteries with intact endothe-
lium. acetylcholine evokes constrictions. However. in
arteries preconstricted with phenylephrine. AC elicits
relaxations. Therefore. acetylcholine may produce
opposite vasomotor responses depending upon prevailing
arterial tone.
LOW-DOSE INTRA-ARTERIAL STREPTOKINASE IN THE MANAGEMENT
OF THROMBOEMBOLIC ARTERIAL OCCLUSIVE DISEASE.
Melvyn RubenUre. M.D •• FACC; Roger Blevins. Pharm.D.;
Philip Cascade. M.D •• FACC; Jerald Maltzman. M.D.
Sinai Hospital of Detroit and Wayne State University.
Detroit. Michigan.
12 patienta (pts) with angiographic evidence of thrombo-
embolic arterial occlusion were treated with low-dose
intra-arterial streptokinase (SK). 7 pts had a history of
aurgical revascularization and presented with occluded
grafts. All pts presented with painful. acutely iachemic
limbs and onset of SYJIIPtoms ranged froll 1 day to 7 weeks
prior to admission. Following angiographic diagnosis. a
5-6F infusion catheter was positioned antegrade into the
clot and SK was given as a 20.000u bolus followed by a
continuous infusion at 5 .OOOu/hr. The infusion rate was
increased by 2.500u/hr at 4-6h intervals in the absence
of a clinical response or a systemic fibrinolytic effect
(SFE). Final infusion rates ransed from 7.500-20.000u/hr
over 18-138h and 8 pts experienced a 5FE which did not
correlate with peak or cumulative 5K dose. Radiographic
evidence of complete or partial lysis was achieved in
10 pts (83%). 5K therapy was completely successful in
2 pts. both with symptoms of less than 1 week. and
surgery was avoided. Therapy was partially successful in
6 pts in which lysis permitted visualization of distal
anatomy and allowed for successful revascularization.
and unsuccessful in 4 pts all of whom had symptoms of
greater than 1 month. No major complications were
encountered. Minor bleeding from the catheter site was
observed in 3 pts. We conclude that this procedure is
relatively safe and effective. however prolonged infusion
periods are required and a trial of short-term high-dose
therapy may be warranted when limb loss is imminent.
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TI/2
hours
34 :t 13
40 :t 16
<0.05
Vd
L/kg
9.7 :t 3.0
8.6 :t 3.8
NS
CLNR
ml/mi n
130 :t 38
88 :t 20
<0.01
TBC CLR
ml/mi n ml/mi n
o 234:t 72 105:t 39
D+A 172 :t 33 84 :t 15
P <0.01 <0.05
All values are mean :t S.D.
Serum reverse T3 levels rose four-fold after
amiodarone treatment; however the kinetic effects were
not related to the magnitJde of change in thyroid
function. Amiodarone produces a 26~ decrease in
total body clearance of digOXin. This is due to
reductions in both renal and nonrenal clearances.
Digoxin volume of distribution is unchanged. Digoxin
half-life is prolonged 18~ by amiodarone.
PHARMACOKINETIC EVALUATION OF THE DIGOXIN-AMIODARONE
INTERACTION
Paul E. Fenster. M.D., F.A.C.C., Neal W. White, Jr.
M.D., University of Arizona Health Sciences tenter,
Tucson, AZ.
Amiodarone is known to raise serum digoxin levels.
This study was designed to evaluate the pharmacokinetic
basis of this interaction. Ten normal volunteers
received 1 mg digoxin intravenously. Blood and urine
were collected for the next 5 days. Oral amiodarone
400 mg daily was then started. After 3 weeks of
amiodarone, the digoxin dose was repeated, followed by
blood and urine sampling for 5 days.
The effects of amiodarone (A) on digoxin (D) total
body clearance (TBC), renal clearance (CLR), nonrenal
clearance (CLNR). volume of distribution (Vd), and
elimination half-life (Tl/2), are shown in the table:
Histamine release (HR) may underlie the allergic (includ-
ing anaphylactoid) properties of angiographic contrast
media (CM). To examine the histamine release properties
of contrast media. we studied the in vitro basophil hist-
amine release of a standard ionic contrast media (sodium
hypaque) and a new non-ionic contrast media (Iopamidol)
in blood obtained from 16 patients (pts) about to undergo
coronary angiography. Washed leukocytes were incubated
with buffer. sodium hypaque and Iopamidol at 5 different
concentrations for 45 minutes at 37oC. The cells were
removed by centrifugation. and histamine release from
basophilic leukocytes into the supernatant was measured
using an automated fluorometric method. Total cellular
histamine release was quantitated by lysis of cell ali-
quots with 3% HCl04. Results:
Molar concen- 0.075 0.25 0.37 0.50 0.75
trations of CM
%HR (m+sd) Induced by CM (16 pts)
Sodium Hypaque 0.7+1 4.9+5 27+20 59+19 56+19
Iopamidol 0.6+1 1.7+2 6.8+7 16+12 28+2.0
p>.5 po;.02 p<.OOl p<-:-OOI p<-:-02
Thus. the dose-response curve for Iopamidol-induced hist-
amine release was shifted to the right approximately two-
fold as compared to sodium hypaque.
We conclude the following: 1) Iopamidol has approximately
one-half the histamine-releasing potential of sodium hypa-
que; 2) this suggests that Iopamidol may cause less hist-
amine-mediated allergic side effects and/or hemodynamic
changes than sodium hypaque.
IONIC ANGIOGRAPHIC CONTRAST MEDIA CAUSES SIGNIFICANTLY
GREATER HISTAMINE RELEASE THAN NON-IONIC CONTRAST MEDIA
Deeb N. Salem. MD. FACC. Steven R. Findlay. MD, Jeffrey
M. Isner. MD. FACC. Marvin A. Konstam. MD. Tufts-New
England Medical Center. Boston, MA.
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THE EFFECT OF A NEW CONVERTING ENZYME INHIBITOR ON
SYSTEMIC AND CORONARY HEMODYNAMICS IN PATIENTS WITH
SEVERE CONGESTIVE HEART FAILURE
Eric R. Powers. M.D.; Anthony L. Pucillo, M.D •• Dennis
S. Reison. M.D., Paul J. Cannon. M.D., F.A.C.C ••
Columbia University, New York, N.Y.
We examined the effect of a new converting enzyme in-
hibitor, MK-422, on systemic and coronary hemodynamics I
in 9 patients with severe congestive heart failure.
Systemic hemodynamics. great cardiac vein flow and ox-
ygen saturation (GCVF and GCVO ). and arterial and GCV
norepinephrine (NE) concentratfons were measured be-
fore and 90 minutes following a 2.5 mg IV bolus of
HK-422. Drug administration resulted in significant
decreases in arterial pressure (78+5 to 67+6 mmHg)
(mean±SEM). systemic_~ascular reaistance (I736±272 to
1384+256 dyne.sec.cm ) and pulmonary capillary wedge
pres8ure (PCWP) (19+3 to 14+4 mmHg) (all P<.05) with
no change in cardiac output:- GCVF and GCV02 "ere un-
changed for all patients. In 5 patients wifh car-
diomyopathy and decreases in arterial pressure of 10
mmHg or greater a constant GCVF was associated with an
increase in GCV02 from 35±7 to 42±6%, (p<.05). Nei-ther arterial nor GCV NE changed significantly follow-
ing drug administration (900+218 to 872+230 and
1759+674 to 1266+356 pg/ml respectively). Repeat
hemodynamic evaluation after one month of therapy on
HK-421. the oral analog of HK-422. demonstrated sus-
tained systemic hemodynamic improvement in 4 of 6 pa-
tients studied. Thus, the acute administration of
MK-422 produces an improvement in systemic and
coronary hemodynamics in patients with severe conges-
tive heart failure. This improvement persists in some
patients during chronic HK-421 therapy.
THE INFLUENCE OF CIMETIDINE ON THE PHARMACOKINETICS AND
THE PHARMACODYNAMICS OF VERAPAMIL
Mark S. Smith. MD; Mark C. Benyunes. BA; Thorir D.
Bjornsson. HD; David G. Shand. MB; Edward L. C.
Pritchett, HD, Duke University Hedical Center, Durham,
NC.
Cimetidine alters the pharmacokinetics of many other
drugs which are metabolized by the liver. The purpose of
this study was to assess the effects of cimetidine on
verapamil metabol ism. Eight healthy subjects were given
verapamil (10 mg IV and 120 mg PO) with placebo and with
cimetidine (300 mg qid x one week) in a cross-over study.
Intravenous and PO verapamil were given on consecutive
days and placebo and cimetidine studies were separated
by two weeks. Cimetidine caused a significant increase
in bioavailability of oral verapamil from 26.3 + 16.8%
with placebo to 49.3 + 2.6% with cimetidine (P ~ .006).
The pharmacokinetics of intravenous verapamil were not
changed by cimetidine.
PR interval prolongation caused by PO verapamil was not
affected by cimetidine administration. The increase in
PR interval with verapamil plus cimetidine was 27 + 20.5
msec and was not significantly different from the -
increase seen with verapamil plus placebo (25 + 21.3
msec. P = .591). Thus, despite a substantial Increase
in oral bioavailability. there was no important increase
in measurable drug effect. Significant changes in
pharmacokinetic variables may not be accompanied by
important clinical effects.
EFFECT OF NITROGLYCERIN INFUSION ON HEMODYNAMICS AND
REGIOIIAL \IALL ~IOTION ill EARLY ANTERIOR TRANSMURAL
MYOCARDIAL INFARCTION
Marcus A. DeWood, MD; George S. Eugster, MD, FACC,
Michael L. Hinnen, MD, FACC; Charles D. Swerdlow, MD;
Robert N. Notske, MD, FACC ; J. Paul Shields, MD, FACC ,
Sacred Heart and Deaconess Medical Centers, Spokane, WA.
Although intravenous (IV) nitroglycerin (NTG) is of t en
used in myocardial infarction, the mechanisms of its
hemodynamic actions are poorly defined. We prospectively
studied 20 patients with anterior transmural myocardial
infarction and total LAD occlusion within 4 hours of onset
by bilateral catheterization with L. ventriculography . Ten
patients were allocated t o cat h alone and 10 received IV
NTG t o titrate ~ in systolic arterial pressure by ~ 10
mmHg . The NTG group BP fell (142121+ 116U8,p<. 05), thus
ensuring an adequate hemodynamic effect of NTG. Regional
LV function was analyzed by dividing the LV (300RAO) from
the center of the Ao valve to apex to obtain a long axis
which was then equally divided by 6 chords (3 anterior,
3 posterior) during end-systole (ES) and end-diastole (ED)
to yield shortening fractions in percent (ED-ES/ED).
Hemodynamic results included: (*p < 0.05; ** =N.S.)
~ R.A. P.Wedge C.Index
~ NTG 125118** 7±3* 1816* 2.21.6*
C NTG 123121 411 1216 2.91.5
Regional function results : (Shortening Fraction)
L.Axis 1 (Ant-Basal) 2 (Mid-Ant) 3 (Dis-Ant)
~ NTG 612** 43115** 5113 ** 1.518**
C NTG 5±2 42±19 6±7.5 0.615
4 (Dis-Post) 5 (Mid-Post) 6 (Post-Basal)
5 NTG 24122* 52±12* 42±13**
~ NTG 50119 62110 38115
Thus: (1) IV IITG improves hemodynamic measures by t
regional function i n the non-infarct zone and (2) does
not improve regional function in the area of myocardial
infarction.
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ABNORHAL ELEVATION OF CREATINE PHOSPHOKINASE-HB IN EXHAUS-
TIVE EXERCISE
Gerry H. Phi llips, HD; Charles R. Berryman, HD, University
of South Alabama, Mobile, Ala.
The percent increase in creatine phosphokinase (CPK) and
the "myocardial band" of CPK (CPK-HB) was determined
after exhaustive exercise in 71 runners in a 10 ki lometer
race , Twelve lead electrocardiograms (ECG), total CPK,
CPK-HB , serum lactate, and percent body fat were deter-
mined pre-race . immed iately post-race. and 12 hours fol -
lowi ng exerci se.
Those with elevation (greater than 1.8 %) of CPK-HB
(Group I) were compared to those with CPK-HB in the nor-
mal range (Group I I). Age (mean 43.3 ± 3.1 vs. 41.4 ±
1.4, P>O .S), percent body fat (21 .7 % ± 1.6 vs . 23 .8 % ±
0.7, P>O.S), and race time (mean 47.1 min ± 3.2 vs. SO.9
min ± 0.9. P>O.S), were comparable in Group I and I I ,
respectively .
CPK-HB was increased above the normal range 12-hours
after exercise in IS .7 % (P<O.OOI) of the runners
(Group I) with a mean of 2.4% ± 0.2 (P<.OI). Lactate
increased from 1.1 meq/1 ± 0.1 to 9.2 ± 1.4 meq/1 (P>O.S)
i n Group I and from 1.1 meq/l ± 0.1 to 6 .7 ± 0.4 meq/l
(P<0.3) in Group II. No runners (Group I and I I) had
symptoms referrable to the cardiovascular system and
specifically had no evidence of ischemic ECG changes.
These data suggest that both total CPK and CPK-HB may be
elevated in a significant number of subjects post exhaus -
tive exercise, may be non-myocardial in origin, and
therefore not necessari ly reflect myocardial damage.
ABSTRACTS
~ IN OOPP!S Km'IC FUJj VELOCITY PARME'l'ERS
IllRDC SUPINE EXmCISE
Jay Kozlowski, til, Julius M. Gardin, MD. FNX:, Ali
D!lbestani, MD, Marge Mur~y, PhD, Catherine Kusnick, MD,
Alice Allfie, Dan Russell, Walter Henry, MD, FNX,
University of California, Irvine, CA
Methods for evaluating the cardiovascular response to
exercise (ex) generally involve either cardiac imaging
or analysis of various waveforms including pressure,
indicator dilutioo or mro tracings. Recently, DoWler
edlocardiograPlY has been shown useful for assessing
resting left ventricular (LV) ejectioo dynamics. To
determine if this noninvasive method could be used to
assess LV ejectioo dynamics wring ex, we measured
DoWler ascending aortic blood flow before, during and
following supine bicycle ex in 17 normal subjects (ages
17-22, mean 19 yrs). Ejection time (ET), peak flow
velocity (PfV) and heart rate (HR) could be measured and
flow velocity integral (FIJI) calculated in 16 of 17
normals. Results are SUIIIIlllr1Ked below:
HR ET PfV FIJI
bpn mlllisec atV'sec em
Pre-u 70.±11 292;U6 1l0.:tl7 lS.3.±2.S
Early ex 96±2l 26~ 127.:tl7 19.1.t2.S
Peak ex lS~33 197.±24 lSO.±22 16.7.±2.S
Early post-ex 129j:16 203.141 l60.±23 lS.S.±2.S
Late poat~ 90.±14 27W4 12WO 19.3±3.1
'!hus, ET decrellses and PfV increases IXogressively
Wring supine ex. At peak ex, the decrease in ET is
relatively greater than the increase in PfV so that FIJI
(llhich is proporti~l to stroke volllDe) falls. '!his
study also demonstrates that Doppler aortic flow
..uurements can be obtained Wring exercise to assess
LV performance in normals and, therefore, may prove
useful in evaluation of Pltients with cardiac disease.
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RIGHT AND LEFTVENTRICULAR FUNCTION AND VOLUME IN A NORMAL
MIDDLE-AGED MALE POPULATION DURING SUBMAXIMAL AND MAXIMAL
EXERCISE.
Donald L. Johnston, MDi Dennis Humen, MD; William J.
Kostuk, MD, FACC, University Hospital, London, Canada
Twenty-eight untrained male volunteers (mean age 54
years) vith no cardiac history, a norul treadmill
exercise (Ex) test and no Ex-induced vall motion
abnormalities underwent supine radionuclide
ventriculography at rest (Ra) and during vorkloads of 3.7
kpm/kg, 8.2 kpm/kg, and 12.9 kpm/kg. A nongeometric
method vas used to aaseas left and right ventricular (LV,
RV) volumes. Correlation of combined scintigraphic
end-systolic and end-diastolic volumes (ESV, EDV) vith
biplane cardiac catheterization vas satisfactory (LV r •
0.98, RV r· 0.78). LV data are shown belovo
Rs 3. 7 kpm/kg 8.2 kpm/kg 12.9 kgm/kg
EF (%) 6715 72±5* 77±5+ 76±6+
ESV (ml/m2) 3l±9 3018 25±10* 26110*
EDV (ml/m2) 93124 101±20+ 103128+ 102±25+
SV (ml/m2) 61±18 71±14* 78±19+ 75±18+
CI (llmin) 4.0tO.8 6.0±1.2+ 8.0±1.8. 9.3±2.1~
Values· mean ± SD, EF • ejection fraction, SV - stroke
volume, CI - cardiac index, *p(O.OS, +p(O.Ol, fP(O.OOl vs
rest.
These data shov that in untrained subjects in the supine
position, EDV increases during the first tvo-thirds of Ex
vhile ESV decreases during the last tvo-thirds of Ex. As
a result, EF remaina unchanged during the last third of Ex.
Although all RV volwaea were larger, LVand RV changea were
similar during all stages of Ex•
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SENSITIVITY OF CARDIAC DIMENSIONS TO TRAINING IS
GENOTYPE DEPENDENT
Fernand Landrtf PhD; Jean G. DUClesnil, nn, FACC; ClaudeLeblanc, lIS ; aude Bouchard, PhD, Physical Activity
Sciences Laboratory and DepartClent of tledi cf ne, Laval
University, Quebec City, QC, Canada.
The presence of LV concentric hypertrophy and cavity di-
latation as a result of training re~ains a controvers ial
issue. To assess the amplitude of training effects on
standard cardiac diClensions and other derived echocardio-
graphic parameters, 24 sedentary subjects (11 males, 13
females, rean age 25.4 years) and 18 monozygot ic (lIZ)
twins (6 female pairs and 3 ~le pairs) were submitted to
a 20-week endurance training program, 4 to 5 times per
week, 40 ~inutes a day, at 80%of ~xi~a1 heart rate,
Significant Clean improvements of 11 and 6 m1/kg.min- ,
both ~p<O .OOl, were noted, respectively, with a wide
range in individual changes. Significant Clean increases
occured in variables associated with hypertrophy. LV
diameter increased from 46.3±4.5 to 48.6±3.8 ~ p<0.05 in
the sedentary subjects but did not in the flZ twins. LV
posterior wall thickness and LV end-diastolic volume in-
creased from C.10±1.2 to 8.77±D.7 mm p<0 .05 and from
1D2.0±29 to 116.C±26 cc p<0 ,D5, respectively, in the se-
dentary subjects but again not significantly in the IlZ
twins. I!ide variations in inter-individual (0 to 21%)
and between sexes changes (0 to 9%), in the sedentary su~
jects, and ~rked post-training increases in intra-class
correlation coefficients in the r:z twins (for example r
0.12 to 0.71 p<0.05 for LVPIIT) were noted. Post-training
variance components between flZ pai rs (thus between geno-
types) consistently tended to increase, while concomi~
tant1y variance co~ponents within pairs (thus for indivi-
duals with the sare genotype) consistently tended to de-
crease. P-esu1ts suggest high specificity and genotype
dependency of cardiac adaptive changes.
MAXIMAL VASCULAR CONDUCTANCE AND EXERCISE CAPACITY IN
MIDDLE -AGED HUMAN SUBJECTS BEFORE AND AFTER INTENSE SWIM
TRAINING
Wade H. Martin, III, MO; James Montgomery, BS ; Peter G.
Snell, PhD ; Jay C. Buckey, MD ; C. Gunnar Blomqvist, MD,
FACC, University of Texas Health Science Center,
Southwestern Medical School, Dallas, Texas
Maximal oxygen uptake (VO zmax) is strongly related to
systemic vascular conductance (SVC) during exercise .
Endurance training increases both VOzmax and maximal SVC,
i .e. decreases total per ipheral resistance (TPR). To as-
sess whether training affects maximal local vascular con-
ductance (Gmax ), we simultaneously measured indirect ann
blood pressure (BP) and maximal calf blood flow (CQmax)
using venous occlusion plethysmography after ischemic
exercise to fatigue in 12 norma l human subjects, aged 38±
7 yrs , before and after 12 weeks of intense swim train ing.
VO zmax dur ing upright bicycle ergometry Increased 19%
from 29.2±5.6 to 34.7±6 .7 ml/kg.min (mean±SD) (p<O.Ol) .
Gmax, defined as CQmax/mean BP, increased 20% from 0.66t
0.19 to 0.79±0. 19 (p<0.02) resulting in a higher CQmax
(76.0±16 .3 vs 64.4±16.6 ml/lOO ml tissue.min; p-O.05) at
simi Jar mean BP (97.5±12.4 vs 99.8±9.7 mmHg) . Changes in
lean calf volume were minor and do not explain the change
in Gmax. Linear regress ions of VOzmax on Gmax were:
Before VO zmax = 14 .2 . Gmax + 19.9; r-0.48; p=O.12
After VO zmax = 25.1 . Gmax + 14.8; r-0.73; p<O.01
At VO zmax, cardiac output, measured with CzHz rebreathing
was 7% higher and TPR 6.5% lower after training. We con-
clude : I) Intense swim training increases VOzmax in
healthy middle-aged human subjects, 2) The improved VOz
max is assoc iated with an increased Gmax and a stronger
correlation between Gmax and VOzmax , and, 3) Training
affects Gmax more than TPR. Further studies are needed to
define the relative importance of training effects on
local and systemic vasoregulatatory mechanisms.
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ABSTRACTS
HEMODYNAMICS AND LEFT VENTRICULAR VOLUMES DURING UPRIGHT
EXERCISE IN NORMAL MALES AGED 20-50 YEARS
Michael B. Higginbotham, MO, Kenneth G. Marris, MO, R.
Sanders Williams, MO, R. Edward Coleman, MO, Frederick R.
Cobb, MD, Duke and VA Medical Centers, Durham, N.C.
Invasive and noninvasive techniques have been combined to
measure hemodynamics and left ventricular (LV) volumes dur-
ing exercise in patients with cardiac disease, however,
age-related normal control data for many of these measure-
ments are not available for comparison. Therefore, 24 sed-
entary healthy male volunteers aged 20-50 yr (mean 35 yr)
were studied with invasive hemodynamic measurements, ra-
dionuclide angiography and expired gas analysis during
staged symptom-limited upright bicycle exercise. Mean
heart rate(HR,bpm) oxyge~ consumption(V02,ml/kg/min), Fi2k
cardiac index(CI,l/min/m ), stroke volume index(SVI,ml/m )
arteriovenous O2 difference (A-V02,vol%) , mean pulmonary
artery wedge pressure(PAWP,mmHg), ejection fraction(EF,%)
and end-diastolic volume index(EDVI,ml) during rest(R) and
maximum(~) exercise (Ex) are tabulated for the group.
HR V02 CI SVI A-V02 PAWP EF EDVIR 72 3.9 3.0 42 5.8 3.4 61 68
Ex 167 30.4 9.7 58 14.1 10.0 76 77
Multiple linear regression analysis demonstrated that age
correlated significantly with max HR(r = -0.63), CI(r =
-0.54) and Vo2 (r = -0.54), but not~ith max EF(r = -0.13),EDVI(r = -0.12), SVI(r = -0.15), PAWP(r =.-O.O~) Or A-V02(r = 0.05). Maximum respiratory quotient(vco2/V02)' anindex of the degree of anaerobic metabolism, was unrelated
to age. Thus, increasing age within the range of 20-50 yr
was associated with reduced maximal aerobic capacity. The
reduced aerobic capacity resulted from a lower cardiac
output during exercise, since peripheral oxygen utiliza-
tion did not decrease with age. The reduced cardiac output
response in older men appeared to be due to a limited max-
imal heart rate rather than to a reduction in LV perfor-
mance.
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EARLY ONSET OF REGIONAL WALL MOTION ABNORMALITIES
DURING EXERCISE IN CORONARY DISEASE
Joseph Wachspress MO, Richard M. Steingart, MD,
Montefiore Medical Center, Bronx, NY.
The temporal relationships among the onset of angina
or ST segment depression (ANG/ST), regional wall motion
abnonnalities (RWMA) and a fall in the left ventricular
ejection fraction (EF) during exercise have not been
defined. We studied 21 pts with corOnary disease (CD),
age 55+10 yrs (mean+SD), who had a ~5 EF unit decrease
during-supine exercise, and 14 normal subjects, age 38+
7 yrs, who had a >5 EF unit increase with exercise.
Gated radionuclide ventriculograms were acquired at
rest, and at each 25 watt (W) workload (WL) to sympto-
matic endpoints. The WL of onset of RWMA was determined
by qualitative analysis and was highly reproducible
(.:+:.56 WLs).
Normal subjects had a rest EF of 69+5.6 and exercised
to a peak WL of 138+34 W, HR 165+18 beats/min, systolic
BP 203+30mmHg. Peak-EF was 88+7.7. None developed RWMA
or ANG/ST. -
In CD pts, the EF at rest was 63+17, and 49+16 at peak
exercise. Peak \~ was 73+32W, HR 130+29 beats/min,
systolic BP 178,:+:1 7mmHg. All had new RWMA with exercise.
RWMA were first seen during exercise at a WL of 36+23W,
before the WL of the first >5 EF unit drop (50+34W~
p<.02). Fifteen pts also developed ANG/ST during
exercise, at a WL of 48,:+:20W, later than ffi~ (28,:+:9W,
p<.Ol), but at a similar WL as the EF drop (42+28W,
p=NS). The WL of onset of ANG/ST was related to the WL
of the first >5 unit EF drop, r=.78, p<.OOl, but not to
the WL of the-first RWMA, r=-.22, p=NS.
RWMA during exercise are the earliest manifestation
of ischemia, preceding the onset of ANG/ST and the EF
drop. ANG/ST and the EF drop are temporally related.
QUANTIFICATION OF LEFT VENTRICULAR EARLY DIASTOLIC
FILLING DYNAMICS BY PULSED DOPPLER ECHOCARDIOGRAPHY.
Marian Limacher MD; Jannet Lewis, MD; Lawrence R.
Poliner, MD, FAlc; Jean Nelson, ROMS; Miguel Quinones,
MD, FACC; Baylor College of Medicine, Houston, TX.
Peak diastolic filling rate (PFR) has been shown to be a
useful index of LV diastolic function. Since velocity (V)
of flow through the mitral annulus by pulsed Doppler
echocardiography (Doppler) may reflect inflow rate, PFR
was calculated by multiplying peak early inflow V (PEV)
by the mitral annular area measured from two-dimensional
echocardiography in 43 patients (mean age, 57 yrs). PFR
was normalized (sec") for the end-diastolic volume by
echo. All patients had radionuclide ventriculography
(RNV) using the gated technique (32 frames; variable re-
gion of interest) within one hour of Doppler. RNV-PFR
was derived as the peak rate of counts during early dias-
tole normalized for the end-diastolic counts. Patients
were divided into 3 groups (Gp): normal LV systolic func-
tion (Gp A), abnormal wall motion with ejection fraction
(EF»O.50 (Gp B), depressed LV with EF<O.50 (Gp C).
Groups n Doppler-PFR RNV-PFR
A 18 2.68±1.36 2.47±O.69
B 9 2.28±O.47 2.02±O.42t
C 16 1.65±O.48*§ 1.28±O.70*0
*p<O.OI vs A; §p<O.OI vs B; tp<O.05 vs A; 0p<O.05 vs B
Patients with depressed PFR frequently had a Doppler
pattern of high atrial V in relation to PEV indicating
greater dependency on atrial filling. Although less sen-
sitive, a PEV<40 em/sec was always predictive of reduced
PFR. In conclusion, mitral inflow Vby Doppler is altered
by changes in LV diastolic filling dynamics so that accu-
rate measurement of PFR is possible from combined use of
Doppler with two-dimensional echocardiography.
PERSISTENT ISCHEMIC DILATATION OF THE LEFT VENTRICLE FOL-
LOWING EXERCISE RADIONUCLIDE VENTRICULOGRAPHY: A SIGN OF
SEVERE CORONARY ARTERY DISEASE.
Teddy ~ Weiss, MO; Stefan Bughi, Me; Jan Nielsen, BS;
Ana Becerra, BS; Jamshid Maddahi, MD; Ernest Garcia,
PhD, HJC Swan, MD, PhD, FACC; Daniel S Berman, MD, FACC;
Cedars-Sinai Medical Center, Los Angeles, CA
Since exercise (Ex) Induced myocardial ischemia Is char-
acterized by reversible left ventricular (LV) di latation,
we assessed whether Its persistence postexercise reflects
severe (S) and/or extensive (E) coronary artery disease
(CAD). Two-minute radonucllde ventrlculographic Imaging
(RNV) in 45° LAO was performed during graded exercise and
Immediately postexercise (IMPEX) imaging In 45 consecu-
tive pts without myocardial infarction undergoing Ex RNV
and coronary angiography. A persistent Ischemic dIlata-
tion (PID) ratio was obtained by dividing the LV end-di-
astolic counts (EDC) at IMPEX by LV EDC at rest.
Results NCA lV~90% 2V~90% 3V~90%
N=12 N=11 N=ll N=11
PID Ratio 0.75 0.82 0.97 1.18
SO + 0.13 0.17 0.11 0.18
NCA=normal coronary arteriograms; %=% stenosis; V=ves-
se l .
AI I CAD pts had at least lV with ~90% stenosis. Patients
with CAD ~90% in 2 or 3 V had a PID ratio of 1.08+0.18 vs
0.79+0.15 In pts with no or less CAD (p<O.OOI). - A PID
ratio of 0.9 was found In 11/11 pts with 3, in 3/11 with
2, in 2/11 with 1 V~90% stenosis and in 1/12 pts with
NCA. A PID ratio ~1.0 was found in 10/11 pts with 3, in
4/11 with 2, in 1 ot 11 with 1 V<90% stenosis, and in
none of the NCA pts. We conclude that PID ratio evalua-
tion in stress RNV Is a potentially valuable marker of
severe and extensive CAD.
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IlfPROVED HEMODYNAMICS FROM AMILORIDE IN PATIENTS WITH
STABLE CONGESTIVE HEART FAILURE ON CHRONIC DIGOXIN AND
DIURETICS
Randolph C. Byrd. MD; Melvin D. Cheitlin. MD, FACC; Joani
Newlands. Michael A. Petru. MD. Medical Service. San Fra~
cisco General Hospital and Dept. of Medicine, Universi t y
of California, San Franc isco. CA.
Five men mean age 63.6 yrs ± 12.7(50) with stable con-
gestive heart failure (CHF) (4 functional class II, 1
functional class III) were studied to determine the hemo-
dynamic (HD) effects of amiloride (A) vs placebo (P) while
on chronic di goxin (D) and hydrodiuri1 (Hy) therapy (Rx).
Patients (pt s ) were s tudied using a double blind random-
ized cr oss- over method by right heart catheterization af-
ter 7 days of added P Rx and after 7 days of added A Rx.
HD values were measured at rest and at the end of 9 min
of graded supine bicycle exercise (Ex) , The last 3 min
of Ex was at 50 watt-sec. Resting HD values were not s ig-
nificantly (sig) different between P and A Rx. During Ex.
A Rx resulted in lower pulmonary capillary pressure (PCW).
a higher mean Ao pressure, and a higher left ventricular
stroke work index (LVSWI). On A Rx heart rate (HR) was
lower . and CI and stroke volume index (SVI) tended to be
higher though th is was not significant.
(Mean ± SD) Ex-D,Hy.P Ex-D.Hy.A P
HR beats/min 94 % 14 92 ± 14 N.S.
PCW mmHg 24 ± 8 19 ± 8 <0.05
Ao mmHg 117 ± 12 122 ± 20 N.S.
CI L/min /M2 4.6 ± .7 4.7 ± . 7 N.S.
SVI cc/beat/M2 50 ± 8 53 ± 10 N.S.
LVSWI gm-m/M2 81 ± 16 92 ± 16 <0.005
A Rx results in improved HD in chronic CHF pts on D and
Hy. These findings suggest a positive inotropic effect
of A.
SPECTRUM OF LEFT VENTRICULAR VOLUMES IN PATIENTS WITH ISO-
LATED LEFT ANTERIOR DESCENDING CORONARY ARTERY DISEASE.
Gervasio A. LamaS, MD . Marc A. Pfeffer. MD. PhD. Harvard
Medical School, Brigham and Women's Hospital, Boston, HA .
To determine the relationship between left ventricular
(LV) volumes and the magnitude of wall motion abnormality
in the chronic post-myocard ial infarction period, the
r ight anter ior oblique left ventr iculogram was analyzed in
44 patients with i sola ted left anter ior descend ing coron-
ary artery disease. The size of the infarct segment was
defined by measuring the percentage of the c ircumference
of the LV silhouette that was ak inetic and/or dyskinetic
(%AD) , Four groups were arb itrar ily def ined accord ing to
the extent of their wall motion abnormality.
Group n tAD EDVI SVI EF
I if -0- 78~4 57~2 75:1
II 6 1-14 91:11 52:6 58:1
III 9 15-29 124+10 51!5 41: 2
IV 6 ~30 205!43 57!7 32:5
(ANOVA) P <0. 001 NS <0. 001
The marked increase in end-d iastolic volume index (EOVI,
ml/m2 ) was closely related to the extent of wall motion
abnormality, with 17, 58, and 163% increases from groups
II to IV, respectively . This increase in EOVI could not be
accounted for by an increase in LV filling pressure (LVED~
mmHg). As expected, ejection fraction (EF,t) was also
closely related to the extent of %AO. However. in the
chronic phase of HI the deterioration in EF was a function
of an increase in EDVI and not a decrease in stroke volume
index (SVI , ml/m2 ) . This study demonstrates that in the
chronic phase of HI. LV remodeling results in alterations
In EDVI t hat are proport ional to %AO. The large increases
in EDVI wel l may contr ibute to the late deteriorat ion in
LV performance follow ing a myocardial infa rct ion.
pH 7.46± .04 7.93± .02 7.42± .02 8.43±.08 7.44± .01
* = p<.Ol carpared to eontrol r ** rmtlg
COnclusion: 1) Acute i schemic dysfunctioo is not
eatpletely due to hypoxia, accunulatioo of toxic
IIetabolites or depressurization, but nore likely is
secondary to effects of pH. 2) Alkalosis taTporarily
minimizes dysfunctioo during hypoxia.
-15%*
38HZ
67%
21±1.3
69%
387±45
98%
150t11
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CO~OO OF REGlOOAL roocTIOO ABOOIM\LITIES IN 02
OEPRIVFD rrn HE1IRl'S BY AU<AID5IS
Richard w. ~.D. ,Ph.D. ,FJ\/X1 It:bert D.
EKa:S;Ph.D., Ka 0 . Kelley ,M.S., Patty M. Richards,
Heinrich Taegt:neyer, M.D. ,D.Phil,F'1IIX., U.T. Medical
SChool at Houston, Houston, Texas.
Regional myocardial dysfunction occurs within seconds
after coronary occlusion, before significant depletioo of
energy stores. To test the hyJ:othesis that hYPcllda and
metabolite aceunulatioo are not the sole causes for the
rapid ooset of dysfunctioo, -...e stooied 6 dogs
instrurent.ed with subclavian to cirClmlflex coronary
shunts equipped with pressure and flow transducers . Re-
gicnal funeticn was lIeasured by sonanicraaeters. Measure-
ments of circumflex(CIR::) SE!C}'l'erltal shortening (55) -...ere
moo in the control state after 45 seconds of shunt
occlusicn and during cnc perfusioo with Krebs-Henseleit
solutioo bubbled with air ,100% N2 , 95%°2/5% CO2 , or
95% N2/5% CO2 , Blood pH, heart rate,aortic pressure ,
coronary pressure during perfusioo and blood P02 did not
change during the experiments. Results:
CIK: Perfusate Gas Envircranent
95% 02 95% N2
5% CO2 lOO%N2 5% CO2<x:clusioo Air
%Control
elK: 55 -10%*
P02** 263t38
EXBlCISE-IRDUCED INCREASE IN LEFT VENTRICULAR F1LLING
YiMDIIElBR:'TED LEFT ANTEIlIOR DESCENDING (LAD)
Ic~cr Ltu• ~i Harla Kie... MD; Ruby Bendeuky. MD;
o ert ~ 6 oa. MD. lACC; Charlel A. Boucher MD FACC;
Peter C. Block. MD. FACC! Gerald M. Pohoat. MD. FAce; H.Will~am Strauaa. ~, FAC~. Maaaachuaetta General
~apltal. Boaton. ftA
We have previoualy demonatrated that increaaed thallium
lUDi upta,e (TLU) during ex,rciae correlatea vith
exerciae-luduced increaae. lU LV filling preaaure (LVFP)
and extent of corouary artery diaeaae. To determine
vhether exerciae can produce increaaed LVFP in iaolated
LAD diae.ae. a. defined by increa.ed TLU. ve a••eaaed 42
9uch pat~ent. b,fore and .fter cor~nary anfioPla.ty(PTCAl vl~h perlal treadmlll exerClae thaI ium imaging.
Thall1um (TIJ .cana vere interpreted qualitatively bt 3
bliuded oba,rv.r,. and alao qaantitat1vel1 to det'~1ue
Tl va.hout lTIWO) ezpre••ed a. the half llfe · (T 1 2) of
Tl,in the .yo~ardiym••TLU va. calculated frca the
lnltial anterlor Vlev uaage a. the average count perpi~l in the .djacent left lung aes-eut divided by that
ln the brighte.t myocardial .ea-ent~ u.iug a previoualye.tabli.h~a upper limit of ,54£ the patienta vere
div i4edinto a group of !4 \~04) vith high TLU who vere
conaldered to have exerc1.e-1nduced incr~aae iD LVFP.
Compared to' the 32 patieutl with n~rmal TLU lung
actJvlty. thea, 14 atleD~a had: more ae ere LAD
l_lOd uarrov1ng (~l)f6% 'II. 8I±1!p<.003! ~ 2) higherper~eotage of .bnormal Tl ~ocardial legmenta per
patleDt (43% VI. 27%. P<.051i and 3 alover clearance of
Tl fr~ the myocardium (T l/~ = 13. +8.0 VI. 6~5~ hrl.
p<.007). The occurrence of increuel LVFP WeB IIDrelated
to exerci.e duration. age. the location of .tenolil in
LAD. and previoua MI. Furtheraore. poat-PTCA the TLU
bec..e DOnaal ill 13/14 patienta in whOlll it vu elevated
pre-PTCA.
III conclu.ionl 1~ Iucrea.e in LVFP occul. in about 30%of patienta vith l.olated LAD di.ea.e; 2 Thia i.related to the aeveritt of i.chemia by T .~all and the
.everity of the atelloa1' by anaiofr~p~y; (3J High TLU
returna to 119..al .fter .ucce.afu PTCA ill mo.t~tient.; (4J The ~.aenee of increa.ed TLU ~ppeara to
ldeDtify a aubaet of.pat~enta yith i,alated ~ dia.ale.
wbo have more exten.lve 1.chea1a dur1ni exerclae aa
mea,ured lIoll-iuva.ively by increa.ed TLU.
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CARDIAC MYOSIN ISOENZYMES: IMMUNOHISTOCHEMICAL STUDY
USING MONOCLONAL ANTIBODIES
John T. Fallon, M.D., Gregory D. Curfman, M.D., Janice
Naftilan, B.A., E. Chester R1dgway, M.D., Ban-An Khaw,
Ph.D., Massachusetts General Hospital, Boston, MA.
Cardiac myosin isoenzyme (CMI) composition may have an
important influence on contractile function, and changes
in contractility may result from shifts in the CHI pro-
file. To examine the spatial distribution of CMI's under
different physiological conditions, several murine mono-
clonal antibodies directed against human cardiac myosin
heavy chain were tested for CMI specificity. One anti-
myosin (RIIDIO) was specific for the V3 CMI of the rat.
In immunohistochemical studies of normal rat left ventri-
cle, this antibody identified three populations of cells:
one which stained strongly, one which did not stain, and
one which was intermediate. Thyroidectomy resulted in a
single population of cells, all of which stained strongly
with RIIDIO. Thyroid hormone administration (20 ug/lOO grn
x 3 weeks) reduced the number of heavily stained cells.
Left atrial tissue did not stain with RIIDIO regardless of
the thyroid state. A second antimyosin (3H3IE6), not
specific for the V3 CMI, strongly stained all cells in the
three thyroid states in both left ventricular and left
atrial tissue, and served as a positive control.
We conclude that antimyosin RIIDIO binds specifically
to the V3 CMI in the rat left ventricle. Left atrial
myosin does not ryossess the antigen site which binds
RIIDIO. Normal rat ventricular myocardium is a mosaic
composed of three populations of cellS, some containing
only V3, some containing only VI, and some both CMI's.
Thyroid state has an important influence on the size and
distribution of these three cell populations within the
left ventricle.
METHIONINE INTOLERANCE: A NEWLY IDENTIFIED RISK FACTOR
FOR CORONARY ARTERY DISEASE
D. Murphy-Chutorian, M.D., M.P. Wexman, M.D., A.J.
Grieco, M.D., J.A. Heininger, Ph.D., G.E. Gaull, M.D.,
E. Glassman, M.D., F. Feit, M.D., K.J. Wexman, B.S.,R.N.,
S. Ng, M.D., A.C. Fox, M.D., New York University Medical
Center, New York, N.Y. and New York Institute for Basic
Research and Developmental Disabilities, Staten Island,
N.Y.
Homocystinuria, an inherited disorder associated with
premature atherosclerosis, represents a severe form of
methionine intolerance. We investigated the relationship
between coronary artery disease (CAD) and mild provocable
methionine intolerance in a population of 138 men aged
31-65 years (mean 53) referred for cardiac catheterizatio~
Plasma homocystine (HC) was measured before and 6 hours
after an oral L-methionine load (O.lg/kg). 39 subjects
found to have normal coronary ~rteries had a mean post-
load HC level of 0.59 jl,M, S.D.- 0.37, range 0.0 to 1.6).111.
A criterion at the 95th percentile (1.64 S.D. above the
mean) was selected and applied to fhe remaining 99 sub-
jects with CAD (mean 0.71 ).1M, S,D.- 0.68 range 0.0 to
4.9 ).1M). 15% (15/99) of subjects with CAD were found to
exceed this level as compared to 2% (1/39) of subjects
without CAD (p<0.05). The risk of CAD in men with pro-
vocable HC was predictive of CAD and independent of
smoking, hypertension, diabetes. serum cholesterol and
age. We propose that men with mild methionine intoler-
ance exposed to the high methionine content of western
diet will develop intermittent HC and be at greater risk
to develop CAD.
EVIDENCE FOR A SARCOLEMMAL LACTATE PERMEASE
Steven Dennis, PhD; Mary Beth Slegowski, BS; Gary
Anderson, MD, FACe; Michael Kohn, PhD; David Garfinkel,
PhD. Cardiovasc. Inst., Hahnemann University, Phila., PA
Further, preliminary studies into the effects of perfus-
ate pH indicate that lactate movement may be determined
by the displacement of the n[H+] [Lac-] in/out n mass
action ratio from the equilibrium constant. The clinical
implication of these findings is that interventions to
increase either the pH or the buffering capacity of the
extracellular space may delay the progression of ischemic
injury through an acceleration of lactate clearance.
To test a prediction that sarcolemmal monocarboxylate
transport is carrier mediated, we have examined the
kinetics of pyruvate and lactate uptake into aerobically
perfused rat hearts. In preparations depleted of intra-
cellular lactate and pyruvate by a 30min pre-perfusion
in the absence of substrates, various concentrations of
14C-Iactate or 14C-pyruvate (O.02Ci/mol) were transiently
(2min) infused, together with 3H-mannitol/ml (0.05
nCi/ml). Uptake (wmol/min/g wet wt) was calculated from
the difference between the level of 14C substrate
predicted from the extracellular distribution of 3H-
mannitol and the actual level (corrected for l4C02
contamination) measured in successive 20 sec samples of
e:fluent perfusate. Computer optimization analyses of
the observed saturation kinetics and cross-inhibition of
lactate and pyruvate uptake (see Table) suggest that
trans-sarcolemmal monocarboxylate movement is controlled
by a rapidly reversible permease.
Pyr Uptake
Lac Uptake
Vmax
8.4 + 1.0
7.7 + 0.4
Km (mH)
3.9 + 0.9
8.6+1.1
Ki (mH)
(pyrl2.30 + 0.50
(pyr)O.16 ~ 0.02
FURTHER EVIDENCE IMPLICATING REACTIVE OXYGEN
RADICALS IN MYOCARDIAL REPERFUSION INJURY. D.
Peterson, MD, PhD., R. Asinger, MD, FACC, J. Elsperger,
CCPT, D. Homans, MD, J. Eaton, PhD. Hennepin County
Medical Center, Veterans Administration Hospital, and
University of Minnesota, Minneapolis, MN.
Reperfusion injury following transient myocardial ischemia
has been postulated to be partially due to oxidant damage from
reactive oxygen radicals. These radicals are also a byproduct
of normal tissue metabolism and endogenous defenses against
them include superoxide dismutase, catalase, and glutathione.
Glutathione reduces hydrogen peroxide and organic hydroper-
oxides in the presence of glutathione peroxidase and gluta-
thione transferase. Catalase breaks down hydrogen peroxide
and superoxide dismutase destroys superoxide.
We determined total glutathione (GSSG+GSH) and catalase
levels from myocardial biopsies of 7 open chested dogs during
a control period (C), after one hour of ischemia (I), and during
30, 60, and 120 minutes of reperfusion (R) of the ischemic
area. In a parallel series of 7 dogs we determined the %
systolic change in the effected wall thickness (%t>th) during
the same conditions. Results Indicate:
C I 30'R 60'R 120'R
GSSG+GSH mean 1.00 .92 .40" .66 .73
(IlMOL/gm protein) St. Dev. .53 .41 .23 .30 .23
Catalase mean 10.1 8.5 5.6 7.6 10.2
(llOD/gm protein) St. Dev. 3.4 4.6 4.8 4.7 6.7
%lith mean 31.6 -12.7.... 13.6.... 14.6" 16.5"
(%) St. Dev. 11.1 10.7 12.2 9.7 10.5
.. P < .05 and .... p < .01 compared with control.
These data are consistent with the concept that oxygen
radicals are produced during reperfusion and deplete endogenous
defense mechanisms. Failure of the effected wall to com-
pletely recover function following reperfusion may in part be
secondary to oxIdant damage from these oxygen radicals. The
effect of exogenous antioxidants on endogenous defenles and
myocardial function during reperfusion deserves further study.
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EFFECT OF NIFEDIPINE ON INTRACELLULAR pH DURING ISCHEMIA
AND REPERFUSION; A 31-P NUCLEAR MAGNETIC RESONANCE STUDY
Tom J.C. Ruigrok, PhD; Cees J.A. van Echteld, PhD; Ben de
Kruijff, PhD; Cornelius Borst, MD; Frits L. Meijler, MD,
FACC, State University, Utrecht, The Netherlands.
The effect of nifedipine (NIF; 0.1 mg/l) on intracellular
pH (pH-int) and high energy phoephates was studied during
global ischemia (ISCH) and reperfusion (REP) using 31-P
NMR. Isolated rat hearts were paced (5 Hz), perfused with
Tyrode solution for 30 min, made totally ischemic for 30
min, and reperfused for 30 min (37·C). During ISCH pH-int
fell from 7.00±0.04 (mean±SD) to 5.89±O.03 without NIF
(n-6), and from 7.04±0.04 to 5.92±0.06 when NIF was added
10 min before ISCH (n-6). The NMR spectra (see Fig.) were
obtained after REP and show extracellular and intracellu-
lar inorganic phosphate (Pi-ext, Pi-int), creatine phos-
phate (CP) and adenosine triphoaphate (ATP) peaks. pH was
measured from the chemical shift of the Pi peaks. With
NIF pH-1nt had returned to the original value (7.04),
whereas without NIF part of the ~ocardium remained isch-
emic (pH-int: 6.13). With NIF recovery of CP was signifi-
cantly better (P<0.OO5). In conclusion, NIF can prevent
the no-reflow phenomenon after ~ocardial iachemia.
3
with NIF
I: pH-ext =7.31
2: pH-int = 7. 04
without NIF
1 : pH-ext= 7.28
2a: pH-int=6.97
2b: pH-int =6.13
o (ppm) 10
-10
I: Pi-rift
2: Pi-int
3: CP
4: '(-ATP
5: a-ATP
6: ~-ATP
~~~bL5 _~.~
I ! J
ACUTE SUPPRESSION OF INSULIN SECRETION AUGMENTS KYOCARDW.
UPTAKE OF BRANCHED CHAIN AMINO ACIDS DURING AMINO ACID
INFUSION IN CONSCIOUS DOGS
Ronald G. Schwartz, MD; Eugene J. Barrett, lID PhD; Ralph
Jacob, BS; Lee A. Surkin; Charles K. Francis, lID, FACC;
Barry L. Zaret, l!D, FACC, Yale University, New Haven, CT.
Physiologic regulation of myocardial amino acid (AA)
metabolism is incompletely defined. We studied myocardial
AA metabolism during somatostatin-induced acute
suppression of insulin (I) secretion and intravenous AA
loading, and during euglycemic hyperinsulinemia with and
without AA loading. Arterial and coronary sinus AA and
thermodilution coronary sinus flow were measured in 17
conscious postabsorptive dogs basally and every 20 min for
100 min during infusion of (i) AA + somatostatin, to
suppress I (61--5.4 ~U/ml, n=6); (ii) AA + I + glucose (I
clamp technique, 6Ia+88.5 ~U/ml, n-6); and (iii) 1+
glucose without AA (61=+52 ~U/ml, n-5). Basally there was
net myocardial uptake only of total branched chain AA
(BCAA) (0.52±0.15 ~mol/min), leucine (0.36±0.07 ~mol/min),
and isoleucine (0.14±0.03 ~mol/min; p<O.Ol for each) and
no significant net flux of valine. During infusions,
arterial BCAA levels rose 380% in (i) and 93% in (ii) and
declined 45% in (iii) (p<O.Ol for each, compared both to
basal and to other groups during infusion). lfean uptake
(60-100 min) of BCAA increased 1239% to 6.80±0.73 ~mol/min
(p<O.Ol) in (i), increased 589% to 2.61±0.32 ~mol/min
(p<O.Ol) in (ii), and was unchanged in (iii) despite
declining arterial BCAA levels. BCAA uptake was greatest
in group (i) > (ii) > (iii) (p<O.Ol for each comparison).
Thus, (I) basally the myocardium extracts only the BCAA
leucine and isoleucine; (2) I+AA, but not I alone augment
BCAA uptake; (3) suppression of I during AA loading causes
marked elevation of arterial levels and myocardial uptake
of BCAA; (4) arterial BCAA level, not I, appears to be the
major determinant of myocardial BCAA uptake.
NMR measurements of absolute PCr and ATP concentrations,
when properly performed, accurately reflect the concen-
trations of these compounds as determined by classical -
biochemical techniques.
Wednesday, March 28, 1984
10:30AM-12:00PM Room 5411
Assessment of Myocardial Metabolism
QUANTITATIVE ABSOLUTE MEASUREMENT OF MYOCARDIAL HIGH
ENERGY PHOSPHATE CONCENTRATIONS USING 31 PHOSPHOROUS
NUCLEAR MAGNETIC RESONANCE
Roger ~ Rehr, M.D.; Andrew Keller, M.D.; J.W.R. Lawson,
M.D.; Ronald M. Peshock,M.D.; L. Maximillian Buja, M.D.,
FACC; Ray L. Nunnally, Ph.D.; University of Texas Health
Science Center at Dallas, TX.
NMR has been used by us and others to examine changes in
myocardial high energy phosphates under a variety of
conditions. Values reported have been expressed as
ratios either to another peak in the same spectrum, or to
the same peak under control conditions. There are ob-
vious limitations to these relative measurements, and in
this project we have used a calibrated phosphonitrilic
chloride trimer standard placed in the left ventricular
cavity to standardize our spectra and to obtain absolute
measurements of myocardial phosphocreatine (PCr) and
ATP concentrations by 31p NMR in 3 Langendorff-perfused
rabbit hearts under control conditions. The hearts were
freeze-clamped immediately after the NMR measurements
were obtained and spectrophotometric (spec) measurements
of PCr and ATP were made for comparison. The table below
shows our results. Concentrations are in ~mol/gram wet
weight of myocardium.
QUANTITATIVE ASSESSMENT Of REGIONAL MYOCARDIAL PERFUSION
AND METABOLISM IN PATIENTS WITH TIME-Of-FLIGHT POSITRON
EMISSION TOMOGRAPHY
E.M. Geltma~ MD, fACC; S.R. Bergmann, PhD; J.E.
Eisenberg,; M.M. Ter-Pogossian, PhD; a.E. Sobel, MD,
FACC, Washington University, St. Louis, MO
Quantitative assessment of regional myocardial metabolism
and perfusion with positron emission tomography has been
limited by the temporal and spatial resolving power of
conventional instrumentation. To overcome these limita-
tions and to provide quantitative data in patients, Super
PETT I was developed. This instrument incorporates time-
of-flight information to provide high resolution (7.5 mm
full-width, half maximum) reconstructions throughout the
entire heart with data collections as brief as 30 sec, a
capability that permits the rapid, dynamic acquisition in
list mode needed for quantitation of flow and metabolism.
Seventeen subjects (7 controls, 10 with cardiac disease)
were studied. Myocardial metabolism was assessed with
llC-palmitate (16 to 20 mCi, i.v.) and myocardial per-
fusion with the H2l50/C150 blood pool subtraction method
(50 to 100 mCi of each tracer) validated previously in
dogs. Myocardial accumulation of llC-palmitate was ho-
mogeneous in controls, and depressed in zones of infarc-
tion. In some cases depressed metabolism was evident in
zones with persistent perfusion. Turnover of llC_
palmitate was monoexponential from 8 to 20 min after in-jection in controls with correlation coefficients ranging
from -0.86 to -0.99. Perfusion, assessed with H2150/
C150, was homogeneous in controls. Regions of depress-
ed ~erfusion were detectable as zones of decreased
H2150 content in patients with coronary artery disease.
The results indicate that regional perfusion and metabol-
ism in man can be assessed quantitatively with the time-
of-flight, fast scanning instrumentation developed.
2.3 +/- 0.1
1.4 +/- 0.2
Spec. conc(~mol/g)
2.5 +/- 0.6 s.d.
1.8 +/- 0.4
NMR conc(~mol/g)Metabolite
PCr
ATP
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THE IMPORTANCE OF BACK-DIFFUSION ON MYOCARDIAL KINETICS
OF lIC-PALMITATE
Keith A. A. Fox, MB, ChB; H. Dieter Ambos; H. Nomura,
M.D.; Steven R. Bergmann, PhD.; Burton E. Sobel, MD,
FACC, Washington University, St. Louis, Mo.
We have previously shown that myocardial washout of ex-
tracted llC-palmitate is qualitatively diminished with
ischemia or hypoxia. To define the quantitative
influence of back diffusion of non-metabolized tracer,
llC-palmitate was injected intracoronarily in 15 open
chest dogs with the LAD perfused extra-corpor~ally. M~O­
cardial blood flow (MBF) was measured wlth H2,l O.
Arterial and coronary venous total fatty acids, llC02,
llC-palmitate, lactate, and 02 were measured directly.
Under baseline conditions or under conditions with no
intervention (control), 60.0 ± 13'.' (mean ± SO) of
initially extracted llC-palmitate was oxidized to llC02,
and 10.1 ± 6.2'.' was liberated unaltered as llC-palmitate
from 1 to 20 min after injection of tracer. With
ischemia (arterial flow < 20'.' of control, n = 6), or
hypoxia (perfusion of venous blood at normal flow,
n = 6), < 25'.' of initially extracted HC-palmitate was
oxidized to 11C02 but> 17'.' appeared as unchanged
llC-palmitate. Quantitative a~alysi~ of efflux fr?ffi
1-20 mi n reveal ed that with 1 scnent a and hypox t a
llC-palmitate back-diffusion comprised 40.3 ± 11.2'.' and
48.9 ± 17.3'.' '.' of total efflux compared with 10.5 ±
3.6'.' in controls. The fraction of extracted
llC-palmitate liberated. as llC02 (in 1-10 min)
correlated closely with MV02 (r = .82, n = 27). Thus,
with hypoxia or ischemia, assessment. of o~idatio.n .of
fatty acid based on analysis of resldue tlme-actlvlty
curves must be corrected for back-diffusion of initially
extracted but non-metabolized fatty acid.
CARBON-13 NUCLEAR MAGNETIC RESONANCE STUDIES OF PYRUVATE
METABOLISM IN INTACT PERFUSED HEARTS.
James R. Brainard, PhD, David E. Hoekenga, MD, FACC,
Judith Y. Hutson, PhD, John K. Leach, MD, FACC, and
Nicholas A. Matwiyoff, PhD, University of New Mexico,
Albuquerque, New Mexico.
Carbon-13 nuclear magnetic resonance was used to follow
intermediary metabolism of 13C enriched substrate in
perfused guinea pig hearts under normoxic, hypoxic, and
anoxic conditions. This study was initiated to better
understand the role of pyruvate in amino acid production
and utilization by the myocardium during periods of
hypoxia. Hearts were perfused in the Langendorff mode
within a 7.0 Tesla magnet using oxygenated Krebs-
Henseleit buffer. Addition of 2.2 mM [3_13C] pyruvate
to the perfusion media resulted in detection of reson-
ances for C3 pyruvate, C3 alanine, C4 glutamate and C3
lactate with only 4 minutes of signal averaging. Under
hypoxic conditions the label from C3 of pyruvate was
first detected in C3 of alanine indidating high activity
of alanine amino-transferase in the myocardium under
these conditions. Incorporation of the label into the
lactate pool was less than 30% of its incorporation into
the alanine pool under the steady state conditions in-
duced by hypoxia. Introduction of anoxia resulted in
rapid incorporation of label from the pyruvate pool in-
to lactate up to a level 60% of that observed in the
alanine pool. These studies provide evidence for the
importance of amino acid metabolism in maintaining
energy stores in the beating heart during hypoxia. They
demonstrate that NMR can be used together with 13C
labeled substrates for real time studies of metabolism
in the beating heart.
DELAYED RECOVERY OF REGIONAL GLUCOSE METABOLISM IN
REPERFUSED CANINE MYOCARDIUM DEMONSTRATED BY POSITRON~T
(R:T) •
M. Schwaiger, MD, H.W. Hansen, H. Sochor, MD, O. Parodi,
MD, L.A. Yeatman, MD, D.J. Ellison, MD, C. Selin, M.
Grover, MD, H.R. Schelbert, MD, FACC, OCLA School of
Medicine, Los Angeles, CA.
We previously examined with the R:T the metabolic in
relation to the functional recovery of ischemically
injured myocardium after reperfusion (R) for 4 weeks in
chronic dogs. Increased regional glucose utilization at
24 hrs of R accurately identified reversible tissue
injury documented by late improvement in segmental func-
tion. To define the early time course of metabolic
recovery after a 3 hr LAD balloon occlusion, 8 dogs were
studied with R:T, N-13 ammonia (NA) and F-18 deoxyglu-
cose (FDG) at 1-2 and at 24 hrs after R. The dogs were
then thoracotomized in order to determine myocardial
(microsphere) blood flow (MBF) and arterio-venous
differences for glucose, lactate and 02 across the
reperfused segment (LAD vein) and the left ventricle
(coronary sinus). In the reperfused territory (RT) , MBF
at 24 hrs was 22*25% lower and regional FOG concentra-
tions 175±73% higher than in control myocardium (C).
Immediately after reperfusion, NA uptake was 73±24% and
FOG uptake in RT only 79±48% of C. At 24 hrs, glucose
consumption (Fick) was 202±107% higher, lactate extrac-
tion 96±85% lower and MVO2 42±26% lower in the RT than
in the entire LV. R:T measured FOG uptake and glucose
consumption correlated well (r=0.94). Thus, the segmen-
tal increase in FOG uptake at 24 hrs reflected increased
glucose utilization that was partially anaerobic as
indicated by the lower lactate and 02 extractions. We
conclude that glucose metabolism initially after R is
depressed but increases within 24 hrs, a time course
that now can be determined noninvasively with R:T.
Wednesday, March 28, 1984
4:00-5:15PM Grand Hall Meeting Room #1
Intracoronary Thrombolysis and Angioplasty
A RANDOMIZED TRIAL OF IMMEDIATE CORONARY ANGIOPLASTY
FOLLOW ING INTRACORONARY THRO~lBOL YS ISIN ACUTE MYOCARD IAL
INFARCTION
John Kalbfleisch, MD, FACC; Mark Friedman, MD, FACC~ .
Richard Slagle, MD, FACC; David Brewer, MD, FACC; Will lam
McEntee, /10; Andrew Roye, MD; Iii 11 i arn Ross, HD; Henry
Hawkins, MD, FACC; Loyal Conrad, MD, FACC; Vee SE Ong, t1~
FACC; St. Francis Hospital Department of Card~ovascular
Services and University of Oklahoma Tulsa Medical Colleg~
Tulsa, OK.
To determine the efficacy of immediate percutaneous trans-
luminal coronary angioplasty (PTCA) following successful
intracoronary streptokinase (SK) thrombolysis in ac~te
myocardial infarction 28 patients (PTS) were randomized
to receive either immediate PTCA (15 PTS) or SK alone
(13 PTS). All PTS had single vessel coronary a~tery dis-
ease or "non-surgical" 2-vessel disease. The right coro-
nary artery was occluded in 16 PTS (9 PTCA, 7 SK alone);
the left anterior descending in 9 PTS (5 PTCA, 4 SK
alone); and circumflex in 3 PTS (1 PTCA, 2 SK alone).
PTCA was immediately successful in 14 of 15 PTS. Followup
angiography was completed in 6 weeks in 22 PTS (11 PTCA,
11 SK alone). All 10 PTS with successful PTCA had patent
vessels, were asymptomatic and none required redilatation
or surgery. In 11 PTS treated with SK alone, 4 of 11 ves-
sels were totally occluded; 8 of 11 had attempted PICA
and one had coronary bypass surgery due to angi~a. After
6 weeks, only 2 of 11 vessels demonstrate? any Imp~ove­
ment in the degree of stenosis of the reSidual leSion. At
followup, the ejection fractions were ~ot changed from
pre SK values in either group. One PT. In t~e PTCA group
died on the third hospital day of perlcardlal tamponade
and electromechanical dissociation. We conclude that
immediate PTCA following SK is feasible, can be done
safely and results in a higher vessel patency rate.
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PERCUTANEOUS TRANSLUMI NAL CORONARY ANGIOPLASTY (PTCA)
DURING EVOLVING ACUTE MYOCARDIAL INFARCTION
David R. Holmes, Jr . , MD, FACC; Ri ck A. Nishimur a , MD ;
Rona l d E. Vl i ets t r a , MB.ChB, FACC; Hugh C. Smith , MD ,
FACC; Guy S. Reeder, MD ; Al f r ed A. Beve, MD, FACC; James
H. Chesebro, MD , FACC, Mayo Clinic , Roches ter, MN
The r ol e of PTCA during evol ving acute myocar di a l i nfa r c-
t i on (AMI) was eva luat ed in 41 patient s (pts ) ; 32 males,
9 females (mean age 54 yrs , r ange 32-71 yrs ). The AMI
was anter i or in 29 pts and inf erior i n 12. The left
anteri or descending ( LAD ) was i nvol ved i n 27/41 pts
(66%), the right coronary (RCA) in 9/ 41 (22%) , and t he
circumf l ex (eire) in 5/41 (12%). Mean pre-PTCA luminal
diameter stenosis was 99% . PTCA was used alone in 11/41
(27%) (Gro up A); PTCA was us ed i ni t i ally f ollowed ty in-
traco~onary streptokinase (SK) in 8/ 41 (20%) (Gr oup B);
and PTCA was used after initial SK in 22/ 41 (54%) (Group
C) . Restoration of flow (impr ovement t o residual steno-
s is of S90%) was seen in 32/41 pts (78% ). Overall, 85%
of pts with LAD stenoses, 78% with RCA stenoses, and 40%
with eire stenoses had restoration of flow. In Group A
(PTCA alone), 10/11 pts (91%) had improvement in stenosis
by ~40%. In Group B (PTCA then SK), 7/8 (87%) had res-
torat i on of flow. In Group C (SK t hen PTCA ), 15/22 (68% )
had restoration of flow. In 13 of the 15 successful
Group C pts with restoration of flow, PTCA was used be-
caus e initial SK did not restore satisfactory patency.
Three pts died in the 2 weeks after PTCA, 1 of low output
CHF (1 day ), 1 of cardiac rupture (7 days), and 1 of r e-
i nfar cti on (3 days). All 3 had i nitia l restoration of
f low. To conclude, PTCA pl ays an important r ole i n
selected pts during AMI: in s ome pts it may be used
alone With excellent success in both r estoring flow and
dilating t he underlying stenosis ; i n ot her s , it may be
used in combination with SK to minimize res idual thrombus
or stenosis.
CHANGE IN COLLATERAL BLOOD SUPPLY DURING
EVOLVING ACUTE MYOCARDIAL INFARCTION. William D.
Nitzberg, MD, Hrudaya P. Nath. MD, William J. Rogers, MD,
FACC, William P.Hood, Jr. FACC, MD, Patrick L. Whitlow,
MD, Russell C. Reeves, MD, and William A. Baxley, MD, FACC.
University of Alabama Medical Center, Birmingham, AL.
The importance of collaterals in evolving acute myocardial
infarction (AMO is controversial; however, collaterals have
usually been evaluated on angio~raphy weeks after AMI. To
assess the change in angiographically-visualized collaterals in
evolving AMI, we compared coronary arteriograms performed
on '3 patients (pts) 6.2 .! 0.2 hrs after onset of AMI symptoms
with followup angiograms performed 14 .! I d later. Collaterals
were graded according to (J) intensity score (0-4), and (2)
percent of distal infarct artery visualized. Collateral intensity
score averaged 0.4 .! 0.1 units at baseline and 0.9 .! 0.2 units at
foUowup (p < .02) in the '3 pts, The percent of distal infarct
vessel visualized by collaterals averaged I' + 4% at baseline and
27 .!,% at followup (p < .0'). In 20 pts having occluded infarct
vessels at followup, significant increases were found in both
collateral intensity score (ll = 1.60 units, p < .ooon and % distal
vessel visualized (ll = 4'%, P < .ooon. In 33 pts having patent
infarct vessels at followup, collateral intensity score and
percent of segment visualized were unchanged at followup.
Among pts with occluded infarct vessels at baseline and
SUbSequent improvement in LV election fraction (EF), baseline
collateral score and percent of segment visuaJized were
significantly greater (p < .0') than in pts whose LV EF failed to
improve.
nus, in pts with evolving AMI: (I) the extent of collaterals
on foUowup angiography is not necessarily representative of
that on the day of AMI; (2) there is a paucity of angio-
graphically-visualized collaterals within hours of AMI; (3)col-
laterals are considerably more common at foUowup 2 wks post-
MI, especially in pts having occluded infarct arteries on fo11ow-
up; and (4) collaterals correlate with improvement in LVEF.
QUANTITATIVE ANGIOGRAPHIC MORPHOLOGY OF CORONARY STENOSES
FOLLOWING ACUTE MYOCARDIAL INFARCTION IN MAN
Robert F. Wilson, M.D.; Myrl Holida, BS; Carl W. White,
M.D., FAce, Onlv. of Iowa &VA Hospitals, Iowa City, IA.
The severity of individual stenoses correlates poorly with
the development of coronary occlusion and myocardial in-
farction (MI). Identification of a stenosis morphology
associated with a high risk of MI would facilitate pro-
spective assessment of the efficacy of infarct prevention
strategies. We studied angiograms of 11 patients (pts.)
4-20 days after acute MI (GP AMI) and 10 pts. without
previous MI or unstable angina but with coronary stenosesjudged visually to be severe ( > 60%) (GP NOMI). The age
and sex of the groups were similar . Two observers blinded
to the history, ventriculogram, and prior angiograms
traced the most severe stenosis in the artery supplying
the infarcted area (GP AMI) or the most severe stenosis in
any coronary artery (GP NOMI). Three frames of each le-
sion were magnified 5x and traced in orthogonal pro-jections. Using computer-based quantitative coronary an-
giography (Brown et all a center line was determined and
the lesion divided into 20-40 sections. The minimum
cross-sectional area and %area stenosis of the lesions
were not significantly different between the groups. Ten
of 11 lesions in GP AMI were less severe in the middle
than at either end, suggesting an ulcerated plaque. We
calculated an "ulceration index" (UI) by dividing the
diameter of the stenosis proximal or distal to the "ulcer"
(whichever was greater) by the largest diameter within the
"ulcer". The UI's of GP AMI (0.59± 0.18, mean ± SO) were
significantly different from GP NOMI (0.94±0.06) (p <
0.001). Ten of 11 patients in GP AMI had an UI < 0.78 and
all of GP NOMI had an UI > 0.83. These data provide
quantitative evidence that coronary lesions associated
with MI have a specific ang10graphic morphology which is
not commonly seen in equally severe coronary obstructions
unassociated with MI.
CORONARY ARTERIOGRAPHIC DESCRIPTORS OF SPONTANEOUS
IMPROVEMENT IN EJECTION FRACTION AFTER ACUTE INFARCTION
Harry Schwartz, MD; Roy H. Leiboff, MD; Alan G.
Wasserman, MD, FAeC; Richard J. Katz, MD, FACC; P. Jacob
Varghese, MD, FACC; George B. Bren, MD; Allan M. Ross,
MD, FACC. George Washington University, Washington, DC
Spontaneous (SP) improvement in left ventricular (LV)
function is seen in some pts following myocardial in-
farction (MI) and must be distinguished from benefits
of acute interventions. Consequently we sought to
characterize the arteriographic features associated with
SP improvement in LV ejection fraction (EF). Analysis
was performed in 33 pts undergoing cardiac catheter-
ization within 6 hours of MI in whom reperfusion was
either not attempted (25 pts randomized to "control" in a
streptokinase trial) or unsuccessful (8 pts). Of the 33
pts, 11 (33%) had a >5%rise in radionuclide EF between
day 1 and 14. Nine of these 11 (82%) had residual flow
(RF) defined as either subtotal occlusion of the infarct
artery or well developed coronary collaterals to the in-
farct zone on initial angio~raphy. Of 22 pts who failed
to demonstrate significant (>5%) SP improvement in global
EF , only 4 (18%) had angiographic evidence of RF. While
the mean 6EF (day 1 to 14) for all pts was +1.2%, when
analyzed with respect to RF the following data were
obtained: Mean 6EF±SEM >5% rise in EF
All RF pts (N=15) +5. 7%±2 .8+ 1p<.05 9 (60%) +1 p<.01
Pts with no RF (N=18) -2.2%±1.8+ 2 (11 %) +
Within the group of pts with RF to the infarct zone the
mean rise in EF was greater in the 9 pts with subtotal
occlusion of the infarct artery (+7.9%) as compared to
the 6 pts with well developed collaterals but no ante-
grade flow (+2.5%). Conclusion : MI pts with residual flow
on initial angiography frequently show SP rise in EF.
Such improvement must be distinguished .from reperfusion
effects in acute intervention trials.
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These data indicate, that in conventionally treated AMI
spontaneous coronary reperfusion is common. However, it
probably occurs late and does not lead to improvement of
LV function.
ENZYME PATTERN, CHANGE OF LV FUNCTION AND CORONARY REPER-
FUSION IN ACUTE IWOCARDIAL INFARCTION.
Freek W.A. Verheugt, 14D, Ernst E. van der Wall, MD, Jan C.
J. Res, MD, and Jan P. Roos, MD.
Dept. of Cardiology, Free University Hospital, Amsterdam,
The Netherlands.
Rapid myocardial enzyme release and improvement of LV
function are often observed in patients (pts) with acute
myocardial infarction (AMI) successfully treated with in-
tracoronary streptokinase (IC-STK) in the infarct related
vessel.
To evaluate the relationship of enzyme pattern, change
in LV function and coronary reperfusion, we studied 29 pts
(age 39-70) with transmural AMI admitted within 4 hours
(hrs) after onset of symptoms. They entered a randomized
study comparing IC-STK with conventional treatment (C).
Blood samples for CK-MB analysis were taken at 0,3,6,12,
24,36 and 48 hrs after admission. Radionuclide angiograms
were obtained at both 24 hrs and 10-14 days after admis-
sion. Change in global LV ejection fraction (6 EF) was
calculated from these images. 2-6 wks after discharge co-
ronary angiography was done in 23 (79%) of the pts.
~ (mean ± SEM)
6 EF (%)
time to peak CK-MB (hrs)
reperfusion chronic(% pts)
IC STK
(n = 15)
+11.5 ± 4.8
7.8 ± 0.8
75
C
(n 14)
-6.0 ± 5.8
20.7 ± 1.8
46
p
<.01
<.001
NS
IS THERE A DOSE-RESPONSE EFFECT WITH BETA-BLOCKING
DRUGS IN SECONDARY PREVENTION FOLLOWING ACUTE MYOCARDIAL
INFARCTION ?
Stanley H. Taylor; B. Silke; G.C.Sutton and B.J.Prout.
Univ. Dept. Cardiovasc. Studies & Dept. Med. Cardiology,
General Infirmary, LEEDS, U.K.
The influence of the dose of Beta-Blocker as a determin-
ant of the outcome during the secondary prevention of
myocardial infarction was evaluated by comparing the
results of 2 randomised clinical trials in the same
participating centres. 723 consecutive male patients
aged 35-65 yr were randomised double-blind to either
placebo or beta-blocking drug between one and three
months after acute myocardial infarction and followed
for 12 months. Inclusion criteria were based on WHO
evidence of infarction and exclusion criteria on the
usual contra-indications to beta-blockers. The first
group (n=342) were randomised between placebo and
oxprenolol 40mg b.d. ;the second group (n=381) between
placebo and oxprenolol 160mg b.d. The groups were well-
matched for major pre-entry variables. Treatment was
commenced on average 68 and 31 days following coronary
occlusion in the 80 and 320mg groups respectively.
Analysed on an 'intention-to-treat' the cumulative
life survival curves for those randomised to placebo
were similar [cumulative survivial (8Omg) 95.9% vs.
(320 mg) 96.0%; p=0.97]. The cumulative sur-vival curves
of the two groups receiving the different doses of beta-
blocker were singificantly different [99.0% (8Omg) vs.
92.4% (16Omg) oxprenolol; p<O.OOI]. The numbers with-
drawn from active treatment were similar [low dose 50
(25.4%); high dose 47 (25,7%)]. It is unlikely that the
different progno.is is explicable on the difference in
time after MI at which oxprenolol was started. These res-
ults imply a possible dose-related benefit of a-blockade.
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Pharmacologic Therapy After Acute Infarction
DO ALL POST MYOCARDIAL INFARCTION PATIENTS BENEFIT FROM
PROPRANOLOL THERAPY? - ANALYSIS OF SUBGROUPS WITH
ELECTRICAL AND MECHANICAL COMPLICATIONS.
Edgar Lichstein, MD, FACC; Curt Furberg, MD; C. Morton
Hawkins, Sc.D.; for the BRAT Research Group.
The Beta Blocker Heart Attack Trial (BHAT) demonstrated
decreased mortality in patients treated with propranolol
(pro) after myocardial infarction. These retrospective
analyses examine the benefit of pro therapy in subgroups
who had electrical (E) and/or mechanical (M) complications
prior to randomization.
A total of 3,837 patients below the age of 70 were
classified based on findings during the hospital stay but
before randomization (average 13.8 days after admission).
E complications included ventricular fibrillation,
ventricular tachycardia, AV block, and atrial fibrilla-
tion. M complications included pulmonary edema, shock,
basilar rales, or signs or symptoms of heart failure.
The cumulative mortality (m) results over an average
follow-up of 25 months for the 4 risk groups was:
pro placebo Relative
Risk group n m% n m% Risk
None 1047 6.2 1079 6.6 .94
E only 443 5.2 423 10.9 .48
M only 201 10.4 202 16.8 .62
E + M 225 12.9 217 17.1 .76
In summary, in the largest subgroup of BRAT patients
with no reported complications, the 25 month mortality
was low and the observed benefit of pro therapy small.
Patients with E complications only had an intermediate
mortality rate and showed a pronounced treatment effect.
Those with M complications had the highest mortality and
experienced an intermediate relative benefit of beta
blocker therapy. Unless these observations are replicated
present practices for prescribing beta-blockers in post
infarction patients should not be altered.
FAILURE OF a-BLOCKER TREATMENT TO SUPPRESS VENTRICULAR
DYSRHYTHMIAS IN SURVIVORS OF MYOCARDIAL INFARCTION
The European Infarction Study Group c/o Coordinating Centre Berlin,
Kllnlkum Steglltz, Frele Unlversltiit Berlin, Germany
In the European Infarction Study, a double blind, placebo-controlled,
secondary prevention a-blocker trial (160 mg slow oxprenolol b.l.d.),
846 of 1.741 patients (pts) aged 35-69 years had 24-hr ECG
recordings up to 5 limes within 1 year follow-up. Differences In
mortality by treatment groups and ventricular dysrhythmlas detected
In the 24-hr ECG prior to entry Into the study (2-4 weeks after
Infarction) are:
Oxprenolol (N=356) Placebo (N~376) Relative
n mortality n mortality risk
total group 358 6.1% (22) 376 4.5% (17) 1.4 ns
o- 1 VPC 154 1.3% (2) 145 2.1% (J) 0.6 ns
>1-10 per 140 8.7% (12) 146 11.8% (7) 1.8 ns
>10 hour 64 12.5% (8) 87 8.0% (7) 1.6 ns
No VP/VT 213 3.3% (7) 220 1.4% (J) 2.4 ns
VP /VT 145 10.3~ (15) 158 3.9'l1 (14) 1.2 ns
(VPC: Ventricular premature contractions, VP: Ventricular pairs,
VT: Ventricular tachycardias (J or more subsequent VPC))
Maximal grading of ~10 VPC/hr, > 10 VPC/hr, Muiliforme VPC,
Bigeminy and VP or VT showed low mortality for VPC ~ 10/hr
(3,7%/1.9%), VPC 10/hr (0%/0%), Muiliforme VPC (J.7o/>/1.2%) and
Bigeminy (0%/0%) In the oxprenolol/placebo group when they
occured as severest dysrhythmlas. 24-hr ECG recordings 7 days and
3, 6 and 12 months after Inclusion did not show any change In the
Incidence of frequent VPC (> 10/hr), VP or VT neither In the placebo
nor In the B-blocker treated group.
Conclusions: The 1 year mortality following acute myocardial Infarc-
tion highly correlates with VPC frequency (p<0.005), VP or VT pre-
sence (p<O.OO 1) and frequency (p<O,005) during 24-hr ECG re-
cordings before discharge from hospital. B-blocker treatment with
slow oxprenolol does neither Significantly Influence the Incidence of
ventricular dysrhythmlas nor mortalily.
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STRESS TESTING SOON AFTER MYOCARDIAL INFARCTION IN
PATIENTS TAKING BETA-BLOCKING AGENTS-Results of a
multicenter study on 665 patients.
Ronald J Krone MD, FACC, J Philip Killer AS, John A
Gillespie MD FACC, Francis H Weld KD FACC and the
!*11ticenter Postinfarction Research Group, Washington
University at St. Louis, Missouri
Low level treadmill tests were performed on 665 patients
at 9 institutions within 2 weeks of their myocardial
infarction (HI). Tvo hundred nine patients were taldng a
beta-blocker at the time of the test and 459 were not.
The predictive value for cardiac death in one year of the
parameters: ST depresaaion (STPOS), angina during or
after the teat (ANGINA), and inability to complete the
test (to Bruce Stage I)(NOT FINISH) vas not significsntly
affected by the presence of beta blockers.
BE TA BLOCKER PARAMETER CARDIAC DEATH
(Odds Ratio)
NO STPOS 1.5
YES STPOS 1.2
NO ANGINA 2.3
YES ANGINA 3.3
NO NOT FINISH 2.7
YES NOT FINISH 5.5
Thua, the predicthe value of the exercise teat early
after ayocardial infarction ia not dt.dniahed in patients
taking beta blocken.
BENEFICIAL EFFECTS OF BEPRIDIL, A NEW CALCIUM ANTAGONIST,
IN PATIENTS WIllI ACUTE MYOCARDIAL INFARCTION .
Daniel Flammang,MD; Marc Waynberger,KD; Romain Paillet,KD
Dept of Cardiology, Angouleme General Hospital. France.
Several Calcium Antagonists are useful i n the treat-
ment of pat ients (pts) with ischemic heart disease. Ac-
cordingly, this study was designed to examine the effects
of Bepridil, a new calcium antagonist, on pts with acute
myocardial infarctions (AMI).
Two hundred consecutive pts with AMI of less than
48 hrs (average 10.9 hr) of duration (eXClusions : pts
with se~ere he~~t failure (Killip class III and IV) and
with 2n and 3 degree AV blocksJ were randomly assigned
to a Bepridil (BEP, n \00) and Isosorbide (ISDN, n 100)
treated groups. BEP was administred intravenously
4 mg/kg/day for 48 hrs ; at the same time, or a l dose was
started 200 mg, 3 t.a.d. for 21 days. ISDN was given
orally 5 mg, 6 t.a.d. for 21 days.
Uneventful evolution occurred in 24 BEP vs 11 ISDN pts
(p-o.02) . Severe ventricular arrhythmias (multifocal
premature ventricular beats and vent r icular tachycardias)
occurred in 29 BEP vs 43 ISDN pts (p=0.03) . Severe heart
fa ilure (Killip III and IV) occurred i n 6 BEP and 14 ISDN
pts (p~0.06) . Antiarrhythmic therapy was needed in 6 BEP
vs 54 ISDN pts (p <0.0001) . Mortali t y was onl y 4 in BEP
and 9 in ISDN pts. Althouth the mortality was less than
half in BEP patients, this was not statistically signi-
ficant.
Thus , Bepridil given in pts with AMI improved their
evolutions from point of view of severe arrhythmias and
severe heart failure. To demonstrate a reduction in mor-
tal ity, a larger study will be needed.
INTRINSIC SYMPATHOMIMETIC ACTIVITY IN BETA BLOCKERS:
THE IMPORTANCE OF BASAL HEART RATE REDUCTION IN THE
TREATMENT OF DAY TIME AND NOCTURNAL ANGINA
Anhed A. Quyyumi, M.B.; Christine Wright; Lorna Bealing;
Kim M. Fox, M.D., National Heart Hospital, London, U.K.
The use of beta blockade in the treatment of rest angina Is
controversial and the effects of intrinsic sympathomimetic
activity (ISA) in beta blockers in the treatment of severe angina
is unknown. We studied 15 patients with angiographically
proven coronary artery disease (7 with nocturnal angina) using
angina diaries, exercise testing and 48 hour ambulatory
monitoring for ST segment changes. Atenolol 100 mg dally
(without ISA) and P1ndolol 5 mg tds (with (SA) were given in a
double-blind randomlsed study. The day time resting and mean
nocturnal (2400-0600 hrs) heart rates on Atenolol (63 bpm
and 59 bpm respectively) were slower than on Pindalol (72 bpm
and 68 bpm respectively) (p (0.01) . Angina was more frequent
and the duration of exercise to ST segmentdepression was
shorter on Plndolol (p (0.01). Also doy time and nocturnal
painful and painless episodes of ST segmentdepression were
more frequent and their duration longer with Plndolol (mean 6.2
episodes of 156 mlns/24 hours) as compared to Atenolol
(mean4.3 episodesof 83 mins/24 hours) (p (0.01) . This study
demonstrates that ISA In a beta blocker mayhave deleterious
effects in the treatment of severe angina and that loweringof
the heart rate is of benefit In treating both effort and nocturnal
angina.
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The Vascular Effects of Calcium and
Calcium Blockers
EFFECTS OF NIFEDIPINE ON GLUCOSE TOLERANCE AND I NSULIN
RELEASE IN MAN.
Prakash Deedwania, MD, FACC; Jayendra Shah, MD; Collier
Robison, MD; Pat Watson, RN; Charles Hurks, BS, VAMC and
University of California. San Francisco at Fresno, Calif.
Calcium channel blockers have been reported to cause im-
pairment of glucose (GL) tolerance and inhibition of
insulin release in both diabetic and nondiabetic patients.
In this study we evaluated the effects of nifedipine (N)
on GL tolerance and insulin release in 17 pts (7 non in-
SUlin-dependent diabetics and 10 nondiabetics) treated
with N for angina . Mean age was 61 .4 yrs (range 39-75).
7 of these (6 diabetics) were 120\ above the ideal body
weight . All pts were on a regular diet and consumed at
least 300gms of carbohydrate/day for 3 days prior to each
test . At time of both tests all pts had similar weights
and were f ree of stress. After an overnight fast a 3-hr
100gm GTT was performed prior to and 2 wks after N (60-
9Omg/day in 3 divided doses). Blood samples for serum GL
and immunoreactive insulin (IRI) were collected at base-
line and 30,60,90,120 and 180 min after the ingestion of
GL. Mean fasting serum GL was 97±9mg/dl before and 110±11
mg/dl after treatment with N (P<.002) . Mean fasting serum
IRI was 11±2~U/ml before and 16±2~U/ml after N (P<.OOl).
These differences in fasting serum GL and IRI in response
to N treatment were also observed when compared i n the
2 groups separately . Mean serum GL and I RI at 30,60 ,90,
120 and 180 min as well as the area under the GL and IRI
cur ves were not significantly different before and after
N i n either group. Conclusion : our results indicate that
nifedipine causes a significant increase in fasting serum
GL and insulin concentration. OUr findings failed to show
any impairment of glucose tolerance or inhibition of in-
sulin releaae in diabetic or nondiabetic pts. These
findings suggest that nifedipine can be used safely in
diabetic patients with coronary artery disease.
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TRE PULMONARY VASCULAR EFFECTS OF CALCIUM CHLO-
RIDE. Kyle W. Toal, M.D., Lambertus i. Drop, M.D., Richard
F. Heitmiller, M.D., Laurence W.V. DeBoer, M.D., Gillian A.
Geffin, M.B.,B.S., Dennis D. 0' Keefe, M.D., Willard M. Daggett,
M.D., F.A.C.C. Departmenta of Surgery and Anesthesia,
Massachusetta General Hospital, Boston, MA 02114
Calcium infusion is common in patienta during and following
cardiac surgery. . We studied the effect of increased plasma
ionized calcium ([Ca++» on pulmonary (PVR) and systemic (SVR)
vascular resistances in dogs with constant pulsatile pulmonary
blood flow (Q), mean aortic pressur~nd left atrial press~.
In 6 dogs, mean pulmonary artery (PAP) and small vein (PVs)
pressures and systemic flow were recorded and resistances
(dyne'sec'cm-5) determined during three 45 min periods: control
([Ca++)-1.15+0.04 mM), stable hypercalcemia ([Ca++)-1.88+0.05
mH, a level seen clinically following calcium therapy);- and
recontrol ([Ca++)-1.14+0.02 mM). Hypercalcemia increased SVR
from 2799+507 to 3265+477, p<0.02, but PVR was unchanged
(control 1207+139 vs hypercalcemia 1193+145). Control and
recontrol resii'tancea did not differ. In 5 additional dogs bolus
doses of calciull chloride (CaC12) were administered into the
puillonary artery (PA) at a Qof 1 L/min to reach higher [Ca++).
The tranaient increase (A) in m was related to peak [Ca++j
determined frOIl pulmonary vein (PV) blood samples drawn every
5 sec. PV. did not change.
CaC12 lIa/ka 5 10 15 20 40 60
Pvtca++lmH 3:-5 7.7 10.3 16.9 17.5 24
~ IImRa 0 0 0 2.9* 5.9t 9.5t
In 5 additional dogs PA infusion of bolus dosea of NaCl,
Na2S04, and MgC12 (in allounta equioamoiar to .20, 40 and 60
IIg CaC12/ka) trallli.ently increased PAP with Q-l L/llin, but
equiosllolar doses of urea, mannitol and alucose did not.
We conclude l)At the upper limite of clinical hypercalcellia
SVIl inereaaea but PVIl doe. not. 2)The 1IP reaponds only to
boluses of CaC12 esceecling 15 'mg/ka, far above the doae used
safely in patienta. 3)The PA respoDle to CaC12 is not related
to the hyperoalloiarity of CaC12' *p<0.03, tp<O.Ol
Hean Ao press.
(mm HfL-
109tl
108tl6
93t14*
RCBF
(ml)
110t42
107t39
100t51
REGIONAL AND GLOBAL RESPONSES IN CORONARY BLOOD FLOW AND
EXERCISE TOLERANCE AFTER INTRACORONARY VERSUS INTRAVENOUS
VERAPAMIL ADMINISTRATION IN CORONARY ARTERY DISEASE
Jack Ferllnz MD FACC and Christodulos S. Stavens, MD;
University ot Illinois, Chicago, and Cook County Hospital,
Chicago, Illinois
To determine If verapamll (V) administration produces
changes in regional coronary blood flow (RCBF) which
parallel those seen for total coronary flow (TCBF), 20
patients (pts) with coronary artery dlsese were studied In
supine position at rest and during exercise in the control
(CONTR) pre-V state, after intracoronary (IC) V (0.5 mg
bolus), and after intravenous (IV) V (0.1 mg/kg bolus,
followed by 0.005 mg/kg/mln infusion). TCBF (from coro-
nary sinus) and RCBF (from great cardiac vein) were
measured by thermodilution; RCBF therefore represents left
anterior descending coronary artery (LAD) drainage. The
majority of pts (55%) had 3 vessel disease, but all had at
least the LAD lesion which was >80% In II pts.
Summary of exercise results: -
Exerc. Exerc. duration TCBF
~hase (sec) (ml)
ONTR 99t52 244tl31
IC V 98t49 286t134*
IV V 151t58* 221tl00
*p <0.001
IC.V therefore preferentially Increases TCBF during exer-
cise, but this increase is not always reflected In the
RCBF, probably because of the severity of the LAD lesion.
Yet, the duration of (pain-limiting) exercise Improved
only after IV V, and was accompanied by a marked decrease
In afterload. These factors are apparently Instrumental
In determining If global Increase In coronary flow Is as-
sociated with amelioration of angina pectoris after Vor
not, with systemic responses (arbitrating the balance be-
tween myocardial oxygen supply and demlnd) probably being
of greater IlIIportance than the magnltUcle of coronary flow.
EFFECT OF INTRAVENOUS DILTIAZEM ON CORONARY
ARTERY DIAMETER IN PATIENTS WITH CAD
Tassilo Bonzel, MD, Helnut Wollschlager, MD, Herbert LOll-
gen, MD, Thanas Miinzel, Brigitte wehrle, Hanj6rg Just, MD,
University of Freihrrg, West~nnany.
The coronary dilati~~ effect of Diltiazem(Dil) in patients
(pts) without evidence of spasm has not been ascertained.
In 22 pts with stable CAD coronary diarreters were studied
before , 5, 10 and 20 min after 20ng of intravenous Dil.
Perpendicular biplane left coronary angiograrns in hemiaxi-
al left anterior cranial and right anterior caudal pro-
jections were obtained. High resolutioo x-ray systems with
>5 line pairs/rrm and standard film processing with a mean
gradient of 1,45 were applied. Low osmotic dye was injec-
ted with a purrp. Mean coronary diarreters (M:D) fran both
planes were measured in well defined corresponding pro-
ximal and distal sites using a digital caliper and cathe-
ter calibration. Table: M:D increase with Dil according to
site and to normal or diseased segment (IM=left main)
Site IM LAD Cx Normal Diseased
n 19 19 17 17 10 19 16 12 12
prox/dist prox/dist prox/dist prox/dist
5 min 0.08 0.18/0.180.13/0.24 0.08/0.28 0.12+/0.12++
10min 0.11 0.18/0.180.15/0.24 0.11/0.25 0.10+/0.11++
20min 0.13 0.17/0.150.18/0.25 0.13/0.24 0.1QnS/0.11++
(+p<0.05; -Hp<0.01; other values p<0.OO1 versus baseline)
M::D increased significantly for IM, LAD and ex, average 8%,
irrespective of normal, or diseased segments. The smallest
increase in M:D was found in diseased segments, the grea-
test increase in normal, distal segments. Within 20 min,the
the tine after Dil had no effect 00 M:D.
we c<J'lclude: Diltiazem has a significant vasodilative ef-
fect 00 epicardial coronary arteries in pts with CAD.
The effect starts within 5 min and is more evi-
dent in angiographically normal, and in distal segments.
NIFEDIPINE 'IHERAPY FUR PUlMJNARY HYPERTENSIOO -
ACUTE AND LOOG~ EFFECTS
Stefan HOhnloser,MD; Tassilo Bonzel,MD; Helnut Wollschla-
ger,MD; Andreas Zeiher,MD; Herbert; LOllgen,MD; Hanj6rg
Just,MD, University of Freihrrg, West Gennany
Medical treatment of pulrronary hypertension is unsatis-
fying. The vasodilating effects of slo.r channel inhibitors
like nifedipine are bainq evaluated.
Methods: We studied the effects of nifedipine in 10 pa-
tients with precapillary pulncnary hypertensioo (PH) and
in 4 normal subjects (N). Pulrronary artery pressures, re-
sistance (PAR) and cardiac output, were determined prior
to and after administra.tion of 10,20 and 30 rn:; nifedipi-
ne sublingually. Control studies were carried out after
3-6 nonths of cootinous treatment with nifedipine.
Results (C= control) : -5
n PAm (mmHg) CO (l/min) PAR(dynxsecxcm)
C Nif C Nif C Nif
PH 10 53/53 4.6/5.3 751/649
N 4 12/14 6.6/6.2 115/148
10 rn:; nifedipine caused a fall in PAR of 13% and a rise
in CO of 15%. In 7/10 patients the decline of PAR was
>10%, in 2/10 < 10%, one patient showed a slight rise
of PAR. Increase of nifedipine dosage to 20 or 30 rn:;
produced little additional effects. The cootrol studies
of nifedipine therapy after 3-6 rronths revealed no loss
of therapeutic efficacy.
Conclusions: Nifedipine reduces PAR in patients with
precapillary pulrrcnary hypertensioo. However, the effects
of the drug have to be examined under herrodynamic con-
trol in each patient. The therapeutic efficacy is main-
tained after long term treatment.
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ACUTE HEMODYNAMIC EFFECTS OF INTRAVENOUS DILTIAZEM IN
PRIMARY AND SECONDARY PULMONARY HYPERTENSION
Eric R. Bates, M.D.; Barry J. Crevey, M.D.; David R.
Dantzker, M.D.; Gilbert D'Alonzo, D.O.; Kishor D. Popat,
M.D.; James S. Bower, M.D.; Bertram Pitt, M.D., FACC,
Veterans Administration Medical Center, Ann Arbor, MI
The effects of diltiazem on the pulmonary circulation
were studied. Hemodynamic measurements were made at rest
and during symptom limited exercise, before and after
acute administration of diltiazem (.25mg/kg over 60 sec;
1.4 mcg/kg/min x 15 min) in 10 patients with primary pul-
monary hypertension (1 0 PHT) and in 13 patients with sec-
ondary pulmonary hypertension (2 0 PHT). Cardiac index
(L/min/m2), mean brachial artery (BA) and pulmonary art-
ery (PA) pressures (mm Hg), and systemic vascular (SVR)
and total pulmonary (TPR) resistances (dynes-sec-cm-5)
were determined. Mean values are shown (* ~ p < 0.05):
Rest CI BA PA SVR TPR
10 PHT Control 2.42 96.3 49.9 1708 1086
10 PHT Diltiazem 2.44 82.5* 45.4* 1502* 995*
Exercise
10 PHT Control 3.85 109.4 60.3 1263 803
10 PHT Diltiazem 4.11 84.6* 49.1* 957* 616*
Rest
20 PHT Control 3.13 94.8 40.0 1246 601
20 PHT Oil t iazem 3.35 84.5* 35.8* 965* 513*
Exercise
20 PHT Control 4.47 111. 7 58.2 1024 595
20 PHT Oil t iazem 4.83 104.2 53.6* 861* 526*
Resting right atrial and pulmonary artery wedge pressures
did not change after diltiazem infusion.
Conclusion: These data suggest that diltiazem may be
useful in the treatment of both primary and secondary
pulmonary hypertension.
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Clinical Coronary Artery Disease:
Vasomotion, Platelets
NOCTURNAL ANGINA: THE IMPORTANCE OF INCREASED
MYOCARDIAL OXYGEN DEMAND
Arshed A. Quyyumi, M. B.; Christine Wright; Lorna Bealing;
Kim M. Fox, M.D., National Heart Hospital, London, U.K.
Increased myocardial oxygen demand is responsible for effort
angina whereas coronary spasm is regarded as causing rest angina.
We studied 11 patients, 6 with day time effort angina and 5
with effort and nocturnal angina (2400-0600 hrs). All had
proven coronary artery disease and episodes of S1 depression
(~ 1 mm)on ambulatory monitoring. Heart rate and ST changes
were measured every 5 seconds and the onset of S1 depression
was timed from the earliest change measured with a magnifying
lens. All nocturnal episodes were compared with each patients
most severe painful and painless effort episodes. In all but one
of the 37 episades (16 nocturnal, 21 effort), the heart rate
rose before the onset of ST depression. ST depression followed
a tachycardia by 65 + 35 secs and ~ + 26 secs during the
painful and painless nocturnal episodes respectively. In
comparison, ST depression followed the tachycardia by 98 + 81
secs and 71 + 41 secs during the painful and painless episodes
respectively(p> 0.05). During effort episodes, the heart rate
increased from 74 + 10 bpm to 94 + 13 bpm and during nocturnal
episodes, it increased from 68 + 14 bpm at rest to 89 + 10 bpm
before the onset of ST depression. No significant differences
existed in these parameters between nocturnal and effort,
painless or painful episodes. These results suggest a similar
pathophysiological mechanism for production of nocturnal and
effort myocardial ischaemia in patients with obstructive coronary
disease.
TRANSIENT IMPAIRMENT OF CORONARY FLOW: A FREQUENT CAUSE UF ISCHEMIA IN
CHRONIC STABLE ANGINA DURING NORMAL DAILY LIFE
Sergio Chierchia, MDj Victor Balasubramanian; MD; t or enza Muiesan, I'D;
Tan Sonec ha , MB; Anthony Davies, MD; Attilio Maseri. MO, FACC; Jilll
Raftery, MD, Hammersmith 0 Northwick Park Hospitals, London, UK.
We have previously shown that in patients (o t s ) with chronic
stable angina (SA) most episodes of transient acute i scheai a are not
preceded by an increase in heart rate (HR). To further investigate the
pathophysiology of these ischemic episodes we studied the behaviour of
the rate-pressure product (RPP), an established index of myocardial
oxygen demand (MV0 2). In 14 ambulant pts with SA, a positive exercise
test (Ex) and severe coronary artery disease, we recorded continuously
the blood pressure (BP. arterial cannula) and one ECG lead during
normal, unrestricted daily life. All recordings were performed off
medication, apart from sublingual GTN, using frequency ecdu l at ed Holter
recorders. A symptom-limited Ex was also recorded at the beginning of
the monitoring period. The ECG and BP were analysed by a coapu t er
program which measures, beat-by-beat, HR, Sf seg.ent derived parameters,
systolic and diastolic BP and RPP.
During 321 hours of continuous monitoring we recorded 204 episodes of
transient ST depression (ST+~ D.lmV) of which 40 were associated with
angina. RPP did not increase in 156 episodes (76.5%) in the 10 oins
preceding the onset of 5T changes. Of the reooining 48 episodes. 20
showed, at the beqi nni nq of ST+, a RPP 20 to 50% lower than that
observed at the onset of Ex-induced 51+. Only 2B episodes had an equal
or greater RPP. Findings were s i ai l ar for episodes with or without pain
and for episodes of different severity (0.1, 0.2, 0.30V STt). All pts
had frequent periods (6-10/pt) of increase in RPP exceeding the level at
which ST depression developed during exercise testing. and not
associated with angina and/or ST depression.
The lack of an increase in RPP prior to aost ischeaic episodes
suggests that either RPP is not a reliable indicator of MVO • or factors
transiently interfering with myocardial supply playa oojol role in the
genesis of transient i sches i a occurring in pts with SA during norlal
daily life.
MYOCARDIAL ISCHEMIA
Raffaele Bugiardini
MD; Antonio Muscari
Medica II, Universi ty
ProstacycJin (PGI2) exerts powerful antiplatelet and vasodilating
effects and has been proposed for the management of patients (pt s )
with stable and unstable angina pectoris. However drugs which mostly
dilate small coronary vessels, as dipyridamole(D), lIIay induce
myocardial ischemia. To ascertain whether PGl2 predominantly dilates
resistive vessels and induces myocardial i s chea i e we infused this drug
(scalar doses up to 10 ng/Kg/lllin I.V.) in 25 consecutive pts w.ith
angina pectoris and critical (~75%) narrowing of at least one of the
major coronary vessels. The effects of PGI2 were ccep er-ed to those of
0(0.60 mg/Kg LV.). All pts underwent bicycle ergometer test (25 W
increments at 2 min intervals). 0 induced typical chest pain and
significant (;;'0.1 mY) 5T segment depression (S1~) in 14 pt s . In 4 of
these subendocardial ischemia was also caused by PGl2 8-10 ng/Kg/min.
The heart rate (HR) and rate pressure product (RPPxI0- 3) at 0.1 oV S1~
during PGI2 infusion were significantly lower than those occuring
during exercise (respectively ,!SD: 94!9 vs 114!8-p<.D2 and 14.2!3.4
vs j9.9±3.3-p<.05). PGIZ responders had acr-e severe coronary lesions
(3 exclusively left lain. I triple vessel disease) than non
responders. Thus our data indicate that PGI2 at therapeutic doses ooy
induce Iyocardial ischeaia, ind.ependently fro. changes in oxygen
deland, in pts with angina pect'o;is and severe coronary lesions. These
findings suggest that PGI2 dilates sooll coronary vessels, even though
to a lesser extent than D. This lay result in a decreased Iyocardial
perfusion pressure, and/or coronary steal.
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DECREASE IN CORONARY BLOOD FLOW DURING REACTIVE HYPEREMIA
AFTER DIPYRIDAMOLE IN PATIENTS WITH CORONARY ARTERY DI-
SEASE.
Jean-Marc Foult, MD; Alain Nitenberg, MD; Samir Zouioue-
che, MD; Fran90ise Blanchet, MD. CHU Xavier-Bichat, Paris,
France.
Passive nar r owi ng of stenotic coronary arteries (CA) has
been postulated as a mechanism for decreased blood flow
in animals experiments. A contrast medium (CM) induced
hyperemic reaction (HPR) was elicited by selective injec-
tion of 8ml CM into the~left CA in 8 untreated patients
with significant left CA stenosis . LV and AO pressures
( P) , coronary sinus blood flow ( CSBF) were continuously
recorded . Coronary resistance (CR) was calculated as mean
AOP /CSBF. The procedure was performed during basal condi-
tions and after a 4 minutes infusion of dipyridamole(Dip)
(0. 14mg/kg/min). Control CSBF was 102 ± 28ml/min/l00gLV
and peaked at 154 ± 38ml/min/l00gLV during HPR. Hyperemia
lasted 25.7 ± 4.2s. After Dip, CSBF increased to 192 ± 60
ml/min/l00gLV, While CR fell from 0.81 ± 0.22 to 0.41 ±
0.11mmHg.ml-1.min (p.c0.001). In all patients, the intra-
coronary injection of CM induced a fall of CSBF from 192
± 60 to 176 ± 53ml/min/l00gLV (p.c0.02) which begun 4.4 ±
1.9s after the intracoronary injection and lasted 18 ±
8.9s. This decrease in CSBF was paralleled by an increase
in CR from 0.41 ± 0.11 to 0.44 ± O.llmmHg.ml- l.min (p~
0.001). The cumulative vasod ilation induced by Dip and CM
may have resulted in a fall of intraluminal pressure dis-
tal to the stenosis. Passive narrowing of the stenotic
segments is therefore hypothetised as the mechanism for
the observed decrease of CSBF and rise of CR.
WASHOUT OF HIGH LEVELS OF INTRACORONARY THROMBOXANE IN
PATIENTS WITH RECENT UNSTABLE ISCHEMIC HEART DISEASE
Paul D. Hirsh, MD, FACC, Medical College of Virginia,
Richmond, Va.
Thromboxane (Tx) is a pro-aggregatory vasoconstrictor.
Some patients (pts) with unstable angina pectoris (UAP)
have elevated Tx coronary sinus (CS)/aortic (AO) ratios.
A subset of pts with UAP or recent myocardial infarction
(MI) have provokable increases in CS and CS/AO Tx levels.
To further define the etiology of increases in transcard-
iac Tx, simultaneous CS and AO samples were obtained for
TxB2 measurement from 18 pts before and after left cor-
onary injection of 8 cc of Renografin-76, Heparinized
saline, and Nitroglycerin (NTG) 0.15 mg in Heparinized
saline. TxB2,the stable TxAZ metabolite, was measured
by radioimmunoassay after C18 column separation, TxBZ
CS levels . increased at least 3-fold after dye in 5 pts,
saline in 4 pts, and NTG in 7 pts. TxB2 CS/AO ratios
increased at least 3-fold after dye in 4 pts, saline in
3 pts, and NTG in 5 pts. 7 pts had both CS and CS/AO
TxBZ increases after either dye, saline or NTG - all 7
had recent UAP (chest pain within 24 hrs) or MI (within
2 mos) , Of the remaining 11 pts, 1 had a recent MI, 0
had UAP, and 7 had significant coronary atherosclerosis.
Thus , coronary sinus and transcardiac TxB2 levels incr-
ease markedly in response to coronary injections of con-
trast dye, saline and nitroglycerin in patients with
recent unstable ischemic heart disease but not in those
with stable or non-ischemic heart disease or non-ischem-
ic chest, pain syndrome. ·Thi s intracoronary TxB2 release
probably represents a washout phenomenon of thromboxane
and/or activated platelets and may explain the recently
demonstrated benefit of aspirin in patients with unsta-
ble angina pectoris.
Wednesday, March 28, 1984
4:00-5:15PM Ballroom A
Cardiac Pacing: New Techniques for Diagnosis
and Treatment
~YOPOTENTIAL INOUCTION OF AUTONO~OUS PACEMAKER TACHYCAROIA
- REVERSION METHOOS AND PREVENTION
Ross Fletcher, I'D. FACe; Andrew Cohen, 1"1), FACe; Benjamin Lee, I'D;
Fred Miller, I'll; D. Joshua Cutler, I'll, FACC; Albert DelNegro, I'll, FACC;
Veterans Actninistration and Georgetown University Medical Centers,
Washington, O.C.
Autonomous pacemaker tachycardia (APT) at rates of 100 bpm in 000 and
ISO ppm in DVI is a potentially dangerous arrhyttvnia seen in the early
experience with Verstrax wal charrber pacemakers. Initiation requires
a progranmed 10lller rate of BO and upper rate of 100 in 000 and 10lller
rate of 100 to 120with AV interval ISO in OVI follOllled by 1 to 2
specifically timed sensed events early in the refractory periods. Our
study in 6 pts defined the ease of induction of this arrhytl'mia Ulith
myopotential sensing, methods for reversion and effectiveness of changes
in programner to eliminate this arrhyttvnia. Programned atrial sensiti-
vity of .75 IIlII in 000 and ventricular sensitivity of 2.5 IIlII in DVI
allOllled myopotential sensing dJring pectoral contraction to Wtiate
autoromous pacemaker tachycardia in 5 of 6 patients otlen progranmed to
susceptible lOUler and upper rates IlIith original progranmers. The tachy-
cardia was sustained with both atrial and ventricular spikes at a
foreshortened AV interval at a rate of 100 bpm ",ith [)[)() and ISO .,ith DVI
mode. The tachycardias contil"lJed desPite magnet application and use of
progranrner inhibit mode. Chest "",11 pacing at a fixed rate of BD
promptly reverted APT in all patients. l'Iyopotentials, and critically
timed early PVC's and reprograrmdng the pacemakers also reverted APT.
After reprograrmli.ng previously susceptible lower rates and AV intervals
with a progralllllE!r altered to prevent this arrhyttvnia none of the 5
patients could be induced.
Our study showed that APT is easily indJced by myopotential sensing but
can not occur on susceptible intervals are avoided. APT is reverted
by chest wall pacing and is one of the first pacemaker anomalies
eliminated by altering the progranrner rather than removing implanted
generators.
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TxB2 36:1:8
6KPG 75:1:28
TxB2 105:1:36
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These results suggest that ASA Inh ibition of TxA2 and
PGI2 is most significant during myocardIal stress.
Furthermore, while both low and high dose ASA suppress
TxA2 and PGI2 production, low dose ASA might allow PGI2
pr~uction to return wlt~in 2~ hours while continuing to
suppress TxA2 production,
DIFFERENTIAL EFFECTS OF LOW AND HIGH DOSE ASPIRIN ON
~YOCARDIAL RELEASE OF THROHBOXANE AND PROSTACYCLIN.
Richard C. Klein, MD, FACC, James Beckmann, MD, Glenn
Peake, MD, VA Medical Center, Univ. of New Mexico, Albu-
querque, NH
Thromboxane (Tx) A2 and Prostacyclin (PGI2) have been
postulated to play important roJes in myocardial ischemia
and Infarction; inhibition of these compounds by aspirin
(ASA) could have important therapeutic implications for
coronary disease. We evaluated the effects of low and
high dose ASA on myocardial release of TxA2 and PGI2 in 9
patients with CAD; evaluations were done at rest and dur-
Ing atrial pacing to angina or 80% of maximum heart rate
before and 2~ hours after either 40mg or 32~mg of ASA.
TxA2 and PGI2 were sampled from arterial and coronary
sinus s ites and measured as metabolites TxB2 and 6-keto-
PGFla (6KPG) by radioimmunoassay . Results in picogram/ml
were (mean:l:SEH):
ABSTRACTS
TELEMETRY OF INTPACARDIAC ATRIAL AND VENTRICULAR
ELECTROGRAMS; A NEWTECHNIQUE FOR ANALYSIS AND Mfu~AGEMENT
OF BRADY AND TACHYARRHYTHMIAS
Richard M. Luceri, MD; Richard J . Thur er , MD , FACC;
Agustin Castellanos, MD, FACC; Liaqat Zaman , MD , Robert
J. Myerburg , MD , FACC, University of Miami, Mi ami , FL.
Real-time radiofrequency telemetry(RT) of intracardiac
electrograms(IE) via a microp rocessor-b ased AV universa l
(DOD) pacemaker(PM) has enabled detailed analy s i s of
tachy and bradyarrhythmias in both i nvas i ve and non-
invasive clinical settings. In this study, va lida t io n of
this technique by conventional and experimental methods i s
described . In one group of 10 patients(pts ) with implanted
DOD PM for a variety of conduction disturbances, RT of
either atrial(A) or ventricular (V) IE enabled non-invasive
diagnosis and/or management of (1) endless l oop tachycar-
dia; (2) myopotential oversens ing; (3) retrograde con-
duction intervals. RT was es pecially usefu l in the
interpretation of PM-associated t achycardic rhythms during
exercise. Non-invasive repro gramming of the PM corrected
the undesirable observations which in turn were verified
by RT of IE. In a second group of 12 pts, a custom-
modified external DOD PM was use d t o validate RT of A and
V IE during electrophysiologic ind uction of supra-V and
V dysrhythmias. Temporary electrodes were positioned in
the atrium and ventricle . Recordings were obta i ned in
the unipolar mode. The transmitted arrhythmias in cluded
A flutter, reentry supra-V tachycardia; A fibrillation in
WPW syndrome, V tachycardia and V fibrillat ion. Simulta-
neous comparison of hard copy RT to standard I Erecordings
during induction, termination and drug intervention of
arrhythmias confirmed the accuracy of the RT technique.
We conclude that RT of both A and V IE i s an accurate and
useful method for evaluation of DOD PM function, and for
non-invasive assessment of A and V arrhythmias.
ixcc Vol. 3. No .2
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SUTURELESS TEMPORARY ATRIO-VENTRICULAR PACING
Gera l d M Lemole, MD, FACe, Paschal M Spagna, MD, FACe,
Michael D Strong, MD, FACC Graduate Hospita l,
Philade lphis , Pennsylvania
A su tureless atrial. ventricular and atria-ventricular
sequential temporsry pacing device (D) was tested i n 20
patients undergoing cardiopulmonary bypass. The
device, consis ting of two electrodes on a soft silas t ic
ches t t ube , was placed in the oblique sinus 50 the
respective electrodes made contact with the posterior
left a trium (PLA) and ventricle (V) . Threshold (T)
vere taken for atrial (A) , ventricular (V). and
a trio-vent r i cular ( A-V) sequential capture. Standard
temporary pacing leads (S) were placed in the right
atrial appendage (RAA) and ventricle (V) and (T) was
recorded. Using a permanent epicardial lead,
thresholds of the atrium were taken at the left atrial
appendage (LAA). (RAA), (PLA) and i nt raat r i al groove
(lAG) •
Results : a) There was no difference in the atrial
threshold at (LAA), (RAA). (lAG) or
(PLA). 2.0 + 3.0 M.A.
b) (D)-(PLA) had lower (T) than (S)-(RAA):
2.0 + 1.5 M.S. versus 6 + 4 M.A.
c) (D)-Tv) had acceptable although higher
(T) than (S)-(V) : 3.8 + 2 veraus
2 . 5 + 2 M.L -
d) (A)-Tv) sequential pacing was
accomplished in all caaes.
A sutureless pacing device placed in the oblique sinus
appears acceptable for temporary atrial, ventricular
and atrioventricular sequential pacing. Anatomic and
histologic background will be presented along with a 90
second film showing insertion and recording.
581
DETERMINATION OF ATRIAL STIMULATION THRESHOLD
Bruce N. Goldreyer, MD, FACC; Milford G. Wyman, MD,
FACC ; David S. Cannom, MD, FACC, San Pedro
Peninsula Hospital, San Pedro. California
Recognition of P waves resulting from atrial pacing using
intracardiac electrograms would have clinical utility for
determining atrial stimulation thresholds but is not possi-
ble with current leads. The ability of a dedicated or-
thogonal electrogram sensor to discr iminate paced P waves
from 5 volt unipolar stimuli was tested in 27 patients.
A standard atrial J catheter was equipped with "floating"
4 mm 2 orthogonal sensors located 1.5 cm proximate to the
stimulating tip. The catheter was positioned within the
right atrial appendage. Electrograms were simultaneously
recorded from both the tip electrode and orthogonal
sensors during sinus rhythm and atrial pacing with high
fidelity and at frequencies between 0.4-1000 Hz. During
atrial pacing, capacitance decay (afterpotentialsl gener -
ated from the unipolar stimuli completely obscured the
atrial electrogram recorded from the stimulating electrode.
Electrograms recorded from the discr iminate orthogonal
sensor however demonstrated discrete stimuli with no
afterpotential . Atrial electrograms followed stimuli with
a latency of 23 :': 8 msec. Evoked atrial response electro-
grams were of high amplitude with P waves averaging
4. 1 :': 1.8 mv. Conducted farfield QRS complexes were
detectable in only 17/27 patients and averaged 0.13 :':
0.1 mv.
Orthogonal electrodes positioned within but not contact-
ing the atrial appendage, will allow paced P waves to be
sensed and atrial thresholds to be accurately determined.
F!' '-lIVL;'" Y AI>ALY~ is uF ~AlU> 1A~ PO d::N"l'IALS. A NLW TLCHlHliUE
rUK V ~ :, r K I ~v LAK TACHYCAlU>1A DETECTION
~dlia ,.. c.r ae l ius i Pnu; San j eev Sakse na .MD ,FACC; Demetrius
Pan t opoulos j Nr. j Syed ~lansoo r Huss a in .MlJ ; Victo r Pa r sormet ,
;·llJ , FAI.. I.. ; Isaac C; i " l c n 1 ns Ky .~W,FACC. Newar k Beth Israel
Ne<llcal Ce nt er , Newark. New Jersey.
Pres"nt a lgor i t hms tor ventr icul a r tachycardia(VT)det ec-
ti un in ant i t achyca r di a devi ces use rate criteria that do
nut u i s t i ngui sn supraventricular t achycardia from VT.We
eval uat ed the use of f requency spe c t ra(FS)of bipolar i n-
t r a ca ru l a c po t e n t i a l s t o r ar rhy thmia det e ction.27pts,aged
bJ!dyrs with ~ wit hout recurrent VI were s tudi ed . Vent ri-
cula r pu te nt1als were obtained tr om KV apical ca t hete r
e lectrodes(indoV)b epica rdial (EpiV)wire e lec t rodes placed
111 norma I appea r ing myoca rdi um .At ria l pot ential s were ob-
t a i neu wi ttl cathe t er e t ec t rodes c kecord i ngs were ana l yzed
111 s iu us rny t nmf Sk) .atr i a l & ventric ul a r pac i ng( AP&V P).
re trograd e a t rial act i vat i on & during VI wit h standard
( 3U-5 uuHz) & wideband (0 .5-5 uUuHz)amplifica tion. FS wer e
ubt a i ned using a spectr um analyze r & were character i zed
by cente r r r equencytCjj of t he ma j or peak.
RE SULTS: F~ from atria l & vent ricula r recordings (EndoV &
Lpi V) in SK had one broad peak wit h C, between 10-40Hz.
c on tain i n~ t he major i ty ot signal ene rgy&2 or 3 addition-
al peaks at highe r f r cquenc Les c Ant egr ade or retrograd e
a t rial ac tiva tion <lid not cons i s t ent ly alter t he FS of
a t rial pote ntia ls .AP&V P up to 4uums had no consis t ent ef-
tee t on FS of EndoV&EpiV potent i a ls. The CF of ventricular
pot en tia ls dur ing SR & VT for 12 ptS were :
SR (Hz) VI (Hz) P (SR vs VT)
Lnuo V J.7!"'j 1'6!'"9"" < •05
Epi V 26 ! 4 18 ! 6 < . 05
CONC LUS IONS: I-The major energy of EpiV&EndoV signals is
between IO-40Hz in SR,AP&VP. 2-ln VT, t her e is a decline
in I'S or both EndoV6EpiV possibl y reflecting delayed in-
tram yocardial conduction.3-FS can distinguish VI from SR,
AP or VP & may enhance algorithms for VT detection.
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FREQU ENCY CHARACTERISTICS OF ANTEGRADE AND RETROGRADE
HID ;AN ATRIAL POTENTIALS
Hil H am Craelius,PhD; Sanjeev Saksen a ,lID ,FACC; Demetris
Pantopoulos ,HE; Stephen Rothbar t , lID , Newar k Beth I srael
Iledical Center, Newar k , New Jer se y
Present modes of atri al sens i ng i n dual chamber pacemake rs
do not distinguish between antegrade atr i al (AA ) & r e tro-
gr ade a t r ial( RA) pot entials . Sensing of RA poten t ials of -
ten leads t o "end l es s l oop" t achycardi as . He examined the
f requency charac terist ics of AA &~ potent ials for pos-
sible enhancement of atri al sensing modes . 14pts aged 37-
79yr s were s t udied . AA & RA potent i als were obta i ned from
bipolar ca t he t er electrodes & placed i n t he high or mid-
a t ria & ampli fi ed a t both wi de(0.5-5 000Irz) & standard (30-
500Hz) bandwidths . Frequency spec t ra(FS) of atrial poten-
tial s were obt ai ned with a spec t r um analyser . FS were
char ac t eris tized by the frequency beyond which no further
signa l energy was present(Fmax)
RESULTS: RA potential durations were significantly longer
th an AA potential durations(64!:l9 vs 52±16ms p<.05). \Jave-
form analysis showed prolongat i on in th e terminal portion
of RA potentials as compared t o AA potentials in all pts,
& in 9pts, i ni t i al activation fo r ces were different for AA
& p~ poten t i al s . FS of AA & F~ potent ials cons i s t ed of 1-3
br oad peaks occuring between 10 & 150Hz, with the maj or i ty
of energy cont ai ned in the l ow f r equency peak. Although
t he mea n Fmax of AA & RA potent i als for al l pts was not
signi f icant ly dif feren t (172±4IHz vs 159±42Hz) i n 3/ 14pts
there was a consis t ent decline in Fmax during retrograde
conduction(f rom a mean of 176Hz t o 131Hz). In th ese pts,
AA signal amplitudes in the 100- 200Hz bandwidth, exceeded
th ose for RA potentials by fac to r s of great er than 10dB.
CONCLUSIONS: In selected pts, AA & RA potentials can be
di stinguished on the basis of wave f orm anal ysis & FS.
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Adverse Effects of Antiarrhythmic Drug Therapy
WINIDINE SYNCDFE: 'mE IMR:RmlO; OF HYR>K1IIa4IA
Michael Brodsky, MD, FACe; Deborah Abate, RN; Walter
Henry, MD, FACe. university of California, Irvine, CA
Q.rl,nidine (Q.rl,n) preparations are effective drugs for
the treatment of both supraventricular and ventricular
arrhytbnias. Side effects are C<XIIOOn. Quin related syn-
cope me to Im0XYsmal nonsustained ventricular tachy-
cardia (vr) or ventricular fibrillation (VF) has been
noted in up to 5% of pstients (pes}, Previous investiga-
tors have associated Quin syncope with 1) Digitalis-QIin
interactions or 2) idiosyncratic O-Jin reactioo. In the
present study, we evaluated 6 ptB 00 chronic Quin ther-
apy who presented because of syncope (3 with documented
vr/VF). 'Du:ee of the pta had hypertensive heart disease,
two had congestive heart failure and one bad no evidence
of heart disease. On presentation, all 6 bad low potas-
sil.lll (K) levels (2.7-3.5 mEq/L, IIIlaJl 3,1), and prolonged
corrected or (ore) intervals (509-626 msec, IIIlaJl 593),
Five of the 6 pta were 00 diuretics and 3 of 6 pta were
00 digoxin (0.6, 0,6, 1.8 ng/ml digoxin levels). In each
pstient Quin was st~ and K was replaced. After senm
K bad normalized (3.6-4.7, IIIlaJl 4.2), the ore returned
to normal (402-465, IIIlaJl 445) (P<0.01 ~ed to pre-
senting ore). After K normalization, baseline invasive
electrqhysiologic studies (BPS) were performed in 5 of
6 pts and revealed no inducible vs or VF. Four of the 5
were acutely rechallenged with Quin and ore increased
significantly (P<O,Ol) to 500-560 (mean 521) but was
still significantly less (P<O.05) than the initial pre-
senting values, During subsequent monitoring on Quin
VT/VF was not seen and could not be provoked by BPS.
'IhllS, it a);p!ars that Quin syncope is related to
significant prolongatioo of the ore in IlOIII!! pta, More
over, it a);p!ars that hypokalemia may potentiate Quin
effects on the ore predisposing pta to Quin syncope.
AHIODARONE RELATED TOXICITY
Jagdish W. Butany, MD, Eugene Downar , MD, Anthony S.
Rebuck, MD, Andrew C. Braude, MD, Wedad Hanna, MD,
Douglas Wigle, MD,FACC. Department of Pathology,
Women's College Hospital, Toronto , Ontario, Canada.
Amiodarone is a Benzofuran derivative used for the
treatment of refractory cardiac arrhythmias in Europe
and South America for 20 years . Reported side effects
include photodermatoses and corneal microdeposits. In
cl inical trials in North America, potentially serious
side effects such as interstit ial pneumonitis have been
reported. Ultrastructurally, inclus ions have been found
in peripheral nerves , cornea, lungs and skin . We examined
tissues taken at autopsy (5 patients[pt]), 1 of whom had
evidence of interstitial pneumonit is; bronchoalveolar
lavage (BAL) cells (5 pt) and peripheral blood cells
(20 pt). We found inclusion bodies of 4 types: a)lamellar,
b)electron luscent, c)electron dense, d) mixed. These
were found in all cell types examined. In peripheral
blood cel Is most were seen in polymorphonuclear leukocytes.
In patients with radiological evidence of pneumonitis
macrophages obtained by BAL were "stuffed" with inclusions.
Some of the lamellar inclusions were membrane bound and
appeared to be intralysosomal accumulations of phospho-
1ipid. This study indicates that Amiodarone related
inclusions occur in widespread tissues . The appearance of
these inc lus ions in leukocytes along with serum drug
levels will. we hope, provide the potential for early
detection of that subgroup of patients likely to develop
toxic symptoms.
SYSTDllC ADVERSE EFFECTS OF LOU DOSE ORAL MllODARONE.
Shoei K Huang, lI.D., lIarilyn D Ezri, ll .D. , F.A.C.C.,
Vi rg i ni a lloeller, R.N., Frank I llarcus, ll.D., F.A.C,C.
University of Arizona Health Sciences Center,
Tucson, AZ
The adverse effects of Amiodarone (A) have been
described. However, it's uncertain that the adverse
effects are dose related. We examined 48 patients (pt)
Ilho received low dose A «400 mg per day) for various
arrhythmias refractory to-conventional drugs. The A
dosag e ranged 100-400 mg per day (~ean 330 ~ 18 mg).
With mean follow up 11.8 + 3. 4 months, 19 pt (40%) had
corneal deposits, 3 (6%) had halo vision, 4 (8%) had
irritation of eye; 12 pt ( 25%) had increased hepatic
transaminase or lactic dehydrogenase without elevation
of al kal i ne phosphatase and bilirubin, 2/12 had
as sociated severe anorexia requiring A withdrawal;
as ympt omat i c elevation of thyroxine (T4) was found in
5 (10%) and severe hypothyroidism resulted in
di scontinuence of A in 1 (2%); photodermstitis in 8 pt
(17%), bluish-grey discoloration of skin in 3 (6%); 4
(8 %) devel oped tremor in which one pt necessitated A
withdrawal, 4 (8%) had ataxia and 1 (2%) had impaired
peripheral sensation; none developed pulmonary
infiltrates and none had gastrointestinal (Gl)
disturbances. Five (10%) had recurrence or poor
control of arrhythmias . Eight (17 %) died during
follOW-Up, 4 died suddenly. We concluded that 1)
sign ificant systemic adverse effects still exist with
low dose A; 2) the incidence of pulmonary and GI
complications appears markedly decreased with lower
dose.
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MIXED RESPONSE TO FLECAINIDE ACETATE
Frank D. Livelli, Jr, MD, Kevin J. Ferrick, MD,
J. Thomas Bigger, Jr, MD, FACC, James A. Reif-
fel, MD, FACC, Jerry I. Gliklich, MD, James
Coromilas, MD. Columbia Univ., New York, NY.
Flecainide acetate (FA) has an outstanding
efficacy/toxicity ratio for sporadic ventricu-
lar premature depolarizations (VPD) , but its
performance against malignant ventricular ar-
rhythmias (MVA) is unknown. Accordingly. we
evaluated FA with electrophysiologic testing in
7 patients (pts): 5 with MVA, i.e., recurrent
sustained ventricular tachycardia/fibrillation
(VT/VF), and 2 with potentially MVA (PMVA).
i.e., VPD and non-sustained VT. The 2 with PMVA
had Holter VPD reduced from >500/hr to <l/hr
and spontaneous VT was abolished, yet they had
inducible VT on oral FA. Of the 5 with MVA: 1
became non-inducible on FA but had sudden death
after 2 mos on drug: 1 remained inducible and
FA was stopped. The other 3 (all with 25% ejec-
tion fractions) had possible proarrhythmic ef-
fects: 1 had 7 hrs of spontaneous VT after in-
travenous FA: 1 had spontaneous VT/VF difficult
to cardiovert: 1 had 7 hrs of induced VT diffi-
cult to cardiovert. All 7 pts had plasma FA
levels in the 400-1000 ng/ml range . All had
failed 3±1 conventional antiarrhythmic drugs
but had no proarrhythmic effects prior to FA.
These early results suggest: (1) In pts with
PMVA, FA may be efficacious clinically despite
lab inducibility, however our experience i s
small: (2) In pts with MVA, FA has a low rate
of efficacy and high incidence of proarrhythmic
effects; and (3) Severity of LV dysfunction may
increase the risk of adverse FA effect.
FLECAINIDE: CORRELATION OF SIDE EFFECTS WITH DRUG
PLASMA LEVELS AND ECG INTERVALS. D. Salerno, MD,
PhD, G. Granrud, MD, P. Sharkey, RN, J. Krejci, RN, T. Larson,
Rl'r, D. Erlian, MS, M. Hodges, MD, FACC. Hennepin County
Medicel Center, University of MN, Minneapolis, MN.
Flecalnlde acetate (F), an effective antiarrhythmic drug,
causes cardlovasculsr side effects (CVSE) and non-CVSE. To
determine which patients (pta) are likely to have SE, we
studied 43 pts treated with F for up to 32 months. At each
clinic visit, we obtained F levels (>8 h post-dose) (n=252),
12-lead ECGs (n=2l8) for computerized ECG intervals, and
evaluation for SE. The following comparisons were made.
No SE CVSE Non-CVSE
II of pta ~ -rr- 21
F dose (mg!d) 325 ~ 104 345 ~ 74 353 = 109
F level (ng/mI) 609 =283 1063 '!: 514* 783 =442*
PR Interval (mSec) 201 '!: 34 258 '!: 65* 208 '!: 38
QRS interval (msee) Ill! 24 146 =38* 119 =31
QTc Int erval (mSec) 428 '!: 35 462 =46* 442 = 3611
JTc interval (mSec) 316 '!: 33 316 ! 26 324 = 24
* =P < 001 * p < .01 Ii p < .05
Nine of 38 F levels >1000 ng/ml (24%) were associated
with CVSE, whereas 10 of 214 F levels <1000 ng/ml (5%) had
CVSE (p<.Ol). Change in QRS (IlQRS) and llPR from pretreat-
ment were compared to CVSE. A 40% incidence of CVSE
occurred for llQRS > 40 mSec vs 5% for llQRS <40 mSec,
p<.005. This was also true for II PR ~60 mSec (31% vs 5%,
p<.005). II QTc and llJTc were not related to CVSE.
CVSE were tschyarrhythmia (I), brsdyarrhythmia (4), heart
failure (3), syncope (2), and bundle branch block (5 pta, 9
events).
In conclusion, the risk of CVSE rises sharply at higher
pla.ma levels of F and is reflected by greater llPR and llQRS
than routinely observed during treatment.
PERSISTENT VENTRICULAR TACHYCARDIA/FIBRILLATlON- A
POSSIBLE ADVERSE INTERACTION BETWEEN FLECAINIDE AND
CLASS I ANTI-ARRHYTHMIC DRUGS.
Lawrence Griffith MD FACC: Edward Platia,MD: Sarah Ord, BA:
Philip Refd, MD, FXCCJohns Hopkins Medical Institutions, Bel t, Md
We have treoted 31 ph with flecainide(F}for control of recurring
hypotensive ventricular tachycardia(HVT}. All had failed conven-
tional antiarrhythmic(AA)therapy and F was used as one of several
investigational drugs. Six ph died suddenly after starting F
(mean 4.5 days, range2-1 O)while 25 had no adverse effect.
The dose of F was 200 mg q 12 hrs. F was either added to onother
AA drug(2 ph) ,started at the same time that the previous drug was
stopped(1 pt),or an interval of one(1 pt},two(B pt),three(1 pt) ,
four(2 pt}ar at least five doys(16 pt}elopsed before F was started.
The drug given prior to F was:aprindine(15 pt),procainamide(5 pt),
quinidine(3 pt},norpace(2 pt) or none(6 pt),
Prior AA Episodes Prior Interval Prior
EF Drugs (no.) HVT/VF (no.) Drug-F (days)
Death(6 pt) ""20"10 3.7 3.2 ,.7
No Death(25pt} 44% 2.9 2.2 6.2
P Value c .05 NS NS <.05
For expired pll, the AA drug preceeding F was aprindine(5 pt) or
procainamide(1 pt).
No pt treated with F had an increase in frequency or complexity
of ventricular ectopy prior to the final event. All exp ired pll were
on ECG monitoring at the time of fatal ventricular fibriliation(VF).
Despite immediate resuscitation efforts,nopt could be cardioverted
to sinus rhythm. One pt had transient bradycardia and hypotension
prior to VT/VF. Five pts had only VT/VF.
The inability to cardiovert sustained VT is uncommon in our
experience. Becouse F blood levels were not routinely obtained, it
can not be determined whether toxic levels of this drug were pre-
sent. An altemative hypothesis may be an adverse interaction
between F and Class I drugs such that sustained VT cannot be
cardioverted to sinus rhythm. In HVT ph, we suggest that blood
levels of prior drug be measured before starting flecoinide.
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Pediatric Surgery
lOtI; TERM RESULTS OP PALLIATIVE MUSTARD'S OPERATION IN
PATIENTS WI'l'H 'l'RANSPOSITION OP 'l'HE GREAT ARTERIES WI'l'H
POI.IIHRY VASaJLAR DISEASE
Janardan P DbasmanA, FRCS, James FN Tayler MD, FACC,
Fergus J Macartney MD, FACC, Philip G Rees MRCP,
Marc de Leva! MD, and Jaroslav stark FRCS, FACe. '1b>racic
Unit, 'n1e Hospital for Sick Children, Great Ormond
street, IDOOon WCl.N 3JH
This is a long term follow up of 41 patients with
transposition of the great arteries .('mAI and pulmonary
vascular disease (P'JD) operated upon between 1973 and
1980. Pulmonary arterial resistance was 13.96±6.7 Uof.
In 34, ventricular septal defect (VSDI was not closed; in
seven it was created. 'n1ere were three hospital and two
late deaths. Follow up of survivors was 2-10 years (mean
76.7~2.8 IOOnths). Preoperative (A) and postoperative (B)
data are shown.
NYHA Class Ilb: Gm% Arterial 02
Situration
I II III IV (Mean) (Mean)
A 0 4 33 4 19.43±3.l4 63.44±1l.29
B 18 17 1 14.1m.30 89.l~7.25
All 41 J;8tients were severely cyanosed before, but only
one after operation. TWelve remained mildly cyanotic and
23 acyanotic. Twenty one of the survivors were
recatheterised: Pulmonary hypertension and high
resistance has not changed. Effective pulmonary blood
flow improved from 1.3 9±0.3 9L/min/m' before, to
2.6Q±O.78I/mUVrn' after operation.
We conclude that palliative Mustard operation carries
low risk and provides excellent improvement up to 10
years in ~tients with 'IGA and severe PI1D.
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CONTROL GROUP I GROUP II
4.7±0.6 6.2i1.9 l5.7i3.9
1l0i15 l23i45 270i60
1-8(1.5) 0.2-5(1.0) 0.2-1.5(0.4)
OPERATIVE EVALUATION OF PERCUTANEOUS BALLOON
PULMONAR Y VALVULOPLASTY
Joseph Walls, MD, FACC; Zuhdi Lababidi, MD, FACC; Jack
Curtis, MD, FACC, University of Missouri, Columbia, MO
Percutaneous balloon pulmonary valvuloplasty (PBPV) is pres-
ently used as a method of treatment of valvular pulmonary
stenosis (PS). Long term results are unknown. The morpho-
logic effects of the balloon forces on the stenotic valve have
not been fully described. Between October, 1982 and April,
1983, 23 consecutive patients underwent cardiac catheter-
ization, cineangiography and PBPV at the University of Mis-
souri-Columbia Hospital and Clinics. The patients ranged in
age from II months to 19 years. Eighteen patients had pure
valvular PS and 5 patients had PS associated with complex
cardiac anomalies. Peak systolic pulmonary valve gradient (G)
and cardiac output were measured before and 15 minutes after
PBPV. All patients with pure valvular PS had improvement in
G (pre-PBPV G=8r~31 mmHg, post-PBPV G=2l~'11 mmHg,
(p <0.00. Peak right ventricular systolic pressure decreased
from 106!31 mmHg to 50!12 mmHg (p <0.00. Five patients
with complex cardiac anomalies underwent operative repair
following PBPV and offered an opportunity to examine their
pulmonary valves. Post-PBPV 4 patients had reduction of G
and I did not. Assessment of the pulmonary valves revealed
opening of the commissure in I patient, tear of the valve cusp
in I patient, avulsion of the valve cusp from the anulus in 2
patients, and no apparent effect in I. Conclusions: No deaths
occurred; PBPV can effectively reduce G in PS in some
patients; the anatomic effects are varied and include commis-
sural opening, leaflet tearing and leaflet avulsion; morphologic
effects of PBPV are less predictable than open pulmonary
valvulotomy during cardiopulmonary bypass, but may be com-
parable to closed operative techniques.
MEASUREMENT OF EXTRAVASCULAR PULMONARY WATER IN INFANTS
AND CHILDREN FOLLOWING CARDIAC SURGERY.
Robert N. Vincent, MD, Peter Lang, MD, Walter J. Gambl~MD
David R. Fulton, MD, Marsha Elixson, RN, William I.
Norwood, MD, Aldo R. Castaneda, MD. Children's Hospital,
Boston, Massachusetts 02115.
Due to the frequently observed radiographic occurrence
of pulmonary congestion after cardiopulmonary bypass, ex-
travascular pulmonary water (EPW) was measured in 16 in-
fants and children following surgical repair of congeni-
tal heart disease using the cold green dye, double indica-
tor dilution technique.
Four patients with optimally corrected tetralogy of
Fallot (TOF) served as controls. EPW was measured in
these patients at the time of a one year postoperative
cardiac catheterization. EPW was also measured in two
groups of 6 patients 1 to 5 hours following surgery.
Group I patients (TOF) had normal or decreased pulmonary
blood flow (PBF) preoperatively, while Group II patients
(VSD and AV canal) were those with increased PBF and con-
gestive heart failure prior to surgery. EPW results are
given as mean ± S.D. Age is range and median.
EPW ml/kg
EPW ml/m 2
Age
EPW in the early postoperative period correlated with pre-
operative hemodynamics and not with a) length of cardio-
pulmonary bypass, b) use of deep hypothermic circulatory
arrest or c) postoperative LA pressure. Chest x-rays
were insensitive in following changes in EPW during the
first 24 hours following surgery.
AVOID CRITICAL OBSTRUCTION ItT TOTAL ANOMALOUS l'ULMONARY
VENOUS DRAINAr.E
Aubrey Galloway, M.D.; David Campbell, M.D.; David Clarke,
II.D., New York University School of Medicine, New York, NY
The purpose of this review is to identify the ma[o r
operative risk factor in patients with total anomalous
pulmonary venous drainage (TAPVD).
Between September 1976 and January 1ge2, 20 patients
with TAPVD underwent total repair at t~e University of
Colorado Health Science Center. The drainage was supra-
cardiac in 11, infracardiac in 7, and into the coronary
sinus in 2. At repair mean age was 9 weeks, and weight
was 3.7 kg. Deep hypothermia and circulatory arrest with-
out chemical cardioplegia was utilized in 18 patients.
Operative technique in extracareiac types includes com-
plete mobilization of the common vein with division of the
anomalous channel when possible. The incision In the con-
fluent vein was extended into the lobar veins when neces-
sary to permit extensive incorporation of this structure
into the posterior wall of the left atrium and resulted in
a non-o~structing stellate tvpe anastomosis.
Operative mortality was 10% (2/20). Death occurred only
among the five patients in whom critical ohstruction to
pulmonary venous return required emergency opera tion, an".
one of these patients has nersistent neurologic deficit.
Late cardiac catheterization has been performed in 10/18
survivors, 6/3 had no or only minor abnormalities, and 2
required reoperation. There have been no late deaths with
followup of 2-3 years (mean=4 years). Currently, all of
the survivors are without cardiac symptoms and only one
requires cardiac medication.
Our experience identifies critical pulmonary venous ob-
struction as the major operative risk factor in patients
with TAPVD. With early operation ~rtality is low and
functional results are excellent.
REPAIR OF ANOI~OUS ORIGIN OF THE LEFT CORONAUY ARTERY IN
THE INFANT AND SIIALL CHILD.
Frank ll. lIideley, M.D. FACC; Donald C. Watson,M.D. ; Lewis
P. Scott, M.D., FACC; Karen N. Kuehl, II.D. Children's
Hospital National aedical Center, Washington. I).C.
Anomalous origin of the left coronary artery (ALCA) from
the pulmonary artery. especially in the infant, is a mal or
challenge to the pediatric cardiac surgeon because it is
associated with myocardial infarction. left ventricular
dysfunction. mitral valve dysfunction and occasional asso-
ciated intracardiac abnormalities. Over five years ten
operative procedures have been performed for ALCA. In
five cases we have employed a technique which utilizes a
posteriorallyapplied flap of the anterior pulmonary ar-
tery wall to serve as a "neocoronary" artery transmitting
aortic flow from a created aorto-pulmonary window to the
pulmonary artery orifice of the anomalous left coronary
artery. The anterior pulmonary artery wall is recon-
structed with a pericardial patch. The ages of these
patients ranged from 3 months to 4 years (mean of 7.7
years). 2 patients were three months of age at the tine of
operation. Heights ranged from 3.7 to 20kg. (mean 9.4kt.).
There was one death at two days postoperatively rlue to
progr ess Lve biventricular failure. Two 3 month 01<' pa"
tients required mitral valve replacement. Addition".' -le..
fects repaired at the time of operation included repair of
atrial septal defects in 3. Three of the four surviving
patients have done well at follow-up of 1 week to 2 1/2
years. One patient has been lost to follow-up. One pa-
tient has undergone follow-up catheterization and has an
intact repair. Aggressive surgical management is safe and
effective even in the infant and small child with persis-
tent. progressive left ventricular dysfunction resultin~
fromALCA and its complications of mitral valve re~ur~it~­
t Lon, The pulmonary artery "neocoronary" procec!ure it>
applicable in all instances of classical ALCA rer,art:!lcss
of the patient's size.
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RISK FACTORS FOR INFANTS UNDERGOING AORTIC VALVOTOMY FOR
CRITICAL AORTIC VALVAR STENOSIS
John W. Hammon, Jr., MD, FACC; Mark D. Parrish, MD; Tho-
mas P. Graham, Jr., MD, FACe; Robert J. Boucek, MD, FACC;
Harvey W. Bender, Jr., MD, FAtC; Vanderbilt University,
Nashville, TN.
Critical aortic valvar stenosis, (AS) presenting in infun-
cy, is associated with a significant operative mortality.
To better understand those factors contributing a poor re-
sults all patients undergoing aortic valvotomy (V) for AS
in the first 6 months of life between January 1972 and
July 1983 have been reviewed. Patients presented at 19 +
7 (S.E.M.) days and weighed 3.5 + .4 Kg. All exhibited
signs of congestive heart failure and 16/19 (85%) poor
perfusion. Preoperative biplane angiocardiography with
left 'ventricular volume and function determinations were
performed in all. Associated lesions were; patent
ductus arteriosus - 12, atrial shunt - 12, mitral sten-
osis - 3, mitral regurgitation - 3, coarctation - 3, wnt-
ricular septal defect - 2. Urgent aortic valvotomy using
profound hypothermia and cardiopulmonary bypass with a
short period of circulatory arrest was the form of sur-
gical management. Operative mortality was 10/19 (53%).
Left ventricular end-diastolic volume was 159.6 + 26% of
predicted normal (PN) survivors (S) and 89.2 + 19% of PN
in non-survivors (NS) (P4.05). There were no-survivors
with less than 60% PN. 8/10 (80%) NS had ST-T wave
changes suggestive of ischemia on ECG whereas only 2/9
(22%) (P(.05) of S had these changes. Dysplastic valves
were present in 7/10 (70%) of NS but only 1/9 (11%) of S
(P(.05l. Small LV, ischemic ST-T wave changes and dys-
plastic valves predicted a poor result in infants with
critical AS.
Wednesday, March 28, 1984
2:00-3:30PM Ballroom C
Ventricular Tachycardia-Mechanisms
CLINICAL AND ELECTROPHYSIOLOGIC CHARACTERISTICS OF VENTRI-
CULAR TACHYCARDIA SUPPRESSIBLE WITH VERAPAMIL: REENTRY
VERSUS TRIGGERED ACTIVITY
Ruey J. Sung, MD, FACC; Der Yan Tai, MD, Edmund C. Keung,
MD, John T. Svinarich, MD, San Francisco General Hospital,
University of California, San Francisco, CA.
To characterize ventricular tachycardia (VT) that can be
suppressed by verapamil (Ve), clinical and electrophysio-
logic data from 7 patients (pts) with such VT were analy-
zed. There were 4 men and 3 women, ranging in ages from
18 to 50 (mean 30 years). All of them were symptomatic
with palpitations and/or dizziness, the duration of which
ranged from 2 to 20 years. None of them had clinical evi-
dence of structural heart disease. During VT, 5/7 pts
manifested a right bundle branch block (RBBB) pattern and
2/7 pts a left bundle branch block (LBBB) pattern with
rates varying from 120 to 200 beats/min. During electro-
physiologic studies, incremental atrial and ventricular
pacing within a critical range of cycle length (720-300
msec) could initiate VT in all 7/7 pts. However, atrial
and ventricular extrastimulation provoked VT in only 2/7
pts. In 4/7 pts it could be demonstrated that the inter-
val between the first beat of VT and the last paced beat
(QRS complex) gradually decreased as the paced cycle len-
gth (R-R interval) progressively shortened. Intravenous
infusion of Ve (0.15 mg/kg followed by 0.005 mg/kg/min)
totally abolished the inducibility of VT in all 7/7 pts.
In contrast, VT became incessant at slower rates follOWing
intravenous infusion of either propranolol (0.2 mg/kg) or
procainamide (20 mg/kg followed by 2 mg/min). We conclude
that: 1) VT suppressible with Ve may manifest either an
RBBB or LBBB pattern and should be suspected when occurr-
ing in pts without structural heart disease and 2) elec-
trophysiologic and pharmacologic responses of such VT are
more consistent with triggered activity than with a re-
entrant mechanism.
REPETITIVE MONOMORPHIC VENTRICULAR TACHYCARDIA: CHAR-
ACTERISTICS IN PATIENTS WITH AND WITHOUT HEART DISEASE
Alfred E. Buxton, MD, FACC, Francis E. Marchlinski, MD,
FACC, John U. Doherty, MD, Harvey L. Waxman, MD, FACC,
Mark E. Josephson, MD, FACC, University of PennsylvanIa,
Philadelphia, PA
We compared clinical and electrophysiologic character-
istics of 20 patients (pts) with repetitive monomorphic
(RMM) ventricular tachycardia (VT) who had no heart
disease (group A), with 6 pts having RMM VT with cardI-
ac disease (group B). All group B pts had prior infer-
ior myocardial infarction: 1/6 had LV aneurysm. VT had
left bundle branch block morpholology in all group A
pts, while 5/6 VT had right bundle branch block morphol-
ogy in group B pts. Seven group A pts and 4 group B pts
had VT maps: VT oriqinated at the RV outflow tract in all
group A pts and at the border of an infarction in all
group B pts. VT was induced by programmed stimulation in
6/20 group A pts versus 5/6 group B pts (p<.05). VT was
induced by isoproterenol In 10/17 group A pts and 4/6
group B pts. Type I antiarrhythmic agents prevented VT
in 13/19 group A pts and 4/6 group B pts. Beta blockers
prevented VT in 10/18 group A pts and 3/3 group B pts.
Fourteen group A pts and 3 group B pts were treated for
symptomatic VT. During follow-up of 3-84 months
(mean, 29.5) no pt developed cardiac arrest or died. We
conclude: RMM VT may occur in patients with and without
heart disease. In pts without heart disease RMM VT most
often originates In the RV. In pts with old myocardial
infarction RMM VT originates in the LV. RMM VT in the
setting of coronary disease is more frequently induc-
ible by programmed stimulation. RMM VT in both set-
tings often responds to both Type I antiarrhythmic agents
and beta blockers. The prognosis appears good for pts
with RMM VT whether or not structural heart disease is
present, regardless of therapy.
CHARACTERISTICS OF INDUCED POLYMORPHIC VENTRI-
CULAR TACHYCARDIA
Jorge L. Gonzalez, MD; Alvaro Mesa, MD; Vance J. Plumb;
MD; FACC, Richard W. Henthorn, MD; Andrew E. Epstein,
MD; Albert L. Waldo, MD, FACC. University of Alabama in
Birmingham, Birmingham, Alabama.
The records of 203 patients (pts) who underwent 356
consecutive programmed ventricular stimulation studies to
assess ventricular tachycardia (VT) were analyzed. 54 (15.2%
incidence) episodes of polymorphic ventricular tachycardia
(PMVT) of 10 or more beats were found in 25 pts. The PMVT
was characterized by different morphology and rates from
beat to beat. The rate of the PMVT ranged from 143 to 333
beats/min (mean 250). The duration of the PMVT ranged from
10 to 76 beats (mean 17). 39 of the 54 (72%) episodes of the
PMVT were self-terminating. 14 of the 54 (26%) of the PMVT
changed to sustained monomorphic VT (MMVT). Of these 14,7
required DC shock, 2 rapid pacing, and 5 were self-
terminating. PMVT was induced by I (5.5%), 2 (33%), or 3
(45%) ventricular extrastimuli and by burst pacing in 13%.
The coupling interval of the initiating extrastimuli was near
the ventricular refractory period in 59% of the episodes. 16
(30%) episodes occurred in pts receiving no antiarrhythmic
agents and 18 (33%) episodes occurred in pts receiving Type I
antiarrhythmic agents. The QTc prior to initiation of PMVT
ranged from .36 to .59 with a mean of .44. Conclusions: J)
PMVT has a relatively low incidence during programmed
ventricular stimulation studies for VT and has a wide spectrum
of characteristics; 2) PMVT is usually self-terminating and
short lived; 3) PMVT usually occurs in the setting of a
prolonged QTd 4) when the PMVT changes to MMVT, the
majority require intervention.
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EPINEPHRINE, U-WAVES, AND VENTRICULAR ECTOPY
Eliot Schechter, MD, FACC; Krishnaswamy Chandrasekaran MD;
Ralph Lazzara, MD, FACC, University of Oklahoma Health
Sciences Center and VA Medical Center, Oklahoma City, OK.
To explore possible automatic or triggered mechanisms
for VT and investigate the role of the U-wave (U) and
its possible reflection of delayed afterdepolariza-
tions (AD) epinephrine (EPI) in physiologic doses
was infused in 26 pts and the amplitude of U on the
ECG was measured in the lead in which it was largest.
In all pts U increased from control (all values in
millivolts) (.09 + .1) to EPI (.27 + .2). Two pts
with the congenti~l long QT syndrom; (LQT) had larger
U in the control (.4) which augmented strikingly
during EPI (8.5) compared with others (control .06 +
.04; EPI .22 ± .09). Eight pts developed ventricul~r
ectopy, 4 VT and 4 PVC's, during EPI. U was larger
both in the control state (.13 + .1 vs .07 + .09) and
during EPI (.33 ± .18 vs .24 ± ~21) in pts with ectopy
than in those without. Three other pts had idioventri-
cular rhythm (2 parasystolic) before EPI. Their U
(control .05; EPI .25 + .07) did not differ from
the group as a whole, ~lthough their rate increased
from control (90 + 10) to EPI (112 + 29). These
observations sugg;st: 1) U may be-the surface
reflection of normally occuring delayed AD, and, like
the latter are augmented by EPI; 2) The larger U
and its greater EPI sensitivity in LQT may reflect
abnormally large AD; 3) U-waves are related to ventri-
cular ectopy in some pts without LQT suggesting AD as
a mechnism; and 4) The U response is normal but the rate
increases in patients with idioventricular rhythm
suggesting it has a different mechanism, perhaps
increased phase 4 depolarization.
LATE PROGRAMMED ELECTRICAL STIMULATION TESTING IN PATIENTS
ON AMIODARONE. Enrico P. Veltri, MD: Philip R. Reid MD
FACC; Lawrence S.C. Griffith, MD FACC; Edward V. Platia,
MD. The Johns Hopkins Hospital, Baltimore, Maryland.
Programmed electrical stimulation (PES) in patients(pts)
on amiodarone(A) for ventricular tachycardia(VT) has
revealed disparity in clinical and electrophysiologic
efficacy. Previous studies have addressed PES testing in
pts within 6 weeks of starting A. To evaluate the value of
late PES testing to predict subsequent arrhythmic
events(AE:syncope or sudden death) in pts on long-term A,
we studied 20 pts with recurrent sustained VT, refractory
to mean 5.2 drugs. Underlying cardiac disease was coronary
disease in 14 pts, cardiomyopathy in 6 pts; mean ejection
fraction(EF)was 32%. Of eighteen pts with control PES
study, all had inducible VT (~3 beats): 14 sustained, 4
nonsustained. Oral loading was mean 1210 mg/day for 14
days; mean maintenance dose was 425 mg/day. PES testing
done at mean 6.7 months(range 6 weeks-28 months) revealed
inducible VT in 18 of 20 pts(15 sustained, 3 nonsustain-
ed); only 2 pts originally inducible became noninducible.
VT cycle length compared to control in 14 pts was increas-
ed in 12, unchanged in 1 and decreased in 1. The ease of
VT inducibility was unchanged in 6, easier in 4, more
difficult in 4. At mean 13.6 months followup, 14 pts(70%)
(13 inducible at late PES) had no AE compared to 6 pts
(30%)(5 inducible at late PES) with AE. There were no
significant differences in VT cycle length change or ease
of inducibility in pts with or without AE. Sixteen pts
(80%) were alive(mean EF 36%) and 4 pts (20%) dead(mean EF
17%), p(.Ol. We conclude that in pts 'on long-term A: 1)
late PES does not predict clinical efficacy, 2) the
frequency of conversion from inducible VT to noninducible
is low, 3) EF appears predictive of survival.
FAILURE OF LIDOCAINE TO PREVENT REPERFUSION ARRHYTHMIAS
INMAN
Karl·Heinz Kuck, MD;.Joachim SChofer, MD; Walter Bleifeld, MD, FACC; Detlef G.
Mathey, MD; Dept of Cardiology, University Hospital Eppendorf, Hamburg, West
Germany
To examine the efficacy of Lidocaine tu in preventing reperfusion arrhythmias
(RA) in m.n we performed. randomized study in 29 consecutive patients (25 men,
4 fe_leI with ecute myocerdial inflrction, in whom the occluded coronary artery
_s successfully recanalized by intracoronary streptokinase (SK) infusion. 14 pts
(mean age 55t,12 yeers, 9 pts LAD, 5 pts RCA occlusion) _re treated at the time of
admiaion to the coronary care unit with a bolus of 200 mg L, followed by a L·in·
fusion at a rate of 1,4 mglmin (group A). Another 15 pts (mean age 52.±.14 years.
7 LAD, 7 RCA, 1 CFX occlusionl were not treated with L before SK _s admini·
stered (group BI. The meantime between duration of symptoms and successful reo
opening of the occluded coronary artery was 3.5h in group A and 3.Sh in group B.
RA in both groups _re characterized by an immediate onset at the time of reper'
fusion without preceding ventricular premature beats (VPBs), VT had always mono·
morphic QRS complex at a regular cycle length. Ho_ver, two different types of VT
could be observed in both groups. 1) VT (12 ptsl at a slow rate (79 ±.R b/min),
which terminated. when the ventricles _re captured by a sinus impulse and 2) VT
(7 pts) at a higher rate (117.±. 24 bIminI, which was initiated by spontaneous VPBs
and/or termineted by spontaneous or stimulated VPBs. We conclude that 1) dif·
ferent mechanisms are responsible for VT following reperfusion: enhanced automa-
ticity causing a slow VT (accelerated ventricular rhythm, AVRI and reentry or
triggered activity causing VT at a faster rate. 21 L does not prevent the occurrence of
RA in the setting of acute myocerdial infarction in man. Ho_ver, the majority of
pts (12 ptsl had AVR and L is known to be ineffective in the treatment of AVR.
Results:
ventricular tachycardia (VT}
ventricular fibrillation (VF)
no arrhythmia
group A
9 pts
2 pts
3 pts
group B
10 pts
3 pts
2 pts
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Cardiac Arrhythmias-Basic Mechanisms
REDUCTION IN EXTRACELLULAR CALCIUM ION CONCENTRATION
PREVENTS REPERFUSION VENTRICULAR FIBRILLATION
F.T. Thandroyen MRCP, L.H. Opie MD FAce, MRC Heart
Research Unit, University of Cape Town, South Africa.
Reperfusion of the acutely ischemic myocardium increases
cellular calcium concentration. The role of calcium
(Ca2+) in reperfusion ventricular fibrillation (RVF)
has not been defined. We investigatged the effect of
reduction in extracellular ca 2+ ion concentration in
the perfusion fluid on (1) incidence of RVF plus
reperfusion ventricular tachycardia (RVT) and (2)
reperfusion metabolic status prior to RVF in the
isolated perfused rat heart subject to 15 min left main
coronary artery ligation and 10 min reperfusion.
Reduction in extracellular Ca2+ ion concentration
decreased incidence of RVF and duration RVF + RVT.
Protection was not associated with alteration in total
coronary flow (CF), heart rate or preservation of
metabolic status.
Procedure RVF RVF+RVT CF Lactate Glycogen
incidence duration ml/min umol/g
sees
ca 2+ 2.5mM 18/18 578 12.1 8.7 8.4
Ca2+ 1.25mM 6/6 326* 10.3
ca 2+ 0.625mM 3/12** 18** 10.7 8.4 9.5
* p <0.05 ** P <0.01
Conclusion: The level of cytosolic calcium appears to
be of importance in the genesis of reperfusion
ventricular fibrillation.
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EXTRACELLULAR K+ GRADIENTS ACROSS AN ISCHEMIC BOUNDARY
Charles Nydesser, MD; Gary Anderson, MD, FACC; Jeffrey
Hill, PhD, Steven Dennis, PhD. Cardiovascular Institute,
Hahnemann University, Philadelphia, PA
From this data we conclude that:
a) although no "border" of intermediate perfusion is
seen, aignificant [K+) gradients exist within the
infarcting region, and
b) these gradients of K+ may contribute to the hetero-
geneity of conduction leading to cardiac arrhythmias.
BURST PACING VERSUS MULTIPLE PREMATURE STIMULATION IN THE
INDUCTION OF REENTRY
Nabil El-Sherif, MD, FACC; Rahul Mehra, Ph.D.; William B.
Gough, Ph.D.; Robert H. Zeiler, Ph.D., Downstate and VA
Medical Centers, Brooklyn, N.Y.
The mechanism of initiation of reentrant rhythms by burst
pacing (BP) and the relationship of this technique to
programmed premature stimulation (PPS) are not well under-
stood. Isochronal maps of ventricular activation were
analyzed in dogs, 1-5 days post-infarction utilizing a 64-
channel multiplexer. Only dogs in which circus movement
reentry could not be induced by a single premature stim-
ulus were analyzed. Reentrant rhythms could be success-
fully induced equally by multiple (double or triple) pre-
mature stimuli and by BP. Successive premature stimuli
as well as successive beats during BP resulted in pro-
gressively longer arcs of functional conduction block
and/or slower circulating wave fronts that eventually
succeeded in initiating reentry. However, for manifest
reentry to be induced by BP, the paced run had to be
terminated following the beat that resulted in a critical
degree of conduction delay. Otherwise, reentrant activa-
tion could be confined (concealed) or interrupted by the
subsequent paced wave front. Termination of a paced run
following this beat would not result in reentry. If the
paced run was extended past this beat a new sequence of
ventricular activation patterns characterized by progress-
ively longer arcs of block and/or slower conduction devel-
oped once again. The number of beats in a paced run that
could initiate reentry varied with the cycle length of
pacing, as well as in different experiments and was dif-
ficult to standardize. This was not the case with PPS.
It is therefore concluded that random burst pacing as a
technique for induction of reentrant rhythms should prob-
ably be abandoned in favor of programmed multiple pre-
mature stimulation.
3
4.0+0.39
5 -
Although the concept of a "border zone" of intermediate
blood flow and injury has been questioned on metabolic
and anatomic grounds, gradients of ST segment elevation
have been shown to exist. To examine the possibility
that K+ diffusion from ischemic to normal tissue may be
the cause of this electrophysiologic border zone, we have
investigated the ~elationship of extracellular [K+l to
the perfusion boundary in 11 coronary artery ligated pigs
(10 -15 kg). In each animal 8-16 [K+]-sensitive plunge
electrodes (0.25 mm diameter) were inserted to a depth of
4mm across the edge of the perfusion bed of the first
marginal branch of the LAD artery. Following ligation,
[K+l and unipolar electrograms were recorded for 90 min.
At the end of the experiment, thioflavin-S was injected
into the ascending aorta and the heart was excised. From
the relationship between the increase in extracellular
[K+l and the distance of the recording electrode from the
perfusion boundary delineated by the thioflavin-S
fluorescence, the progreasive development of K+ gradients
was examined. The results after 50 min of ligation are
illustrated in the table (mean! SEll * - !<O.OOI
Normal ~ lschem'ic
4.4!0.37 6.9+3.7* 14.3+7.7* 19.8+9.3*
(in) - 3 - 5
EFFICACY OF PROPRANOLOL AND TIMOLOL IN PREVENTING
INDUCIBLE SUSTAINED VENTRICUT.AR TACHYCARDIA IN A CANINE
HODEL OF MYOCARDIAL INFARCTION
James Coromilas, MD, Elizabeth W. Uhl, BS, J. Thomas
Bigger, Jr., MD, FACC, Eli S. Gang, MD. Columbia
University, New York, N.Y.
Beta-blockers decrease the incidence of sudden death
follOWing myocardial infarction but the mechanism of
this effect is unknown. We studied the antiarrhythmic
and antifibrillatory potential of propranolol (PRO) and
timolol (TIM) in a canine model of induced sustained
ventricular tachycardia (VT) after myocardial infarc-
tion. The myocardial infarction was made in closed
c est dogs by occluding the anterior descending coronary
artery with a balloon for 2 hours. Four days after myo-
cardial infarction, programmed ventricular stimulation
using double and triple extrastimuli induced sustained
VT in 50% of the dogs, Eight dogs with VT were random-
ized to beta-blocking doses of PRO or TIM; PRO in doses
of 0.1, 0.3, and 1.0 mg/kg and TIM in doses of 0.01,
0.03 and 0.1 mg/kg. The experiment ended when VT was no
longer inducible or after all 3 drug doses were tried.
The following day, the second beta-blocker was studied.
PRO prevented induction of VT in 7/8 dogs and TIM in 5/8
dogs (p-NS). TIM was effective at the lowest dose in 5/5
dogs and PRO in 3/7 dogs (p<0.05). Ventricular fibril-
lation threshold decreased after myocardial infarction
and returned towards nor~l after treatment with either
PRO (26±12 to 36±18 p<0.05) or TIM (35±21 to 38 ± 19
p-NS). Both PRO (l68± 16 to 179±22 p<0.05) and TIM (168±
12 to 175± 24 p-NS) increased the effective refractory
period. In conclusion, beta-blockers have potent an-
tiarrhythmic and antifibrillatory effects in this post
infarction VT model that may be responsible for the
reduction of sudden death in post myocardial infarction
clinical trials.
CRITICAL ~lASS ANJ THE SURGICAL TflEATMCNT OF VE:lTRICULAR
FIGRILLATION: THE ::FFECT OF RIGHT VENTRICULAR ISOLATION
ON VENTRICULAR FIGRILLATION THRESHOLDS. Ralph J. Damiano,
Jr., :I.D.; Tetsuo Asano , M.D.; Peter I~. Smith. :-I.D.;
Raymond E, Ideker, ~.D., Ph.D.; James L. Cox, M.D., Duke
University Medical Center, Durham, NC
A certain critical mass of myocardium is required to
initiate and maintain ventricular fibrillation. The
right ventricular isolation procedure (RVI), employed
clinically to confine ventricular tachyarrhythmias to the
right ventricle, decreases the available ventricular
muscle mass by isolatins the ventricles from each other.
The effect of the procedure on ventricular fibrillation
thresholds (VFT) is unknown. Left and right VFT's were
measured both before and after RVI in ten adult mon~rel
dogs, utilizins ~ single 5 msec. stimulus of increasins
current strength applied to the epicardium durin~ the
vulnerable period. There were no significant differences
in heart rate, aortic blood pressure, left atrial pres-
sure, temnerature, notassium, DR, 002, oCOZ' or re~1onal
mvocardial blood flow, as measured by radioactive tracer
microspheres, between the study periods. In 9 of 10
dogs, the isolated RV could not sustain VF desoite the
utilization of stimulus strengths of un to 80 rnA. In the
tenth doS, the RVFT increased 150% from 20 to 50 rnA. The
LVFT markedly increased in every dog, with an ave rase in-
crease from 23+2 to 40+4 rnA (p<.0005). In order to deter-
mine if either-time, cardiopulmonary bypass or a RV inci-
sion could result in similar chanses in VFT, five dif-
ferent doss underwent the entire experimental protocol,
except that the RV was not completely isolated. There
were no significant changes in either LVFT or RVFT in
these dogs. Thus, in the canine model, RVI not only can
prevent the occurrence of sustained fibrillation in the
isolated RV. but also significantly increases the LVFT.
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PACEMAKER SHIFT AS A RESULT OF HETEROGENEITY OF RESPONSE
TO ADENOSINE IN RABBIT ISOLATED PERFUSED HE~~TS AND
ISOLATED SA NODE
G. Alexander West, Ph.D., Luiz Belardinelli, H.D., Univer-
sity of Virginia, Charlottesville, Virginia.
Adenosine (ADO) has a negar.ive chronotropic effect and
has recently been implicated in mediating bradycardia
during and after ischemia. In isolated perfused hearts
(n-9) and isolated SA node (SAN, n=18) ADO caused a
shift in leading pacemaker site. In I so lated hearts,
extrace1.1.ular e Lec t r ogr ans were recorded from high SAN
region (HSA), low SAN region, right ar r i a (RA) near
cristae terminalis (CT), and left atria. During ADO
infusion activation of atria shifted from HSA to RA.
Irit rr.ce 1.1.u l.ar recordings in the iso lated SAN showed
that during control conditions, the SAIl cells lead acti-
vat ion of CT by 54. 7 ~ 5.16 msec (me~~ ~ SEt!). In con-
trast in the presence of ADO (l x 10 H) ac t i vat ion
of CT' preceded SAN by 26.68 ~ 3.2 msec. To further in-
vestigate the responses of different areas of the SAN
to ADO, small (300 x 300~m) voltage homogeneous prepara-
tion were used. In this preparation, simultaneous re-
cording with two microelectrod!:~ revealed that no shift
occurred during ADO (at 1 x 10 H), (; cycle l~~th ~C!.)­
21.0 t 50 msec or Acetylcho line (Ach) (2.5 x 10 H), ~
CL = 239 t 26 msec. SmaJ.l. preparations within the sa!!.'g
SAN had different sensitivities to ADO. NBHPR, 1 x 10
H, an ADO uptake blocker, potentiated the response of
"true" pacemaker cells by a factor of 5-7, e.:.§. from
(; CL • l20 ms to (; CL - 720 ms at ADO 2 x 1.0 M. In
areas closer to CT responses to ADO were less and not
potentiated «2 fold) by NBMPR.
These results suggest that the primary pacemaker ceJ.l.s
are more sensitive to ADO than subsidiary pacemakers
and therefore allows for pacemaker shift as seen in the
isolated SMI as well as isolated perfused heart.
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A RAPID DIGITAL ANGIOGRAPHIC TECHNIQUE FOR DETERMINING
RELATIVE CORONARY BLOOD FLOW: VALIDATION AND LIMITATIONS
John McB. Hodgson, M.D.; Fred M. Aueron, M.D.; G.B. John
Mancini, M.D.; Victor LeGrand, M.Do) Eric R. Bates, M.D.;
William W. O'Neill, M.D.; Michael T. LeFree, B.S.; Robert
A. Vogel, M.D., Veterans Administration Medical Center,
Ann Arbor, Michigan
Previously described techniques for measuring coronary
blood flow (CBF) by digital angiography are laborious and
limited to large arteries. We have implemented a tech-
nique which is easy to perform and allows calculation of
regional myocardial blood flow reserve within minutes of
data acquisition. Eight open chest dogs were instrumented
with an electromagnetic flow probe (EMF) on the left an-
terior descending artery (LAD). Angiography was per-
formed using ECG-gated contrast injections and standard
catheterization equipment interfaced to a second-
generation digital radiographic computer. Using a region
of interest over the LAD perfusion bed, myocardial con-
trast appearance time (AT), which is inversely proport-
ional to blood flow, was determined by densitometry at
baseline and during peak contrast-induced hyperemia. The
ratio of hyperemic and baseline AT was compared to cor-
responding EMF ratios. AT ratios correlated signifi-
cantly with EMF ratios <3.25 (r~.90, n=27). The tech-
nique was reproducible (+12%), but underestimated EMF
ratios >3.25. Limitatio~s of using contrast to induce
hyperemia included persistance of contrast in the myocar-
dium during subsequent hyperemic flow determinations and
short duration of hyperemia. Also, AT was found to be
critically dependent on the timing of injection. We con-
clude that this technique holds promise for allowing
rapid assessment of coronary blood flow changes and de-
termination of the hemodynamic significance of individual
coronary stenoses during routine cardi~c catheterization.
VALIDATION a= MYOCARDIAL BLOOD FLOW MEASURE-
MENTS USING DIGITALSUBTRACTION ANGIOGRAPHY
J Kevin Drury, MD; James S. Whiting, PhD; J. Martin Pfaff,
65; SClmuel Meerbaum, PhD, FACC; Eliot Corday, MD, FACC;
James S. Forrester, MD, Cedars-Sinai Medical Center, Los
Angeles, CA
We have developed a method to quantify myocardial blood
flow using digital subtraction angiography by analyzing the
time density curves (TDC) obtained after coronary artery
contrast injection. In 6 open-chest dogs, left circumflex (LCF)
coronary artery flow was measured by electromagnetic flow-
meter. Different levels of flow were established by intra-
venous infusion of dipyridamole and progressive snare
occlusion. At each flow level Renografin-76 was injected
directly into the coronary artery. Fluoroscopy was performed
at 3 rnA and 75 kVp and the television images of the left
ventricle were digitized at 30 frames/sec. Videodensitome-
trically corrected TDC's from a myocardial region of interest
(ROJ) distal to the LCF occluder were analyzed to derive an
experimental washout half time (T 1/2). LCF flow ranged
between 20 and 140m I/min. Regression analysis revealed a
relationship between coronary flow (Q) and myacardial con-
trast T 112 as follows: T 1/2=-0.2Q + 4.6, r=0.93, SEE=.366
seconds. Coronary blood flow was further categorized as
ischemic «40 ml/min), narmal (40-65 ml/min), and hyperemic
(> 100 ml/min). The T 1/2's for each flow level were:
ISCHEMIC NORMAL HYPEREMIC
T 1/2(sec) 4.2:t1.1* 3.1:to.9 1.7:t0.4**
*p<.05, **p<.OOI compared with normal
CONCLUSION: Coronary blood flow can be assessed from
digital subtraction angiography by analysis of myocardial con-
trast washout rate following selective coronary injection. This
new technique may permit evaluation of the hemodynamic
significance of coronary artery stenoses.
CORRELATION OF CORONARY STENOSIS AND CONTRAST DENSITY
DECAY CURVES BY ON-LINE SUBTRACTED DIGITAL FLUOROSCOPY
Rodney A. Johnson, MD; Alan G. Wasserman, MD, FACC;
Richard J. Katz, MD, FACC; Roy H. Leiboff, MD; George B.
Bren, MD; P. Jacob Varghese, MD, FACC; Allan M. Ross, MD,
FACC; George Washington University, Washington, DC
Subtraction fluoroscopy techniques now allow on line
digital acquisition and semi-quantitative measurement of
coronary flow patterns in man. We recorded density decay
curves over left ventricular areas of interest using 2 to
8 cc of selective intracoronary contrast injection.
Studies were obtained 30 sec to 2 min following a previous
contrast injection to achieve a hyperemic state. Back-
ground and then arterial phase images were masked and
subtracted from the myocardial phase of contrast transit.
Analysis started with post injection catheter-coronary
disengagement. Maximum density decay rate (from peak
myocardial opacification) was computer generated as a
declining slope and expressed as percent decrease in
density over time (% decrease/sec). This rate in the
distribution of 25 coronary arteries (13 normal, 12
stenotic) ranged from 16%/sec to 3%/sec. In the dis-
tribution of normal vessels the peak decay rate mean was
11.6±2.4%/sec. Decay rates in perfusion zones of
arteries with 75-99% stenosis was only 5.6t2.3%/sec.,
p < .01. Decay rate related to arteries with 50-74%
stenosis was intermediate at 8.7t.23%/sec., p < .05
compared with the mean rates in both the normal and the
more severely stenotic zones. Conclusions: 1) Digital
subtraction fluoroscopy can be used to generate contrast
decay (washout) curves which correlate c1ose1¥ to patency
or stenosis of the related coronary artery; 2) This
technique may bridge the gap between the anatomic descrip-
tion of a coronary stenosis and quantitative evaluation
of its physiologic consequence.
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CHARACTERIZATION OF CHANGES IN CORONARY BLOOD FLOW
DURING THE FIRST SIX SECONDS AFTER CONTRAST I NJECTIO~
John McB. Hodgson , M.D.; G. B. J ohn Ma nc in i , M. D. ; Rober t
A. Vogel, M.D. , Ve t e r ans Administ r a t i on Med i cal Cent e r ,
Ann Arbor, Mi chigan
Although it i s wel l estab l i s hed t ha t in t r acor ona r y in jec-
ti ons of r adi ographi c co nt rast mat e ri a l can in duce in -
c r ease s in co ro na ry b lood f low ( CBF) a f ter ten s ec onds,
t he i mmed ia t e effect s hav e not been ca ref u lly eva l ua ted.
Wi th cur r ent in t eres t in di g i t a l a ng i ogra phi c t echnique s
for eva lu ati ng CBF, these ea r ly e f fec t s are import ant. We
inves t iga te d t he e f fec ts of ECG-ga t ed int r acorona r y i n j ec-
tion of co nt r as t on CBF wi t h differen t i nj ecti on rat es
(3 -6 cc /sec) , amount s ( 1-6 cc ) , a nd cont r a s t co nce nt ra -
ti ons (~ , f ul l st re ngth ) , a s wel l as differ ing condi t io ns
of CBF ( 40- 110 cc / mi n) and hea r t r a t e ( 120- 200 / mi n) .
Eig ht open ches t dogs wer e in s t r umen t ed wi th el ec tromag-
ne t i c f l ow pro bes on the l e f t ante r i or de sc end i ng artery.
Dur ing in tra coronary injections of co n t r a s t , an increase
in CBF of 10-20% was observed duri ng t he fi rs t beat post-
injection . This was not seen whe n i nj ect i on r a t e s wer e
l ow or CBF high , implying a mech ani cal e f fec t . A decrease
in CBF of 49-59% was se en a t 2. 3+. 5 (mean + S. D.) seconds
wi t h ret ur n t o baseli ne CBF l evel at 4 .5~. 7 seconds re -
gardless o f amount in j ec t ed, CBF or hea r t r ate ; however ,
inc r easi ng in jection rat e ca used an ea r lier nad i r ~ A s i-
milar t ime cour se wit h att en ua t ed cha nges in CBF was se e n
using ha l f s t r engt h cont ra st . We co nc l ude t ha t de sp i te
wide va r i a t ions i n CBF, hea rt ra t e and amount of i nt ra co-
ron a ry cont r a s t i njec ti on , ch ange s i n CBF oc c ur ri ng i n t he
i mme d i a t e pos t- in ject i on per i od are predictabl e and mos t
inf luence d by i n j ec ti on r a t e. The r e fore , di gita l an gi o-
gra phi c t ec hni ques usi ng t h i s t ime per i od t o make CBF
estimates should be accura te i f these cha r act e r i s t ic
changes a re taken int o account.
RIGHT VENTR ICU LAR EJ ECTION FRACTION BY VIDEODENSITOMETRY
OF INTRAVENOUS DIGITAL SUBTRACTION ANGIOGRAMS: EXPERI-
MENTA L VA LIDATION AND INITIAL CLI NICAL RESULTS
St e ven E. Nis se n , MD, Bruce Fr iedman, MD , J ohn Wa t e rs, MD,
David Booth , MD , FACC; Ant hony DeMa ria , MD, FACe ;
Uni ve r s i t y of Kentucky , Lexi ngt on , KY .
Vid eodens itomet ry (V) i s a me th od where by ejec t ion fra c t i on
(EF) can be ca l cul a t ed without geome t ric ass ump ti ons f ro m
the re la ti ve br i ght nes s values of su mmat ed pixel s in dig-
itized cardiac images. We have pre vi ous l y appl i ed video-
den sit omet r y of digital sub trac ti on ang i ogr ams (DSA) to
ca l cula t e left ventricular ( LV) EF. In thi s st udy , we ap-
pl ied t hi s me thod to in travenous DSA image s of the mor e
geome t rical ly compl ex r ig ht ve ntr ic l e(RV) . VEF was expe r -
i me nt a l l y vali da t ed fo r t wo pl asti c hear t mode l s of d i f-
fe r en t geome t ry , mechanica ll y pumped to s imulat e EF of 10
t o 60% . Cl os e cor r e l at io n ( r=0. 98) was ac hi eved fo r VEF
and act ua l EF for both model s . RV VEF was a na l yzed i n 47
pa ti e nt s ( pt s ) . 16 norma l s ; 10 va l vul a r disease ; 18 cor -
ona ry disea se ; 3 cardiom yopa thy . Mea n RV VEF in normal s
wa s 51! 6% an d was si mi l ar t o radi onuc l i de RV EF, 59 ~5% .
VEF was re duced i n pts wi th pu lmona r y hype rtens ion ,
«X >20) , mean 39% ( p~.O I) and LV f ai lure (~~1 8 mmHg) ,
mea~ 37% ( p~.O I ) . Howeve r , RV VEF was inc re ased i n pt s
wit h tri cusp i d r egurg i t a t i on , mean 62% (p~. 0 5 ) an d was not
re duced i n pt s wi t h anteri or MI wi t hout hea r t f a i l ur e ,
mean 53%. RV VEF was dec r eased i n some but not a l l pt s
wi th infe r io r MI and was s l ightl y d imi nis hed for t he
group, mean 4 5% ( p~.05 ) . Thes e da t a demonstrate that VEf
of i nt ra venou s DSA prOV i des a reli ab l e, re l at i ve l y non-
i nvas i ve method fo r as ses smen t of RV fun c ti on wi thout
geome tr i c assumptions , and pr ov i des use ful data in a va r -
ie t y of disea se s ta t es. Vide odensi tome try detec ted s i gni f -
ica nt r educ tion i n RV Ef in pul mona r y hypert en s ion a nd LV
fai l ure . RV' VEF was norma l in pt s 'wi t h a nter i or MI wi t hout
LV fai l ure but was abn orma l i n so me pt S Wi th i nf e r io r MI,
ev~ i n t he absence of c l i ni ca l RV in fa rc t io n .
IIOODm\MIC ASSESSHENr OF VENTRICUIAR RESPONSE TO DIFFt:RENT
PAC I r«J MODES - VAUJE OF RADIONICLIlI: ANGIOGRAPHY (RNi\)
H. Sochor , MD, W. Scheiblhofer , MD , O. Pachinger, MD, E.
O8ris, RD, A. Laczkovics, MD, F. Kaindl, MD, K. Schwaiger, MD,
H. Schelbert, It>, FACe, Dept. of Cardiology, University of
Vienna , Aust ria and OCIA School of Medicine, Los Angeles, CA
Physiologic pacing (PHYS) is gaining increasing importance
because of optimized a-v stimulation and preserved rate adapt-
ability during exercise (EX). To investigate the hemdynamic
sequelae of PIlYS, 17 pts with DOO pacemakers underwent 109 RNi\
studies at rest (n-25), during submax1msl (5CM ) supine exer-
cise (n-38) and after varying av-delays, pacing rate and
pacing lIDde (n-46). LVEF, SV , EDV , ESV, and CO were calcu-
lated frOID RNi\ by a count-based method. While different
pacing lIDdes did not significantly alter LVEf, shortening of
av-<!elays (220 msec, 150 msec, 95 sec) reduced LVEf (54t2%,
48t3%, /06±3%); p(0.01). While av-sequential pacing did not
significantly affect SV for the entire patient group, in
patients with a greater than 15% CO rise, EDV increased by
38t9% (p<O.OI), while "non-responders" were unable to increase
EDV (-I6t11 X). I:Uring EX, LVEF Yl8 simlar during WI
( 48t17%) , DVI (48;1;6%) and vro (49±7%). CO was IIISllimal during
VDD pacing due to increased HR, while EDV increased only
slightly by 15%. The increase i n CO during DVI and VVl was
chiefly related to higher EDV. We conclude that in av-sequen-
tial pacing, various a-v delays affect ventricular performance
at rest. The inconsistent SV response obscures the fact that
SOllIe pta lIllly benefit while others do not, lIla1nly dependent on
EDV. PHYS during EX ..rkedly improves the CO response lIDstly
due to increased HR, while WI pacing increases CO less, again
by increasing EDV. The favorable effects of PHYS in IIlOst
patients can be demonstrated with RN'. which provides a
practic:a.l meana for analYZing noninvasively the individual
hemodynamic response to various lIDdes of pacemaker
atiDulation.
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Radionuclide Ventriculography-Measurement of
Volume and Clinical Application
LEFT VENTRICULAR VOLUME DETERMINATION UTILIZING
GATEDm.oon POOL TOMOGRAPHY
/l.4ichael Stadius, MOLGeorge Harp, PhD; David Williams, PhD;
James L. Ritchie, MD, FACC, VA Medical Center and
University of Washinl!:ton, Seattle, Wash.
Gated blood pool tomography (GBPT) was performed in 25
pat ients (pts) with 25 mCi technit ium 99M, and LV end systolic
(ES) and end diastolic (ED) volumes were determined. Images
were acquired with a GE 400T gamma camera that rotated 1800
about the anterior thorax collecting 64 views. Images were
reconstructed by filtered backprojection from 80 msec of ED
and 50 msec of ES.
The ED and ES images were reoriented along true myocardial
long and short axes. The apex and base were identified by an
ent irely automated process, ut ilizing the phasic difference
between ES and ED counts to separate the LV from the LA.
Regions of interest (ROIs) were determined for ES and ED short
axis slices perpendicular to the long axis in a semi-automated
manner. The LV ED and ES volumes were then determined
from the summed areas of th~ ROIs of the short axis slices. All
pts underwent 300 RAO - 60 LAO contrast LV angiography 24
hrs prior to GBPT. At ES, the correlation coefficient between
GBPT and angio volumes was 0.96 with a standard error of the
est imate (SEE) of 13.5 cc. At ED, the correlati on coefficient
was 0.1l3 and the SEE was 34.1 cc.
We oondude: n Original 3-dimensional count data can be
reoriented to any desired perspective. 2) Structures that
overlie the LV {the RV and LA) can be excluded in a semi-
automated manner. 3) LV ES and · ED volumes can be
determined without makinl!: geometric assumptions about the
shape of the LV, and 4) These ES and ED volumes compare
favorably to the LV volumes determined by biplane
angiography.
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GATED BLOOD POOL TRANSAXIAL TOMOGRAPHY: LEFT
VENTRICULAR VOLUMES AND EJECTION FRACTION
James R. Corbett, MD, Donald E. Jansen, MD, Samuel E. Lewis,
MD, Christopher Wolfe, MD, Pascal Nicod, MD, Gregory R.
Redish, MD, Gregory Gabliani, MD, Neil Filipchuk, MD, James T.
Willerson, MD, FACC, University of Texas Health Science Center,
Dallas, TX.
Preliminary reports have suggested the feasibility of gated blood
pool transaxial tomography (Torno) using a rotating gamma
camera. In this study we tested the hypothesis that Torno
provides an accurate measure of left ventricular (LV) volumes at
end diastole (EDV) and end systole (ESV). Thirty-five patients
with ischemic heart ~ease were studied. Torno projections were
acquired through 180 from RAO to LPO with individual projec-
tions acquired for one minute at 15 frames/cardiac cycle.
Transverse sections were reconstructed by filtered bBckprojection
at end diastole and end systole. Ejection fractions (EF) were
compared with planar gated blood studies acquired the same day,
and in 29 patients that underwent contrast ventriculography (mean
of 8.8±11.8 [SO] days) comparisons of EDV and ESV were, also,
made. Two independent observers each measured Torno volumes
using a simple thresholding procedure. EFs were calculated from
the Torno volumes.
Angio Observer 1 Observer 2
EDV (n=29) 129±36 I28:!:33 132:!:33
range (63-223) r=0.89 r=0.86
Regression Equations y=0.83x+20.9 y=0.80x+27.8
ESV Nn=29) 60128 66127 67128
range (J8-146) r=0.85 r=0.92
Regression Equations y=0.82x+17.1 y=0.9Ix+13.4
EF (n=35) 52±16 49t13 49tll
range (J2-76) r=0.79 r=0.81
Regression Equations y=O.64x+15.2 y=0.57x+20.0
We conclude that Torno assessment of LV volumes and ejection
fraction are feasible and accurate.
THE VALUE OF EXERCISE RADIONUCLIDE VENTRICULOGRAPHY AS A
PREDICTOR OF CLINICAL OUTCOHE IN PATIENTS WITH AORTIC
INSUFFICIENCY
Cesar M. Pellerano, lID; James Osborne, HD; J. Randolph
Perry, lID.; Kirk F. Adams, lID, The University of North
Carolina, Chapel Hill, N.C.
This study evaluates the ability of exercise
radionuclide ventriculography (EX RNV) to predict the
clinical course of patients (pts) with chronic aortic
insufficency. We determined the relationship between the
change in left ventricular ejection fraction with stress
and clinical outcome retrospectively in 30 patients with
pure aortic insufficency. These 30 pts were identified
after exclusion of 13 additional pts due to the presence
of associated aortic stenosis (peak to peak gradient > 20
mm Hg), significant mitral regurgitation, or coronary
artery disease(> 60 % stenosis of more than one vessel).
All pts underwent EX RNV with imaging at rest and gated
list mode acquisition during exercise. A significant
change in left ventricular ejection fraction (EF) was said
to occur if stress EF differed by > 5 compared to rest EF.
All 8 pts i~ NYHA < II who had a-significant increase in
EF with exercise remained clinically unchanged, follow up
(f!u) 3-23 months(mos). Two of 8 pts in NYHA < II without
significant change in EF with exercise develop;d worsening
of symptoms and requred aortic valve replacement(AVR)(f!u
18 -26 mas). Of the 7 pts in NYllA < II with a decrease in
ejection fraction with exercise, 5 developed worsening of
symptoms and 3 underwent AVR (f!u 12-18 mos). Six of 7
pts in NYHA > II had an abnormal ejection fraction
response to exercise and worsening of symptoms within 3
mos with AVR in S.
This data suggests that an inability to increase ejec-
tion fraction with exercise precedes elineal deterioration
in AI. Pts with AI and an abnormal exercise response
should be observed for worsening of clinical status.
EXERCISE GATED NUCLEAR ANGIOGRAPHY IN THE DIAGNOSIS OF
CORONARY ARTERY DISEASE IN AORTIC STENOSIS
Julio C. Milanes, MD; Herbert N. Hultgren, MD, FACC;
Mario R. Romero, MD; David A. Goodwin, MD, Stanford
University School of Medicine, Palo Alto, California.
The detection of coronary artery disease (CAD) in aortic
stenosis (AS) has important implications regarding treat-
ment and prognosis. The purpose of this study is to as-
sess the value of exercise gated nuclear angiography in
the diagnosis of CAD in AS. We studied 26 patients, all
males, mean age 63 years (range 42-88 years). All had 2
pure or predominant AS. Severe AS (valve area < 0.8 em )
was present in 13 patients. Twelve patients had CAD, and
14 patients had normal arteriograms. Computerized func-
tional imaging for wall motion analysis and LV ejection
fraction (LVEF) determination were obtained throughout
supine cycle exercise. Regional wall motion abnormalities
were present in all but 2 patients (both had diffuse
abnormalities) among the group with CAD. In the group
without CAD regional abnormalities were absent in II pa-
tients and present in 3 patients (all 3 had severe AS).
LVEF during exercise fell in all patients with CAD while
the same response occurred in 7 patients without CAD, all
with sZvere AS. All patients with an aortic valve area>
0.8 em , without CAD, had at least a 5% increment of LVEF
during exertion. The presence of normal wall motion ex-
cludes CAD, and when a normal increment in LVEF during ex-
erZise is also found, predicts an aortic valve area> 0.8
em. We conclude that exercise gated nuclear angiography
is a useful non-invasive method of detecting CAD in the
presence of AS and probably predicts severity of AS. In
those patients with a normal exercise gated nuclear angio-
graphy (wall motion analysis and LVEF response to exer-
cise) invasive evaluation can be safely deferred.
RADIONUCLIDE FOURIER AMPLITUDE ANALYSIS TO PREDICT POST-
ANEURYSMECTOMY EJECTION FRACTION
David M. McCarthy, MD, FACC; J. Patrick Kleaveland, MD;
P. Todd Makler, Jr., MD, FACC, University of
Pennsylvania, Philadelphia, PA
Post-operative LV ejection fraction (EF) is an impor-
tant determinant of outcome following aneurysmectomy but
is difficult to predict noninvasively. First harmonic
Fourier analysis of radionuclide angiography (RNA) in
patients with aneurysms gives characteristic phase and
amplitude images which delineate contractile and dys-
kinetic regions. Since pixel amplitude is proportional
to stroke counts, the summed amplitude values from the
contractile region (CR) and the aneurysm should reflect
regional stroke volumes. A predicted post-operative LVEF
may be determined from the pre-operative global LVEF and
the proportion of the total amplitude located in the CR.
We studied 19 patients undergoing LV aneurysmectomy
with pre- and post-operative RNA. Three patients were
excluded for technical reasons, leaving 16 patients for
analysis. There were 13 males, and the mean age was 56.8
yrs (range 45-78). All patients had a history of ante-
rior myocardial infarction and were undergoing surgery
for recurrent sustained ventricular tachycardia. The
global LVEF increased from 0.25±.13 (sd) pre-operatively
to 0.38±.11 following surgery (p<.OOl). The amplitude-
predicted post-operative LVEF (from the pre-operative
RNA) averaged 0.3S±.13 and correlated significantly with
the actual post-operative LVEF (r=0.87, SEE=.06, p<.OI).
The results suggest that the LVEF following aneurysm-
ectomy can be predicted from Fourier amplitude analysis
of the pre-operative RNA.
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ASSESSMENT OF LEFT ANTERIOR FASCICULAR BLOCK B~ ~C1Nl1­
GRAPHIC PllASE ANALYSIS
Michael Dae, MD ; Yin-Mei Wen, MD ; Elias Botvinick, MD,
FACC; Melvin Scheinman, MD, FACC, University of Cal ifor-
nia , San Francisco , Calif.
Left anterior fascicular block (LAFB ) r ema ins an uncertain
diagnosis by scalar ECG, particularly with coexi s t ing in -
ferior infarction. To assess the utility of phase analy-
sis in LAFB, LV phase and amplitude (AMP ) maps were eva l u-
ated in the 700 left anterior oblique (LAO) pro j ect io n in
8 control patients (pts) and 12 pts with LAFB by Warner
ECG cr i t er i a. The LV region was di vided i nto anter io r (A)
and inferior (I) segments . Contract i on pa t terns were as -
sessed by examining the sequence of phase angles ( ~), r el-
ative contraction time was assessed from th e di f ference
between segment mean phase angles [6f{A- I) ] determined
f rom the phase histogram (HI ST) , durat i on of cont r ac tion
was assessed by HIST width, and r elat i ve s t r oke vol ume was
assessed on the amplitude image.
Eight controls demonstra~ed normal a~plitude, cont r act io n
ofoA Before I segment, 6¢{A- I )=-7 0±5 , narrow HIST width,
46 ±7 , and normal ECG. Among 12 pts with ECG LAFB . 7
were concordant with phase analys i s demonstrating A con-
traction delay, 2/7 pts with 6~{A- l ) =+100+2°, narr ow HIST00 -(50 ±8 ). and normal AMP were compatibl e wi 5h pgr e A con-duction d~laY3 and 5/7 pts with 6~ (A-I)=+36 ±15 , br oad
HIST (137 +43 ) and reduced A AMP, compa t ib l e wi t h A i n-
farction. Phase analysis was dis cordant with LAFB diagno-
sis in 5 pts. Although all showed cont r act io n of A befor e
I segments, 3 had 6f {A- I)=- 280+l 2° , a br oad HlS T (1190+
340 ) and reduced I AMP, compatible with prior I infarct i on
without LAFB , and 2 had normal phase and AMP maps.
Phase patterns appear char ac t eris t ic i n LAFB, wit h or with-
out associated infarction. Phase and AMP ana lysis may
clarify ECG diagnosis of LAFB and pr ovide etiologic in s Igh t .
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Left Ventricular Function in Hypertension
VENTRICULAR ARRHYTHMIAS IN MILD ESSENTIAL HY PERTEN SION :
ASSOCIATION WITH \/ORKPLACE SYSTO LIC BLOOD PRES SURE AND
LEFT VENTRICULAR MASS.
Walter A. Kornienko, MD; Paul KI igf ield, MO , FACC;
Richard B. Devereux, MO; Thomas G. Pickering, MO, PhD ;
Gregory Harshfield, PhD; John H. Laragh, MD , FACC, Cornell
Medi ca l Center, New York, NY.
We evaluated the complex ity and frequenc y of ventr i cul ar
premature comp lexes (VPCs ) detected by amb ulato ry ECG in
unmed icated patients (pts ) with mi l d es sen ti a l hyperten-
sion (mean clinic blood pressure (OP ) 150+4(SE ) /95+2 mm
Hg) . Find ings were related to s imu ltaneous 24hr amb ul a-
tory BP, random cl in ic BP, quant ita t ive echoca rd iographi c
measurements, and age. Among 59 pt s , 26(4 1:%) had no VPCs,
17(29%) had s imple VPCs (peak Lown 1-2) , and 16(27%) had
complex VPCs (peak Lown 3-5) . Mean workplace sys to l i c BP
(SBP) was higher in pt s with complex VPCs ( 153+3) t han in
pts with simple VPCs (140+5, p< .05 ) and those-with no
VPCs (128+2, p <.00l) . Workplace SBP was also l inear l y
correlated with log of mean VPC frequency ( r=.28 , p<.05).
In cont rast, mean 24hr SBP was no higher in pt s wi th com-
plex VPCs (134+4) than in pts with simple VPCs ( 136+5)
but each was hi ghe r than in pts with no VPCs ( 1 2 5~3~ both
p< .05). Simi larly, mean random cl i n i c SBP was no hi ghe r
in pts with complex VPCs (157+5) than in pts with simple
VPCs (155+5), but each was higher than in pt s with no VPCs
(140+3, both p< .OI) . Ne ither 24hr SBP nor cl inic SBP
correl~ted with VPC f requency . LV ma ss index (LVMI)
correlated with VPC frequency (r=.26, p<.05), but was not
signif icantly different in pts with complex ( 110+6),
simple (10)+7), or no VPCs (98+5) . VPC comp le xity and
frequency correlated wi th age,-but age did not correlate
with either workplace SBP, 24hr SBP , cl in ic SBP, o r LV"I.
We conclude that VPC complexity and frequency in pts with
mild essential hypertens ion are associated more closely
with mean workplace SBP than with either average da ily
SBP . random cl in i c SBP , or LV~I/ .
VENTRICULAR TOPOGRAPHIC ALTERAnONS CAUSED BY
AFTERLOAD INCREASE DURING EXPERIMENTAL MYOCAR-
DIAL INFARCTION
Haim Hammerman, MD; Frederick J. Schoen, MD, PhD; Eugene
Braunwald, MD, FACC; Robert A. Kloner, MD, PhD, FACC,
Harvard Medical School and Brigham and Women's Hospital,
Boston, MA.
Increase in afterload may occur dur ing the acute phase of
myocardial infarct ion. Since it is unknown whether pressure
loading of the infarcted heart leads to permanent topographic
alterations, experimental myocardial infarction was produced in
14 open-c hest dogs by left anterior descending coronary liga-
tion. Dogs were random ized to a methoxamine group (n = 7)
with an infusion dose of 30.3 tl.9 llg/kg/m in (mean tSEM) start-
ing I hr post ligation for 4 hrs and to a saline control group (n =
7). Methoxamine increased systolic blood pressure from 137 t 6
(mmHg tSEM) to 174t 5 compared to controls in which blood
pressure was not changed. Seven days later the animals were
sacrificed and hearts examined. Ratio of infarct thickness to
normal wall thickness was 1.13 t 0.03 (mean t SEM)in control and
smaller in the methoxamine group 10.99 t 0.03, P< 0.01l. Expan-
sion index was determined as previously reported and expans ion
was considered if expans ion index> 1.09. Expansion index was
0.98 t 0.07 in the control and 1.22 t 0.07 in methoxamine group lp
< 0.0:». Percent infarct mass/left ventricle was 1:>.3 t 2.7 in the
control and 24.6 t 4.3 in the methoxamine group lp = NS);
however percent endocardial circumference which was infarc t-
ed was larger in the methoxamine group, 32.8:!:4.0 vs control
20.2 t 2.4 lp < 0.025). Thus, early short term increase in
afterload causes permanent expansion and stretch of myocar-
dial infa rction.
DEPRESSED LEFT VENTRICULAR FUNCTIONAL RESERVE IN ESSEN-
TIAL HYPERTENSION: PATHOPHYSIOLOGICAL IMPLICATIONS
Michael Jason. MD ; Edmund Herrold, MD; Jef frey S. Borer,
MD , FACC : Richar d B. Devereux , MD , FACC ; Thomas Pi cker-
ing, MD ; Jef frey Fisher, MD; Gregory Harsh field, PhD;
Betty Yan ; John H. Laragh, MD , FACC, Cornell Medical
Cent er , New York , NY.
Left ventr i cular (LV) functi onal reserve (ej ection
f rac t i on [EF] response to exercise [AEFRest-ex]) is sub-
normal in many pts with essential hypertens ion (EH) . To
asses s t he pat hophysiol ogi c impl i cations of this f i ndi ng ,
we used rad ionuclide cineangiography (RNCA) and echocar-
di ograph y (ECHO) to assess LV size and funct i on in 54 EH
pts wi t hout i schemi c or congest ive symptoms . In 38/ 54
pts funct i onal r eserve was normal ( n l :~F~5% , with exer-
cise EF~54% ) ; funct io nal reserve was subnl in 16 pt s .
Gr oups were simil a r in age (47 vs 51 yrs , NS), dur at ion
of hypertens ion {10 vs 6 yr s . NS\ arter ial pressure
(157/l04 vs 164/103, NS), rest EF (58% vs 56%, NS), and
end sys t ol i c LV wall stress (66 vs 70xl03 dynes/cm2, NS).
However , the subnl gr oup had greater LV mass (M) (182 vs
225 gm , p( .Ol) and LV end diastol i c voume (EDV, 118 vs
148 ml , p<.05) . There was a modes t inverse relat io n be-
tween EF and LVM (r=- . 45, p<.OOl) which was s t r ongest
in the subnl gr oup (r=- . 59 , p<.Ol ), and a weak inv erse
relation be tween EF and LVEDV (r =- .2 9 , p<. 05) . Thus,
in EH, (l) a s t r ong as socia t i on exist s between LV hyper-
t r ophy and LV systolic dysfunction with exercise stress;
(2) this relation is independent of severity or duration
of EH; th erefore, (3) hypertrophied myocardium in EH
f unct i onally may be i ntr i nsical ly subnormal.
592 lACC Vol. 3. No.2
February 1984:592
ABSTRACTS
To inve.tig.te left ventricul.r function
.eri,lly in rat. vitb .pontaneou. hyperten.ion(SUR), left ventricul.r ejec~ioD fr.ction(LVEl) .nd region.l vall aot~on vere me••ured
by g.ted blood pool .c.n. Fifteen SHR vere
.tudied montbly co••encing .t 6 veek. of .ge(ae.n BP l15~8) .nd folloved up to 38 veek. of
age. Arterial blood pre ••ure va. a,ain
aea.ured at 14 veek' 1 and .11 .niaa • badbyperten.ion (.ean By l60~6asRg).
IMPAIRED INOTROPIC RESPONSE OF THE LEFT VENTRICLE TO
GLUCAGON IN RENAL HYPERTENSIVE RATS
K. Shimamatsu, MOi F. Fouad, MD, FACC; R. C. Tarazi, MD.
FAcc, Research Division. Cleveland Clinic Foundation,
Cleveland, Ohio
Previous studies have shown that left ventricular
hypertrophy (LVH) in renal hypertensive rats (RHR) was
associated with reduced responsiveness to a-adrenergic
stimulation (isoproterenol) but not to calcium or car-
diac glycosides. In order to determine whether this
impairment was restricted to a-receptor agonists or
extended to include other stimulants of the adenylate
cyclase system, inotropic responsiveness to glucagon was
determined in isolated paced hearts (Langendorff prepar-
ation) from 13 RHR and 13 matched sham-operated con-
trols. The studies were performed at 2 levels of
perfusion pressure (PP 50 and 80 mmHg). At both levels.
the LV dP/dt response was significantly lower in RHR
Whether expressed in absolute values or in %of baseline
both by ANOVA an21for maximum dP/dt response (+374 !
103(SE) mmHg.sec vs +1026 ! 166, p <0.005, and
+120% ! S vs +143% !17, p <0.02, for PP SO mmHg, and
+392 ! 154 mmHg.sec vs +1732 ! 251, p <0.01, and
+112% ! 4 vs +160% ! 2, p <0.001 for PP 80 mmHg).
Since glucagon acts through its own receptor, the
results indicate that the impa irment in inotropic
responsiveness associated with LVH in RHR is not exclu-
sively dependent on a a-receptor abnormality but extends
to different agonists of the adenyl ate cyclase system.
Moreover, the impaired response was not dependent on
differences in myocardial flow rate between hypertro-
phied and normal ventriCles.
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Experimental Myocardial Infarction: Expansion of
Infarct Size
INFLUENCE OF HIGH O2 DEMANDS OF DYSKINETIC SEGMENTS ONRECOVERY DURING REPERFUSION
Bradley S. Allen, M.D., Eliot R. Rosenkranz, M.D., Gerald
D. Buckberg, M. D., Jakob Vi nten-Johansen, Ph. D., Fumiyuk i
Okamoto, M.D., and Jerry Leaf. M.S. UCLA, Dept of Surgery
Los Angeles, CA 90024
Hypothesis: Recovery of post-ischemic contractile func-
tion can be enhanced by lowering the 02 demands using
cardiopulmonary bypass to decompress the heart.
Methods : Regional myocardial O2 demands were measured in
the beating working segment, the dyskinetic segment (made
dyskinetic by regional cardioplegia via the LAD artery
without bypass) and the arrested segment on bypass. After
2 hours of LAD ligation, five dogs were reperfused in the
beating working state and 6 others were reperfused in the
beating empty state on bypass . Segmental shortening (S5)
was 'measured with ultrasonic cryst al s.
Results: O2 demand of the dyskinetic, cardioplegia per-fused segment was 65%(4-8 cc ' s/ lOOgm/min) of the con-
tracting beating working segment (7-12 cc's/lOOgm/min)
compared to only 0.8-1.2 cc's/lOOgm/min for the arrested,
perfused segment on bypass. Ischemia produced severe
dyskinesis (-24%control SS). Reperfusion in the workinq
ventricle failed to restore contractile function (-27 + .
4%con~ro l 55). In contrast, lowering 02 demands by re-
perfuslon on bypass restored cont ract i le function in 4
of 6 hearts (15 + 13%control 5S).
Conclusion : Failure to recover function with postischemic
reperfus10n may not only be secondary to the reperfusate
as has been thought, but also to . the conditions of reper-
fusion. This is demonstrated by the previously unappre-
ciated high 02 demands of the dyskinetic segment. There-
fore mechanical reduction of 02 demands may be necessary
if return of function is to be expected with reperfusion
of a post-ischemic insult.
38
57
8
86
31
53
5
100
23 27
63 58
7 3
64 100
19
64
10
55
15
67
7
20
11
69
9
15
6
73
7
o
~~%) me.n
SD
%popul.tion
of Apical
HypoTtineaia
The data vere evaluated by tbe veigbted
polynosinal refre •• ion analy.i. and .imple
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r
i g9 i f i ca n t ~rop ~n LVEr vitb inFrea.i9g a.e
Er(t) = 81 +4.3) - 1.225 (+4.2) z t (veet.).
Slope p<O.O ~l. r=O.95)]. Tn addition.
apical hYPokineIi. beca.e more prevalent vitb
increa'in. age % population of ,pi~al
bypokine.l. = - 7.3+3.4 t (ve.k.). (r=O.92)].
Thl. deterioration in refional function va'
al.o reflected in dilata ion of the LV and
.ild global hIPokine,i. in tbe la.t 3 Itudie ••
In .u.mary, ( ) In pr,-byperten.ive .t.ge.
LVEr va. h~.b nor.al (nor•• l LVEr in
Wi.tar-Kyoto rat.l 67~7Z) .nd ••all -tight- LV
~avity va' ob.erved; \2} With ti.e(byperten.ion develop.) LVEr d,teriorared vith
.pp,aran~. of ,Pic'l bypokine.l. and • Id LV
callt dl1atatlon; 3} After 7 veek•••11
anlaaI. deaon.trate LV functIonal abnor.ality
altbongb LVEr va. veil .aintained.
ECHOCARDIOGRAPHIC-CLINICAL CORRELATION OF HEART FAILURE IN
HYPERTENSION
Thomas E. Ratts, 11.0.; Brent Addington, M.D.; Paul Gerlach
/1. 0. ; Linda Conway; Jay /1. Sullivan, /1.0., University of
Tennessee Center for Health Sciences, t~mphis. Tennessee
LV function was assessed by 20 and f1-mode echocardiograms
in S6 patients with long standing hypertension and recent-
onset heart failure. Patients were divided into two groups
based on fractional shortening : normal or exaggerated
shorteni ng >2S%(NLSH). and decreased shorteni ng < 2S%
(DSH). The majority had normal shortening (61%vs 39%). In
~LSH. endsystolic dimensions were smaller (ISiS mm/m2)
than DSH (28t7 mm/m2) p<.aol and relative wall thickness
was greater (.44t.OS) vs (.14t .07) p<.OQl . Differences in
LA size were minor (47±6 mm) vs (SOtS mm) p<.OS.
The patients ' records were i ndependent ly analyzed and
comparisons made between the 9roups . In NLSH, an 54 was
present in 2D (S9%) p<.OS, a systolic ejection murmur in
18 (S4%) p<.OS and renal disease with serum creatinines
between 2-3 mg/dl in 20 (S9%) p<.OS. In DSH, there were
other complicating diseases in 79%(p<.al) with diabetes
in 10 (4S%). alcoholism in 6 (27%). previous myocardial
infarction in 6 (27%) and left bundle branch block in S
(22%) 0<.01. No significant differences were found between
the 2 groups regarding presence of angina pectoris. dura-
tion of hypertension, range of BP, presence of 53' ECG or
radiographic abnormalities.
We conclude that patients with heart failure and hyper-
tension : I) can be classified into 2 functional groups
with important therapeutic implications, 2) the majority
have normal shortening with probable diastolic dysfunction
often complicated by volume overload, 3) the minority
have decreased shortening and a high prevalence of other
diseases .to account for their systolic dysfunction and 4)
usual cllnical parameters do not easily discriminate be-
tween the groups.
NATURAL HISTORY OF LEFT VENTRICULAR FUNCTION
IN SPONTANEOUSLY HYPERTENSIVE RATS.
T.unehiro Y••ud•• KD; Rich.rd A. Wil.on. MD;
R.nd.ll Zu•••n. MD. FACC; Kennetb A. McKu.ick.
MD; H. Willi•• Str.uI •• MD. lACC.
M•••• cbu.ett. Gener.l Ho.pit.l. Bo.ton. MA.
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Thaae dete suggeat that evan if institutian of
PLA-fA ia delayed for aa long aa 4 hrs after the
oneat of LV ischeaie, PLA-FA etill offere
aignificant protaction froa expanaion of ayocardial
infarct aize. The reeulta eaphaaiza the potential
clinical benefita of LV unloading even after the
occurrence of relatively long perioda of ayocardial
iecheaie •
PULSATILE LEFT ATRIAL-FEMORAL ARTERY BYPASS LIMITS
MYOCARDIAL INFARCT EXPANSION EVEN AfTER PROLONGED
ISCHEMIA
E.A. Graeei, M.D., K.H. Krieger, M.O., J.N.
Cunnlnghea, jr, M.O., H.R. lIeiee, H.D., I.M. Nathan,
Ph.D., J.C. Laechinger, H.D., C.E. Hunter, M.D.,
F.C. Spencer, H.O., New Yark Univ. Medicel Center,
New Yark, N.Y.
Previaue wark hae ehown thet if pulsatile left
atrial-feaorsl artery bypaes (PLA-FA) ie inetituted
sfter periads af LAO ligation ranging fro. 15 .in to
2 hrs, PLA-FA csn eignificantly li.it the eize af
the infarct reeuiting 4 hre later. The preeent etudy
inveetigated whether PLA-FA begun after .ore
clinicaliy pertinent initial ieche.ic tiae periode
can atill pravide eignificent li.itation af infarct
expaneion. Following baaeline aeasureaente of
heaodyna.ice, preeeure-ti.e index, and regional
ayocardial blood flow in 11 open cheet, adult dogs,
the LAO wae ligated. The control group (n:5) waa
eubjected to 8 hrs of ieche.is and aonitoring
without further intervention. The experiaental group
(n=6) waa aonitored during 4 hrs af ische.ia and
then placed on PLA-FA for an additionsl 4 hre. At
the end of 8 hre, all dogs had gentian violet
injected into the circulation and were eacrificed.
Slicaa of the left ventricle (LV) were planiaetered
ta aeeaure total LV area, the gentian violet
delineated area at risk (AR), and the
triphenyltetrazoliua chloride de.arcated area of
infarct (AI). The reeulta are eua.arized below:
INFARCT EXPANSION AND THE PERICARDIUM
David E. Bush, MD; Judith S. Hochman, MD; Harlan F.
Weisman, MD; Bernadine Healy Bulkley, MD, FACC, The Johns
Hopkins Medical Institutions, Baltimore, Md.
Why expansion, regional dilatation and thinning after
transmural MI occurs in some hearts, but not all, is un-
known. One potential variable is pericardium which as an
external restraint may limit expansion. We studied the
effect of both parietal (outer) and visceral (inner adher-
ent) pericardium on infarction expansion in 2 animal mod-
els. We produced infarction by LAD coronary ligation in
New Zealand rabbits with and without parietal pericardiec-
tomy. At 21 days, hearts were arrested in diastole,
transverse histologic sections prepared, and the presence
of epicarditis (a proliferation of inner visceral pericar-
dium occurring variably in this model) assessed. Of the
31 animals who survived, 21 had transmural MIs, of which
10 had had pericardiectomies. There were no differences
in size of infarcts between the two groups, and no differ-
ence in the frequency or severity of expansion with and
without intact parietal pericardia (6/10 vs 8/11, p=NS).
Diffuse visceral pericarditis or epicarditis over the in-
farct was present in 7 (30%) animals, 3 with intact pari-
etal pericardium and 4 without. Of these, only 2 (29%)
had expansion, compared to 12 of 14 (86%) animals without
epicarditis (p = .01). We also looked at 12 rat hearts
with infarcts prepared with open pericardium but develop-
ing spontaneous purulent visceral pericarditis, and com-
pared them to 20 age, infarct size matched controls.
Again, infarct expansion was significantly less in hearts
with purulent epicarditis (7/12 vs 19/20, p < .01).
Thus, normal parietal pericardium does not appear to limit
expansion. When the visceral pericardium becomes inflamed,
however, and densely attaches to myocardium, infarct ex-
pansion appears to diminish.
ARILV (~)
AllAR (~)
p< .nm )
Control
25.1+2.6
85.5:t4.6
lli.::I!
JJ. J+2. 8·
J7.4.6.9··(. = p).05; •• =
EARLY INFARCT EXPANSION: STRUCTURAL OR FUNCTIONAL?
Jay A. Erlebacher, MD, Richard C. Richter, MD; Daniel R.
Alonso, MD; Richard B. Devereux, MD; William A. Gay, Jr.,
MD, FACC, Cornell University Medical College, New York,
New York.
The end diastolic length (EDL) of myocardial segments
increases rapidly with the onset of ischemia, but this
early expansion has been said to be functional because
it is absent or minimal in post-mortem specimens. To
study this, we produced myocardial infarction in 5 dogs
by LAD coronary occlusion and measured segment length in
the midischemic (IZ) and normal zones (NZ) using sono-
micrometers. After IV KCl arrest at 3 hours, biopsies
were taken from the IZ and NZ. Sarcomere length was
measured from electron micrographs and myofiber width
from light photomicrographs. At 3 hours of ischemia, IZ
EDL had increased significantly more than NZ EDL (117±S.8
(SE)% vs 102.8±1.9% of control EDL, p<.OS), while 2
minutes after KCl arrest, both IZ and NZ returned to pre-
ischemic length (99.8±2.6 and 97.2±1.O%), suggesting a
functional IZ abnormality. However, IZ myofibers were
significantly thinner than NZ myofibers (7.9±.12~ vs
9.42±.14~, p<.OOl), and IZ sarcomere lengths were
significantly longer than those in the NZ (1.89±.lO~ vs
1.5l±.03~, p<.005). Buckling or waviness of myofibers
was seen in all IZ, but in none of the NZ. These data
suggest that systolic stretching of IZ segments during
ischemia results in sarcomere stretching, myofiber
thinning and diastolic segment lengthening. The apparent
normalization of IZ segment length seen post-mortem is
due to viscoelastic retraction which causes buckling of
abnormally stretched and thinned myofibers. Tfiusj infarct
expansion at 3 hours cannot be considered to be merely
functional.
FAVORABLE EFFECTS OF AN INCREASE IN ARTERIAL PRESSURE ON
COLLATERAL BLOOD FLOW AND INFARCT SIZE IN DOGS.
Ewa ksiezycka, MD; Peter R. Maroko, MD, FACC, Deborah
Cardiovascular Research Institute, Browns Mills, NJ.
The effects of elevating AO pressure on collateral blood
flow and infarct size remains controversial. Thus, 28
dogs were randomized either to control or treated
(6 h infusion of phenylephrine sufficient to maintain
mean AO pressure of 180t3 mmHg) groups, 7 min after cor-
onary artery occlusion (CAO). To determine the transmural
regional ~yocardial blood flow (TRMBF), 2x106 micro-
spheres (7-10~ in diameter) labelled with 85Sr or l~lCe
were injected into the LA,S min and 1 h after CAO. To
determine the extent of hypoperfused zone (HZ), 99mTc_
labelled microspheres were injected into the LA. After
6 h all dogs were sacrificed and LV slices were planim-
etered for necrosis using triphenyltetrazolium stain and
for HZ using autoradiography. Heart rate, mean AO pres-
sure and CO did not change in controls, but in treated
dogs fell from 135t4 to 116t6 beats/min (p<.02) rose from
95t4 to 180t3 mmHg (p<.OOl) and fell from 3.8tO.4 to 2.9t
t.2 l/min (p<.025), respectively. In controls, TRMBF
(ml/min/100g) was unchanged in the normal [136t15 vs
110t8 (NS)], border [22t4 vs 19t3 (NS)] and ischemic
[11t2 vs 12t3 (NS)] zones. In contrast, in treated dogs,
TRMBF increased in the normal zone (as expected) from
142t9 to 292t25 (p<.OOl). Most importantly, it augmented
in the ischemic [22t3 to 51t11 (p<.Ol)] and in the border
[38t4 to 90t13 (p<.OOl)] zones. The percent of HZ that
evolved to necrosis was 85t4~ in controls, but only 58t2
in treated dogs (p<.OOl). Thus, the induction of severe
hypertension markedly increased the collateral blood
flow to the border and ischemic zones of the ~ocardium
after CAO and therefore reduced ~ocardial necrosis by
3ZS, showing that 02 balance is affected favorably by
increased flow which overrides increased afterload.
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TTC STAINING TECHNIQUE DOES NOT PREDICT ~YOCARDIAL
NECROSIS
R. JameSkBarnard, Ph.D., Gerald D. BuckberQ, H.D., Eliot
R. Rosen ranz, M.D., Jakob Vinten-Johansen, Ph.D.,
Fumiyuki Okamoto, M.D., Bradley S. Allen, M.D., and
Helen I. Bugyi, Ph.D. University of California at Los
Angeles, Department of Surgery, Los Angeles, CA 90024
INCREASED FREQUENCY OF HLA DR4 AND B27 IN IDIOPATHIC DI-
LATED CARDIOMYOPATHY: EVIDENCE FOR IMMUNE RESPONSE FAC-
TORS
Jeffrei L. Anderson. MD, FACC; John F. Carlquist, PhD.;
Joan • Lutz. RN; Charles W. DeWitt, MD; Elizabeth H.
Hammond, MD, LOS Hospital, University of Utah, Salt Lake
City, Utah.
These results show that the TTC staining method does not
predict myocardial necrosis and that appropriate reper-
fusion following 2 hours of ischemia will result in re-
covery of myocardial shorteninQ despite transmural non-
staining.
Several autoimmune diseases have been associated with
specifi c histocompati bllity (HLA) anti gens whi ch may be
linked to immune response genes. Idiopathic dilated car-
diomyopathy (IDCM) has been proposed to have autoimmune
features, but HLA associations have not been established.
We performed HLA typing in 37 patients (pts) with IDCM.
HLA A and 8 haplotype frequency in pts was compared with
that among 5,726 local controls. B27 haplotype frequency
was 0.145 in pts versus 0.033 in controls (p<.OOI).
Also, 9 (2~) of 31 pts were 827 positive versus 1 (3~)
of 35 concurrent blood bank controls (p<.02). Relative
risk of B27 is thus 13.9 and etiologic fraction 0.27.
HLA DR typing also revealed differences. OR4 was present
in 54~ (19/35) of pts versus 32~ (26/82) of blood bank
controls (p<.02). Relative risk of DR4 is thus 2.2 and
etiologic fraction 0.29. 68~ of pts were positive for
DR4 and/or 827; the summed et i 01ogic fract ion is thus
0.56. HLA DR6Y was underrepresented, being present in ~
(3/35) of pts versus 26~ (21/82) of controls (p<.04). A
distinct clinical profile was not associated with partic-
ular HLA types. 827 is also associated with ankylosing
spondylitis and DR4 with rlleumatoid arthritis and juve-
nile diabetes, other diseases of postulated autoimmune or
virus-immune etiology. DR6Y is associated with a compe-
tent immune response and reject ion of forei gn anti gens
(i.e., transplanted organs). Although these associations
will require independent confirmation, they suggest that
immune response factors may playa role in IDCM in cer-
tain pts.
Non-Staining Pattern
Transmural Subendo Patchy
11 12 3
3 10 2
Shortening
Bulging
Triphenyl tetrazolium chloride (TTC) has been used to
detect irreversibly damaged tissue after regional ische-
mia and reperfusion. We have used this staining techni-
que in our studies of myocardial ischemia and reperfusion
and found that transmural TTC non-staining is not an
accurate predictor of myocardial necrosis: functional re-
covery occurs despite non-staining. Mongrel dogs (n=4l)
were anesthetized and made ischemic via ligation of the
LAD coronary artery. Regional myocardial function was
assessed by using ultrasonic crystals. Following 2 hours
of ischemia the ligature was removed and the hearts re-
perfused for 2 hours under a variety of conditions. The
hearts were then removed and incubated in TTC at 370C for
20-40 min. The pattern of non-stainin9 varied and did
not correlate with regional contraction following 2 hours
of reperfusion.
Regional Function
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VENTRICULAR TACHYCARDIA IN DILATED CARDIOMYOPATHY: A
VARIABLE INDEPENDENT OF HEMODYNAMICS. MORPHOLOGY, AND
PROGNOSIS
Maria Rosa Costanzo-Nordin. MD: John B. O'Connell. MD.
FACC: Richard S. Engelmeier, MD: John F. Moran, MD, FACe:
Patrick J. Scanlon, MD, FACC, Loyola University ~ledical
Center, Maywood, II.
Fifty-five patients (P) with dilated cardiomyopathy under-
went cardiac catheterization. endomyocardial biopsy, 24
hour ambulatory monitoring, echocardiography, and radio-
nuclide ventriculography. 28 P had treadmill exercise
testing. Ventricular arrhythmia was quantified and
related to the above parameters. Frequent (>30/hr)
premature ventricular beats (PVBs) were noted in 42 P
(76%): complex PVBs (multifocal, salvos, R on I) in 35 P
(64%) and unifocal PVBs in 7 P (13%). 272 episodes of
nonsustained ventricular tachycardia (VT) were seen in 22
P (5 episodes/Pl. In 16 P, the VT rate was >150 beats/
min. All P with VT had multifocal PVBs. All P with
multifocal PVBs and R on Thad VT. No difference in
functional status, ECG, supraventricular arrhythmia. CI,
pulmonary capillary wedge pressure, ejection fraction and
LV dimensions was noted between VT and non VT P. Clinical
or hemodynamic deterioration did not correlate with VT.
Severity of morphologic abnormalities on biopsy was
similar in VT and non VT P. Ventricular arrhythmia
improved during exercise testing in 8/12 VT P. Follow-up
monitoring in 16 P showed no VT in 5/6 VT P and 6/10 with-
out initial VI. Follow-up VT was independent of anti-
arrhythmic therapy. 9 P died: 4 had VT, 5 did not.
Conclusions: (I) P with cardiomyopathy commonly have
nonsustained VT, which is unrelated to hemodynamics,
morphology, and prognosis. (2) Ventricular arrhythmia
may improve with exercise in these P. (3) This VT is
episodic and may not be detected on a single 24 hour ECG.
ALCOHOLIC HEART MUSCLE DISEASE - ALCOHOL INTAKE,
MYOCARDIAL FUNCTION AND TISSUE ENZYME ACTIVITIES
IN DILATED CARDIOMYOPATHY
Peter J. Richardson, MRCP; Alex Wodak, FRACP; Lynne
Atkinson, BSc; John Saunders, MRCP; David E. Jewitt,
FRCP. Cardiac Department, King's College Hospital,
London, England.
The association of dilated cardiomyopathy and excess
alcohol intake is recognised although a causal
relationship remains controversial. No quantitative
studies relate myocardial damage to alcohol consumption
as exist for liver disease. Detailed drinking
histories were taken in 38 patients, 36 males and 2
females, with dilated cardiomyopathy diagnosed by
cardiac catheterisation and left ventricular myocardial
biopsy. Myocardial tissue enzyme activities (MEA) of
creatine kinase (CK) , malic dehydrogenase (MDH) ,
a-hydroxybutyric dehydrogenase (a-HBD) and lactic
dehydrogenase (LOH) were assayed. Cumulative lifetime
alcohol intake (CLAI) was bimodally distributed with
clear separation of light (CLAI <2S0kg) and heavy
drinkers (CLAI >2S0kg) .Significant differences in MEA
were found between these two groups. LDH (1674 ± 129
and 2719 ± 225mu/mg protein, p<O.OOI), CK, a-HBD, MDH
were similarly significant. Multiple regression
analysis showed significant correlations between MEA
and both CLAI (for CK r=O.69 p<O.OS) and ejection
fraction (for CK r=O.58 p<O.OI), independent of blood
pressure. The finding of a strong correlation between
alcohol consumption, left ventricular function and MEA
in myocardial biopsy samples from patients with dilated
cardiomyopathy lends support to the concept of
alcoholic heart muscle disease.
ABSTRACTS lACC Vol. 3. No, 2
February 1984:595
595
nl
CM1
INCIDENCE OF FUNCTIONAL MITRAL AND TRICUSPID REGURGITATION
IN DILATED CARDIOMYOPATHY: ASSESSMENT BY 2D-DOPPLER AND
CONTRAST ECHOCARDIOGRAPHY
John S. Gottdiener, MD, FACC; D. Joshua Cutler, MD, FACC;
Andrew I. Cohen, MD,FACC; Theodore A. Monitz, MD; Ross D.
Fletcher, MD, FACC; Veterans Administration and Georgetown
Medical Centers, Washington, D.C.
While functional mitral (MR) and tricuspid regurgitation
(TR) have been noted in pts with dilated cardiomyopathy
their incidence and physiologic significance are unknown.
Therefore, we studied 26 pts (av age 58tlO SD yrs) usin3
phased-array 2D pulsed Doppler with a steerable sample
volume to determine the frequency and severity of MR, and
2D-Doppler with contrast echo to evaluate TR. Severity of
MR and TR was estimated by 2D-Doppler from the analog flow
velocity integral, spectral broadening, and distribution
of systolic flow reversal in the LA and RA respectively.
MR was detected in 10/26 (38%) pts, none of whom had
structural mitral valve abnormality on 2D-echo, and was
'mild' in 6 pts and 'moderate' in 4 pts. LV end-diastolic
volume was greater (p<0.05) in pts with MR (249±22 SD ml)
than pts without MR (202124 ml).
TR was detected in 18/26 (69%) pts on 2D-Doppler and was
'severe' in 5/18 pts, 'moderate' in 8/18 pts, and 'mild'
in 5/18 pts. LV ejection fraction was worse in pts with TR
(3015%) than pts without TR (4015%, p<.Ol). Careful pros-
pective bedside evaluation failed to detect TR in 10/18
pts (56%) and MR in 3/10 (30%) pts.
Hence, 1) functional MR (38%) and TR (69%) are more
common in dilated cardiomyopathy than previously recog-
nized, but TR is often not detectable by physical exam, 2)
MR is associated with the extent of LV dilatation, and 3)
the presence of TR is related to the extent of LV dysfunc-
tion.
CORONARY RESERVE IN PATIENTS WITH NON OBSTRUCTIVE CARDIO-
MYOPATHY.
Jean-Marc Foult, MD; Alain Nitenberg, MD; Marie-France
Huyghebaert, MD. CHU Xavier-Bichat, Paris, France.
Coronary reactive hyperemia (HPR) was performed in 8 nor-
mal subjects (nl) and in 12 untreated patients (pts) with
normal coronary arteries (CA) and non obstructive cardio-
myopathy (CN) proven by LV endomyocardial biopsy. HPR was
elicited by selective injection of 8 ml contrast medium
into the left CA, while coronary sinus blood flow (CSBF)
was continuously recorded. Control CSBF (CSBFc), volume
of HPR (Q), and peak CSBF (CSBFp) were measured. Quanti-
fication of HPR relative intensity was made by Q/CSBFc
and CSBFp/CSBFc ratios. Patients were separated in 2
groups: CMl with LV mass<90g.m-2(75 ± 12g.m-2 , n ~ 7),
CM2 with LV mass3'90g.m-2 (102 ± 8g.m- 2 ,n 5). LV mass
in 8 nl was 70 ± 16g.m-2 .Results:
CSBFc CSBFp CSBFp/CSBFc Q/CSBFc
,r;99 :: 17 180:!: 35 r 1. 82 :!: 0.21 rO.15 :!: 0.03
~67 ± 16 148 ± 32 'L2.27 ± 0.61" 0.22 ± 0.09,
CM2 't'33 ± 39 199 ± 50 1.51 ± 0.131Lo.10 ± 0.021
CSBF in ml/min/100gLV. ,pc:O.05 "pc:O.Ol
Conclusion: in CM1, CSBFc was low, but CSBFp was normal.
In CM2, HPR relative intensity is blunted when compared
to CM1 an nl. These data suggest the presence of a rever-
sible impairmentof the coronary resistance circulation in
CM with normal LV mass, and evidence a decreased coronary
reserve in those with increased LV mass. Coronary arte-
riolar functional impairment noticed in early stage CM
might progress to an irreversible damage limiting corona-
ry reserve in severe CM.
PROGNOSIS IN DILATED CARDIOMYOPATHY
Donald V. Unverferth. MD. FACC; Raymond D. Magorien. MD.
FAtt; Melvin L. Moeschberger. phD; Carl V. Leier. MD,
FACC. Ohio State University. Columbus. OH.
This study was designed to determine prognostic risk indi-
cators of non-ischemic dilated cardiomyopathy (DC).
Seventy-seven patients were studied; each had a history
and physical examination. electrocardiogram, echo-
cardiogram. catheterization, 24 hour monitoring and endo-
myocardial biopsy. Mortality at one year was 34~ (26
deaths). Univariate analysis revealed that the most
powerful predictor of prognosis was the pulmonary capil-
lary wedge pressure (PCWP). The higher the PCWP the
greater the mortality (p<0.OD5). The presence of a left
intraventricular conduction delay was also predictive of
mortality (p< 0.005). Other significant factors in order
of importance included the echocardiographic ~t\D (p<
0.01). ventricular arrhythmias (p< 0.05), angiographic e-jection fraction (p<0.05) and the presence of an S3 gallop
(p <0.05). Factors such as duration of symptoms, presence
of mitral regurgitation. atrial arrhythmias, end diastolic
diameter. myocardial cell size and ~ fibrosis in the
biopsy and treatment with vasodilators. antiarrhythmics
and anticoagulants were not significant predictors. Logi-
stic regression analysis was used to determine which com-
bination of factors could most accurately predict survival
and death. The most important factors were PCWP. ventric-
ular arrhythmias and a past history of hypertension. This
combination accurately predicted survival in 91~ and accu-
rately predicted mortality in 54~. The addition of the
echocardiographic ~~ D. the next most important factor.
did not improve predictive ability. Thus. a thorough
evaluation of DC patients can produce a clinical profile
for prognostication'and for treatment including decisions.
regarding transplantation.
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OPTIMIZATION OF MYOCARDIAL AND CEREBRAL FLOW DURING
CARDIOPULMONARY RESUSCITATION
Henry R. Halperin, M.D.; Joshua E. Tsitlik, Ph.D.; Alan
Guerci, M.D.; Nisha Chandra, M.D.; Myron L. Weisfeldt,
M.D., FACC; Johns Hopkins Hospital, Baltimore, Md.
Optimization of vi tal organ flow is the goal of
cardiopulmonary resuscitation (CPR). However, the
instability of CPR preparations makes it difficult to
study the large number of different combinations of
rate, peak sternal force, and compression duration
needed for optimization • We developed and validated a 12
compartment cardiovascular model to simulate and optimize
flow for these interventions. We compared the model's
predictions with hemodynamic data from manual chest
compression in 11 21-32kg dogs. There was no surgical
manipulation of the chest. The model correctly predicts
ra te insensi tivi ty for blood flow by intra thoracic
pressure manipulation. In dogs, with a rate increase from
60 to 150/min there was no change in cerebral [mean !
S.E.] (16.7 ! 4.8 vs 13.8 ~ 3.5 ml/100g-min, nK11, p
N.S.) or myocardial (27.9 1: 7.1 vs 27.4 1: 7.7 ml/l00g-
min, n-11, p N.S.) microsphere blood flows. In contrast
to rate insensitivity, the lIodel predicts marked
dependence of flow on peak force and compression
duration. In dogs, myocardial flow was strongly
correlated with mean aortic - right atrial pressure
gradient (r - .85, p < .001). This myocardial perfuBion
gradient was lower at low force (20kg) than at high force
(40kg) (4.8: 1.4 vs 18.4 1: 3.7 uHg, n - 11, p < .005).
Ths model predicts optimal lIyocardial flow at durations
of 22 to 42% of the cycle, but optimal cerebral flow at
40 to 60%. Optimal CPR occurs in the overlap of these
ranges. In dogs, floWB were best near this overlap
region (45.7 ! 3.5%). Thus, the lIodel accurately predicts
the hemodynamics of CPR, and gives an explicit basis for
rate independence, and peak force and compression
duration dependence of vital organ flow.
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HIGH-DOSE EPINEPHRINE DOES NOT IMPROVE THE
BALANCE BETWEEN MYOCARDIAL OXYGEN SUPPLY AND
DEMAND DURING CARDIOPULMONARY RESUSCITATION IN
DOGS R.V. Ditchey, MD, FACC, Univ. of Colo. Hlth, Sci. Ctr.,
Denver, CO
Although large doses of epinephrine increase coronary
perfusion pressure and blood flow during cardiopulmonary
resuscitation (CPR), epinephrine also increases myocardial
oxygen consumption. To test the hypothesis that epinephrine
improves the balance between myocardial oxygen supply and
demand during CPR, myocardial lactate and adenosine
triphosphate (ATP) concentrations were measured before and
immediately after 10 minutes of CPR in 7 control dogs and 8
dogs given intravenous epinephrine (I mg bolus followed by 0.2
mg/min). Left ventricular myocardial blood flow during CPR
was measured with radioactive microspheres and was
significantly higher in the epinephrine group (48.9.tI4.8 vs,
17.9±4.9 m!/min/100 gm, p< .05). However, myocardial lactate
increased nearly ten-fold after CPR in both groups (from .4:t.1 to
3.9±.5 nm/mg in the control group and from .7:t.2 to 5.9±.9 nm/mg
in the epinephrine group, both p <.00. Myocardial ATP tended to
be lower after CPR in both control and epinephrine groups,
although these changes were of borderline statistical
significance. The observed changes in myocardial ATP and
lactate concentrations after CPR were comparable in magnitude
in control and epinephrine dogs (p=NS between groups). These
data suggest that high dose epinephrine may fail to improve the
balance between myocardial oxygen supply and demand during
CPR, despite a substantial increase in coronary blood flow.
POSITIVE ANTINUCLEAR ANTIBODY TESTS IN PRIMARY PUUIONARY
HYPERTENSION
Bruce H. Brundage, riD, FACC; Stuart Rich, MD, FACC;
Bertron M. Groves, MD, FACC; Nancy A. Chiesa, ffiJ;
John D. Stobo, MD; David B. Hellman, University of
Illinois, Chicago, Illinois.
An increased incidence of positive antinuclear antibody
(ANA) tests has been reported in primary pulmonary hyper-
tension (PPH). To further evaluate this association, the
sera of 17 patients with PPH were tested for ANA; 12 were
also tested for antibody to double stranded DNA and 7 for
anticer~romere antibody. The ANA test was positive (+)
(titer >20) in 14 PPH patients (82%). The antibody
nuclea:i..-,.Iui.:.tern was diffuse in 7, speckeled in 6 and
peripheral in 1. Elevated anti-DNA antibody was observed
in only one patient and none had increa~ed anti centromere
antibodies. Only 2 patients were known to be taking
hydralazine prior to the ANA test. To determine if the
high incidence of ANA tests was a response to the
extensive pulmonary vascular damage in this disease, the
sera of 7 patients with a similar sex and age distribu-
tion and severe pulmonary vascular disease secondary to
congenital heart disease were tested. None had a + ANA
test (X2=lO.65, p<O.OOl). The results indicate that the
incidence of + ANA tests in PPH is much higher than
previously reported and the cause of the + test is
unlikely to be a response to the extensive pulmonary
vascular damage since the ANA is negative in congenital
heart disease patients with similar lung pathology.
QUANTITATIVE COMPARISON OF SEVERAL METHODS OF
EXTERNAL CARDIAC MASSAGE
Joseph R. Newton, BA; Donald D. Glower,MD; J. Alan Wolfe, BA;
George S. Tyson, MD; John A. Spratt, MD; J. Scott Rankin, MD
Duke University Medical Center, Durham, N.C.
Recent studies have provoked controversy regarding which
technique of external chest compression optimizes hemodyna-
mics during cardiopulmonary resuscitation (CPR). Eight dogs
were chronically instrumented with ascending and descending
aortic flow probes while matched micromanometers measured
mean diastolic aortic and left ventricular pressures. Coronary
perfusion pressure (CPP) was calculated as the difference be-
tween mean diastolic aortic and left ventricular pressures, and
bracheocephalic flow (BCF) was computed as total cardiac
output (CO) minus descending aortic flow. Control data were
recorded after morphine anesthesia and endotracheal intubation.
Ventricular fibrillation was induced electrically, and five CPR
methods were performed randomly in each preparation over a 10
minute period. CPR methods included high impulse manual
compression at ISO/min (HIC), mechanical compression with si-
multaneous ventilation at 60/min (MC), MC with either systolic
or diastolic abdominal compression (SAC or DAC), and pneuma-
tic vest compression at 60/min (V). By multivariate analysis CO,
BCF, and CPP were significantly better with HIC than with the
other techniques studied. Although results may vary with the
physiologic state or the experimental preparation, these data
suggest the HIC technique provides superior hemodynamic sup-
port in this animal model.
HIC MC SAC
CO (%controJ) 44 21 17
BCF (% control) 44 21 15
CPP (mmHg) 32 24 23
DAC
27
14
24
V
11
17
12
HEART-LUNG TRANSPLANTATION FOR PULMONARY VASCULAR
DISEASE; FOLLOW-UP HEMODYNAMIC DATA.
Keith D Dawkins MB, Sharon A Hunt MD FACC, Stuart W
Jamieson MB FACC, James Theodore MD, Philip E Oyer MD
FACC, Edward B Stinson MD FACC, Norman E Shumway MD
FACC. Stanford University School of Medicine, CA.
Over a two and a half year period 15 patients have
undergone combined heart-lung transplantation for
pulmonary vascular disease, caused by primary pulmonary
hypertension in 5 patients and Eisenmenger's syndrome
in 10. Mean age at the time of operation was 32.7
(range 22-45) years, with an early mortality of 26.7%
in 14 patients (one patient remains in hospital), and
no late mortality during the follow-up period of 145
patient/months. All survivors have a normal subjective
exerci se tolerance (NYHA I). Cardi ac catheteri zati on 1
year after operation in 4 patients revealed normal
hemodynamics apart from elevated systemic pressures
attributable to cyclosporine therapy (PA 14/2 m=8, PAW
m=3, LV 146/0/4, Ao 147/100 ~=117, PVR 0.7+0.3 units,
CO 4.0 l/min, CI 3.0 l/min/m ). Arterial blood gases
were also normal (On ai r: pH 7.41, pC02 40 mmHg, p02 87
mmHg, Satn 96.4%). Coronary arteriography was normal in
all patients. 2 patients were restudied 2 years after
operation with no significant change in hemodynamics.
Conclusions:
1. Heart-lung transplantation is an appropriate form of
treatment for severe pulmonary vascular disease.
2. Symptomatic improvement following operation is
excellent.
3. Hemodynamics and coronary arteriography were normal
in those patients studied 1 and 2 years after operation,
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Thus, in patients with I-MI, early measurements of EI
are predictive of subsequent QRS-SS estimated infarct
size, and could be used to select patients most or least
likely to benefit from size limiting interventions.
THE ABILITY OF INITIAL QUANTITATIVE EPICARDIAL INJURY TO
PREDICT INFARCT SIZE ESTIMATED BY QRS SCORE
Anne T. Corsa, MD, Nancy B. Hindman, BA, Robert M.
Califf, MD, Ray A. McKinnis, PhD, Galen S. Wagner, MD.
Duke University Medical Center, Durham, NC.
A quantitative 32 point QRS scoring system (QRS-SS)
has been validated by post mortem studies to estimate
size of single initial myocardial infarcts (I-MI): each
point ~3% of LV. The purpose of this study waa to
determine whether quantitative ST segment (STS) deviation
reflecting epicardial injury (EI) on standard 12 lead
ECGs early in the course of (I-MI) is predictive of
subsequent I-MI size.
The study group consisted of 146 consecutive patients
with I-MI whose initial EGG showed EI but no ventricular
hypertrophy or bundle branch block. Using the initial
ECG, STS elevation was measured in all leads but aVR;
depression was recorded in VI-V3' Anterior, inferior or
posterolateral groups were identified by location of
maximum EI. The QRS-SS was applied to the last EGG
before hospital discharge. Both number of leads with EI
and sum of the amplitude of EI were significantly related
to I-MI size as determined by the QRS-SS:
AUGMENTED NOREPINEPHRINE RESPONSE DURING EXERCISE IN
CARDIAC TRANSPLANT PATIENTS.
Dennis S. Reison, M.D., Joseph J. Marcella, M.D., An-
thony L. Pucillo, M.D., Lynne L. Johnson, M.D., Ronald
E. Drusin, M.D., Eric R. Powers, M.D., Paul J. Cannon,
M.D.,F.A.C.C. Columbis University, New York, N.Y.
Cardiac transplantation (CT) may result in an altered
sympathetic response to exercise. We studied the
changes in venous norepinephrine concentration (NE),
heart rate (HR), mean blood pressure (MBP) and double
product (DP) in 7 patients following CT and 10 normal
volunteers (N) during symptom limited upright bicycle
ex!~cise (E). DP was calculated as HR x systolic BP x
10 • NE was measured by radioenzymatic assay. At
rest NE (782+76 v 504+49 pg/ml) (mean+SEM), MBP (103+3
v 89+2 mmHg)~ HR (105+6 v 79+4 beats/min) and DP -
(13.4+1.0 v 9.4+0.5) were significantly greater in CT
patients than N~ (p<.Ol). At peak E HR was greater in
N than in CT patients (177+3 v 145+6) (p<.Ol) but NE,
BP, and DP were not signifIcantly different in the 2
groups. The change in DP during E was significantly
greater in N than in CT patients (21.5+1.3 v 12.2+1.6)
(p<.Ol) and was due to the difference In HR response
between the 2 groups (N: +92+4 v CT: +40+6) (p<.Ol).
The relationship between changes in DP and changes in
NE during E were different in the two groups. During
E increases in DP in CT patients were associated with
significantly greater increases in NE than in normals
(p<.Ol). We conclude that CT results in elevation of
HR, BP, and NE at rest. During E CT patients increase
HR less than normals. In CT patients increases in DP
during E are associated with a significantly greater
rise in NE than in normals. These data suggest that
CT results in an altered sympathetic response to exer-
cise.
Anterior (n ~ 45)
Inferior \n ~ 81)
Post/Lat (n ~ 20)
Total Group
II ST /',
p - 0.0001
P • 0.0001
p - 0.029
p - 0.0001
L ST/',
P - 0.015
P - 0.0001
P - 0.014
p - 0.0001
LATERAL Q Wl'.VES: PREDICTIVE VALUE FOR SITE OF LEFT
VENTRICULAR ASYNERGY AND EXTENT OF INFARCTION
Edward W. Bough, MD, FACC and William E. Boden, MD. The
Miriam Hoapital and Brown University, providence, RI.
Wednesday, March 28, 1984
2:0o-3:30PM Room 8411
Clinical Electrocardiography
In 300 selected patients (65 normal, 235 with ischem-
ic heart disease), non-parametric statistical methods
were used to calculate the index of predictive associa-
tion (A) between pathologic Q waves in standard ECG
lead groups (2-3-AVF, I-AVL, VI-2, V3-4, VS-6) and
asynergy in 9 left ventricular (LV) segments determined
by radionuclide ventriculography. Lateral Q waves rarely
occurred in isolation (l-AVL: 6/300, V5-6: 0/300) and
exhibited values of ~ too low to allow meaningful pre-
diction of asynergy in lateral LV segments. A Q in VS-6
had marginal value for predicting apical asynergy.
Despite their limited value in localizing LV asyn-
ergy, the presence (+) or absence (-) of lateral Q
wavea in patients with anterior (QVI-4) infarctions
(AMI) or inferior (Q2-3-AVP) infarctions (IMI) defined
subgroups with significantly lower mean Oft) LV ejection
fraction (EF):
LVEF (' 1Ii:t SEM)
INCREASED AVL VOLTAGE ON THE ELECTROCARDIOGRAM:
LACK OF CORRELATION WITH ECHOCARDIOGRAPHIC EVI-
DENCE OF LEFT VENTRICULAR HYPERTROPHY
William D. Knopf, MD; Betty J. Erb, MD; Michael Lipsitt, MD ;
Nanette K. Wenger, MD, FACC ; Joel M. Feiner, MD, FACC,
Emory University School of Medicine, Atlanta, GA
No single electrocardiographic (ECG) criterion is diagnostically
specific for left ventricular hypertrophy (LVH). An R wave in
lead aVL (RaVL) greater than 11 mm is reported to have low
sensitivity, but high specificity for LVH. 31 consecutive ECGs
from the ECG Reading Room at Grady Memorial Hospital had
an RaVL > 11 mm as the sole criterion for LVH. Mean RaVL
was 13.74 mm (range 1l.5 - 19.5). Mean QRS axis was -12.450
(range +230 to -40"). These 7 male and 24 female patients had
a mean age of 53.2 years (range 30-75). Mean body surface area
(BSA) was 1.81 m 2 (range 1.45 - 2.16). Each patient had measured
on echocardiogram (ECHO): ventricular septal thickness (VST),
posterior left ventricular wall thickness (PWT), and left ventricu-
lar internal diameter (LVID). Mean VST was 10.23 mm (range
8-16); mean PWT was 9.82 mm (range 8-15); mean LVID was
48.61 mm (range 36-57). Left ventricular mass (LVM) was calcu-
lated usin.g two formulas: (I) LVM= 1.04 (VST + PWT + LVID) ,
- (LVID)'J -14 gm. When LVM was indexed to BSA, mean LVMI=
113.74 gm/m 2 (range 80-184), 11/31 patients had LVMI > 125
grn/rn", evidence of LVH. (2) LVM= 1.05 (VST + PWT + LVID)'
- (LVID)') was plotted on a standard nomogram comparing LVM
to age and BSA. 6/31 patients had LVH by this method. Based
on ECHO measurements, RaVL > II mm as the sole ECG criterion
for LVH does not have high specificity for the diagnosis of LVH
when LVM is corrected for age and/or BSA.
(-)
38±2
Ql-AVL
(+)
30!4 ..
unpaired t test)
(+) (-)
26+3.... 39±2
44+2" 51+1
<.05,-....p <.Ol-by
AMI (n-36)
IMI (n-l04)
("p
These data provide mathematical confirmation that
lateral Q waves do not pr09ide sufficient predictive
localizing infor~ation to warrant the highly specific
~nclature ee-monly assigned them by electrocardio-
graph.ra. Lateral Q wavea do, however, identify
patients with ~re severely depressed LV function and
presumably ~re extensive ~ardial daaage.
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ANNIHILATION AND MODULATION OF SPONTANEOUS PARASYSTOLIC
RHYTHMS
Agustin Castellanos,MD,FACC; Federico Moleiro,MD; David
S. Kayden,MD;Richard M.Luceri,MD;Robert J.Myerburg,MD,
FACC, University of Miami, Miami, FL.
This study deals with the electrocardiographic findings
in 8 patients(pts) having ventricular parasystole in
whom the latter could be modulated by nonparasystolic
beats(NPB). None of the pts were taking any antiarrhyth-
Mic medication when parasystolic beats(PB) were first
detected. In all pts it was possible to measure directly
the intrinsic (nonmodulated) parasystolic cycle lengths
(PCL) given by the intervals between 2 consecutive PB
without any interposed NPB. The corresponding values
ranged between 1200 and 2350 msec (rates of 25-50/min).
In addition, the modulating effects could be determined
by observing the effects that single NPB interposed be-
tween 2 consecutive PB had on the PCL. In all pts, NPB
falling during the first half of the cycle prolonged(by
8-16%) the PCL while those appearing later in the cycle
shortened (by 9-23%) the PCL. Plotting this prolongation
or shortening as a function of the temporal position of
the NPB in the cycle yielded biphasic phase response
curves in which the maximal effects occurred close to the
middle of the cycle and were separated by a sharp rever-
sal point. Six pts had symmetrical phase response curves
and 2, asymmetrical curves. In 2 pts, NPB falling very
early in (at the initial 24-33% of) the cycle caused
parasystolic annihilation (cessation of parasystolic
activity). In conclusion, these findings: a) constitute
the clinical counterpart of the experimental studies of
Moe et ali and b) suggest that the annihilation (produc-
ed by very early NPB) of modulated parasystole is a
distinct phenomenon, different than the "extinction" or
"disappearance" (occurring after relatively late NPB)
of the so called intermittent parasystoles.
A FURTHER LOOK AT THE VALUE OF THE QRS WIDTH AND AXIS IN
DIAGNOSING THE ORIGIN OF A WIDE QRS-COMPLEX TACHYCARDIA.
Jeronimo Farre MD,Rosana Hernandez MD,Angel Grande MD and
Pedro Rabago MD.Fundacion Jimenez Dlaz,Madrid,Spain.
We have measured the width (w) and the axis (a) of the QRS in )52
con se cu t ive regu lar tachycardias (T)with a wide ventricular
(V)complexC;;)20 ms)documented in 92 patients(P)during anelec
trophysiologic study. There were 76 VT in 33P and 76 supraven--
tricu1ar T(SVT)in 59P. Wide QRS-comp1exes in SVTwere due to
aberrancy (ABE) (47/76,62%), preexist ing organic bundle branch
block(OBBB) (J5,2070)and A-V conduction over an accessory path-
way(AP) (14,18%) . T have been class if ied into RBBB and LBBB ac-
cording to their BBBconfiguration(CONF)in VI.The results are
shown in the table. We have used conventional definitions for
sensitivity(S),specificity(SP)and predictive value(PV). Only
CONF wQRS or aQRS VT ABE OBBB AP S SP PV VT had a wQRS>
RBBB w <0.15 sees 4'34-8-4--- 180ms(S24%,
RBBB w .::,0.15 sees 43 0 3 591% 85% 84% SP&PV 100%).
RBBB w 'ZO. 17 sees 22 34 9 9 By combining
RBBB w ;:,,0. 17 sees 25 0 2 0 53% 96% 93% the aQRS and
LBBB w <0. 15 sec s 12 )2 2 4 wQRS ,t he diag-
LBBB w ~0.15 sees 17 I 2 I 59% 82% 81% nostic value
LBBB w 'ZO. 17 sees 19 13 3 5 was enhanced
LBBB w ~O. 17 sees 10 0 I 0 34% 95% 91% in Twith RBBB
RBBB a .=)0°+-180° 38 5 6 2 81% 75% 75% CONF(left aQRS
RBBB 11 oo~ +180° 9 28 5 7 +wQRS.':,O. 15 s,
LBBB a -90°"'+90°* 13 0 0 0 45% 100%100% S 74%;SP 98% ,
LBBB a-75° ++75° 16 13 4 5 PV 97%). CON-
*from +900to ±1800and from -90 0to ±1800 CLUSIONS: In
wide QRS-complex T of P not on antiarrhythmic drugs ,a QRS width
>180 ms is diagnost ic of VT. A wQRS~1 70 ms is very spec ific and
strongly suggestive ofVT. A left aQRSC~-30°)favoursVTonly
in T with RBBB CONF and if OBBB and an AP are excluded. The combi
nat ion of a left aQRS and a wQRS ~150 ms in T wi th RBBB CONF sug-:'
gests VT. In Twith LBBB CONF an aQRS from +90'+ ±I80°& -900",± I80°
(right and opposite lis diagnostic of VT.
THE CARDIOlf'.lTEGRAM: DETECTION OF CORONARY
ARTERY DISEASE IN PATIEt'!TS I,A'ITH NORMAL RESTING
ELECTROCARDIOGRAMS
Louis E. TeichholCMD, FACC; Marilyn Y. Steinmetz, BS; DorisEscher, f}D, FAC ; Michael V. Herman, MD, FACC; Donald V.
flAahony, MD, FACC; Myrvin H. Ellestad, MD, FACC; & Shapur
Naimi, f/tD, F ACC. Mount Sinai, Montefiore, Westchester Cty,
St. Judes, Memorial, and New Eng Medical Centers, NY, t'IY,
Valhalla, NY, Fullerton and Long Beach, CA, and Boston, MA
The cardiointegram (CIG) computes and plots against each
other the first and second integrals of the voltage vs, time
format of 2 complexes of Leads I, II, \/4, V5, and V6 of the
resting electrocardiogram (EKG) using a Motorola 6809 based
microprocessor. This CrG is compared to previously determined
templates of normality for each lead. An abnormal CIG test is
defined as 4 or more abnormal complexes out of 10. To
determine the usefulness of the CIG in the detection of
coronary artery disease in patients with normal resting EKG's, a
multicenter study was performed in 186 patients with normal
EKG's undergoing coronary arteriography (CATH). There were
140 males & 46 females. Results for the 140 males:
CAD at CATH No CAD at CATH
Abnormal CIG 76 8
Normal CIG 28 28
Chi-square analysis showed this to be highly significant (p <
0.0000 I). The overall sensitivity was 73% (40-83% in individual
centers), overall specificity was 78% and accuracy was 74%.
Of interest, one false positive was diagnosed as cardiomyopathy
and another as mitral valve prolapse. In females, although the
sensitivity was high (82%), the specificity was low (24%), thus
the test appears not to be useful presently in females. In
conclusion, in males the CIG appears to be a useful, non-
invasive method for the detection of coronary artery disease in
patients with a normal resting EKG.
Wednesday, March 28, 1984
4:00-5:15PM Room 8411
Cardiac Catheterization Techniques-
Miscellaneous Topics
NON-IONIC CONTRAST AGENTS DO NOT INDUCE
BIOCHEMICAL ISCHEMIA DURING CARDIAC ANGIOGRAPHY
Judith A. Wisneski, MD, FACC; Edward W. Gertz, MD, FACC;
Richard Neese, PhD; University of California & Veterans
Administration Medical Center, San Francisco,CA
An abnormal myocardial lactate response suggestive of
cellular ischemia occurs after standard ionic contrast
angiography. These lactate abnormalities persist longer than the
well-documented hemodynamic and ECG changes. To determine
if the lactate abnormality is due to cellular ischemia, we used
tracer methods recently developed in our laboratory employing
14 C-l-lactate to quantitate lactate release. We compared in a
randomized, double-blind study a new non-ionic contrast agent
(loparnidol) with Renografin-76; 9 CAD patients were included.
A thermodilution flow catheter was placed in the coronary sinus
(CS). CS and arterial blood samples for chemical and isotopic
analyses were obtained prior to and for a 20 minute period
following the left ventriculogram (LVG).
Four patients received iopamidol and 5 Renografin-76. The
chemical myocardial lactate extraction in the iopamidol group
was 11±6% prior to the LVG and 1·1± 7% following LVG (p=NS).
In the Renografin-76 group the lactate extraction was 25 ±4%
and decreased significantly to 14±8% following the contrast
injection (p<O.025).14 C-l-lactate analyses demonstrated that
the fall in lactate extraction following Renografin-76 was due
to an increase in lactate release. With Renografin-76, there was
a 54 ±38% increase in lactate release post LVG (p<0.025); while
after iopamidol, there was no significant change in lactate
release.
These data suggest that myocardial ischemia is induced with
standard ionic contrast agents and the duration of cellular
ischemia is longer than previously realized. In comparison, the
new non-ionic contrast agents are less toxic to the myocardium
and do not produce cellular myocardial ischemia.
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VALIDATION OF INTRACARDIAC MARKER CATHETER FOR
DETERMINATION OF BIPLANE LEFT VENTRICULAR
VOLUMES, Robert C. Bourge, M.D., Roger C. Osborn, M.D.,
Lloyd L. Hefner, M.D., FACC, William P. Hood, Jr., M.D.,
FACC, William J. Rogers, M.D., FACC. University of Alabama
in Birmingham Medical Center, Birmingham, Alabama.
Ouantitative cardiac an~o"aphy is often limited by the
method of radiographic magnification factor (MF)
determination. A recently developed angiographic pigtail
catheter system has 3 radiopaCJIe bands 2 cm apart near the
catheter tip, allowing calculation of magnification factors
directly from within the chamber being imaged, using a newly
deri vee formula. * However, this new catheter system has not
previously been validated for biplane ventriculography.
Therefore, we utilized the catheter for biplane left ventricular
an~ography (right anterior obliq.Je (RAO}-Ieft anterior oblique
(LAO) projections) in 15 patients (pts) undeqloing routine
diagnostic an~ography. Excellent correlations between marker
catheter-derived volumes and volumes derived Irorr- our
previously validated biplane anl!iographic system were foune! for
the followins variables: (I) end-clastolic volume: r = 0.91; (2)
end-systolic volume: r =. 0.97; (3) stroke volume: r = .90; (4)
election fraction: r= 0.99. Sbortcomlnes of the new catheter
system observed in < 20% of pts included: (I) inadequate
visualization of marker bands; (2) minor variability in inter-
band distance; and (3) difficulty in evaluating catheter position
in the same phase of the cardiac cycle in RAO and LAO views.
Thus, U) the new intracardiac marker catheter provides a
convenient and accurate means for assessment of radioj!raphic
magnification factors for use in calculating biplane LV volumes;
and (2) occasional shortcomings of the catheter system are
observed in a minority of pts.
*MFRAO = 2/.,Ar"(D-l-)2-+-m-2-x-S-in-41-)-2where Oland D2 are
marker band distances in RAO and LAO views, respectively,
and 41 = angle between catheter and LAO vertical film edge.
MULTICENTER TRIAL OF A NEW GUIDEWIRE
THERMODILUTION CATHETER
Bertron M. Groves, MD, FACC; R.V. Ditchey, MD, FACC; J.T.
Reeves, MD; B.H. Brundage, MD, FACC; C.R. McKay, MD,
FACC; E. Powers, MD; R. Barst, MD; L.J. Rubin, MD; U.T.
Aker, MD, FACC; R. Siegel, MDj H. Zadaca, University of
Colorado Health Sciences Center, Denver, CO.
Difficulty is occasionally encountered in monitoring pulmonary
artery (PA) and wedge pressure in patients with large right
hearts, pulmonary or tricuspid regurgitation, pulmonary
hypertension, and low cardiac output. A new American
Edwards Laboratories catheter has been designed to overcome
these difficulties. In addition to the balloon-tip, right atrial
port, distal thermistor, and distal pressure lumen, this 7.5 F
heparin-coated catheter has a separate "blind" lumen which
allows insertion of a 0.028 inch guidewire. Retraction of the
indwelling guidewire a variable distance from the catheter tip
produces altered flexibility to enhance catheter performance.
This guidewire catheter was used in 7 centers in 51 patients in
whom a standard balloon-tipped catheter failed. The venous
approach was femoral in 26, brachial in 14, subclavian in 7,
and internal jugular in 4. Wedge pressure was obtained in
47/51 and PA pressure in 49/51. PA mean pressure was 41±17
mm Hg. Despite a mean duration of pressure monitoring of
32.91:42.7 hrs (range 10 min to 7.28 days), prolapse from PA to
right ventricle occurred only once. We conclude that this
gUidewire catheter is advantageous for right heart
catheterization in patients with pulmonary hypertension and
right heart enlargement.
PATENT DUCTUS ARTERIOSUS IN PATIENTS OVER AGE 50 YEARS
Amw S. Ng, MB,BSj Ronald E. Vlietstra, MB,ChB, FACC;
Hugh C. Smith, MD, FACC; Robert L. Frye, MD, FACC; Gordon
K. Danielson, MD, FACC; Francisco J. Puga, MD, FACC, Mayo
Clinic, Rochester, HN.
During 1945-1983, a definitive diagnosis of patent ductus
arteriosus (PDA) was first made after age 50 years in 39
patients (pts)--by cardiac catheterization in 32, opera-
tion in 6, and autopsy in 1. There were 27 women and 12
men, ages 50-79 years (mean, 58); 20 were in NYHA Classes
1 and 11 and 19 were in III and IV. Mean duration of
symptoms was 11 years. All 39 pts had precordial murmurs
but only 26 had a continuous murmur. The mean arterial
pressure was 150 mm Hg systolic and 75 mm Hg diastolic.
Differential cyanosis was present in 2 pts. The clinical
diagnosis was correct for FDA in 21 pts; it was valvular
heart disease in 13, atrial septal defect in 3, and
coronary arteriovenous fistula in 2. Ductal or peri-
ductal calcification was present radiologically in 11.
In 32 pts studied, pulmonary systolic pressure was >30 mm
Hg in 21 and >50 mm Hg in 10. Mean Qp/Qs was 1.8 (range,
1.1-2.8). Of 10 pts treated medically, 2 later developed
infective endocarditis. During follow-up of 9 pts for a
mean of 32 months (1-132 months), 3 died of congestive
heart failure. Twenty-nine pts were treated surgically.
Ductal calcification was noted in 16 (55%) and average
ductal diameter was 9 mm (range, 4-25 mm). Ligation was
performed in 7 pts, division and suture in 19, and intra-
vascular patch closure in 3. Three pts with ligation had
recurrence of PDA. There was 1 intraoperative death from
uncontrollable hemorrhage; thus, in 31 procedures on the
29 pts, hospital mortality was 3.2%. During follow-up in
23 surgical pts for a mean of 79 months (2-214 months), 2
pts died. In the older age group, FDA frequently mas-
querades as other conditions. Surgical treatment may be
performed with an acceptable risk.
KAPOSI'S SARCOMA OF THE HEART IN THE ACQUIRED IMMUNE
DEFICIENCY SYNDROME
Marc A. Silver, MD; Abe M. Macher, MD; Cheryl M.
Reicherl, MD, PhD; Joseph E. Parrillo, MD; Shyh-Ching
Lo, MD, PhD; William C. Roberts, MD, FACC. Nalional
Hearl, Lung, and Blood Inslilule, Belhesda, MD
At the Nalional Institutes of Health we have sludied
at necropsy 17 palienls wilh acquired immune
deficiency syndrome (AIDS). of them, 4 had analomic
abnormalities of the hesrl which, in each, was focal
infiltrates of Kaposi's sarcoma (KS). The 4 palients,
all white men, ranged in age from 38-52 years (mean
45). All hsd cUlaneous and visceral involvemenl by
KS. The lenglh of time from inilial manifeslalion of
AIDS (i.e., KS) lo death was 6-11 monlhs (mean 8.5).
None had symploms or signs of cardiac dysfunclion; in
2 patients, serial determinalions of cardiac outpul
and pulmonary capillary wedge pressures were normal.
Electrocardiograms and heart size by chest radiographs
were normal. Al necropsy, the hearls were normal
except for KS involving the subepicardial sdipose
lissue surrounding 1 or more major epicsrdial coronary
arteries. In none did KS invade coronary artery or
myocardium. In previous descriptions KS of the hearl
unassociated with AIDS characlerislically involved lhe
right alrial wall and cavity and generally led to
falal cardiac dysfunction. Thus, KS wilh AIDS appears
lO be limiled lO focal subepicardial involvemenl and
is nOl of sufficient extent lO cause cardiac
dysfunction.
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DETERMINATION OF CONTRIBUTION OF ARTERIOVENOUS FISTULAE
TO TOTAL CARDIAC OUTPUT BY DOPPLER COMPUTER. P Anthony N
Chandraratna, MD, FACC; Michele Nanna, MD; Ananda Nimala-
suriya, MD; Vito Campese, MD; Donald Feinstein, MD; John
Collins, MD; Saul Massry, MD; Shahbudin H Rahimtoola MD
FACC. USC School of Medicine,Los Angeles,CA. "
The cardiac output (CO) in 15 patients on hemodialysis
were determined using a new Doppler computer by placing a
Doppler transducer on the suprasternal notch. We previ-
ously validated this technique by comparison with thermo-
dilution CO (raO.97). After obtaining control CO (CI),
the forearm fistula (AVF) was occluded and the CO (OCI)
was repeated after 2 minutes. The cuff was deflated and
another control CO obtained (C2)' The cuff was then
applied around the normal arm, a control CO (C3) obtained
after which CO at the end of 2 minutes of occlusion
normal arm (OC2) was done.
Results: Mean CO (L/min)tlSD:
CI OCI C2 C3 OC2
9.2t2.5 7.9t2.3 9.2t2.5 9.lt2.4 9.2t2.3
There was no significant difference among CI, C2' C3' &
OC2' OCI was significantly lower than CI or C2 (P(.OOl).
The change in CO following occlusion of AVF varied from
7.0% to 26% (mean l3.3t5.3%). In 1 patient, Doppler CO
(DCO) & thermodilution CO (TDCO) were simultaneously per-
formed during fistula occlusion. Control DCOa5.9 and
TDCO-5.65, during occlusion DCOa5.0 and TDCOa4.9.
Following fistula occlusion, the change in DCO was 15.2%
and TOCO was 13.3%.
CONCLUSION: Change in CO following AVF occlusion is
variable and can be estimated by Doppler computer. This
information will be of value in management of patients
with AVF in heart failure.
Thursday, March 29, 1984
8:3O-10:00AM Grand Hall Meeting Room #2
Does Heparin Prevent Coronary and
Ventricular Thrombi?
HEPARIN AND ANTIPLATELET DRUGS FOLLOWING
STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTiON:
WHA T ARE THEIR EFFECTS ON VESSEL PATENCY? Jerry W,
Chandler, MD; FACe; Hrudaya P. Nath, MD. William J.
Rogers, MD, FACC, UAB Medical Center, Birmingham AL.
An~coagulant ~nd anti platelet drugs are frequently used
following streptokinase (STK) therapy in acute myocardial
~nfarction (AMO, but it is unclear whether such therapy
Improves subsequent vessel patency. To assess their role in
maintaining vessel patency, we retrospectively evaluated 58
consecutive patients (pts) in whom the results of IV or IC
str~ptokinase therapy were documented by acute coronary
angiography and also by f ollowup coronary angiograpy 14 + I d
later. Following STK therapy, 42 pts had patent infarct-related
vessels. Of these, at followup cath patent infarct vessels were
found in 26/26 000%) .o~ pts receiving> 3 d IV heparin vs only
9/1~ (56%) of pts receiving ~ 3 d IV heparin (p < .005). Severity
of Infarct vessel stenosis immediately post STK was 75 + 4%
among the 35 pts with patent vessels at followup cath- and
92 :!. 2% among the 7 pts with "reocclusions" (p< .10). Following
STK treatment, 16 pts had occluded infarct vessels. At
followup cath, 5/10(50%) of those treated with> 3 d heparin had
patent vessels cor,npared to 0/6 pts treated with ~ 3 d heparin
(p<',05). !ransfuSion for major hemorrhagic complications was
required In 4/36 (11%) of pts receiving> 3 d IV heparin vs 4/22
(18 %) of pts .receiving s 3 d IV heparin (PNS). Antiplatelet
th~~apy ~AspJrln 325 mg qd and Dipyridamole 50 mg tid) was
utilized In 39/40 (98%) of pts with patent infarct vessels at
followup and 1~/18 000%) of pts with occluded vessels (pNS).
Thus, IV hepann for> 3 d following streptokinase therapy in
AMI 0) appears effective in maintainaing vessel patency short-
term, (2) may be instrumental in facilitating recanalization and
continued patency in pts apparently failing STK treatment (3)
is not associated with excessive bleeding, and (4) may be a ~ore
important determinant of followup vessel patency than severity
of stenosis or antiplatelet therapy.
HEMORRHAGE VERSUS RETHROMBOSIS AFTER CORONARY THROMBOLYSIS:
THE EFFECT OF DELAYING HEPARIN
G. C. Timmis, MD, FACC, V. Gangadharan, MD, E. Mamman,
R. Ramos, MD, C. Kanelas, RN, S. Gordon, MD. FACC,
William Beaumont Hospital, Royal Oak, and Wayne State
University, Detroit, Michigan
Bleeding occurred in 23% of the first 116 patients (pts)
receiving intracoronary streptokinase (SK) for myocardial
infarction (MI). It was suspected that heparin which was
infused immediately after SK in this subset (Group A) in-
teracted with reduced fibrinogen (fibr) activity and high
levels of its degradation products (FDP/fdp) to increase
hemorrhage risk. This interaction was reassessed by a
second study of 52 pts having an average of 2.7 combined
bio- (B) and immunoassays (I) of both plasma and serum
fibr ~nd FDP/fdp (latex agglutination):
-t-- ~__ .10 •'.. '--' .. r"'~ :r~-
::[ \ -'.] :\. \p., T ::; 1~-'
::1 \ ;/ ~/l:i .d~ -r ::1 ~y1,,/-
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"I i ' '\ ,·1."~ • -- !: ~ It. I: , , ,7': :.l:" I :: t " I " , , , ~ i ~l . .,.!:: t c • J t : ,
These data indicate that low B-fibr is an artifact of the
anticoagulant effects of FDP/fdp. Plasma I-fibr levels
(corrected for soluble serum fragments) were too high to
explain bleeding. Heparin was therefore delayed for 12
hours in the last 62 (Group B) of 198 SK pts. Bleeding was
reduced to 13%; only 3% required transfusions vs 7% in
Group A. Rethrombosis of the infarct vessel occurred in
15.9% of 63 Group A pts and 15.4% of 26 Group B pts.
CONCLUSIONS: Post-SK bleeding is more likely caused by a
heparin-FDP/fdp interaction than by systemic hypofibrino-
genemia; it may be reduced without increasing the risk of
rethrombosis by delaying heparin infusion for 12 hours.
INFLUENCE OF HEPARIN ON LEFI' VENTRICULAR THROMBI FORMATION
DURING THE FIRST EPISODE OF ACUTE TRANSMURAL MYOCARDIAL
INFARCTION. A PROSPECTIVE RANDOMIZED STUDY.
Pascal Gueret, MD, FACC; Alain Ferrier, MD; Jean C. Farco~
MD, FACC; Olivier DUbourg, MD; Marc Terdjman, MD; Jean
Bardet, MD, FACC; Jean P. Bourdarias, MD, FACC. Ambroise
Pare Hospital, UER Paris-Ouest, Boulogne (France).
The incidence of left ventricular thrombi (LVT) after acute
transmural myocardial infarction (AMI) has been studied with
two-dimensional echocardiography (2DE). Yet, a preverrti.ve
action of early therapeutic anticoagulation with Heparin
(H) has not been demonstrated. We prospectively studied
74 patients (pts ) (62 men, 12 women), mean age 56.4 :t 11. 6
years, admitted within 4.4:1:3.3 hours (h) after the onset of
symptoms of their first episode of AMI (38 anterior. 36 in-
ferior). Pts were randomly assigned to therapeutic anti-
coagul~tion with H(+) or no anticoagulation (H-). All pts
had da.iLy ECG, serial creatine kinase (CK) determinations
every 4 h to detect the peak, right heart pressure and CI
monitoring and arterial blood gases analysis. LV cine-
angiography was performed on day (D) 30-50. Serial 2DE were
recorded on the day of admission (DO), D1, D4-10,D30-50,
to detect the formation of LVT. On the first 2DE (12.5 ±
9.6 h) no LVT was visualized. In pts with inferior MI no
LVT further developped. In pts with anterior MI, 16 thrombi
developped within 5.1 ± 3.5 days, 6/19 (31.6 %) in H+ pts and
10/19(52.6%) in H-pts. (X2=1.89;NS).No difference was
found between these sUbgrou~s in terms of age, MYHA class,
number of Q waves, peak CK, pulmonary capillary wedge pres-
sure, CI, P02, extent of akinesia on LV angio, and mortality
Conclusion: in this preliminary study, therapeutic Heparin
reduced by only 21 %the incidence of LVT formation in ante-
rior acute myocardial infarction and this reduction vas net.
statistically significant vhen compared with the non-trea-
ted group.
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VErlTRICUlAR THROI~BI INACUTE I~ Y OCARD I Al IN FARCTI ON :
I llCIDENCE ~, ~OIlP~ ICATI OUS ~, AND EFFE CTS Of ANTI COAGULATI ON
Ashok J. Kothar i , I~ . D . ; saren Paczkows ki , 11. 0. ; Kennet h 11.
Baker, M.D . ; St ephen C. Schreck, 11.0., Richard J . Bu tcher
I~.D.; Donna I~. Kl i ne ; Franci s J . Mena pace , 11 . 0., FAC C,
Geisinger I~edical Center, Danville, PA.
Seventy- t hree patients (pts ) wi th acut e myocar dial in-
farction were st udied uti li zing seri al 2-D echocard io-
grams. Thirty pts had anterior myocardia l infar cti on:
13 witil lef t vent ri cula r t hromb i (43 ); 29 pts had i n-
feri or nyocerdial i nfar ct ion: 5 with l ef t vent r ic ul ar
th rombi (17::) ; 14 pts had non-Q wave myocarc tel infarc-
t i on: 0 with thrombi. Five pts wi th in fer ior myocardi al
infa rcti on al so had right ventr icul ar (RV) myocardia l in-
farc t ion: 3 pts had RV thrombi. Forty-five pe rce~t of
thromb i were present at 72 hrs; 75 at 96 hrs . Twenty-
one thrombi we re identifi ed in 19 pts , all thrombi vere
locat ed in t he area of in farction. Eje ct ion fraction by
MUGA scan was lower in pts ,li th thrombi (35 ~3 vis 46 :!:2
P<0.01 ) . CP K-MB va1ues did not correI ate witn thrombus
formation (p>0 .1). Eleven pt s with th romb i we re placed
on oral ant i coagulation (OA) : 1 embol i c event occurcd i n
a pt with an anterior myocardial infarction. Eiq.it P LS
were not placed on OA: I embol ic event occurred i n a pt
with an ant erior myocardial infar ction . In 53 pt s I'Jil;' -
out thromb i , 2 embo l ic events occurred. There was reso-
l ut i on of 4/21 thrombi at 1 month: 2 pts received OA.
We conclude : 1) Til romb i occur red only in pts wi th trans-
mural myocard ia l infarct ion and wer e 2. 5 t ines more fre -
quent in anter ior myocardial i nfarct ion t han in inferior
myocardia l i nfarc ti on; 2) The inci dence of embolic events
was 5.5 ~ and embol i occurred i r respective of the presence
of thrombus or OA; 3) An ti coagulation did not affect the
resolution of ventricular thrombi; 4) Ej ecti on fraccion
was lower in' pts wi ch thrombi .
EARLY SYSTEMIC THROMBOLYTIC THERAPY PREVENTS
LEFT VENTRICULAR MURAL THROMBUS FORMATION IN
ACUTE ANTERIOR MYOCARDIAL INF ARCTION
N. Eigler, MD; G. Maurer, MD; Prediman K. Shah, MD, FACC,
Cedars-Sinai Medical Center, Los Angeles, CA
Left ventr icular mural thrombi develop frequently follow-
ing ocute transmural anter ior myocardia l infarction. Mural
thrombi are always associated with apical dyssynergy. Sys-
temic anticoagulation with heparin alone has not reduced the
frequency of mural thrombus formation. To determine the
eftec ts of intravenous throrrbolytic therapy, we prospec t iveIy
studied 22consecutive patients with acute transmural anterior
myocard ial infarct ion with radionuclide ventr iculography and
serial two-dimensional -echocardiography. Twelve patients
present ing within 3 hours aft er myocardial infarction rece ived
IV streptokinase followed by IV hepar in as thrombolyt ic treat -
ment. The remaining 10 pat ients seen later than 3 hours
served as controls. The left ventr icular eject ion froct ion was
<0.40 in 3 of 12 patients rece iving IV streptok inase and in 7 of
10 controls (p<0. (5). Apical dyssynergy was observed in 10 of
12 pat ients treated with streptokinase and in 8 of 10 controls
(p=NS). Ap ical mural thrombi were detected by two-dirnen-
sionol echocardiography in 7 of 10 (70%) controls compared to
I of 12 (8%) patients rece iving IV streptok inase (p<0.005).
Mural throrrbi were present within 36 hours of infarction in 5
controls. Conclusions: Left ventricular mural thrombi often
occur within 36 hours of anter ior myocardia l infarc t ion. Early
thrombolyt ic therapy with intravenous streptokinase followed
by heparin greatly reduces the frequency of mura l throrrbus
formation. This occurs in the set t ing of preserved global left
ventriculcr function and despite the persistence of apical
dyssynergy.
PREDICTION OF REVERSIBLE ASYNERGY PRIOR TO CORONARY
THROMBOLYSIS IN MAN
William W. O'Neill , MD; Nathan Laufer, MD ; Patrick D,V.
Bourdill on, MD; Harry T. Colfer , MD ; Joseph A Wal ton Jr .,
MD; Ber tr am H. Pitt, MD . Univ er si ty Hospi t al and Vet er ans
Administration Medical Center , Ann Arbor, Michigan
The abi li t y t o differentiate revers ibly ischemi c fr om
i r reversib l y i nfarcted myocard ium would have utili t y in
se lec ting patients with acute myocardial infarcti on (AMI)
for thrombol yt i c therapy. Usi ng programmed atrial ext ra -
syst oles, we have evaluated the abilit y of post -ex tra-
syst olic potent i at i on (PESP) to predi ct improvement i n
global and regional ejection fract i on (EF) after success-
ful coronary thrombol ysis. Contrast vent riculograms
(CVG) were obtai ned in 9 pts during evolvi ng ~~I . Six
of these pts had recannalized, patent infarc t vesse ls
and had CVG repeated 10 days post AMI . Programmed st im-
ulati on consi s ted of 4 atrial paced beats (S S = 600
msec) fol lowed by an atrial premature beat (SlSZ = 350
msec) . Global (G) and regional (R) EF was det ermined
usi ng the area method. Changes i n wal l mo tion between
pre-reperfusion sinus and PESP beats were compar ed to
changes between pre- and post-reperfusion si nus beats .
A sign i ficant relationship exists for changes in REF
of i schemic areas (r=. 77 , y=l. 3Zx - . 10, p< .05). The
presence or absence of a (+) GEF PESP response (defined
as a ~ . 04 increase in GEF) pre-reperfusio n, cor rectl y
predic ted the presence or absence of a ~ •04 in crease in
GEF chronical l y in 5/6 pts.
Conclusions : The PESP response pri or to cor onary reper-
fusion may predict the extent of improvement of GEF and
REF chronica l ly and, thus , i dent i fy those pt s who ar e
most likely to benefit f rom cor onary reper fusion.
Thursday, March 29, J984
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Results of Valve Replacement
BIOPROSTHE TI C HEART VALVE FA ILURE: PATHOGENESIS OF
CALC IFIC DEPOSITS. Frederick J. Schoen, MD , PhD, Robert
J. l evy, MD, Alan C. Ne lson,~h~iam-F~ernhard,
MD , Aws Nashef, PhD, Marguer i t e Hawley , Br igham &Women' s
Ho sp, Children 's Hosp Med Ctr , Bost on, MA
To study evolution of bioprost hetic va lve calci fi ca-
tion (CAL), 76 glutar al dehyde-treat ed porcine aorti c
cusps were implant ed subcutaneously in 3-week-old rats
(RI ) for 3, 7, 14, and 21 days, and 8 calves recei ved
stent -mount ed porci ne va lves as mi tral replacement s (el).
Ca lc ium. as in cl ini cal explants , was 123+/-6 ug/mg dry
wt (mean+/- SEM , n=54 ) i n RI at 21 d and 105+/-17 (n=5) in
CI after 27- 148d . CAL wa s seen, chemical ly (28+/-B,
n=10) , and morphological ly, by 3d in RI. Depos its were
associated wi t h col lagen and devita lized porcine cel l s .
In both mOdel s, CAL increasi ngly predominated in the
valv ar spong iosa as diffuse microcryst a ls . with late
enhancement t o conf luent nodu les at the spongiosa-fibrosa
junction, and at mechanica l strain foc i, such as cuspal
commissures and bases in CI and at fo lds in RI. By li ght
microscopy of RI, only 10% of sites sampled at 3d, but
69% of those at 21 d, had CAL great er in spongiosa t han
fi brosa. Scanning elect ron mic roscopy/e nergy-dispersive
x-ray analysis of RI demonstrat ed early fibrosa satu-
ration with ca lcium by 7d impl ant ation, never exceeding
5, 315 count s/min (n=4). In contrast, calcium in the
spongiosa increa sed wi th t ime to 44,022 counts/min (n=4)
at 21 d (spongiosa/ f ibrosa rat io = 20. 7) . It is concluded
that 1) di ffuse calcif ication in the spongiosa is t he
probable initia l lesi on in cl inic al failures, and 2) the
patho logy of CAL in RI. Cl, and cl inica l valves is equi -
valent, sharing a common pathophysio logy, wi t h degree and
mo rpho logy of CAL cor re lat ing with host facto rs, sub-
strate struct ure and mechanical st ress . Furthermore,
thes e resu lts suggest that ei t her prevent ion of cryst al
nucleat ion or limitati on of growth of established mi cro-
depos rt s may be t herapeut ic.
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LATE DEGENERATIVE CHANGES IN SIMULTANEOUSLY IMPLANTED
AND EXPLANTED TRICUSPID AND MITRAL PORCINE (HANCOCK)
BIOPROSTHESES.
Steven R. Cohen, MD; Marc A. Silver, MD; Charles L.
Mcintosh, MD, PhD; Michael Jones, MD, FACC; William C.
Roberts, MD, FACC. National Heart, Lung, and Blood
Institute, Bethesda, MD
Little information is available on morphologic
alterations in porcine bioprostheses (PB) in the
tricuspid (T) position. In addition, degenerative
changes in PBs in the T position have never to our
knowledge been compared to changes occurring in
simultaneously implanted and explanted PBs from the
mitral (M) position. Accordingly, 12 PBs (6T and 6M)
from 6 patients, 2 men and 4 women, aged 30 to 64
years at implantation (mean 45) were reexamined 62 to
128 months (mean 100) later. Anatomic degenerative
changes were present in all 12 PBs. Calcific deposits
were more extensive in the M PBs in 3 of 6 pairs,
greater in the T PBs in 1 of 6 pairs and equally
distributed in 1 of 6 pairs. The most extensive
calcific deposits were in the I patient aged 30 years
at implantation. Cuspal tears were present in 5 PBs,
all from the M position. Thrombus was present in only
I PB from the T position. Fibrous thickening was
present in 4 pairs of PBs and equally distributed
between the H and the T PBs. Thus. anatomic
degenerative changes occur in both T and H PBs
implanted simultaneously, however, degenertion is most
severe in the PBs explanted from the H position.
LATE IN VIVO HEMODYNAMICS AND HEMODYNAMICS AT ~~IMAL
EXERCISE FOR THE SILASTIC BALL AORTIC PROSTHESIS
Steven E. Reinhart, lID; Henry DeMots, MD; Edward S.
11urphy, MD; Siavosh Khonsari, MD; Albert Starr, MD.
Portland VA Medical Center and Oregon Health Sciences
University, Portland, Oregon.
We performed hemodynamic evaluations in patients with
Starr-Edwards silastic ball aortic prostheses (model
1260) with emphasis on the late performance and on
performance at maximal supine bicycle exercise.
We evaluated 13 patients 39.6 + 24.1 months (mean + 50)
(range 4-87 months) after valve replacement. Prosthetic
size varied from 21 mm (8A) to 29 mm (I3A).
Hemodynamic Measurements (mean + S.D.)
N Gradient Cardiac Outp~t Valve Area
mm Hg Ilmin cm2
9.0 + 10.8 4.8 +.6 1.66 + .44
13.1 + 14.4 7.6 + 1.6 1.72 + .38
27.1 + 10.9 10.1 + 1.6 1.58 + .36
36.7 ~ 10.4 13.0 ~ 1.5 1.57 ~ .40
Five patients had no gradient at rest and 11 of 13 had
gradients of 12 mm Hg or less. The mean gradient at
maximal exercise was 16.7 + 16 rom (n = 10). There was
no systematic decline in v~lve area with prosthesis
age. No patient failed to achieve a higher cardiac
output at each level of exercise. The 1260 prosthesis
offers excellent hydraulic performance at maximal
exercise and its performance is maintained as late as
7 year s after surgery.
VALVE REPLACflolENT IN TIlE ELDERLY
MacArthur A. Elayda, HO; Robert J Hall, HD, FA<X:; Albert G.
Gray, Virendra S. Mathur, HO, FACC; Oenton A.Cooley, HD, Clayton
Foundation for Research-St. Luke's Episcopal Hospital and Texas
Heart Ins ti tute, Houston. Texas
Patients (pt) with serious valvular heart disease and a:!vanced
symptcms are seen with sane frequency in the elderly pt (age 70
years lI'ld over). Fran 1971 to 1981, 5.383 underwent aortic
(AVR) or mitral valve replacement (HVR) in our institution.
8.87' of these were elderly pt. All with rare exception were in
NYHA Fe III or IV. Early mortality (f}l) was contrasted with EM
in pt 69 years lI'ld younger:
AVR was performed tbr calcific stenosis in majority of EP.
Majority received Cooley-eutter prosthesis (<X:P)(44S) or an
Ionescu-Shlley bio~osthesis (ISP)(43S). MVR in elderly pt was
predaninantly for mitral regurgi tattoo (86S) of which over one
quarter were secondary to a:!VlllCed mitral valve ~olapse and/or
ruptured chordae tendineae. The mitral valve was replaced with
<X:P (46S) or lI'l ISP (40.6Sl in majority of pts , Five-year
survival was 75S in AVR; 65.3S, AVR-CAB; 51. 7S, MVR; and, 39.4S,
HVR~.
Functional 1m~ovement tbllowing valve replacement in the
elderly pt Cllll be very drllllatic. Perioperative canplication and
~olonged recovery time is IIDre frequent than in the yowger pt
and the EM is significantly higher thll'l younger pt. The risk of
HVR is especially high in the elderly pt.
PULSED DOPPLER ECHOCARDIOr.RAPHIC EVALUATION OF PROSTHETIC
VALVULAR DYSFUNCTION: VALUE AND LIMITATIONS
Kiran B. Sagar, MD, FACC, Walter H. J. Paulsen, MD, FACC;
Donald W. Romhilt, MD, FACC, Medical Co11e~e of Vir~inia,
Richmond, Virginia.
Forty-five patients with suspected prosthetic valvular
dysfunction were prospectively evaluated with pulsed
Doppler and two-dimensional echocardiography. The
results of these methods were compared to cardiac cath-
eterization and/or surgery in 23 patients and to a
clinical follow-up of at least six months in 22 patients.
Abnormal valve function was present in 16 patients,
proven by catheterization and/or surgery and normal
valve function was present in 29 patients, proven by
catheterization in seven patients and clinical follow-up
in 22 patients. Pulsed Doppler correctly predicted
prosthetic valvular malfunction in 15 of 16 patients:
mitral stenosis, 3 of 3 patients (2 porcine, 1 Bjork-
Shiley); tricuspid stenosis, 1 of 1 patient (Starr-
Edwards); mitral requroitation, 1 of 1 patient (porcine);
aortic stenosis, 1 of 2 patients (porcine); and aortic
reourgitation, 9 of 9 patients (8 porcine, 1 B~ork-
,Shi ley) . Whereas, two-dimensional echocardioqraphy
identified only 9 of 16 abnorma1s, failing to detect
aortic regurgitation in 6 of 9 patients and aortic
stenosis in 1 of 2 patients. 80th pulsed Doppler and
two-dimensional echocardioaraphy correctly identified
normal valves in 29 patients. Thus, pulsed Doppler was
superior to two-dimensional echocardiography (P = .02).
Three critically ill patients underwent urgent surgery
on the basis of the pulsed Doppler without cardiac cath-
eterization. We conclude that pulsed Doppler is reliable
and superior to two-dimensional echocardionraphy alone
for the evaluation of prosthetic valve dysfunction and
may obviate the need for cardiac catheterization in
critically ill patients.
AVR
HVR
AVR + HVR
AVR + CAB
HVR + CAB
TOTAL
69 Years or Younger
Pt EMS
2118 3.6
1429 7.2
546 13.2
590 9.8
224 16.1
5383
70 Years and Over
Pt EMS
193 12.9
74 28.4
17 29.4
167 15.6
25 28.0
476
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CORONARY BYPASSAS A RISK FACTOR IN AORTIC
VALVE REPLACEMENT: A MULTIVARIATE ANALYSIS AT
TEN YEARS.
P.H.Kay, M.D., D.Nunley, M.D., G.L.Grunkemeier,
Ph.D., Albert Starr, M.D., FACC
Oregon Health Sciences University, Portland, Oregon
The additional risk of coronary bypass surgery (CBS) in
patients requiring aortic valve replacement (AVR) is
analyzed in 742 patients operated upon at the Oregon
Health Sciences University between 1969 and 1981. 197
patients underwent combined AVR-CBS with a mean
number of grafts of 1.6 per patient. 545 patients with no
coronary artery disease underwent AVR alone. There were
no significant differences in the preoperative hemodynamic
characteristics of the two groups of patients. There were
47 (8.6%) operative deaths in the AVR group and 20
(10.2%) in the AVR-CBS group. Since 1976 operative
mortality has fallen to 5% and the rate of perioperative
myocardial infarction to 2% following AVR-CBS. Ten-year
actuarial survival (±S.E.) was 57(±3)% following AVR and
49(±6)% following AVR-CBS (p( 0.3).
A multivariate analysis including both groups of patients
revealed the following factors affected 10-year survival:
age, functional class and year of operation (p <0.05);
CBS (p=0.06) and left ventricular end diastolic pressure
(p=O.ll. Within the AVR-CBS group cohorts with a high
LVEDP, large transvalvular gradient or low cardiac index
showed a further reduction in survival, compared with
similar cohorts undergoing AVR alone.
Thus, the need for CBS decreases 10-year survival in
patients undergoing AVR. Abnormal ventricular function
in the combined AVR-CBS group further decreases survival
when compared to AVR alone.
Thursday, March 29, 1984
8:30-10:00AM Ballroom A
Assessment of Fontan Procedure: Diagnostic Methods
ACCURACY OF CONTINUOUS WAVE 2D ECHO DOPPLER STUDIES FOR
PREDICTION OF GRADIENTS ACROSS PULMONARY ARTERY BANDS:
CLINICAL STUDIES
Lilliam M. Valdes-Cruz,M.D., FACC, David J. Sahn, M.D.,
FACC, Sarah Scagnelli, Carlos Oliveira Lima. M.D. Univ-
ersity of California, San Diego Medical Center, San
Diego, CA.
In this study, we performed continuous wave (Irex IIIB)
2D echo Doppler examinations to noninvasively measure
maximal (MAX) systolic velocities across pulmonary (PA)
bands in 14 children 1 month-17 years of age who had
complex congenital heart lesions. Ten patients were
studied during cardiac catheterization and the other 4
were studied within 24 hours of their hemodynamic study.
Whether in an anterior or posterior (transposed) posi-
tion, the PA was imaged in its longitudinal course to
allow Doppler sampling in a direction perpendicular to
the line of the imaged band (a direction assumed to be
parallel to flow across the band). Maximal velocities
were corrected for any angles of incidence between the
presumed direction of flow through the band and the dir-
ection of sampling. Maximal velocities ranged between
238-492 em/sec and correlated quite well (r=0.95, SEE=30
em/sec) with measured gradients between 30-9Omm Hg.
Using th zsimplified Bernoulli equation (gradient=4xMAX
velocity), Doppler predicted gradients also correlated
well with actual gradient (r=0.95, SEE=7 mm Hg), but
Doppler slightly overestimated the gradients measured at
catheterization across tighter bands. Our results sug-
gest that 2D echo Doppler is a serially applicable and
useful noninvasive method for estimating the pressure
gradients across pulmonary artery bands in patients with
complex congenital heart disease.
FUNCTIONAL ASSESSMENT OF THE FONTAN OPERATION: COMBINED
M-MODE, TWO-DIMENSIONAL, AND DOPPLER ECHOCARDIOGRAPHIC
STUDY
Donald J. Hagler, MD, FACC; James B. Seward, MD, FACC;
Abdul J. Tajik, MD, FACC; Donald G. Ritter, MD, FACC,
Mayo Clinic, Rochester, MN.
Combined M-mode, two-dimensional, and Doppler echocardio-
graphic studies were utilized to assess the postoperative
status of 28 patients (pts) after a modified Fontan pro-
cedure. Twenty-five pts were studied early «2 months
postoperatively) but the study period ranged from 1 day
to 6 years; 30 examinations were performed. Eleven pts
had tricuspid atresia, 9 had double-inlet left ventricle
with hypoplastic right ventricular outlet chamber, and 8
had complex lesions. Twenty pts had surgical repair by
simple RA-PA anastomosis. The rest had repair with a
prosthesis. Postoperative assessment by M-mode and two-
dimensional echocardiography demonstrated normal or
mildly reduced ventricular function (ejection fraction
>40%) in 20 (71%). Pulsed Doppler echocardiography
demonstrated a "normal" venous flow pattern--predomi-
nantly diastolic flow with atrial waves similar to the
flow pattern in the superior vena cava. "Abnormal" flow
patterns--disorganized systolic flow, absence of atrial
waves, and little response to inspiration--were observed
in 7 studies. Doppler studies also demonstrated mild
dynamic subaortic obstruction in 2, atrioventricular
valve insufficiency in 8, and residual ventricular septal
defect in 2. In 7 patients, comparison with hemodynamic
studies suggests good correlation with detection of
abnormal flow pattern, residual shunts, or poor ventricu-
lar function. These results demonstrate the utility of
echocardiography in postoperative assessment of the
Fontan operation. Prominent atrial flow waves demon-
strated by Doppler studies suggest significant atrial
contribution to pulmonary flow.
COMPARISONS OF VENTRICULAR FUNCTION IN TRICUSPIO ATRESIA
PATIENTS WITH FONTAN REPAIR VS. PALLIATIVE SHUNTS.
Mark O. Parrish, Thomas P. Graham, Robert J. Boucek, and
Harvey Bender. Vanderbilt Medical Center, Nashville, TN.
Comparative long term effects on ventricular function of
the Fontan repair of Tricuspid Atresia vs. the effect of
palliative shunts are unknown. For this reason, we per-
formed exercise ergometry with radionuc1ide ventriculo-
graphy on 8 patients (pts) with tricuspid atresia. Four
pts (12 to 25; (Group 1) had undergone Fontan repair 22
to 59 months (mean 38 months) nrior to the radionuc1ide
study and 4 pts (14 to 28: 11t:8 yrs (Group 2) had received
palliative shunts only. Ten normal children 14±1 yrs =
mean~SEM) were also studied (Group 3). Total work per-
formed was decreased (p<.05) in all tricuspid atresia
pts, ~lthough Group 2 pts performed less work (1130±275
KPM/M2) than did the pts with Fontan repair (2201~357KPM/M ) or the normal pts (4893t780 KPM/m2). Resting
(REST) and peak exercise (EX) left ventricular ejection
fractions were lower in Groups 1 &2 than for the normal
~roup but no differences were found between Groups 1 &2
(p<.05). (Gro~p 1 RESr ejection fraction ~ 49±1% EX
ejection fractl0n = 45-6%; ~roup ~ REST ejection fraction
= 53±5%: EX ejection fractlon = 6±10%; Gr~up 3 REST
ejection fraction = 65~3% EX ejection fractl0n = 72~2%).
Serial radionuclide studies in Group 1 (8 studies in 4
pts) revealed a positive correlation between REST ejec-
tion fraction and post-operative time (r = .82). We
conclude that both exercise tolerance and ventricular
response to exercise were abnormal in tricuspid atresia,
but exercise tolerance was greater following Fontan repair
compared to pts with palliative shunts. In addition,
very abnormal ventricular function, early after Fontan
repai~ tended to improve with time.
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RESPONSE TO VALSALVA MANEUVER FOLLOWING THE
FONTAN OPERATION
Samuel S. Gidding, MO; Amnon Rosenthal, MO, FACC, C.S.
Mott Children's Hospital, University of Michigan, Ann Arbor,
MI
RV failure is reported to result in an abnormal response
to the Valsalva maneuver. To assess response to Valsalva
maneuver with an absent or hypoplast ic RV pump we studied
at cardiac cath 8 pts with congenital heart disease repaired
by RA to PA or RA to hypoplastic RV anastomosis (Fontan)
and 6 control pts. PA and systemic blood pressure (BP)
and ECG were continuously monitored and CO measured.
All Fontan patients had a resting RA pressure >14 mmHg.
Two different response patterns were observed in pts. with
Fontan. A normal overshoot was present in 3/8 and an
abnormal Valsalva maneuver response with no overshoot was
recorded in 518 Fontan pts (table; * p<.05).
Increue in Increue in DecJint' in
PP mmHc Sfst BP m,"HI Heart Rate Bran to
~ (Owrshoot) (0 ..,_1 ~ ~
Control 13" 2611 -2106 ,.2
F·rml YM 22.6 27.7 ·26 •• 12t3
F..-bn VM 6.3" Itll- 2t'· absent peM
Fontan pts. with normal Valsalva maneuver had higher CO
(2.7±O.3 vs. 2.2±2 ml/beat/m2; p<.05) and stroke volume
05 ±I vs 28±2 ml/beat m2; p<.05) than Fontan pts, with
abnormal Valsalva maneuver. There was no difference in
RA pressure between the two groups. We conclude that
an absent or hypoplastic RV and elevated RA pressure do
not preclude a normal response to Valsalva maneuver. The
Valsalva maneuver may also serve as a noninvasive test of
cardiac performance for Fontan pts,
ECHOCARDIOGRAPHIC RECOGNITION OF MYOCARDIAL
SCARS IN PRE:1ATURE INFANTS.
R. Clifton Way, M.D.,F.A.C.C., Derick DeSa, M.D.
John 1'Iatts, ~LD., and Connie Manning, R.T.
I1cMaster University 11edical Centre, Hamilton,Ont
Hi ghly Refractile Echoes (HRE's) in the
myocardium resulting from increased fibrosis
and calcification have been recoanized through
the use of 2-D Echocardiography • .
Extensive myocardial scarring and even cal-
cification has been well documented in premature
infants dying of asphyxiating lung disease.
One of our premature infants de~onstrated
extens i ve HRE's in the Septum and Subendocard-
ially i n both ve n t r i c l e s . At Dost mortem ex-
amination the infant was found to have ex-
tensive myocardial scars and calcium deposits
which clearly represented the source of the
HRE's . This prompted us to start a prospecti ve
wa t.ch f o r other patients. standard Echocard-
Lo q r aph i c techniques utilizing a 5 11HZ Mech-
anical Sector Transducer (ATL 11ark 300C ) have
been used. To date myo c a r di a l scars or calcifi-
cation have been confirmed at post mo r t e m
examination in 4 oatients. An additional 60
patients are being followed . All affected
patients had birth weights less than 1.4 kgs.
(680-1400 gms) and de veloped severe pulmonary
disease . Recognition of advanced myocardial
scarring and calc ification in premature infants
appears feasable with 2-D Echocardiography.
The implication of such scarring for long term
survivors remains unknown.
GALLIUM-67 SCAN FOR SCREENING OF KAWASAKI SYNDROME
Masato Takahashi, M.D. , FACC, John H. Mi l l er , M.D . ,
Lance Si eger , M.D. , Wilbert H. Mason , M.D . , Alan B.
Lewis, M.D . , FACC , and Barbara S. Reid , M.D. , Childrens
Hospital of Los Angel es and Uni ver s i t y of Southern
Cal i fo rn i a School of Medicine , Los Angeles , CA
Intravenously injected Gallium-67 is taken up by bone ,
liver and i nf lammatory t issues . We have observed car di ac
uptake of Gall ium-67 in patients wi t h Kawasaki syndr ome
during acute phase . We tes t ed t he hypothesis that high
Gal l ium-67 uptake cor relates wi t h coronary ar tery
aneurysms . Fifteen patient s with Kawasaki sy ndro me , ages
4 mos to 6 yrs (medi an 1 . 4 yrs) , had Gal lium -67 scans .
Gall ium-67 cit r at e 0.04 mCi/kg was i njected 3 to 27 days
(mean 10 .4 days ) after onset of illness. Scint iphotos of
t he chest were obtained in anter i or and l ef t anterior
obl i que views 48 to 96 hours after injection . The den-
sity of Gallium-67 uptake by t he heart was compared t o
the ribs, sternum and the liver , and was rated 0, 1+,
2+, 3+ or 4+. Two observers who had no knowledge of the
patient s' cl i ni cal status r ead the sc i nt i phot os using
t he r ating scal e . The re sul t s were analys ed for inter-
obser ver di f ferences and compared to presence or abs ence
of coronary ar t ery aneury sm by 2-d imensional echo-
card i ography and coro nary ar teri ogr aphy. There was ex-
cel lent inter observer agr eement . Four of 15 pat ients de-
veloped coronar y artery aneurysms . All of t he 4 pat ients
showed Gallium-67 uptake of 2+ or more ( p < .005) . The
test has s ens itivity of 100% and speci ficity of 91%.
In concl usion , Gal l i um-67 scan appea rs t o be a useful
acut e phase sc r eeni ng t es t for coronary artery aneury sm
in Kawas aki syndrome .
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AMIODARONE - A POTENT PHOSPH OLIPASE INHIBITOR
Eugene Downar, MD; Nisar Shaikh, PhD; Jagdish Butany, MD,
University of Toronto, Toronto, Canada.
Amiodarone (A) therapy has long been known to produce
corne al microdeposits in most patients . The electron-
micr oscopic appearance of these is cons i s t ent with l yso-
somal i ncl us i ons some of which are lamellar while others
are granul a r . We have previously rep orted that chr onic A
therapy results in widespread l ysosomal in clusions which
can be found in all cell t ypes i nc l udi ng polymorph leuko-
cytes , al veol a r macrophages, hepatocytes and cardiac myo-
cyt es . Chloroquine (C), a known phospholipase inhibitor
(PI ), produces identi cal l ysosomal i nc l us i ons which result
from phospholipid accumulation . Chl orpromazine (CZ) i s
another PI that pr oduces s imi l ar l ysosomal inclusions.
To determine if A is also a PI we compared the effects of
A, C and CZ on in vitro phospholipase A2 and C systems :-% Inhibition of Activity
Drug Cone . PLA2 (Naj a Naj a) PLC (Cl. Welchi)
mg/assay A C CZ A C CZ
0.5 0 0 0 0 0 0
2.5 9 17 14
5.0 14 29 30
8.0 22 50 90 98 95 99
Thes e results indicate that Ami odarone i s a potent
phosphol i pase- i nhi bi to r . The characteristic intracyto-
pl asmi c inclusions pr oduced by Amiodarone are most likely
due t o systemic inhibition of l ysosomal phospholipases.
This act i on is probably responsible for some of the toxi c
effects of Amiodarone and may be related to its anti-
arrhythmic properties.
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AMIODARONE: ELECTROPHYSIOLOGIC EFFECTS ARE SIMILAR TO
CLASS I DRUGS
Eric N. Prystowsky, MD, FACC; Elwyn A. Lloyd, MD;
James J. Heger, MD, FACC; Naomi Fineberg, PhD; Elizabeth
Darling, RN; Douglas P. Zipes, MD, FACC, Krannert
Institute of Cardiology, Indiana University School of
Medicine, Indianapolis, Indiana.
We investigated whether oral amiodarone (Am) caused dif-
ferent electrophysiologic (EP) effects from class I drugs
in humans. Patients had control (C) and at least one
drug EP study using Am (800 mg/d for 14d) , quinidine (Q),
procainamide (P), disopyramide (D) or encainide (E). The
mean changes from control in msec are listed in the table.
Drug SCL AH HV VERP VT CL
Am{n=46) 105.0* 16.5* 5.2* 18.8* ~
Q (n=24) -59.1* 4.7 7.4* 33.9* 84.2*
P (n=20) -59.4* -0.2 6.0* 23.3* 51.8*
D (n= 9) -21.4 5.0 1.2 22.P* 34.3
E (n=17) -29.5 22.2* 21. 2* 29.3* 57.5*
SCL = sinus cycle length, VERP = ventricular ERP, VT CL =
ventricular tachycardia cycle length, * = p<.05.
Oral Am exerted similar EP effects as class I drugs re-
garding HV, VERP and VT CL; its effects on SCL and AH
differ, in part possibly because of its antiadrenergic
properties. A subset of 13 patients had a C, Am and P EP
study and the mean values (msec) were: SCL 829 (C), 967
(Am), 796 (P); AH 88 (C), 110 (Am), 96 (P); HV 53 (C), 60
(Am), 58 (P); VT CL 248 (C), 298 (Am), 311 {pl. Changes
from control were significant for Am and P for all vari-
ables, and except for SCL the drug effects did not differ
from each other. We conclude that the EP effects o~ oral
amiodarone in humans resemble those of class I drugs.
PREDICTING THERAPEUTIC EFFICACY WITH AHIODARONE: A COM-
BINED HOLTER/ELECTROPHYSIOLOGIC APPROACH. Eleanor E.
Kennedy, MO, William P. Batsford, MD, Lynda E. Rosenfeld,
MD, Nancy A. 8orstelmann, BS, Alan H. Gradman, MD, FACC,
West Haven VAMC and Yale University, New Haven, CT.
THE ADEQUACY OF LOW DOSE AMIODARONE FOR THE PREVENTION OF
VENTRICULAR TACHYCARDIA
Douglas C. Westveer, MD, FACC, James R. Stewart, ~rn, FACC,
Donna VanDam, RN, Seymour Gordon, MD, FACC, Gerald C.
Timmis, MD, FACC, William Beaumont Hospital, Royal Oak and
Oakland University, Rochester, Michigan.
Amiodarone was administered to 30 patients (pts) with
paroxysmal, sustained ventricular tachycardia (VT) refrac-
tory to conventional drug therapy using a 1 week loading
dose and chronic maintenance dose of 1400 mg/day and 400
mg/day, respectively (group A). Sudden death or docu-
mented VT recurred within 3 mos in 3%, and over 16.9+ 7.0
mos (mean ± SD) in 13%. An attempt was made to improve
this therapeutic response in 49 subsequent pts (group B)
by using a similar loading dose but increasing the main-
tenance dose to 800 mg/day. There were no group differ-
ences in a~e, the frequency of pre-treatment VT, its
morphologies or rate, reverse T3 levels or ejectionfraction. Sudden death or documented VT recurred within
3 mos in 6% of group B pts and at 13.4+8.9 mos in 17%.
Life table survival analysis during followup were
similar in both groups. Dose reductions were necessary
in 45% of group Band 7% of group A pts due to side
effects. Nevertheless, mean maintenance doses at 3, 6,
9 and 12 mos remained considerably higher in group B pts
(p<.OOOl). Pulmonary fibrosis occurred in one group A
patient and 5 group B patients; other side effects
occurred with equal frequency in both groups.
CONCLUSION: Low dose Amiodarone (400 mg/day) is as
effective as higher maintenance doses in preventing re-
current VT or sudden death. Pulmonary fibrosis may occur
less frequently, although other side effects are not
appreciably reduced.
ROLE OF INTRAVENOUS AMIOOARONE IN THE ACUTE CONTROL OF
SUPRAVENTRICULAR TACHYARRHYTHHIAS
Koonlawee Nademanee. 110, FACC; Gregory Feld, 1m; JoAnn
Hendrickson, BS; Vanida Intarachot, RN; Bramah Singh, 1m,
FACC, Wadsworth VA Hospital, Los Angeles, Ca.
We conclude that 1) Holter data add an additional impor-
t.nt component to the assessment of amiodarone efficacy.
2) PVC frequency SI/1000 Nindependently predicts long-term
success. 3) Pts with PVC frequency ~1/1000 N should un-
dergo invasive electrophysiologic evaluation and amio-
darone therapy reconsidered if sustained VT is found to
be inducible.
Clinical response to amiodarone is not well correlated
with suppression of ventricular tachycardia (VT) induci-
bility during programmed electrical stimulation (PES). To
develop more accurate predictors of long-term response, we
performed ambulatory electrocardiographic monitoring (mean
18.8 hours) and PES in 24 pts (mean age 61 years) ?4.5
weeks after initiation of oral amiodarone (dose range 200-
800mg/day). There were 6 treatment failures (recurrent
symptomatic VT or death) and 18 successes over a mean
follow-up of 8 months. A low premature ventricular com-
plex (PVC) frequency (sl/1000 normal beats (N)) proved the
best predictor of success while failure was predicted by a
combination of a PVC frequency ~1/1000 N and inducible
sustained VT (SVT) at PES rather than by each alone. The
accuracy of each of these findings in predicting success
or fai lure was:
Success
Fai lure
PVC S '"
13/14(93%)
1/14 (7%)
1'p<.OS
PVC ~1
S/10{SO%)
S/10(SO%)
(success vs
SVT
7/12(S8%)
S/12(42%)
fai lure)
PVC ?1
+ SVT*
1/S{20%)
4/S(80%)
Oral Amiodarone (Amo) is an effective agent in chronic
prophylaxis of symptomatic supraventricular tachyarrhyth-
mias (ST), but the value of intravenous Am (Amiv) in
acute treatment of ST is unknown. Thus, we tested Amiv
5mg/kg) in 28 patients (pts) with ST; 13 with PSVT (Gr.I)
and 15 (Gr II) with atrial fl utter (AF). .'\11 gr. I pts un-
derwent electrophysiologic studies before and after Am i v
bolus. All had inducible PSVT (6 with Accessory Pathway
(AP). 7 with AV nodal reentry (AVNR)) which lasted longer
than 10 min prior to Amiv' Amiy terminated (by antegrade
block in 2 and retrograde in 4) induced PSVT in 2/6 pts
with AP and slowed the tachycardia rate in the others.
Termination and cycle length of ST occurred solely at the
antegrade AV node without effect on retrograde bypass.
This is consistent with EP data which revealed no signif-
icant change in bypass tract ERP both antegrade and retro-
grade but there was marked change in AVNERP antegrade
from 29B±41 to 346±25 msec and retrograde 308±69 to 430±
139 msec (p<O.OI). In Gr II, Amiv 5mg/kg converted AFL to
normal rhythm in only 2/15 pts, but Amiv slowed ventricu-
lar response in all pts (from 1l1±23 to 86±28bpm and
lengthened the atrial flutter cycle length from 214±20 to
246±25msec p<O.OI). Onset of action in most cases was af-
ter 5 min and plateaued at 15 min. Conclusions: Amiv ex-
erts its main effect on AV node refractoriness both ante-
grade and retrograde with little or no effect on bypass
tracts. overall effects consistent with the drug'S effic-
acy in acutely terminating narrow QRS PSVT, and in slow-
ing ventricular response in atrial flutter and fibrilla-
tion.
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CONCLUSION: 1) Serum amiodarone measurement has little
clinical utility. 2) Markedly elevated RT3 levels maypredict an increased risk of pulmonary fibrosis.
Of the 4 pts with pulmonary fibrosis, 1 was taking 400
mg/d and 3, 800 mg/d, yet all had markedly elevated RT3levels. No difference in reverse T3 or serum amiodarone
was seen among individuals treated with 400, 600, or 800
mg/day.
THE RELATIONSHIP OF SERUM AMIODARONE AND REVERSE T3 LEVELSTO DRUG EFFICACY AND SIDE EFFECTS
James R. Stewart, MD, FACC, Douglas C. Westveer, MD, FACC,
Donna VanDam, RN, Seymour Gordon, MD, FACC, Gerald C.
Timmis, MD, FACC, William Beaumont Hospital, Royal Oak and
Oakland University, Rochester, Michigan.
QUANTIFICATION OF ROTATIONAL THALLIUM-201 STRESS-REDIS-
TRIBUTION MYOCARDIAL TOMOGRAM5: METHOD AND PILOT STUDY
Ernest Garcia,~; Kenneth Van Train, B5; Jamshid Mad-
dahi, MD; Florence Prigent, MD; Joseph Areeda, John
Friedman, MD; James Bietendorf; Alan Waxman, MD; Dan-
iel Berman, MD, FACC; Cedars-Sinai Medical Center, Los
Angeles, CA
Rotational tomography offers potential for assessing the
3-d imens ional (D) myocardial Tl-201 distribution, but
clinical implementation requires an efficient, objective
approach to image interpretation. Thus, we developed a
new compu ter me thod to quan tHy the rela tive space/ time
myocard ial dis tr ibu tion of Tl. At 6 min and 4 hrs af ter
exercise T1 injection, 32 projections were acquired for
30 seconds each over a 180· arc in 20 normal pts (nls)
and 16 with CAD (>50% stenosis). Long and short axis
cu ts of the lef t-ven tricle were recons truc ted and subse-
quently quantified using circumferential profiles (CP).
Washout (W) CPs were calculated as %W from stress for
each cut. Lower limits of nl (LLN) were calculated as
the mean -2.5 SD from each CP and WCP of the pooled nls.
The computer compared each pt's CP and WCP to its corres-
ponding LLN and displayed the results as 2D polar maps of
the 3D distributions. Criteria for perfusion defect (PD)
or W abnormality were developed as a % of the normal
myocardium in question. The % abnormal area threshold
for detection of CAD was 3% by PD and 5% by slow W, for
localizing anterior (LAD) or posterior (LCX, RCA) abnor-
mality was 6% by either PD or slow W. These criteria re-
sulted in the correct identification of 15/16 CAD pts ,
19/20 nls, and 27/32 myocardial territories. This new
method of quantifying myocardial Tl-201 and expressing
the percent of abnormal myocardium should be a signifi-
cant advancement towards the accurate, objective, and ef-
ficient noninvasive characterization of CAD.
TIME
(months)
l4.0±1.l
11. 0+2.3
13.Ot3.0
1. 6+. 34
2.5+.51
72+ 10
110t 29
700+100* 355+115* 2.6+.8 8.5+1.6
to group witho~t pulmonary fibrosis.
41 505± 30 118+ 20 2.4+.17
GIlOUP
The relationship of reverse T3 and serum amiodarone (SA)levels to drug efficacy and sIde effects was studied in
41 patients (pts), mean age 63+7.3 yr, treated with oral
amiodarone from 3 to 36 (14+6.8) months. Daily doses of
Amiodarone ranged from 200 to 800 (505+179) mg and
were adjusted on the basis of efficacy-and side effects.
Reverse T3 (RT3) and serum amiodarone (SA) levels were
obtained every 6 months or when side effects occurred,
with the following results (mean ±SEM):
RT3 SA
n DOSE (mg) (ng/dl) (~g/ml)
Tota~ group
No side
effects 6 457+ 71
Drug failure 7 57l± 92
Pulmonary
fibrosis
(PF) 4
*p=<.05 compared
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Thallium-201 Myocardial Imaging
STENOSIS SEVERITY: ANALYSIS USING T1-201 SCINTI-
GRAPHY AND INTRACORONARY PRESSUREGRADIENTS
Timoth~ Bateman, MD' Marjorie Raymond, RN; Lawrence
Czer,D; Aurelio chaux, MD, FACC; Robert Kass, MD,
FACC; Jock Matloff, MD, FACC; Daniel Berman, MD,
FACC; Richard Gray, MD, FACC, Cedars-Sinai Medical Cen-
ter, Los Angeles, CA.
To clarify the relationship between angiographic ond
hemodynamic stenosis severity and the appearance duri"9
stress-redistribution myocardial T1-201 scintigraphy (Ex-TO
of a visual (V) or quantitative (Q) perfusion defect (PD) or
washout (WO) abnarmality, 24 pts with CAD underwent
introcoronary pressure gradient study at bypass surgery
(CABG). All had pre-CABG Ex-TI without interval deteriora-
tion. The mean diastolic pressure gradient (MDG) measured
at reproducible hyperemic flow rates was determined for 34
stenases (13 LAD, 7 LCx, 14 RCA) and compared with the
results of Ex-TI in subtended myocardial regions (LAD=anter-
ior; LCx:posterolateral; RCA=inferior). Fourteen stenoses
(50-99% diameter narrowing) were unassociated with VPD
despite maximal exercise: MDG was 9:t5 mmHg, with
MDG/mean aortic diastolic pressure (ADP) ratio of 0.12:t0.07.
QPD and QWO analysis detected 8 of these. Thirteen
stenoses (90-100% severity) led to reversible VPD: MDG was
36:t11 mmHg, Mrx./ADP ratio was 0.52:t0.17, and Q analysis
was abnormal in 12/13. Seven stenoses (90-100% severity)
subtended infarcted myocardium: MDG was 42:t21,
MDG/ADP ratio was 0.52:t0.18, and V and Q analyses were
abnormal in all. Conclusions: I) Ex- TIcorrelates better with
hemodynamic severity of stenoses thon does angiography;
2) V abnormalities identify stenoses of major angiographic
and hemodynamic severity, while Q analysis detects some
(57% in this study) stenases of lesser severity; 3) stenoses
causing reversible Ex- TI abnarmalities present similar hemo-
dynamic impediments to those causing myocardial infarcts.
QUANTITATIVE ANALYSIS OF SERIAL THALLIUM IMAGES AFTER
DIPYRIDAMOLE INFUSION.
T~r[fP,e D,~Ydgy. MD' Robert D. Okada. MD. FACC;~ar es A.uc er.:M6. FACC; H. William Straussr MOl
Gerald M. Pohost. MO. FACC. Massachusetts Genera
Hospital. Boston. MA
Qualitative interpretation of serial thallium (Tl)
imaging after dipyridamole (DP) infusion has been shown
be to an acceptable alternative to exercise Tl imaging.
Although quantitative techniques have been validated for
exercise Tl images. quantitative analysis of DP images
requires further investigation because Tl kinetics
differ after exercise compared to after DP.
Accordingly. we utilized a computer-aaaisted
quantitation of DP Tl images to determine relative
regional Tl uptake and absolute regional clearance rates
in 59 patients with chest pa~~ (47 with and 12 without
coronary artery disease (CAD}}.
After a 4 minute i.v. DP infusion (0.14 ~/kg/min).
3 serial Tl scans were acquired in 3 views. Iiages were
quantif~ed with a recently developed computer method
which I} utilizes an elliptical region-of-interest which
more closely a~proximates LV shape to improve background
subtractionr' 21 automatically superimposes the images
after trans atlon and rotation to ~nsure accurate
comparison of serial images; and 3} calculates relative
reflonal Tl clearance rates. Scans were anallzed for
re ative regional Tl activity in the initial tmages and
regional Tl clearance rates.
The lowest relative regional acti1ity in the
patients with CAD (52,4±l7.8%, meaQiSD was less than in
patients with DO CAD l7T.4±9.n%. p<O.O). The frequency
of a negative c~earance rate in the patlents with CAD(40/47 or 81.5% was gre,ter than in patients with no
CAD (3/12 or 25 • p<0.06}.
Conclusion: Quantitative analysis can be applied
to DP Tl imaging. The kinetics of Tl activity after DP
in patients with CAD differ from P4tienu with DO CAD.
Reglonal Tl uptake is lower in patients with CAD than in
patientl with DO caP'. Tl upta~e.in most patients with
no CAD washes out wlth a ~sltlve clearance rate.
whereas in most patients with CAD there is a failure of
Tl waahou~ aeen as a negative clearance rate.Quantitatlve analysis of DP Tl images is potentially
u.eful in 4ifferentiating patients with CAD from
patlents wlth no CAD.
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QUANTIFICATION OF MYOCARDIAL HYPOPERFUSION IN SINGLE-VES-
SEL DISEASE USING STRESS-REDISTRIBUTION TI-201
SINGLE-PHOTON EMISSION COMPUTERIZED TOMOGRAPHY (SPECT)
Florence Prigent, MD; Jamshid Maddahi, MD; Ernest Gar-
cia, PhD; Kenneth Van Train, BS; John Friedman, MD,
James Bietendorf; HJC Swan, MD, PhD, FACC; Daniel Ber-
man, MD, FACC; Cedars-Sinai Med Ctr, Los Angeles, CA
Although single-vessel coronary disease (SVD) generally
carries a good prognosis, the associated risk is related
to the extent (E) and severity (S) of myocardial hypoper-
fusion (MH). Thus we assessed the abi I ity of TI-201
SPECT to quantify MH in SVD. In 14 patients (pts) having
angiographic SVD (8 LAD, 4 LCX, 2 RCA), early and 4 hrs
after exercise TI injection 32 projections were obtained
over a 180· arc. Long- and short-axis cuts of the left
ventricle were reconstructed and subsequently analyzed
using maximum count circumferential profi les (60
points/profi Ie). Profi les of al I cuts were compared with
previously establ ished normal (n l ) I imits derived from 20
nl patients. E of MH was defined as the percentage of
profi Ie points fall ing below normal and S was expressed
as the percentage by which the abnl points fel I below nl
I imits. Although al I pts had SVO, the range of E and S
of MH was wide (0 to 60% and 0 to 24% respectively).
Coronary arteriograms were interpreted using a 15-point
scoring system (CS) accounting for the distribution of
the diseased coronary artery, location and degree of
stenosis, and col lateral supply. CS varied from 1.2 to
8. E and S significantly correlated with CS (r=.63,
p=.008 and r=.71, p=.002, respectively). We conclude
that 1) patients with SVD have highly differing degrees
of extent and severity of MH; 2) E and S scores from TI-
201 SPECT correlate favorably with the angiographic ex-
tent of disease; 3) SPECT offers potential for quantifi-
cation of the extent and severity of MH, and may there-
fore become a useful, noninvasive prognostic indicator.
NORMALIZATION OF PERSISTENT DEFECTS ON THALLIUM SCANS
AFTER MYOCARDIAL REVASCULARIZATION: SCAR OR ISCHEMIA?
lll.t..eL....Li; Marla C. Kieu. MDi Robert D. Okada. MD.
~ A. Boucher. MD. FAC~; Peter C. Block. MD.
FACC; H. William Strauss. MD. FACC. Gerald M. Pohost.
MD. FACC. Massachusetts General Hospital. Boston. MA.
Persistent defects (PD) on serial thallium (Tl) scans
are commonly thought to represent fibrosis or scsr. and
this interpretation may affect clinical decision making.
However, others haye suggested that such a pattern may
occur wloth severe uchem18 as well. To better
understand PD. we reviewed serial Tl scans o{ 50
p.tients pre- and ~st-coronary angioplasty (PTCA) for
slongle veasel LAD disease. and determloned whether the
PD. as assessed visually. normalized after
revascularization. All the scans were rated by 3
blinded observers on a scale from 0 to 2. and the
results averag~d•.The scans were also subjected to
computer quantlotatlove assessment to determlone the
relative regional Tl content. PD were defined
gualitatively as defects showing <0.5 grade increase
6etween ~he lonitial and d~layed images. and transient
defects (TD) were those wloth a >1 grade increase on the
delayed scans. Eleven patients with 16 myocardial
s~~ents with ~ were compare4 to another 11 patients
Wloth ~O myoc.rd~al se~en~s Wloth TD. The 2 groups did
not dloffer 'lognloflo~antly lon the freqyency of previous
myocardloal lonfarctloon (J/11 vs. 4/1I) or degree of
coronary luminal narrowing (80±l2% vs. 85~2%.
mea~lSD). Relative regional Tl content lon the a9n0rmal
segments of the PD ,roup (70~6%) was below that lon the~ g~o~p (78±l.(6%). ut the dlofference did not reach
slognloflocance p=.u6. There were more abnormal Tl
segments per patient in the PD groups (3.l±l.7) than in
the TD group (1.9±l.Ot p<.05), J.mplying a greater
severity and extent or loschemloa in the PD group. The
changes after PTCA follow:
Pre-PTCA Post-PTCA
Normal TD PD
PD 16 12 1 3
TD 20 17 1 2
We conclude that PD on Tl scan often revert to normal
after PTCA (12/16 or 75%). This may occur because' (1)~D is d~e to reversible iSChemia; or (2) areas of •
lonfarctlo9n develop normal thallium uptake after
~eperfuslo9n. PD should not preclUde consideration of anlonterventloou. such as PTCA.
PREVALENCE OF HIGH RISK TL-201 SCINTIGRAPHIC FINDINGS IN
PATIENTS WITH CORONARY ARTERY DISEASE: RELATION TO
CORONARY ANATOMY AND ECG STRESS TEST FINDINGS
James ~ Ryan, H.D., Thomas W. Nygaard, M.D., Robert S.
Gibson, M.D., Joseph A. Gascho, M.D., FACC, Denny D.
Watson, Ph.D., George A. Beller, M.D., FACC, University
of Virginia, Charlottesville, Va.
The prevalence of a high risk exercise (Ex) Tl-201 (Tl)
scintigram (scint) was determined in 295 consecutive
patients (pts) with angiographic (angio) ("'50% stenosis)
coronary artery disease (CAD) and co r re lated with extent
of CAD and Ex stress test findings. A high risk scint
by quantitative criteria was defined as either: I) a
typical left main (LM) CAD pattern showing ·25% homo-
genous disease in r t activity in septal and-postero-
lateral walls; 2) a multivessel disease (MVD) pattern
showing abnormal TJ uptake and/or washout in multiple
vascular scan segments; 3) increased Lung TI uptake.
The typical LMCAD pattern was observed in 6 of 43 pts
(14%) with LMCAD compared to 2% of 53 pts with 3VD (p=
0.03), 3% of 99 pts with 2VD (p=0.02) and 2% of 100 pts
with IVD (p=O.Ol). The MVD scint pattern was seen in 67
% of pts with UICAD compared to 49% (p=0.05) in 3VD p t s ,
41% (p=0.004) in 2VD pts and 24% (p=<O.OOOl) in 1VD pts.
Prevalence of abnormal lung T1 was comparable in LMCAD
(42%), 3VD (38%) and 2VD (34%) pt s , but greater than
observed in IVD pts (26%.p=0.05). High risk ECG stress
test was defined as 2 or more of: 1) >2.0 nun of ST };
2) >1.0 nun ST • persisting >5 min post-Ex; 3) ST • at 2.5
METS; 4) >10 nun Hg I in Ex blood pressure. A high risk
ECG stress test was observed in 587. of LMCAD pts com-
pared to 32% of 3VD pts (p=0.009) , 31% of 2VD pts (p=O.
003) and J6% of lVD pts (p<O.OOOl). Eight-siX % of
LMCAD and 70% of 2 and 3VD pts had either a high risk
Ex scint or stress test. Thus, Ex Tl-201 scint appears
useful in identifying high risk CAD pts.
Thursday, March 29, 1984
10:30-1l:45AM Ballroom B
Myocardial Protection
THE EFFECT OF GLOBAL ISCHEMIA AND REPERFUSION
ON LEFT VENTRICULAR GEOMETRY
Gary L. Pellom, MS, Peter Van Trigt. MD, Michael K.
Pasque, MD, Robert N. Jones, MD, Andrew S.
Wechsler, MD,FACC
Duke University Medical Center., Durham, NC
Left ventricular (LV) chamber geometry directly
affects LV function. In functional analyses of
ischemic injury, assumptions concerning the stability
of LV geometry during reperfusion cannot be made
without validation. Eight dogs were instrumented with
an LV micromanometer and ultrasonic crystals to
measure LV major (A), minor (B), and wall thickness
(H) dimensions. On cardiopulmonary bypass (CPB),
hearts were subjected to 30 minutes of normothermic
global ischemia (I), and were reperfused for one hour.
LV filling curves to assess diastolic properties were
obtained on CPB during control (C) and at 30 and 60
minutes of reperfusion (R). The LV was modelled as an
ellipsoid. The minimum unstressed length of each
dimension (Lo) increased significantly from C at 30
and 60 minutes of R, however, the eccentricity (E) of
the LV was not significantly changed:
E LoA(cm) LoB(cm) LoH(cm)
C: .70l!.04l7.043!.214 5.769!.132 1.694!.056
30: .7l2!.038 7.303!.203* 5.989!.13l* 1.806!.065*
60: .7l6!.042 7.369!.202* 5.982!.124* 1.803!.053*
*p<.05 vs control (values are mean!SEM)
These results show that 1 and subsequent R result in
deformations of the A and B dimensions of the 1.V
concomitant with an increase in H. Furthermore,
preservation of E supports the extension of elliptical
modelling to the ischemic LV.
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RISK OF NON-HOMOGENEOUS DELIVERY OF COLD CARDIOPLEGIA
AS MONITORED BY p-31 NUCLEAR MAGNETIC RESONANCE
Glenn J.R. Whitman. M.D •• Russell Roth. B.A•• Jeffrey
Crowley. B.A•• John Haselgrove. Ph.D•• Michael B.
Simson. M.D •• FACC. Alden H. Harken. M.D •• FACC,
University of Pennsylvania. Philadelphia, PA
During multidose, cold (4-8°C) K+ cardioplegia. septal,
LV. and RV temperatures (T) were measur~d in patients
undergoing cardiopulmonary bypass surgery. T beyond
patent vessels varied between 12+30 and 17+30 • Distal
to total occlusions, T varied between 17+30 and 26+20 •
The purpose of this study was to: 1) monitor continuous-
ly myocardial high energy phosphate content during isch-
emia and recovery of left ventricular function follow-
ing graded global cardiac ischemia, and 2) determine
the temporal limits of myocardial preservation afforded
by K+ cardioplegia at 170C and 27°C. Rabbit hearts (30)
were perfused, equipped with an LV balloon, and placed
in an NHR magnet. Phosphocreatine (PCr) fell to 43+4%
and 10+2% of pre-ischemic control at 1 and 10 minutes
of 370-ischemia. ATP fell to 70+3% and 19+7% at 10 and
40 minutes. After one hour of reperfusion~ regression
analysis of final developed pressure (DP) on end isch-
emic ATP concentration (EIATP) revealed: DP z 1.1
(EIATP) + 15.7 (r-0.9l). After one hour of ischemia
with KCl, ATP fell only to 93+2% of control at 17° but
dropped to 68+5% with 27° cardioplegia. Functional re-
covery was 95+5% at 17° but 79+6% at 27°. We conclude
that: 1) EIATP predicts the recovery of LV contractile
function, 2) EIATP < 76% leads to incomplete functional
recovery, 3) maintenance of 17° hypothermia following
single dose K+ cardioplegia provides full functional
protection, 4) myocardium distal to occlusive coronary
disease receives suboptimal protection during standard
multidose cold cardioplegia.
THE PROTECTIVE EFFECT OF BRANCHED CHAIN AMINO ACIDS IN
MYOCARDIAL ISCHEMIA,
Gideon Uretzky,M.D.;Itzchak Vinograd,M.D.;Herbert Freund
M.D.;Esther Yaroslavsky;Yori J. Appelbaum,MSc.;Joseph B.
Borman,M.D.,FACC; Lunenfeld's Cardiac Surgery Research
Center, Hadassah University Hospital, Jerusalem, Israel.
In order to determine the protective effect of Branched
Chain Amino Acids (BCAA) on the ischemic myocardium, a
passively perfused normothermic (370 ) isolated rat heart
model was used. A small latex balloon-tipped catheter
was placed into the left ventricle and used to measure
intracavitary pressures. The times to initiation of
ischemic contracture (IC) and completion of contracture
(CC) were measured in 4 animal groups: I. Each heart was
subjected to initial ten minute perfusion with modified
Krebs-Henseleit (KH) bicarbonate buffer followed by 2min
glucose-free Krebs-Henseleit (GFKH). II. 12 min perfusion
with KH solution. III. 10 min perfusion with 3.Smmol/l
amino-acid formulation containing 42% BCAA, followed by
2 min GFKH. IV. 12 min perfusion with 3.Smmol/l 42% BCAA.
Dose response studies for BCAA were constructed, demon-
strating 3.5mmol/l BCAA as the optimal concentration.
The results of this study are shown in the table:
Group No. Perfusion Time to IC(min)* Time to CCt
-1-- 39 10'KH+2'GFKH lS.9±1. 7 22.4 t1.4
II 20 12' KH 18.2t1.7 24.2 t1.9
III 17 lO'BCAA+2'GFKH 19.4±2.3 2S.4 t2.6
IV 17 12' BCAA 20.1±2.6 2S.S±2.8
All values meantSD. *1 vs II, I vs IV. I vs III-p<O.OOl;
II vs IV p<O.02;tI vs II p,O.002;I vs IV peO.OOl;
In conclusion, BCAA protects the heart against myocardial
ischemic injury, delays the time to ischemic contracture,
particularly in the depleted ischemic heart.
PRESERVATION OF LEFT VENTRICULAR FUNCTION AFTER HYPOTHERMIC
POTASSIlJ4 CARDIOPLEGIA BY SINGLE DOSE VERAPAMIL
Hartmut H.nnlng 14), W.R. Eric J.mleson, 14), FACC, Hilton
Ling, MO, Cheryl A. Devl.s, AN, Donald M. Lyst.r, PhD,
Unlv.rslty of British Columbl., V.ncouv.r, Can.d••
To assess the .ff.ct of r.perfuslon on myocardial
function .ft.r hypothermic cardlopl.gl. (HCl w. comp.red HC
.Ith .nd without V.r.pemlt lVl In 2 groups of 7 dogs. Group
I HC 1370 mClsmlL; K 25 mEq/I); Group II: HC with slngl.
dose V (HC-SOV, 0.5 mg prior to r.perfuslon). Myo-cardl.1
temp.r.tures wer. maintained betw••n 15-19'C for 2 nr s of
Ischeml. during cardlopullllOn.ry byp.ss (CPBl. LV function
w.s me.sured by uI tr.sound as LV Int.rn.1 dI ....t.r
short.nlng (ALl .nd v.loclty of fiber short.nlng (vet), .nd
reglon.1 function .s LV wall thlck.nlng (S4h). Per-fus lon
was measured by mlcrospheres.s .ndo/.plc.rdl.1 flow rat tos
(EEFR) .nd reglon.1 blood flow (RBFl.
At 30 min .ft.r CPB AL declined by 16.!.IO. In Group I
(HC) .nd Incr.....d In Group II (He-SOVl by 15!.12. (p<O.OI).
Vcf declined by 17+10. In I, but Incr••sed by 21+16. In II
(p<O.OOI). Th. me-;n Ah d.creas.d by 431.8. In I,-.nd 15!.8.
In "(p<O.OOll. Systemic vascuter reslst.nces w.r. not
ch.nged .ft.r HC (34.!.12 RUl .nd He-SOV 139.!.14 RUl .nd not
d Iff.r.nt between groups (pNS). EEFR w.s not d Iffer.nt
(pNS) before CPB (I: 0.95!. 0.15, II: 0.B7.!.0.23).nd .ft.r
CPB (I: 1.08.!.0.25. l l : 0.96.!.0.19). Ther. was no corr.l.t Ion
between chang.s In RBF and changes In Ah. we conclude: (I)
LV function I.pel .....nt aft.r HC .nd CPB Is pr.vented by SOV
.t the end of CPB, (2l LV function I..pelrment Is caused by
r.perfus Ion r.ther then by HC per 58, (3) both HC end
HC-SOV do not ch.ng. lIIYocardlel perfusion.
THE ELECTRICAL STATUS OF THE HEART AS A DETERMINANT OF
REINFUSION CARDIOPLEGIA FLOW DISTRIBUTION
T. Bruce Ferguson. Jr., HO; Peter K. Smith, HO; William H.
Buhrman, HO; Gary K. Lofland, lID; James L. Cox, HO.
Duke University Iledical Center, Durham, North Carolina
Using muitiple intramural needle electrodes, low ampli-
tude electrical activity (LEA) undetectable by standard
EKG monitoring has been shown to occur in the atria, AV
node. and ventricles during cardioplegic (CP) arrest at
myocardial temperatures previously thought to prohibit
electrical depolarization. The comparative effects of
total electrical quiescence, LEA. and visible mechanical
activity of the ventricles on the transmural distribution
of CP solution was studied in 23 adult dogs subjected to
40 minutes of CP arrest. Hyperkalemic CP solution (SOO
ml LU. 40C) was infused initially and after 20 min of CP
arrest. CP flow was determined by the radioactive micro-
sphere technique. The atria, AV node, and ventricles
were monitored continuously during CP arrest at septal
temperatures below ISoC. Ventricular endocardial/epi-
cardial (ENDO/EPI) CP flow ratios during the CP reinfu-
sion at 20 min were determined as was the time from CP
reinfusion to rearrest of the ventricles and were as
follows (MiSEU):
n ENDO/EPI Arrest Time (min)
Electrical Quiescence 10 1.22±0.04S 0.0
Only LEA Present 8 I.07±0.047* O.S±O.I*
,1echanical Activity S O.77±O.159* 1.1±0.3*
(*p<O.05 compared to Electrical Quiescence)
Thus, the presence of L~A at the time of CP reinfusion
significantly decreases endocardial CP flow and prolongs
the time to ventricular electrical rearrest. This sug-
gests that CP protection cannot be optimal if LEA is
allowed to occur prior to the time of CP reinfusion.
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S&SP for sVT
S SP
IVES 45% 93%
2VES 76% 87%
3VES 89% 80%
LONG TERM PROGNOSIS OF FASCICULAR CONDUCTION DISTURBANCE
ACQUIRED DURING CORONARY ARTERY BYPASS SURGERY USING COLD
POTASSI UM CARDIOPLEGIA
Diane E. Wallis, MD; John B. O'Conne ll , MD , FACC; Sara h
A. Johnson. MD, fACC; Patrick J. Scanlo n , MD, FACC ,
Loyola University Medical Center . Maywood, II.
We have previously described a high in cidence of benign
transient post-operative f asc i cul a r conduct i on disturb-
ances (FCD) following coronary ar te ry bypas s gr a f t i ng
(CABG ) using col d potassium card i oplegia. To establish
the long term course of FCD. we followed a l l 50
previously reported CABG pat ients (P) fo r 3 year s . P
with an abnormal pre-op ECG (LVH , prior MI, or preexist-
ing FCD) or LV dysfunction were exc lu ded. Per i - op
clinical and hemodynamic variables, and t ime of death ,
funct ional status, and recurrent hos pita l iza t i ons were
compared in P with and those without per i-op FCD. The 31
P (62 %) without FCD (Group I) had no ca rdi ac deaths.
There was 1 peri-op MI and 10% ex pe r i enced late MI. 74%
were NYHA Class I and 26% Clas s II. Grou p II consisted
of 14 P (28%) with transient (less than 24 hours) FCD
(5 RBBB, 2 RBBB and left axis deviation, 5 LBBB, 2 IVCD).
There was 1 peri-op MI in this group. There was 1
cardiac death within 2 months of CABG i n a P with tran-
sient LBBB, and 1 death at 26 months from a neoplasm. 73%
of survivors were Class I. IB% Class I I, and 6% Class III.
Group III included 5 P ( 10%) with permanent FCD; I RBBB .
1 LBB8. and 3 IVCD. At follow-up 60%were Cl as s I and 40%
were Class II. 26% in Group I and 11% of Gr oups II and
III were rehospitalized for ca rdiac sy mpt oms . No
significant differences in any of the variables could be
elic ited between the groups. In conclusion, in patients
with normal pre-operative ventr i cular fun ction transient
FCD acqui r ed during isolated CABG us ing cold potassium
cardioplegia is not associated with an increased
morbidity or mortality at 3 year follow-up .
Thursday, March 29, 1984
8:3O-10:00AM Ballroom C
Use of Programmed Stimulation in
Ventricular Arrhythmias
SENSITIVITY OF A VENTRICULAR STIKULATION PROTOCOL USING
TWO VENTRICULAR EXTRASTIMULI AT TWICE DIASTOLIC THRESHOLD
AND 20mA.
Pedro Srugada. KD; Hoshiar Abdallah, MD; Hein JJ Wellens,
MD, FACC. Dept. of Cardia!., Univ. of Limburg, Annadal
Hospital, Maastricht, The Netherlands.
A stimulation protocol using a lIlsximUll of 2 ventricular
extrastimuli (VE) given during pacing at 100/min at the
RV apex and outflow tract at twice diastolic threshold
(2xT) and 20 mA has been reported to be very sensitive in
identifing patients (pts) after myocardial infarction
prone to Ufe-threatening arrhythmic cOlDpI1catlons. The
sens itivity of this protocol to induce ventricular tachy-
cardia (VT) was prospectively anessed in 20 pts with
clinically documented VT. After the above mentioned
protocol had been perfonned, stimulation was continued
frOID the RV apex, with pacing at 120 and l40/llin and a
lIuimUlll of 3 VE at 2xT. VT wa. inducible in all 20 pt s ,
and was induced in each pt at least twice.
Results: 10 pts were inducible both during 2xT and 20 aA
atimulation. Only 1 pt vaa only inducible during 20 aA
stimulation. In 9 pta VT waa only induced by 2xT stiaula-
tion, but not by 20 aA atimulation . In only 1 of theae 9
pts VT waa induced by aUmulation at 100 b/min and 2 VE
at 2xT. Thia indicates that a stimulation protocol at
100/min frOID RV apex and outflow tract O8inl a mu:iaUll of
2 VE at bT and 20 mA fails to identify 40% of patienta
vith clinical VT. When VT is not induced by 2 VE frOID the
IV apex at lOO/ain at 2xT, increase of pacing rate frOID
RV apex and/ or n_ber of VE to 3 at 2xT is aore effective
to initiate VT tbat increaaing aUmulua strengbt to 20
mA, or chanae of atimulation site to ltV outflow tract.
The. results have important i .. plicationa for the aoat
auccessful order of ventricular stimulation during elee-
trophyaioloaic atudiea to induce VT.
SENSITIVITYAND SPECIFICITY OF INDUCI NGSUSTAINEDVENTRICULAR
TACHYCARDIAS WITHUP TO THREE RIGHT VENTRICULAR EXTRASTIMULI
Jer onimo Far re MD ,Angel Gr ande MD , Ros ana Hernandez MD , Fr anci s
co Marti MD , Pedro Rabago MD . Fund J imenez Diaz ,Madrid ,Spain. -
We have pr osp ectively studied th e sensitivit y (S)and spe c i.f i, -
city( SP)of pr ogrammede l ect r ical stimulation(PES ) rel at ive
to th e i nduc t i on of sustained ventr i cular tachycardia (sVT) .
PES was perf ormed from the RV apex and outflowt r ac t at x2 dias
t oI i c thre sho l d with pul ses 2 ms wide. introducing 1,2 &3 ven-:'
t ricul ar ex tras t imuli(VES) dur ing 3 Vpacing cycl e lengths
(600, 500&400 ms) . When ut iliz ing 201' 3 VES, t he last deliver-
ed impulse was sc anned until V r efractoriness and all preced-
i ng YES had a fixed coupling i nte rva l that was the shortes t pos
sible one >190 ms not resu I t ing i n V repet i t i ve responses. ThiS
pr ot ocol has been used i n 4 gro ups(Gr )of patients (P).Gr A(38 P)
with clinical sVT,Gr B(8 p)with clinical nonsu stained(ns )VT,
Gr C( 16 p)with syncope of unknownorig i n without previous myo-
ca rdial in farction(MI) and Gr D(21 P) with previous MI and
studied for various reasons but without clinically documented
VT .The r esults are shown in the t ables.
Results of PESYES to induce sVT
Group P sVT nsVT no VT IYES 2VES 3VES
A:sVT 3834-2---2- -1-7- --12- --5-
B:nsVT 8 0 2 6
C: synco pe 16 21 0 14 2
D: MI 2 1 72 4 10 3 1 3
Iboth were mult i fo rmVT degenerating into V Fibrillation(F )
26/ 7 VTwer e uniformand did not degenerate into VF
CONCLUSIONS:PES protocol s uti lized to indu ce sVT gain in S and
l ose in SP by increasing th e number of VES from I to 2 . and from 2
t o 3. In con t r as t with other invest igators I statements ,we can
i nduce uniform sVT in pat ients with prev ious MInot hav ing so
far developed this arrhythmia cl i nica l l y .To determine the cl i
ni cal s i gnificance of sVT induced by PESin patients with a -
pr evious MI,it is urgently needed to unify the protocols of sti
mulat i on us ed at different laboratories. -
PROGRAMMED ELECTRICAL STI MULATION TO PREDICT LATE SUDDEN
DEATH I N SURVIVORS OF COMPLICATED MYOCARDIAL I NFARCTION
Lawrence E. Waspe. MD. FACC; David Seinfeld. MD . FACC;
Ai l een Ferrick ; Dani el Fi nk ; Gal e Scavi n; Mar k Wanl i s s ;
Soo G. Kim. MD. FACC ; Jeffr ey A. Matos . MD; Joh n D.
Fi sher. MD . FACC. Montefiore Medica l Center . Bronx. NY .
I nduct i on of ventricular arrhythmi as by programmed
e lectrical s timul a t ion (PES) i n t he recovery phase of
acute myocardial i nfar cti on (MI) may i ndi cate high risk
of late sudden death. We eva l uated the pro gnos t i c s igni-
ficance of ventricular arrhythmias i nduced by PES in 48
pa t ients (pts) (age 65~10 years) survi vi ng MI complicated
by: conduc t i on block (41 pts). heart failure (28 pts).
and/ or ventr icul ar tachycardi a (VT) (22 pt s ) . PES was
performed 7-36 days after MI on no antiarrhythmic therapy.
using extrastimul i (ES) at 4X di astOlic threshold at 1- 2
RV sites : s ing le ES-4 8 pta . single and paired ES- 40 pts .
and a maximum of 3 ES- 26 pts . Two gro ups were identi f ied:
17 pts with >7 repe ti t i ve ventricular responses (RVR) to
some form of PES (11 pts had VT >15 sec). and 31 pts with
0- 7 RVR t o maximal PES e ffor t s. The groups di d not differ
in age . c l i ni ca l s tatus . LV ejection frac t i on. HV inter -
val . or incidence of spontaneous VT . However. inducti on
of >7 RVR was associated wi t h sudden death dur ing 18. 3+
14. 6 mas of fo l low up (5/1 7 vs 0/ 31 pts with 0-7 RVR . -
p<.Ol) . Identificat ion of pts Wi t h sudde n death was
r e l ated to maximum number of ES used : 1 ES-none . 2 ES- l
pt . 3 ES-4 pts (sensi t i vi t y of PES wi t h up to 3 ES;lOO\.
speci f i ci ty;52\) . Ant iar rh ythmi c dr ugs were used more
of ten in pt s with >7 RVR (8/17 vs 5/ 31. p<.05). but
a- bl ocker . pacemaker . and surg i ca l t herapy did not di ffer
bet ween t he groups. Conc l us ions : In duction of >7 RVR i n
t he r ecovery phase of complica t ed MI may i den t i f y a group
a t high ri sk of late sudd en death i ndependent of ot her
r iSk fac tors Or t herapy. PES with 3 ES may be r equ ired t o
iden t ify high risk pt s . although spe cifi city i s reduced.
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PROGNOSTIC SIGNIFICANCE OF INDUCIBLE VENTRICULAR
TACHYCARDIA AFTER MYOCARDIAL INFARCTION
A.R. Denniss FRACP, D.V. Cody FRACP, B. Ho MB, P.A.
Russell FRACP, A.A. Young FRACP FRCP, D.L. Ross FRACP FACS
J.B. Uther FRACP, Westmead Centre, Westmead, Australia.
A previous study from our group indicated that patients
with >lOsec of inducible ventricular tachycardia (VT) or
fibrillation (VF) after myocardial infarction (MI) are at
increased risk of subsequent clinical ventricular tachy-
arrhythmias (VA), either spontaneous VT or instantaneous
death. The current study sought to evaluate the relative
prognostic significance of inducible VT versus inducible
VF in a new cohort of patients.
From July 1981-July 1983, 290 patients (~65 years) with
transmural MI (45% anterior) underwent programmed right
ventricular stimulation (PS) with ~2 extrastimuli 1-4 weeks
after MI; no patients had manifested spontaneous VT >2
days after MI. After PS, 59 patients with inducible VT or
VF were placed on antiarrhythmic therapy (AA). During
follow-up (mean 7 months), 15 patients developed VA.
Results: [Inducible VT or VFI (No VT or VF induciblel
___ ............... No AA
VF VT
,....-'6 6'-", 194
AA No AA AA No AA 1
18 28 21 29
~ ~ ~ ~
OVA 1 VA 2 VA 5 VA 7 VA
(O\) (3.6\) (9.5%) (l7.2\) (3.6%)
~NS--'L...-p < 0.01---'
Sensitivity of inducible VT (AA + no AA) as a predictor of
VA is 47\ and specificity is 84% (odds ratio = 4.7). Com-
bining inducible VT and VF, sensitivity is 53%, specifi-
city 68% (odds ratio = 2.4).
Conclusion: Inducible VT rather than inducible VF
implies risk of VA.
A PROSPECTIVE STUDY OF PROGRAMMED CARDIAC STIMULATION IN
PATIENTS WITH HIGH GRADE ECTOPY. ELECTROPHYSIOLOGIC FIND-
INGS AND PROGNOSIS FOR SURVIVAL.
Joseph Gomes, MD,FACO; Robert Hariman, MD,FACC; Nabil El-
Sherif ,MD ,FACC; Juliann Lyons,RN; Philip Barreca,BS,SUNY
Downstate and VA Medical Centers, Brooklyn, N.Y.
The significance and treatment (Rx) of ventricular
premature beats (VPB) in patients (pts) without sustain-
ed (sust) ventricular tachycardia (VT),sudden death (SD),
or syncope (Sy) remains unclear. We undertook a prospec-
tive study of programmed cardiac stimulation (PCS) (up to
2 extrastimuli and burst pacing) in 73 pts (age=60±lOyrs)
with high grade VPB's who had no evidence of sust VT/SD
or sy(48 hr rest + 48 hr holter monitoring).78% had isc-
hemic heart disease;14% had myopathy and 8% no evident
heart disease; 51% had Lown's grade IVB; 41% grade IVA
and 8% grade III VPB's. PCS identified 2 groups (Gr):Gr 1
(inducible)comprised of 20 pts (27%) in whom VT or ven-
tricular fibrillation was induced. Gr 2(non-inducible)
comprised of 53 pts (73%) in whom no significant ventri-
cular arrhythmias were induced. There was no significant
difference in the grade of VPB's between the 2 Gr's.Gr 1
pts were placed on PCS guided antiarrhythmic (AT) Rx.
Gr 2 pts were randomized to prophylactic AT Rx. A total
of 70 pts have been followed for 30±15 months. The inci-
dence of sust VT and/or SD (31.5% v 2%,p<.001) and car-
diac death (CD) (26% vs 7.8%,p<.04) was significantly
higher in Gr 1 when compared to Gr II. There was no dif-
ference in SD or CD in the treated vs non treated pts in
Gr II. The probability of surviving 1 yr (0.75 vs 1.0)
and 48 months (0.35 vs. 0.67) was significantly lower
(p<.0008) in Gr 1 compared to Gr 2. In conclusion: (1)
PCS defines a high risk and a low risk subset for SD in
pts with high grade VPB's (2) non inducible pts have a
low incidence of SD and an excellent survival; these pts
do not need prophylactic AT-Rx.
PROGRAMMED VENTRICULAR STIMULATION AFTER
CORONARY ARTERY SURGERY IN PATIENTS WITHOUT
ANTECEDENT HISTORY OF VENTRICULAR TACHYCARDIA
Richard W. Henthorn, MD, Mark D. Cohen, Vance J. Plumb,
MD, FACC, Albert L. Waldo, MD, FACC, University of
Alabama, Birmingham, Alabama.
We studied 23 patients (pts) with no antecedent history of
syncope, documented sustained ventricular tachycardia or
cardiac arrest by 24 hour ambulatory monitoring and
programmed ventricular stimulation seven days after coronary
artery bypass surgery and followed them prospectively.
Programmed ventricular stimulation consisted of 1, 2, ~ 3
premature extrastimuli and burst pacing from temporary right
and left ventricular wire electrodes. There were five pts with
inducible sustained ventricular tachycardia {IVT}, 2 requiring
cardioversion and 3 pacing for termination. The rernalnjng 18
pts had a mean maximum inducible repetitive ventricular
response (IRVR) of 3 (range 1-7). There was no statistically
significant difference between the IVT group and the IRVR
group when comparing preoperative ejection fraction (37 t 16
vs 49 t 16), premature ventricular beats per hour (123 t 169 vs
113 t 204), maximum spontaneous repetitive ventricular beats
(3.2 t 2 vs 3.2 t 4), preoperative coronary anatomy (2.8 vessels
± .4 vs 2.7 t .6), presence of segmental disease, age, and
follow-up period in months (13 t 8 vs 11 ± 5). Two of 5 IVTpts
had events: I-ventricular fibrillation with sudden death, 1-
ventricular tachycardia (VT). One of 18 IRVR pts had VT, but
had been placed on quinidine empirically. We conclude that: 1)
there is a 22% incidence of inducible ventricular tachycardia
in this study population without history of spontaneous
ventricular tachycardia, and 2) while not statistically
significant, there is an early trend suggesting that inducible
ventricular tachycardia patients may be at increased risk for
spontaneous ventricular tachycardia.
Thursday, March 29, 1984
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WolfT-Parkinson-White Syndrome
SURFACE ELECTROCARDIOGRAPHIC CLUES SUGGESTING THE
PRESENCE OF A NOOOVENTRICULAR MAHAIM FIBER
Gust H. Bardy, MD; John M. Fedor, MD; Lawrence D.
German, MD; Douglas l. Packer, MD; John J. Gallagher,
MD, FACC, Duke University, Durham, NC.
Standard 12 lead electrocardiograms (ECG) were
reviewed for features that might be characteristic of
tachycardia utiliZing a nodoventricular Mahaim fiber
from 87 consecutive patients with left bundle branch
block morphology tachycardia analyzed during detailed
electrophysiologic studies. The study population
consisted of 13 patients with documented nodo-
ventricular tachycardia, 34 with supraventricular
tachycardi a and aberrant conduction over the
His-Purkinje system, 22 with ventricular tachycardia,
and 18 with antidromic tachycardia utiliZing a
right-sided accessory atrioventricular pathway.
Six ECG parameters dur ing 1eft bund1e branch block
morpho logy tachycard ia were predict i ve of a nodoven-
tricular fiber when all six were present: cycle length
between 220-450 ms; QRS axis of 00 to _750 ; QRS
duration < 0.15 sec; "R" in limb lead 1; "rS" in pre-
cord ia1 lead VI; and a precord iaI trans it ion from a
negative to a positive QRS after V4. Al1 six criteria
were present in 16/87 pat i ents. No pat ient with ven-
tricular tachycardia satisfied these criteria whereas
3/34 with supraventricular taChycardia, 1/18 with anti-
dromic tachycardia, and 12/13 with tachycardia
utilizing a nodoventricular fiber did. If all six
electrocardiograph ic features were present, the
predictive value was 75%. We conclude that analysis of
the surface electrocardiogram during tachycardia may
suggest the presence of a nodoventricular fiber.
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MECHANISMS OF VERAPAMIL-INDUCED CONDUCTION BLOCK IN
ANOMALOUS ATRIOVENTRICULAR BYPASS TRACTS
Der Yan Tai, MD; Mau-Song Chang, 1m; Benjamin N. Chiang,
MD, FACC: Ruey J. Sung, MD, FACC, Veterans General Hos-
pital, Taipei, Taiwan, China and San Francisco General
Hospital, University of California, San Francisco, CA.
Verapamil, a calcium-channel blocker, has been demonstrated
to have no direct electrophysiologic effect on anomalous
atrioventricular (AV) bypass tracts (BT). Of 39 patients
(pts) with AV reciprocating tachycardia utilizing left-
sided parietal BT for retrograde conduction, intravenous
infusion of verapamil (0.15 mg/kg body weight) terminated
the tachycardia in 31 pts. Verapamil consistently de-
pressed AV nodal conduction, however, verapamil inter-
rupted AV reciprocating tachycardia circuit by induction
of retrograde conduction block of BT in 5/31 pts. The
occurrence of this latter phenomenon could be accounted
for by two distinctly different mechanisms: (1) In 3 pts,
verapamil induced alternating fast and slow conduction
in the AV node resulting in alternating short and long
cycle lengths during the tachycardia; consequent develop-
ment of the Ashman phenomenon in BT terminated the tachy-
cardia and (2) In the remaining 2 pts, left-sided parietal
BT exhibited refractory-dependent progressive conduction
delay similar to that of the AV node; verapamil provoked
development of the Wenckebach phenomenon in BT, thereby
terminating the tachycardia. We conclude that, depend-
ing on functional properties of BT, verapamil may inter-
rupt the AV reciprocating tachycardia circuit by exert-
ing direct or indirect depressive action on BT.
PREEXCITED RECIPROCATING TACHYCARDIA IN THE WOLFF-
PARKINSON-WHITE SYNDROME: INCIDENCE AND MECHANISMS
Gust H. Bard~, MD; Douglas L. Packer, MD; Lawrence D.
German, MD; ohn J. Gallagher, MD, FACC; Duke
University, Durham, North Carolina.
Electrophysiologic studies were performed in 424
patients referrea for evaluation of Wolff-Parkinson-
White syndrome. During the electrophysiologic study, 40
patients (9%) had preexcited reciprocating tachycaraia
(RT) defined as a reentrant tachycardia that utilized an
accessory atrioventricular (AV) pathway for antegrade
conduction and the AV node and/or another accessory
pathway for retrograde conduction.
Preexcited RT occurred in 21/366 (6%) patients with
single accessory pathways compared to 19/58 (33%) with
multiple accessory pathways (p<O.OOI). In the 21
patients with a single accessory pathway and true
antidromic RT, all accessory pathways but two were at
least 4 cm from the AV node. No patient with true
antidromic RT had a posterior septal accessory AV
pathway. Only in patients with multiple accessory
pathways was a posterior septal accessory AV pathway
used as the antegrade limb.
We conclude that preexcited RT is a rare tachycardia
most likely observed in patients with multiple accessory
pathways. True antidromic RT utiliZing a posterior
septal accessory pathway is distinctly unusual. In
patients with a single accessory AV pathway and
antidromic RT, proximity of the accessory pathway to the
AV node (i.e. < 4cm) may decrease the likelihood of
functional dissociation between the two pathways
necessary for the initiation of reentry.
ELECTROPHYSIOLOGIC DEMONSTRATION OF CONCEALED CONDUCTION
IN ANOMALOUS ATRIOVENTRICULAR BYPASS TRACTS
John T. Svinarich, MD: Edmund C. Keung, MD; Ruey J Sung,
MD, FACC; Letterman Army Hospital and the Cardiovascular
Research Institute, University of California, San Fran-
cisco, CA.
Concealed conduction (CC) is defined as the effect of a
nonpropagated impulse on subsequent impulse conduction.
To demonstrate the occurrence of this unique electro-
physiologic phenomenon in anomalous atrioventricular (AV)
bypass tracts (BT), nine patients with the Wolff-Parkin-
son-White syndrome were studied. All patients had left-
sided BT capable of both antegrade (Ant) and retrograde
(Ret) conduction. Multiple pairs of catheter electrodes
were placed in the high right atrium, coronary sinus, AV
junction and the right ventricle (RV). After every eighth
atrial or RV driVing beat (51) at a constant cycle length,
two successive atrial or RV premature beats (52 and 51)
were delivered. The 5l-S interval was fixed at 20-30
msec more than the effect!ve refractory period (ERP) of
the atrium or RV but less than the ERP of BT in Ant or
Ret direction. This allowed 52 to capture the atrium or
RV but no BT. The 53 was delivered from late diastole
with a progressively shorter 52-53 interval until atrial
or RV refractoriness was encountered. Of note, the pre-
sence of 52 prevented Ant or Ret conduction of 51 over BT
despite 51-53 intervals being longer than the Ant or Ret
ERP of BT. Moreover, removal of 52 invariably resulted
in the resumption of Ant or Ret conauction of 5, over BT.
We conclude that CC occurs in BT in both Ant and Ret
directions and the technique 515253 electrical stimulation
may be used to quantitate CC in BT.
EFFECT OF EXERCISE ON ORTHODROMIC TACHYCARDIA INDUCTION
AND TERMINATION 8Y PACING.
Robert Frank, MD; Guy Fontaine, MD, FACC:
Joelci Luiz Tonet, MD: Yves Grosgogeat, MD.
Hopital Jean Rostand, Ivry, France.
MATERIAL AND METHOD: 10 patients,S with bidirectional, 5
with unidirectional retrograde atrioventricular (AV) con-
duction through an AV accessory pathway, were submitted
to bicycle exercise test from 20 to 140 watts, with 6
minutes and 30 watts steps. Left atrium was paced through
a temporary coronary sinus quadripolar electrode.
Measurements were done in the supine, sitting position
and for each step of the exercise : (1) Atrial, Kent and
AV nodal effective refractory periods (ERP) on sponta-
neous rate, and on paced rate at 130/mn. (2) Orthodromic
reentrant tachycardia (ORT) was induced with the same
pacing procedure. (3) ORT was then interrupted by one or
more atrial premature stimuli.
RESULTS: (1) ERP constantly shortened with exercise
(\i<.01 at 50 watts). (2) Induction rate of ORT by extra-
stimulus on sinus rhythm and on a DO/mn atrial driven
rhythm was hIgher when the patient was seated (80%. and
~%) than in the supine (64% and 23%) position due to a
more important decrease of AV nodal ERP than Kent ERP.
(3) ORT was faster with exercise due to a shorter AV
conduction when VA conduction did not change (~.Ol).
(4) Shorter coupling interval and more pacing stimuli
were needed to stop the tachycardia due to shorter nodal
RP and to the parallel shortening of atrial ERP and AV
conduction time with exercise.
This may explain the failure of automatic antitachy-
cardia pacemaker in terminating ORT by one extrastimulus
in upright position or at exercise.
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THE EFFECT OF POSTURE AND EXERCISE ON THE
ELECTROPHYSIOLOGICAL PROPERTIES OF DIRECT
ATRIOVENTRICULAR ACCESSORY PATHWAYS
Ghazwan S. Butrous, MB; Anthony W. Nathan, MB; Rodney S.
Bexton, MB; Kevin J. Hellestrand, MB; A. John Camm, MD,
FACC, St. Bartholomew's Hospital, London, England.
This study was performed to evaluate anterograde (A) and
retrograde (R) accessory pathway effective
refractoriness (ERP) and conduction in 11 patients
whilst at rest in both supine and upright positions, and
during supine isometric and upright treadmill exercise:
supine upright isometric treadmill
A ERP 321+117 260+48 NS 328+123 NS 249+43 NS
R ERP 274~23 252~14 p<O.05 296~35 NS 249~17 NS
Standing caused the largest change (maximum of 18%-in A
ERP and 35% in R ERP) While very little additional
decrease was observed after treadmill exercise( maximum
of 8% in A ERP and 6% in R ERP). There were no
significant changes on standing if the anterograde ERP
was less than 240 ms or the retrograde ERP was less than
270 ms. In patients with refractory periods above these
values, refractoriness decreased in all with the largest
percentage change occurring in those with the longest
refractory periods. Isometric exercise whilst supine
showed variable and inconsistent changes in both A ERP
and R ERP. There was a significant shortening of
orthodromic tachycardia cycle length on standing
(377+117 to 317+94 ms, p<0.05) due to shortening of the
AV interval (235~120 to 175+104 ms, p<0.05) with little
effect on the -VA interval. Similarly VA intervals
measured during constant rate ventricular pacing were
identical quring supine, standing, isometric exercise
and treadmill exercise. Both postural changes and
treadmill exercise affect the accessory pathway their
predominant effect is on the AV node.
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Assessment of Cardiac Function by
Doppler Echocardiography
VALUES FOR INTRACARDIAC BLOOD FLOW VELOCITY BY DOPPLER
ULTRASOUND IN NORMALS: RELATION TO AGE, SEX, HEART RATE,
AND BODY SURFACE AREA.
Rodney Handshoe, MO, Sharon Handshoe, Oi Ling Kwan, James
Cooper, MO, Anthony DeMaria, MO, FACC; University of
Kentucky, Lexington, KY
Few data exist regarding normal values for maximal blood
flow velocity(VEL) by doppler. We performed continuous(CW)
and pulsed(PD) wave doppler in 60 clinically normal sub-
jects (29 in whom catheterization was normal) ages 13 to
87. Systolic(SYS) and diastolic(DIA) VEL were obtained by
CW and PD from the ascending aorta(Ao) via the supra-
sternal notch, from left ventricular outflow tract(LVOT)
and left ventricular inflow tract(LVIT) with the ultra-
sound beam oriented from the apex, and from right ventri-
cular inflow tract(RVIT) and pulmonary artery(PA) with the
beam directed from parasternum. In addition, VEL was also
measured'by PD in the left atrium(LA). VEL (mean and stan-
dard deviation) in cm/sec for CW were: Ao(SYS) 115±23,
LVOT(SYS) 107±17, LVOT(DIA) 39±37, LVIT(DIA) 83±15, RVIT
(DIA) 71±14, PA(SYS) 88±20. VEL for PD were: Ao(SYS) 117±
22, LVOT(SYS) 106±19, LVOT(DIA) 6±22, LVIT(DIA) 82±15,
RVIT(DIA) 53±13, PA(SYS) 90±15. Difference in VEL between
CW and PD for LVOT(DIA) was statistically significant (P<
.0001). Values for SYS VEL by CW with the beam oriented
through the LA was greater than that obtained by PD posi-
tioned in the atrium [41±28(CW),11±26(PW),P<.0001]. No
significant correlation of heart rate, sex, or body sur-
face area with VEL was demonstrated; however, a statisti-
cally significant reduction of velocity of nearly 0.5
cm/sec/yr for the aorta and 0.2 cm/sec/yr for the PA was
shown. Thus, these data establish normal values for flow
VEL by doppler. CW yields higher velocity than PD in the
LVOT(DIA) and LA(SYS) probably due to superimposition of
flow sampling. Peak Ao and PA VEL significantly de-
creases with age but is not related to heart rate, sex, or
bodY surface area.
DETERMINATION OF LEFT VENTRICULAR PEAK DIASTOLIC FILLING
RATE WITH PULSED DOPPLER ECHOCARDIOGRAPHY: COMPARISON
WITH CINEANGIOGRAPHY.
Roxann Rokey, MD; William Zoghbi, MD; Lawrence Kuo, MD;
Marian Limacher, MD; Miguel A. Quinones, MD, FACC; Baylor
College of Medicine, Houston, TX.
Early peak diastolic filling rate (PFR) is a useful index
of LV diastolic function. Peak early velocity of blood
flow through the mitral annulus (peak V) as measured by
Doppler echocardiography (echo) may reflect LV PFR. Ac-
cordingly, we compared PFR derived by LV angiography and
Doppler in 18 patients, none of whom had aortic regurgi-
tation or mitral stenosis. Ejection fraction was normal
in 14 patients (Group A) and depressed in 4 (Group B).
Angiographic PFR (cc/sec) was derived from the derivative
of the LV volume curve (30-60 frames/sec). Doppler PFR
was calculated as peak V (cm/sec) times mitral annular
area (cm2 ) by two-dimensional echo. A normalized PFR
(NPFR) in sec- j was obtained for each technique by divid-
ing PFR by end-diastolic volume derived from the angio-
gram or echo. Doppler PFR (276±206) and NPFR (1.9±0.8)
correlated well with angiographic PFR (267±184) and NPFR
(1.9±0.9)(r=0.89 and 0.86 respectively). Peak Valso
correlated with angiographic PFR (r=0.69) and NPFR(r=0.70) (p<.002).
PFR
Doppler Angio
Group A 308±221 311±186
Group B 166±41t 113±38*
*p < 0.01; tp < 0.05
Thus, NPFR by Doppler is a sensitive indicator of LV
diastolic filling that correlates well with angiographic
NPFR. Although peak V is simpler to measure, overlapping
of values between groups A and B were observed. A peak
V<40, however, was always associated with reduced NPFR.
RELATION BE'1WEDI OOPPLER 'lRANSMI'mAL DIAS'IDLIC FIaI
AND IEFT VEmRICIlLAR FILLIKi
Ali mbpstani. MDI Warren D. Johnston, MD; Jonathan M.
Tobis, MD, FACe; Julius M. Gardin, MD, FACe; Alice
Allfie; Cora Burn, R.N.; Walter L. Henry, MD, FACe;
University of california, Irvine, CA.
Measurement of flow velocity through the mitral valve
(MV) by ~ppler has been suggested as a method for
evaluating left ventricular (LV) CCqlliance. To
determine if diastolic MV flow velocity is closely
related to LV filling we obtained transmitral pulsed
D.:>ppler flow velocity recordings in 10 IBtients (pts)
in whan digital subtraction LV angiograms were
performed. Peak flow velocity in early diastole (PFVE)
and peak flow velocity during atrial systole (PFVA)
were measured fran each D.:>ppler flow tracing and the
ratio of pFVA/PFVE (AlE RATIO) was calculated. LV
volume changes c:iJring diastole were determined fran
videodensitanetric analysis of digital LVangiograms
and the percent LV vollllle change at 50% of total
diastolic filling time was calculated. Mid-<1iastolic LV
vollllle changes were closely correlated with PFVE (r =
0.92) and the AlE RATIO (r=O.90). Five of the 10 pta
had catpleted at least 65% of LV diastolic filling by
50% of diastole and all had PM >40 an/sec and AlE
RATIO <1.0. In contrast, the other 5 IBtients had
reduced early and mid-<1iastolic filling so that less
than 65% of the LV vollllle change had occurred by 50% of
diastole and all five had PtVE <40 cnv'sec and AlE RATIO
> 1.0. we conclude that 1) IBtients with abnormal
diastolic LV filling have a depressed early diastolic
filling velocity ~ted by an algnented atrial
flow velocity 2) Doppler transmitral diastolic flow
measurements appear to be a useful noninvasive method
to assess LV diastolic filling characteristics.
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MFA
tOIINVASIVE S'lUDIES CF VamUOJLAR FILLmi wrm OOPPInl.
EaIX1IRDIcx;w>HY:~ OF 1lGINi ctl EARLY AND LAn:
DIMJDLIC 'mANSMI'DW. PUM
Juliua M. Gardin. MD, FAa;7 Ali Dabestani, MD, Mary K.
RcJban, MIlrk Sklansky, Raymond Garcia, Margaret Knoll,
walter L. Henry, MD, FNX., Long Beach VA Medical center
and University of California, Irvine, CA
Previous studies usin9 various techniques have dem0n-
strated thicker left ventricular (LV) walls and altered
LV fillin9 characteristics with aging. Recent Dowler
studies of m1tral valve (MV) flOli suggest that this
method m19ht pt'ovide useful informatioo aIxlut LV fillin9
(and possibly <XIIPliance). Before Dowler fIN flOli
recordings can be used to evaluate patients with
susPecte<1 alteratioos in LV filling and <XIIPliance, it
is iftIx>rtant to waluate the effects of age on fIN flOli
velocity parameters. l\CCOrdi~ly, we studied 38 adllt
notmals (ages 21-70 years) using pulsed Dowler echo to
record MV flOli velocity fran the apical four""1:hantler
view. All subjects had a noIlllll1 EKG, chest x-ray, and
fHlIlde echo and no history of hypert:.enBicn or cardiac
disease. Peak flOli velocity in early diastole [PFV(E) I
and cl1ri~ atrial systole [PFV(A) I were measured and a
ratio (A/E RM'IO) CQItlUted. Results are sUlIIlI&Iized belOli
for the youngest and oldest age 9I<qlIl:
lQ; GIQIP I n W!g) W!Al AlE RATIO
21-40 I 13 66f;9 40.±7 0.6llO.13
51-70 I 17 I SD±lO* I 54t,9i' I l.l3iO.37*
*p<0.001
OUr results dIIDcrlstrate a decrease in early diastolic
filling velocity, and increases in atrial systolic
velocity and AlB MrIO with aging which IIIISt be taken
into account when evaluating patients with suspected
alterations in LV f~.
ASSESSMENT OF RIGHT VENTRICULAR COMPLIANC E USING
DOPPLER ECHOCARDIOGRAPHY.
Benoit Diebold, MDjGenevleve Colonna, MD; Rabea Touati, MDj
Didier Blanchard, MD; Pierre Peronneau, PhD; Jacqueline Forman,
MD; Jean-leon Guermonprez, MD and Pierre Maurice, MD. Clinique
Cardiologlque et Unite INSERM 256, H6pltal 8roussals. Paris. France.
The non Invasive diagnosis of Impaired right ventricular diastolic
filling is Important, especially In case of perlcardlal effusion;
unfortunately, It Is up to now often difficult. For this purpose, thrs
study has been designed to test the Interest of non Invasive analysis
of velocity curves at the level of vena cava, using Doppler
Echocardlography. .
Velocity masurement have been pertormed with the ultrasonic probe
located in the epigastricarea or the the lower right Intercostalspaces
and the sample volume positioned within vena cava or venae
hepaticae, using echo landmarks.
Typical modifications of vena caval velocity curves (VC) have been
described by stUdying 5 patients with cardiac tamponade (I) before
and after relief of ( : in case of I, the normal negaflve diastoliC
component either disappears or is modified by (he occurence of a
middiastofic reversal flow.
The sensitivity and the specificity of these pattems have been
blindly studied on a series of 265 consecuflve patients who all
underwent both right heart catheterization and VC analysis. Among
those patients, 13 demonstrated a deep plateau on the right
ventricular pressure curve: 12 of them had typical VC modifications,
the remaining one had normal VC but his deep plateau appeared only
during respiratory manoeuvers, None of the 254 other patients
showed evidence of Impaired right ventricularfilling on their VC. The
calculated senslllvity was, therefore, or 900/0 and the speciflly or
100')(,.
In conclusion, recording or blood velocity curves at the level of
vena cava, uslng Doppler Echocardlography, allows an accurate
detection of Impaired right ventricular IIIling, namely in case of
perteardial effusion.
AN IMPROVED METHOD FOR ESTIMATION OF PULMONARY ARTERY
PRESSURE USING DOPPLER VELOCITY TIME INTERVALS
Leng Jiang, MD; William J. Stewart, MD; Mary Etta King,MD;
Arthur E. Weyman, MD, FACC; Massachuset t s General Hospital,
Boston, MA
Doppler velocity patterns of pulmonary arterial (PA) flow
in patients (pts) with pulmonary hypertension (PH) are
characteris tic, with a late onset , early peak, and early
cessation. To determine which Doppler velocity time in-
tervals correlated best with systolic, diastolic and mean
PA pre ssure (PASP, PADP and KrA), we studied 22 pts, in-
cluding 16 with low cardiac output and 8 with RV failure,
by pulsed Doppler echocardiography within 1.9 days (range
0-7 days ) of cardi ac catheterization. Two pts with bundle
branch block were excluded. There were 8 pts with normal
PA pressure (PAP), 14 with PH (mean PAP 35.3 mmHg, range
23- 55) . PA Doppler velocity time intervals at the pulmonic
valve level were measured as follows: 1) Q wave to onset
of flow (Q-O); 2) onset of flow to peak velocity (O-P);
3) onset t o cessation of flow (O-C). Correlations (r) with
PAP were:
Q-O/O- p O-p/O-C O-P Q-O/O-C
0.87 -0.79 -0 .83 0.61
0.85 -0.74 -0.80 0.66
0.86 -0.76 -0.80 0.63
(p value~.002 for all correlations)
The best cor rel at i on with PAP was Q-O/o-P. Intervals re-
ported by previous authors. O-P/o-C, Q-O/O-C and O-P,
correlated less well. Q-O/O-P~l.l was present in all pts
with PH and in no pt with normal PAP, and can be readily
estimated at the bedside. In conclUSion, the Doppler velo-
ci ty time interval, Q-O/o-p is a new, accurate and con-
veni ent non-invasive predictor of PAP even in pts with low
car di ac out put and/ or right hear t failure .
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Echocardiography: Applications in Coronary
Artery Disease
TWO DIMENSIONAL ECHO DETECTION OF IMPROVED WALL MOTION
AND LEFT VENTRICULAR FUNCTION IMMEDIATELY AFTER EXERCISE
IN EARLY POST MYOCARDIAL INFARCTION PATIENTS
Lo ui s J . Del l Tl t al i a , MD; K. Wray Amon, BS; Michael H.
CraWford, MD,FACC;University of Texas Health Science Cntr
and Veterans Administration Hospital, San Antonio, Texas
Improvement in regional wall motion abnormalitie~ (WM~)
and left ventricular (LV)ejection fraction (EF) lmmedl-
atel y after upright exerci se may be of valu~ f?r det~ct­
ing LV re serve in patients (pts) with chronlc lschemlc
heart di sea se and an abnormal res ting EF . However, no
information exi sts concer ni ng immediate post-exerci se LV
funct ion in pt s early after acute myocardial infarction
(MI ) . Thu s , we successfully recorded biapi cal two-
dimens ional echoes in 27 of 40 (68%) acute MI pt s before.
during and immediately after « 30 sec) upright bicycle
exercis e pr i or to hospital discharge. EF was calculated
f rom meas ur ement s of LV volume at end-diastole and end-
sys t ol e usi ng Simpson's r ule. Also , wa l l mot ion was
scored vi suall y for 5 segment s in each apical view
(10 to ta l ypt ) using : 0 =normal , l=hypokinetic, 2=akin-
et ic and 3=dys ki net i c . Resting EF was 45~lO% (SO) a~d
did not change s i gni f i cant l y at peak exercise ( 4 5~ 1 3%) .
Immed iate post exerci se EF increased s i gni f i cant l y to
54~13% compar ed to rest and peak exercise (p<.OOl). Also,
166 of 270 potential segments showed resting WMA and 167
had WMA a t peak exerc i se . Improvement wa s noted immed-
iate ly post-exerCise in 68 of the 166 segments (41%)
with resting WMA . Average WM scor e/ 10 segments improved
from .81+ .6 at rest to .6 0 ~ .6 immediately post-exercise
(p<.05) . We conclude that in pt s early after MI, ass:ss-
ment of LV function by 2-D echo immediately after uprlght
exercise frequently demonstrates areas of reversible WMA
and improved LV function which may be of prognostic and
th erape uti c importance.
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COMPARATIVE RECOGNITION OF LEFT VENTRICULAR
THROM818Y ECHOCARDIOGRAPHY AND
CINEANGIOGRAPHY
Toshihiko Takamoto, MDj Ducksoo Kim, MD; Paul M. Urie, MD;
Diana F. Guthaner, MD; Helen J. Gordon, MD; Andre Keren, MDj
Richard L. Popp, MD, FACC; Stanford University School of
Medicine, Stanford, CA.
Negative predictive accuracy is quite good for both methods.
The superior positive predictive accuracy of 2DE is due both to
detailed soft tissue resolution by 2DE and to overdetection of
mural thrombi by ANGlO in cases of aneurysms without mural
thrombi. Mural thrombi were present in 3 of 20 pts with
preceding anticoagulation and in 10 of 19 pts without anti-
coagulation, and there was a statistically significant difference
between these two groups (p <0.05). The results emphasize that
2DE is more reliable than ANGlO when recognition of thrombus
is important. Anticoagulation reduces the presence of thrombus
chronically.
ConcIus ion: 1. SK I does not reduce the inc idence of CLOT
following AMI. 2. CLOT is present as early as 4 hours
after AMI. 3. SKI may reduce the incidence of systemic
embol i following AMI.
Previous studies have found the incidence of left ventri-
cular thrombus(CLOT)detected by two-dimensional echocar-
diography(2DE)following acute myocardial infarction(AMI)
to be 20%. To evaluate whether early systemic anticoagu-
lation reduces incidence of CLOT, 2DE were performed with-
in 12 hours of AMI in 53 patients(PTS)who had received an
infusion of intracoronary streptokinase(SKI)resulting in
systemic anticoagulation. Adequate 20E were obtained in
44/53 PTS. Right coronary occlusion was evident in 21
PTS, LAD occlusions in 13 PTS and circumflex occlusion in
10 PTS.
CLOT was detected by 2DE in 8 PTS(18%)each of whom had
vessel patency established following SKI. Of these PTS 7
had LAD occlusion and all had apical involvement of the
AMI. CLOT was detected as early as 4 hours following AMI.
PTS with CLOT had lower ejection fractions(0.51tO.07 vs
0.55tO. 14 p<O.OOI)however there was no difference in SKI
dose(337,500±101,350 units vs 292,460±68.690 p=NS) or time
from onset of AMI to SKI (297t55 min. vs 240±87 min. p=NS)
between the two groups. After a follow-up of 7±5 months
systemic embol i have not occurred in any PTS receiving SKI.
DOES INTRACORONARY STREPTOKINASE FOLLOWING ACUTE MYOCAR-
DIAL INFARCTION PREVENT LEFT VENTRICULAR THROMBUS FORMA-
TION?
Mark Friedman, MD,FACC, John Kalbfleisch, MD,FACC, David
Brewer, MD,FACC, Richard Slagle, MD,FACC, Charles McEntee,
MD, Loyal Conrad, MO,FACC, Henry Hawkins, MD,FACC, Saint
Francis Hosp. and Univ. of Okla. Tulsa ned ica l College,
Tulsa, OK.
ANGlO
63% (5/8)
67% (12/18)
45% (5/ll)
80% (12/15)
Sensitivity
Specificity
Positive Predictive Value
Negative Predictive Value
To assess: J) the diagnostic accuracy of two-dimensional echo-
cardiography (2DE) and standard single plane cineangiography
(ANGlO), and 2) the effect of anticoagulation therapy on preven-
tion of mural thrombi formation, we reviewed these studies
performed in 47 patients (pts) who underwent surgery for
aneurysmectomy or cardiac transplantation. 2DE in 37 pts and
ANGlO in 25 pts were analyzed independently by sets of 2
observers experienced in the respective methods and all 4
observers blinded to the pathological/surgical findings regarding
thrombus. Mural thrombus was present in 14 of 47 pts, with 11
of these 14 pts having intra-aneurysmal thrombus.
2DE
83% (10/12)
88% (22/25)
77% (10/13)
92% (22/24)
SERIAL ECHOCARDIOGRAPHIC EVALUATION OF MURAL
THROMBI
David J. Weinreich. MD, James F. Burke, MD, Ferrel Jo
Paulette, MD, The Lankenau Hospital, Philadelphia, PA
A key area of interest today is to identify a subgroup of
patients with acute myocardial infarction who are at risk for
systemic embolization. We studied a group of 42 patients with
acute myocardial infarctions and left ventricular thrombi as
identified by 2-D echocardiography. All but 2 of the patients
had anterior wall infarctions and all patients had apical
involve men t of the infarct. Surv ivors of infarction were
followed for a minimum of six months and a maximum of 38
months (mean 15 months). Anticoagulation was given to 57%
(24 of 42) of patients. Death occurred in 33% (14 of 42) of
patients. Embolization occurred in 7 patients who were not
anticoagulated--an incidence of 39% in this subgroup. None of
the 24 patients receiving anticoagulation had an embolic
event. All embolic events occurred within the first four
months of the infarction, even though 61% (17 of 28) of the
surviving patients had thrombus on follow up two-dimensional
echo study. Massive myocardial necrosis was not a pre-
requisite for thrombus formation; the mean left ventricular
ejection was 37% ! 1.6.
We conclude that: (I) two dimensional echocardiography can
identify a subgroup of anterior infarction patients at high risk
of systemic embolization, (2) embolization is unlikely to
occur if anticoagulation is employed, (3) continued
anticoagulation beyond a four month period is of uncertain
value, and (4) persistence of thrombus does not predict those
patients predisposed to embolic events.
SIGNIFICANCE OF INTRAOPERATIVE MYOCARDIAL ECHO INTENSITY
AS A SIGN OF OLD INFARCTION
Kenneth Franklin MD, Nathaniel Reichek MD, Erwin
Mermelstein MD, Joel S. Raichlen MD, Theodore Plappert,
Martin St. John Sutton MB FACC, Alden Harken MD FACC,
Cardiovascular Section, University of Pennsylvania,
Philadelphia, PA
Increased myocardial echo intensity (IME) may be a
useful.sign of old myocardial infarction. To determine
the significance of IME in a setting where high reso-
lution imaging of the entire left ventricular myocardium
is possible, we compared visually identified IME on open
chest two dimensional echocardiographic short-axis images
obtained during coronary surgery in 40 subjects to pre-
operative history of infarction (Hx), EKG Q waves,
angiographic and ventriculographic findings in a
prospective blinded manner. IME was found in 6/40
subjects (15%) and was associated with segmental akinesis
in 5/6 (83%) and hypokinesis in 1/6. All had EKG Q
waves, and a coronary occlusion in the area of IME, while
5/6 had Hx of infarction. In contrast, only 5/34 (15%)
subjects without IME also had Q waves, an occluded vessel
and Hx of infarction (p<.OOl). Without IME, akinesis was
present in only 10/34 (29%, p<.05). No subject with IME
and associated akinesis showed improved segmental func-
tion in that region after coronary bypass, while 5/10
with akinesis but no IME improved. We conclude that
visually identified IME ;s a specific but insensitive
sign of old infarction and a marker of irreversible
segmental dysfunction.
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mE NATURAL HISTORY OF REGIONAL DYSKINESIS IS A FUNCTION
OF EPICARDIAL COLLATERALIZATION IN TIlE INFARCTED CANINE
LEFT VENTRICLE
Edward F. Gibbons, MO; Thomas D. Franklin, PhD; Robert D.
Hogan, PhD; Mark Nolting, Arthur E. Weyman, MD, FACC;
Massachusetts General Hospital, Boston, MA
To examine the relationship of recovery of regional blood
flow within the MI zone in relation to cross-sectional
echocardiographic (CSE) wall motion abnormalities (WMA),
we performed serial CSE on 12 c l osed- ches t dogs at 0 time,
30 min, 48 hr, 1 wk, 3 wk, and 6 wks after acute coronary
ligation (5CCA, 3LAD, 4shams) . Radiolabelled microsphere
blood flows (BF) were obtained for each period and the
extent of infarction defined by histologic staining at
6 wks. WMA was defined as a de ficit in fractional holo-
systolic· Shortening along 36 r adii. Four dogs. Group A
(3LAD, lCCA) , had significant residual WMA and four,
Group B (4CCA), had no residual WMA (p 0.001), despite
equivalent ~-1A extent at 48 hr. Epicardial (epi) and
endocardial (endo) pieces from infarcted and non-infarc-
ted tissue were analyzed separately . Calculated BF for
time 0, 30 min, 48 hr and 1 wk were adjusted for scar
contraction using the correction factor CF - (t i me 0
flow of normal/time 0 flow of infarct). Group A epi BF
was significantly lower than that of Group B at 1 wk and
3 wks post MI (p 0.01). Since WMA correlates well with
reduced blood flow at all periods (r =0. 88) , we conclude
that epi collateralization determines the rate of re-
covery of regional dysfunction in the chronic canine
infarct .
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Hypertension: New Concepts of Therapy
THE EFFECTS OF HYPERTENSION AND PHYSICAL TRAINING ON
HEART MASS AND CORONARY FLOW
!~~~_M. Buttrick, MD: Thomas F. Schaible, PhD: James
Scheu er, MD, FACC, Hontefiore 'ledical Center-Albert
Einstein College of Uedicine, Bronx, N.Y.
The cardiac hypertrophy resulting from reno-vascular
hypertension has been associated with a diminished coro-
nary microvascular reserve. We reasoned that the super-
imposit ion of exercise-induced hypertrophy on this path-
ol ogi c s t a t e might further limit coro na ry fl ow. Four
gr oups o f female rats were studied : normotensi ve seden-
tary an imals (C): normotensive animals condi ti oned by an
8-10 wk swi mmi ng program (SIJ): sedentary animals made
hypertensive by c l i ppi ng th e left renal arter y (H) ; and
hypertensive swimmers (H-SIJ). Hearts wer e perfused in a
Langendorf apparatus at 120 ern H20 ao r ti c pr es sure and
paced a t 5 Hz. Aft er mea suring basal co ronary flow (CF),
maximal cor onary flow (MCF) was det ermined by perfusing
each heart under two conditions: 05% N2: 5% C02 as gas ; and
12rnM adenos ine (95 % 02: 5% C02)' Results are: (n=10- 12 in
each group: *p <0.05 vs . cop<0.05 vs. H) .
C Sw H H-Sw
BW 280 2 73 272 2'i""4
DHW 0.1530 0. 1800* 0.202* 0. 2500*
BP wkl/wk8 100/ 100 100/ 100 180*/ 181* 175*/ 161*0
Basal CF 78 80 72 51*0
MCF 1710 194*0 115* 120*
{BW=body weight (gm) ; DHW=dry heart weigh t (gm) : BP=blood
pressure ~ vivo (mmHg); CF=coronary fl ow (ml .gm DHW-l/
min) }. DHW increased 18% in SW, 32% in H, and 63% in H-Sw
relat ive to C. MCF probably reflect s the microvascular
capacity of the heart which is enhanced in exercise in-
duced hypertrophy and diminished in hypertensive hyper-
trophy. Exaggeration of hypertensive hypertrophy by super-
imposing exercise does not appear to worsen the micro-
vascular deficit.
TREATMENT OF MILD HYPERTENSION: THE POSSIBILITY OF
INTERMITTENT RATHER THAN CONTINUOUS THERAPY
Frank A. Finnerty, Jr., MD, FACC; The Washington Center
for Clinical Studies, Washington, DC
Previous studies from this clinic have demonstrated that
controlling the arterial pressure for 6 months frequently
permitted the use of fewer drugs in lower doses in the
majority of patients with moderately severe and severe
hypertension. Prompted by these observations, we began
in a stepwise fashion to reduce the dose of chlorthali-
done (mono therapy) and then discontinue it after the
diastolic pressure had been under 85 mm Hg for 6 months
in 67 patients with mild hypertension (diastolic between
90 and lOa mm Hg). These patients have now been followed
for a period of 48 months. Initially we found that a
daily dose o f 25 mg chlorthalidone was just as effective
as 50 mg in controlling the arterial pressure in all
patients, and it was not until the daily dose was reduced
to 12.5 mg that the arterial pressure increased in 8
patients. Annoying symptoms and metabolic side effects
were either decreased or eliminated. We were able to
discontinue chlorthalidone in 36 of the 67 patients.
The ability to discontinue therapy in these patients
at least as long as 48 months suggests the possibility
of intermittent rather than continuous lifelong therapy,
which gives the patient with mild hypertension a much
brighter outlook.
DECREASE I N SERUM TOTAL CHOLESTEROL CONCENTRATI ON AFTER A
CHANGE FROM CHLORTHALIDONE TO SPIRONOLACTONE IN THE TREAT-
MENT OF HYPERTENSION . Richard Ames, MD and Peter Peacock,
MD, American Health Foundation, New York, N. Y.
Treatment of hyperte~sion with thiazide-type diuret ic
drugs is ac companied by an increase in serum total choles-
terol. This mitigates the benefit of treatment on the
probability of developing coronary heart disease. To
ascertain whether a potass ium-spar ing diuretic has a
similar effect on cholesterol, we undertook a study in
which 23 hypertensive men showing an increase in choles-
terol after starting chlorthalidone (C) treatment were
randomized t o 2-4 months of spironolactone (S) or to
continued C t r ea t ment . Placebo therapy was eschewed so
t hat blood pressure (BP) control coul d be maintained.
Chol es t e r ol de creased 24 mg/dl i n t he 11 men placed
on S whereas i t decreased only 3 mg/dl i n the 12 men
remaining on C (p < 0. 05 by non-paired t test). On
switching back from S to C, chol este r ol increased 17
me/d l whereas it decreased 11 me/dl in the C group dur i ng
t he correspond i ng period of study (p < 0 . 01 ) . Fast ing
t r i gl ycer i de dec r eased during S therapy but di d not in-
crease on resuming C. Triglyceride did not cha nge in t he
C group. Weight increased 4 pounds, but BP remained
stable on S. Serum uric acid decreased and potass ium
increased on S t her apy , as expected. Both reverted on
resuming C. Fas ting glucose did not change t hr oughout
the study. Thus, a more favorable coronary risk profile
obtained during S than during C treatment. S may be
preferable t o thiazide-type diuret ics as first-line
therapy for uncomplicated hypertension.
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OUTPATIENT THERAPY OF ESSENTIAL HYPERTENSION WITH DIETARY
CALCIUM SUPPLEMENTATION. Lawrence M. Resnick, M.D.,
John P. Nicholson, M.D. and John H. Laragh, M.D., F.A.C.C.
Cardiovascular Center, Cornell Univ. Med. ColI., NY, NY.
Short-term oral calcium loading may lower blood pres-
sure in inpatient essential hypertensives under metabolic
balance conditions (Resnick & Laragh, 1983). To study the
long-term potential antihypertensive efficacy of oral
calcium therapy in outpatients, we measured diastolic
blood pressure (DBP) , serum ionized calcium (Ca), mag-
nesium, (Mg), plasma renin activity (PRA) , and 240 urinary
excretion of sodium (UNa), calcium (UCa), and aldosterone
(UAldo) before and after longer-term (av. 5 mo.) dietary
calcium supplementation with CaC03 2 Gm./d. in divided
doses given to 15 subjects with essential hypertension.
For the group, DBP fell only modestly (93!2 to 89!2
rnrnHg, p<O.05). However, patients whose diastolic blood
pressure fell >5% (97!2 to 87!2 mmHg, p<O.005, n=7) had
significantly lower initial Ca (2.25!O.04 vs. 2.38!O.02
mEq/l, p<O.Ol), higher initial Mg (1.99!0.04 vs. 1.83!0.03
mEq/l, p<0.05) and higher initial urinary Na (134!11 vs.
66!11 mEq/d, p<O,005) than did non-responders. Thus, the
%~DBP was directly related to the initial Ca (r=0.7l,
p<O.005) and inversely related to UNa (r=-0.66, p<0.02).
PRA rose (1.9!0.4 to 2.3!0.4 ng/ml/h, p<0.05), and Mg fell
(1.94!O.05 to 1.87!0.04 mEq/l, p<O.05) while UNa (108!11
vs. l08!14 mEq/d., p=NS) and UAldo (10.2!0.3 vs. 8.8!1.0
mcg/d., p=NS) did not change.
We conclude: 1) dietary calcium supplementation may be
an effective antihypertensive in some patients with es-
sential hypertension, 2) patients with lower serum ionized
calcium, higher magnesium levels, and greater sodium in-
take achieve the greatest hypotensive benefit, and 3) oral
calcium loading may blunt adrenal aldosterone responsive-
ness to elevations of PRA. These results suggest the im-
portance of calcium in the pathophysiology and therapy of
hypertension.
DURATION AND DIURNAL VARIATION OF THE HYPOTENSIVE
EFFECT OF ENALAPRIL IN PATIENTS WITH ESSENTIAL
HYPERTENSION.
Roderick I. Jones, MB, MRCP; Robert S. Hornung, MB,
MRCP; P.M.M. Cashman, BSc, PhD; E.B. Raftery, MD,
FACC; Dept. of Cardiology & Division of Clinical
Science, Northwick Park Hospital & Clinical
Research Centre, Harrow, Middx. England.
The Oxford system for ambulatory monitoring of
direct arterial blood pressure, was used to assess
the duration of the hypotensive effect of enalapril
(20-40 mg o.d.) in patients with essential
hypertension. Eighteen patients were recruited and
three later withdrawn. Blood pressure was reduced
for 24 hours although the effect was less during
the night. A within patient comparison of
consecutive mean hourly systolic and diastolic
blood pressure demonstrated a significant reduction
(p<0.05 - p<O.OOI) for eighteen of the twenty four
hours. Mean daytime intra-arterial pressure
(12.00-06.00 hrs) was reduced from 180 + 25.3/109 +
13.3 to 152 + 16.3/93 + 14.9 (p<o.OO: Separate
analysis of the two dosage regimens (20 mg o.d. n-6
and 40 mg o.d. n-9) revealed that the duration of
hypotensive effect was dose dependent. Three
patients demonstrated an increase in pressure in
response to enalaprU. There was an additional
orthostatic fall in blood pressure following head
up tUt 151 + 24.4/87 + 16.0 to 138 + 25.7/84 +
21.6 (p<O.OI-systolic irs diastolic). -Peak blood
pressure was significantly reduced during isometric
and dynamic exercise. In conclusion once daUy
enalapril may be an effective form of
antihypertensive treatment in selected patients.
STIMULATORY EFFECTS OF CLONIDINE ON BETA-ENDORPHIN IN
HYPERADRENERGIC HYPERTENSION
Stanley A. Tan. HOi Lee S. Berk, DHSc; Linda G. Tan, MD,
FACC, Lorna Linda University, Lorna Linda, California.
Clonidine releases immunoreactive B-endorohin (B-EP) from
brainstem slices of spontaneously hypertensive rats, but
not that of normal rats. B-EP has hypotensive effect and
may potentiate antihypertensive property of clonidine.
To assess possibility of B-EP release in human blood by
clonidine, 8 normal male and 9 hypertensive male subjects
were given clonidine. Plasma epinephrine (E), norepineph-
rine (NE) and B-EP were measured at baseline, Ih, 2h & 3h
after in~estion of 0.3 mg clonidine. E & NE were mea-
sured by IIPLC and B-EP by RIA. No significant drop in E
or NE, and no rise of B-EP were observed after clonidine
ingestion by normal subjects. 2 hypertensive subjects
who had elevated basal E & NE and 1 with elevated basal
NE showed NE and/or E drop after clonidine, and a delayed
but significant (P < 0.01) rise of B-EP 3h after clonidine.
The 3 subjects became normotensive with clonidine (0.1 mg
bid) theraoy alone. 5 hypertensive subjects who had nor-
mal basal E & NE showed slight drop in E & NE after clo-
nidine, but B-EP rise was not significant. These 5 sub-
jects did not respond to clonidine therapy alone, and re-
quired additional diuretic and/or beta blocker. One hy-
pertensive subject had elevated NE which was not suppres-
sed by clonidine, and his basal B-EP was higher than nor-
mal and dropped slightly after clonidine. He was found
to have pheochromocytoma. Thus in "central hyperadrener-
gic" hypertensive state (CHHS), clonidine can release
B-EP which may potentiate the antihypertensive property.
Measurement of B-EP during clonidine test can identify
the CHHS and predict effectiveness of clonidine therapy.
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Mechanisms of Antiarrhythmic Drug Effect
FLECAINIDE: UNUSUAL USE-DEPENDENT KINETICS
Richard L. Page, BS; Lawrence H. Frame, MD, FACC; Brian F.
Hoffman, MD, FACC, Department of Pharmacology, Columbia
New York, NY
Relative differences in use-dependent (UD) kinetics among
different drugs may playa role in antiarrythmic efficacy.
We studied the kinetics of the onset of and recovery from
UD depression of Vmax for flecainide (F, 2 ~g/ml). Stand-
ard microelectrode techniques were used to study canine
subendocardial Purkinje fibers, superfused with Tyrode's
(Kt-4.0 mM, pH-7.4, 3T!0.50C). Data were included only
from the trials in which impalements were maintained in
both control and F study (n-6). F caused a rate-
dependent depression of Vmax during steady pacing through
a range of cycle lengths(CL): (*p 0.05)
CL: 300 500 1000 2000 (mS)
1'Vmax: 43t3* 33t3* 19t3* 12t4* (mean!SEM)
At lower ~cing rates (7-10S), F caused no significant
change in Vmax vs control. FollOWing rest, pacing at CL
of 1000 and 500 mS caused the fibers to reach 63% of their
steady state depressions of Vmax after l6!2 beats andl3tl beats, respectively. To study UD recovery kinetics, a
test stimulus(S2) was introduced after a pause in steady
pacing (SI-S2-0.5-180S). The plot of recovery of Vmax vs
SI-S2 gave an exponential curve with the time constant of
28t4.0S. Conclusions: The clinical effects of F may
depend on its slow un kinetics. Specifically: 1) F shows
rate dependent depression of Vmax through physiologic CL;
2) Even with the "high therapeutic" concentrations of F
used, "tonic" effects are negligible; and 3) F shows UO
kinetics which are one to two orders of magnitude slower
than the principal class I antiarrhythmic drugs in
clinical use.
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APDt
13%
22%
18%
12%
o
in %
Kin
9%
21%
28%
19%
32%
factorContributing
Drug N R decrease ms ERP APDe/APDb
F 8 -62.6 + 6.9t 30% 48%
M 10 -62.3 + 4.5t 27% 30%
L 12 -55.8 + 5.4t 35% 9%
Q 14 -47.2 ~ 6.2t 35% 34%
PA 8 -28.7 + 9.2* 9% 59%
D decreased R by -14 ~ 11.5 ms (NS).
*p < 0.05 tp < 0.01
We conclude that antiarrhythmic drugs belonging to the same
class differ in their effect on the R of premature APD, and
On the mechanism which leads to the decreased APD R. There-
fore, different drugs are expected to create different
changes in the dispersion of repolarization inthe Purkinje
fibers.
EFFECT OF ANTIARRHYTHMIC DRUGS ON THE RANGE OF PREMATURE
ACTION POTENTIAL DURATIONS IN CARDIAC PURKINJE FIBERS
Andras Varro,MD; Victor Elharrar,PhD; Borys Surawicz, MD,
FACC; Krannert Institute of Cardiology, Indiana Uni versi ty
School of Medicine, Indianapolis, IN
Dispersion of repolarization is partly determined by the
range (R) of premature action potential durations (APD) dur-
ing impulse propagation. The prrpose of our study was to def-
ine the normal R of premature APD during first 100 ms after
effective refractory period (ERP) in dog Purkinje fibers and
the effect of 6 antiarrhythmic Class I drugs: flecainide (4
ug/rnl. (F), quinidine (5 ug/ml ) (Q), procainamide 30 IJg/ml (PA) ,
disopyramide 10 IJg/ml (D), lidocaine 4 ug/ml. (L), and mexile-
tine 4 ug/ml (M) on the R. The control R was 99.0+1.9ms (n=
59). Drugs decreased this Rby4 mechanisms: l)longer ERP;
2) greater ratio of earliest AID(APDe) to basic APD (APDt);
3) slower kinetics of restitution of APD (kin) , and 4) short-
er APDt. All drugs except Ddecreased the R significantly by
an average of 29-64%. The total decrease in R and the contri-
bution of individual factors for each drug were as follows:
LK+ +25%* +23%* + 6% + 7% +15%* +12%* + 5% + 6%
NK+ +36%* +31%* +17%* +12* +27%~ +42%* +13%* +28'i,~
Proloogaticn of APD am ERP after S was significantly re-
duced in all fibers in presence of W. S causes signi-
ficantly greater increase of refractoriness in the IZ as
canparErl to the NZ at ~, bJ.t not at W. AP amplitude,
max:ilnun upstroke velocity or conducticn velocity were not
significantly alterErl by S at both extracellular potas-
sium ccncentraticns. Ccnclusicns: In presence of lcM ex-
tracellular potassdum ccncentraticns associated with en-
hancErl susceptibity of the heart to arrhytltnias, the an-
tiarrhytl1nic class III properties of sotalol are markedly
reduced, 'Ibis effect appears to be IOC>re pronounced in
ischanically danagErl fibers as c~Erl to normal fibers.
DETERMINANTS OF ACTION POTENTIAL PROLONGATION
BY QUINIDINE. Dan M. Roden, MD, FACC and Brian F.
Hoffman, MD, FACC. Vanderbilt University, Nashville, TN
and Columbia University, New York, NY.
Fast sodium channel blockade in canine Purkinje fibers
typically causes shortening of action potential duration (APD)
presumably due to "window current" depression. However,
quinidine (Q) prolongs .APD despite depressing maximal phase
o upstroke slope (\lnax). We studied APD at 90%
repolarization during I Hz stimulation in canine Purkinje
fibers sUJ>erfused with Tyrode's (Ko=2.7 or 5 mM; Ca=2.7 mM;
T=37 ! 1 ; pH=7.35) both after prolonged stimulation ("steady-
state", APDss) and after pauses of 5-60 sec. In the absence ofQ, lowering KQ from 5 to 2.7 m~ increased APDss from 286 !
11 (x ! SE) to J02 ! 11 msec (6.4! 2.2%, n=2I, *p < 0.05). APD
prolongation immediately after a pause (as a % of APDss) was
linearly related to pause duration (slope .35 ! .03, r =.82, **p <
O.OOll at both KQ• With the resumption of 1 Hz stimulation
after pauses ~ 30 sec, APD returned to APDss in a mono-
exponential fashion (time constant (T, sec) 34.6 ! 3.9) in 8/11
experiments. A low concentration of Q (I 11M) prolonged
APDss 12.0 ! 4.0%* in Ko=5 mM and lowering Ko to 2.7 mM
further increased APDss 12.3 ± 2.7%*. Pause duration and
post-pause APD prolongation were still linearly related
(r=.83**) in the presence of Q, but the slope was increased (to
.81 ± .09**). Whereas a mono-exponential decline to APDss
was evident in the absence of drug, a bl-exponential fit (with
T=4.2 ± 2.1 and 40.7 ± 6.2) was now required in 14/19*
experiments. Q (111M) had no effect on .\lnax, but at 10 \.1M
the T for development of use-dependent \lnax depression was
4.6 ! 0.4 (n=12). Hence Q-induced APD prolongation was due
to (I) a "tonic" action additive with the effects of lowering
Ko' and (2) an action dependent on previous cycle length which
"as reversed with a T similar to that for the development of
'ohIax depression, suggesting that unblocking of the "window
current" contributed to APD changes at long cycle lengths.
INDUCTION OF EARLY AFTERDEPOLARIZA nONS BY LOW
CONCENTRA nONS OF QUINIDINE IN VITRO: RELAnON TO
CYCLE LENGTH AND POTASSiUM:"" DailM. Roden, MD,
FACC and Brian F. Hoffman, MD, FACC. Vanderbilt
University, Nashville, TN and Columbia University, NY, NY.
Arrhythmias and marked QT prolongation provoked by quinidine
(Q) often occur at low plasma Q, and characteristically are
unaccompanied by QRS widening, are worsened by slow heart
rates and low serum potassium (K), and are reversed by
increasing heart rate or administering K. We have therefore
assessed the e1ectrophysiologic effects of a range of Q
concentrations (0.1 - 10 \.1M = 0.03 - 3.0 IIg/mJ) in canine
Purkinje fibers in Tyrode's with low Ko (2.7 mM) over a range of
cycle lengths (CL, rnsec), Results (x ± SE):
Q (11M) 0 0.1 1.0 10
CL300: \lnax 585 ± 64 555! 69 543! 73 323 ± 46*
APD90 198 ± 4 206! 5 208! 6 214! 4*
CL2000: \max 620 ± 65 605 ± 74 598! 81 508 ± 62*
APD90 289 ± 10 315 ± 16 355 ± 21* 417 ± 42*
* P < 0.05 compared to no Q (analysis of variance)
~PD90: Action potential duration at 90% repolarization (rnsec)
'hlax: Maximum phase 0 upstroke slope (Vlsec)
At longer CL (> 4000, spontaneous or stimulated), Q produced
multiple early afterdepolarizations (EADs) in a concentration-
related fashion: 1/25 (4%) of fibers at baseline; 1/9 (II %) at
0.1 11M; 7/14 (50%) at 1.0 \.1M; 14/18 (78%) at 10 \.1M. EADs
were abolished by shortening CL, by raising Ko to 5 mM or by
adding tetrodotoxin (TTX, I IlM). TTX shortened APD90 more
at CL200g (17.6 ! 3.3%) than at CUOO (2.9 ! 3.1%), while
lowering 'hlax more at the shorter CL (22.6 ± 6.3% vs 15.0 ±
~.9%). In summary, Q-induced APD90 prolongation, unlike
'hlax depression, was present at low Q concentrations, was
most pronounced at long CL and was reversed by TTX. Low Q
concentrations also induced EADs at slow stimulation rates and
low Ko' These results may explain the development of adverse
effects at low plasma Q in some patients.
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THE USE OF BETA BLOCKING AGENTS AS ADJUNCT THERAPY IN
THE TREATMENT OF MALIGNANT VENTRICULAR ARRHYTHMIA
Geoffrey Hirsowitz, MD, Philip Podrid, MD, FACC, Steven
Lampert. MD. Joseph Stein, MD, Bernard Lewn, MD, FACC,
Harvard School of Public Health, Brigham and Women's
Hospital, Boston, MA
While beta blockers (BB) are effective in some patients
(PTs) with ventricular arrhythmia, little data exists
on their use as adjuncts to membrane stabiliZing drugs
(MS). Fifty pts were considered uncontrolled on MS by
ambulatory monitoring (MON) and 29 by exercise testing
(ET) due to ventricular tachycardia (VT), couplets (C)
or frequent VPBs of >30/hr for >12 hrs (F). PTs under-
went MON and ET on MSD or BB alone and the combination.
The following comparisons were made:.
MON MSD BB MSD & BB
50
1·38+0.5
4.16.0.8
7 66~1 .2*
11
4.36+1.9
9.09·2.7
14.72~2.7
50
1·56+0.4
6.90.0.9
12.46~1 .2
Number=
VT (hre)
CP (hra)
>30 VPBs/hr (hrs)
ET
Number= 29 8 29
VT (total) 1.03+0.3 2.50+1.53 0.07 +0.04*
CP (total) 3.79.2.1 4.25.' .63 0.89+0.8
VPBs 159.2~36.4 166.6~54.6 66.9~24.8
+=Standard error of the mean *·p<.05
MSD & BB by MON resulted in significant reduction in F
but not VT or C and with ET, was significantly reduced
(P<0.01). BB alone did not reduce F, Cor VT compared
to MSD alone. The combination hOwever had a significant
effect during ET by the abolition of VT in 91% of PTs. C
in 90% & 50% rsduction of F in 64%. Thus in PTs whose
arrhythmia is provoked by ET the addition of BB to MSD
has a salutary effect.
ELECTROPHYSIOLOGICAL STUDIES ON ANTIARRHYTHMIC ACTIVITY
OF TIMOLOL
E. Neil Moore, D.V.M., Ph.D., FACC and Joseph F. Spear,
Ph.D., FACC University of Pennsylvania, Philadelphia, PA
We determined if the decreased tncidence of sudden card-
iac death reported with Timolol(T) treatment results part-
ly from T ability to decrease cardiac arrhythmias.
Since no animal model alone can predict antiarrhythmic
activity we studied the electrophysiological effects of
T using different in vivo and in vitro models. T did not
alter action potential duratio~membrane potential, ac-
tion potential amplitude or maximum rate of depolariza-
tion of canine Purkinje fibers (PF) at T doses between
20 and 300 ug/ml. Only at 100 and 500 ug/ml did T alter
slow current activity in barium depolarized PF. Atrial,
bundle of His and ventricular electrograms were recorded
simultaneously with a lead II ECG and T administered in
doses between 6.25 and 1000 ug/ml. Atrial, ventricular
and His-Purkinje conduction times (CT) were not altered
even at lOx the beta blocking dose (1000 ug/kg). AV
nodal CT was increased with maximal increase in CT at
100 ug/ml. Neither AV block nor death occurred in any T
treated dog even at 1000 ug/kg. In contrast, propranolol
at similar lOx beta blocking dose (10 mg/kg) resulted in
completed heart block, severe myocardial depression and
death in 315 animals. The ventricular fibrillation thres-
hold was elevated in a dose related manner between 25
and 400 ug/ml. T also suppressed ventricular tachyar-
rhythmias initiated with programmed electrical stimula-
tion in 7 of 9 canine chronic myocardial infarction ani-
mals. We found that T has antiarrhythmic activity and
little myocardial depression even at lOx its beta
blocking dose.
*during programmed
stimulation
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Pharmacologic Management of
Ventricular Arrhythmias
DOES CESSATION OF ANTIARRHYTHMIC DRUGS RESULT IN
RECURRENCE OF VENTRICULAR TACHYCARDIA OR VENTRICULAR
FIBRILLATION IN LONG TERM SURVIVORS OF MALIGNANT
VENTRICULAR ARRHYTHMIA?
Thomas B. Graboys, MD, FACC, Edilson Almeida, M.D.,
Bernard Lawn MD. FACC Philip J. Podrid, MD. FACC,
Steven Lampert, MD, Harvard School of Public Health and
Brigham and Women's Hospital Boston MA
Since study of antiarrhythmic drug (AAD) efficacy in pa-
tients (PTs) with noninfarct related malignant ventricu-
lar arrhythmia (MVA) i.e. ventricular fibrillation (VF)
or hemodynamically compromising ventricular tachycardia
(VT), has not been either randomized or blinded, it is
possible that factors other than the AAD select for im-
proved survival. We have reported a mortality of only
2.6% annually in such AAD treated PTs. The endpoint of
therapy was abolition of paroxysms of VT during both am-
bUlatory ECG monitoring (MON) and exercise stress testing
(EST). In a group of 16 with MVA (13 males; average age
51·5 years; 12 with coronary or cardiomyopathic heart
disease), AAD were withdrawn an average of 29 months
(range 6 60) from initiation of drug therapy. Fifteen of
the 16 PTs (93.7%) exhibited recurrence of MVA as
detailed below,
MVA NO PTs.
V fibrillation 3
V. tachycardia (MON) 7
V. tachycardia (ET) 2
V. tachycardia (induced)* 3
Four of the 16 PTa died suddenly - all within three
months of either a change in original AAD or self termi-
nation of therapy. These data suggest that selected
antiarrhythmic drug, affords protection from recurrence
in MVA PTs and that changes or cessation of a proven drug
program results in high acute sudden fatality rate.
PROPHYLACTIC LIDOCAINE: MYOCARDIAL INFARCTIO:,
Heather M.Ounn MB, Janet M.Mccomb MD, Norman P.S.Campbell
MD, Robert G.Shanks MD, A.A.Jennifer Adgey MD, FACC.
Dept Cardiology, Royal Victoria Hospital, Belfast,Northern
Ireland.
In a double blind randomized trial of lidocaine (t) vs
placebo (p) 402 patients (pts) (286 male, 116 female,
mean age 56 yrs) were studied: 204 had had acute myo-
cardial infarction (mil. Within 2 hrs of the onset of
symptoms 207 (51%) pts were treated and 351(87%) within 4
hrs; 313 were treated outside hospital. None had an
initial heart rate ~50 bpm or >.110 bpm, 20 or 30AV block,
ventricular fibrillation (VF),sustained ventricular
tachycardia (VT), systolic BP~ 80 rnm.Hg, acute pulmonary
oedema or were on antiarrhythmic agents. Each pt
received either 300 mg t into the deltoid followed by
100 mg IV over 3 mins or p. All pts were assessed for
1 hr post-injection using continuous EKG monitoring. Of
pts with mi 108 received t and 96 p. Mean plasma t 10
mins post-injection was 3.3 ± so 1.8 ~g/ml and at 60 mins
3.5 ± so 1.9 ~g/ml. For those already on S-blocking
agents, plasma l levels were similar. VF occurred in 3
pts given p but in none given t. Sustained VT occurred
in 3 pts who had t. Heart rate >, 110 bpm occurred in 31
pts with t and in 20 with p. Systolic BP ~ 80 rnm.Hg
occurred in 7 pts with 2 and in 2 with p. Of the 4 pts
who died from asystole within the hr, 3 had had t and 1 ~
Although therapeutic plasma levels were reached a similar
incidence of VT and VF was found among those receiving t
or p, and 6% receiving t as against 2% with p became
hypotensive during the first hour of t.
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COMPARATIVE ELECTROPHYSIOLOGIC EFFECTS OF INTRAVENOUS ANO
ORAL PROCAINAMIOE IN PATIENTS WITH VENTRICULAR
TACHYCARDIA
Francis E. March1inski, MD, FACC; Joseph Vassallo, MD;
Alfred E. Buxton, MD, FAtt; Dennis M. Cassidy, MD; John
U. Doherty, MD; Harvey L. Waxman, MD, FACC; Mark E.
Josephson, MD, FACC, University of Pennsylvania,
Philadelphia, PA.
Thirty patients with sustained ventricular tachycardia
underwent e1ectrophysio1ogic testing after intravenous
(IP) and oral (OP) procainamide. Two groups were identi-
fied: Group I = 14 patients (pts) with serum concentra-
tion (C) after IP and OP within 3 mg/d1 and Group II = 16
pts with disparate C. C are expressed as mean ± SO in
units of mg/d1; NAPA = Nacety1 procainamide:
IP-C NAPA-C OP-C NAPA-C
Group I 9.0±2.4 1.2±.8 9.0±2.6 6.6±2.8
Group II 9.8±6.2 1.0±.5 14.3±5.5 9.9±5.9
In Group I, response to programmed stimulation was the
same after IP and OP with ventricular tachycardia
inducible in 9/14 pts. In Group II, 2/16 pts had no
inducible tachycardia after IP vs. to 4/16 pts after OP.
There was a discordant response to IP and OP in 0/14 pts
in Group I and 4/16 pts in Group II (p<.07). Regardless
of route, the effective procainamide C was> the ineffec-
tive C in 3/4 pts with a discordant response. The change
in ventricular refractoriness in Group I was similar
after IP and OP (+38±20 vs +36±22 msec), while in Group
II refractoriness was increased more after OP than IP
(+32±21 vs. +23±26, p=NS) and paralleled the difference
in procainamide C. We conclude l)IP closely predicts the
e1ectrophysio10gic effects of OP when similar serum Care
achieved; 2)NAPA contributes little to the e1ectrophysio-
logic effect of procainamide; and 3)the effect of OP
should be e1ectrophysio10gica11y tested if greater C of
procainamide can be achieved than after IP.
VARIABILITY OF NON-SUSTAINED VENTRICULAR TACHYCARDIA ON
AMBULATORY ECG RECORDING: RESULTS OF 3 DAYS OF AMBULATORY
ECG IN 113 PATIENTS WITH VENTRICULAR TACHYCARDIA
Craig M. Pratt, MD, FACC; Ann Wierman, PA-C; Don Slyman,
phD.; James B. Young, MD,FACC; Robert Roberts, MD, FACC,
Baylor College of Medicine, Houston, TX
Previous studies estimating percent(%) reduction in
episodes of ventricular tachycardia(VT) necessary to
infer treatment effect(Rx) rather than "spontaneous
variability" were based on small sample size(:;:20 patients
[pts]) using various methods of analysis of variance
(mixed-model vs random effects model). Since this is
important in planning clinical trials to assess anti-
arrhythmic therapy, we studied 113 pts with VT(mean l2±84
VT runs/hour, 80 ~,33 ~, mean age 59.4 yrs), 61 of which
had documented coronary artery disease(CAD). Three days
of contro1(C) ambulatory ECG recordings(AECG) and analy-
sis of variance (ANOVA) using 2-tai1ed criteria showed:
%REDUCTION VT REQUIRED FOR STATISTICAL DIFFERENCE(a<.05~
CONTROL PERIOD 1 DAy 3 DAYS 3 DAyS DAY
TREATMENT PERIOD 1 DAY 3 DAYS 7 DAYS 10 DAYS
1. All vT pts(n=113) 69.7% 49.8% 44.1% 39.3%
2. CAD pts(n=61) 61.0% 42.0% 36.9% 32.6%
3. All VT pts(n=113)
(I-tailed t) 62.5% 43.2% 38.0% 33.7%
4. Pts with
~10 runs/day 85.3% 67.0% 60.8% 55.2%
A slightly higher %reduction was necessary to infer Rx
effect in the group as a whole compared to previous
studies. The number of pts required to demonstrate Rx
effect decreased approximately 5% for each additional day
of monitoring. CAD pts appear to exhibit less vari-
ability. Importantly, 32 pts with> 10 runs VT/day exhib-
ited greater variability in VT and required greater %
reduction in VT to demonstrate a statistical difference.
ANTIFIBRILLATORY EFFECTS OF LIDOCAINE AND BRETYLIUM DUR-
ING CARDIAC ARREST AND CARDIOPULMONARY RESUSCITATION.
Moses S. S. Chow, PharmD; Jeffrey Kluger, MD, FACC: RObert
Lawrence, ASEE; Arnold Fieldman, MD, FACC, Hartford Hosp~
tal, Hartford, CT, and University of Connecticut, School
of Pharmacy, Storrs, CT.
The effects of intravenous lidocaine (2 mg/kg) and brety-
lium (5 mg/kg) on ventricular fibrillation threshold ~T)
were investigated in dogs undergoing conventional cardio-
pulmonary resuscitation (CPR) following induced ventricu-
lar fibrillation arrest. CPR was performed by a pneuma-
tic device set to compress the chest 60 times and inflate
the lung 12 times a minute. The compression force was ad-
justed to yield a diastolic arterial pressure of 30 mmHg
and the lung was inflated with an inspiratory pressure of
30 em H20 (with 100% O2), VFT was determined immediatelyfollowing a successful defibrillation by a train of elec-
trical stimuli delivered endocardially via a bipolar ca-
theter positioned at the right ventricular apex. The mean
VFT ± SD in ma at 5,10, and 15 minutes following initia-
tion of control-CPR (7 dogs), lidocaine-CPR (7 dogs), and
bretylium-CPR (5 dogs) are shown below:
Time Control-CPR Lidocaine-CPR Bretylium-CPR
-s-min 14.6 + 8.0 26.5 + 12.3* 22.4 + 20.8
10 min 18.9 + 8.1 23.9 + 8.3 38.54+ 27.2
15 min 17.4:;: 10.6 25.5:;: 9.6 62.1 :;: 25.7**
*p<.05 **p<0.005 when compared to Control~CPR
The results of the study indicate that a "standard" dose
of lidocaine rapidly increased VFT during CPR whereas
bretylium increased VFT by a greater magnitude but at a
later time than lidocaine. In view of the differences in
the potency and onset of action of these two drugs, lido-
caine and bretylium should be used concurrently during
CPR when antiarrhythmic therapy is indicated.
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Hypertrophic Cardiomyopathy
PULSED DOPPLER AORTIC FLOW-VELOCITY AND ECHOCARDIOGRAPHIC
FINDINGS IN OBSTRUCTIVE AND NONOBSTRUCTIVE HYPERTROPHIC
CARDIOMYOPATHY: EVIDENCE OF "TRUE" SUBAORTIC OBSTRUCTION
Barry J. Maron, MD, FACC, John S.Gottdiener, MD, Javier
Arce, MD, Yvonne E. Wesley, Stephen E.Epstein, MD, FACe,
NHLBI, Bethesda, Maryland
Many pts with hypertrophic cardiomypathy (HCM) demonst-
rate subaortic pressure gradients. Such gradients are
generally considered to represent an obstruction to LV
emptying; however, some have concluded that these grad-
ients do not constitute a true impedance to outflow but
are due only to early completion of LV ejection. To in-
vestigate this, pulsed doppler echo was performed in 37
pts with HeM (13 obstructive, 24 nonobstructive) and 20
normals. In pts with obstruction (obs) patterns of ascen-
ding aortic flow reflected initial rapid LV emptying fol-
lowed by mid-systolic impedance to outflow: aortic flow
decreased sharply after 50-75% of systole (84+4% stroke
volume ejected in first 1/2 of systole), concommitant
with marked mitral systolic anterior motion (SAM) and
also partial midsystolic aortic valve closure. Each pt
had evidence of continued aortic flow in the last 1/3 of
systole and prolonged systolic ejection time (381+8msec).
Pts without obs showed no impedance to LV outf10w~ Ejec-
tion time (303+5 msec; p<O.OOl) and aortic valve motion
were normal: SAM was absent. In 22 of 24 pts without obs
aortic flow was similar to normals (65+2% stroke volume
ejected in first 1/2 of systole) with flow continuous to
aortic valve closure. Hence, in HCM, 1) aortic f10w-ve1-
ocity patterns, mitral valve motion and ejection time
differ distinctly between pts with and pts without grad-
ient: 2) pts with gradient show rapid, early LV emptying
impeded in midsystole by marked SAM, 3) pts without
gradient usually show no impedance to LV ejection; 4)
these findings support the concept that pts with HeM and
subaortic gradients have "true" obstruction to LV outflow.
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MECHANISM OF SYSTOLIC ANTERIOR MOTION OF THE MITRAL
VALVE IN HYPERTROPHIC CARDIOMYOPATHY: THE PREVIOUSLY UN-
RECOGNIZED IMPORTANCE OF THE POSTERIOR MITRAL LEAFLET
Paulo Spirito, MD, Barry J.Maron, MD, NHLBI, Maryland
A substantial proportion of pts with hypertrophic card-
iomyopathy (HCM) show dynamic subaortic pressure grad-
ients due primarily to systolic anterior motion of the
mitral valve (SAM). However, the precise mechanism and
structures responsible for SAM remain controversial. With
two-dimensional echo we identified a variety of patterns
of SAM in 62 consecutive pts with HCM. In most pts (36,
or 58%), both anterior and posterior mitral leaflets
appeared to participate importantly in SAM, although the
anterior leaflet actually contacted or most closely ap-
proached the septum during systole because of its anter-
ior anatomic position. In a substantial proportion of pts
(19, or 31%), SAM Was produced selectively by the poster-
ior mitral leaflet. In only 6 pts (10%), did the anterior
leaflet alone move toward the septum in systole. In just
1 pt the chordae tendineae appeared to be primarily res-
ponsible for SAM. In most pts (51 or 82%), only the dis-
tal portion of the anterior or posterior leaflets pro-
duced SAM. In 9 pts both body and tip regions of the an-
terior leaflet produced SAM; subaortic gradients (average
95 mmHg) and SAM were most severe in these pts. Hence,
in obstructive HCM; 1) structures responsible for SAM
and subaortic obstruction are not identical in all pts
and a variety of patterns of SAM occur; 2) SAM produced
selectively by the anterior mitral leaflet or chordae
tendineae is uncommon; 3) SAM is usually produced primar-
ily by the distal segments of the mitral leaflets; and
4) the posterior mitral leaflet plays an important role
in SAM in almost 90% of pts, either by producing SAM
alone (31%) or by moving anteriorly in concert with
the anterior leaflet (58%).
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LASER MYOPLASTY FOR HYPERTROPHIC CARDIOMYOPATHY: INITIAL
IN-VIVO EXPERIENCE WITH A CANINE MODEL (TRANSARTERIAL)
AND HUMAN APPLICATION (INTRA-DPERATIVE)
Jeffrey M. Isner, MD, FACC; Richard H. Clarke, PhD; Natesa
G. Pandian, MD; Roberta F. Donaldson, BS; John G. Bonin,
BS; Edwin W. Lojeski, BA; Deeb N. Salem, MD, FACC; Marvin
A. Konstam, MD; Douglas D. Payne, MD; Richard J. Cleveland
MD, FACC, Tufts-New England Medical Center, Boston, MA
The feasibility of performing a myotomy/myectomy (MM) for
hypertrophic cardiomyopathy (HC) by means of laser (L)
phototherapy was evaluated in a series of canine experi-
ments and then applied to a human patient intra-operative-
ly. Our previous in-vitro experience demonstrated that the
focused beam of either the argon gas or carbon dioxide L
could both cut and vaporize myocardium producing a MM
morphologically similar to that produced by conventional
blade technique. Because optical fibers for a carbon di-
oxide L are not available, we used an argon L interfaced
with a 20Q~ fiber to perform a L myoplasty in 5 closed-
chested, anesthetized dogs. Although these dogs did not
have HC, they were used to determine the feasibility of
establishing contact between the fiber and ventricular
septum in a beating heart of sufficient duration to pro-
duce a MM, Using a specially designed guiding catheter,
the fiber was advanced under fluoroscopy to the septum
from the carotid (2 dogs) or femoral (3 dogs) artery. 2D
echo was then used to confirm fiber-septum contact. In 3/5
dogs, necropsy confirmed that a L myoplasty had been
achieved, including 1 dog electively sacrificed 7 days fol-
lowing the procedure. L myoplasty was then performed in-
tra-operatively in a patient with HC using a 200~ fiber
interfaced with an argon L. Measured L power was 1.5 watts;
cumulative exposure was <4 minutes; myoplasty trough
measured 4 x 1 x .5 em. Post-operative hemodynamic study
is pending. This initial in-vivo experience establishes
the feaSibility of L myoplasty for the treatment of HC.
INCREASED EXERCISE TOLERANCE BY VERAPAMIL IN HYPERTROPHIC
CARDIOMYOPATHY: RELATION TO ENHANCED LEFT VENTRICULAR
DIASTOLIC FILLING
Robert O. Bonow, MD, FACC, Vasken Dilsizian, MD, Douglas
R. Rosing, MD, FACC, Ulla Indanpaan-Heikkila, MD,
Stephen E. Epstein, MD, FACC, NHLBI, Bethesda, Maryland
Verapamil improves exercise tolerance and decreases symp-
toms in many patients (pts) with hypertrophic cardiomyo-
pathy (HCM). The mechanisms responsible for these effects
are not understood completely, although previous studies
indicate that verapamil enhances LV relaxation and dias-
tolic filling in such pts. To investigate the association
between changes in LV filling and exercise tolerance after
verapamil, we studied 43 HCM pts by radionuclide angio-
graphy and graded treadmill testing before and after 1-4
weeks of oral verapamil therapy, 320-480 mg per day. The
verapamil-induced increase in peak LV filling rate (PFR)
at rest (from 3.0+1.2 to 3.6+1.1 end-diastolic volume/sec,
p<.OOl) was assocIated with an increase in exercise
tolerance (from 5.9+3.9 to 9.0+5.0 min, p<.OOl): exercise
capacity increased In 28 of 32-pts manifesting an increase
in PFR but only 3 of 11 pts with unchanged or decreased
PFR (p<.OOl). This initial trend persisted in 18 pts
studied after 1 year of therapy: 10 of 11 pts with a per-
sistent increase in PFR had persistent improvement in ex-
ercise tolerance relative to pre-verapamil values, com-
pared to only 1 of 7 pts in whom PFR was unchanged or
decreased relative to pre-verapamil (p(.Ol). The short
and long-term changes in PFR also correlated with changes
in functional class (p<.OOl). Hence, verapamil-induced
changes in LV PFR were associated significantly with sub-
jective and objective symptomatic improvement. These data
indicate that enhanced LV diastolic filling is an import-
ant mechanism contributing to the clinical improvement
experienced by many HCM pts during verapamil therapy.
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HYPERTENSIVE HYPERDYNAMIC CARDIOMYOPATHY: A DIASTOLIC
DISORDER
Eric J. Topol, MD; Thomas A. Traill, MD; Nicholas J.
Fortuin, MD, The Johns Hopkins University, Baltimore, Md.
Echocardiographic features of secondary left ventricular
hypertrophy (LVH) have been described but their clinical
counterpart is ill-defined. We identified 21 hypertensive
patients by 2D echo cardiography with marked concentric
LVH (mean wall thickness 1.8tO.2cm), reduced end-diastolic
and end-sytolic cavity dimension (transverse dimension,
D, =3.6tO.4, 2.3tO.4cm respectively) and increased 2D
ejection fraction (79~4%). Other myopathic features were
delayed mitral valve opening (126t18msec after min D),
systolic anterior motion in 6, left atrial enlargement
(4.2tO.3cm). Digitized M-mode data include reduced peak
diastolic D increase (11t5cm/sec; nml=18t3, p<.Ol) and
protracted filling period (279t20msec; nml=160t50,p<0.01).
.However peak VCF was normal (3.3tl.4 sec-I, p=ns). Demo-
graphic data include mean age 73.3 yrs (59 - 91); 15/21
were black; 16/21 female; known to be hypertensive for
mean 8.2yrs (lmo - 20yrs). Mode of presentation was: con-
gestive heart failure in 9, stroke in 4, chest pain in 4,
hynertension in 3 and syncope in 1. There was marked
intolerance to vasodilators; 6/12 had severe hypotensive
response to nitrates, hydralazine, prazosin or captopril
including one death, while nine had dyspnea or chest pain
relieved by either beta or calcium channel blockade (sig-
nificant difference between treatments; p=0.019, Fisher's
exact). Thus a subset of hypertensive patients have a
clinical syndrome of excessive left ventricular emptying
and marked LVH characterized by: (1) predilection for
elderly black females (2) LVH out of proportion to length
or severity of hypertension (3) pulmonary congestion due
to abnormal left ventricular relaxation (4) marked intol-
erance to vasodilator drugs and (5) amelioration of
heart failure with negative inotropic agents.
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Exercise and Risk of Cardiovascular Events
EXERCISE TRAINING AFTER MYOCARDIAL INFARCTION: EFFECTS
ON SMOKnlG RATE
Craig B. Taylor, MD, William 1. Haskell, PhD, Nancy H.
Miller, BSN, Deborah Barnes, BA, Robert F. DeBusk, MD,
FACC, Stanford Univ. School of Medicine, Stanford, CA
Patients undergoing exercise training (TR) after myocar-
dial infarction (MI) are said to have a lower rate of
smoking than those who do not train. To evaluate this
issue, thiocyanate (T) was measured in 93 men aged 54±6
years 3, 11 and 26 weeks after clinically uncomplicated
Ill; T values >100 were equated with smoking (T+).
In the TR gro~p, 31/70 men (44%) reported smoking pre-III
of whom 10/31 (32%) had T+ at 26 weeks. In the no TR
group 15/23 (65~) patients reported smoking pre-MI of
whom 7/15 (47%) had T+ at 26 weeks (NS vs. TR group). Of
the 46 men who reported smoking pre-MI, 20%, 28% and 37%
had T+ at 3, 11 and 26 weeks respectively. Participants
in the TR trial were advised by a physician and nurse
of the risk of smoking, were urged to quit and were
given written materials to assist them in quitting.
Adherence to TR was significantly lower in former smokers
who continued to smoke post-MI than in those who quit
(p< 0.05). Self-report smoking data were available in an
additional 60 men; in the entire group of 153 men those
who reported smoking or had T+ at 3, 11 or 26 weeks had a
rate of infarction, death and coronary surgery within 6
months which was significantly higher (13%, 7/55) than
former smokers who were not smoking at these times (6%,
2/36) or nonsmokers (5%, 3/62)(p < 0.05 for both compari-
sons). CONCLUSIONS: 1) Recidivism was lower in patients
undergoing training than in those who did not train. 2)
Even within this low risk population, smoking adversely
affected prognosis. 3) Intervention specifically
targeted on smoking behavior, especially at 3 weeks,
appears necessary to diminish smoking after MI.
THE EFFECT OF EXERCISE INTENSITY ON THE ACUTE RESPONSE OF
HDL AND THE HDL SUBFRACTIONS. William P. Follansbee, MD,
FACC; Judith E. Orie, MD; Peter S. Rahko, MD; Edward I.
Curtiss, MD, FACC; Edward J. Sinkule, MS; and Ronald E.
LaPorte, PhD. University of Pittsburgh, Pittsburgh, PA.
It is known that regular exercise is associated with an
increase in HDL cholesterol, but the effect of intensity
of exercise has not been established. We exercised 10
sedentary, non-smoking, fasting males (ages, mean ± SD:
31.9 + 3.1 years) on a treadmill for 20 minutes on 3 dif-
ferent occasions at increasing levels of exercise. Serum
cholesterol, total HDL cholesterol (HDL-C) and HDL sub-
fractions 2 (HDL2) and 3 (HDL3) were measured before
exercise and 4 hours post exercise.
The peak heart rates achieved at the three levels of
exercise were significantly different (level I, 49 ± 7% of
predicted maximum, level 2, 68 ± 8% and level 3, 89 ± 7%) .
HDL-C 3nd HDL3 were both significantly increased post ex-
ercise at level 1 (HDL-C 46.3+6.5 mg/dl to 48.5±7.6,
p<O.Ol; HDL3 35.9±3.9 mg/dl-to 38.4±4.4, p<0.005) and
at level 3 (HDL-C 46.2+8.2 to 49.2+9.6, p<0.03; HDL3
36.4 + 5.1 to 41. 3 + 6.1;- p < 0.02) • They increased similar-
ly d~ring exercis;level 2 but these differences were not
statistically significant (HDL-C 45.5±6.6 to 47.52:7.9;
HDL3 34.8+3.4 to 36.4+3.0. There were no significant
changes in either HDL2-or total cholesterol at any exer-
cise level. Analysis of variance determined that there
was no significant difference in the respective increases
in either HDL-C or HDL3 at the three different exercise
levels.
We conclude that in sedentary males, HDL-C increases
after individual periods of exercise. This increase is
due to an increase in HDL3. HDL2 does not significantly
change. It appears that these increases in HDL-C and HDL3
are not primarily related to the intensity of the exercise.
EXERCISE-RELATED SUDDEN DEATH IN 27 CONDITIONED
SUBJECTS AGED <30 AND >30 YEARS: CORONARY ARTERY
ABNORMALITIES ARE THE CULPRIT
Bruce F. Waller,MD,FACC,Patricia Newhouse,MD,John
Pless,MD,Lee Foster,MD,Edward Wills,MD,Indi~na
University Medical Center,Indianapolis, Indlana
Cardiovascular(CV) deaths associated with vigor-
ous exercise are being reported with increasing
frequency.Little attention,however, has focused
on CV abnormalities(abn) observed in ~(~30yr)
compared to 01der(>30yr)conditioned subjects(CS).
Thus, we studied the hearts of 27 CS with exer-
cise-related sudden death(SD):17 aged l3-29yr
(mean(m)=20)(14males),and 10 aged 37-65yr(m=48)
(lOmen).Of the 27 CS,16(59%)were competative
athletes at highschool,colleage,or professional
levels. The remaining 11 CS exercised regularly
for several yr before SD. Of the~ CS, CV
abn were found in l5(88%):LVH=6,I~,congenital
coronary anomaly=2,floppy mitral valve=2,Ebstein
tricuspid valve=l.Only 2(12%)hearts were normal.
Of the 10 older CS, all were runners, running 1-
55miles/week for 1-12 yr. All 10 had at least 1
major coronary artery narrowed 76-100% in cross-
sectional area by atherosclerotic plaque, and 6
had myocardial infarcts(clinically silent events
in 5).Of the total 27 CS with exercise-related
SD, 25(93%) had at least one CV abn at necropsy:
12(48%) coronary arterial(congenital or acquired)
10(40%) myocardial; and 3(12%) valvular. Only
2(7%) CS had normal hearts. Thus, of conditioned
subjects with exercise-related SD, coronary
artery abnormalities are the major killer.
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SPORTSRELATEDSUDDEN DEATH IN YOUNG PERSONS
H.L. Kennedl' M.D., F.A.C.C., J.A. Whitlock, B.S.; Division of
Cardiology, t, Louis University Medical Center, St. Louis, Mo.
Active sports participation is feared as a precipitating mechan-
ism of sudden death (SO)in young persons with known (K) or
unknown(Unk) cardiovascular disease (CVD). To examine the
incidence of sports related sudden death (SRSD), we reviewed the
death certificates 000%), autopsy reports (64%), medical
examiner case investigations (100%), and personal medical history
(100%) of 220 total SO of persons aged 1 to .50 years occurring
during 1981 and 1982 in an urban (St. Louis County) population. A
total of 11 SRSD occurred during or immediately after cessation
of the activity. Activities included basketball (3), racketball (3),
jogging (2), football (1), soccer (1), and golf (1). Documented
pathologic evidence showed:
AGE TOTAL TOTAL CVD DOCUMENTED
-- SO SRSD K UNK CAD HCM CAA UNK
1-9 13 -0- "0-0- --0---0---0- --0-
10-19 13 3 0 3 0 2 0 1
20-29 24 1 0 1 0 0 I 0
30-39 .51 4 0 4 4 0 0 0
40-49 119 3 1 Q 3 0 0 0
TOTAL no n 3 8 '7 2' T T
CAD=coronary artery disease; HCM=Hypertrophic
Cardiomyopathy; CAA=Coronary Artery Anomaly
Thus, SRSD in young persons was found
I) to account for .5% (11/220) of all SO.
2) most commonly occurred in persons over 30 yrs of age, in
whom .50% were known to have CAD. and
3) when it occurred under 30 yrs of age was related to HCM or
CAA.
EXERCISE AFTER MYOCARDIAL INFARCTION REDUCES MORTALITY:
EVIDENCE FROM RANDOMISED CONTROLLED TRIALS (RCTs).
Rory Collins, MBBS; Salim Yusuf, DPhil; Richard Peto,Msc;
Cardiac Department"John Radcliffe Hospital, Oxford, UK.
Since the RCTs of exercise rehabilitation have been too
small to detect moderate (but still important) reductions
in mortality, we have pooled data from all available
RCTs, using retrospective stratification to calculate the
pooled odds ratio (POR) and 95\ confidence interval (CI)
for mortality and non-fatal re"infarction.
Exercise Control Exercise group deaths
MORTALITY group group O-E Variance
Rehabilitation started within 3 months of index MI
Kentala 32/98 35/105 -0.3 11.3
Sanne 28/158 35/157 -3.6 12.6
Kallio 41/188 56/187 -7.6 18.0
Carson 12/151 21/152 -4.4 7.4
Vermeulen 2/47 5/51 -1.4 1.6
Sub-total 115/642 (18\) 152/652 (23%) -17.4 50.9
POR: 0.71; 95\ CI: 0.54 to 0.94; 0.01<2P<0.05
Rehabilitation started up to 36 months after index MI
NEHDP 15/323 24/328 -4.4 9.2
E-HCS 36/379 26/354 +3.9 14.2
Sub-total 51/702 (7\) 50/682 (7\) -0.4 23.4
POR: 0.98; 95\ CI: 0.66 to 1.47; NS
Overall 166/1344(12\) 202/1334(15\) -17.8 74.3
POR: 0.79; 95\ CI: 0.63 to 0.99; 0.01<2P<0.05
INFARCTION: 134/1344 (10\) 116/1334 (9\)
POR: 1.2; 95\ CI: 0.89 to 1.5; NS
Conclusions: Exercise rehabilitation may reduce mortality
by about 20\, particularly if started early after MI.
There is, however, a small (non-significant) excess of
non-fatal reinfarctions in the exercise group. Reliable
demonstration of this worthwhile benefit might require
the randomisation of 5-10,000 patients between early
exercise and control.
ATHEROSCLEROSIS RISK FACTORS AND PHYSICAL FITNESS IN
ADOLESCENT MALES. Raymond R. Fripp, MD. FACC; Robert B.
Winter; James L. Hodgson, PhD; Peter O. Kwiterovich. MD;
John C. Werner, tID, FACC; Victor Whitman. MD. M. S.
Hershey Med. Ctr .• Penn State University, Hershey. PA
In order to define the relationship between atherosclero-
sis risk factors and physical fitness in a population
where atherosclerosis begins and progresses. we evaluated
37 male adolescents (mean age 15.4 yrs). Risk factors
included weight, body mass index (BMI), resting heart
rate (RR) and resting systolic and diastolic blood pres-
sure (SBP, DBP), and blood lipids [total cholesterol
(TCHL). total triglyceride (TGL) , high density lipopro-
tein cholesterol (HDL-C). low density lipoprotein choles-
terol (LDL-C) and low density lipoprotein B (LDL-B)].
Physical fitness was determined by maximal treadmill test
with measurements of KV02, exercise duration (ED). and
maximum heart rate (tmR). Statistical analysis was by
linear and multiple linear regression. TGL was negative-
ly related to both ED (p<O.OI) and to KVOZ (p<O.05). HDL-
C and HDL-C/TCHL were both positively associated with ED
(p<O.05). BMI and weight were negatively related to both
ED and KVOZ (p<O.Ol). A negatiye association existed be-
tween SBP and ED (p<O.OI) and MVOZ (p<O.05) as well as
between DBP and ED and MVOZ (p<O.OI). Multiple linear
regression, using HDL-C or TGL as the dependent variable
and ED, BMI and weight the independent variables, re-
vealed that weight was the variable most strongly associ-
ated with either lipid. The associations shown in this
report have been noted in adult studies and indicate that
physical fitness and anthropometric measurements relate
to atherosclerotic risk factors in a similar manner in
both adolescents and adults. Further studies will de-
termine whether improved aerobic physical fitness modi-
fies these risk factors.
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Signal Averaging and Ventricular Arrhythmias
IDENTIFICATION OF PATIENTS WITH VENTRICULAR TACHYCARDIA
AFTER MYOCARDIAL INFARCTION FROM THE SIGNAL AVERAGED
ELECTROCARDIOGRAM
Michael B. Simson, MDf FACC; Rita A. Falcone, MS; CarolA. Dresden, MS; Mark. Josephson, MD, fACC; Hospital of
the University of Pennsylvania, Philadelphia, PA
We examined different test criteria in order to find
those which identified patients (pts) with ventricular
tachycardia (VT) after transmural myocardial infarction
(MI) with the highest sensitivity and specificity. We
studied 42 normal volunteers, 52 pts (No VT-HI) with MI
>10 days old and with <200 premature ventricular beats
and no complex ventricular ectopy on 24 hour Holter
monitoring, and 82 pts (VT-HI) with inducible and sus-
tained VT after MI. No pt had bundle branch block. A sig-
nal averaged ECG was recorded and processed with a bidi-
rectional filter at 25 and 40 Hz. Filtered QRS duration,
voltage in the last 20-60 msec of the QRS, and the dura-
tion the voltage was <10-50 ~v at the end of the QRS
were studied. Results: At 40 Hz the best criteria were
(A) the filter~durationwas >110 msec, (B) the late
QRS voltage remained under 40 ~v for >40 mset, (C) the
voltage in the last 40 msec was <15 ~v , and (D) a com-
bination of filtered QRS duration >110 msec and voltage
in the last 40 mset < 20 ~v. The percent of each group
correctly clasaified was: overall
criterion Normal No VT-HI VT-HI accuracy
A 97.6~ 88.5~ 84.2% 88.6%
8 100~ 90.4% 70.7% 83.5~
C 97.6~ 88.5% 72.0% 83.0%
D 100~ 90.9% 82.9~ 89.2%
Filtering at 25 Hz gave similar accuracy within 1%.
Conclusions: pts with VT post MI can be identified with
high senaitivity and specificity. A combination of the
filtered QRS duration and voltage meaaurement in the last
40 maec offers the highest overall accuracy.
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NON-INVASIVE DETECTION OF ARRHYTHMOGENIC LATE DIASTOLIC
POTENTIALS IN PATIENTS WITH SUSTAINED VENTRICULAR
TACHYCARDIA OR FIBRILLATION
Michael Oeff,MDI Enz-R.v.Leitner.MDI Sergio Erne.PhD;
H.-D.Hahlbohm.PhDI H,P.Lehmann,PhD
Dept.of Cardiology. Klinikum Steglitz. Freie Univer.it~t
Berlin and Phys.Techn.Bundesanstalt. Inst.Berlin.
Fed,Rep.Germany
Until now in 8 p.tients (pts) with a history of sust-
.ined ventricul.r tachycardiA (VT.n-~) or fibrillation
(VF,n-3) be.t-to-be.t registration of the high-reso-
lution ECB from the body surface and left ventricular
endoc.rdi.1 mapping were performed. The body surface
registr.tion w.s m.de in the Berlin magnetically shiel-
ded room in which together with an appropriate electro-
nic system the tot.l noise w.s reduced to the pts in-
trinsic noise, Left ventricul'r endoc.rdi.l m.pping w.s
performed sep.rately from.t least 8 sites using an
electrode catheter with an interelectrode distance of 1
cm,
In 6/8 pts l.te di.stolic potentials .fter the T-wave
're detected with the endocardial mapping technique.
Beat-to-be.t registr.tion from the body surface revealed
simil.r sign.ls in 4 of the. too. Their .mplitude was up
to 60 uV, Morphology .nd time rel.tionship to the pre-
ceeding QRS-complex showed rem.rc.ble differences from
be.t to be.t,
In 2 pts ventricular prem.ture beats occurred during
body surface recording, They .lw.ys .rose from the l.te
diastolic potenti.ls thus suggesting their .rrhythmo-
genic nature,
CONCLUSION, Using high resolution be.t-to-be.t recording
in p.tients with • history of sust.ined VT/VF l.te
diastolic potenti.ls could be detected non-inv.sively.
These ..y represent. new m.rker for .align.nt ventri-
cular .rrhythmias,
SUPERIORITY OF HIGH RESOLUTION ECG TO 24 HOUR
MONITORING TO PREDICT PROGNOSIS IN POST
MYOCARDIAL INFARCTION PATIENTS
Enz-R.von Leitner.MD; Michael Oeff,MD; Christoph
Spielberg,MD; Dieter Gast,MD; Dorothea LoocK,MD;
Claudia PiesczeK,MD; Barbara Jahns,MD; Kl iniKum
St.gl itz, Freie Universitit Berl in, Germany
The aim of this study was to evaluate the pro-
gnostic significance of delayed depolarizations
in the ST-segment<DD) and to compare these
findings to the results of 24 hour monitoring.
METHODS: 518 survivors of myocardial infarction
w.r. studied 2 months after the acute event.
High resolution ECG was recorded from the bodY
surface <gain 10000 to 25000 fold, band pass
filt.ring 100-300 Hz at 6 dB/oct.) using a
Princ.ton 4202 signal averager. 24 hour Holter
monitoring was performed using a R.ynolds
Pathfind.r system. Th. patients <pts.) were
follow.d for a m.an of 13 months.
RESULTS: 110/518 patients <21,5%) had DO, 88
<17%)had v.ntricular pairs, and 73<14%) had
v.ntricular tachycardias<)2 VPB in a row) during
24 hour monitoring<VP/VT). During follow up 19
pt •. di.d of cardiac cau•••. 9 of th.se had DO,
and 8 had VP/vT, 2 had both. Th. pr.dictive
value of DO was 7,4%, 5% for VP/VT and 5% for
00 and/or VP/VT. Pts. without 00 had a lower
mortal ity than tho.e without VP/vT <2,2 vs.~/').
CONCLUSION, In the chronic stag. of myocardial
infarction the high r ••olution ECG allows b.tt.r
pr.diction of the progno.i. than 24 hour Holt.r
monitoring, In the individual pati.nt, how.v.r,
the pr.dictive value of both m.thods i. too low
to draw definite conclusions,
HIGH FREQUENCY SIGNAL AMPLITUDE IN THE EARLY AND MIDDLE
QRS IN PATIENTS WITH AND WITHOUT VENTRICULAR TACHYCARDIA
Michael G. Kienzle, MD; Rita A. Falcone, MS; Mark E.
Josephson, MD, FAtt; Michael B. Simson, MD, FACC,
University of Pennsylvania, Philadelphia, PA,
Patients with ventricular tachycardia (VT) after myo-
cardial infarction often have high frequency, low level
late potentials at the end of the signal-averaged QRS.
The characteristics of the initial and mid-portion of the
QRS have not been described in patients with VT. Signal
averaged ECGs recorded from bipolar X, Y, Z leads were
processed with a bidirectional filter at 40 Hz. QRS
duration and root mean squared amplitude in the first 40
and 80 msec were obtained in 42 normal volunteers, 61
patients with anterior (A) infarction (33 with sustained
VT) and 37 patients with inferior (I) infarction (13 with
VT). Angiographic ejection fraction was performed in 53
patients.
Duration Amplitude (~V)
Group (msec) First 40 First 80
Normal 96±9 86±3 85±28
A-No VT 93±14 71±28** 68±23** .50±.16
I-No VT 100±11** 72±26** 76±21 .59±.13
A-VT 140±34* 38±12* 51±13* .35±.17*
I-VT 138±24* 44±12* 55±18* .38±.09*
*p<.005, VT vs all other. ** p<.05 vs normal. Values are
mean ± standard deviat ion.
The ejection fraction correlated weakly with amplitude at
40 msec (r=0.47) and 80 msec (r=0.13). We conclude: l)QRS
duration by signal averaged ECG is longer in patients
with VT. 2)The high frequency amplitude measured in the
first 40 and 80 msec decreases significantly after
infarction. 3)Early high frequency signal amplitude is
significantly lower in patients with VT and may be
another marker for VT.
COMPARISON OF VENTRICULAR ACTIVATION TIMES OBTAINED
BY SIGNAL AVERAGED ECG AND EPICARDIAL MAPPING
A.R. Denniss FRACP, D.L. Ross FRACP, FACC, D.C. Johnson
FRACS, G. Nunn FRACS, J.B.Uther FRACP, Westmead Centre,
Westmead, Australia.
Delayed ventricular activation potentials (DP) detected by
signal averaged surface ECG can predict patients with myo-
cardial infarction (MI) who are prone to spontaneous vent-
ricular tachycardia (VT).
This study compared ventricular activation times (VAT) and
DP detection obtained by computer signal averaging of 350-
450 beats of the Frank vectorcardiogram (VCG) with meaS-
urements obtained at epicardial mapping (EM) of 25 vent-
ricular sites (1000 gain).
Thirty-nine patients with previous MI (49% anterior) were
studied. DP were defined as potentials >140ms after QRS
onset. VAT was measured from QRS onset to offset of latest
ventricular activation (including DP if present) .
Results: DP on VCG No DP on VCG
-----oF at EM 22 8
No DP at EM 0 9
VCG detected DP in 22/30 patients with DP at EM. Mean
sites of DP per patient at EM was 9.0±4.2 (SEM)for the 22
concordant patients versus 4.4±2.3 for the 8 discordant
patients (p<0.005) all of whom had inferior MI. VAT in the
concordant group with DP was 199±16ms at EM and 167±17ms
on VCG (p<O.Ol).
In the 9 patients with no DP at VCG or EM,VAT was 111±16ms
at EM and 118±9ms on VCG (NS).
Conclusions:
1. EM is more sensitive at detecting OP than VCG, which
might miss small areas of DP with inferior MI.
2. VCG underestimates VAT by 30ms in patients with DP at
EM and VCG.
3. VCG does not detect DP in absence of DP at EM.
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LATE POTENTIALS IN ANTERIOR VERSUS INFERIOR MYOCARDIAL
INFARCTION
Michael B. Simson, MD, FACC; Rita A. Falcone, MS; Carol
A. bresden, HS; Hark E. Josephson, MD, FACC; Hospital of
the University of Pennsylvania, Philadelphia, PA
Late potentials appear to be due to delayed and asyn-
chronous ventricular activation. Since the inferior and
bssal portions of the heart are activated last, late po-
tentials would be expected to have a longer duration and
be more easily recorded after inferior myocardial infarc-
tion (IMI) than after anterior MI (AMI). We compared the
signal averaged ECG (40 Hz bidirectional filtering) in 5
groups of patients (pts): 42 normal volunteers; pts with
sustained and inducible ventricular tachycardia (VT)
after MI,"VT-AMI" (39 pt s) and "VT-IMI" (43 pts); pts
with no complex ventricular arrhythmias after MI, "No VT-
AMI" (24 pts) and "No VT -IMI" (28 pts). Results: The
filtered QRS duration was similar for normal (96=9
msec), the No VT-AMI (93+14 msec) and the No VT-IMI
(100+11 msec) groups (p=NS). The filtered QRS duration
was Tonger (p<0.001) in both VT groups, but there was no
difference between VT-AMI (136+30 msec) and VT-IMI (136
+22 msee, p=NS). The voltage in the last 40 msec of the
7iltered QRS was lower in groups with IMI. (No VT-IMI,
29+17 ~v vs No VT-AMI, 46+34 ~v, p=0.01; VT-IMI,
10+7 ~ v vs VT-AMI, 14+14 pv, p=.03). VT pts had a
lower amplitude than pts without VT (p<0.001). The dura-
tion the voltage remained under 40 ~ v was similar in both
VT groups (VT-IMI, 60+19 vs VT-AMI, 53+29 maec) and
was longer (p<.001) ftJr VT groups as compared to others
(normal, 29+7; No VT-IMI, 31+10; No VT-AMI, 27+12
msec). We conclude the filtered QRS duration is similar
in VT pts with AMI and IMI. There is a lower amplitude
of high frequency voltage late in the QRS complex in pts
with IMI, both with and without VT. The duration of the
late potential is similar in VT pts with IMI and AMI.
